October 22-26, 2012 - TCT Conference

TCT2012 

program 

October 22-26, 2012 

miami Beach Convention Center · miami, Fl 

www.tctconference.com 

The World’s Premier inTervenTional exPerienCe

Resolute Integrity 

ZOTAROLIMUS-ELUTING CORONARY STENT SYSTEM

* Based on bench test data on file at Medtronic, Inc. 

† Per the Resolute Integrity DES Indications for Use.

Indications 

The Resolute Integrity Zotarolimus-Eluting Coronary Stent System is indicated for improving coronary luminal 

diameters in patients, including those with diabetes mellitus, with symptomatic ischemic heart disease due to de 

novo lesions of length ≤ 27 mm in native coronary arteries with reference vessel diameters of 2.25 mm to 

4.20 mm. 

Contraindications 

�� 

known hypersensitivity or allergies to aspirin, heparin, bivalirudin, clopidogrel, prasugrel, ticagrelor, ticlopidine, 

drugs such as zotarolimus, tacrolimus, sirolimus, everolimus or similar drugs or any other analogue or derivative 

�� 

�� ® polymer or its individual components 

�� 

�� 

angioplasty balloon or proper placement of the stent or stent delivery system 

Warnings 

�� 

�� 

stent implantation procedures, which include subacute and late vessel thrombosis, vascular complications 

�� 

recommended antiplatelet therapy. 

Precautions 

�� 

placement should only be performed at hospitals where emergency coronary artery bypass graft surgery can 

�� 

�� 

�� 

of the stent implantation should be assessed for patients with a history of severe reaction to contrast agents. 

�� 

��Indications for Use, patient outcomes may differ from the results observed in 

��Indications for Use,�� 

patients and lesions outside of the labeled indications, including more tortuous anatomy, may have an increased 

�� 

Care should be taken to control the position of the guide catheter tip during stent delivery, deployment, and 

�� 

�� 

�� 

�� 

�� 

The safety and effectiveness of the Resolute Integrity stent have not yet been established in the following 

�� 

�� 

�� 

�� 

�� 

�� 

�� 

�� 

�� 

�� 

2 

MANDARIN ORIENTAL 

TIME WARNER CENTER 

80 COLUMBUS CIRCLE 

NEW YORK, NY 

�� 

with longer than 24 months of follow-up 

The safety and effectiveness of the Resolute Integrity stent have not been established in the cerebral, carotid or 

peripheral vasculature. 

Potential Adverse Events 

�� 

�� 

�� 

�� 

�� 

�� 

�� 

�� 

�� 

�� 

�� 

�� 

Adverse Events Related to Zotarolimus 

�� 

�� 

�� 

�� 

�� 

��Instructions for Use for more information regarding indications, warnings, 

precautions and potential adverse events. 

CAUTION:�� 

�� 

at the toll-free numbers or websites listed. 

www.medtronic.com 

www.medtronicstents.com 

Medtronic, Inc. 

�� 

�� 

�� 

Tel: 707.525.0111 

LifeLine Customer Support 

�� 

�� 

Product Services 

�� 

�� 

SAVE THE DATE FOR 2012 

HONORING THE 

AMERICAN COLLEGE OF CARDIOLOGY 

AND SPECIAL GUESTS 

FRIDAY, DECEMBER 14, 2012 · 6:30 PM 

Cocktails, Dinner, and Dancing 

FOR MORE INFORMATION, 

PLEASE CONTACT IRMA DAMHUIS 

AT 646-434-4690 

OR IDAMHUIS@CRF.ORG. 

Trademarks may be registered and are the property of their respective owners. 

��

The World’s Premier Interventional Experience 


TranscaTheTer 

cardiovascular 

TherapeuTics 

WWW.TCTConfErEnCE.Com 3

4 

Table oF conTenTs 

overvieW 

TCT for Surgeons, Nurses/Technologists, and Fellows .................................6 

Directors and Organizers ............................................................................8 

Associations and Affiliations .....................................................................10 

Acknowledgments ...................................................................................12 

Commercial Support ................................................................................19 

Special Activities ......................................................................................20 

Learning Labs ..........................................................................................22 

ACC and CRF Joint Activities ...................................................................24 

CME/CNE Information ..............................................................................26 

TCT 2012 Awards ....................................................................................28 

TCT Week at a Glance .............................................................................29 

FaculTy 

International Faculty .................................................................................33 

TCT Advisory Faculty ...............................................................................40 

United States Faculty ...............................................................................41 

Live Case Sites and Operators/Factoid Faculty ..........................................49 

sunday 

ABCs of Interventional Cardiology: An Introductory Course ........................50 

Monday 

Board Review Course with Self-Assessment for Interventional 

Cardiology with Concepts of Endovascular Therapy (Part 1) .................52 

TCT for Nurses and Technologists 

21st Annual Cardiovascular Nurse and Technologist Symposium ............52 

Registered Cardiovascular Invasive Specialists (RCIS) Review Course ....53 

Scientific Symposia 

Chronic Total Occlusions: Evolutionary Approaches ...............................53 

Core Training Curriculum in Clinical Research ........................................54 

Endovascular Intervention 2012 (Part 1) ................................................56 

Interventional Innovation: Novel Therapies and 

the “Best” New Device Concepts for 2012 ............................................58 

Left Main and Bifurcation Stenting: An Advanced Operator’s Workshop ......60 

Strategies for Cardiovascular Repair: Stem Cells and Beyond ................61 

The Drug-Eluting Stent Summit: Appropriate Utilization 

of Current Generation Devices..............................................................62 

The Valvular Heart Disease Summit (Part 1): Aortic Valve Therapies ........64 

PFO and ASD Closure: Evolving Indications, 

Patient Selection, Devices, and Techniques ..........................................66 

Special Twilight Sessions 

Featured Clinical Research I .................................................................67 

Featured Clinical Research II ................................................................67 

Focus on India: Interactive Case Review and Panel Discussion ..............67 

Approach to Complex PCI and STEMI: From Revascularization to 

Complication Management...................................................................68 

How to Treat Complex Coronary Lesions ..............................................68 

Left Main and Bifurcation Stenting: Integrated Use of FFR and IVUS .......68 

Snapshot of Latin America Practice and Research.................................69 

TCT Russia .........................................................................................69 

The Elderly Patient: Better Treatment in the United States or Europe? ....69 

Tuesday 

Breakfast Meetings .............................................................................. 164 

Special Sessions 

SCAI ELM Session ..............................................................................72 


Cardiology with Concepts of Endovascular Therapy (Part 2) .................72 

TCT for Nurses and Technologists 

Breakout Symposium I. The Great Debates ...........................................73 

Breakout Symposium II. Leadership Session: Integration and Innovation ....73 


Surgical, Interventional, and Hybrid Procedures (Part 1): 

Coronary Intervention ..........................................................................74 

Peer-Reviewed Research 

Poster Abstract Sessions .....................................................................74 

Challenging Case Video Presentations ..................................................98 

Oral Abstract Sessions ...................................................................... 100 

Presentation Theater............................................................................ 165 


Endovascular Intervention 2012 (Part 2) .............................................. 105 

First-in-Human Studies: Global Regulatory 

and Translational Considerations ........................................................ 106 

Hot Topics in Cardiology: ACC.12 with TCT Highlights for 

the Interventional, Invasive, and General Cardiologist .......................... 107 

Identifying the High-Risk Patient and Lesion: 

From Vulnerable Plaque to Ischemia ................................................... 108 

Interventional Heart Failure ................................................................. 109 

Launching and Sustaining Your Career ............................................... 109 

Left Atrial Appendage Closure: Indications, Devices, and Techniques ........ 109 

Next-Generation DES and Bioabsorbable Scaffolds ............................. 110 

The Valvular Heart Disease Summit (Part 2): Mitral Valve Therapies ...... 111 

Transradial Angiography and Intervention: From Basic to Advanced ..... 112 

Evening Programs ................................................................................ 166 

Wednesday 


Main Arena ........................................................................................... 116 

How to Treat Theater: Coronary Artery Disease ................................... 117 

How to Treat Theater: Structural Heart and Endovascular Disease .... 118 

International Multiplex Theater 

Challenging Case Theater 1 ............................................................... 118 


Maintenance of Certification (MOC) Course ......................................... 120 


Japan-US Synergies in Global Medical Device Innovation: 

Harmonization by Doing (HBD) at TCT ................................................ 120 

Edited Taped Case Presentations ........................................................ 121 

Challenging Case Video Presentations ................................................ 121 

Presentation Theater............................................................................ 170

Morning Spotlight Sessions 

Deep Dive: Stroke Prevention Therapies ............................................. 123 

From Clinical Trial Evidence to Clinical Practice: 

Unraveling the Issues ......................................................................... 123 

Innovative Surgical Techniques and Technologies ................................ 124 

Next-Generation Transcatheter Mitral Valve Therapies ......................... 124 

The Use and Abuse of Appropriate Use Criteria (AUC): 

A Case-Based Tutorial ....................................................................... 125 

Lunchtime Activities 

Hot Topics ........................................................................................ 125 

Learn the Technique .......................................................................... 127 


Afternoon Spotlight Sessions 

Deep Dive: Hypertension and Renal Artery Denervation ....................... 130 

Next-Generation Transcatheter Aortic Valve Therapies ......................... 131 

Optimizing Use of Today’s Antithrombotic and 

Antiplatelet Drugs in ACS and PCI ...................................................... 132 


Valvular and Structural Heart Disease ................................................. 132 

The Skeptic’s Corner: Controversies in Interventional Cardiology .......... 133 


Thursday 


Main Arena ........................................................................................... 136 


How to Treat Theater: Endovascular and Structural 

Heart Disease Theater ......................................................................... 138 






FDA Town Hall Meeting ...................................................................... 140 


Alcohol Septal Ablation Symposium .................................................... 142 

Aortic Aneurysm Repair and Stent-Graft Devices ................................. 143 

Integrating IVUS and FFR into Clinical Practice .................................... 143 

Primary PCI for STEMI: Drugs, Devices, and Technique Controversies .. 144 

Edited Taped Case Presentations ........................................................ 144 


Presentation Theater............................................................................ 175 

Lunchtime Sessions 

Hot Topics ........................................................................................ 146 




Drug-Coated Balloons (DCB): Clinical Data and Applications ............... 151 

International Debating Chamber: Interventional Cardiology on Trial ....... 151 

Next-Generation Intravascular Imaging and Physiology: 

RF-IVUS, OCT, NIR Spectroscopy, iFR, and CT-FFR ............................ 152 



Friday 


TranscaTheTer 


TherapeuTics 


Main Arena ........................................................................................... 156 



RESPECT and PC Trial Deep Dive: Implications for PFO 

Closure to Prevent Cryptogenic Stroke ............................................... 157 

TAVR Site Readiness: Starting a Program and 

Achieving Optimal Outcomes ............................................................. 157 

The STEMI Center of Excellence: Strategies to 

Optimize Outcomes in AMI ................................................................. 158 


Hot Topics ........................................................................................ 159 


saTelliTe syMposia 

Tuesday 

Breakfast Meetings ............................................................................ 164 

Presentation Theater Programs .......................................................... 165 

Evening Programs ............................................................................. 166 

Wednesday 




Thursday 




Friday 


Maps 

Poster Abstracts (Hall D) Map .............................................................. 182 

Miami Beach Convention Center.......................................................... 184 


6 

TcT For surgeons 

TcT For FelloWs 

TcT For nurses/TechnologisTs 

TcT: an inTegraTed course For surgeons 

and inTervenTionalisTs 

Monday 

The Valvular Heart Disease Summit (Part 1): Aortic Valve Therapies ........64 

Tuesday 


Coronary Intervention ..........................................................................74 

The Valvular Heart Disease Summit (Part 2): Mitral Valve Therapies ...... 111 

Wednesday 

Innovative Surgical Techniques and Technologies ................................ 124 


Valvular and Structural Heart Disease ................................................. 132 

Thursday 

Aortic Aneurysm Repair and Stent-Graft Devices ................................. 143 

special TcT sessions For 

cardiology FelloWs 

Monday 


Cardiology with Concepts of Endovascular Therapy (Part 1) ...................52 

Tuesday 


Cardiology with Concepts of Endovascular Therapy (Part 2) ...................72 

Wednesday 


Thursday 


TcT For nurses and TechnologisTs 

Monday 

21st Annual Cardiovascular Nurse and Technologist Symposium ............52 

Registered Cardiovascular Invasive Specialists (RCIS) Review Course ....53 

Tuesday 

Breakout Symposium I. The Great Debates ...........................................73 

Breakout Symposium II. Leadership Session .........................................73

1 

laTe breaking 

clinical science 

2 

pracTical 

knoWledge 

3 

neTWorking 

WiTh colleagues 

4 

Focused 

educaTional 

acTiviTies 

5 

5 reasons To aTTend TcT 

inTeracTive 

MeeTing 

Technology 

Late Breaking Trials and First Report Investigations 

A cornerstone of every TCT, late breaking trials are typically the initial worldwide presentation of clinical trials, 

impactful single-center or multicenter registries, or important follow-up data from major randomized trials and 

first-in-man experiences with novel devices or drugs. 


Continuing to grow in popularity, Special Twilight Sessions are can’t-miss evening sessions that highlight featured 

clinical research and presentations on the hottest topics in a more casual setting with hors d’oeuvres. 

Dedicated Oral, Poster, and Challenging Case Video Abstract Presentations 

TCT 2012 will feature a four-hour block dedicated to oral and poster abstract presentations and, new this year, 

challenging case video abstracts. This will provide the opportunity to interact with peers in an intimate setting 

for critical review of science. 

“How to Treat” Live Case Theaters 

For practitioners desiring a state-of-the-art review of contemporary interventional practice, TCT’s 

“How to Treat” Live Case Theaters are there to provide step-by-step approaches to basic and advanced 

interventions, covering a broad knowledge base as well as numerous new techniques and tips and tricks 

to improve care for patients with cardiovascular disease. 


Multiple international societies representing the global spectrum of interventional cardiology will present 

their most challenging cases at TCT 2012. 

Attendees consistently report that participating at TCT provides them with a platform to develop their 

professional and personal networks. Hospitals, institutions, and companies from around the world are 

represented in ever-larger numbers. 

You can connect with your fellow attendees in person or use the CRF Mobile App to build your own 

professional network with TCTMD Connect. 

15th Annual Interventional Cardiology Board Review Course with Self-Assessment and 

Maintenance of Certification (MOC) Sessions 

The world-class Board Review Course with Self-Assessment at TCT 2012 will offer a thorough primer on 

the core components of interventional cardiology and endovascular therapy. 

21st Annual Cardiovascular Nurse and Technologist Symposium 

The Annual Nurse and Technologist Symposium provides a forum for discussion of the latest advances in 

interventional, pharmacologic, structural heart, and endovascular strategies for the management of the 

cardiovascular patient. 

TCT: An Integrated Course for Surgeons and Interventionalists 

This is an in-depth course presented during TCT 2012 that focuses on novel and advanced surgical 

techniques for surgeons, interventionalists, and all others interested in the most contemporary 

surgical techniques and catheter-based approaches. 

CRF Meetings Mobile App 

To stay up to date with everything TCT has to offer, download the CRF Meetings Mobile App from iTunes for 

iPhone/iPad or Google Play for Android phones/tablets. The free TCT mobile app is available from iTunes using 

the keyword “TCT”. A mobile Web site is available for those not using Apple products. 

Smart Tags 

With your mobile device, access detailed information on the go including late breaking trial slides as well as other 

presentations, exhibitor details and locations, and useful tips on Miami and the Miami Beach Convention Center. 


8 

direcTors and organizers 

direcTors 

Martin B. Leon, MD 

Gregg W. Stone, MD 

co-direcTors 

George D. Dangas, MD, PhD 

William A. Gray, MD 

Roxana Mehran, MD 

Gary S. Mintz, MD 

associaTe direcTors 

Alexandre Abizaid, MD, PhD 

Bagrat Alekyan, MD, PhD 

Gary M. Ansel, MD 

Sorin J. Brener, MD 

David J. Cohen, MD 

Antonio Colombo, MD 

Elazer R. Edelman, MD 

Michael D. Ezekowitz, MB, ChB, DPhil 

Ted E. Feldman, MD 

Run-Lin Gao, MD 

Philippe Genereux, MD 

Bernard J. Gersh, MB, ChB, DPhil 

C. Michael Gibson, MD 

A. Marc Gillinov, MD 

Juan F. Granada, MD 

Liliana R. Grinfeld, MD 

Eberhard Grube, MD 

Marian C. Hawkey, RN 

James B. Hermiller Jr, MD 

Ziyad M. Hijazi, MD, MPH 

David Hildick-Smith, MD 

David R. Holmes Jr, MD 

Alice K. Jacobs, MD 

Michael R. Jaff, DO 

Pieter Kappetein, MD, PhD 

Barry T. Katzen, MD 

Dean J. Kereiakes, MD 

Ajay J. Kirtane, MD, SM 

Susheel Kodali, MD 

Ran Kornowski, MD 

Alexandra J. Lansky, MD 

Chaim Lotan, MD 

Michael J. Mack, MD 

Akiko Maehara, MD 

Oscar Mendiz, MD 

Ian T. Meredith, MBBS, PhD 

David J. Moliterno, MD 

Masahiko Ochiai, MD, PhD 

Manish Parikh, MD 

Seung-Jung Park, MD, PhD 

LeRoy E. Rabbani, MD 

Mark Reisman, MD 

Patrick W. Serruys, MD, PhD 

Ashok Seth, DSc 

Sigmund Silber, MD 

Robert J. Sommer, MD 

Corrado Tamburino, MD, PhD 

Paul S. Teirstein, MD 

Martyn R. Thomas, MD 

Alec S. Vahanian, MD 

Renu Virmani, MD 

John G. Webb, MD 

Giora Weisz, MD 

Christopher White, MD 

Harvey D. White, MD 

Mathew Williams, MD 

Stephan Windecker, MD 

scienTiFic coMMiTTee 

David H. Adams, MD 

Dominick J. Angiolillo, MD, PhD 

Josef Bartunek, MD, PhD 

Eric R. Bates, MD 

Olivier F. Bertrand, MD, PhD 

Deepak L. Bhatt, MD, MPH 

William E. Boden, MD 

Steven F. Bolling, MD 

Russell A. Brandwein, RPA-C 

Emmanouil S. Brilakis, MD, PhD 

Ralph G. Brindis, MD, MPH 

Todd J. Brinton, MD 

Bruce R. Brodie, MD 

Lutz Buellesfeld, MD 

Daniel Burkhoff, MD, PhD 

Jacques Busquet, MD 

Josep Rodés-Cabau, MD 

Christopher P. Cannon, MD 

Louis A. Cannon, MD 

John D. Carroll, MD 

David A. Cox, MD 

Michael E. Crawford, MD 

Frank J. Criado, MD 

Michael D. Dake, MD 

Justin E. Davies, MBBS, MRCP 

Henricus J. Duckers, MD, PhD 

Mark A. de Belder, MD, MA 

Bernard de Bruyne, MD, PhD 

Elazer R. Edelman, MD, PhD 

Andrew Farb, MD 

David P. Faxon, MD 

William F. Fearon, MD 

Francisco Fernandez-Aviles, MD, PhD 

Michael A. Fifer, MD 

Peter J. Fitzgerald, MD, PhD 

John M. Flack, MD, MPH 

William J. French, MD 

Anthony H. Gershlick, MD 

James A. Goldstein, MD 

Christopher B. Granger, MD 

J. Aaron Grantham, MD 

Giulio Guagliumi, MD 

Michael Guiry, RPA-C 

Paul A. Gurbel, MD 

Christian W. Hamm, MD 

Martial Hamon, MD 

Kishore J. Harjai, MD 



W. Craig Hooper, PhD 

Yong Huo, MD 

Yang-Soo Jang, MD, PhD 

Peter Juni, MD 

David E. Kandzari, MD 

Samir R. Kapadia, MD 

Aaron V. Kaplan, MD 

Saibel Kar, MD 

John W. Karanian, PhD 

Sanjay Kaul, MD 

Morton J. Kern, MD 

Raghu Kolluri, MD 


Hans Krankenberg, MD 

Mitchell W. Krucoff, MD 

Henry Krum, MBBS, PhD 

Jean-Claude Laborde, MD 

Massoud A. Leesar, MD 

Thierry Lefevre, MD 

JoAnn Lindenfeld, MD 

William L. Lombardi, MD 

Yves R. Louvard, MD 

Francesco Maisano, MD 

Ganesh Manoharan, MD 

Steven P. Marso, MD 

James B. McClurken, MD 

John A. McPherson, MD 

Shamir R. Mehta, MD, MSc 

D. Christopher Metzger, MD 

James K. Min, MD 

Neil E. Moat, MD 

Marie-Claude Morice, MD 

Sherif F. Nagueh, MD 

Srihari S. Naidu, MD 

Brahmajee K. Nallamothu, MD, MPH 

Jagat Narula, MD, PhD 

Hilary Nierenberg, NP, MPH 

Patrick T. O’Gara, MD 

E. Magnus Ohman, MD 

Semih Oktay, PhD 

Jeffrey W. Olin, DO 

John A. Ormiston, MB, ChB 

Manish A. Parikh, MD 

Helen Parise, ScD 

Amit Patel, MD, MS 

Tejas Patel, MD 

Marc S. Penn, MD, PhD 

Nicolo Piazza, MD 

Nico H.J. Pijls, MD, MPH 

Ileana L. Pina, MD 

Stuart J. Pocock, PhD 

Jeffrey J. Popma, MD 

Francesco Prati, MD 

Matthew J. Price, MD 

Sunil V. Rao, MD 

Vivek Y. Reddy, MD 

Simon Redwood, MD 

Evelyn S. Regar, MD, PhD 

Bernhard Reimers, MD 

Charanjit S. Rihal, MD 

Krishna J. Rocha-Singh, MD 

Ivan C. Rokos, MD 

Manel Sabate, MD, PhD 

Dierk Scheinert, MD 

Bruno Scheller, MD 

Joachim Schofer, MD 

Peter A. Schneider, MD 

Allan Schwartz, MD 

Warren Sherman, MD 

Georgios Sianos, MD, PhD 

Horst Sievert, MD, PhD 

Ulrich Sigwart, MD 

Daniel I. Simon, MD 

Paul A. Sobotka, MD 

Paul Sorajja, MD 

Martina Kelly Speight, RN, BSN 

H. Robert Superko, MD 

Wilson Y. Szeto, MD 

David Taggart, MD, PhD 

Guillermo Tearney, MD, PhD 

Holger Thiele, MD 


Craig A. Thompson, MD, MMSc 

Vinod H. Thourani, MD 

Leif Thuesen, MD 

Henry H. Ting, MD, MBA 

Jonathan M. Tobis, MD 

Zoltan G. Turi, MD 

E. Murat Tuzcu, MD 

Alec Vahanian, MD 

Marco Valgimigli, MD 

Nicolas M. van Mieghem, MD 

Stefan Verheye, MD, PhD 

Ron Waksman, MD 

Thomas Walther, MD 

Gerald S. Werner, MD, PhD 

Janet F. Wyman, MSN, ACNS-BC 

R. Michael Wyman, MD 

Paul Yock, MD 

Christopher K. Zarins, MD 

Thomas Zeller, MD 

Bram D. Zuckerman, MD 

organizaTional 

coMMiTTee 

Andrea Abizaid, MD, PhD 

Fernando Alfonso, MD, PhD 

Yele Aluko, MD 

Somjot S. Brar, MD 

Stephen Balter, PhD 

Antonio L. Bartorelli, MD 

Lee N. Benson, MD 

Elchanan Bruckheimer, MBBS 

Joseph Carrozza, MD 

Christina A. Chadwick, RN, MSN 


Michael B. Collins, MD 

Joseph S. Coselli, MD 

Nick Curzen, PhD 

Tony Das, MD 

Anthony N. DeMaria, MD 

Tony J. DeMartini, MD 

Simon R. Dixon, MBChB 

John S. Douglas Jr, MD 

Andrejs Erglis, MD, PhD 

Michael E. Farkouh, MD, MSc 

Frederick Feit, MD 

Eulogio J. Garcia, MD

Ulrich Gerckens, MD 

Cindy L. Grines, MD 

Jonathan L. Halperin, MD 

Howard C. Herrmann, MD 


Richard R. Heuser, MD 

John McB. Hodgson, MD 

Leo Nelson Hopkins, MD 

Kurt Huber, MD 


Sanjit S. Jolly, MD 


Adnan Kastrati, MD 

Osamu Katoh, MD 

Spencer B. King III, MD 

Neal S. Kleiman, MD 

Bon-Kwon Koo, MD, PhD 

Edward M. Kreps, MD 

Frederick Kushner, MD 


Glenn N. Levine, MD 

Scott Lim, MD 

Brij Maini, MD 

Raj Makkar, MD 

Tift Mann, MD 


Doff B. McElhinney, MD 

Margaret B. McEntegart, MD 


Philip M. Meyers, MD 

Issam D. Moussa, MD 



Sahil A. Parikh, MD 

Manesh R. Patel, MD 

Anna Sonia Petronio, MD 

Mahmood K. Razavi, MD 

John F. Rhodes, MD 

David G. Rizik, MD 

Josep Rodes-Cabau, MD 

Lowell F. Satler, MD 

Binoy K. Singh, MD 

A.J. Conrad Smith, MD 

Thomas D. Stuckey, MD 

Jennifer A. Tremmel, MD 

Etsuo Tsuchikane, MD, PhD 

Frans van der Werf, MD 

Clemens von Birgelen, MD, PhD 

Bonnie H. Weiner, MD, MSEC 

David O. Williams, MD 

Bernhard Witzenbichler, MD 



TranscaTheTer 


TherapeuTics 


10 

associaTions and 

aFFiliaTions 

Advanced Cardiovascular Solutions 

in Partnership with TCT 

American Association for 

Thoracic Surgery 

American College of Cardiology 

Angioplasty Summit-TCTAP 2013 

ASEAN Federation of Cardiology 

Association on Cardiovascular 

Interventions of the Polish 

Cardiac Society 

Belgian Working Group of 

Interventional Cardiology 

Brazilian Society of Cardiology 

Brazilian Society of Hemodynamics 

and Interventional Cardiology 

Brazilian Society of 


British Cardiovascular 

Intervention Society 

Canadian Association of 


Cardiac Society of Australia 

and New Zealand 

Cardiology Society of India 

Cardiovascular Intervention 

Association of Thailand 

Cardiovascular Research Foundation 

China Interventional Therapeutics 

(CIT) 2013 in Partnership with TCT 

Chinese Society of Cardiology 

Circulation: Cardiovascular 

Interventions 

Colegio Argentino de 

Cardioangiologia Intervencionista 

Croatia Working Group of 

Interventional Cardiology, 

Croatian Cardiac Society 

Cyprus Society of Cardiology 

Czech Working Group of 

Interventional Cardiology of 

the Czech Society of Cardiology 

Danish Group of 


Doctrina Med 

Dutch Society of 


Dutch Working Group on 


Egyptian Society of Cardiology 

Finland Working Group on 


German Working Group of 


Global Summit on Innovations in 

Interventions (GI2) at 

SOLACI/SBHCI 2013 in 

Partnership with TCT 

Greece Working Group on 


Heart Association of Thailand 

Under the Royal Patronage of 

His Majesty the King 

Hellenic Cardiological Society 

Icelandic Society of Cardiology 

Innovations in Cardiovascular 

Interventions 

International Society of 

Endovascular Specialists 

International Symposium on 

Endovascular Therapy 


Society of Mexico 

Interventional Council of the 

Cardiac Society of Australia 

and New Zealand 

Interventions of the Polish 

Cardiac Society 

Iran Heart Association 

Iranian Society of 


Israeli Working Group on Interventional 

Cardiology/The Israel Heart Society 

Italian Society of Cardiology 

Invasive and Intervention 

Italian Society of Invasive Cardiology 

Japanese Association of 


and Therapeutics 

Joint Interventional Meeting (JIM) 2013 

Journal of the American 

College of Cardiology 

Korean Society of Cardiology 

Malaysian Interventional 

Cardiology Society 

Mexican Society of Cardiology 

Morocco Working Group on 


Nordic-Baltic Study Group of 


p-c-i live in Partnership with TCT 

Pediatric Interventional 

Cardiac Symposium 

Polish Cardiac Society: Association 

of Cardiovascular Interventions 

Preventive Cardiovascular 

Nurses Association 

Russian Society of 

Endovascular Surgery 

Russian Society of Interventional 

Cardiology and Angiology 

Saudi Arabia Cardiology 

Interventional Group 

Science Innovation Synergy 

Singapore Cardiac Society 

Sociedad de Cardiologia 

Intervencionista de Mexico 

Sociedad Latino Americana de 

Cardiologia Intervencionista 

Society for Cardiovascular 

Angiography and Interventions 

Society of Invasive 

Cardiovascular Professionals 

Spanish Society of Angiology 

and Vascular Surgery 

Spanish Working Group on 


Stanford Biodesign 

Swedish Working Group on 

Coronary Heart Disease 

Swedish Working Group on PCI/ 

Swedish Society of Cardiology 

Swiss Society of Cardiology 

Taiwan Society of 

Cardiovascular Interventions 

Taiwan Transcatheter Therapeutics 

TCT Mediterranean 

TCT Russia 

TCT at Taiwan Transcatheter 

Therapeutics 

Turkish Association of PCI 

Turkish Society of Cardiology 

Victory Project Congressi 

Working Group on Interventional 

Cardiology and Acute Coronary 

Syndrome/Swiss Society 

of Cardiology 

Working Group on Interventional 

Cardiology of the Austrian 

Society of Cardiology 

Working Group on PCI, Danish 

Society of Cardiology Dutch 

Society of Interventional Cardiology 

Working Group on PCI, Swedish 

Society of Cardiology

TcT inTernaTional 

advisory coMMiTTee 

Argentina 

Ernesto M. Torresani, MD 

Australia and New Zealand 

James Cameron, MD 

Belgium 

Glenn Van Langenhove, MD, PhD 

Brazil 

Alexandre Abizaid, MD 

Canada 

Michael Love, MD 

Chile 

Oscar A. Mendiz, MD 

China 

Dayi Hu, MD 

Croatia 

Aleksander Ernst, MD 

Cyprus 

Petros Agathangelou, MD 

Czech Republic 

Petr Widimsky, MD, PhD 

Denmark 

Søren Galatius, MD 

Egypt 

Mohamed Sobhy, MD 

Europe 

Jean Fajadet, MD 

Finland 

Hannu Romppanen, MD 

Greece 

Georgios Parcharidis, MD 

Iceland 

Thorarinn Gudnason, MD, PhD 

India 

Ashok Seth, MD 

Iran 

Mahmood Hashemian, MD 

Israel 



Italy 

Alberto Cremonesi, MD 

Japan 

Takeshi Kimura, MD 

Latin America 


Malaysia 

Rosli Mod Ali, MD 

Mexico 

Joel Estrada Gallegos, MD 

Netherlands 

Jan J. Piek, MD 

Poland 

Dariusz Dudek, MD 

Russia 

Bagrat G. Alekyan, MD 

Saudi Arabia 

Mohammed Balghith, MD 

Serbia 

Milan Nedeljkovic, MD 


Singapore 

TranscaTheTer 


TherapeuTics 

Bernard Kwok, MD 

South Korea 

Jae Eun Jun, MD 

Spain 

Francisco Javier Goicolea Ruigómez, MD 

Sweden 

Göran Olivecrona, MD 

Switzerland 

Christoph Kaiser, MD 

Taiwan 

Jun-Jack Cheng, MD 

Thailand 

Sarana Boonbaichaiyapruck, MD 

Turkey 

Omer Goktekin, MD 

United Kingdom 



12 

acknoWledgeMenTs 

The TCT program development and organization is 

a year-round effort. many people play important 

roles that ensure the success of TCT by contributing 

their experience and expertise. The Cardiovascular 

research foundation wishes to give special thanks 

to all those who have worked tirelessly and with 

great dedication to our mission. 

ManageMenT TeaM 

Johnnie White, CMP 

Executive Director 

CRF Center for Education 

Stephen Cannarelli 

Senior Design Manager 

Marketing and Creative Services 

Jeff Chamlee 

Multimedia Manager 


Irma Damhuis 

Director 

External Relations 

Josh Hartman 

Director 

Educational Services and 

Strategic Relations 

Jason Kahn 

Manager, Academic Content 

Editorial Services 

Fun Lee, CMP 

Director 

Meetings and Conventions 

Ted Silverstein 

Director 


Todd Wagner 

Manager, Print Production 


Colleen Whelan 

Director 

CME Program Development 

planning group 

Elizabeth Burke 

Executive Assistant 


Caitlin C. Cox 

Senior Medical Writer/Editor 


Kim Dalton 

Medical Writer/Editor 


Alexander Damhuis 

CME Coordinator 


Christina DiFrancesco 

Senior Coordinator, Grants 

Industry Relations 

Stephanie Gutch 

Manager, Operations and Content 

Web Sites 

Katie Herrion 

Senior Associate 


Guadalupe Hogarty, CMP 

Meeting Manager 

Meetings and Conventions 

Michael Houk 

Multimedia Designer 


Yael L. Maxwell 



Laura A. McKeown 



Lilian Moreira 

Associate Project Manager 


Thomas Mortimer 

Proofreader 


Leonard Posso 

Graphic Designer 


Tricia Rawh 

Program Project Manager 


Abby Rees 

Program Coordinator 


Diana Sanchez 

Junior Graphic Designer 


Adam Saunders 

E-Marketing and Customer 

Service Coordinator 

Web Sites 

Greg Simsic 

Consultant 


Denise Tong 

Project Coordinator 


Scott Allan Wallick 

Senior Copy Editor 


Margaret Zetts 

Senior Program Coordinator 


senior ManageMenT 

group 

William A. Himmelsbach, 

MPH, FACHE 

President and Chief Executive Officer 

Matthew P. Pazaryna 

Chief Financial Officer 

Donald L. Abrams, Esq 

General Counsel 


Executive Director 


adMinisTraTive 

supporT sTaFF 

Kelly Clyde 

Nancy Collins 

Robin Dennis 

Gabriella Gallo-Cisak 

Ruth Mansueto 

Diane Salerno-Madrid 

crF clinical 

Trials cenTer 

Maria Alfonso 

Sonia Burgher 

Isabel Corral 

Ecaterina Cristea 

Rosa De Jesus 

Ossen Delbrun 

Marina Dizik 

Champika Djurkovic 

Ovidiu Dressler 

Monica Embacher 

Martin Fahy 

Dominic Francese 


Christopher Grady 

Alejandra Guerchicoff 

Cecilia Jade Hart 

Raza Hijazi 

Irene Hueter 

Stephen Iacono 

Sharwat Jahan 

Jaclyn Jacobson 

Elena Konovalova 

Laura LaSalle 

Wangyue Liu 

Mitchel Lustre 

Katharine Lymberis 

Sujatha Menon 

Catalin Mindrescu 


Gopinathan Mohan 

Sophia Papamitrou 


Nicoleta Pavlovici 

Khary Perry 

Ecaterina Prepelita 

Antonio Pullano 

Saira Punjwani 

Eugene Salgado 

Raquel Sanchez 

Lena Slawitsky 

Christina Tien 

Shawnalee Vassell 

Stephanie Wolin 

Douey Wright 

Ke Xu 

Finance 

Yuliya Bogomolny 

Arlene Brown 

Jenni Kong 

Eileen Morales 

Cheryl Turnbull 

huMan resources 

Kelli O’Toole 

Emilia K. Valtcheva 

oFFice services 

Aryel Flores De Valgaz 

inForMaTion Technology 

Louis Cruz 

Richard Han 

Alain Moise 

Kapil Nayyar 

exTernal relaTions 

Irma Damhuis 

Judy Romero 

oFFice oF legal aFFairs 

Donald L. Abrams, Esq

QualiTy assurance 

Whitney Petrie 

Maria Rossolino 

Garreth Sharp 

crF skirball 

research cenTer 

Leslie Anglin 

Yan-Ping Cheng 

Gerard B. Conditt 

Adrienne Dardenne, DVM 

Duane Dennis 


Anguo Gu 

Jaime Guzman 

Greg L. Kaluza, MD, PhD 

Patricia Madlinger 

Jennifer McGregor 

Patricia Mount 

Athanasios Peppas 

Jodi Robinholt 

Armando Tellez, MD 

Kathy Troyan 

Alyssa Wagner 

Kimberly White 

Geng-Hua Yi 

crF FelloWs 

Tomotaka Dohi, MD 

Liang Dong, MD 

Nobuaki Kobayashi, MD 

Seung Jin Oh, MD 

Takehisa Simizu, MD 

Lin Wang, MD 

Mayank Yadav, MD 

Jong Shiuan Yeh, MD 

board oF direcTors oF 

The cardiovascular 

research FoundaTion 

Eric B. Woldenberg, Esq 

Chair 

William A. Himmelsbach, 

MPH, FACHE 

President and Chief Executive Officer 

Joseph G. Beck 

Colette Y. Gardner 

Robert L. Glenning 

Jeffrey W. Moses, MD 

Arthur J. Pergament 

Eric A. Rose, MD 

Marvin L. Woodall 

Patricia Woods, PhD 



TranscaTheTer 


TherapeuTics 


14 


coluMbia universiTy 

Medical cenTer 

Faculty 

Mark A. Apfelbaum, MD 


Braulio Flores, MD 

Alexander Gorodnitskiy, MD 


Rebecca Hahn, MD 

Nellie Kalcheva, MD 



Edward M. Kreps, MD 




LeRoy E. Rabbani, MD 

Norbert Rainford, MD 

Abdollah Sedighi, MD 






Clinical Instructors 


Vishal Kapur, MD 

Omar Khalique, MD 

Farhan Khawaja, MD 

Jorge Magallon, MD 

Jean-Michel Paradis, MD 

Fellows 

Hemal Gada, MD 

Philip Green, MD 

Kendra Grubb, MD 

Tamim Nazif, MD 

Torsten Vahl, MD 

Clinical Staff 

Wilson Arango, FNP-BC 



Jessica Forman, RPA-C 

Administrative Staff 

Regina Amelko 

C. Jeanette Bermeo 

Donna Brown 

Teri FitzGerald 

Rosie Calcano 

Yemilet Gonzalez 

Stacy Hall 

Suzanne Jakubiak 

Rona Kahn 

AnnMarie Kelly 

Eileen Madison 

Erika Marrero 

Enid Montalvo 

Dora Mussenden 

Jessica Ramirez 

Jacqueline Rosenthal 

Tiesha Ruiz 

Diane Salerno-Madrid 

Joann Serrano 

Annicia Thomas 

Samantha Tsiolis 

Aja Washington 

Viktoriya Yakhyaeva 

Clinical Research Staff 

Alejandro Aramburu, BA 

Andy Morales, MD 

Angeli Feri, BS 

Angelica Castaneda, BS 

Ashlee Mattone, BS 

Autumn Austin, BA, MPH 

Ben Lerman, BS 

Diane Weber, BA 

Diaa Hakim, MD, PHD 

Eric Adegbite, BS 

Eunice Dilone 

Fernando Sosa, BS 

Joyce Ann Thomas, BS 

Kate Dalton, MS, RD 

Luz Jaquez, BS 

Lauren Privitera, MPH 

Matthew Brinkman, MS 

Rosa Lazarte, MD 

Treena Williams, BE 

Vasiliki Chantziara, MD 

Yasir Qureshi, MD 

Cath Lab 

Aabrana Evans, RCIS 

Alex Castillo, RT 

Alla Ogii-Landis, RN 

Andrew Stefanski, RT 

Anne Rose Ermita, RN 

Annelle Williams 

Araceli Limbaga, RN 

Barbara Stock, RN 

Beatriz Custodio 

Benny Joseph, RN 

Betty Yu-Chong, RN 

Brian Aquino, RN 

Brian Padilla 

Byron Johnson 

Cheery de Padua, RN 

Christine Carthy, RN 

Christopher Bechtel, RCIS 

Claudia Echeverry, RCIS 

Danielle Thompson 

Darlene Wise, RN 

David Borsh, RN 

Debbie Donaldson 

Debbie Maccaro 

Deborah Plant, RN 

Deirdre Conlon, RN 

Delita Glori-Feri, RN 

Denise Groff, RN 

Dennis Sta. Maria, RN 

Derrick Horne, RN 

Dionysius Tejero, RN 

Edelmira Quintero 

Ellen Moreno, RN 

Ellen Pitiger, RN 

Emil Osorno, RN 

Errol Ellis 

Eufemia Penaflor, RN 

Evaine Iral-Fallurin, RN 

Felicia Leon 

Fely Ballongay, RN 

Gerard Cowles, RN 

Gina Uy, RN 

Gleonisi Ramirez 

Harold Stella 

Hilda Devlin, RN 

Holly McCall, RN 

Hongge Wei, RCIS 

Ingrid Lora 

Isidro Gonzalez 

Jaime Crist, RN 

Jan Greenfield, RN 

Jaysen Hernandez, RCIS 

Jhan Nunez 

Joanna Castro, RT 

Jodi Conway, RN 

Joel De Jesus 

Justine Wee-Boac, RN 

Kathleen Casey, RN 

Kelly Brocker, RN 

Kelly Light, RN 

Ketevan Telia 

Khady Fall 

Kristin Fagerlin, RCIS 

Laura Thomas, RN 

Lenny Guzman, RT 

Leslyn Hall 

Lihua Fang, RCIS 

Louella Galarpe Danao, RN 

Louis Lopez 

Lu Kan Gorman RN 

Margaret Griffin, RN 

Maria Antonio, RN 

Maria Bernardez, RN 

Maria Damayo-Medina, RN 

Maria Lourdes Tan-Uy, RN 

Maria Mamuri, RN 

Maria Younessian, RN 

Maricar Jordana, RN 

Mary Egan, RN 

Mary Ellen Morgan, RN 

Melanie Diaz, RN 

Melissa Pusterla, RN 

Michael De Leon, RN 

Michael Guiry, RPA-C 

Michael Sgarella, RCIS 

Michele Foley, RN 

Michelle Lindquist, RN 

Michelle Murray, RN 

Michelle Rodriguez, RN 

Michelle Tan, RN 

Miriam Candaroma, RN 

Moira Smith, RN 

Myriam Medrano 

Nenita Generales, RN 

Nina Editha Pajimna, RN 

Noel Castor, RN 

Norma Ennis 

Osama Amine, RCIS 

Patrick Hayford 

Patrick Kline, RN 

Paul Kelley, RN 

Phyllis Rodriguez 

Regel Del Mundo, RN 

Rene Ambrona 

Rodello Diamante 

Ronald Rigor, RN 

Rose Ang, RN 

Rosemary Valencia, RN 

Sandra Smith 

Serge Sabo, RCIS 

Sheehan Raab, RT, RCIS 

Sheri Pinto, RN 

Siobhan Reilly, RN 

Soojin Horland, RN 

Stephanie Quach Luc, RN 


Tamara Grazette, RN 

Tammy Van Gelder, RCIS 

Viola King 

Vivian Tamara, RN, RCIS 

Wayne Clarke 

Woodley Perpignan, RN 

Yuan Fang, RCIS 

Yovana Chardon 

Yvette Reyes 

Zoraya Boissard 

Physician Assistants 

Alicia Adams, RPA-C 

Sean Ahearn, RPA-C 

Anna Akker, RPA-C 

Gretchen Andersen, RPA-C 

Michael Bergman, RPA-C 

Mario Buss, RPA-C 

Kamman Chan, RPA-C 

Tara Collins, RPA-C 

Pilar Dolcimascolo, RPA-C 

Galina Dumchin, RPA-C

Marian Elbert, RPA-C 

Neisha Hariprashad, RPA-C 

Seing Houy, RPA-C 

Daria Jilinskaia, RPA-C 

Melissa Katzman, RPA-C 

Nancy Copeland-Kelley, RPA-C 

Simon Krivor, RPA-C 

Brittany Macdonald, RPA-C 

Kristin Pasquarello, RPA-C 

Irina Pilosova, RPA-C 

Michael Querijero, RPA-C 

Eileen Redmond, RPA-C 

Sofia Romero, RPA-C 

Madeline Seergy, RPA-C 

Jamie Shein, RPA-C 

Yana Smolyaninova, RPA-C 

Mindy Sporn, RPA-C 

Cheri Tomasino, RPA-C 

Bethany West, RPA-C 

coluMbia hearT 

valve cenTer 

Faculty 

Michael Argenziano, MD 

Emile Bacha, MD 


Rebecca T. Hahn, MD 




Craig R. Smith, MD 

Mathew R. Williams, MD 

Clinical Staff 

Isaac George, MD 

Kendra Grubb, MD 

Russell A. Brandwein, RPA-C 

Tiffany Wong, RPA-C 

Fellows and Clinical 

Instructors 


Omar Khalique, MD 

Tamin Nazif, MD 

Kishore Harjai, MD 



Administrative Staff 

Maria Alu 

Diane Amato 

Larry Beilis 

Julie Feliz 

Julie Fisher 

Charlette Gomez 

Lisa Hathaway Stella 

Rona Kahn 

Patricia E. Knipper, RN 

Marilyn Noda 

Braydon Pace 

Alina Sokolinskaya 

Research Team 

Elizeth Brito 

Vasiliki Chantziara 

Kate Dalton 


Ben Lerman 

Dawn Scott, RN 

Jeanie Sohn 


TranscaTheTer 


TherapeuTics 


16 


absTracT revieWers 

The TCT Course Directors and the 

Abstract Selection Committee, 

chaired by Gary S. Mintz, MD, 

wish to express their sincere 

appreciation to the physicians 

who selflessly donated their 

time and expertise as TCT 

Abstract Reviewers. 

Abstract Selection Committee 

Chair: Gary S. Mintz, MD 

Joseph D. Babb, MD 

Charles E. Chambers, MD 

Philippe Généreux, MD 



Lloyd Klein, MD 

TCT Abstract Reviewers 


Alex Abou-Chebl, MD 

William Abraham, MD 


Tayo Addo, MD 

Takashi Akasaka, MD 

Fernando Alfonso, MD 

Steven Lee Almany, MD 

John Ambrose, MD 

Zahid Amin, MD 

Max Amor, MD 

Dominick Angiolillo, MD 

Brian H. Annex, MD 

Gary Ansel, MD 

David Antoniucci, MD 

Robert Applegate, MD 

Constantine Aroney, MD 

Herbert Aronow, MD 

Yasushi Asakura, MD 


Shmuel Banai, MD 

Sripal Bangalore, MD 

Adrian Banning, MD 

Gerald Barbeau, MD 

Antonio Bartorelli, MD 

Jozef Bartunek, MD 

Theodore Bass, MD 


Jeroen Bax, MD 

Kevin Beatt, PhD 

Jorge Belardi, MD 

Lee Benson, MD 

Nirat Beohar, MD 

Daniel Berman, MD 

Olivier François Bertrand, MD 

Rafael Beyar, MD 

Giancarlo Biamino, MD 

Giuseppe Biondi Zoccai, MD 

John Bittl, MD 

James Blankenship, MD 

Steven Bolling, MD 

Raoul Bonan, MD 

Johannes Bonatti, MD 

Laurent Bonello, MD 

Roberto Botelho, PhD 

Bruce Bowers, MD 

Somjot Brar, MD 

Stephen Brecker, MD 

Sorin Brener, MD 

Carlo Briguori, MD 

Emmanouil Brilakis, MD 

Ralph Brindis, MD 


Maurice Buchbinder, MD 



Pawel E. Buszman, MD 

Robert Byrne, MBBCh 

Adriano Caixeta, MD 

Louis Cannon, MD 

Davide Capodanno, MD 

Ronald Caputo, MD 

John Carroll, MD 

Joseph Carrozza Jr, MD 

Graham Anthony Cassel, MD 


Charles Chan, MD 

John Cheatham, MD 

Shao Liang Chen, MD 

YunDai Chen, PhD 

James Chesebro, MD 

Bernard Chevalier, MD 

Alaide Chieffo, MD 

Kenneth Chin, MD 

Nicolas Chronos, MD 

David Cohen, MD 

Eric Cohen, MD 

Marc Cohen, MD 

Mauricio G. Cohen, MD 

Tyrone Collins, MD 


Anthony Comerota, MD 

Jose Condado, MD 

Marco Costa, MD 

Ricardo A. Costa, MD 

Jose Costa Jr, MD 

Michael Cowley, MD 

David Cox, MD 

Alain G. Cribier, MD 

Fernando Cura, MD 

Nick Curzen, PhD 

Donald Cutlip, MD 

Joost Daemen, MD 

Jason Daiger, MD 

Haim Danenberg, MD 


Debabrata Dash, MD 

Harold Dauerman, MD 

Charles Davidson, MD 

Justin Davies, PhD 

Adam de Belder, MD 

Mark de Belder, MD 

Jose M. De la Torre Hernandez, MD 

Giuseppe De Luca, MD 

Robbert J. de Winter, MD 

Larry Dean, MD 

Anthony DeMaria, MD 

Tony DeMartini, MD 

Carlo Di Mario, MD 

Germano Di Sciascio, MD 

Vasken Dilsizian, MD 

Stefanie Dimmeler, PhD 

Simon Dixon, MBChB 

Ozgen Dogan, MD 

Henricus Duckers, MD 

Dariusz Dudek, MD 

Vladimír Džavík, MD 

Adrian Ebner, MD 

Neal Eigler, MD 

Stephen Ellis, MD 

Andrejs Erglis, MD 

Michael Ezekowitz, MD 


Michael Farkouh, MD 

David Faxon, MD 

William Fearon, MD 


Marc Feldman, MD 

Ted Feldman, MD 

Francisco Fernandez-Aviles, MD 


Tim Fischell, MD 

John Flack, MD 

Nicolas Foin, PhD 

Olaf Franzen, MD 


Alfredo Galassi, MD 

Daljeet S. Gambhir, MD 

James Gammie, MD 

Ripal Gandhi, MD 


Eulogio Jesus Garcia, MD 

Lawrence Garcia, MD 

Hector M. Garcia-Garcia, MD 

Efrain Gaxiola, MD 

Junbo Ge, MD 



Ulrich J. Gerckens, MD 

Bernard J. Gersh, MBChB 

Anthony Gershlick, MD 

Gary Gershony, MD 


Ian C. Gilchrist, MD 

Robert Giugliano, MD 

Dietmar Glogar, MD 

Sheldon Goldberg, MD 

Steven Goldberg, MD 

Mark Goldberger, MD 

James Goldstein, MD 


Christopher Granger, MD 



Paul Grayburn, MD 

Cindy Grines, MD 

Liliana Grinfeld, MD 

Luis Gruberg, MD 


Victor Guetta, MD 

Vivek Gupta, MD 


Lee Guterman, MD 

Luis Guzman, MD 

Alison Halliday, MS 

Michalis Hamilos, MD 

Christian Hamm, MD 

Yaling Han, MD 

Kishore Harjai, MD 

Robert Harrington, MD 

Michael Haude, MD 

Jose P.S. Henriques, MD 

Michel Henry, MD 

Timothy D. Henry, MD 

Richard Heuser, MD 

Ziyad Hijazi, MD 


Jonathan Hill, MD 

David Holmes Jr, MD 

Yasuhiro Honda, MD 

Myeong-Ki Hong, MD 

Eric Horlick, MD 

Angela Hoye, MD 

Dayi Hu, MD 


Ioannis (John) Iakovou, MD 

Thomas Ischinger, MD 

Alice Jacobs, MD 

Michael Jaff, DO 

Allan Jaffe, MD 

Farouc Jaffer, MD 

Ik-Kyung Jang, MD 

Lisette Okkels Jensen, MD 

Allen Jeremias, MD 

Sanjit Jolly, MD 

Michael Joner, MD 

Petr Kala, MD 

Anne Kaltoft, MD 

Greg L. Kaluza, MD, PhD

David Kandzari, MD 

Soo-Jin Kang, MD 

Paul Hsien-Li Kao, MD 

Samir Kapadia, MD 

Aaron Kaplan, MD 

A. Pieter Kappetein, MD 

Saibal Kar, MD 

Dimitri Karmpaliotis, MD 


Upendra Kaul, MD 

Zaza Kavteladze, MD 

Elvin Kedhi, MD 

Henning Kelbaek, MD 

Dean Kereiakes, MD 

Morton Kern, MD 

R. Stefan Kiesz, MD 

Hyo-Soo Kim, MD 

Young-Hak Kim, MD 


Spencer King III, MD 


Neal Kleiman, MD 



David Kong, MD 

Bon-Kwon Koo, MD 

Jacques Koolen, MD 


Zvonimir Krajcer, MD 

Paul Kramer, MD 


Takashi Kubo, MD 

Karl-Heinz Kuck, MD 

Sreenivas Kumar, MD 


Roger Laham, MD 

Rudiger Lange, MD 


John Lasala, MD 

Jens Flensted Lassen, MDA 

Zeem Latib, MD 

Michel Le May, MD 

Guy LeClerc, MD 

Michael Lee, MD 

Massoud Leesar, MD 


Pedro Lemos, MD 


Norman Lepor, MD 

Amir Lerman, MD 

Michael Lim, MD 

Scott Lim, MD 

Thosaphol Limpijankit, MD 

A. Michael Lincoff, MD 


Italo Linfante, MD 

William Lombardi, MD 

Hugo Londero, MD 

Robert Lookstein, MD 


Yves Louvard, MD 

Michael P. Love, MD 

Reginald I. Low, MD 

Sumaira Macdonald, MD 

Lindsay Machan, MD 






Steven Manoukian, MD 

Steven Marso, MD 

Detlef Mathey, MD 

Klaus Mathias, MD 

Jon Matsumura, MD 

Luiz Mattos, MD 

Daniel J. McCormick, DO 

Doff McElhinney, MD 


Thomas McNamara, MD 

John McPherson, MD 

Julinda Mehilli, MD 


Shamir Mehta, MD 

Bernhard Meier, MD 


Maurizio Menichelli, MD 

Ian T. Meredith, PhD 


Philip Meyers, MD 

James Min, MD 

Erich Minar, MD 


Greg Mishkel, MD 

Neil Moat, MD 


Michael Mooney, MD 

Pedro Moreno, MD 


Issam Moussa, MD 

Michael Mullen, MD 

David W.M. Muller, MD 

Brad Munt, MD 

Toshiya Muramatsu, MD 

Christoph Naber, MD 



Masato Nakamura, MD 

Sunao Nakamura, MD 

Brahmajee Nallamothu, MD 

Massimo Napodano, MD 

Kenya Nasu, MD 

Gjin Ndrepepa, MD 

Franz-Josef Neumann, MD 

Christoph A. Nienaber, MD 

Eugenia Nikolsky, MD 



Michelle O’Donoghue, MD 

Patrick O’Gara, MD 

William O’Neill, MD 

Andrzej Ochala, MD 

Masahiko Ochiai, MD 

Takao Ohki, MD 

Keith G. Oldroyd, MD 

Jeffrey Olin, DO 

Eustaquio Maria Onorato, MD 

John A. Ormiston, MD 

Miodrag Ostojic, MD 

Igor Palacios, MD 

Tullio Palmerini, MD 

Manotosh Panja, MD 

Keyur Parikh, MD 

Sahil Parikh, MD 

Duk-Woo Park, MD 

Seung-Jung Park, MD 

Juan Parodi, MD 

Amit Patel, MD 

Manesh Patel, MD 


Constantino Pena, MD 

Marc Penn, MD 



Augusto Pichard, MD 

Jan Piek, MD 

Nico Pijls, MD 

Ileana Piña, MD 

Duane Pinto, MD 

Jeffrey Popma, MD 


Matthew Price, MD 

Ramon Quesada, MD 

LeRoy Rabbani, MD 

Lorenz Räber, MD 

Afzalur Rahman, MD 

Sunil Rao, MD 

Sudhir Rathore, MD 

Mahmood Razavi, MD 

Michael J. Reardon, MD 

Rita F. Redberg, MD 


Evelyn Regar, MD 


Expedito Ribeiro, MD 

Charanjit Rihal, MD 

Michael Rinaldi, MD 

Stéphane Rinfret, MD 

David Rizik, MD 


Alfredo Rodriguez, MD 

Matthew Roe, MD 

Jason Rogers, MD 

Kenneth Rosenfield, MD 

Mohd Ali Rosli, MD 

Carlos E. Ruiz, MD 

TranscaTheTer 


TherapeuTics 

Manel Sabate, MD 

Robert Safian, MD 

Shigeru Saito, MD 

Luigi Salemme, MD 

Habib Samady, MD 

Shaun Samuels, MD 

Giuseppe Sangiorgi, MD 

Maurice Sarano, MD 

Gary Schaer, MD 

Robert M. Schainfeld, DO 

Erick Schampaert, MD 



Paul Schoenhagen, MD 


Gerhard Schuler, MD 


Robert S. Schwartz, MD 

Amit Segev, MD 

Patrick Serruys, MD 


Samin Sharma, MD 


Thomas M. Shimshak, MD 

Mehdi Shishehbor, DO 

Georgios Sianos, MD 

Dirk Sibbing, MD 

Peter Sick, MD 

Horst Sievert, MD 


Frank Silvestry, MD 

Daniel Simon, MD 

Varinder P. Singh, MD 

Kimberly Skelding, MD 

Marvin Slepian, MD 

Richard Smalling, MD 

Peter Smits, MD 


Robert Sommer, MD 


Konstantinos Spargias, MD 

Sack Stefan, MD 

Christodoulos Stefanadis, MD 

Philippe Gabriel Steg, MD 

Terje Steigen, MD 

Pieter Stella, MD 

Peter Stone, MD 

Bradley Strauss, MD 

Thomas Stuckey, MD 

Rakesh Suri, MD 

Takahiko Suzuki, MD 

Corrado Tamburino, MD 

Huay Cheem Tan, MBBS 

Jean-François Tanguay, MD 

Gunnar Tepe, MD 


Martyn Thomas, MD 

Craig Thompson, MD 


18 


Vinod Thourani, MD 


Jonathan Tobis, MD 

Pim A.L. Tonino, MD 

On Topaz, MD 

Konstantinos Toutouzas, MD 

Hendrik Treede, MD 

Jennifer Tremmel, MD 

Dietmar Trenk, PhD 

Etsuo Tsuchikane, MD 

Zoltan Turi, MD 


Philip Urban, MD 

Alec Vahanian, MD 

Marco Valgimigli, MD 

Frans Van de Werf, MD 

Glenn Van Langenhove, MD 

Nicolas M. Van Mieghem, MD 

Freek Verheugt, MD 

Stefan Verheye, MD 

George W. Vetrovec, MD 


Clemens von Birgelen, MD 

Szilard Voros, MD 

Pascal Vranckx, MD 

Marco Wainstein, MD 


Simon Walsh, MD 


Bonnie H. Weiner, MD 

William Weintraub, MD 

Neil Weissman, MD 


Peter Wenaweser, MD 

Gerald S. Werner, MD 

Grayson Wheatley, MD 

Brian Whisenant, MD 

Mark Wholey, MD 

Michael Wholey, MD 

Robert Wilensky, MD 

Jeffrey Williams, MD 




Stephen Wiviott, MD 

Jochen Wöhrle, MD 

Wojciech Wojakowski, MD 

S. Chiu Wong, MD 

Bo Xu, MD 

Steven Yakubov, MD 

Masahisa Yamane, MD 

Robert Yeh, MD 

Alan Yeung, MD 

Christopher Zarins, MD 

Andreas M. Zeiher, MD 


challenging case 

revieWers 

The Challenging Case Committee 

led by Alexandre Abizaid, MD, 

PhD, and the TCT Course Directors 

would like to express their 

gratitude to the physicians who 

provided time and expertise as 

Challenging Case Reviewers. 


David Adams, MD 

S. Hinan Ahmed, MD 

Dominick Angiolillo, MD 

Steven Bailey, MD 


Mark Bates, MD 

Jorge Belardi, MD 

Lee Benson, MD 

John Bittl, MD 

James Blankenship, MD 

Peter Block, MD 


Emmanouil Brilakis, MD 

Jeffrey Brinker, MD 

Samuel Butman, MD 

Charles Chambers, MD 


Mehmet Cilingiroglu, MD 


Tyrone Collins, MD 


Marco Costa, MD 


Charles Davidson, MD 


Douglas Drachman, MD 

David Faxon, MD 

Marc Feldman, MD 





Steven Goldberg, MD 

James Goldstein, MD 

Paul Grayburn, MD 


Rebecca Hahn, MD 

James Hermiller Jr, MD 


Richard Heuser, MD 


John Hirshfeld, MD 

Michael Jaff, DO 

Allen Jeremias, MD 

Thomas Jones, MD 

Samir Kapadia, MD 


Navin Kumar Kapur, MD 



Morton Kern, MD 

Carey D. Kimmelstiel, MD 





Richard Lange, MD 

Massoud Leesar, MD 

Pedro Lemos, MD 

Scott Lim, MD 





Neil Moat, MD 


Douglas Morrison, MD 

John A. Ormiston, MD 

Igor Palacios, MD 


Lynn Peng, MD 



Duane Pinto, MD 

Vivek Reddy, MD 

John Reilly, MD 



Carlos E. Ruiz, MD 

Stefan Sack, MD 


Elias Sanidas, MD 



Gerhard Schuler, MD 


Patrick Serruys, MD 


Frank Silvestry, MD 

Martyn Thomas, MD 

Jonathan Tobis, MD 

On Topaz, MD 

Jennifer Tremmel, MD 

Thomas Tu, MD 

Zoltan Turi, MD 


Barry Uretsky, MD 

Nicolas van Mieghem, MD 


Bonnie H. Weiner, MD 

Brian Whisenant, MD 



laTe breaking Trial and 

FirsT reporT revieWers 

The TCT Course Directors, 

Martin B. Leon, MD, and 

Gregg W. Stone, MD, would like 

to thank the following physicians 

who provided their expert 

assistance in the selection process 

and who made the late breaking 

trial and first report investigation 

review process possible. 

Gary Ansel, MD 

Sorin Brener, MD 



Michael Ezekowitz, MBChB 



Bernard J. Gersh, MBChB 



Liliana Grinfeld, MD 


James Hermiller Jr, MD 



David Holmes Jr, MD 

Alice Jacobs, MD 












Ian T. Meredith, PhD 


Masahiko Ochiai, MD 



LeRoy Rabbani, MD 





Corrado Tamburino, MD 


Harvey D. White, MD 


Stephan Windecker, MD

coMMercial supporT 

TCT 2012 is sponsored by the Cardiovascular Research Foundation and partially funded 

through educational grants from commercial supporters. 

The Cardiovascular Research Foundation strives to ensure that its programs are as educational as possible and free from bias. To support this endeavor, 

TCT directors and co-directors create organizational and scientific committees to assist in educational content development and content oversight for 

live cases, spotlight sessions, case reviews, practical workshops, and scientific symposia. These sessions are developed without influence from 

commercial supporters. The educational grant support of our industry colleagues, who, like the Cardiovascular Research Foundation, are dedicated 

to educating medical professionals and the public to enhance patient outcomes, helps to make each TCT possible. 

The Cardiovascular Research Foundation 

gratefully acknowledges the 

TCT 2012 MAJOR BENEFACTORS: 

Abbott Vascular 

Boston Scientific Corporation 

Cardiovascular Systems, Inc. 

Cordis Cardiac and Vascular Institute SM 

Edwards Lifesciences 

Gilead Sciences, Inc. 

Medtronic CardioVascular 


gratefully acknowledges the 

TCT 2012 BENEFACTORS: 

AstraZeneca 

Cook Medical 

St. Jude Medical, Inc. 

Terumo Medical Corporation 

The Medicines Company 


appreciates the educational grant support 

for TCT 2012 provided by: 

ACROSTAK Corporation 

AirStrip Technologies 

AngioScore, Inc. 

BIOTRONIK 

Baxter Healthcare Corporation 

BridgePoint Medical, Inc. 

CardioKinetix, Inc. 

CircuLite, Inc. 

Cytori Therapeutics 

Daiichi Sankyo, Inc. and Lilly USA LLC 

Direct Flow Medical, Inc. 

Eurocor GmbH 

HeartFlow, Inc. 

Lutonix/Bard 

Mesoblast, Ltd. 

SentreHEART, Inc. 

STENTYS S.A. 

Thoratec Corporation 

Valtech Cardio, Ltd. 

W. L. Gore & Associates 


appreciates the educational grant support for the 

Faculty Support Program provided by: 

ABIOMED, Inc. 

AngioScore, Inc. 

BIOTRONIK 




MAQUET Cardiovascular 


The Cardiovascular Research Foundation appreciates 

the educational grant support for TCT: An Integrated Course 

for Surgeons and Interventionalists provided by: 



Thoratec Corporation 

The Cardiovascular Research Foundation appreciates the 

educational grant support for the 21st Annual Cardiovascular 

Nurse Technologist Symposium provided by: 

Disclosure Statement 






It is the policy of the Cardiovascular Research Foundation to ensure balance, independence, objectivity, 

and scientific rigor in all of its sponsored educational activities. Commercial support from industry 

does not influence educational content, faculty selection, and/or faculty presentations, and, therefore, 

does not compromise the scientific integrity of the educational activity. 

Discussion of off-label product usage and/or off-label product use during live cases is made at 

the sole discretion of the faculty. Off-label product discussion and usage are not endorsed by the 

Cardiovascular Research Foundation or the conference directors of this activity. 

Faculty participating in continuing medical education activities sponsored by the Cardiovascular 

Research Foundation are required to disclose to the activity audience any real or apparent conflicts of 

interest related to the content of their presentations. Faculty not complying with this policy 

are not permitted to participate in this activity. 


20 

special acTiviTies 

Education 

Peer-Reviewed Oral, Poster, and 

Challenging Case Abstracts 

The presentation of original peer-reviewed 

research is the basis of scientific discovery, 

representing the heart of academic medicine and 

offering participants opportunities to interact 

with peers in an intimate setting for critical 

review prior to manuscript generation. 

To emphasize TCT’s belief in the importance 

of such research, all accepted abstracts will 

be presented in a dedicated four-hour block. 

Abstracts, both poster and oral, will be 

downloadable during TCT in electronic format 

via TCTMD.com and from the cyber center 

stations located throughout the Miami Beach 

Convention Center. Abstracts are published 

in a special supplement of the Journal of the 

American College of Cardiology, available in 

the attendee meeting bag. New this year, the 

top oral abstracts will be available to view 

in an interactive format via iPads available 

outside the Main Arena. Challenging Case Video 

Presentations will be available during the Poster 

Abstract Sessions and also on Wednesday and 

Thursday. Please see pages 74-105 for complete 

listings or visit www.tctconference.com. 

Tuesday, OcTOber 23 

Poster Abstract and Challenging Case 

Video Presentations 

8:00 am-10:00 am 

Oral Abstract Sessions 

10:30 am-12:30 pm 

Wednesday and Thursday, OcTOber 24-25 

Top Oral and Poster Abstracts 

iPad Display 

8:00 am-6:00 pm 

Challenging Case Video Presentations 

10:00 am-11:00 am, 2:00 pm-3:00 pm 

The top poster abstracts will be moved to the 

Exhibit Hall and available for viewing during 

Exhibit Hall hours. 

3-D Theater 

New at TCT you can experience full 3-D 

demonstrations of present and future 

technologies for structural heart disease using 

3-D technology. The new 3-D Theater will host 

video vignettes focused on demonstrations of 

aortic and mitral valve anatomies. 

A special dedicated edited taped case will 

present a novel technology in the 3-D Theater, 

“3-D Interventional Cardiovascular Procedure,” 

on Wednesday, October 24, from 1:30 pm-2:00 pm. 

The 3-D Theater is located in the Physician 

Training Center inside the Exhibit Hall of the 

Miami Beach Convention Center. 


3-D 30-Minute Vignettes 

1:30 pm - 3-D Aortic Valve 

2:30 pm - 3-D Mitral Valve 

3:30 pm - 3-D Potpourri of Anatomies 


Wednesday, OcTOber 24 


9:30 am - 3-D Aortic Valve 

10:30 am - 3-D Mitral Valve 

11:30 am - 3-D Potpourri of Anatomies 




Thursday, OcTOber 25 


9:30 am - 3-D Aortic Valve 

10:30 am - 3-D Mitral Valve 

11:30 am - 3-D Potpourri of Anatomies 






Challenging case presentations will be 

highlighted in the new International Multiplex 

Theater with two society-sponsored Challenging 

Case Theaters offering sessions organized under 

the auspices of numerous societies from around 

the world. The International Multiplex Theater 

is located in Hall A of Miami Beach Convention 

Center. Please see pages 118 and 138 for 

complete listings or 

visit www.tctconference.com. 

ACC Educational Sessions 

Co-sponsored by the American College of 

Cardiology (ACC) and the Cardiovascular 

Research Foundation (CRF) 

These sessions will be planned and developed 

by the ACC in partnership with CRF. 


1:00 pm-6:00 pm 

Hot Topics in Cardiology: ACC.12 with TCT 

Highlights for the Interventional, Invasive, 

and General Cardiologist (page 107) 

Launching and Sustaining Your Career: 

A Joint Session of the ACC’s Cardiovascular 

Leadership (page 109) 


12:15 pm-1:45 pm 

ACC Special Fellows Session I. Valvular Heart 

Disease: Year in Review 2012 (page 125) 


12:15 pm-1:45 pm 

ACC Special Fellows Session II. Oral 

Anticoagulation 2012: VTE, Atrial Fibrillation, 

and Valvular Heart Disease (page 146) 

Special JACC Session: How to Write and 

Evaluate Medical Journal Articles (page 148) 

Maintenance of Certification 

(MOC) Course and ABIM 

Simulation Sessions 

The MOC Course will prepare you with the 2010, 

2011, and 2012 update modules, enhance your 

knowledge base, and get you updated for your 

ten-year recertification on the ABIM and ABVM 

exams. You can earn up to 30 credit points from 

the home study module sessions at the MOC 

Course and an additional 20 credit points for 

participating in the Practice Improvement Module 

(PIM). TCT can offer you up to 50 credit points, 

half of the 100 credit points needed to sit for the 

secure recertification examination. Please 

see pages 120 and 140 for complete listings 

or visit www.tctconference.com. 

Hands on Hearts Pavilion 

Hands on Hearts includes actual pathological 

specimens demonstrating human heart disease 

as well as CT-generated casts of human hearts 

prior to intervention, ventricular septal defects, 

valvular pathology, cardiomyopathies, and 

coronary anomalies. Don’t miss the scheduled 

live demonstration vignettes that will be 

displayed on a large screen in the extended 

area of Hands on Hearts. Please visit the Hands 

on Hearts Pavilion in Hall A of Miami Beach 

Convention Center. 

Hands on Hearts Pavilion Hours 


9:00 am-5:00 pm 

Friday, OcTOber 26 

9:00 am-12:00 pm 

Hands on Hearts Live Demonstrations 


10:00 am-10:30 am - Aortic Valve Disease and 

Normal Anatomy 

3:00 pm-3:30 pm - Mitral Valve Disease 

and Normal Anatomy 


10:00 am-10:30 am - Atrial Septal Defects, 

PFOs, and Atrial Appendage Anatomy 

3:00 pm-3:30 pm - Aortic Valve Disease 

and Normal Anatomy

ABCs of Interventional Cardiology: 

An Introductory Course 

This five-hour course (page 50), held Sunday, 

October 21, the day before the opening of 

TCT, will provide a primer for physicians, allied 

health professionals, and others interested in 

the basics of cardiac anatomy and angiography, 

cardiovascular pathophysiology, and an 

introduction to coronary angioplasty/stenting. 


For the first time all the Twilight Sessions will 

be hosted on one evening only: Monday, 

October 22. Special Twilight Sessions will 

highlight featured clinical research, presentations 

on the hottest topics in interventional cardiology, 

and hosted must-see international sessions in a 

more casual setting with hors d’oeuvres. 

Please see pages 67-69 for complete listings or 



Learn the Technique sessions (pages 127, 148, and 

160) will demonstrate step-by-step approaches 

to advanced interventional techniques, relying 

heavily on patient cases to showcase tips and 

tricks to achieve success while avoiding (and, if 

necessary, managing) complications. Hot Topics 

(pages 125, 146, and 159) will cover current 

controversies and other special topics. 

Spotlight Sessions 

Spotlight Sessions (pages 123, 130, 142, 

151, and 157) offer focused, clinical issuecentered 

sessions with featured lectures, case 

presentations, and special “summary” sessions. 

TCT: An Integrated Course for 

Surgeons and Interventionalists 

The integrated course within TCT Week will be of 

special interest to cardiac and vascular surgeons 

and general cardiologists, highlighting advanced 

techniques and emerging devices specific to 

cardiovascular surgery as well as emphasizing 

areas of percutaneous and minimally invasive 

therapies including transcatheter valve therapies 

and structural heart and aortic aneurysm repair. 

Please see page 6 for complete listings or 


21st Annual Cardiovascular Nurse 

and Technologist Symposium 

Join us as we celebrate the 21st anniversary 

of this symposium. TCT for Nurses and 

Technologists is the preeminent forum to 

learn and discuss the latest advances in 

interventional, pharmacologic, structural heart, 

and endovascular strategies for the management 

of the cardiovascular patient. Please see page 6 

for listings or visit www.tctconference.com. 

nEtworking 

TCT Global Educational 

Partnerships 


TCT Booth 459 

Come visit over a dozen international 

organizations which CRF has collaborated with 

throughout the year in presenting educational 

programs outside the United States. You will 

have the opportunity to network with your 

colleagues, relax and have a café latte in the 

morning and smoothies and popcorn in the 

afternoon. The booth will be equipped with 

wireless and you can charge your laptop. 

p-c-i live with TCT 

November 29-30, 2012 

Munich, Germany 

Innovations in Cardiovascular Interventions (ICI) 

December 2-4, 2012 

Tel Aviv, Israel 

TCT @ Taiwan Transcatheter Therapeutics (TTT): 

Highlights of TCT 2012 

January 12-13, 2013 

Taipei, Taiwan 

Joint Interventional Meeting (JIM) 2013 

February 14-16, 2013 

Rome, Italy 

China Interventional Therapeutics (CIT) 


March 20-23, 2013 

Beijing, China 


April 2013 

Turkey 

Angioplasty Summit-TCTAP 

April 23-26, 2013 

Seoul, South Korea 


June 9-11, 2013 

Moscow, Russia 

GI2 Global Summit on Innovations in Interventions 


July 24-26, 2013 

São Paulo, Brazil 

Sociedad Latino Americana de Cardiologia 

Intervencionista (SOLACI) in Partnership with TCT 



Advanced Cardiovascular Solutions (ACVS) 


August 8-11, 2013 

Hyderabad, India 

TCT @ Colegio Argentino de Cardioangiólogos 

Intervencionistas (CACI) 

October 3-6, 2013 

Buenos Aires, Argentina 


TranscaTheTer 


TherapeuTics 

Partnership Pavilion 

Come visit the CRF Partnership Pavilion 

booth outside the Main Arena to learn 

about the services CRF offers and also meet 

representatives from the American College of 

Cardiology (ACC) and NewYork-Presbyterian/ 

Columbia University Medical Center. 

For more information about each of these 

organizations, please visit CRF at www.crf.org, 

ACC at www.cardiosource.org/acc, 

NewYork-Presbyterian at www.nyp.org, and 

Columbia University Medical Center 

at www.cumc.columbia.edu. 

Exhibit Hall Opening 

Please join us at the opening of the Exhibit Hall 

for lunch at 12:00 pm on Tuesday, October 23. 

The Exhibit Hall will help you explore and 

discover the latest developments with industry 

leaders in interventional cardiology. 

Exhibit Hall Hours 


12:00 pm-5:00 pm 


9:00 am-5:00 pm 

Art from the Heart 

Art from the Heart is a sculpture exhibition 

provided by the international award-winning 

sculptor Akiva Huber. Please visit Mr. Huber’s 

exhibition during TCT outside the “How to Treat” 

Theaters in Hall A. 


22 

special acTiviTies 

in MEMoriuM 

Special Memorial to 

Geoffrey O. Hartzler, MD 

Please join us in the Main Arena for a memorial 

to Geoffrey O. Hartzler, MD, including a special 

video tribute of Dr. Hartzler in his own words. 

Please see page 116 for the memorial session. 


Plenary Session III. A Memorial to 


9:35 am-10:20 am 

Main Arena (Hall D) 

MEals at tct 

Lunches will be served during Scientific 

Symposia (Monday, October 22), at the opening 

of the Exhibit Hall (Tuesday, October 23), and 

during lunchtime activities (Wednesday through 

Friday, October 24-26). Concession stands will 

be available throughout the Exhibit Hall and the 

Miami Beach Convention Center and will include 

a kosher stand this year. 

tEchnology 

Smart Tags at TCT 

With only your mobile device, access detailed 

information and the slides from the late breaking 

trial presentations and abstract posters. Smart 

tags will be located on the signs outside the 

room where late breaking trials are presented 

and in the Poster Abstract Sessions. 

CRF Meetings App for 

iPhone/iPad and Android 

The CRF Meetings App is made possible 

through support from Cook ® Medical 

Keeping up to date with news and finding the 

best sessions at TCT has never been easier with 

our free app. You can get up-to-date information 

on TCT, search agendas, exhibitors, and faculty, 

add sessions to your calendar, and view the 

Virtual TCT stream. You can rate speakers, 

sessions, and cases with the app and network 

with faculty and other attendees. The free CRF 

Meetings App is available for download from 

iTunes and Google Play. 

TCTMD Premium 

Enhance the unparalleled educational 

experience available at TCTMD.com with 

access to PowerPoint slides, webcasts of TCT 

presentations, live case videos, and a host of 

educational content from TCT and other leading 

meetings in interventional cardiology. New 

this year, all TCTMD premium content is now 

available from within the TCTMD mobile app. 

Visit the TCTMD booth during TCT or 

www.tctmd.com to learn more and test drive 

TCTMD’s premium offerings, TCTMD Gold 

and TCTMD Prime. 

TCTMD Gold provides unlimited access to more 

than 10,000 PowerPoint slides and webcast 

presentations from TCT, TVT, and premier 

interventional cardiology conferences as well 

as a library of live case videos from cath labs 

around the world. TCTMD Gold members have 

access to all of TCTMD’s content, premium 

and standard. 

TCTMD Prime offers preparation for the 

interventional board exam and ongoing 

interventional education. TCTMD Prime 

includes PowerPoint slides and webcasts of all 

presentations from the annual TCT Board Review 

Course with Self-Assessment and CRF’s annual 

Fellows Courses as well as access to all factoid 

PowerPoint slides. TCTMD Prime members also 

receive biweekly e-newsletters with multiple 

choice questions and answers similar to those on 

the board exams. 

TCTMD Mobile App 

Stay up-to-date with content from TCT by 

downloading the free TCTMD mobile app for 

iPhone and iPad. The app provides TCTMD 

subscribers with access to all TCTMD Web site 

content, including daily news articles, case 

studies, and TCTMD premium content in a 

mobile friendly format. TCTMD’s professional 

networking program, TCTMD Connect, is also 

included and allows subscribers to communicate 

with colleagues and follow the TCT Blog while 

on the go. The free TCTMD App is available for 

download from iTunes. 

Virtual TCT 

Virtual TCT delivers live and on-demand viewing 

of the Main Arena during TCT 2012 and for 30 

days after the conference. Access to Virtual TCT is 

provided complimentary to registered TCT Week 

and TCT in 3 attendees. 


8:00 am-6:00 pm 

Friday, OcTOber 26 

8:00 am-3:15 pm 

lEarning labs 

Learning Labs are dedicated to creating an 

intimate educational atmosphere in which 

physicians and healthcare professionals 

can interact with a company’s clinical 

specialist to enhance their knowledge and 

understanding of treatment techniques 

and devices. 

Learning Lab Sponsored 

by Medtronic, Inc. 

Medtronic iLab 

At the Medtronic iLab, registrants will 

experience a range of new manufacturing 

technologies and therapy innovations currently 

in development at Medtronic. Medtronic’s iLab 

is conveniently located in the Exhibit Hall with 

sessions Tuesday through Thursday, October 

23-25, during Exhibit Hall hours. Attendees 

may visit the Medtronic iLab in the Exhibit Hall 

to register for an appointment. 

Physician training 

cEntEr 

Be sure to visit the Physician Training Center 

where you will have the opportunity to view 

our 3-D movies highlighting aortic valve 

demonstrations, mitral valve demonstrations, 

and demonstrations of other anatomies. 

And in this area you can test your skills 

and knowledge on a number of 

simulation applications.

Save the Dates 

p-c-i Live with TCT 

November 29-30, 2012 


Annual Pulse of the 

City Gala 

December 14, 2012 

New York, NY 

Conference on Cell Therapy 

for Cardiovascular Disease 

January 23-25, 2013 

New York, NY 

Complex PCI: Left Main and 

CTO Summit 

February 21-23, 2013 

New York, NY 

China Interventional 

Therapeutics (CIT) in 


March 20-23, 2013 


CardiovasC ular 

r esearC h 

Foundation 

Save the dates for these upcoming meetings sponsored 

by the Cardiovascular Research Foundation. 

Optimizing PCI Outcomes 

March 2013 

San Francisco, CA 

ACC.13/i2 Summit with TCT 

March 9-11, 2013 



Fellows Course 

April 14-17, 2013 

San Jose, CA 

Visit us at the Partnership Pavilion located in Hall D, Level 1. 

Educational Activities 

Angioplasty Summit-TCTAP 

April 23-26, 2013 



April 2013 

Turkey 


June 9-11, 2013 


Transcatheter Valve 

Therapies (TVT) 2013 

June 12-15, 2013 

Vancouver, Canada 

Sociedad Latino 

Americana de Cardiologia 

Intervencionista (SOLACI) 




Gi2 with TCT 



Transcatheter 

Cardiovascular Therapeutics 

(TCT) 2013 

Oct 28-Nov 1, 2013 

San Francisco, CA

24 

JoinT acTiviTies 

Joint Conflict of Interest (CoI) 

and relationship with Industry 

(rWI) Policies of the 

Cardiovascular research 

foundation (Crf) and the 

American College of Cardiology 

foundation (ACC) 

CRF/ACC require and collect disclosure of 

relationships with industry (RWI) from all 

individuals who are in a position to control 

or influence educational content. This is 

done annually in conjunction with all of 

CRF’s meetings and educational offerings 

for which CME is offered (including 

TCT, CRF’s major annual educational 

event) and all of ACC’s meetings and 

educational offerings for which CME 

is offered (including the annual ACC 

scientific session). All individuals involved 

in directing, planning, and delivering 

educational content for CRF and ACC 

(course directors, planning committee 

members, faculty, staff, etc) are required 

to submit RWI disclosures prior to 

participation; otherwise their participation 

in the event is precluded. If disclosure 

of RWI information is not already on file 

at the inception of a new activity, that 

information is collected at confirmation of 

individual participation. This information 

is also confirmed and updated prior to the 

development of each CME activity to ensure 

that the most up-to-date information is 

collected and available. Likewise, nonphysician 

staff are required to complete RWI 

Disclosure Declaration forms. 

COI (RWI) DeClaRatIOn 

The online Required Faculty Disclosure 

Declaration form requires each individual 

to identify financial relationships that 

he or she and/or his or her spouse or 

partner have had with any organization 

within the preceding 12 months or that 

is anticipated in the next 12 months that 

could be perceived as a relevant conflict 

of interest. Any individual who does not 

complete the form is not permitted to 

participate; this includes course director(s) 

and planners (who are then excluded from 

planning the activity) as well as faculty. For 

a live activity, each faculty is required to 

check-in upon arrival; and faculty who have 

not completed their RWI declarations are 

not allowed to enter the CME activity. For 

enduring activities, the CME product is not 

published, either online or in print, until all 

declarations are completed. 

COI ResOlutIOn 

Director(s) and planning committee 

members are required to complete the 

COI Resolution form prior to content 

development. In the event that a conflict 

of interest exists, the activity content is 

reviewed by course director(s), planning 

committee members, CME committee 

members, or designees who do not have 

conflicts of interest. 

Speakers, Presenters, Moderators, 

Panelists, and Live Case Operators who 

have declared a COI or RWI are required 

to complete a COI Resolution form online 

to indicate that they will resolve their 

conflict(s) by one or more of the following: 

1. Confirming that no patient care 

recommendations will be made to the 

learners regarding the use of drugs or 

devices from companies with which they 

have a financial relationship 

2. Confirming that if patient 

recommendations will be made to the 

learners regarding the use of drugs or 

devices from companies with which 

they have a financial relationship, the 

conflict will need to be resolved (see next 

paragraph) 

3. Submitting an alternate resolution of 

the conflict that is then reviewed by the 

CME Committee, course director(s) and/ 

or planning committee, and if acceptable, 

approved 

4. Recommending an alternate speaker 

5. Agreeing to divest themselves of the 

financial relationship 

Upon receipt of the COI Resolution form, 

the course director(s), planning committee 

members, or CME committee members or 

their designees review each COI Resolution 

form to determine the course of action, 

if any, necessary to resolve the conflict. 

Possible conflict resolution mechanisms, 

based on the educational design of the 

program, include using a variety of 

approaches including, but not limited to: 

1. Knowledge of speakers (for example, in 

the past has the individual participated 

in unbiased presentations, discussions, 

published literature, etc) 

2. Knowledge of content 

3. Interview with speakers 

4. Slide peer review 

5. Abstract peer review 

6. Replacing the presenter 

For TCT and ACC annual scientific sessions 

where presentations number in the 

thousands, a committee is formed to 

review all faculty financial relationships 

to determine whether slide review is 

necessary; if so, slides are reviewed prior to 

presentation and, when necessary, changes 

are recommended and implemented. 

In July 2010, in response to an ACCME 

update, sessions with industry employee 

speakers are allowed to be certified under 

the following circumstances: 

1. The presentation is about the scientific 

or discovery process itself 

2. The presentation is about products that 

have not yet entered the clinical arena 

(including products that are under 

investigation) 

3. Presentation slides are submitted at 

least 2 weeks before the start of the 

CME activity, and the presenter agrees 

in advance to any and all modifications 

requested by the CME committee

DIsClOsuRe tO attenDees 

Standard practices to ensure that faculty 

financial relationships are disclosed to the 

learners prior to the activity include: 

1. Online disclosures available only 

at www.tctconference.com 

2. A COI slide prepared by the presenter 

is inserted at the beginning of the 

presentation. COI slide templates are 

e-mailed to all faculty approximately one 

month prior to the activity. Audiovisual 

vendors review each presentation to 

ensure that a COI slide has been inserted, 

and are instructed not to load or confirm 

the speaker’s presentation without a valid 

COI slide being present. 

aDDItIOnal POlICIes Of 

the CaRDIOvasCulaR 

ReseaRCh fOunDatIOn 

CRF requires members of the Board of 

Directors, all employees, and affiliated 

physicians to disclose on an annual basis 

any relevant financial interests. The process 

is managed and the policy is enforced 

by CRF’s Compliance Oversight Review 

Committee of the Board of Directors and 

its Compliance Officer. 


For the TCT scientific sessions, abstracts 

are peer-reviewed and if accepted are 

presented at the meeting and published 

in the Journal of the American College of 

Cardiology. Approximately 379 physicians 

grade the abstracts, 82% of whom are TCT 

Course Directors, Co-directors, or Associate 

Directors, planning committee members, 

or faculty, and their Disclosure Declarations 

are on file. The abstract review process is 

performed online, is blinded, and requests 

reviewers to recuse themselves from 

grading abstracts for which they may have 

a COI or RWI. Ten reviewers are assigned 

to grade each abstract, and the high and 

low scores are discarded. This process 

was selected to mitigate the effect of any 

one individual who may have a conflict of 

interest. Late Breaking Trial review is also 

performed online similar to the abstract 

review process. For TCT 2011, 25 physicians 

graded the Late Breaking Trial submissions 

with an average of 16 reviewing each study. 

As part of the selection process, outlier 

as well as mean scores are reviewed to 

confirm that grading is fair. 


TranscaTheTer 


TherapeuTics 

For all live activities except TCT, CRF has 

mandatory slide review for all individuals, 

even individuals who attest that (1) 

recommendations will be based on data 

and findings from peer-reviewed sources 

or, in the absence of adequate peerreviewed 

material, will rely on the best 

available evidence based medicine, and 

(2) content will be fair and balanced, and if 

any product specific drugs or devices are 

discussed, alternative drugs or devices will 

be discussed. Slides are reviewed prior to 

presentation, and when necessary, changes 

are recommended and implemented. 

Faculty members at all CRF educational 

events are instructed to communicate 

verbally to the audience the RWIs displayed 

on the COI slide. CRF’s audiovisual vendor 

has developed a system that requires that 

the COI slide cannot be advanced until a 

sufficient time has elapsed to allow it to be 

read by the audience. 



cMe/cne inForMaTion 

Overview 

Transcatheter Cardiovascular Therapeutics 

(TCT) is the world’s largest and most important 

educational meeting specializing in interventional 

cardiovascular medicine. For more than 20 years, 

TCT has been the center of the latest advances in 

current therapies and clinical research. 

CME Accreditation 

and Designation 

The Cardiovascular Research 

Foundation is accredited by the 

Accreditation Council for 

Continuing Medical Education to provide 

continuing medical education for physicians. 


designates this live activity for a maximum of 

47.50 AMA PRA Category 1 Credits. Physicians 

should claim only the credit commensurate with 

the extent of their participation in the activity. 

One contact hour equals 60 minutes of learning 

time. This does not include Breakfast Meetings, 

Evening Symposia, or other specialty programs 

such as Hands on Hearts. 

Documentation of awarded credit is provided for 

registered attendees in exchange for completed 

online activity evaluations. Certificates of 

attendance are provided to all registered 

attendees in their meeting bags. 

CNE Accreditation 

and Designation 

The American College of Cardiology 

Foundation (ACCF) is accredited 

as a provider of continuing nursing 

education by the American 

Nurses Credentialing Center’s Commission 

on Accreditation. 

The ACCF designates TCT 2012 educational 

activity for a maximum of 43.5 contact hours. 

Requirements for successful completion are 

attendance at TCT 2012 sessions offering 

continuous nursing education in their entirety 

and completing the evaluation tool. Each nurse/ 

nurse practitioner attendee may only claim 

the contact hours commensurate with the 

extent of their separate or combined successful 

completion in the activities. 

Target Audience 

This symposium is designed for interventional 

cardiologists, radiologists, clinical cardiologists, 

basic scientists, vascular medicine specialists, 

cardiac and vascular surgeons, nurse 

practitioners, nurses, cath lab technicians, and 

other health care professionals with a special 

interest in the field of interventional and 

vascular medicine. 

Needs Statement 

TCT provides the latest evidence-based data 

presented by leading physicians, nurses, 

and scientists that will affect the practice of 

interventional cardiology and endovascular 

medicine, current and emerging techniques and 

technologies with practical applications, and 

unparalleled diversity of live-case presentations 

from universities and medical centers around the 

world. In the field of interventional cardiology, 

only TCT combines late breaking science and 

practical learning that physicians need to 

improve patient outcomes. 

Activity Goals 

The overall goal of this activity is to improve 

competence and performance of our target 

audience by delivering new cutting-edge 

educational content that showcases the latest 

advances in current therapies and clinical 

research. We hope that our long-standing 

commitment to life-saving innovation will 

translate into improved patient care. 

Learning Objectives 

By the end of the symposium, participants 

should be able to: 

• Apply the results from important clinical 

trials and evidence-based medicine to guide 

management of patients with atherosclerosis 

and structural heart disease 

• Incorporate new interventional technologies 

and procedures into the care of patients with 

complex coronary and endovascular disease 

• Integrate advances in diagnostic evaluation 

and therapeutics to patients with carotid and 

peripheral arterial disease 

• Implement appropriate pharmacologic 

management in the care of patients 

undergoing diagnostic arteriography and 

interventional therapies before, during, and 

after catheterization 

• Identify new interventional technologies and 

propose appropriate applications for patients 

with cardiovascular disease 

Disclosure Statement 

It is the policy of the Cardiovascular Research 

Foundation and the American College of 

Cardiology Foundation to ensure balance, 

independence, objectivity, and scientific rigor 

in all of its sponsored educational activities. 

Commercial support from industry does not 

influence educational content, faculty selection, 

and/or faculty presentations, and, therefore, does 

not compromise the scientific integrity of the 

educational activity. 

Discussion of off-label product usage and/or 

off-label product use during live cases is made 

at the sole discretion of the faculty. Off-label 

product discussion and usage are not endorsed 

by the Cardiovascular Research Foundation, 

the American College of Cardiology Foundation 

or the conference directors of this activity. 

Faculty participating in continuing medical 

education activities sponsored by the 

Cardiovascular Research Foundation and the 

American College of Cardiology Foundation are 

required to disclose to the activity audience any 

real or apparent conflicts of interest related to 

the content of their presentations. Faculty not 

complying with this policy are not permitted to 

participate in this activity. 

CME and CNE Credit Claim 

To claim your CME or CNE credits, please 


Successful completion requires a brief evaluation 

for each of the sessions attended as well as an 

evaluation for the TCT conference as a whole. 

Evaluations will address content, presentation, 

possible bias, and future educational needs. 

For any CME or CNE related inquiry, 

please contact cme@crf.org. 

Program Sponsorship 

This symposium is sponsored by the 

Cardiovascular Research Foundation. 

This symposium is co-provided by the 

American College of Cardiology Foundation. 

Program Support 

This symposium is partially funded through 

educational grants from commercial supporters. 

The Cardiovascular Research Foundation and 

the American College of Cardiology Foundation 

ensure that these programs are educational and 

meet the needs of the target audience. 

To support this endeavor, the directors and 

co-directors of TCT create organizational and 

scientific committees to assist in educational 

content development and content oversight 

for live cases, concurrent sessions, case 

reviews, abstract sessions, practical workshops, 

and scientific symposia. These sessions are 

developed without influence from 

commercial supporters. 

Disclaimer 

nOnenDORsement Of PRODuCts 

Accredited status does not imply endorsement 

by the ANCC of any commercial products 

displayed in conjunction with this activity.

With the passing this March of Geoffrey O. Hartzler, MD, 

who performed the first coronary angioplasty to 

treat acute myocardial infarction (MI) in 1979 at the 

Mayo Clinic, the world lost a true medical pioneer. 

Dr. Hartzler earned his MD from Indiana University, 

Bloomington, in 1972 and started the angioplasty 

program at the Saint Luke’s Mid America Heart 

Institute (Kansas City, MO) in 1980. 

He broadened the reach of angioplasty from 

simple discrete lesions to complex lesions and 

patients including multivessel disease, chronic 

total occlusions, and acute MI. 

Dr. Hartzler and his colleagues trained a generation 

of cardiologists around the world in PCI, through 

the use of live and taped cased at the biannual 

“Hartzler courses” in Kansas City and Hawaii. 

His creation of the first comprehensive 



special Tribute to 

geoffrey o. hartzler, Md 

The original master operator 

Wednesday, october 24 

main Arena 

Plenary Session III. A memorial to 

Geoffrey o. Hartzler, mD 

9:35 am-10:20 am 

TranscaTheTer 


TherapeuTics 

computerized database in interventional cardiology 

set the standard for critical outcomes analysis for 

the subspecialty and served as the spark for today’s 

emphasis on evidence-based medicine to guide 

patient clinical decision-making. 

Dr. Hartzler founded the first Advanced Angioplasty 

Fellowship, which has been the template for 

programs around the world. His trainees include 

TCT Course Director Gregg W. Stone, MD, of 

Columbia University Medical Center, New York, 

among many other well-known names. 

In 2009, the Master Clinical Operator Award 

given annually at TCT to recognize an interventional 

operator who has distinguished himself or 

herself as an innovator in the field was named 

for Dr. Hartzler. 

Please see page 116 for the memorial session. 


28 

geoffrey o. hartzler 

Master clinical 

operator award 

Wednesday, Ocotber 24, at 10:20 am 

2009 


2010 


Takahiko Suzuki, MD 

Hideo Tamai, MD 

2011 

Horst Sievert, MD 


Barry D. Rutherford, MD 

TcT 2012 awards 

Please join us in the main Arena for the 

presentation of the following awards: 

TcT career 

achievement award 

Thursday, Ocotber 25, at 11:00 am 

1994 


1995 

David R. Holmes, MD 

1996 


1997 

John B. Simpson, MD 

1998 


1999 

Julio C. Palmaz, MD 

2000 

Donald S. Baim, MD 

2002 

William W. O’Neill, MD 

2003 

J. Eduardo M.R. Sousa, MD, PhD 

2004 

Eugene Braunwald, MD 

2005 

James T. Willerson, MD 

2006 

Paul Yock, MD 

2007 


2008 


2009 


2010 


2011 

Eric J. Topol, MD 



Thomas J. linnemeier 

spirit of interventional 

cardiology young 

investigator award 

Friday, October 26, at 11:00 am 

2003 


2004 

Farouc Jaffer, MD, PhD 

2005 


2006 


2007 

Wojciech Wojakowski, MD, PhD 

2008 

Mehdi H. Shishehbor, DO, MPH 

2009 

Robert A. Byrne, MD 

2010 

Colin M. Barker, MD 

2011 

Davide Capodanno, MD 

Robert W. Yeh, MD 

2012 Finalists 

Ehrin J. Armstrong, MD, MSc 


Giulio G. Stefanini, MD

October 22-26, 2012 

MIAMI BEACH CONVENTION CENTER 

MIAMI, FL 

Week at a Glance 


9:30 

pm 

9:00 

pm 

8:30 

pm 

8:00 

pm 

7:30 

pm 

7:00 

pm 

6:30 

pm 

6:00 

pm 

5:30 

pm 

5:00 

pm 

4:30 

pm 

4:00 

pm 

3:30 

pm 

3:00 

pm 

2:30 

pm 

2:00 

pm 

1:30 

pm 

1:00 

pm 

12:30 

pm 

12:00 

pm 

11:30 

am 

11:00 

am 

10:30 

am 

10:00 

am 

9:30 

am 

9:00 

am 

8:30 

am 

8:00 

am 

7:30 

am 

7:00 

am 

Registration: All Attendees and Exhibitors 

SUNDAY, 10/21 

ABCs of Interventional Cardiology 

Registration: All Attendees and Exhibitors 

TCT for Surgeons 

Scientifi c Symposia 

MONDAY, 10/22 

Board Review Course with Self-Assessment for Interventional Cardiology (Part 1) 

21st Annual Nurse and Technologist Symposium Registered Cardiovascular Invasive Specialists (RCIS) Review Course Special Twilight Sessions 

Breakfast Meetings Poster Abstracts Oral Abstracts Scientifi c Symposia 

Board Review Course with Self-Assessment for Interventional Cardiology (Part 2) 

TCT for Surgeons Lunch in Exhibit Hall TCT for Surgeons 

TUESDAY, 10/23 

Presentation 

Theater 

21st Annual Nurse and Technologist Symposium 

Exhibit Hall Evening Programs 

Breakfast Meetings Maintenance of Certifi cation (MOC) Session 


Main Arena 

How to Treat Theater: Coronary Artery Disease 

How to Treat Theater: Structural Heart Disease How to Treat Theater: Endovascular Disease 

Learn the Technique 






WEDNESDAY, 10/24 

Hot Topic 



TCT for Surgeons TCT for Surgeons 

Presentation Theater 


Breakfast Meetings Maintenance of Certifi cation (MOC) Session 

Main Arena 


How to Treat Theater: Endovascular Disease How to Treat Theater: Structural Heart Disease 







TranscaTheTer 


TherapeuTics 

THURSDAY, 10/25 

Hot Topic 


TCT for Surgeons 

FDA Town Hall Meeting 

Presentation Theater 


WWW.TCTConfErEnCE.Com 29 

Breakfast Meetings Main Arena 


FRIDAY, 10/26 




SunDAy - oCTobEr 21, 2012 

Hot Topic 

Lunchtime Sessions

For more information, contact: 


Executive Director, 

Meetings and Educational Services 

Tel: 646-434-4392 

E-mail: jwhite@crf.org 

Josh D. Hartman 

Director, Educational Services and 

Strategic Relations 

Managing Editor, TCTMD 

Tel: 646-434-4604 

E-mail: jhartman@crf.org 

CRF is certifi ed to accredit programs for 

continuing medical education (CME). 

CARDIOVASCULAR 

RESEARCH 

FOUNDATION 

Looking for someone to execute a 

fl awless meeting, symposia, conference, 

or educational program on your behalf? 

You found us. 


Center for Education 

STRATEGIC PLANNING · MEETING LOGISTICS · PROGRAM DEVELOPMENT 

FACULTY MANAGEMENT · POST-MEETING RECONCILIATION 

MARKETING AND BRANDING · GRAPHIC DESIGN · WEB SITE DEVELOPMENT 

VIDEO AND INTERACTIVE MEDIA · E-LEARNING 


RESEARCH FOUNDATION ® 

a passion for innovation

traNScatheter 

cardiOvaScular 

therapeuticS 

twenty-fifth 

AnniversAry 

Save the date 

Oct 28-NOv 1, 2013 

SaN FraNciScO 

the MOScONe ceNter 

www.tctconference.com

inTernaTional FaculTy 


Instituto Dante Pazzanese de Cardiologia 


Andrea Abizaid, MD, PhD 



Sergey A. Abugov, ScD 

BV Petrovsky Russian Centre of 

Science of Surgery 


Madhavpeddi Sai Aditya, MD 

Nizam’s Institute of Medical Sciences 


Tom Adriaenssens, MD 

University Hospitals Leuven 

Leuven, Belgium 

Taehoon Ahn, MD, PhD 

Gachon University Gil Medical Center 

Incheon, South Korea 

Takashi Akasaka, MD, PhD 

Wakayama Medical University 

Wakayama, Japan 

Marco Alcantara, MD 

Instituto Nacional de Cardiologia 

Mexico City, Mexico 

Bagrat Alekyan, MD, PhD 

Bakoulev Center for Cardiovascular 

Surgery RAMS 


Dimitrios Alexopoulos, MD 

Patras University Hospital 

Patras, Greece 

Fernando Alfonso, MD, PhD 

Hospital Universitario San Carlos 

Madrid, Spain 

Yaron Almagor, MD 

Shaare Zedek Medical Center 

Jerusalem, Israel 

Jose A. Alvarez, MD 

Universidad del Salvador 


Max Amor, MD 

Clinique Louis Pasteur 

Essey-les-Nancy, France 

Robert Amyot, MD 

CAE Healthcare 

Montreal, Canada 

Henning Rud Andersen, MD 

University of Aarhus 

Aarhus, Denmark 

Teeranan Angkananard, MD 

Vajira Hospital 

Bangkok, Thailand 

Stefan Anker, MD, PhD 

Charité, Campus Virchow-Klinikum 

Berlin, Germany 

David Antoniucci, MD 

Careggi Hospital 

Florence, Italy 

Priyadarshini Arambam, MD 

Institute and Fortis Vasant Kunj 

New Delhi, India 

Akaki Archvadze, MD 

N. Kipeshidze Central University Hospital 

Tbilisi, Georgia 

Yasushi Asakura, MD 

Toyohashi Heart Center 

Toyohashi, Japan 

Abid R. Assali, MD 

Rabin Medical Center 

Petah Tikra, Israel 

Ihab Attia, MD 

Ain Shams University 

Giza, Egypt 

Panayiotis Avraamides, MBBS 

Limassol General Hospital 

Nicosia, Cyprus 

Zdravko Babic, MD, PhD 

University Hospital Sestre Milosrdnice 

Zagreb, Croatia 

Jorge A. Baccaro, MD 

Instituto de CardiologÌa de Corrientes 

Juana F. Cabral 

Corrientes, Argentina 

Vinay K. Bahl, MD, DM 

All India Institute of Medical Sciences 


Stephan Baldus, MD 

University Hospital of Hamburg-Eppendorf 

Hamburg, Germany 

Shmuel Banai, MD 

Tel Aviv Medical Center 


Amal Kumar Banerjee, MD, DM 

Advanced Medical Research Institute 

Kolkata, India 

Adrian P. Banning, MD 

John Radcliffe Hospital 

Oxford, United Kingdom 

Vinayak Bapat, FRCS, CTh 

Guy’s and St. Thomas’ 

London, United Kingdom 

Thomas Bartel, MD 

Medical University Innsbruck 

Innsbruck, Austria 

Antonio L. Bartorelli, MD 

University of Milan 

Milan, Italy 

Jozef Bartunek, MD, PhD 

Cardiovascular Center, OLV Hospital 

Aalst, Belgium 

Stanislaw Bartus, MD 

Jagiellonian University Medical College 

Iwanowice, Poland 

Andreas Baumbach, MD 

Bristol Heart Institute 

Bristol, United Kingdom 

Jeroen J. Bax, MD 

Leiden University Medical Center 

Leiden, The Netherlands 

Kevin J. Beatt, MBBS, PhD 

Croydon University Hospital 


Francesco Bedogni, MD 

Istituto Clinico S. Ambrogio 

Milano, Italy 

Jorge A. Belardi, MD 

Instituto Cardiovascular de Buenos Aires 


Edouard R. Benit, MD 

Jessa Ziekenhuis 

Hasselt, Belgium 

Lee N. Benson, MD 

The Hospital for Sick Children 

Toronto, Canada 

Ivo Bernat, MD, PhD 

University Hospital Pilsen 

Pilsen, Czech Republic 

Robert Bernat, MD, PhD 

Magdalena Clinic for 

Cardiovascular Diseases 

Krapinske Toplice, Croatia 

Chiara Bernelli, MD 

San Raffaele Hospital, Milan 

Milan, Italy 

Sergio Berti, MD 

CNR-Institute of Clinical Physiology 

Massa, Italy 

Olivier F. Bertrand, MD, PhD 

Institut Universitaire de Cardiologie et de 

Pneumologie de Québec 

Quebec City, Canada 

Rafael Beyar, MD, DSc 

Rambam Medical Center 

Haifa, Israel 

Silvio Bezerra, MD 

Universidade Federal de 

Rio Grande do Norte 

Natal, Brazil 

Balram Bhargava, MD, DM 

All India Institute of Medical Science 


Sanjeev Bhatt, MD 

Meril Life Sciences Pvt. Ltd. 

Vapi, India 

Giancarlo Biamino, MD, PhD 

Clinica Montevergine 

Mercogliano, Italy 

Giuseppe Biondi Zoccai, MD 

Sapienza University of Rome 

Latina, Italy 

Daniel J. Blackman, MD 

Leeds General Infirmary 

Leeds, United Kingdom 

Erwin Blessing, MD 

University of Heidelberg 

Heidelberg, Germany 

Jorge Bluguermann, MD 

Policlinica Bancaria 


Wolfgang Bocksch, MD, PhD 

Tubingen University Hospital 

Tubingen, Germany 

Peter Boekstegers, MD, PhD 

Heart Center Siegburg 

Siegburg, Germany 

Michael Böhm, MD 

University Hospital of Saarland 

Homburg/Saar, Germany 


Montreal Heart Institute 



Hôpital Universitaire Nord 

Marseille, France 

Alessandro S. Bortone, MD, PhD 

Interventional Lab Cardiac Surgery 

University of Bari 

Bari, Italy 

Roberto Botelho, MD, PhD 

Triangulo Heart Institute 

Uberlandia, Brazil 

Marian Branny, MD 

Hospital Podlesi 

Trinec, Czech Republic 

Stephen J.D. Brecker, MD 

St. George’s Hospital 


Carlo Briguori, MD, PhD 

Clinica Mediterranea 

Naples, Italy 


Schneider Children’s Medical Center 

Petach Tikva, Israel 


Bern University Hospital 

Bern, Switzerland 

Siro Buendia, MD 

Son Espases Palma de Mallorca 

Palma de Mallorca, Spain 

Francesco Burzotta, MD, PhD 

Institute of Cardiology, Catholic University 

of the Sacred Heart 

Rome, Italy 


Clinique Chirurgicale Val d’Or 

Paris-Saint Cloud, France 

Pawel E. Buszman, MD, PhD 

American Heart of Poland 

Katowice, Poland 

Robert A. Byrne, MB, BCh, PhD 

Deutsches Herzzentrum 


Adriano Caixeta, MD, PhD 

Hospital Israelita Albert Einstein 


Patrick A. Calvert, MD, PhD 

Papworth Hospital NHS Foundation Trust 

Cambridge, United Kingdom 

Edoardo Camenzind, MD 

University Hospital of Geneva 

Geneva, Switzerland 

Felipe De Jesus Gonzalez Camid, MD 

Hospital San Jose Tec de Monterrey 

San Pedro Garza García, Mexico 

Davide Capodanno, MD, PhD 

Ferrarotto Hospital 

Catania, Italy 

Mauro Carlino, MD 

San Raffaele Hospital 

Milan, Italy 

Mario Carminati, MD 

Istituto Policlinico San Donato 

Milan, Italy 

Didier Carrié, MD, PhD 

Hôpital Rangueil 

Toulouse, France 

Graham A. Cassel, MD 

Milpark Hospital 

Johannesburg, South Africa 


34 


Salvatore Cassese, MD 

Deutsches Herzzentrum 

München, Germany 

Alp Burak Catakoglu, MD 

Florence Nightingale Hospitals 

Istanbul, Turkey 

Murat Cayli, MD 

Adana Numune Education and 

Research Hospital 

Adana, Turkey 

Pavel Cervinka, MD, PhD 

Masaryk Hospital 

ÚstÌ nad Labem, Czech Republic 

Inho Chae, MD, PhD 

Seoul National University 

Bundang Hospital 

Seongnam, South Korea 

Charles Chan, MD 

Gleneagles Medical Centre 

Singapore 

Praveen Chandra, MD 

Medanta Medicity Hospital 

Guragon, India 

Virendrasinh C. Chauhan, MD 

Bhailal Amin Hospital 

Vadodara, India 

Kamaldeep Chawla, MD 

Sterling Hospital 

Gujarat, India 

Jiyan Chen, MD 

Guangdong Provincial People’s Hospital 

Guangzhou, China 

Shao Liang Chen, MD 

Nanjing First Hospital of Nanjing 

Medical Center 

Jiangsu, China 

YunDai Chen, PhD 

Chinese PLA General Hospital 


Jun-Jack Cheng, PhD 

Shin Kong Hospital 

Taipei City, Taiwan 

Anson Cheung, MD 

St. Paul’s Hospital 


Bernard R. Chevalier, MD 

Institut Cardiovasculaire Paris Sud 

Massy, France 

Paul T.L. Chiam, MD 

National Heart Center Singapore 

Singapore 


San Raffaele Scientific Institute 

Milan, Italy 

Kenneth Chin, MBBS 

Pantai Hospital 

Kuala Lumpur, Malaysia 

Yoon Sin Chong, MD 

Serdang Hospital 

Kajang, Malaysia 

G.H. Choo, MD 

Sime Darby Medical Centre 

Subang Jaya, Malaysia 

Evald H. Christiansen, PhD 

Aarhus University Hospital 


Christos Christou, MD 

American Heart Institute 


Kook-Jin Chun, MD 

Pusan National University Yangsan Hospital 

Yangsan, South Korea 

Wook Sung Chung, MD, PhD 

Catholic University of Korea 


Eric A. Cohen, MD 

Sunnybrook Health Sciences Centre 



Columbus Hospital/San Raffaele Hospital 

Milan, Italy 

Jose A. Condado, MD 

Centro Medico de Caracas 

Caracas, Venezuela 

Stéphane Cook, MD 

Swiss Cardiovascular Center 

Fribourg, Switzerland 

Thierry Corcos, MD 

American Hospital of Paris 

Neuilly-sur-Seine, France 

Kristoff Cornelis, MD 

AZ Maria Middelares 

Ghent, Belgium 

Roberto Corti, MD 

University Hospital Zurich 

Zurich, Switzerland 

Ricardo A. Costa, MD 



Jose de Ribamar Costa Jr, MD 



Alberto Cremonesi, MD 

Maria Cecilia Hospital 

Cotignola, Italy 


Hôpital Charles Nicolle 

Rouen, France 

Alberto J. Crottogini, MD, PhD 

Favaloro University Hospital 


Fernando Cura, MD, PhD 

Instituto Cardiovascular de Buenos Aires 


Nick Curzen, BM, PhD 

Southampton University Hospitals 

Southampton, United Kingdom 

Joost Daemen, MD, PhD 

Erasmus Medical Center 

Rotterdam, The Netherlands 

Miles C. Dalby, MD 

Harefield University Hospitals 

Harefield, United Kingdom 

Felix Damas de los Santos, MD 

Instituto Nacional de Cardiologia 


Anibal A. Damonte, MD 

Instituto Cardiovascular de Rosario 

Rosario, Argentina 

Benoit Daneault, MD 

Centre Hospitalier Universitaire de 

Sherbrooke 

Sherbrooke, Canada 

Haim Danenberg, MD 

Hadassah Medical Center 


Sameer I. Dani, MD 

Apollo Hospital International Ltd. 

Ahmedabad, India 

Debabrata Dash, MD, DM 

S.L. Raheja Hospital 

Mumbai, India 

Justin E. Davies, MBBS, MRCP, PhD 

Imperial College London NHS Trust 


Adrian Davila Bortoni, MD 

Centro Medico Ingles 

Monterrey, Mexico 

Khairy Abdel Dayem, PhD, MD 


Cairo, Egypt 

Adam J. de Belder, MD 

Brighton and Sussex University Hospitals 

Brighton, United Kingdom 

Mark A. de Belder, MD, MA 

The James Cook University Hospital 

Middlesbrough, United Kingdom 

Bernard De Bruyne, MD, PhD 

Cardiovascular Center Aalst 


Jose M. de la Torre Hernandez, MD, PhD 

Hospital Universitario 

Marques de Valdecilla 

Santander, Spain 


Eastern Piedmont University 

Novara, Italy 

Peter Den Heijer, MD, PhD 

Amphia Hospital Breda 

Breda, The Netherlands 

Marjo de Ronde, RN 



Robbert J. de Winter, MD, PhD 

Academisch Medisch Centrum 

Amsterdam, The Netherlands 

Devang Desai, MD 

Shree B.D. Mehta Mahavir Heart Institute 

Gujarat, India 

Walter Desmet, MD, PhD 

Katholieke Universiteit 



Royal Brompton Hospital 


Germano Di Sciascio, MD 

Campus Bio-Medico University 

Rome, Italy 

Stefanie Dimmeler, PhD 

University of Frankfurt 

Frankfurt, Germany 

Henricus J. Duckers, MD, PhD 



Dariusz Dudek, MD, PhD 

Jagiellonian University 

Krakow, Poland 

Ariel Duran, MD 

University School of Medicine 

Montevideo, Uruguay 

VladimÌr DžavÌk, MD 

Peter Munk Cardiac Centre, University 

Health Network 


Adrian Ebner, MD 

Italian Hospital 

Asuncion, Paraguay 

Mohammed El Deeb, MD 

Royal Hospital 

Muscat, Oman 

Adel El Etriby, MD 


Alexandria, Egypt 

Helene Eltchaninoff, MD 


Rouen, France 

Stephan M. Ensminger, MD, DPhil 

Heart and Diabetes Center NRW 

Bad Oeynhausen, Germany 

Raimund A. Erbel, MD 

University Duisburg-Essen 

Essen, Germany 

Andrejs Erglis, MD, PhD 

P. Stradins Clinical University Hospital 

Riga, Latvia 

David Erlinge, MD 

Lund University Hospital 

Lund, Sweden 

Aleksander Ernst, MD, PhD 

Clinical Hospital Center Zagreb 


Javier Escaned, MD, PhD 

Hospital ClÌnico San Carlos 

Madrid, Spain 

Jacques R. Essinger, MD 

Symetis SA 

Ecublens, Switzerland 

Joel Estrada Gallegos, MD 

Hospital de Cardiologia del Centro 

Medico Nacional 


Ali Faizal, MD, DM 

Malabar Institute of Medical Science 

Calicut, India 


Clinique Pasteur 

Toulouse, France 

El Sayed Farag, MD 

Zagazig University 

El-Zakazik, Egypt 

Vasim Farooq, MD 

Thoraxcenter 


Fausto Feres, MD 



Francisco Fernandez-Aviles, MD, PhD 

Hospital General Universitario 

Gregorio Marañon 

Madrid, Spain

Gudrun Feuchtner, MD 

Innsbruck Medical University 

Innsbruck, Austria 

Hans R. Figulla, MD 

Friedrich-Schiller Universitat 

Jena, Germany 

Ariel Finkelstein, MD 

Tel Aviv Medical Center 


Iraj Firouzy, MD 

Shahid Rajaei Heart Center 

Tehran, Iran 

Nicolas Foin, MSc, PhD 

International Centre for Circulatory Health 


Darrel P. Francis, MD 

St Mary’s and Hammersmith Hospital 


Douglas G. Fraser, MD 

Manchester Heart Centre 

Manchester, United Kingdom 

Ole Frobert, MD, PhD 

Orebro University Hospital 

Orebro, Sweden 

Xianghua Fu, MD, PhD 

The Second Hospital of Hebei 

Medical University 

Shijiazhuang City, China 

Alfredo R. Galassi, MD 

Cannizzaro Hospital 


Edvard Galic, MD, PhD 

Clinical Hospital Sveti Duh 


Daljeet S. Gambhir, MD, DM 

Kailash Hospital and Heart Institute 


Habib Gamra, MD 

University of Monastir 

Monastir, Tunisia 

Vladimir Ganyukov, MD 

Scientific Research Institute for 


Kemerovo, Russia 


Fu Wai Hospital 


Eulogio J. Garcia, MD 

Hospital Clinico San Carlos 

Madrid, Spain 

Miguel A. Garcia-Fernandez, MD, PhD 

Hospital Clinico Universitario 

San Carlos Madrid 

Madrid, Spain 

Hector M. Garcia-Garcia, MD, PhD 

Thoraxcenter, Erasmus Medical Center 


Philippe Garot, MD 


Quincy-sous-Senart, France 

Jorge Gaspar, MD 

National Institute of Cardiology 


Efrain Gaxiola, MD 

Jardines Hospital de Especialidades 

Jalisco, Mexico 

Lei Ge, MD 

Shanghai Zhongshan Hospital 

Shanghai, China 

Guido Gelpi, MD 

University of Milan 

Milan, Italy 

Georgios Georgiou, MD 

Nicosia General Hospital 


Ulrich J. Gerckens, MD 

Hospitial St. Petrus 

Bonn, Germany 

Anthony H. Gershlick, MD 

University of Leicester 

Leicester, United Kingdom 

Michal Geva 

Triventures 

Herzilya, Israel 

Georges Ghanem, MD 

University Medical Center-Rizk Hospital 

Beirut, Lebanon 

Niccoli Giampaolo, MD, PhD 

Catholic University of the Sacred Heart 

Rome, Italy 

Robert J. Gil, PhD 

Central Clinic Hospital 

Warsaw, Poland 

Martine Gilard, MD, PhD 

Brest University 

Brest, France 

Arturo Giordano, MD 

Pineta Grande Hospital 

Castelvolturno, Italy 

Dietmar H. Glogar, MD 

University of Vienna 

Vienna, Austria 

Alejandro Goldsmit, MD 

CACI SOLACI 


B.K. Goyal, MD, FRCP 

Bombay Hospital and Medical 

Research Centre 

Mumbai, India 

Carmelo Grasso, MD 

Ferrarotto Hospital Cardiology Division 


Roger M. Greenhalgh, MD 

Charing Cross Hospital 


Liliana R. Grinfeld, MD, PhD 

CENPEC 


Ladislav Groch, MD 

University Hospital St. Anna 

Brno, Czech Republic 


University Hospital Bonn 

Bonn, Germany 


Ospedali Riuniti Di Bergamo 

Bergamo, Italy 

Antoine Guédès, MD 

CHU Mont Godinne-UCL 

Yvoir, Belgium 



Victor Guetta, MD 

Heart Institute Chaim Medical Center 

Tel-Hashomer, Israel 

Wenyi Guo, MD 

Xijing Hospital 

Xi?an, China 

Vivek Gupta, MD, DM 

Indraprastha Apollo Hospitals 


Hyeon-Cheol Gwon, MD, PhD 

Samsung Medical Center 


Alison Halliday, MS, FRCS 

Oxford University Hospitals NHS Trust 


Michalis Hamilos, MD 

University Hospital of Heraklion 

Crete, Greece 

Christian W. Hamm, MD 

Kerckhoff Clinic 

Bad Nauheim, Germany 

Martial Hamon, MD 

University Hospital of Caen 

Caen, France 

Kyoo-Rok Han, MD, PhD 

Kangdong Sacred Heart Hospital 



Shenyang Northern Hospital 

Shenyang, China 

Claude Hanet, MD, PhD 

University of Louvain Medical School 

Yvoir, Belgium 

Jan Harnek, MD 

Skane University Hospital 

Lund, Sweden 

Mahmoud Hashemian, MD, FACC 

Day Hospital, Tehran 

Tehran, Iran 


Lukaskrankenhaus Neuss 

Neuss, Germany 

Stuart J. Head, MSc 

Erasmus University Medical Center 


Robert A. Henderson, DM 

Nottingham University Hospitals 

Nottingham, United Kingdom 

Christian Hengstenberg, MD 

Leitender Oberarzt Kardiologie 

Regensburg, Germany 

Jose P.S. Henriques, MD, PhD, MBA 

Academic Medical Center 


Michel Camille Henry, MD 

Cabinet de Cardiologie 

Nancy, France 

Yutaka Hikichi, MD 

Saga University School of Medicine 

Saga, Japan 

David J. Hildick-Smith, MD 

Sussex Cardiac Centre, Brighton and 

Sussex University Hospitals 


TranscaTheTer 


TherapeuTics 

Jonathan M. Hill, MD, MRCP 

King’s College Hospital 


Lynne Hinterbuchner, RN, DGKS 

Salzburg University Hospital 

Salzburg, Austria 

Rainer Hoffmann, MD 

University Hospital Aachen 

Aachen, Germany 

Ilona Hofmann, MD 

Göethe University Frankfurt 


Myeong-Ki Hong, MD, PhD 

Yonsei University College of Medicine 


David Horak, MD 

District Hospital Liberec 

Liberec, Czech Republic 

Eric Horlick, MD, CM 

University Health Network 

Toronto General Hospital 


Jingbo Hou, MD 

Harbin Medical University 

Harbin, China 

Patrick Houthuizen, MD 

Catharina Hospital 

Eindhoven, The Netherlands 

Angela Hoye, MD, PhD 

Castle Hill Hospital 

Kingston-upon-Hull, United Kingdom 

Hsuan-Li Huang, MD 

Buddhist Tzu Chi General Hospital 

Taipei City, Taiwan 


Wilhelminen Hospital 


Fernando Huerta Liceaga, MD 

National Institute of Cardiology 


Ioannis Iakovou, MD, PhD 

Onassis Cardiac Surgery Center 

Athens, Greece 

Keiichi Igarashi, MD, PhD 

Hokkaido Social Insurance Hospital 

Sapporo, Japan 

Yuji Ikari, MD, PhD 

Tokai University School of Medicine 

Kanagawa, Japan 

Huseyin Ince, MD, PhD 

University Hospital Rostock 

Rostock, Germany 

Naoto Inoue, MD 

Sendai Kousei Hospital 

Sendai, Japan 

Thomas A. Ischinger, MD, PhD 

Kardiologie im Zentrum 


Louis B. Jacques, MD 

US Food and Drug Administration 

Baltimore, MD 

Ronen Jaffe, MD 

Carmel Medical Center 

Haifa, Israel 


36 


Stefan K. James, MD 

Uppsala Clinical Research Center 

Uppsala, Sweden 

Yang-Soo Jang, PhD 

Yonsei University Health System 


Jens R. Jensen, MD, PhD 

Sundsvalls Sjukhus 

Sundsvall, Sweden 

Lisette Okkels Jensen, MD, DMSci, PhD 

Odense University Hospital 

Odense, Denmark 

Ulf Jens Jensen, MD 

Department of Cardiology 

Stockholm, Sweden 

Gillian A. Jessurun, MD, PhD, MBA 

Scheper Ziekenhuis Emmen 

Emmen, The Netherlands 


McMaster University 

Hamilton, Canada 

Michael Joner, MD 

Deutsches Herzzentrum München 


Anders Jonsson, MD 

Sodersjukhuset 


Risto Jussila, MD 

Södersjukhuset 


Kazushige Kadota, MD 

Kurashiki Central Hospital 

Kurashiki, Japan 

Christoph A. Kaiser, MD 

University Hospital Basel 

Basel, Switzerland 

Olli A. Kajander, MD 

Tampere University Hospital, Heart-Center 

Tampere, Finland 

Petr Kala, MD, PhD 

University Hospital and Medical Faculty 

Masaryk University 

Brno, Czech Republic 

Anne K. Kaltoft, MD, PhD 

Aarhus University Hospital, Skejby 


Ioannis (John) Kanakakis, MD, PhD 

Alexandra University Hospital 


Soo-Jin Kang, MD 

Asan Medical Center 


Paul Hsien-Li Kao, MD 

National Taiwan University Hospital 

Taipai, Taiwan 

A. Pieter Kappetein, MD, PhD 

Thoraxcenter 


Pasi Karjalainen, MD, PhD 

Satakunta Central Hospital 

Pori, Finland 

Seyed Ebrahim Kassaian, MD 

Tehran Heart Center 

Tehran, Iran 


Deutsches Herzzentrum und Medizinische 

Klinik der Technischen Universitat Munchen 



Kusatsu Heart Center 



Fortis Escorts Hospital 



The Centre of Endosurgery 

and Lithotripsy 


Masayuki Kawahara, MD 

Pharmaceuticals and Medical 

Devices Agency 

Tokyo, Japan 

Elvin Kedhi, MD 

Maasstad Ziekenhuis 


Henning Kelbaek, MD 

Rigshospitalet 

Copenhagen, Denmark 

Alexander N. Kharlamov, MD 

Ural Institute of Cardiology 

Yekaterinburg, Russia 

Hyo-Soo Kim, MD, PhD 

Seoul National University Hospital 


Young-Hak Kim, MD, PhD 




Kyoto University Hospital 

Sakyo-ku, Japan 

Franz X. Kleber, MD 

Charité University Medicine Berlin 


Young-Guk Ko, MD 

Yonsei University 


Karel T. Koch, MD, PhD 

Academic Medical Center Amsterdam 


Akihiro Koide, PhD 

Pharmaceuticals and 

Medical Devices Agency 

Tokyo, Japan 

Javad Kojuri, MD, PhD 

Nemazee Hospital 

Shiraz, Iran 

Bon-Kwon Koo, MD, PhD 

Seoul National University Hospital 


Jacques J. Koolen, MD, PhD 






Jan Kovac, MD 

University Hospital of Leicester 

Leicester, United Kingdom 


Angiologikum Hamburg 


Tomislav Krcmar, MD 

Sisters of Mercy University Hospital 


Po-Ming Ku, MD 

Chi-Mei Medical Center 

Yong-kang City, Taiwan 

Takashi Kubo, MD, PhD 

Wakayama Medical University 

Wakayama, Japan 


Asklepios Hospital St. Georg 


Prathap Kumar, MD 

Meditrina Hospital 

Kerala, India 

Sreenivas Arramraju Kumar, MD, DM 

CARE Hospitals 


Vijayalakshmi Kunadian, MBBS, MD 

Freeman Hospital 

Newcastle upon Tyne, United Kingdom 

Vincent On-Hing Kwok, MD 

Hong Kong Sanatorium and Hospital 

Hong Kong, China 


St George’s Hospital 


Antoine Lafont, MD 

Hôpital European Georges Pompidou 

Paris, France 

Yat-Yin Lam, MD 

Chinese University of Hong Kong 


Rudiger Lange, MD, PhD 

German Heart Center Munich 


Jens Flensted Lassen, MD, PhD 



Azeem Latib, MB, BCh 

EMO-GVM Centro Cuore Columbus 

Milan, Italy 

Sandra Lauck, PhD 



Michel R. Le May, MD 

University of Ottawa Heart Institute 

Ottawa, Canada 

Guy LeClerc, MD 

Centre Hospital Universitaire de Montreal 


Michael Kang-Yin Lee, MBBS 

Queen Elizabeth Hospital 

Kowloon, China 

Wen-Lieng Lee, MD 

Taichung Veterans General Hospital 

Taichung City, Taiwan 


Institut Hospitalier Jacques Cartier 

Massy, France 

Jorge H. Leguizamon, MD 

Argentine Society of Interventional 

Cardiology 


Jacek Legutko, MD, PhD 


Kraków, Poland 

Jonathon A. Leipsic, MD 



Jose L. Leiva-Pons, MD 

Hospital Central 

San Luis Potosi, Mexico 

Suhas S. Lele, MD 

Indian Heart Association 

Vadodara, India 

Pedro A. Lemos, MD, PhD 

University of São Paulo Medical School 


Jonathan Leor, MD 

Sheba Medical Center 

Tel-Hashomer, Israel 

Maciej Lesiak, MD, PhD 

University Hospital 

Poznan, Poland 

Eli I. Lev, MD 



Thosaphol Limpijankit, MD 

Ramathibodi Hospital 

Bangkok, Thailand 

Rikard B.A. Linder, MD, PhD 

Danderyds University Hospital 


Axel Linke, MD 

University of Leipzig Heart Center 

Leipzig, Germany 

Jian Liu, MD 

Peking University People’s Hospital 


Xuebo Liu, MD 

East Hospital, Tongji University 


Hugo F. Londero, MD 

Sanatorio Allende-Cordoba 

Cordoba, Argentina 

Chaim S. Lotan, MD 

Hadassah University Hospital 


Yves R. Louvard, MD 


Massy, France 

Michael P. Love, MB, ChB, MD 

Queen Elizabeth II Health 

Sciences Centre 

Halifax, Canada 

Shuzheng Lu, MD 

Beijing An Zhen Hospital 


George Lutter, MD, PhD 

University Hospital Schleswig-Holstein 

Kiel, Germany 

Philip A. MacCarthy, BSc, PhD, FRCP 



Sumaira Macdonald, MD, PhD 



Lindsay S. Machan, MD 

Vancouver Hospital and 

Health Sciences Center 


Ayman Magd, MD 

Azhar University 

Cairo, Egypt 

Ahmed Magdy, MD 

National Heart Institute in Cairo 

Cairo, Egypt 

Felix Mahfoud, MD 

Klinik für Innere Medizin III 

Homburg/Saar, Germany


San Raffaele Hospital 

Milan, Italy 

Jose Armando Mangione, MD 

BeneficÍncia Portuguesa Hospital 



Royal Victoria Hospital 

Belfast, United Kingdom 

Marco Manzi, MD 

Policlinico Abano Terme 

Abano Terme, Italy 

Kristina Maric, MD 

Working Groups on Interventional 

Cardiology for Croatia, Greece, 

and Serbia 


Majid Naghibzadeh Mashayekh, MD 

Mehrad Hospital 

Tehran, Iran 

Martin Mates, PhD 

Na Homolce Hospital 

Prague, Czech Republic 

Samuel K. Mathew, MD, DM 

Apollo Hospitals 

Chennai, India 

Detlef G. Mathey, MD 

Hamburg University 

Cardiovascular Center 


Klaus D. Mathias, MD 

Radiologische Klinik 

Dortmund, Germany 


Golden Jubilee National Hospital 

Glasgow, United Kingdom 

Julinda Mehilli, MD 

Deutsches Herzzentrum und Medizinische 

Klinik der Technischen Universitat München 


Shamir R. Mehta, MD, MSc 

Hamilton Health Sciences 


Bernhard Meier, MD 

Swiss Cardiovascular Center Bern 



Fundacion Favaloro 


Maurizio Menichelli, MD 

Spaziani Hospital Frosinone 

Frosinone, Italy 


Monash Medical Centre Clayton 

Melbourne, Australia 

José Alfredo Merino Rajme, MD 

Centro Medico Nacional 20 de Noviembre 


Francesco Meucci, MD 

Azienda Ospedaliero-Universitaria 

Careggi Firenze 

Firenze, Italy 

Erich Minar, MD 

Medical University Vienna 


Sundeep Mishra, MD, DM 



Kazuaki Mitsudo, MD 

Kurashiki Central Hospital 

Kurashiki, Japan 

Shunichi Miyazaki, MD, PhD 

Kinki University 

Osaka, Japan 

Neil E. Moat, MD 



Helge Moellmann, MD 

Kerckhoff Heart Center 


Friedrich W. Mohr, MD, PhD 

Heart Center Leipzig 


Victor P. Moles, MD 

Cardiology Center, University Hospital 

Santa Fe, Argentina 

Gilles Montalescot, MD, PhD 

Centre Hospitalier Universitaire 

Pitié-Salpêtrière 

Paris, France 

Marie-Angele Morel, BSc 

Cardialysis B.V. 


Jose Gomez Moreno, MD 

Cardiovascular Institute of Missions 

Misiones, Argentina 

Jacques Moret, MD, PHD 

Beaujon University Hospital 

Clichy, France 



Massy, France 

Harald G.W. Mudra, MD 

Klinikum Neuperlach 


Ajit Mullasari, MD, DM, DNB, FRCP 

Madras Medical Mission Hospital 

Chennai, India 

David W.M. Muller, MBBS, MD 

St. Vincent’s Hospital 

Darlinghurst, Australia 

Brad I. Munt, MD 



Toshiya Muramatsu, MD 

Saiseikai Yokohama-City Eastern Hospital 

Yokohama, Japan 

Aung Myat, BSc, MBBS, MRCP 

BHF Centre of Research Excellence, 

St Thomas’ Hospital 


Christoph K. Naber, MD, PhD 

Contilia Heart and Vascular Center 


Masato Nakamura, MD 

Toho University Ohashi Medical Center 

Tokyo, Japan 

Sunao Nakamura, MD, PhD 

New Tokyo Hospital 

Chiba, Japan 

Koichi Nakao, MD 

Saiseikai Kumamoto Hospital 


Kumamoto, Japan 


Padova University Hospital 

Padova, Italy 



Muda Nasir, MD 

Institut Jantung Negara 


Kenya Nasu, MD 



Franz-Josef Neumann, MD 

Universitäts-Herzzentrum Freibrug 

Bad Krozingen 

Bad Krozingen, Germany 

Martin Ng, MD, PhD 

Royal Prince Alfred Hospital 

Sydney, Australia 

Georg Nickenig, MD 

University of Bonn 

Bonn, Germany 

Matti Jaakko Niemela, MD 

University of Oulu 

Oulu, Finland 

Christoph A. Nienaber, MD, PhD 

University of Rostock 

Rostock, Germany 

Eugenia Nikolsky, MD, PhD 

Rambam Medical Center 

Haifa, Israel 

Stephane Noble, MD 

Hôpitaux Universitaires de Genève 


James Nolan, MD, MB, ChB 

University Hospital North Staffordshire 

Stoke on Trent, United Kingdom 

Andrzej J. Ochala, MD 



Masahiko Ochiai, MD, PhD 

Showa University Northern 

Yokohama Hospital 


Takao Ohki, MD, PhD 

Jikei University School of Medicine 

Tokyo, Japan 


West of Scotland Regional Heart 

and Lung Centre 

Glasgow, United Kingdom 

Goran K. Olivecrona, MD, PhD 

Skane University Hospital 

Lund, Sweden 

Gustavo V.L. Olivotti, MD 

Hospital BeneficÍncia Portuguesa 


Elmir Omerovic, MD, PhD 

Sahlgrenska Universtiy Hospital 

Guldheden, Sweden 

Eustaquio Maria Onorato, MD 

Clinica Montevergine, Mercogliano 

Gussago, Italy 

Yoshinobu Onuma, MD 

Thoraxcenter, Erasmus Medical Center 



Mercy and Auckland City Hospitals 

Auckland, New Zealand 

Alexander Grigorievich Osiev, MD 

State Research Institute of 

Circulation Pathology 

Novosibirsk, Russia 

TranscaTheTer 


TherapeuTics 

Miodrag C. Ostojic, MD, PhD 

Clinical Centre of Serbia 

Belgrade, Serbia and Montenegro 

T. Oude Ophuis, MD 

Canisius Hospital 

Nijmegen, The Netherlands 


Policlinico S. Orsola 

Bologna, Italy 

Manotosh Panja, MD, DM 

Belle Vue Clinic 


George Parcharidis, MD 

AHEPA University Hospital 

Thessaloniki, Greece 

Keyur H. Parikh, MD 

Care Institute Medical Sciences 


Jai-Wun Park, MD 

Asklepios Kliniken 


Seung-Jung Park, MD, PhD 



Tejas Patel, MD, DM 

APEX Heart Institute 


Lekha R.A. Pathak, MD, DM, FRCP 

Nanavati Hospital, Nanavati 

Heart Institute 

Mumbai, India 

Carlos Pedra, MD, PhD 



Marco A. Perin, MD, PhD 

Hospital Albert Einstein 



Ospedale di Cisanello 

Pisa, Italy 

Petur Petursson, MD, PhD 

Sahlgrenska University Hospital 

Gothenburg, Sweden 


Cardialysis 


Philippe Pibarot, DVM, PhD 

Quebec Heart and Lung Institute 


Jan J. Piek, MD 

University of Amsterdam 


Mikko Pietila, MD, PhD 

Turku University Hospital 

Turku, Finland 

Nico H.J. Pijls, MD, PhD 



Hrvoje Pintaric, MD, PhD 

University Hospital Sestre Milosrdnice 


Ruben A. Piraino, MD 

Sanatorio Plaza 

Rosario, Argentina 

Sunil Pisharody, MD 

Kerala University 

Malapuram, India 


38 


David Planer, MD 

Hebrew University-Hadassah 



Stuart J. Pocock, PhD 

London School of Hygiene 

and Tropical Medicine 


Antonio Pocovi, MD 

Sanatorio San Lucas 


Piotr Ponikowski, MD, PhD 

Medical University, Military Hospital 

Wroclaw, Poland 

Suzanne Marie Pourbaix, MD 

CHR Citadelle 

Liege, Belgium 


San Giovanni Hospital 

Rome, Italy 

Jerzy Pregowski, MD 

Institute of Cardiology 


Alexey Protopopov, MD 

Krasnoyarsk Regional 


Krasnoyarsk, Russia 

Jie Qian, MD 



Shubin Qiao, MD 

Beijing Fuwai Hospital 


Hany Ragy, MD 

National Heart Institute 

Cairo, Egypt 

Afzalur Rahman, MD, PhD 

National Institute of 


Dhaka, Bangladesh 

Angelo Ramondo, MD 

Centro Studi di Cardiologia Invasiva SRL 

Bassano del Grappa, Italy 

Vishal Rastogi, MD 

Fortis Escorts Heart Institute 


Sudhir Rathore, MD 

St Georges Hospital 


Saumitra Ray, MD 

Cardiological Society of India 


Krzysztof W. Reczuch, MD, PhD 

Military Hospital Wroclaw 

Wroclaw, Poland 

Ashraf Reda, MD 

Menoufiya University 

Cairo, Egypt 

Gokul M. Reddy, MD 

Consultant Care/ACVS Core Committee 



St Thomas’ Hospital 


Evelyn S. Regar, MD, PhD 




Ospedale di Mirano 

Mirano, Italy 

Expedito E. Ribeiro, MD, PhD 

The Heart Institute/University 

of São Paulo 


Stéphane Rinfret, MD, SM 

Quebec Heart and Lung Institute 



Quebec Heart and Lung Institute/ 

Laval University 

Quebec, Canada 

Alfredo Rodriguez, MD, PhD 

Sanatorio Otamendi 


Ariel Roguin, MD, PhD 

Rambam Healt Care Campus 

Haifa, Israel 

Hannu Romppanen, MD 

Kuopio University Hospital 

Kuopio, Finland 




Jamil Abdalla Saad, MD 

Fundação, Felisse Rosso 

Belo Horizonte, Brazil 

Manel Sabate, MD, PhD 

Thorax Institute, Hospital Clinic 

Barcelona, Spain 


Klinikum Schwabing 


Carlos Alberto Sada 

Beneficencia Portuguesa de São Paulo 



Shonan Kamakura General Hospital 


Negar Salehi, MD 

Shaheed Rajaei Cardiovascular 

Tehran, Iran 

Luigi Salemme, MD 

Montevergine Clinic 

Naples, Italy 

Giuseppe M. Sangiorgi, MD 

University of Rome tor Vergata 

Rome, Italy 

Gennaro Sardella, MD 

Policlinico Umberto I University 

Rome, Italy 

Rogerio Sarmento-Leite, MD, PhD 

Instituto de Cardiologia do Rio 

Grande do Sul 

Porto Alegre, Brazil 

Erick Schampaert, MD 

Hopital du Sacre-Coeur de Montreal 



Park-Krankenhaus Leipzig 



Universitätsklinikum des Saarlandes 

Homburg, Germany 

Markus P. Schlaich, MD 

Baker IDI Heart and Diabetes Institute 


Andrej Schmidt, MD 

University of Leipzig-Heartcenter 



Hamburg University Cardiovascular Center 


Gerhard C. Schuler, MD 

Herzzentrum Leipzig 


Amit Segev, MD 

Chaim Sheba Medical Center 

Tel Hashomer, Israel 

Jacques Seguin, MD 

CoreValve 

Paris, France 

Philippe Selleslagh, MD 

ZOL Genk 

Genk, Belgium 

Sayan Sen, MBBS 

National Heart and Lung Institute 


Martinez Sepulveda, MD 

Chile 


Thoraxcenter 



Escorts Heart Institute and 

Research Centre 


Georgios Sianos, MD, PhD 

AHEPA University Hospital 

Thessaloniki, Greece 

Dirk Sibbing, MD 

Deutsches Herzzentrum München 


Peter Sick, MD 

Krankenhaus Barmherzige 

Brüder Regensburg 

Germany 


CardioVascular Center Frankfurt, 

Sankt Katharinen 



University of Geneva 


Jozica Sikic, MD 




Heart Center at the Isar 


Kui-Hian Sim, MD 

University Malaysia 

Sarawak, Malaysia 

Tabassome Simon, MD, PhD 

Hospital St. Antoine UPMC 

Paris, France 

Ajay Radheshyam Sinhal, MBBS, MD, 

DM, FRACP 

Flinders Medical Centre 

Adelaide, Australia 

Tomislav Sipic, MD 

Magdalena Clinic for Cardiovascular 

Diseases 

Krapinske Toplice, Croatia 

Dimytri Siqueira, MD, PhD 



Elliot Smith, MD 

Queen Mary University of London 


Peter C. Smits, MD, PhD 

Maasstad Ziekenhuis 


David Smyth, MD 

Christchurch Hospital 

Christchurch, New Zealand 


Alexandria University 


Lars Sondergaard, MD 

Rigshospitalet-Copenhagen 


Copenhagen, Denmark 

Giovanni Sorropago, MD 


Avellino, Italy 

Konstantinos Spargias, MD, PhD 

Hygeia Hospital 


James Spratt, BSc, MD 

Forth Valley Royal Hospital 

Larbert, United Kingdom 

Eugenio Stabile, MD, PhD 


Mercogliano, Italy 

Rod H. Stables, MA, DM 

Liverpool Heart and Chest Hospital 

Liverpool, United Kingdom 

Josef Stasek, MD, PhD 

University Hospital Hradec Kralove 

Hradec Kralove, Czech Republic 

Christodoulos I. Stefanadis, MD 

University of Athens 



Groupe Hospitalier Bichat - Claude Bernard 

Paris, France 

Terje K. Steigen, MD, PhD, FESC 

University Hospital of Northern Norway 

Tromso, Norway 

Pieter R. Stella, MD, PhD 

University Medical Center Utrecht 

Utrecht, The Netherlands 

Roman Stipal, MD 


Olomouc, Czech Republic 

Martin G. Stoel, MD 

Medisch Spectrum Twente 

Enschede, The Netherlands 

Bradley H. Strauss, MD, PhD 

Sunnybrook Health Sciences Center 


Maja Strozzi, MD 

Zagreb University Hospital Center 


Daniel Suerder, MD 

Fondazione Cardiocentro Ticino 

Lugano, Switzerland

Satoru Sumitsuji, MD 

Osaka University 

Suita, Japan 

Gabor Sutsch, MD 

HerzZentrum Hirslanden 


Maarten J. Suttorp, MD, PhD 

St. Antonius Hospital 

Nieuwegein, The Netherlands 

Tomohisa Tada, MD 

Deutsches Herzzentrum Munich, 

ISAR Center 


David Taggart, MD, PhD 

John Radcliffe Hospital 





Huay Cheem Tan, MD 

National University Heart Centre 

Singapore 

Jean-François Tanguay, MD 

Montreal Heart Institute 


Koen Teeuwen, MD 

St. Antonius Hospital 

Nieuwegein, The Netherlands 

Gunnar Tepe, MD 

Hospital of Rosenheim 

Rosenheim, Germany 

Per Thayssen, MD 

Odense University Hospital 

Odense, Denmark 





St. Thomas’ Hospital 





Pim A.L. Tonino, MD 



Ernesto M. Torresani, MD 

Sanatorio Modelo Quilmes 


Konstantinos Toutouzas, MD 

Athens Medical School 


Hendrik Treede, MD 

University Heart Center Hamburg 


Chuen-Den Tseng, MD, PhD 

National Taiwan University Hospital 


Konstantinos P. Tsioufis, MD 

First Cardiology Clinic, University of 

Athens, Hippokration Hospital 


Etsuo Tsuchikane, MD, PhD 



Jorge Tuma, MD 

CENCOR / Maison de Sante Clinic 

Lima, Peru 

Shiro Uemura, MD, PhD 

Nara Medical University 

Kashihara, Japan 

Takafumi Ueno, MD, PhD 

Kurume University Hospital 

Fukuoka, Japan 

Philip M. Urban, MD 

La Tour Hospital 


Gian Paolo Ussia, MD 



Alec S. Vahanian, MD 

Hôpital Bichat 

Paris, France 

Marco Valgimigli, MD, PhD 

University Hospital of Ferrara, 

Cardiovasuclar Institute 

Ferrara, Italy 

Tim P. van de Hoef, MD 



Frans Van de Werf, MD 

University of Leuven 


René J. van der Schaaf, MD, PhD 

Onze Lieve Vrouwe Gasthuis 


Antonius F.W. van der Steen, PhD 



Robert-Jan van Geuns, MD 

Erasmus University Rotterdam 


Isabelle Van Herzeele, MD, PhD 

University Hospital Ghent 

Ghent, Belgium 

Glenn Van Langenhove, MD, PhD, MBA 

Middelheim Hospital Antwerp 

Antwerpen, Belgium 

Nicolas M. van Mieghem, MD 



Freek W.A. Verheugt, MD 

Onze Lieve Vrouwe Gasthuis 



Antwerp Cardiovascular Institute, 

Middleheim Hospital 

Antwerp, Belgium 

Paul Vermeersch, MD, PhD 

AZ Middelheim 

Hove, Belgium 

Josef Veselka, MD, PhD 

Motol University Hospital 

Prague, Czech Republic 

Luis R. Virgen Carrillo, MD, PhD 

Hospital Angeles del Carmen 

Guadalajara, Mexico 

Clemens von Birgelen, MD, PhD 

Thoraxcentrum Twente 

Enschede, The Netherlands 

Jeroen Vos, MD 

Amphia Hospital Breda 

Breda, The Netherlands 

Pascal Vranckx, MD 

Hartcentrum Hasselt 

Hasselt, Belgium 

Marco V. Wainstein, MD, DSc 

Hospital de Clinicas de Porto Alegre 

and Hospital Moinhos de Vento 

Porto Alegre, Brazil 

Simon Walsh, MD, MRCP 

Belfast Trust 


Darren L. Walters, MBBS, MPhil 

The Prince Charles Hospital 

Brisbane, Australia 


Kerckhoff Klinik Bad Nauheim 


Haichang Wang, MD 

Xijing Hospital 

Xi’an, China 

Jian’an Wang, MD, PhD 

Second Affiliated Hospital, Zhejiang 

University School of Medicine 

Hangzhou, China 

Lefeng Wang, MD 

Beijing Chaoyang Hospital 


Weimin Wang, MD 

Peking University People’s Hospital 





Mark W.I. Webster, MB, ChB 

Auckland City Hospital 


Daniel Weilenmann, MD 

Cantonal Hospital St. Gallen 

St. Gallen, Switzerland 

Francis C. Wells, MD 

Papworth Hospital 

Cambridge, United Kingdom 

Robert C. Welsh, MD 

Mazankowski Alberta Heart Institute 

Edmonton, Canada 

Peter Wenaweser, MD 

University Hospital Bern 


Gerald S. Werner, MD, PhD 

Klinikum Darmstadt 

Darmstadt, Germany 

Harvey D. White, DSc 

Green Lane Cardiovascular Service, 






Adam Witkowski, MD, PhD 




Charité University of Medicine Berlin 



University Hospital Ulm 

Ulm, Germany 

Wojciech Wojakowski, MD, PhD 

Third Division of Cardiology 


David A. Wood, MD 

St. Paul’s and Vancouver General Hospital 


Stephen G. Worthley, PhD 

Royal Adelaide Hospital 


Nina C. Wunderlich, MD 

University Hospital Mainz 

Mainz, Germany 

Bo Xu, MD 




Sayama Hospital 

Sayama City, Japan 

Hongbing Yan, MD, PhD 

Cardiovascular Institute and 



Joo-Young Yang, MD 

NHIC Ilsan Hospital 

Koyangshi, South Korea 

Yuejin Yang, MD, PhD 

Cardiovascular Institute and 



Uri Yaron, PhD 

Biosense- Webster 

Tirat Carmel, Israel 

Jian Ye, MD 



Antti Ylitalo, MD 


Pori, Finland 

Michael Yonash, MD 

Kaplan Medical Center 

Ramat Gan, Israel 

Amr Mahmoud Zaki, MD 

Alexandria University 


Robaayah Zambahari, MBBS 



Andreas M. Zeiher, MD 

University Hospital Medical Center 


Michael Zelizko, MD, PhD 

Clinic of Cardiology IKEM 

Praha, Czech Republic 


Herzzentrum Freiburg-Bad Krozingen 

Bad Kronzingen, Germany 

Bin Zhang, MD 

Guangdong General Hospital Guangdong 

Cardiovascular Institute 


Qi Zhang, PhD 

Shanghai Ruijin Hospital 


Yujie Zhou, MD, PhD 

Beijing Anzhen Hospital 



40 

TcT advisory FaculTy 

Siddamsetty Abbaiah, DM 

Atul Abhyankar, DM 

D.G. Adwani, MD 

Rahman Afzalur, MD 

D.K. Agarwal, MD 

Praveer Agarwal, MD, DM 

Sanjeev Agarwal, MD, DM 

Rajiv Agarwal, MD, DM 

Rajiv Agarwal, MD 

Sunil Ishwarchand Agarwal, MD, DNB 

Desai Ajit, MD 

Valiyakath Ali Faizal, MD, DM 

Banerjee Amal, MD 

Dhall Anil, MD 

Katdare Anil, MD 

Shah Anupam, MD 

Singhal Anurag, MD, DM 

Manjunath Anusuya, MD 

Kochar Arun, MD, DM 

Das Arvind, MD 

Madhu Asawa, MD 

Ashraf Ashraf, MD 

Safiya Manzil Ashraf, MD, DM 

B. Ashalatha, DM 

Mehta Ashwin, MD 

Lakshmi Narayanan Aswathaman, MD 

B. Ramesh Babu, MD, DM 

Raghuraman Bagirath, MD 

V.K. Bahl, MD 

Narasimha Bhatta Balakrishnan, MD, DM 

Singh Balbir, MD 

Gopalakrishna Sudhakar Balijepalli, MD 

Parthasarathi Banerjee, DM 

Karun Behal, DM 

Anupam Bhambani, MD 

Naveen Bhamri, MD, DM 

Suman Bhandari, MD, DM 

Narayan M. Bhat, MD, DM 

Kinjal Bhatt, MD, DNB 

Jagadesa Subramanya Bhuvaneswaran, MD, DM 

Rajneesh Calton, DM 

Shilpesh Champaneria, DNB 

Subash Chandra, MD, DM 

Nishith Chandra, MD 

Moorthy Chandran, MD 

Mahantesh Rachayya Charantimath, MD 

Virendra C. Chauhan, MD 

Chandrakant Chavan, MD 

Kamaldeep Chawla, DNB 

Bino Benjamin Chizhuthanikkal, MD 

Manjunath Cholenally, MD 

Nagendra Singh Chouhan, MD, DNB 

Issac Cibi, MD 

Suresh Davis, MD 

Davidson Deepak, MD, DM 

Saha Deepak, MD 

Mandar Dattatraya Deo, MD, PhD 

Aseem Dhal, MD, DM 

Aseem Dhall, MD 

Aniruddha Dharmadhikari, MD 

Krishnakumar Dhoot, MD 

Sharma Dhruva, MD 

Ratnani Dilip, MD 

Prabhakar A. Dorairaj, MBBS 

Vaidiyanathan Doraiswamy, MD, DM 

Jaskaran Singh Dugal, MD, MNAMS, DM 

S.K. Dwivedi, MD 

Rajeev Edakutty, MD 

G. Keshavamurthy, MD, DM, DNB 

Aniket Gadre, MD 

Dalbir Singh Gambhir, MD 

Shah Atit Gaurang, MD 

Oomen K. George, MD, DM 

Thomas George, DM 

Harpreet Singh Gilhotra, DM 

Anand Gnanaraj, MD, DM, FNB 

Pravin Kumar Goel, MD 

Reddy Gokul, MD 

Nagendra Prasad Golla, MD 

Kondal Rao Gollamandala, MD 

Sreenivas Colanakuduru Gopal, MD 

Elangovan Govindarajan, MD 

B.K. Goyal, MD 

Purvez Keki Grant, MD 

Anil Grover, MD 

Ramesh Gudapati, MD 

Surya Prakash Gulla, MD 

Suvir Gupta, DM 

Kandaswami Gurunath, MD 

Haridas Haridas, MD 

Sanadhya Harish, MD 

P.K. Hazra, MD 

Behera Hemanta MD 

M.S. Hiremath, MD 

Dev Indranil, MD 

Biju Chandy Isaac, MD 

Prakash Jain, MD 

Sharad Jain, MD 

Neeraj Jain, MD, DM 

Vidhut Kumar Jain, MD 

Ezhilan Janakiraman, MD 

Satej Janorkar, MD 

Rakesh Kumar Jaswal, DM 

Kannan Bawaramalingam Jawaharlal, MD 

T.G. Jayakumar, MD 

Jayanna Jayanna, MD 

Prajapati Jayesh, MD 

D.K. Jhamb, MD 

Rakesh C. Jindal, DM 

Abhijeet Joshi, MD 

Sreemannarayana Jujjuru, MD 

Kannan Jyothi, MD 

Nitin Kabra, MD 

Jain.T. Kallarakkal, MD 

B.C. Kalmath, MD 

Ghanashyam R. Kane, MD, DM 

Anil Saleem Kanhirala, MD 

Das Mrinal Kanti, MD 

Deepak Kapila, DM 

Aditya Kapoor, MD 

Atul Kasliwal, DM 


Murthy Keshav, MD 

Javed Ali Khan, MD 

Uday Khanolkar, MD 

Rajeev Kumar Khare, MD 

K.S. Kishore, MD 

Damodara Rao Kodem, MD 

Yogesh Amrutlal Kothari, MD, DNB 

Asokan Parayoru Kottayil, MD 

Koduru Gopala Krishna, DM 

Lanka Satya Rama Krishna, MD, DM 

Vinod Krishnan, MD 

Abhay Kumar, MD 

Agarwal Kishna Kumar, MD 

Ajith Kumar, MD 

Badhan Brajesh Kumar, MD, DM 

Baruah Dibya Kumar, MD, DM 

Goyal Gajinder Kumar, MD, DM 

Ganesh Kumar, MD, DM 

Malhotra Ashish Kumar, MD 

Yadav Mukesh Kumar, MD, DM 

Nikhil Kumar, MD, DM 

Prabhat Kumar, MD 

Rajeeve Kumar, MD 

R. Shiva Kumar, MD 

Renju Kumar, MD 

Shiva Kumar, MD 

Viveka Kumar, MD, DM 

Kumaran Sunitha Kumari, MD, DM 

Yusuf A. Kumble, MD, DM, DNB 

Subrata Lahiri, MD, DM 

Purushotam Lal, MD, DM 

Tilak Kishor Lall, MD 

Krishna Lanka, MD 

Pathak Lekha, MD 

Amal Louis, MD, DM 

Ali Mabboob, MD 

C. N. Makhale, MD 

Ajay Kumar Umakant Mahajan, MD 

Ashok Malpani, MD 

Panja Manatosh, MD 

Bagur Venkataramaiah Manjunatha, MD, DM 

Rajan Joseph Manjuran, MD 

Anil Kumar Mannambeth, MD 

Kumar Manoj, MD 

Ashraf Safiya Manzil, MD 

Viney Mathavan, MD 

Thomas Mathew, MD 

Chandra Bhan Meena, MD 

Haresh Mehta, MD, DNB 

Ajit R. Menon, MD, DM 

Bishav Mohan, DM 

Asawa Madhusudhan Mohanlal, MD, DM 

S.C. Mondal, MD 

Bishav Mohan, MD, DM 

Behara Mrintunjay, MD 

Omer Hasan Mustafa, DM 

A.C. Nagamani, MD 

Venugopal Krishnan Nair, MD 

Sinha Nakul, MD 

Ganesan Nambirajan, MD 

Panigrahi Nanda Kumar, MD 

Hemant Narayan, DM 

Srichandran Lakshmi Narayanan, MD 

Padmanaban Narayanan, MD, DM 

Pamnani Naresh, MD 

Ranjit Nath, MD, DM 

Mathew Naveen, MD 

P.D. Nigam, MD, DM 

Tripathi Nitynand, MD 

Vishnu Prabhu Oonu Rajan, MD 

Raveendran Pachakkoottathil, MD 

Balaji Pakshirajan, MD 

Murali Sankar Reddy Palchuri, MD 

Mahesh Babu Panchanathan, MD 

Neeraj Pandit, MD, DM 

Nanda Kishore Panigrahi, DM 

Jagdish Parikh, MD, DM 

Mukesh Parikh, MD 

Nikhil Parikh, MD 


Piyush Patel, MD 

Saurin Patel, MD 

Piyush Patel, MD, FACC 

Balagopal Jayagopal Pathiyil, MD 

Rahul Raosaheb Patil, MD, DNB 

Sachin Narendra Patil, MD, DNB 

Venkata Surya Sambhu Patimalla, MD 

U. Patnaik, MD 

A.C. Perierra, MD 

M.G. Pillai, MD 

Brian Pinto, MD 

Sunil Pisharody, MD 

Pawan Poddar, MD 

Anil Potdar, MD 

Kawthekar Girish Prabhakar, MD 

Halkatti Prabhu, MD 

Sitaram Manthri Pragada, MD 

Sharma Ved Prakash, MD, DM 

Niraj Prasad, MD 

Nyayadish Prasanna, MD 

Charanjit Singh Pruthi, MD 

Charanjit Singh Pruthi, MD 

Lakkaraj Rajasekhar, MD 

Deshmukh Rajendra, MD, DM 

Khare Rajiv, MD 

Arora Rakesh, MD 

Chengala Damodara Ramakrishna, MD, DM 

Balakrishnan Ramamurthy, MD, DM 

Puri Raman, MD 

Gudapati Ramesh, DM 

Ramalingam Rangarajan, MD 

Alok Ranjan, DM 

Anand Rao, MD, DNB 

Vithala Surya Prakasa Rao, DM 

J. Shivkumar Rao, MD 

Rajeev Rathi, MD, DM 

Parvathareddy Krishna Malakonda Reddy, MD, DM 

Ravindra Nath Reddy, MD 

Roopa Reddy, MD 

Sharat Reddy, MD 

Vinod Revankar, MD 

Gupta Ripen, MD 

Mody Rohit, MD, DM 

Sanjeeb Roy, DM 

David Rozario, DM 

John Satish Rudrapogu, MD 

Amit Sambare, MD 

Manjinder Singh Sandhu, DM 

Porwal Sanjay, MD 

Murugan Sankaranarayanan, MD 

Rakesh Sapra, MD, DM 

Vaidya Satish, MD, DM 

Devnani Satish, MD 

Routray Satyanarayan, DM 

Ashok Seth, MD, DM 

Selvamani Sethuraman, MD 

Bhupesh Shah, MD, DNB 

Jay Shah, DM 

Om Shankar, MD 

Gautam Sharma, MD 

Sanjeev Kumar Sharma, DM 

Anil Sharma, MD 

Chetan Sharma, MD 

Amit Sharma, MD 

Jagdish Kumar Sharma, MD 

Shashi Mohan Sharma, MD 

B.K. Shastry, MD 

Joshi Radhey Shyam, MD 

Gurappa Gojanur Shetty, MD, DM 

Srikanth Shetty, MD 

Dutta Shuvo, MD 

Mukerjee Siddharth, MD, DM 

Prabhu Dayal Singh, MD 

Harnoor Singh, MD 

Amar Singhal, MD, DM 

Ramanand Sinha, MD 

Ramanand Sinha, DM 

Nanda Kumar Sivasankar, MD 

Trivedi Skand, MD 

Kothari Snehal, MD 

Chozhakkat Somanathan, MD, DM 

S.L. Soneji, MD 

Madhu Sreedharan, DM 

P. Sreekala, MD 

Sangeetha Sreenivasan, MD 

N. Sridhara, MD, DM 

V.S. Srikanthan, MD 

Chandra Subhash, MD, DM 

Natarajan Subramanian, MD 

Kodangla Subramanyam, MD 

Chacko Sujith Thomas, MD 

Mantravadi Sai Sudhakar, MD, DM 

Sethi Sumeet, MD, DM 

Mishra Sundeep, MD 

Shyam Sunder, MD, DM 

Pujar Venkateshacharya Suresh, MD, DM 

Patted Suresh, MD 

Vijan Suresh, MD 

Krishnan Suresh, MD 

Pawan Suri, MD 

Ahmed Tamzeed, MD 

Mihir Tanna, MD, DNB 

Rajesh Thachathodiyl, MD 

Neelambujan Thanulingam, MD 

Sunil Thanvi, MD 

Saravanan Duraisamy Mohana Thiruvenkada, MD 

Alexander Thomas, MD 

P.L. Tiwari, MD 

Devasia Tom, MD 

S. Toshniwal, MD 

Haque M. Touhidul, MD 

Mahendra Prasad Tripathy, DM 

Rutvik Trivedi, DM 

Shailendra Trivedi, MD 

Kaushik Trivedi, MD 

Kalaichelvan Uthaikumar, MD 

Saha Uttam Kumar, MD, DM 

Asmit Vaidya, MD 

Kesava Vallabhapurapu, MD 

Das Vashisth, MD 

Karthik Vasudevan, MD, DM 

Bang Vijay, MD 

Purohit Bharat Vijay, MD, DM 

Chopra Vikas, MD 

Agrawal Vikas, MD 

Bhatia Vineet, MD 

Vijan Vinod, MD 

Muthukrishnan Viswanathan, MD 

Gurpreet Singh Wander, DM 

R.D. Yadave, MD, DM

uniTed sTaTes FaculTy 

Keith D. Aaronson, MD 

University of Michigan Health System 

Ann Arbor, MI 

Amr Abbas, MD 

William Beaumont Hospital 

Royal Oak, MI 

J. Dawn Abbott, MD 

Rhode Island Hospital 

Providence, RI 

Alex Abou-Chebl, MD 

University of Louisville Stroke Center 

Louisville, KY 

William T. Abraham, MD 

Ohio State University 

Columbus, OH 


Mount Sinai Medical Center 

New York, NY 

Tayo A. Addo, MD 

UT Southwestern Clinical Heart Center 

Dallas, TX 

Ramesh K. Adiraju, MD 

RENU-CA Research Institute 

Bristol, PA 

Gorav Ailawadi, MD 

University of Virginia 

Charlottesville, VA 

Jodi Akin, VP 


Irvine, CA 

Ziad A. Ali, MD, DPhil 


New York, NY 

Steven L. Almany, MD 


Boomfield Hills, MI 

Elissa Altin, MD 

NewYork-Presbyterian Hospital/ 


New York, NY 

Yele Aluko, MD 

Presbyterian Cardiovascular Institute 

Charlotte, NC 

John A. Ambrose, MD 

UCSF Fresno 

Fresno, CA 

Zahid Amin, MBBS, MD 

Rush University Medical Center 

Chicago, IL 

Max Amor, MD 

Clinique Louis Pasteur 

Essey-les-Nancy, France 

Karthik Ananthasubramaniam, MD 

Henry Ford Health System 

Detroit, MI 

Mark B. Anderson, MD 

Albert Einstein Healthcare Network 

Philadelphia, PA 

Rick Anderson 

PTV Sciences 

Austin, TX 


University of Florida-Shands 

Jacksonville, FL 

Lon S. Annest, MD, MBA 

BioVentrix 

San Ramon, CA 

Brian H. Annex, MD 

University of Virginia 



Riverside Methodist Hospital 

Columbus, OH 

Robert J. Applegate, MD 

Wake Forest University School of Medicine 

Winston-Salem, NC 




New York, NY 

Herbert D. Aronow, MD, MPH 

St. Joseph Mercy Hospital 

Ypsilanti, MI 

Thomas Aversano, MD 

Johns Hopkins Medical Institutions 

Baltimore, MD 

Mohammad Ali Aziz-Sultan, MD 

University of Miami School of Medicine 

Miami, FL 

Ali Azizzadeh, MD 

University of Texas Houston 

Houston, TX 

Vasilis Babaliaros, MD 

Emory University School of Medicine 

Atlanta, GA 

Joseph D. Babb, MD 

East Carolina University School of Medicine 

Greenville, NC 

Usman Baber, MD 


New York, NY 

Richard G. Bach, MD 

Barnes-Jewish Hospital 

St. Louis, MO 


Morgan Stanley Children’s Hospital 

New York, NY 

J. Michael Bacharach, MD, MPH 

North Central Heart Institute 

Sioux Falls, SD 

Steven R. Bailey, MD 

University of Texas Health Science 

Center at San Antonio 

San Antonio, TX 

Husam H. Balkhy, MD 

The Wisconsin Heart Hospital 

West Allis, WI 



New York, NY 

Sripal Bangalore, MD, MHA 

New York University School of Medicine 

New York, NY 

Gust Bardy, MD 

University of Washington 

Carnation, WA 

Paddy Barrett, MD 

Scripps Translational Science Institute 

La Jolla, CA 



Theodore A. Bass, MD 

University of Florida Health Science Center 



University of Michigan Medical Center 

Ann Arbor, MI 

Mark C. Bates, MD 

CAMC Vascular Center of Excellence 

Charleston, WV 

James F. Benenati, MD 

Baptist Cardiac and Vascular Institute 

Miami, FL 


Columbia University Division of Cardiology 

at Mount Sinai Medical Center 

Miami Beach, FL 

Daniel S. Berman, MD 

Cedars-Sinai Medical Center 

Los Angeles, CA 

Robert M. Bersin, MD 

Swedish Heart and Vascular 

Seattle, WA 

Stefan C. Bertog, MD 

University of Minnesota Medical School 

Minneapolis, MN 


VA Boston Healthcare System and Brigham 

and Women’s Hospital 

Boston, MA 

Emma Birks, MBBS, PhD 

Jewish Hospital Transplant Center 


John A. Bittl, MD 

Munroe Regional Medical Center 

Ocala, FL 

Tony Blank 

Boston Scientific 

Natick, MA 

James C. Blankenship, MD 

Geisinger Medical Center 

Danville, PA 

Peter C. Block, MD 

Emory University Hospital 

Atlanta, GA 

Ashley B. Boam, MSBE 


Silver Spring, MD 

William E. Boden, MD 

Stratton VA Medical Center 

Albany, NY 

Steven F. Bolling, MD 

University of Michigan 

Ann Arbor, MI 

Brett E. Bouma, PhD 

Massachusetts General Hospital 

Boston, MA 

Frank Bowen, MD 

The Cooper Health System 

Camden, NJ 

Bruce Bowers, MD 

Dallas Cardiovascular Specialists 

Dallas, TX 

Biykem Bozkurt, MD 

Michael E. DeBakey VA Medical Center 

Houston, TX 

TranscaTheTer 


TherapeuTics 

Peter A. Brady, MB, ChB, MD 

Mayo Clinic 

Rochester, MN 

Russell A. Brandwein, PA-C 



New York, NY 

Somjot S. Brar, MD 

Kaiser Permanente 


Sorin J. Brener, MD 

New York Methodist Hospital 

Brooklyn, NY 

J. Matthew Brennan, MD, MPH 

Duke University Medical Center 

Durham, NC 

Bryan Brewster, MD 

Washington Hospital Center 

Washington, DC 

Perry Bridger, MHS 



Emmanouil S. Brilakis, MD, PhD 

VA North Texas Health Care System and 

UT Southwestern Medical Center 

Dallas, TX 

Ralph G. Brindis, MD, MPH 

Northern California Kaiser Permanente 

Oakland, CA 

Todd J. Brinton, MD 

Stanford University Medical Center 

Stanford, CA 

Bonnie Brown 

Saint Luke’s Health System 

Kansas City, MO 

David Brown, MD 

Health Sciences Center 

Stony Brook, NY 

David L. Brown, MD 

The Heart Hospital Baylor Plano 

Dallas, TX 

Charles L. Brown III, MD 

Piedmont Healthcare 

Atlanta, GA 


Foundation for Cardiovascular Medicine 

San Diego, CA 

Michael Buck 

Abbott Laboratories 

Abbott Park, IL 

M. Nicholas Burke, MD 

Minneapolis Heart Institute Foundation 


Mark W. Burket, MD 

University of Toledo Medical Center 

Toledo, OH 


CircuLite 

Saddle Brook, NJ 

Robert M. Califf, MD 

Duke Clinical Research Institute 

Durham, NC 

Louis A. Cannon, MD 

Northern Michigan Hospital Heart and 

Vascular Institute, Petoskey Cardiology 

Petoskey, MI 


42 


Daniel Canos, MPH 



Ronald Caputo, MD 

SJH Cardiology Associates 

Syracuse, NY 

Blase A. Carabello, MD 

Veterans Affairs Medical Center 

Houston, TX 


University of Colorado Denver 

Aurora, CO 

Joseph P. Carrozza Jr, MD 

Steward St. Elizabeth’s Medical Center 

Boston, MA 


Hershey Medical Center 

Hershey, PA 

Jeffrey Chambers, MD 

Metropolitan Cardiology Consultants 


John P. Cheatham, MD 

Nationwide Children’s Hospital 

Columbus, OH 

S. James Chen, PhD 

University of Colorado Hospital 

Aurora, CO 

James H. Chesebro, MD 

UMass Memorial Medical Center 

Worcester, MA 

Nicolas A.F. Chronos, MD 

Saint Joseph’s Medical Group 

Atlanta, GA 

Sarah Clarke, MSN, NP 

Scripps Clinic and Research Foundation 

La Jolla, CA 


Saint Luke’s Mid America Heart Institute 


Howard A. Cohen, MD 

Temple Universtiy Health System 


Marc Cohen, MD 

Newark Beth Israel Medical Center 

Newark, NJ 


University of Miami Hospital 

Miami, FL 

William E. Cohn, MD 

Texas Heart Institute at St. Luke’s 

Episcopal Hospital 

Houston, TX 




New York, NY 

Tyrone J. Collins, MD 

Ochsner Clinic Foundation 

New Orleans, LA 

Anthony J. Comerota, MD 

Jobst Vascular Institute 

Toledo, OH 

Christopher J. Cooper, MD 


Toledo, OH 

David Cormode, DPhil 

Perelman School of Medicine at the 

University of Pennsylvania 

Philadelphia, PN 

Nicola Corvaja, MD 

Stamford Hospital 

Stamford, CT 

Joseph N. Cosico, MA, CRA, CCRC 



Marco A. Costa, MD, PhD 

University Hospitals Case Medical Center 

Cleveland, OH 

Robert J. Cottone 

OrbusNeich Medical 

Ft. Lauderdale, FL 

Todd D. Courtney, MS 



Michael J. Cowley, MD 

Medical College of Virginia 

Richmond, VA 


Lehigh Valley Hospital 

Bethlehem, PA 

Megan Coylewright, MD, MPH 

Mayo Clinic 

Rochester, MN 

Frank J. Criado, MD 

Medstar Union Memorial Hospital 

Baltimore, MD 

Gary Curtis, MD 

Los Altos, CA 

Jeptha P. Curtis, MD 

Yale University 

New Haven, CT 


Beth Israel Deaconess Medical Center 

Boston, MA 

Michael D. Dake, MD 

Stanford University School of Medicine 

Stanford, CA 

Kate Dalton, MS, RD 


New York, NY 

Richard C. Daly, MD 

Mayo Clinic 

Rochester, MN 



New York, NY 

Tony Das, MD 

Presbyterian Heart Institute-Dallas 

Dallas, TX 

Harold L. Dauerman, MD 

Fletcher Allen Healthcare/ 

University of Vermont 

Burlington, VT 

Rajesh M. Dave, MD 

Holy Spirit Cardiovascular Institute, 

Holy Spirit Hospital 

Camp Hill, PA 

Charles J. Davidson, MD 

Northwestern Memorial Hospital 

Chicago, IL 

Michael J. Davidson, MD 

Brigham and Women’s Hospital 

Boston, MA 

Jeff Davis, RRT, RCIS 

Edison State University 

Fort Myers, FL 

Keith D. Dawkins, MD 


Natick, MA 

Anthony Dawson, MSN, RN 

NewYork-Presbyterian Hospital 

New York, NY 

Larry S. Dean, MD 


Regional Heart Center 

Seattle, WA 

Regina Deible, BSN, RN 

Suburban Hospital/ 

Johns Hopkins Medicine 

Bethesda, MD 

Augustin Delago, MD 

Albany Medical Center 

Albany, NY 

Anthony N. DeMaria, MD 

University of California, San Diego 

School of Medicine 

San Diego, CA 

Tony J. DeMartini, MD 

Prairie Cardiovascular 

Springfield, IL 

Harit Desai, DO 

DEBORAH Heart and Lung Center 

Brown Mills, NJ 

Todd M. Dewey, MD 

Medical City Dallas 

Dallas, TX 

Nabil Dib, MD, MSc, FACC 

Chandler Regional and Mercy Gilbert 

Medical Centers/Catholic Healthcare West 

Gilbert, AZ 

Edward B. Diethrich, MD 

Arizona Heart Foundation 

Phoenix, AZ 

Eric J. Dippel, MD 

Cardiovascular Medicine, PC 

Davenport, IA 

Simon R. Dixon, MBChB 

Beaumont Hospital 

Royal Oak, MI 

Ozgen Dogan, MD 


New York, NY 

Pilar Dolcimascolo, RPA-C 


New York, NY 

Feng Dong, MD, PhD 

Northeast Ohio Medical University 

Rootstown, OH 

Dennis J. Donohoe, MD 

Micell 

Durham, NC 

Shephal Doshi, MD 

Pacific Heart Institute 

Santa Monica, CA 

Pamela S. Douglas, MD, MAcc 


Durham, NC 

John S. Douglas Jr, MD 

Emory University School of Medicine 

Atlanta, GA 

Robert D. Dowling, MD 

University of Louisville 



Douglas E. Drachman, MD 


Boston, MA 

Danny Dvir, MD 



Elazer R. Edelman, MD, PhD 


Cambridge, MA 

Neal L. Eigler, MD 

St. Jude Medical 

Sylmar, CA 

Andrew J. Einstein, MD, PhD 


New York, NY 

Sally Elliott, BS, CCT, RCIS 

Sentara 

Chesapeake, VA 

Stephen G. Ellis, MD 

Cleveland Clinic Foundation 

Cleveland, OH 

Stephen E. Epstein, MD 



Michael D. Ezekowitz, MB, ChB, DPhil 

Lankenau Medical Center 

Wynnewood, PA 

Andrew Farb, MD 



Michael E. Farkouh, MD, MSc 

Mount Sinai School of Medicine 

New York, NY 

David P. Faxon, MD 


Boston, MA 



Stanford, CA 


New York University Medical Center 

New York, NY 

Marc D. Feldman, MD 




Ted E. Feldman, MD 

Evanston Hospital 

Evanston, IL 

Valerian Fernandes, MD 

Medical University of South Carolina 

Charleston, SC 



Boston, MA 

Tim A. Fischell, MD 

Heart Institute at Borgess Medical Center 

Kalamazoo, MI



Stanford, CA 

John M. Flack, MD, MPH 

Wayne State University 

Detroit, MI 

Thomas J. Fogarty, MD 

Fogarty Institute for Innovation 

Mountain View, CA 

Gregory P. Fontana, MD 

Lenox Hill Hospital Heart and Vascular 

Institute Lenox Hill Hospital 

New York, NY 

Theresa Franklin-Bond, MS, PA-C 


New York, NY 


Harbor - UCLA Medical Center 

Torrance, CA 

Glenna Friedman, RN 



New York, NY 

Valentin Fuster, MD, PhD 


New York, NY 

James S. Gammie, MD 

University of Maryland Heart Center 

Baltimore, MD 

Roger Gammon, MD 

Austin Heart 

Austin, TX 

Ripal T. Gandhi, MD 


Miami, FL 

Lawrence A. Garcia, MD 

St. Elizabeth’s Medical Center 

Boston, MA 



New York, NY 



New York, NY 

Robin E. Germany, MD 

University of Oklahoma College 

of Medicine 

Oklahoma City, OK 

Adam Geronemus, MD 


South Miami, FL 


Mayo Clinic 

Rochester, MN 


John Muir Cardiovascular Institute 

Piedmont, CA 



Boston, MA 


Penn State/Hershey Medical Center 

Hershey, PA 



Cleveland, OH 

Giuseppe Gioia, MD 

Drexel University Medical College 

Pomona, NJ 

Lee Giorgi, MD 

St. Luke’s Hospital 

Duluth, MN 

Sachin S. Goel, MD 


Cleveland, OH 

Sheldon Goldberg, MD 

Cardiology Consultants of Philadelphia 


Steven L. Goldberg, MD 


Seattle, WA 

Mark Goldberger, MD 


New York, NY 


Beaumont Health System 

Royal Oak, MI 

John Goncalves, MD 

Winthrop University Hospital 

Mineola, NY 

Kenneth A. Gorski, RN, RCIS, RCSA 

Cleveland Clinic 

Cleveland, OH 

Nilesh Goswami, MD 

Prairie Cardiovascular 



CRF Skirball Research Center 

Orangeburg, NY 

Christopher B. Granger, MD 


Durham, NC 


University of Missouri Kansas City and Mid 

America Heart Institute 




New York, NY 

Paul A. Grayburn, MD 

Baylor University Medical Center 

Dallas, TX 



New York, NY 


Detroit Medical Center 

Detroit, MI 

Kendra J. Grubb, MD, MHA 



New York, NY 

Luis Gruberg, MD 

Stony Brook University Medical Center 


Alejandra Guerchicoff, PhD 

NYU Cardiovascular Genetics Program 

New York, NY 

Michael Guiry, MBA, RPA-C 


New York, NY 




Sinai Hospital of Baltimore System 

Baltimore, MD 

Hitinder S. Gurm, MD 

University of Michigan Medical Center 

Ann Arbor, MI 

Lee R. Guterman, MD, PhD 

Catholic Health System of Buffalo 

Amherst, NY 

Robert A. Guyton, MD 


Atlanta, GA 

Luis A. Guzman, MD 

University of Florida 


Rory Hachamovitch, MD, MSc 


Cleveland, OH 

Rebecca Tung Hahn, MD 


New York, NY 

Jonathan L. Halperin, MD 

Mount Sinai Medical Institution 

New York, NY 

Adam Hansgen, BS 

University of Colorado Health 

Sciences Center 

Aurora, CO 


Guthrie Clinic 

Sayre, PA 

Robert A. Harrington, MD 


Stanford, CA 

Mahmoud Hashemian, MD, FACC 

Day Hospital, Tehran 

Tehran, CA 




New York, NY 

William E. Hellenbrand, MD 

Yale New Haven Children’s Hospital 

New Haven, CT 

Timothy D. Henry, MD 




St. Vincent Hospital/The Heart 

Center of Indiana 

Indianapolis, IN 


Hospital of the University of Pennsylvania 


Richard R. Heuser, MD 

St. Luke’s Medical Center 

Phoenix, AZ 

Jo Carol Hiatt, MD, MBA 


Pasadena, CA 

Karen A. Hicks, MD 





Chicago, IL 

TranscaTheTer 


TherapeuTics 

Frank Hildner, MD 

Central Florida Heart Center 

Ocala, FL 

Matthew G. Hillebrenner, MSE 



John McB. Hodgson, MD 

Geisinger Health System 

Edwardsville, PA 

David R. Holmes Jr, MD 

Mayo Clinic 

Rochester, MN 

Marsha Holton, CCRN, RCIS 

Cardiovascular Orientation Programs 

Indian Head, MD 

Shunichi Homma, MD 



New York, NY 

Yasuhiro Honda, MD 


Stanford, CA 

W. Craig Hooper, PhD 

Centers for Disease Control and Prevention 

Atlanta, GA 

L. Nelson Hopkins, MD 

Buffalo General Medical Center 

Buffalo, NY 

Robert A. Hopkins 

Bank of America Merrill Lynch 

New York, NY 

Syed Hossainy, PhD 


Santa Clara, CA 

Frank F. Ing, MD 

Texas Children’s Hospital 

Houston, TX 

Bob Jackson, BBA 

Keller, TX 

Elizabeth A. Jackson, MD, MPH 

University of Michigan Health System 

Ann Arbor, MI 


Boston University Medical Center 

Boston, MA 

Jamey Jacobs, BS 


Menlo Park, CA 

Michael R. Jaff, DO 


Boston, MA 

Allan S. Jaffe, MD 

Mayo Clinic 

Rochester, MN 

Farouc Jaffer, MD, PhD 


Boston, MA 

Alexander J. Javois, MD 

Hope Children’s Hospital 

Oak Lawn, IL 

Lisa K. Jennings, PhD 

University of Tennessee Health 

Science Center 

Memphis, TN 


44 


Tamara Syrek Jensen, JD 

Centers for Medicare and 

Medicaid Services 

Baltimore, MD 

Allen Jeremias, MD, MSc 

Stony Brook University Medical Center 


Hasan Jilaihawi, BSc, MBChB 

Cedars-Sinai Heart Institute 


Nils Johnson, MD, MS 

University of Texas Medical School 

Houston, TX 

Warren L. Johnson, MD 

Keystone Colorado 

Frisco, CO 

Thomas K. Jones, MD 

Seattle Children’s Hospital 

Seattle, WA 

James D. Joye, DO 

El Camino Hospital 


William H. Julien, MD 

South Florida Vascular Associates 

Coconut Creek, FL 

Lowell Kabnick, MD 

New York University Medical School 

New York, NY 

Joel Kahn, MD 


West Bloomfield, MI 

Ankur Kalra, MD 

Minneapolis Heart Institute at Abbott 

Northwestern Hospital 


Greg L. Kaluza, MD, PhD 




Piedmont Heart Institute 

Atlanta, GA 

Samir R. Kapadia, MD 


Cleveland, OH 

Aaron V. Kaplan, MD 

Dartmouth-Hitchcock Medical Center 

Lebanon, NH 

Navin K. Kapur, MD 

Tufts Medical Center 

Boston, MA 






Atlanta, GA 



Miami, FL 

Sanjay Kaul, MD 



Clifford J. Kavinsky, MD, PhD 


Chicago, IL 

Polly Keller, RCIS 

Valencia College 

Ocoee, FL 

Dean J. Kereiakes, MD 

The Christ Hospital 

Cincinnati, OH 


University of California Irvine 

Irvine, CA 

R. Stefan Kiesz, MD 

San Antonio Endovascular 

and Heart Institute 


Michael Kim, MD 


New York, NY 

Michael S. Kim, MD 


Aurora, CO 

Carey D. Kimmelstiel, MD 


Boston, MA 


Saint Joseph’s Heart and Vascular Institute 

Atlanta, GA 

Nicholas N. Kipshidze, MD, PhD 

Lenox Hill Hospital 

New York, NY 




New York, NY 

Neal S. Kleiman, MD 

Methodist DeBakey Heart and 

Vascular Center 

Houston, TX 

Patricia E. Knipper, RN 


New York, NY 




New York, NY 


Prairie Vascular Institute 


Maya Kommineni, MD 

Evanston Northwestern Healthcare 

Chicago, IL 

David F. Kong, MD, AM, DMT 


Durham, NC 


St. Luke’s Episcopal Hospital 

Houston, TX 

Paul H. Kramer, MD 

Liberty Cardiovascular Specialists 

Sunny Isles Beach, FL 

Prakash Krishnan, MD 


New York, NY 

Mitchell W. Krucoff, MD 


Durham, NC 

Spencer H. Kubo, MD 

Heart Leaflet Technologies 

Maple Grove, MN 

Aaron D. Kugelmass, MD 

Baystate Medical Center 

Springfield, MA 

Frederick Kushner, MD 

Heart Clinic of Louisiana 

Marrero, LA 

Robert Kutys, MS, PA(ASCP) 

CVPath Institute, Inc. 

Gaithersburg, MD 

Jeffrey T. Kuvin, MD 


Boston, MA 

Elena Ladich, MD 



Roger J. Laham, MD 


Boston, MA 

John R. Laird Jr, MD 

UC Davis Medical Center 

Sacramento, CA 

Gervasio A. Lamas, MD 


Miami Beach, FL 


Yale School of Medicine 

New Haven, CT 

Tim J. Lapp, RCIS 

Lancaster General Hospital 

Lancaster, PA 

John M. Lasala, MD, PhD 

Washington University School 

of Medicine 

St. Louis, MO 

John Laschinger, MD 



Randall T. Lashinski 

Claret Medical 

Santa Rosa, CA 

Harold L. Lazar, MD 

Boston Medical Center 

Boston, MA 

Robert J. Lederman, MD 

National Heart, Lung, and Blood Institute 

Bethesda, MD 

Michael S. Lee, MD 

UCLA Medical Center 


Randall J. Lee, MD, PHD 

University of California, San Francisco 


W. Anthony Lee, MD 

Lynn Heart and Vascular Institute 

Boca Raton, FL 

Massoud A. Leesar, MD 

University of Alabama-Birmingham 

Birmingham, AL 

Nicholas J. Lembo, MD 


Atlanta, GA 




New York, NY 

Jane A. Leopold, MD 


Boston, MA 

Norman E. Lepor, MD 


Beverly Hills, CA 

Amir Lerman, MD 

Mayo Clinic 

Rochester, MN 

John C. Lewin, MD 

Lewin and Associates LLC 


Michael J. Lim, MD 

Saint Louis University 

Saint Louis, MO 

Scott Lim, MD 

UVA Medical Center 


A. Michael Lincoff, MD 


Cleveland, OH 


University of Colorado Health 


Aurora, CO 

Italo Linfante, MD 


Miami, FL 

William C. Little, MD 

Wake Forest University School of Medicine 

Winston-Salem, NC 

Frank Litvack, MD 



Julie Logan, RN 


La Jolla, CA 

William L. Lombardi, MD 

PeaceHealth St. Joseph Medical Center 

Bellingham, WA 

Anthony Long, MBA 

Navigant 

Blanchard, OK 

Robert A. Lookstein, MD 


New York, NY 

Monica Losquadro, MS, PAC 

St. Francis Hospital 

Roslyn, NY 


UC Davis Heart Center 


Ulrich C. Luft, MD 


Browns Mills, NJ 

Alan B. Lumsden, MD 

Methodist DeBakey Heart and 

Vascular Center 

Houston, TX 


The Heart Hospital Baylor Plano 

Plano, TX 

Ryan D. Madder, MD 

Frederik Meijer Heart and Vascular Institute, 

Spectrum Health System 

Grand Rapids, MI



New York, NY 


Pinnacle Health System 

Harrisburg, PA 




Thomas H. Maloney, MHA, RCIS 

Memorial Regional Medical Center 

Mechanicsville, VA 

Steven V. Manoukian, MD 

Sarah Cannon Research Institute 

Nashville, TN 

James R. Margolis, MD 

Jackson South Community Hospital 

Miami, FL 

David J. Maron, MD 

Vanderbilt Chest Pain Center 

Nashville, TN 

J. Jeffrey Marshall, MD 

Northeast Georgia Heart Center 

Gainesville, GA 


St. Luke’s Health System 


Tim R. Martin, RCIS 

Lancaster General Hospital 

Lancaster, PA 

Verghese Mathew, MD 

Mayo Clinic 

Rochester, MN 

Laura Mauri, MD, MSc 


Boston, MA 

Meital Mazor, MD 

Vessix Vascular 

Laguna Hills, CA 

Patrick M. McCarthy, MD 

Northwestern University 

Chicago, IL 

Daniel J. McCormick, DO 

Hahnemann University Hospital 


Doff B. McElhinney, MD 

NYU Medical Center 

New York, NY 

Casey McGlynn, JD 

Wilson Sonsini Goodrich and Rosati 

Palo Alto, CA 

James F. McKinsey, MD 



New York, NY 

Dennis M. McNamara, MD 

University of Pittsburgh Medical Center 

Pittsburgh, PA 

Thomas O. McNamara, MD 


Carson City, NV 

John A. McPherson, MD 

Vanderbilt University 

Nashville, TN 

Jessica L. Mega, MD 


Boston, MA 

David M. Mego, MD 

Arkansas Heart Hospital 

Little Rock, AR 



New York, NY 

Sameer Mehta, MD 

Columbia Cedars Medical Center 

Miami, FL 

Carlos I. Mena, MD 

Yale-New Haven Hospital 

New Haven, CT 

John C. Messenger, MD 

University of Colorado School of Medicine 

Aurora, CO 


Wellmont CVA Heart Institute 

Kingsport, TN 

Philip M. Meyers, MD 



New York, NY 

Robert E. Michler, MD 

Montefiore Medical Center 

New York, NY 

Stephanie Lynn Mick, MD 

Cleveland Clinic Health System 

Cleveland, OH 

Issam Mikati, MD 


Chicago, IL 

D. Craig Miller, MD 

Stanford University Medical School 

Stanford, CA 

Leslie W. Miller, MD 

University of South Florida 

Tampa, FL 

Paul J. Miller, MS 


Maple Grove, MN 

James K. Min, MD 







Prairie Cardiovascular Consultants 



University of Kentucky 

Lexington, KY 

Michael Mooney, MD 



Pedro R. Moreno, MD 


New York, NY 

David A. Morrow, MD, MPH 


Boston, MA 






New York, NY 

Issam D. Moussa, MD 

Mayo Clinic, Jacksonville 


James E. Muller, MD 

InfraReDx 

Burlington, MA 


Methodist DeBakey Heart and Vascular 

Center, The Methodist Hospital 

Houston, TX 



Mineola, NY 

Masataka Nakano, MD 

CVPath Institute, Inc 


Brahmajee K. Nallamothu, MD, MPH 

University of Michigan Medical School 

Ann Arbor, MI 



New York, NY 

Tamim Nazif, MD 


New York, NY 

Christopher M. Nelson, RN, RCIS 

Sentara College of Health Sciences 

Chesapeake, VA 

Graham Nichol, MD, MPH 

Harborview Medical Center 

Seattle, WA 

Christopher D. Nielsen, MD 





New York, NY 

Vuyisile T. Nkomo, MD 

Mayo Clinic 

Rochester, MN 

John O’Connell, MD 

Heart Failure Consultants 

Sunset, SC 

Michelle O’Donoghue, MD, MPH 


Boston, MA 



Boston, MA 



Durham, NC 

Semih Oktay, PhD 

CardioMed Device Consultants 

Baltimore, MD 

Jeffrey W. Olin, DO 


New York, NY 


University of Miami 

Miami, FL 

TranscaTheTer 


TherapeuTics 

Christopher D. Owens, MD 

University of California, San Francisco 



Igor F. Palacios, MD 


Boston, MA 

James M. Palazzo, MBA 

Navigant 

Southlake, TX 

Julio C. Palmaz, MD 




Samir B. Pancholy, MD 

Wright Center for Graduate Medical 

Education and the Commonwealth 

Medical College 

Clarks Summit, PA 

Vasilios Papademetriou, MD 

VA Medical Center 




New York, NY 

Duk-Woo Park, MD 

Duke Clinical Researc Center 

Durham, NC 



New York, NY 

Sahil A. Parikh, MD 


Cleveland, OH 



New York, NY 

Juan C. Parodi, MD 


Pinecrest, FL 

Amit Patel, MD, MS 

University of Utah 

Salt Lake City, UT 

Manesh R. Patel, MD 


Durham, NC 

Sonna M. Patel-Raman, PhD 



Raghotham R. Patlola, MD 

Cardiovascular Institute of the South 

Lafayette, LA 

Bray Patrick-Lake 

PFO Research Foundation 

Boulder, CO 

Wesley R. Pedersen, MD 



Constantino S. Pena, MD 


Miami, FL 

Lynn F. Peng, MD 


Stanford, CA 

Marc S. Penn, MD, PhD 

Summa Health System 

Akron, OH 


46 


Emerson C. Perin, MD, PhD 

Texas Heart Institute 

Houston, TX 

Ashish Pershad, MD 

Heart and Vascular Center of Arizona 

Phoenix, AZ 

Harry R. Phillips, MD 


Durham, NC 

Augusto D. Pichard, MD 



Ileana L. Pina, MD, MPH 

Montefiore Medical Center 

Bronx, NY 

Duane S. Pinto, MD, MPH 


Boston, MA 

Roel R. Pinzon, BSN, RN 


New York, NY 

Donna Polk, MD, MPH 

Hartford Hospital 

Hartford, CT 

Jeffrey J. Popma, MD 


Newton, MA 

Thomas J. Povsic, MD, PhD 


Chapel Hill, NC 

Alex Powell, MD 


Miami, FL 


Scripps Clinic 

La Jolla, CA 

Lauren T. Privitera, MPH 

Columbia University Medical Center, 

Health Policy and Management 

New York, NY 

Andrew W. Proctor, MS 


Lyndhurst, OH 

John D. Puskas, MD, MSc 

Emory University Hospital Midtown 

Atlanta, GA 

Christopher Pyne, MD 

Lahey Clinic 

Burlington, MA 

Robert T. Pyo, MD 


New York, NY 


Baptist Cardiac and Vascular 

Institute of Miami 

Miami, FL 

C. Venkata S. Ram, MD 

Dallas Nephrology Associates 

Dallas, TX 

Stephen R. Ramee, MD 

Ochsner Medical Center 




Durham, NC 

Richard J. Rapoza, PhD 



Mahmood K. Razavi, MD 

St. Joseph Cardiac and Vascular Center 

Orange, CA 

Michael J. Reardon, MD 

The Methodist Hospital 

Houston, TX 

Vivek Y. Reddy, MD 


New York, NY 

Glenn Reicin 

Skyline Ventures 

Palo Alto, CA 


Swedish Heart and Vascular Institute 

Seattle, WA 

Matthew R. Reynolds, MD, MSc 


Boston, MA 

John F. Rhodes, MD 


Durham, NC 

Joseph J. Ricotta II, MD, MS, FACS 

Northside Hospital Health System 

Atlanta, GA 

Charanjit S. Rihal, MD 

Mayo Clinic 

Rochester, MN 

Michael J. Rinaldi, MD 

Sanger Heart and Vascular Institute/ 

Carolinas Medical Center 

Charlotte, NC 

Marian K. Rippy, DVM, PhD 

Rippy Pathology Solutions 

Woodbury, MN 


Scottsdale Heart Group 

Scottsdale, AZ 

Rhonda Robb 

Medtronic 


Jonathan S. Roberts, MD 

Baptist Cardiac and Vascular Institute, 

Baptist Hospital of Miami 

Miami, FL 


Prairie Heart Institute, St. John’s Hospital 


Matthew T. Roe, MD, MHS 


Durham, NC 

Jason H. Rogers, MD 



Joseph G. Rogers, MD 

Duke University School of Medicine 

Durham, NC 

Ivan C. Rokos, MD 

Olive View Medical Center 

Sylmar, CA 

Eric A. Rose, MD 


New York, NY 

Eric E. Roselli, MD 


Cleveland, OH 

Marlon Rosenbaum, MD 

Columbia Universtiy Medical Center 

New York, NY 

Gregg Rosner, MD 


New York, NY 

Martin T. Rothman, MD, MB, ChB 



Joshua Rovin, MD 

Morton Plant Hospital 

Clearwater, FL 

Stanton J. Rowe 


Irvine, CA 

Stephen Rowland, PhD 

OrbusNeich 

Fort Lauderdale, FL 

Carlos E. Ruiz, MD, PhD 

Lenox Hill Hospital and North Shore Long 

Island Jewish Health System 

New York, NY 

John H. Rundback, MD 

Holy Name Hospital 

Teaneck, NJ 

Barry D. Rutherford, MD 

Cardiovascular Consultants, PC 


Joseph F. Sabik, MD 


Cleveland, OH 

Robert D. Safian, MD 


Royal Oak, MI 

Kenichi Sakakura, MD 


Sean Salmon, MBA 

Coronary and Renal Denervation 


Habib Samady, MD 


Atlanta, GA 

Gregory Sampognaro, MD 

P & S Surgical Hospital 

Monroe, LA 

Shaun L. Samuels, MD 


Miami, FL 

Maurice E. Sarano, MD 

Mayo Clinic 

Rochester, MN 

Ashwani Sastry, MD 



Lowell F. Satler, MD 

Washington Cardiology Center 


Jeffrey L. Saver, MD 

UCLA Stroke Center 


Sonia Scalf, RN, BSN 

Vanderbilt Heart and Vascular Institute 

Nashville, TN 

Gary L. Schaer, MD 


Chicago, IL 



Boston, MA 

Richard A. Schatz, MD 

Scripps Clinic 

La Jolla, CA 



Honolulu, HI 

Susan J. Schnell, ACNP-BC 

Meridian Health Systems 

Neptune, NJ 

Theodore L. Schreiber, MD 

Cardiovascular Consultants 

Warren, MI 



New York, NY 

Richard Keith Schwartz, MD 


Garden City, NY 

Robert S. Schwartz, MD 



Kimberly Selzman, MD, MPH 

University of Utah Health Sciences Center 


Samin K. Sharma, MD 


New York, NY 

Fayaz Shawl, MD 

Washington Adventist Hospital 

Takoma Park, MD 

James R. Shay, JD, BSE 

Shay Glenn LLP 

San Mateo, CA 


NewYork-Presbyterian Hosptial 

New York, NY 

Thomas M. Shimshak, MD 

Wheaton Franciscan Healthcare 

Racine, WI 

Mehdi H. Shishehbor, DO, MPH 


Cleveland, OH 

Adhir Shroff, MD, MPH 

University of Illinois Hospital and Health 

Sciences System 

Chicago, IL 

Robert J. Siegel, MD 



Frank E. Silvestry, MD 



Robert D. Simari, MD 

Mayo Clinic 

Rochester, MN 



Cleveland, OH

Pamela P. Simons 


Plymouth, MN 

Charles A. Simonton, MD 



John B. Simpson, MD, PhD 

Sequoia Hospital 

Redwood City, CA 

Varinder P. Singh, MD 



New York, NY 

Kimberly A. Skelding, MD 

Geisinger Medical Center 

Danville, PA 

Kristen Skelton 

Edwards Lifesciences Corporation 

Irvine, CA 

Marvin J. Slepian, MD 

The University of Arizona Health 


Tucson, AZ 

Richard Smalling, MD, PhD 

Memorial Hermann Heart and 

Vascular Institute 

Houston, TX 

A.J. Conrad Smith, MD 

Heart and Vascular Institute, 

UPMC Presbyterian 


Craig R. Smith, MD 



New York, NY 


Hennepin County Medical Center 

West St Paul, MN 

Daniel Soffer, MD 


New York, NY 

Richard Solomon, MD 

University of Vermont 

Burlington, VT 



New York, NY 


Mayo Clinic 

Rochester, MN 

John A. Spertus, MD 

Mid America Heart Institute 


Douglas Spriggs, MD 

Morton Plant Hospital 

Clearwater, FL 

Mukta Srivastava, MD 

University of Maryland Medical Center 

Baltimore, MD 

Frederick G. St. Goar, MD 

Advanced Cardiovascular Specialists 


Richard S. Stack, MD 

Duke University 

Chapel Hill, NC 

Niel F. Starksen, MD 

Guided Delivery Systems Inc. 


William N. Starling, MBA 

Synecor, LLC 

Portola Valley, CA 

Evan A. Stein, MD 

Metabolic and Atherosclerosis 

Research Center 

Cinncinati, OH 

Allan Stewart, MD 


New York, NY 




New York, NY 

Peter H. Stone, MD 


Boston, MA 

Dave Strelow 



Thomas D. Stuckey, MD 

Moses Cone Heart and Vascular Center 

Lebauer Cardiovascular Research 

Foundation 

Greensboro, NC 

Mitchell Sugarman, MBA 

Medtronic 


H. Robert Superko, MD 

Saint Joseph’s Translational 

Research Institute 

Alameda, CA 

Lars G. Svensson, MD, PhD 


Cleveland, OH 

Brian Sweeney, RN, MBA 

Thomas Jefferson University Hospitals 


Molly Szerlip, MD 

The Univerity of Arizona Sarver 

Heart Center 

Tucson, AZ 


University of Pennsylvania Medical Center 


Jacqueline E. Tamis-Holland, MD 

St. Luke’s-Roosevelt Hospital 

New York, NY 

Guillermo Tearney, MD, PhD 


Boston, MA 


Scripps Clinic and Research Foundation 

La Jolla, CA 

David E. Thaler, MD, PhD 


Boston, MA 


Yale New Haven Hospital 

New Haven, CT 



Atlanta, GA 



Henry H. Ting, MD, MBA 

Mayo Clinic 

Rochester, MN 

Jonathan M. Tobis, MD 



Thomas M. Todoran, MD 



Sadaf Toor, MS 



On Topaz, MD 

Charles George Veterans Affairs 


Asheville, NC 

Sara Toyloy 

ElixirMedical 

Birmingham, AL 

Jennifer A. Tremmel, MD 


Stanford, CA 

Alfredo Trento, MD 



Thomas M. Tu, MD 

Louisville Cardiology Medical Group 


Mark A. Turco, MD 

Covidien 


Zoltan G. Turi, MD 

Cooper University Hospital 

Camden, NJ 



Cleveland, OH 

Mahesh M. Uberoi 

MphRx 

Princeton, NJ 

Santosh Venkatesha, MBA 

Vigilant Medical 

Baltimore, MD 

Ralph J. Verdino, MD 

University of Pennsylvania 



VCU Medical Center 

Richmond, VA 




Szilard Voros, MD 

Integrated Cardiovascular Research Group 

East Setauket, NY 


Medstar Heart Institute 


Craig M. Walker, MD 

Cardiovascular Institute of the South 

Houma, LA 

Howard T. Walpole, MD, MBA, CPE 

Okyanos Heart Institute 

Belleair Bluffs, FL 

TranscaTheTer 


TherapeuTics 

Bonnie H. Weiner, MD, MSEC, MBA 

Worcester Medical Center 

Worcester, MA 

Michael Weinstein 

Dallas, TX 

William S. Weintraub, MD 

Christiana Care Health Services 

Newark, DE 

Neil J. Weissman, MD 

MedStar Washington Hospital Center 





New York, NY 

Grayson H. Wheatley, MD 

Arizona Heart Institute 

Phoenix, AZ 

Brian K. Whisenant, MD 

Intermountain Medical Center 


Christopher J. White, MD 

Ochsner Heart and Vascular Institute 


Patrick L. Whitlow, MD 


Cleveland, OH 

Mark H. Wholey, MD 

Allegheny General Hospital 


Michael H. Wholey, MD 

Christus Santa Rosa Medical Center 


Josiah N. Wilcox, PhD 



Robert L. Wilensky, MD 



Jose M. Wiley, MD 


New York, NY 

David O. Williams, MD 


Boston, MA 




New York, NY 

Steve Winitsky, MD 


Rockville, MD 

Stephen D. Wiviott, MD 


Boston, MA 

S. Chiu Wong, MD 


Weill Cornell Medical College 

New York, NY 

Larry L. Wood 


Irvine, CA 

Janet F. Wyman, DNP 

ACCF Cardiac Catheterization and 

Intervention Committee 

Grosse Pointe Park, MI 


48 


R. Michael Wyman, MD 

Torrance Memorial Medical Center 

Torrance, CA 

Jay S. Yadav, MD 

Piedmont Hospital 

Atlanta, GA 

Steven J. Yakubov, MD 


Columbus, OH 

Robert W. Yeh, MD, MBA 


Boston, MA 

Alan C. Yeung, MD 


Stanford, CA 

Paul G. Yock, MD 

Stanford University Biodesign Program 

Stanford, CA 

Sibin Zacharias, MD 


Royal Oak, MI 

Christopher K. Zarins, MD 


Stanford, CA 

James P. Zidar, MD 

Rex Healthcare 

Raleigh, NC 

John R. Zimmerman, MSN, RN 

Memorial Regional Medical Center 

Chester, VA 

David Zimrin, MD 


Baltimore, MD

live case siTes and 

operaTors/FacToid FaculTy 

High-definition live case 

transmission sites span 20 

locations around the globe. 

Live cases offer unique, invaluable 

learning opportunities at TCT. 

International 



Emanuele Barbato, MD, PhD 

Jozef Bartunek, MD, PhD 


Tom De Potter, MD 

Marc Vanderheyden, MD 

William Wijns, MD, PhD 

Eric Wyffels, MD 

Cardiovascular Centre, 

ZNA Middelheim Hospital 


Carl Convens, MD 

Glenn Van Langenhove, MD, PhD 


Paul Vermeersch, MD, PhD 

CARE Hospitals 


Nageshwar Rao Koneti, MD, DM 

Sreenivas Kumar, MD, DM 

B. Soma Raju, MD, DM 

P. Raghava Raju MD, DM 



M. Di Salvo, MD 

S. Imme, MD 

A. La Manna, MD 

C. Sgroi, MD 


Fundación Favaloro 


Gaspar Caponi, MD 

Carlos A. Fava, MD 

Gustavo A. Lev, MD 


León R. Valdivieso, MD 


Rouen, France 


Helene Eltchaninoff, MD 

Matthieu Godin, MD 

Instituto Dante Pazzanese 

de Cardiologia 



Magaly Arraes, MD 

Daniel Chamie, MD 


Ricardo Costa, MD, PhD 

Fausto Feres, MD, PhD 

Carlos Pedra, MD, PhD 

Eduardo Sousa, MD, PhD 

Rodolfo Staico, MD, PhD 



Sven Bräunlich, MD 


Andrej Schmidt, MD 

Matthias Ulrich, MD 

Royal Sussex County Hospital 


Adam J. de Belder, MD 

Lucy Blows, MD 

David J. Hildick-Smith, MD 

Stephen Holmberg, MD 



Shaare Zedek Medical Center 


Yaron Almagor, MD 

Jonathan Balkin, MD 

Adi Butnaru, MD 

Marc Klutstein, MD 

David Meerkin, MD 

David Rosenmann, MD 

St. Paul’s Hospital/ 

University of British Columbia 


Anson Cheung, MD 


David A. Wood, MD 


Bonn, Germany 


Andreas Hoeft, MD 

Georg Nickenig, MD 

Armin Welz, MD 

Nikos Werner, MD 

United States 

Baptist Cardiac and 


Miami, FL 

James F. Benenati, MD 

Ripal T. Gandhi, MD 


Constantino S. Pena, MD 



Shaun L. Samuels, MD 


Miami, FL 





Giora Wiesz, MD 

Nationwide Children’s Hospital 

Columbus, OH 

John P. Cheatham, MD 

Sharon L. Cheatham, ACNP, PhD 

Ralf J. Holzer, MD 

NewYork-Presbyterian 

Hospital/Columbia University 


New York, NY 







Atlanta, GA 

Harold Carlson, MD 

Anna Kalynych, MD 



Nicholas J. Lembo, MD 


Chicago, IL 

Qi-Ling Cao, MD 


Cliff Kavinsky, MD, PhD 

Damien Kenny, MD 

Scripps Green Hospital 

La Jolla, CA 


Curtiss Stinis, MD 



Swedish Health Services 

Seattle, WA 

Robert Bersin, MD 

Amish Desai, MD 

Paul Huang, MD 

John Petersen II, MD 


Factoid Faculty 

Elissa Altin, MD 

Adriano Caixeta, MD, PhD 

Daniel Silva Chamié de Queiroz, MD 

Vasiliki Chantziara, MD 

Bimmer E. Claessen, MD, PhD 


Hemal Gada, MD 


Nilusha Gukathasan, MD 

Shinji Inaba, MD 

Nisharahmed Kherada, MD 

Thosaphol Limpanjit, MD 


Elias Sanidas, MD 

Takehisa Shimizu, MD, PhD 

Madhusudhan Tarigopula, MD 

Kleanthis Theodoropoulos, MD 

Torsten P. Vahl, MD 


50 

Sunday, OctOber 21 

abcs of intErvEntional 

cardiology: an 

introductory coursE 

1:00 pm-6:00 pm 

Junior Ballroom C 

This session is not CME/CNE accredited. 

Session I. Basics of Cardiac 

Anatomy and Angiography 

Moderators: George D. Dangas, Frederick Feit 

1:00 pm - Cardiac and Coronary Anatomy 

Vijayalakshmi Kunadian 

1:12 pm - Discussion with Q&A 

1:15 pm - Right Heart Catheterization: 

Technique and Hemodynamics 

Robert T. Pyo 


1:30 pm - Left Heart Catheterization: 

Technique and Hemodynamics 

Duane S. Pinto 


1:45 pm - Coronary Angiography 1: 

Basic Technique and Interpretation 

Vijayalakshmi Kunadian 


2:00 pm - Coronary Angiography 2: 

Artifacts and Pitfalls 

Ajay J. Kirtane 


2:15 pm - Intravascular Imaging: 

Core Concepts 

Ziad Ali 


2:30 pm - Break 

Session II. Basics of 

Cardiovascular Pathophysiology 

Moderators: Juan F. Granada, Duane S. Pinto 

2:45 pm - Coronary Artery Disease: 

Pathology and Pathogenesis 

Juan F. Granada 


3:00 pm - Coronary Pathophysiology 

and Fractional Flow Reserve (FFR) 

Jason Kovacic 


3:15 pm - Acute Coronary Syndromes: 

NSTEMI 



3:30 pm - Acute Coronary Syndromes: STEMI 

Michael S. Kim 


3:45 pm - Valvular Heart Disease for 

the Interventionalist 

Susheel Kodali 


4:00 pm - Congestive Heart Failure 

and Cardiomyopathy 

Sean P. Pinney 



Session III. Introduction to 

Coronary Angioplasty 

and Stenting 

Moderators: Ajay J. Kirtane, Manish A. Parikh 

4:30 pm - Cath Lab Room Setup 



4:45 pm - Vascular Access 

Routes and Technique 

Robert T. Pyo 


5:00 pm - Guiding Catheters and Wires 

Manish A. Parikh 


5:15 pm - Balloon Angioplasty: 

Equipment and Results 



5:30 pm - Metallic Stent Technology: 

Design Considerations 



5:45 pm - Drug-Eluting Stent Systems 

and Outcomes: Good and Bad 

Ziad A. Ali 


6:00 pm - Adjourn


Cardiology with Concepts of Endovascular Therapy (Part 1) ..............52 

TCT for Nurses and Technologists .......................................................52 

TCT: An Integrated Course for Surgeons and Interventionalists .........64 


Chronic Total Occlusions: Evolutionary Approaches ..................................53 

Core Training Curriculum in Clinical Research ............................................54 

Endovascular Intervention 2012 (Part 1) .....................................................56 

Interventional Innovation: Novel Therapies and the 

“Best” New Device Concepts for 2012 .......................................................58 

Left Main and Bifurcation Stenting: An Advanced Operator’s Workshop ....60 

Strategies for Cardiovascular Repair: Stem Cells and Beyond ...................61 

The Drug-Eluting Stent Summit: Appropriate Utilization 

of Current Generation Devices ...................................................................62 

The Valvular Heart Disease Summit (Part 1): Aortic Valve Therapies ..........64 

PFO and ASD Closure: Evolving Indications, 

Patient Selection, Devices, and Techniques ...............................................66 


Featured Clinical Research I .......................................................................67 

Featured Clinical Research II ......................................................................67 

Focus on India: Interactive Case Review and Panel Discussion .................67 

Approach to Complex PCI and STEMI: From Revascularization 

to Complication Management ....................................................................68 

How to Treat Complex Coronary Lesions ...................................................68 

Left Main and Bifurcation Stenting: Integrated Use of FFR and IVUS.........68 

Snapshot of Latin America Practice and Research ....................................69 

TCT Russia .................................................................................................69 

The Elderly Patient: Better Treatment in the United States or Europe? ......69 

Monday 

October 22, 2012 MIaMI BEaCh COnvEnTIOn CEnTEr · MIaMI, FL 



TranscaTheTer 


TherapeuTics

52 

Monday, ocTober 22 

board rEviEw coursE 

with sElf-assEssMEnt 

for intErvEntional 

cardiology with 

concEPts of 

Endovascular 

thEraPy (Part 1) 

8:00 am-6:00 pm 


This session is only CME accredited. 

8:00 am - Welcome and Introduction 

George D. Dangas 

Central Concepts of PCI 

Moderators: Tayo A. Addo, George D. Dangas 

Discussants: Robert J. Applegate, 

Usman Baber, Stephen Balter, 

Varinder P. Singh 

8:05 am - Medical Statistics and Trial Design: 

Lessons from Recent Publications 

Usman Baber 

8:25 am - Discussion with Q&A 

8:30 am - Radiation Principles and Safety 

Stephen Balter 


9:00 am - Femoral Vascular Access: 

Technique, Closure Devices, and 

Complications 

Robert J. Applegate 


9:20 am - Radial Artery Access and Closure: 

Technique, Results, and Complications 



9:40 am - Break 

PCI Strategies, Indications, 

Guidelines, and Outcomes 

Moderators: Emmanouil S. Brilakis, 


Discussants: Tayo A. Addo, Manish A. Parikh, 


10:00 am - PCI in Stable Coronary Artery 

Disease: Risk Stratification and Comparison 

with Medical and Surgical Alternatives 



10:30 am - PCI in Acute Coronary Syndromes 

and NSTEMI: Guidelines, Strategies, 

and Outcomes 



11:00 am - Primary PCI for STEMI: Guidelines, 

Strategies, and Outcomes 

Tayo A. Addo 


11:30 am - Pharmacoinvasive Strategies 

(Facilitated, Rescue, and Transfer PCI) 

in STEMI 



12:00 pm - Cardiogenic Shock and 

Hemodynamic Support Alternatives 



12:30 - Lunch Break 

Interventional Pharmacology: 

Guidelines and Practice 

Outcomes 

Moderators: Tayo A. Addo, George D. Dangas 

Discussants: Emmanouil S. Brilakis, 

Matthew J. Price, Gregg W. Stone 

1:30 pm - Pharmacotherapy for Elective 

(Nonurgent) PCI 

Matthew J. Price 


2:00 pm - Pharmacotherapy for Acute 

Coronary Syndromes/NSTEMI 

Emmanouil S. Brilakis 


2:30 pm - Pharmacotherapy for PCI in STEMI 

Gregg W. Stone 


3:00 pm - Platelet Reactivity, Genetics, and 

Thienopyridine Responsiveness: Theoretical 

and Real-world Implications 




Valvular and Structural 

Heart Disease 

Moderators: Susheel Kodali, Zoltan G. Turi 

Discussant: Robert J. Sommer 

4:00 pm - Aortic Valve Disease Hemodynamics 

and Intervention with Approved Devices 

(Including Related Guidelines) 



4:30 pm - Mitral Valve Disease Hemodynamics, 

Balloon Valvuloplasty and the Edge-to-Edge 

Approach (Including Related Guidelines) 

Zoltan G. Turi 


5:00 pm - Essentials of Adult Congenital Heart 

Disease Intervention: Diagnosis, Devices, 

and Outcomes 

Robert J. Sommer 


5:30 pm - Specialized Structural Interventions: 

Approaches to HOCM, Paravalvular Leak, 

Acute MI VSD, and LAA Closure 



6:00 pm - Adjourn 

tct for nursEs and 

tEchnologists 

8:00 am-5:30 pm 

Room B118-122 

This session is only CNE accredited. 

21st Annual Cardiovascular 

Nurse and Technologist 

Symposium 

8:00 am - Introduction and Review of 

Learning Objectives 

Marian C. Hawkey 

8:10 am - Technical Aspects of TAVR: 

Past, Present, and Future 

Alain G. Cribier 

Presentations and Panel Discussion 

with Integrated Audience Response 

Applying the AppropriAte Use CriteriA 

(AUC) to the pAtient with MUltivessel 

CoronAry Artery DiseAse 

Moderator: Thomas H. Maloney 

Discussants: William F. Fearon, Michael Guiry, 

David J. Maron, Sonia Scalf 

8:40 am - The Appropriate Use Criteria: 

Genesis, Application, and Next Steps 

Thomas H. Maloney 

8:50 am - Case Introduction 


8:55 am - Assessment: Clinical Cardiologist 

David J. Maron 

9:03 am - Assessment: Interventional 

Cardiologist 

William F. Fearon 

9:16 am - Assessment: Hospital Administrator 

Michael Guiry 

9:11 am - Case Continuation 


9:20 am - Discussion with Q&A

UtilizAtion of preproCeDUre 

risk AssessMents to prevent 

postproCeDUre CoMpliCAtions 

Moderator: Janet F. Wyman 

Discussants: Ralph G. Brindis, Siro Buendia, 

Sarah Clarke, Roxana Mehran 

9:30 am - Contrast-Induced Nephrotoxicity 

Roxana Mehran 

9:42 am - Vascular Damage 

Sarah Clarke 

9:54 am - In-Hospital Mortality and Major 

Complications (NCDR CathPCI) 

Ralph G. Brindis 


trAnsCAtheter AortiC vAlve 

replACeMent (tAvr) 2012 

Moderator: Marian C. Hawkey 

Discussants: Marjo de Ronde, Susheel Kodali, 

Sandra Lauck, Roel R. Pinzon, 

Susan J. Schnell 

10:20 am - Current Landscape: One-Year 

Post-Initial FDA Approval 


10:32 am - Patient Selection: The Balance 

Between Utility and Futility 

Sandra Lauck 

10:44 am - Preventing and 

Managing Complications 


10:56 am - Real-world Integration of OR 

and Cath Lab Staff for TAVR Procedures 

Roel R. Pinzon 


fUtUre teChnologies 

Moderator: Russell A. Brandwein 

Discussants: Hector M. Garcia-Garcia, 

Lynne Hinterbuchner 

11:10 am - LAA Closure Devices 

Russell A. Brandwein 

11:25 am - Renal Sympathetic 

Denervation for HTN 

Lynne Hinterbuchner 

11:40 am - Bioresorbable Stents 

Hector M. Garcia-Garcia 


12:00 pm - Adjourn with Lunch Pick-up 

Registered Cardiovascular 

Invasive Specialists (RCIS) 

Review Course 

Session I. Fundamental Knowledge 


Discussants: Sally Elliott, Elena Ladich, 

George W. Vetrovec 


12:15 pm - Introduction and 

Session Objectives 


12:20 pm - Coronary Angiography from the 

Interventional Cardiologist’s Perspective 


12:40 pm - Basics of the Heart and 

Related Structures from the 

Pathologist’s Perspective 

Elena Ladich 

1:00 pm - Hemodynamics of the Normal 

Heart from the Technologist’s Perspective 

Sally Elliott 


Session II. The Aortic Valve: A Deep Dive 


Discussants: Polly Keller, Susheel Kodali, 

Tim J. Lapp 

1:30 pm - Fundamental Knowledge: 

Aortic Valve Anatomy, Function, 

and Relational Pathology 

Polly Keller 

1:50 pm - Hemodynamics and Interactive 

Calculations for Aortic Stenosis Using 

the “John Madden Telestrator” 

Tim J. Lapp 

2:10 pm - Cardiologist’s Perspective: 

How I Use Anatomical and Hemodynamic 

Data in Clinical Decision Making 



Session III. The Mitral Valve: A Deep Dive 


Discussants: Jeff Davis, Scott Lim, 

Tim R. Martin 

2:40 pm - Fundamental Knowledge: 

Mitral Valve Anatomy, Function, 

and Relational Pathology 

Tim R. Martin 

3:00 pm - Hemodynamics and Interactive 

Calculations for Mitral Stenosis and Mitral 

Regurgitation Using the “John Madden 

Telestrator” 

Jeff Davis 

3:20 pm - Cardiologist’s Perspective: 

How I Use Anatomical and Hemodynamic 

Data in Clinical Decision Making 

Scott Lim 


Session IV. Bioskills Session: Anatomical 

Dissection for Structural Heart Therapies 

Moderators: Marsha Holton, 

John R. Zimmerman 


TranscaTheTer 


TherapeuTics 

3:50 pm - Taped Case from Seattle Science 

Foundation at Transcatheter Valve 

Therapies 2012 (Courtesy of 

Mark Reisman) 

Session V. Hands on Heart 

Bioskills Session 

4:30 pm - Hands on Hearts (Cadaver Hearts 

Courtesy of CVPath Institute and 

Renu Virmani) 


sciEntific syMPosia 

Chronic Total Occlusions: 

Evolutionary Approaches 

8:00 am-5:57 pm 

Ballroom A 


Session I. CTO PCI: Introduction 

to a Skillset 

Moderators: Carlo Di Mario, 

Barry D. Rutherford 

Discussants: Greg L. Kaluza, Masahiko Ochiai, 

Ashish Pershad, Stéphane Rinfret, 

Bradley H. Strauss, Satoru Sumitsuji, 

Etsuo Tsuchikane, Patrick L. Whitlow 

8:00 am - Angiographic Evaluation to 

Determine Procedural Approach 

Ashish Pershad 

8:10 am - Does CT for CTO Planning Help 

Improve Success and Efficiency? 

Masahiko Ochiai 

8:20 am - IVUS Interpretation During CTO PCI: 

True and False Lumen Discrimination, 

Identifying the Proximal Cap, and More 

Satoru Sumitsuji 

8:32 am - The CTO Toolbox: 

What Do I Need in the Lab? 


8:40 am - Preparation and Role of the 

Cath Lab Staff for CTO PCI 

Stéphane Rinfret 

8:48 am - CTO Case Volumes and the 

Learning Curve: Insights from the 

European CTO Registry 

Carlo Di Mario 

8:58 am - J-PROCTOR: A Multicenter Registry 

Evaluating the Clinical Outcomes of 

Antegrade vs. Retrograde Approaches 

Etsuo Tsuchikane 

9:08 am - ACE-CTO: Angiographic Follow-up 

After Everolimus-Eluting Stents in CTO 


WWW.TCTCOnFErEnCE.COM 53 

MOnday - OCTOBEr 22, 2012

54 


9:18 am - Ad Hoc vs. Planned PCI: 

The Case for Staged Procedures 

Patrick L. Whitlow 

9:28 am - What Can We Learn from 

Novel CTO Models? 

Greg L. Kaluza 

9:36 am - Pharmacologic Lesion 

Modification: Status Update 

Bradley H. Strauss 


Session II. Barriers to CTO PCI: 

Myth Busters 

Moderators: J. Aaron Grantham, 


Discussants: M. Nicholas Burke, 

James B. Hermiller Jr, Dimitri Karmpaliotis, 

Yves R. Louvard, James Spratt, 

Gregg W. Stone, Gerald S. Werner 

10:04 am - Justifying CTO PCI in the Era of 

Evidence-Based Medicine and Appropriate 

Use Criteria 

J. Aaron Grantham 

10:19 am - Is the Complication Rate Too High 

to Justify the Procedure? “Real Data” of the 

Safety for PCI, Surgery, and Medical 

Therapy for CTO 

Gerald S. Werner 

10:31 am - New Insights into the Importance 

of Incomplete Revascularization 

Giora Weisz 

10:43 am - Can CTO PCI Only Be 

Accomplished by Technical Masters? 

The Case for “Skillsets” vs. “Skills” 

James Spratt 

10:53 am - Is CTO PCI from the Radial 

Artery Too Complex? 

Yves R. Louvard 

11:03 am - Can the Experienced Operator in a 

Busy Practice Learn the CTO Skillset? 

James B. Hermiller Jr 

11:13 am - The Clinical Business Model for 

CTO PCI in the United States: Do Procedure 

Time, Reimbursement, and Costs Preclude 

Development of CTO PCI Programs? 

Dimitri Karmpaliotis 

11:25 am - Interventionalist to Interventionalist 

Referral for PCI: A Viable Specialty Triage 

Mechanism or Zone of Repugnance? 

M. Nicholas Burke 


Session III. Geographic Differences 

in Approach to CTO PCI 

Moderators: Georgios Sianos, Gregg W. Stone 

Discussants: Osamu Katoh, 

Craig A. Thompson, Gerald S. Werner 

11:50 am - Japanese Approach to Anatomy 

and Teaching 

Osamu Katoh 

12:05 pm - European Approach to Anatomy 

and Teaching 


12:20 pm - Hybrid US Approach to Anatomy 

and Teaching 

Craig A. Thompson 


Session IV. Technical Approaches 

for CTO PCI 

Moderators: Craig A. Thompson, 


Discussants: Tony J. DeMartini, 

Carlo Di Mario, J. Aaron Grantham, 

Kazuaki Mitsudo, Masahiko Ochiai, 

Barry D. Rutherford, Etsuo Tsuchikane, 

R. Michael Wyman 

12:50 pm - Antegrade CTO Wiring Strategy 

and Technique 


1:05 pm - Antegrade Dissection and Reentry 


1:20 pm - Retrograde Techniques: From 

Collateral Wiring to Corsair Management 


1:35 pm - Retrograde Dissection and Reentry: 

Reverse CART and CART 


1:50 pm - Approach to the Case with 

Limited/No Retrograde Options 


2:05 pm - Approach to the Case with 

Limited/No Antegrade Options 

Tony J. DeMartini 

2:20 pm - When to Accept Failure (and How to 

Prepare for a Reattempt) 

Barry D. Rutherford 


Session V. Complications of CTO PCI: 

Prevention and Management 

Moderators: Carlo Briguori, R. Michael Wyman 

Discussants: Yasushi Asakura, Stephen Balter, 

Charles Chan, Alfredo R. Galassi 

2:50 pm - Radiation Injury: Prevention, 

Consequences, and Mitigation 


3:05 pm - Contrast Nephropathy: Risk Scores 

and Prophylaxis 

Carlo Briguori 

3:20 pm - Specific Antegrade Complications 

Yasushi Asakura 

3:35 pm - Specific Retrograde Complications 

Alfredo R. Galassi 


Session VI. Case Presentations 

with Discussion 

Moderators: Tony J. DeMartini, 


Discussants: Sameer I. Dani, Debabrata Dash, 

Paul Hsien-Li Kao, Yves R. Louvard, 

Samuel K. Mathew, Toshiya Muramatsu, 

Sunao Nakamura, 

Alexander Grigorievich Osiev, Jochen Wöhrle 

4:05 pm - Case 1: An Antegrade Success That 

Changed My Clinical Practice 

Simon Walsh 

4:19 pm - Case 2: A Retrograde Success That 



4:33 pm - Case 3: An Antegrade Failure That 



4:47 pm - Case 4: A Retrograde Failure That 


Georgios Sianos 

5:01 pm - Case 5: An “Impossible” 

Case Success That Changed My 

View of CTO PCI 

Toshiya Muramatsu 

5:15 pm - Case 6: A Complication That 

Changed How I Perform CTO PCI 


5:29 pm - Case 7: What I Learned from a Case 

That Went Longer Than Four Hours 

Alfredo R. Galassi 

5:43 pm - Case 8: A Previous Failure 

That Succeeded Two Years Later: 

What Changed? 



Core Training Curriculum 

in Clinical Research 

8:00 am-4:00 pm 

Room A101-102 

Session I. How to Establish and Maintain a 

Successful Research Program 

Moderators: David A. Cox, Giora Weisz 

Discussants: Priyadarshini Arambam, 

Kate Dalton, Theresa Franklin-Bond, 

Timothy D. Henry, James B. Hermiller Jr, 

D. Christopher Metzger, Thomas D. Stuckey 

8:00 am - Welcome and Introduction: 

Objectives of this Session 

Giora Weisz 

8:05 am - Why Do Clinical Research? 

The Pros and Cons 

Thomas D. Stuckey 

8:15 am - How to Establish a Viable Clinical 

Research Program in Your Hospital: 

Essential First Steps and Standards 

Timothy D. Henry

8:25 am - How to Handle and Improve 

Efficiencies in Your Institution with IRB, 

Budgets, and Contracts: The Cardinal Rules 

Giora Weisz 

8:35 am - The Perfect Site: Improve 

Processes, Enhance Enrollment, and 

Score High! 


8:50 am - Screening Patients for Clinical Trial 

Eligibility: The Painful but Essential Step 

David A. Cox 

9:00 am - Informed Consent: Difficult 

Case Scenarios 

Theresa Franklin-Bond 

9:10 am - Quality Control: Investigator’s 

Responsibilities 

Alexandra J. Lansky 

9:20 am - How to Handle Monitoring Visits 

and Audits 

Kate Dalton 


Session II. Investigator-Initiated Research 

Moderators: David F. Kong, Paul S. Teirstein 

Discussants: Andrew Farb, David E. Kandzari, 

Charles A. Simonton, Ron Waksman 

9:50 am - Industry-Sponsored vs. Investigator- 

Initiated Research: Similarities, Differences, 

and Pathways to Success 

David E. Kandzari 

10:05 am - Research Ideas, Writing a Protocol: 

Key Elements 

Ron Waksman 

10:15 am - When Is an IDE/IND Required for 

Investigator-Initiated Research? 

Andrew Farb 

10:25 am - How to Apply for and Receive 

Industry Funding for Investigator-Initiated 

Research 

Charles A. Simonton 


Session III. Clinical Trial Interpretation: 

Pitfalls and Practical Lessons 

Moderator: Roxana Mehran 

Discussants: Giuseppe Biondi Zoccai, 

Somjot S. Brar, David J. Cohen, Sanjay Kaul, 

Ajay J. Kirtane, Helen Parise, Nico H.J. Pijls 

10:50 am - Randomized Trials vs. 

Observational Studies: Advantages 

and Pitfalls 

Roxana Mehran 


11:05 am - Composite Endpoints in Clinical 

Trials: Why Do We Need Them and How 

Do You Interpret Them? 

Giuseppe Biondi Zoccai 



11:20 am - Site Reported vs. Adjudicated 

Events: What’s the Difference and Why 

Should I Care? 

Sanjay Kaul 


11:35 am - Importance of Adequately Powered 

Studies in Clinical Medicine: Case Studies 

Sanjay Kaul 


11:50 am - Noninferiority Exposed: 

Uses and Abuses 

Helen Parise 


12:05 pm - Meta-analyses: Strengths 

and Weaknesses 



12:20 pm - An Introduction to Costeffectiveness 

Analyses: Who Pays 

(and Should They?) 

David J. Cohen 


Session IV. Standardized Data 

Definitions, Risk Stratification, 

and Personalized Medicine 

Moderator: Laura Mauri 

Discussants: Sorin J. Brener, David J. Cohen, 

Andrew Farb, Alejandra Guerchicoff, 

Karen A. Hicks, Alexandra J. Lansky, 

Roxana Mehran 

the iMportAnCe of stAnDArDizeD 

DAtA eleMents AnD Definitions 

12:35 pm - The FDA View 

Karen A. Hicks 

12:40 pm - The Clinician’s View 

Sorin J. Brener 

12:45 pm - The Trialist’s View 

Laura Mauri 

the CeC proCess: is hArMonizAtion 

neeDeD? ArC AnD others 

12:50 pm - US Perspective 

Roxana Mehran 

12:55 pm - EU Perspective 


1:00 pm - FDA Perspective 

Andrew Farb 

1:05 pm - The Utility of Risk Scores: How to 

Properly Interpret and Use Them 

Davide Capodanno 

1:15 pm - Quality of Life: Should This Be the 

Key Parameter in Choosing Therapies? 

John A. Spertus 


TranscaTheTer 


TherapeuTics 

1:25 pm - Personalized Medicine: 

Current Tools and the Future of Clinical 

Research in Practice 



Session V. Multidisciplinary Clinical 

Research: Crossing the Borders 

Moderators: Ted E. Feldman, 

A. Pieter Kappetein 

Discussants: David H. Adams, Alaide Chieffo, 

Joseph N. Cosico, George D. Dangas, 

Alejandra Guerchicoff, Rebecca Tung Hahn, 

Saibal Kar, David F. Kong, Nicholas J. Lembo, 

Michael J. Mack, Lauren T. Privitera, 

Maurice E. Sarano, Mathew Williams 

pArt 1: the pAtient with vAlvUlAr 

heArt DiseAse 

1:50 pm - How Do You Set Up a Clinical 

Research Program in Valvular Heart Disease: 

Crucial First Steps 

Maurice E. Sarano 

2:00 pm - The Multidisciplinary Team: 

What Is Really Involved? 

Michael J. Mack 

2:10 pm - The Imaging Team: Essential 

Component for Success 

Rebecca Tung Hahn 

2:20 pm - How Do You Get Everyone 

“Onboard”? 

Bruce Bowers 

pArt 2: why yoU neeD A MUltiDisCiplinAry 

heArt teAM 

2:30 pm - Case Scenario 1: Transcatheter 

Aortic Valve Replacement 

Mathew Williams 

2:40 pm - Case Scenario 2: Transcatheter 

Mitral Valve Repair 

Saibal Kar 

pArt 3: CABg vs. pCi triAls: 

the heArt teAM At work 

2:50 pm - Heart Team Logistics and 

Patient Selection 

Nicholas J. Lembo 

3:00 pm - Informed Consent Process 


3:05 pm - Screening and Enrollment 

Alaide Chieffo 

3:10 pm - Follow-up 

Joseph N. Cosico 




56 


pArt 4: renAl DenervAtion stUDies 

for hypertension 

3:25 pm - Patient Selection 

Krishna J. Rocha-Singh 

3:35 pm - Informed Consent 

Lauren T. Privitera 

3:40 pm - Screening and Enrollment 


3:45 pm - Nuances of Unblinded vs. Blinded 

Follow-up Procedures 

David F. Kong 



Endovascular Intervention 

2012 (Part 1) 

8:00 am-6:21 pm 

Room A208-209 


Session I. Carotid Intervention I 

Moderators: Tyrone J. Collins, 

Lee R. Guterman 

Discussants: Tony Das, Sheldon Goldberg, 

Richard R. Heuser, R. Stefan Kiesz 

pAtient seleCtion 

8:00 am - The Delphi Consensus and Its 

Validation: Guiding the Lesser Experienced 

Interventionalist on Patient Selection 

Sumaira Macdonald 

rApiD fire: CAs go AnD no-go pAtient 

seleCtion AlgorithMs 

8:07 am - CAS Decision Making 

in Octogenarians 

Michel Camille Henry 

8:13 am - CAS Decision Making in Women 

Isabelle Van Herzeele 

8:19 am - CAS Decision Making in Recently 

Symptomatic Patients 


8:25 am - CAS Decision Making in 

Asymptomatic Patients 

J. Michael Bacharach 

8:31 am - CAS Decision Making in Difficult 

Aortic Arches 

D. Christopher Metzger 


MeDiCAl AnD sUrgiCAl MAnAgeMent 

hAs A role BUt when? 

8:47 am - Which Asymptomatic Patients 

Benefit from CAS or CEA? 

Peter A. Schneider 

8:54 am - What Is Optimal Medical 

Management for Carotid Disease, and 

What Residual Risk Remains Without 

Revascularization? 

Michael R. Jaff 

9:01 am - Are CEA Outcomes 

Continuing to Improve? Evolution of 

a 60-Year-Old Procedure 

Takao Ohki 


rApiD fire: CAs teChniqUes 

froM the experts 

9:15 am - Managing the Tortuous Arch 

Alberto Cremonesi 

9:20 am - Managing the Tortuous Carotid 


9:25 am - Step-by-Step Tips for Filter 

Deployment and Retrieval 

Thomas A. Ischinger 

9:30 am - Step-by-Step Tips for the WL Gore 

NPS Flow Reversal System 

Juan C. Parodi 

9:35 am - Step-by-Step Tips for the Mo.Ma 

(Medtronic) Proximal Occlusion System 

Bernhard Reimers 

9:40 am - Step-by-Step Tips for the 

MICHI (Silk Road Medical) Direct Carotid 

Access System 



Session II. Carotid Intervention II 

Moderators: Robert M. Bersin, 


Discussants: Klaus D. Mathias, 

Carlos I. Mena, Stephen R. Ramee, 

Isabelle Van Herzeele 

21st CentUry CArotiD iMAging 

9:52 am - Advanced Cerebral Imaging 

(DWMRI, PET, Cerebral Perfusion): 

Role (If Any) in Patient Selection 

and Procedure Planning 

Alex Abou-Chebl 

9:59 am - What Can Advanced Stent Imaging 

Tell Us About In-Stent Restenosis, Plaque 

Prolapse, and Design of Future Stents? 

Mark H. Wholey 

10:06 am - Post-CAS Cerebral MRI Lesions: 

Frequency and Implications 


10:13 am - Is Myocardial Infarction a 

Reasonable or Relevant Endpoint to Assess 

Carotid Intervention and Stroke Prevention 

Therapies in Clinical Practice and Trials? 

Carlos I. Mena 


rApiD fire: CAs top 5 lists 

10:25 am - Top 5 Things I Learned 

from Recent CAS Studies 

William A. Gray 

10:30 am - Top 5 Tips to Make CAS Safer 

Klaus D. Mathias 

10:35 am - Top 5 Ways to Educate and 

Improve the CAS Environment 

L. Nelson Hopkins 

10:40 am - Top 5 Challenges 

Remaining in CAS 

Jay S. Yadav 

10:45 am - Top 5 Blue-sky Wish List 

for CAS Device Improvements 

Daniel J. McCormick 


CAse-BAseD MAnAgeMent in 

CAs DiffiCUlties 

10:57 am - Case 1: Slow Flow in 

a Filter Protection Case 

Jay S. Yadav 

11:02 am - Case 2: Intolerance During 

Proximal Protection 

Robert M. Bersin 

11:07 am - Case 3: Neurological Symptoms 

During the Procedure 

Max Amor 

11:12 am - Case 4: Sheath Loses Position 

Gary M. Ansel 

fACing the fUtUre of CAs 

11:17 am - Recanalization of Carotid Artery 

CTOs: Indications and Methods for a 

Controversial Procedure 

Paul Hsien-Li Kao 

11:24 am - Optical Coherence Reflectometry: 

What Can It Tell Us About Our Technique 

and Our Equipment? 


11:31 am - The Impact of CAS on 

Neurocognitive Function 

Oscar A. Mendiz 

11:38 am - CAS Following CREST: 

Now That the Noise Has Settled, 

What Is the Role of the Therapy? 

Herbert D. Aronow 

11:45 am - Designing the Perfect Trial: 

Addressing the Remaining Critical 

Issues in CAS 


11:52 am - Update on the Only Remaining 

Carotid Multicenter Randomized 

International Trial in the World: ACST 2 

Alison Halliday

11:59 am - What Data Will Be Available and 

When? An Overview of the Progress of 

ACST 2, SPACE 2, and ECST 2 Studies 

Alison Halliday 


Session III. Renal and Visceral Intervention 

Moderators: Lawrence A. Garcia, 

John H. Rundback 

Discussants: Mark C. Bates, 

Adam Geronemus, Thosaphol Limpijankit, 


visCerAl 

12:13 pm - Endovascular Approaches to 

Acute and Chronic Mesenteric Ischemia 

Adam Geronemus 

12:20 pm - Diagnosis and Technical 

Management of Renal and Visceral 

Aneurysms 

Ripal T. Gandhi 

12:27 pm - Management of Mesenteric 

Arteries in EVAR 

Jacques Busquet 


renAl 

12:39 pm - Role of Renal Revascularization in 

2012 and Predictions for the Future 


12:46 pm - Selecting the Patient Most Likely to 

Benefit from Renal Intervention 

Massoud A. Leesar 

12:53 pm - Treating Fibromuscular Dysplasia in 

the Renal Artery 

Robert A. Lookstein 

1:00 pm - Avoiding Complications in Renal 

Artery Stenting: Lessons from a Master 

Mark C. Bates 

1:07 pm - DES for Vascular Erectile 

Dysfunction: Follow-up from the ZEN 

First-in-Man Study 



Mini-DeBAtes 

1:21 pm - Debate 1: Is Embolic Protection 

Mandatory in Renal Artery Stenting? Pro! 

Michel Camille Henry 

1:26 pm - Debate 1: Is Embolic Protection 

Mandatory in Renal Artery Stenting? Con! 

Christopher J. Cooper 

1:31 pm - Debate 1: Discussion and Vote 

1:36 pm - Debate 2: Should Renal Artery 

Stenting Only Be Done Using FFR and 

IVUS? Pro! 

Mehdi H. Shishehbor 


1:41 pm - Debate 2: Should Renal Artery 

Stenting Only Be Done Using FFR and 

IVUS? Con! 

Christopher J. White 


Session IV. Venous Intervention 

Moderators: Raghu Kolluri, Greg Mishkel 

Discussants: Anthony J. Comerota, 

Paul H. Kramer, Lindsay S. Machan, 

Thomas O. McNamara 

overview AnD lAtest DevelopMents 

1:51 pm - The Clinical Epidemiology of Venous 

Thrombosis and Thromboembolism: 

A Primer for the Interventionalist 

Raghotham R. Patlola 

1:58 pm - DVT of the Upper Extremity: 

When and How to Initiate Pharmacologic 

and Mechanical Modes of Therapy 

Greg Mishkel 

2:05 pm - The Importance of Central Venous 

Occlusion, Techniques for Intervention, 

and Long-term Expectation of Outcomes 

Michael D. Dake 

2:12 pm - Thoracic Outlet Syndrome: 

Diagnosis and Management 


2:19 pm - Methods for Successful 

Endovascular Management of 

Iliofemoral DVT 


2:26 pm - Diagnostic Testing of, Indications 

for, and Endovascular Approaches to Venous 

Obstruction in the Pelvis 

Raghu Kolluri 

2:33 pm - Update on CCSVI: Are We Any 

Closer to Understanding This Entity and 

Its Therapy? 

Michael D. Dake 


Mini-DeBAtes 

2:47 pm - Debate 1: Is a Strategy of 

Endovascular Thrombus Resolution Best for 

Iliofemoral DVT? Pro! 

Anthony J. Comerota 

2:52 pm - Debate 1: Is a Strategy of 

Endovascular Thrombus Resolution Best for 

Iliofemoral DVT? Con! 

Erich Minar 


3:02 pm - Debate 2: Is Aggressive 

Endovascular Treatment of Pulmonary 

Embolism Justified? Pro! 

Gary M. Ansel 


TranscaTheTer 


TherapeuTics 

3:07 pm - Debate 2: Is Aggressive 

Endovascular Treatment of Pulmonary 

Embolism Justified? Con! 



Session V. Aortic Intervention 

Moderators: Jacques Busquet, Takao Ohki 

Discussants: Robert M. Bersin, 

Hugo F. Londero, Eric E. Roselli, 

Christopher K. Zarins 


3:17 pm - Next-Generation of AAA EVAR 

Grafts: Iterative or Transformative? 

Robert M. Bersin 

3:24 pm - Chimney and Snorkel Techniques: 

A Primer 

Takao Ohki 

3:31 pm - The Final Frontier: Progress Report 

in Ascending Aorta and Arch Endografting 

Grayson H. Wheatley 

3:38 pm - Managing the Type II Endoleak: 

Watchful Waiting but Then Which 

Intervention? 

Barry T. Katzen 

3:45 pm - Branch or Embolize? Managing Iliac 

Aneurysms Involving the Hypogastrics 

James F. McKinsey 

3:52 pm - Final Results from the Lombard 

Pythagoras Study for Angled Neck 

Abdominal Aneurysms 



Mini-DeBAtes 

4:09 pm - Debate: Do the Data Support 

Endovascular Therapy for Descending 

Thoracic Aortic Dissections? Pro! 

Eric E. Roselli 

4:14 pm - Debate: Do the Data Support 

Endovascular Therapy for Descending 

Thoracic Aortic Dissections? Con! 

Christoph A. Nienaber 

4:19 pm - Debate: Discussion and Vote 

Session VI. Iliac and Superficial Femoral 

Artery Intervention 

Moderators: Gary M. Ansel, Barry T. Katzen 

Discussants: Mark W. Burket, 

Hans Krankenberg, David Planer, 

Craig M. Walker 


4:24 pm - Final Data on the ICARUS Trial of 

Covered Stents for Obstructive Iliac Disease 

John R. Laird Jr 

4:31 pm - What is the Potential Economic 

Impact of Antiproliferative Technologies 

in the SFA? 

Mark W. Burket 



58 


4:38 pm - Drug-Coated Balloons for SFA 

In-Stent Restenosis: A Simple Solution 

for a Tenacious Problem? 

Eugenio Stabile 

4:45 pm - Drug-Coated Balloons and 

Atherectomy: Additive, Synergistic, 

or Without Advantage? 

Luigi Salemme 

4:52 pm - Update on Important SFA Therapies: 

VIBRANT, VIPER, and Zilver PTX Studies 

Gary M. Ansel 

4:59 pm - What is the Current Role of Metal 

Prostheses in the SFA? Master Perspectives 

Giancarlo Biamino 

5:06 pm - Expanding the Borders: 

Endovascular Intervention for Common 

Femoral and Popliteal Disease 

Thomas Zeller 

5:13 pm - Development of a Bioresorbable 

Scaffold for the SFA 

Richard J. Rapoza 

5:20 pm - Adventitial Injection for SFA 

Restenosis: Results of an Exploratory Study 

Christopher D. Owens 

5:27 pm - A Modern Algorithm for 

Noninvasive Testing Following Lower 

Extremity Vascular Stenting 


5:34 pm - Final 12-Month Outcomes from the 

SUPERB Trial Using the Supera Woven 

Nitinol Stent 

Lawrence A. Garcia 


Mini-DeBAtes 

5:51 pm - Debate 1: Are Drug-Eluting Stents 

Now the Default Strategy for SFA 

Intervention? Pro! 

Gary M. Ansel 

5:56 pm - Debate 1: Are Drug-Eluting Stents 

Now the Default Strategy for SFA 

Intervention? Con! 



6:06 pm - Debate 2: Should Embolic 

Protection Be Mandatory in Lower 

Extremity Intervention? Pro! 


6:11 pm - Debate 2: Should Embolic 

Protection Be Mandatory in Lower 

Extremity Intervention? Con! 




Interventional Innovation: Novel 

Therapies and the “Best” New 

Device Concepts for 2012 

8:00 am-6:15 pm 

Room A201-205 


Session I. Innovation in Transition 

Moderators: Elazer R. Edelman, 


Discussants: Rick Anderson, Sanjeev Bhatt, 

John M. Capek, Andrew Farb, 

Peter J. Fitzgerald, Thomas J. Fogarty, 

Aaron V. Kaplan, Mitchell W. Krucoff, 

Hank Kucheman, Martin B. Leon, 

Chaim S. Lotan, Martin T. Rothman, 

Sean Salmon, Jacques Seguin, Mark A. Turco 

keynote leCtUres 

8:00 am - Is Innovation in the United States 

on the Road to Recovery? An Interim 

Analysis and Critique 

Elazer R. Edelman 

8:15 am - A Collaborative Multidisciplinary 

Approach to Medical Innovation 

John M. Capek 

8:30 am - New FDA Innovation Pathways 

and Initiatives 

Andrew Farb 

8:45 am - The Globalization of Innovation 

Is Here to Stay: Reasons, Realities, 

and Consequences 

Mitchell W. Krucoff 

9:00 am - From Hardware (Devices) to 

Software (Information Technology): 

How the Digital Revolution Will 

Change Medical Innovation 

Peter J. Fitzgerald 

9:15 am - Discussion: Transitional Challenges 

Session II. The Cath Lab of the Future 

Moderators: John D. Carroll, Horst Sievert 

Discussants: Jorge A. Belardi, 

Elchanan Bruckheimer, Louis A. Cannon, 

Run-Lin Gao, Samir R. Kapadia, 

Jacques J. Koolen, John A. Ormiston, 

Augusto D. Pichard, Ashok Seth, 

Samin K. Sharma 

new CliniCAl tArgets 

9:30 am - Taped Case 1: Use of the 

Covidien OneShot Renal Denervation 

System for Hypertension 

John A. Ormiston 

9:45 am - TCT-105. Long-term Intravascular 

Blood Pressure Monitoring with a Novel 

Wireless Sensor System: Results from 

Chronic In-Vivo Studies 

Nina Cleven 


teleMAnipUlAtion AnD roBotiCs 

9:55 am - Taped Case 2: 

The Corindus Robotic-Assisted 

Coronary Angioplasty System 

Giora Weisz 

MUltiple iMAging MoDAlities 

10:10 am - The RealView Holographic Imaging 

System for Adult Congenital, Structural, 

and Valvular Heart Disease 

Elchanan Bruckheimer 

10:20 am - Magnetic Resonance Imaging 

Guidance During Interventional 

Cardiovascular Procedures 

Robert J. Lederman 

10:30 am - A Visionary Look at the Cath 

Lab in 2020: Multispecialty, Multiple Imaging 

Modalities, Multiple Clinical Targets, Fully 

Integrated, and IT Enabled: A Cardiovascular 

Diagnostic and Therapeutic Melting Pot 

Martin B. Leon 

10:45 am - Discussion: The Cath Lab 

of the Future 

Session III. The Inventor’s Workshop 2012 

Moderators: Thomas J. Fogarty, 

Julio C. Palmaz 

Discussants: Louis A. Cannon, 

Keith D. Dawkins, Peter J. Fitzgerald, 

Rick Geoffrion, L. Nelson Hopkins, 

Ran Kornowski, Hank Kucheman, 

Casey McGlynn, Semih Oktay, 

Stanton J. Rowe, Jacques Seguin, 

Richard S. Stack, Uri Yaron 

11:00 am - Lessons from the Stanford 

Biodesign Program: Creating a Culture 

and Teaching a Process 


11:10 am - TCT-106. BioInnovate Ireland: 

A Multidisciplinary Approach to Medical 

Device Innovation 

Mark Bruzzi 

11:18 am - Discussion 

11:20 am - The Israeli “Start-up Nation” 

Approach to Medical Innovation: 

Defining the Ecosystem 

Ran Kornowski 


A stepwise priMer on MeDiCAl 

DeviCe innovAtion 

11:30 am - Step 1: Needs Assessment 

Louis A. Cannon 

11:40 am - Step 2: Invention 

Richard S. Stack 

11:48 am - Step 3: Intellectual Property 

Casey McGlynn

11:56 am - Step 4: Preclinical Assessments 


12:06 pm - Step 5: First-in-Human Use 

Alexandre Abizaid 

12:14 pm - Step 6: Clinical Regulatory Pathways 

Semih Oktay 

12:22 pm - Step 7: Funding Opportunities 

Rick Anderson 

Session IV. The Transcatheter Valve 

Therapy (TVT) Explosion: An Innovator’s 

Dream Scenario 

Moderators: Eberhard Grube, 

Lars G. Svensson 

Discussants: Henning Rud Andersen, 

Shmuel Banai, Bernard R. Chevalier, 

Charles J. Davidson, Hans R. Figulla, 

Raj Makkar, Ganesh Manoharan, 

Stanton J. Rowe, Nicolas M. van Mieghem, 

Thomas Walther 

1:00 pm - TVT Goes Viral: New Valve 

Systems and Accessory Devices Will 

Transform the Future 

Eberhard Grube 

1:15 pm - Taped Case 3: Heterotopic 

Transcatheter Tricuspid Valve Implantation 

for Patients with Severe Tricuspid 

Regurgitation 

Hans R. Figulla 

1:30 pm - TCT-107. A Novel Catheter-Based 

Mitral Valve Bioprosthesis: Short-term 

Preclinical Results 

Shmuel Banai 

1:38 pm - Discussion 

1:40 pm - TCT-108. Performance and Safety of 

the TRUE Dilatation Balloon Valvuloplasty 

Catheter for Aortic Balloon Valvuloplasty in 

Patients Undergoing TAVR 

Felix Woitek 


1:50 pm - TCT-109. A New Generation 

Transcatheter Heart Valve with a Novel 

Nanocomposite Material and Fully 

Retrievable Design 

Benyamin Rahmini 


2:00 pm - TCT-110. First Experience with a 

Novel Anatomically Adapted Percutaneous 

Heart Valve for the Tricuspid Position 

Desiree Pott 


2:10 pm - TCT-111. First-in-Man Experience 

with a Two-Part Exchangeable Leaflet 

Bioprosthetic Valve 




2:20 pm - The Apica Left Ventricular Apical 

Access and Closure System: First-in-Human 

Use Experiences During TAVR 

Thomas Walther 

2:30 pm - Discussion: Futuristic TVT Therapies 

Session V. Med-tech Meets Infotech: 

Synergistic Impact 

Moderators: Neal L. Eigler, Peter J. Fitzgerald 

Discussants: Robert Amyot, Yuval Binur, 

Roberto Botelho, Daniel Burkhoff, 

Rick Geoffrion, James K. Min, Sean Salmon, 

Frederick G. St. Goar 

2:45 pm - Featured Lecture: Impact of 

Telemedicine on Patient Care: STEMI: 

A Global Case Study 

Roberto Botelho 


3:05 pm - Can HeartFlow Change the Clinical 

Management Paradigm for Patients with 

Coronary Disease? 

James K. Min 

3:20 pm - TCT-112. Two-way Real-time 

Interaction by Means of a Novel 

Telecommunications Software Improves 

Management of Patients with ST-Segment 

Elevation Myocardial Infarction 

Gabriel Sardi 


3:30 pm - Advanced Simulation Tools for 

Physician Training and Case Planning 

Robert Amyot 

3:40 pm - Hemodynamics for “Dummies:” 

A Novel iPad Application for Medical 

Education, Patient Selection, and 

Device Development 

Daniel Burkhoff 

3:50 pm - Discussion: Med-tech 

Meets Infotech 

Session VI. Innovation for Mainstream 

Clinical Applications: Old “Friends” 

and Emerging Frontiers 

Moderators: Chaim S. Lotan, Renu Virmani 

Discussants: Alessandro S. Bortone, 

David Cormode, Keith D. Dawkins, 

Tim A. Fischell, Navin K. Kapur, 

Nicholas N. Kipshidze, Amir Lerman, 

Manish A. Parikh, Krishna J. Rocha-Singh, 



TranscaTheTer 


TherapeuTics 

feAtUreD leCtUres 

4:00 pm - The “Hottest” New Cardiovascular 

Device Concepts from the Israeli 

Innovation Pipeline 

Chaim S. Lotan 

4:15 pm - Exciting Cardiovascular Device 

Innovation from Europe: From Balloons to 

Stents to Closure Devices and More 

Alessandro S. Bortone 

enDovAsCUlAr horizons 

4:30 pm - Taped Case 4: Complex Pelvic 

Reconstruction: Endovascular Treatment 

of Benign Prostatic Hypertrophy and 

Erectile Dysfunction 

Akaki Archvadze 

4:45 pm - TCT-113. Focal Treatment of Lower 

Extremity Post-PTA Dissection Using the 

Tack-It Endovascular Stapler System: 

First-in-Man Trial with One-Year Follow-up 



4:55 pm - TCT-114. Feasibility of 

Noninvasive Atherectomy: Plaque 

Ablation with Cavitation-Based 

Focused Ultrasound (Histotripsy) 

Adam Maxwell 


vUlnerABle plAqUe opportUnities 

5:05 pm - Intravascular Photoacoustics: 

Progress and Potential for Vulnerable 

Plaque Imaging 

Antonius F.W. van der Steen 

5:15 pm - Emerging Applications of 

Nanotechnology for the Diagnosis 

and Management of Vulnerable 

Atherosclerotic Plaque 

David Cormode 

5:25 pm - Simultaneous Localization and 

Treatment of Vulnerable Plaque by 

Tin-117m Conversion Electrons: 

First-in-Human Results 

Renu Virmani 

interventionAl heArt fAilUre: 

the next Big BreAkthroUgh 

5:35 pm - The Emergence of Interventional 

Heart Failure and Advanced Cardiac Support 

as an Important Clinical Subspecialty: 

Clinical Targets, Device Concepts, 

and Physician Training 

Navin K. Kapur 

5:50 pm - Transcatheter Interatrial Shunt 

for Heart Failure with Preserved Ejection 

Fraction (HFPEF) 

Brad I. Munt 



60 


6:00 pm - Discussion: Cardiovascular 

Innovation for Mainstream Applications 


Left Main and Bifurcation 

Stenting: An Advanced 

Operator’s Workshop 

8:00 am-6:11 pm 

Junior Ballroom D 


Session I. Non-Left Main Bifurcation 

Stenting: Overviews 

Moderators: Yves R. Louvard, Leif Thuesen 

Discussants: Somjot S. Brar, 

Antonio Colombo, Nick Curzen, 

Debabrata Dash, Nicolas Foin, 

Liliana R. Grinfeld 

8:00 am - Non-Left Main Bifurcation Stenting: 

Highlights from the Last 12 Months 

Nick Curzen 

8:10 am - What Can Preclinical Models Teach 

Us About Bifurcation Stenting? 


8:18 am - Bifurcation Anatomy, Angulation, 

and Lesion Complexity: Implications 

for Procedural Outcomes and 

Long-term Patency 

Debabrata Dash 

8:26 am - Impact of Stent Design on 

Outcomes After Bifurcation Stenting 

Nicolas Foin 

8:34 am - Non-Left Main Bifurcation Stenting: 

Updated Meta-analysis of Simple vs. 

Complex Techniques 

Somjot S. Brar 

DeBAte: whAt is the AppropriAte 

freqUenCy for iMplAnting two stents 

in non-left MAin BifUrCAtion lesions? 

8:42 am - The Data Are Clear: The Careful 

Operator Should Implant Two Stents in No 

More Than 10% of Bifurcation Lesions! 


8:49 am - Randomized Trials Don’t Reflect 

the Real World: Two Stents Should Be 

Used in 50% of Bifurcation Lesions or More! 

Antonio Colombo 


Session II. Non-Left Main Bifurcation 

Stenting: Technique Practicum I 

Moderators: Issam D. Moussa, 

Terje K. Steigen 

Discussants: Vinay K. Bahl, 

Antonio L. Bartorelli, Carlo Briguori, 

Efrain Gaxiola, Angela Hoye, John M. Lasala, 

Afzalur Rahman 

9:11 am - Provisional Stenting Technique: 

Step-by-Step Tutorial (Including 

Crossover Techniques) 


9:21 am - Provisional Stenting Technique 

Cases 1 and 2: Getting by with 

One Stent Only 

Francesco Burzotta 

9:31 am - Provisional Stenting Technique 

Cases 3 and 4: Second Stent Needed 

(Before and After the First Stent) 

Jeffrey W. Moses 

9:41 am - Planned Two-Stent Techniques: 

Step-by-Step Tutorial and Use 

Recommendations for T, Modified T, TAP, 

Mini-Crush, Culotte, SKS, V, and More 

David J. Hildick-Smith 

9:56 am - Planned Two-Stent Technique 

Cases 5 and 6: Modified T and TAP 

Vladimír Džavík 


Cases 7 and 8: Mini-Crush and Culotte 



Cases 9 and 10: SKS and V 

Samuel K. Mathew 

10:26 am - Discussion with Q&A 

Session III. Non-Left Main Bifurcation 

Stenting: Technique Practicum II 

Moderators: Ioannis Iakovou, 

David G. Rizik 

Discussants: Carlo Di Mario, Gary Gershony, 

Bon-Kwon Koo, Alexandra J. Lansky, 

Akiko Maehara, Detlef G. Mathey 

10:41 am - The Importance of Bifurcation 

Lesion Preparation and How to Do It 

Gary Gershony 

10:49 am - Uses and Utility of IVUS During 

Bifurcation Stenting 

Akiko Maehara 

10:57 am - Uses and Utility of OCT During 



11:05 am - Uses and Utility of FFR During 


Bon-Kwon Koo 

11:13 am - Uses of Drug-Eluting Balloons for 

Coronary Bifurcation Lesions: Rationale, 

Data, and Practice 

Detlef G. Mathey 

11:21 am - Importance of Sidebranch Closure 

After Bifurcation Stenting: When Should 

We Care? 



Session IV. Dedicated Bifurcation Stents for 

Left Main and Non-Left Main Bifurcations 

Moderators: Jens Flensted Lassen, 

Ashok Seth 

Discussants: Alexandre Abizaid, 

Fernando Cura, Martin B. Leon, 

John A. Ormiston, David G. Rizik, 

Stefan Verheye 

11:44 am - Rationale for Dedicated Bifurcation 

Stents, and a Proposed Classificiation 


11:52 am - Dedicated Bifurcation Stents: 

Tryton Program Update 


12:00 pm - Dedicated Bifurcation Stents: 

Cappella Program Update 

Fernando Cura 


Biosensors Program Update 



STENTYS Program Update 



Xience SBA Program Update 



Minvasys Nile Program Update 



Session V. Left Main Stenting: Overviews 

Moderators: David E. Kandzari, 

Friedrich W. Mohr 

Discussants: J. Matthew Brennan, 

Mauro Carlino, Ted E. Feldman, 

Young-Hak Kim, Takeshi Kimura, 

Tullio Palmerini, Patrick W. Serruys, 

Gregg W. Stone, Leif Thuesen, 

Marco Valgimigli 

12:44 pm - Left Main Stenting: Highlights from 

the Last 12 Months 


12:54 pm - SYNTAX Five-Year Results: 

Left Main Cohort 

Ted E. Feldman 

1:04 pm - A Detailed Analysis of Stent 

Thrombosis from the SYNTAX Trial (All 

Patients and Left Main vs. Multivessel 

Disease Cohorts): Frequency, Timing, Vessel, 

and Contribution to Adverse Events 

Patrick W. Serruys 

1:12 pm - Left Main PCI vs. CABG: Updated 

Bayasian Meta-analysis 

John A. Bittl 

1:20 pm - Stroke After PCI vs. CABG 

(All Patients and Left Main Disease) 

Tullio Palmerini

1:28 pm - Left Main PCI in the United States: 

Report from the NCDR 

J. Matthew Brennan 

1:36 pm - Are the Outcomes of Left Main 

Stenting Improving with Second Generation 

Stents? Results of PRECOMBAT-2 

Young-Hak Kim 

1:44 pm - Case 1: Left Main Disease with 

Syntax Score >32: PCI vs. CABG 

Takeshi Kimura 

1:52 pm - Case 2: Left Main Disease Plus 

Triple-Vessel Disease and Syntax 

Score

62 


Session III. Optimizing Delivery 

and Retention 

Moderator: Warren Sherman, Jorge Tuma 

Discussants: Nabil Dib, Henricus J. Duckers, 

Amit Patel, Andreas M. Zeiher 

10:20 am - Safety of the Stop-flow 

Intracoronary Technique: 

Single-center Experience 

Andreas M. Zeiher 

10:32 am - A New Device for 

Intracoronary Infusion 

Nabil Dib 

10:44 am - IM Delivery: Current and 

Future Status 

Warren Sherman 

10:56 am - Retrograde Coronary Injection: 

Current and Evolving Status 

Amit Patel 

11:08 am - Fiberoptic Cardioscopy for Use 

in Epicardial Injection of Cell Suspensions 

and Biomaterials 

Henricus J. Duckers 


Session IV. Clinical I: Chronic 

Symptomatic Ischemia 

Moderators: Amit Patel, Andreas M. Zeiher 

Discussants: Francisco Fernandez-Aviles, 

Timothy D. Henry, Thomas J. Povsic 

11:40 am - Gene Therapy for Peripheral 

Arterial Disease: Status Update 

Timothy D. Henry 

11:55 am - Phase II and III Clinical Trials: 

Off and Running! 

Amit Patel 

12:10 pm - Mobilized CD 34+ Cells 

for Refractory Angina 

Thomas J. Povsic 

12:25 pm - Combined G-CSF and 

Intramyocardial Injection of Autologous Bone 

Marrow Mononuclear Cells in Ischaemic 

Heart Failure Improves Cardiac Function and 

Symptoms at One-Year: Results of a 

Randomized Clinical Trial 

Anthony Mathur 

12:40 pm - Precise Trial Results: Adipose 

Derived Cells for CMI 

Francisco Fernandez-Aviles 


Session V. Clinical II: Acute 

Myocardial Injury 

Moderators: Jozef Bartunek, Hyo-Soo Kim 

Discussants: Henricus J. Duckers, 

Warren Sherman, Jochen Wöhrle, 


1:15 pm - Perivascular MAPCs: Long-term 

Follow-up and Next Steps 


1:30 pm - Mechanisms of Stem Cell Effects: 

Insights from MRI in the SCAMI Trial 

Jochen Wöhrle 

1:45 pm - AMICI: Use of Mesenchymal 

Precursor Cells in the Treatment of STEMI 

Patients (FIM/IIB Study) 

Henricus J. Duckers 

2:00 pm - Bone Marrow Cell Transfer for 

STEMI: The BAMI Program Progress Report 



Session VI. Stem Cells for Cardiac Repair 

in the Chronic Setting 

Moderators: Emerson C. Perin, 


Discussants: Jozef Bartunek, 

Timothy D. Henry, Amit Patel, Marc S. Penn 

2:35 pm - SDF-1: Circumventing the 

Application of Cell Products in Heart Failure 


2:50 pm - Retrograde Application of 

Autologous BM Cells: Phase 2 Study Results 

Amit Patel 

3:05 pm - Lineage Specified Mesenchymal 

Cells for HF: C-Cure Update 

Jozef Bartunek 

3:20 pm - Allogenic Cells for Chronic 

Left Ventricular Dysfunction: 

US Experience and Beyond 

Emerson C. Perin 

3:35 pm - Ixmyelocel-T for CHF: 

Results of Catheter-Based Study 



Session VII. Defining Clinical Strategies 

and New Directions 

Moderators: Warren Sherman, 


Discussants: Stephen G. Ellis, 

Stephen E. Epstein, Joshua M. Hare, 

Hyo-Soo Kim, Raj Makkar 

4:10 pm - CCTRN: Second Cycle Studies 

Emerson C. Perin 

4:22 pm - Autologous vs. Allogeneic Cardiac 

Stem Cells: The Allstar Trial 

Raj Makkar 

4:34 pm - Endpoint Selection: Focus on STEMI 

Stephen G. Ellis 

4:46 pm - Stents and Vascular Healing: 

New Concepts 

Hyo-Soo Kim 

4:58 pm - The Evolution of a Stem Cell-Based 

Strategy: From Enhanced Collateral Function 

to Wound Healing 

Stephen E. Epstein 



The Drug-Eluting Stent Summit: 

Appropriate Utilization of 

Current Generation Devices 

8:00 am-6:03 pm 

Hall A-Coronary Theater 


Session I. Keynote Address 

Moderator: Martin B. Leon 

8:00 am - DES the Year in Review: Trends, 

Utilization, Science, and Controversies 


Session II. The Emergence of 

Neoatherosclerosis as a Major Contributor 

to Late Stent Outcomes 

Moderators: Juan F. Granada, 

Seung-Jung Park 

Discussants: Marco A. Costa, 

Hector M. Garcia-Garcia, Michael Joner, 

Gary S. Mintz, Pedro R. Moreno, 


8:12 am - Neoatherosclerosis After BMS 

and DES: Pathologic Insights 

Renu Virmani 

8:20 am - Neoatherosclerosis After BMS 

and DES: Experimental Insights 


8:28 am - Imaging Studies of Late Restenosis 

and/or Stent Thrombosis: Is 

Neoatherosclerosis the Final Common 

Pathway of DES Failure? 

Soo-Jin Kang 

8:38 am - Neoatherosclerosis Mediated 

Plaque Vulnerability and Periprocedural 

Myocardial Infarction 

Ziad A. Ali 

8:46 am - Case Presentation: 

Neoatherosclerosis and Its Sequelae 

Marco A. Costa 


Session III. Stent Trial Updates and 

Meta-analyses from the Major 

DES Programs 

Moderators: Ian T. Meredith, 

Stephan Windecker 

Discussants: Herbert D. Aronow, 

Bernard R. Chevalier, Upendra Kaul, 

Jens Flensted Lassen, Miodrag C. Ostojic, 

Duk-Woo Park, Philip M. Urban, Alan C. Yeung 

9:06 am - TAXUS: Final Five-Year SYNTAX 

Results (Entire Study Population) 


9:16 am - PROTECT: Three-Year Results 

of a Randomized Mega-trial of 

Endeavor vs. Cypher 

Edoardo Camenzind

9:26 am - Everolimus-Eluting Stents: 

SPIRIT and PLATINUM Update 


9:36 am - Multiple DES: Latest Results 

from the COMPARE I and II Trials 

Peter C. Smits 

9:46 am - RESOLUTE All-Comers at 

Three Years 

Sigmund Silber 

9:51 am - BIOMATRIX: Final Five-Year 

LEADERS Results 


9:56 am - Stent Thrombosis Meta-analysis 

Tullio Palmerini 

10:03 am - DES Clinical Outcomes 

Meta-analysis 

Sripal Bangalore 


Session IV. PCI and DES in Stable 

Ischemic Heart Disease 

Moderators: David J. Cohen, John A. Spertus 

Discussants: Sripal Bangalore, 

William E. Boden, Rory Hachamovitch, 

John McB. Hodgson, Azeem Latib, 

Ahmed Magdy, David J. Maron, 


10:25 am - Are COURAGE and FAME 

Irrelevant (or Less Relevant) with Current 

Generation DES? 

Dean J. Kereiakes 

DeBAte: iDentifying the thresholD 

for pCi AnD Des in stABle isCheMiC 

heArt DiseAse 

10:35 am - Position 1: Use PCI and DES 

Sparingly, and If at All, Only After OMT 

Truly Fails! 

David Brown 

10:43 am - Position 2: If PCI Is Required, 

Use BMS for Low-Risk TVR Lesions! 

John A. Spertus 

10:51 am - Position 3: Ischemia Matters: 

Use PCI with DES Principally to 

Eliminate Ischemia! 

Bernard De Bruyne 

10:59 am - Position 4: Patient Preference 

Matters: Use PCI with DES Early and 

Liberally in Most Patients! 



11:22 am - Case Presentation (with 

Discussion): DES vs. BMS vs. OMT in 

Stable Ischemic Heart Disease 

Frederick Feit 


Session V. DES in Complex Lesion Subsets 

Moderators: Antonio Colombo, 

Paul S. Teirstein 

Discussants: Pawel E. Buszman, 

John M. Lasala, Alfredo Rodriguez, 

Giuseppe M. Sangiorgi, 

Glenn Van Langenhove, Simon Walsh 

11:32 am - Bifurcation and Left Main Disease: 

Technical Approaches to Optimize 

Long-term Outcomes 

Philippe Garot 

11:47 am - Case Presentation 

(with Discussion): Distal Left Main 

Bifurcation Technique 

Jean Fajadet 

11:57 am - Case Presentation (with 

Discussion): Non-Left Main True 

Bifurcation Technique 

John M. Lasala 

12:07 pm - Multivessel Disease 1: 

Final Five-Year SYNTAX Results in 

the MVD Cohort 


12:17 pm - Multivessel Disease 2: 

Use of Physiologic Lesion Assessment 

and IVUS to Improve DES Results 


12:27 pm - Case Presentation (with 

Discussion): Complex Multivessel 

Intervention with FFR and IVUS 

Bon-Kwon Koo 

12:37 pm - Calcified Lesions: New Insights 

in Stable CAD and ACS from Large-Scale 

Clinical Trials 

Philippe Généreux 

12:47 pm - Case Presentation (with 

Discussion): Decalcification with the 

Orbital Atherectomy System 

Jeffrey Chambers 

12:57 pm - Restenosis After Coronary Stenting 

in 10,004 Patients with Follow-up 

Angiography 

Salvatore Cassese 

1:07 pm - DES Restenosis: Treatment Options 

and Recurrent Event Rates 


1:17 pm - Case Presentation (with Discussion): 

Recurrent DES Restenosis 

Simon Walsh 

1:27 pm - DES Thrombosis: Acute Evaluation 

and Management for Short-term Success 

and Late Prevention 

Huay Cheem Tan 

1:37 pm - Case Presentation (with Discussion): 

Recurrent DES Thrombosis 

Jose M. de la Torre Hernandez 


TranscaTheTer 


TherapeuTics 

Session VI. Antiplatelet Therapy Decisions I 

Moderators: Nick Curzen, Adnan Kastrati 

Discussants: Dimitrios Alexopoulos, 

Laurent Bonello, Efrain Gaxiola, 

Hyeon-Cheol Gwon, Michelle O’Donoghue, 

Dirk Sibbing, Jean-François Tanguay 

1:47 pm - P2Y12 Inhibitors: New Insights into 

Absolute and Relative PK and PD Responses 

Laurent Bonello 

1:57 pm - P2Y12 Inhibitors: Specific Agents 

for Specific Patient Cohorts? (STEMI, 

Diabetes, CKD, Prior Stroke, Etc) 

Dirk Sibbing 

2:07 pm - Genotyping and Platelet Function 

Testing: Too Early for Clinical Use or 

Consider in Specific Circumstances? 

Michelle O’Donoghue 

2:17 pm - When Triple Therapy Is Needed: 

Warfarin, Dabigatran, Rivaroxaban, and 

Cilostazol Considerations 

Harvey D. White 

2:27 pm - When Surgery Is Needed: Bridging 

Strategies Today and Tomorrow 



Session VII. Antiplatelet Therapy 

Decisions II: DAPT Duration 

Moderators: Mitchell W. Krucoff, 


Discussants: Myeong-Ki Hong, 

Ioannis Iakovou, Takeshi Kimura, 

Duane S. Pinto, Peter Wenaweser, 

Wojciech Wojakowski 

2:52 pm - Rationale and Data for Different 

DAPT Durations: Three to 30 Months 

(or Longer) 


3:02 pm - Do Patient and Stent 

Platform Specific Variables Matter 

(eg, ACS vs. Stable CAD, First- vs. 

Second-Generation DES)? 

Elvin Kedhi 

3:12 pm - A Preview to OPTIMIZE 

Fausto Feres 

3:17 pm - DAPT Trial Update 

Laura Mauri 

3:22 pm - ISAR-SAFE Update 

Adnan Kastrati 


Session VIII. Controversies in Stenting: 

Two Sides to Every Story 

Moderators: Gregg W. Stone, 


Discussants: Joost Daemen, Frederick Feit, 

Philippe Garot, Lisette Okkels Jensen, 

Guy LeClerc, John A. Ormiston, 

Manesh R. Patel, Sigmund Silber 



64 


3:38 pm - DES vs. BMS in STEMI: 

Why Is This Such a Difficult Decision? 

Giuseppe De Luca 


3:53 pm - Should the Presence of Diabetes 

Affect Decisions on PCI vs. CABG, and 

Which DES to Choose? 

Duk-Woo Park 


4:08 pm - Does CABG Convey a Survival 

Advantage Compared to PCI in Complex 

Patients and Lesions (and If So, Why)? 



4:23 pm - Should the AUC Determine How We 

Select Patients for PCI? 



4:38 pm - What Definition Should Be Used to 

Define Periprocedural MI in Clinical Trials 

and Practice? 


4:48 pm - Relative Frequency and Implication 

of Periprocedural vs. Spontaneous MI 


4:58 pm - Should Interventionalists Even 

Assess Post-PCI Biomarkers (CKMB, 

Troponins, or ECGs)? 

Allan S. Jaffe 


5:18 pm - Longitudinal Stent Deformation One 

Year Later: How Important an Issue Is This? 



5:33 pm - Complete vs. Incomplete 

Revascularization: Impact on Outcomes 

and Implications for Strategy 

Giora Weisz 


5:48 pm - OK, PCI May Be Performed at Low 

Volume Centers with No On-site Surgery, but 

Are There Quality and Cost Advantages to 

Centralizing Care? 




The Valvular Heart Disease 

Summit (Part 1): Aortic 

Valve Therapies 

8:00 am-6:05 pm 

Hall A-Structural and Endovascular Theater 

Session I. Changing Perspectives in 

Aortic Stenosis: Epidemiology, Diagnosis, 

and Treatment 

Moderators: Blase A. Carabello, 


Discussants: Robert A. Guyton, Jan Kovac, 

D. Craig Miller, Friedrich W. Mohr, 

Vuyisile T. Nkomo, Patrick T. O’Gara, 

Allan Schwartz, Alec S. Vahanian, 

Neil J. Weissman 

8:00 am - The Epidemiology of Valvular 

Aortic Stenosis in the 21st Century 

Vuyisile T. Nkomo 

8:07 am - Demographics and 

Echocardiography of Aortic Stenosis in the 

Modern Era: Insights from the PARTNER Trial 



8:17 am - Contemporary Surgical Outcomes 

in Normal and High-Risk Patients with 

Aortic Stenosis 

Vinod H. Thourani 

8:24 am - Appropriate Use of Balloon Aortic 

Valvuloplasty in Aortic Stenosis Patients 

Helene Eltchaninoff 


8:35 am - Aortic Stenosis Diagnostic and 

Therapeutic Clinical Pearls: A Selective 

View from the Guidelines (and Beyond): 

What Is Known! 

Blase A. Carabello 


8:47 am - My Five Most Vexing Clinical 

Management Dilemmas in Aortic Stenosis 

Patients: What Is Not Known! 

Allan Schwartz 


Session II. The TAVR “Explosion:” 

Status Update of a Breakthrough 

Medical Technology 

Moderators: Martin B. Leon, Michael J. Mack 

Discussants: David H. Adams, 

Henning Rud Andersen, Peter C. Block, 

Stephen J.D. Brecker, Alain G. Cribier, 

Raimund A. Erbel, Eberhard Grube, Axel Linke, 

Nicolo Piazza, E. Murat Tuzcu 

8:59 am - TAVR Use Patterns on the European 

Continent: Growth, Penetration, and 

Reimbursement 

Nicolo Piazza 


tAvr refleCtions: oBservAtions froM 

the pAst DeCADe AnD preDiCtions for 

the next DeCADe 

9:09 am - Pioneer and 

Interventional Perspectives 

Alain G. Cribier 

9:18 am - World Thought Leader and 

Surgical Perspectives 



9:31 am - The “Heart Team” Management 

Approach in Valvular Heart Disease: 

Components and Value Proposition - 

A Sustainable Model for the Future? 



tAvr 2012: the yeAr in review 

9:41 am - Technology and Procedural Changes 


9:51 am - Clinical Outcomes 

and Complications 



Session III. Patient Selection 

Considerations and Procedural 

Planning for TAVR 

Moderators: Michael J. Mack, 

Jeffrey J. Popma 

Discussants: Nirat Beohar, Haim Danenberg, 

Philip Green, Rebecca Tung Hahn, 

Rudiger Lange, Jonathon A. Leipsic, 

Scott Lim, Francesco Maisano, 

Ganesh Manoharan, Neil E. Moat, 

Martyn R. Thomas, John G. Webb 

10:07 am - The Art and Science of 

Risk Stratification in Aortic Stenosis: 

Updates on Risk Scores, Futility, and 

Other Imponderables 


10:15 am - The Importance of Frailty 

Assessments in TAVR Patient Selection: 

Phenotype Description, Measurement Tools, 

and Impact on Clinical Outcomes 

Philip Green 


perspeCtives on pAtient seleCtion 

for tAvr in 2012 

10:26 am - Intentional Risk “Drift” vs. 

Refinement in Risk Assessment: Data from 

SOURCE and Personal Experiences 

Martyn R. Thomas 

10:33 am - Case Selection Caveats from 

the US CoreValve Pivotal Clinical Trial 

Jeffrey J. Popma

10:40 am - My Criteria for Selecting 

Transapical TAVR (vs. Transfemoral TAVR 

or Open Surgery) 

Rudiger Lange 

10:47 am - “Nuggets” on Patient Selection 

After > 1,000 TAVR Cases (Performed and/or 

Proctored): Balloon-Expandable TAVR 

John G. Webb 

10:52 am - “Nuggets” on Patient Selection 

After > 1,000 TAVR Cases (Performed and/or 

Proctored): Self-Expanding TAVR 

Ganesh Manoharan 


11:03 am - The Essential Echocardiographic 

Screening Examination for TAVR (Including 

Annulus Measurements) 


11:11 am - The Essential Multi-Slice CT 

Screening Examination for TAVR 

(Including Annulus Measurements 

and Vascular Assessments) 

Jonathon A. Leipsic 


A ‘live’ MUltiDisCiplinAry heArt teAM CAse 

presentAtion for possiBle tAvr 

Moderators: Neil E. Moat, Martyn R. Thomas 

11:22 am - Presentation 

Isaac George 


Session IV. Case Management Conundrums 

in Aortic Stenosis (with Case Examples): 

The Patient with . . . 

Moderators: Patrick T. O’Gara, 

Alec S. Vahanian 

Discussants: Blase A. Carabello, 

Ulrich J. Gerckens, James B. Hermiller Jr, 

Howard C. Herrmann, David J. Hildick-Smith, 

Rudiger Lange, Philippe Pibarot, 

Simon Redwood, Allan Schwartz, 

Lars G. Svensson, Vinod H. Thourani, 

John G. Webb 

11:34 am - “Asymptomatic” Severe Aortic 

Stenosis: Use of Exercise Testing and 

Watchful Waiting vs. Early Valve 

Replacement 



11:43 am - Severe COPD and Aortic 

Stenosis: Screening Evaluations and 

Management Considerations 



11:52 am - Decreased LV Function and 

Aortic Stenosis: Assessment and 

Treatment Preferences 




12:01 pm - Concomitant CAD and 

Aortic Stenosis: Implications and 

Revascularization Strategies 



12:10 pm - Moderate or Severe Mitral 

Regurgitation and Aortic Stenosis: 

Surgery or TAVR? 

John G. Webb 


low flow-low grADient AortiC stenosis 

with AnD withoUt reDUCeD lv fUnCtion 

12:19 pm - Echocardiographic Features 

and Clinical Implications 

Philippe Pibarot 

12:26 pm - Therapy Considerations: 

When to Choose TAVR or Surgery 

Howard C. Herrmann 


Session V. TAVR Evidence-Based Medicine 

Corner I: Updates from PARTNER and Other 

Important Clinical Trials 

Moderators: D. Craig Miller, E. Murat Tuzcu 

Discussants: Todd M. Dewey, 

Gregory P. Fontana, Martine Gilard, 

Stuart J. Head, Ajay J. Kirtane, Axel Linke, 

Ian T. Meredith, Anna Sonia Petronio, 

Stefan Sack 

12:37 pm - The VARC 2 Consensus Document: 

Meaningful Refinements to Improve TAVR 

Clinical Research 

Stuart J. Head 


pArtner perspeCtives AnD new DAtA 

12:47 pm - The Influence of Gender on Clinical 

Outcomes in the PARTNER Trial 


12:54 pm - Lessons from the Quality-of-Life 

Studies in Inoperable and High-Risk Patients 


1:01 pm - New Data from PARTNER Continued 

Access (Nonrandomized): Transapical 

Outcomes After TAVR 

Todd M. Dewey 

1:08 pm - New Data from the PARTNER 

Continued Access (Nonrandomized): 

Transfemoral Outcomes After TAVR 


1:15 pm - Early Insights on Cost-effectiveness 

After TAVR 

Matthew R. Reynolds 

1:22 pm - Discussion 


TranscaTheTer 


TherapeuTics 

1:28 pm - STACCATO Revisited: Reflections 

and Take-home Messages 

Leif Thuesen 


Brief CliniCAl UpDAtes froM the 

iMportAnt registries 

1:36 pm - The SOURCE Multicenter EU 

Registries (Including XT) 


1:41 pm - The PREVAIL XT (TF and TA) 

Registries 

Stefan Sack 

1:46 pm - The FRANCE 2 Registry 

Martine Gilard 

1:51 pm - The ADVANCE TAVR Registry 

Axel Linke 

1:56 pm - The Canadian TAVR Registry 

Josep Rodes-Cabau 

2:01 pm - The United Kingdom TAVR Registry 

Neil E. Moat 

2:06 pm - The Italian TAVR Registry 

Anna Sonia Petronio 

2:11 pm - The Australia-New Zealand 

TAVR Registry 

Ian T. Meredith 

2:16 pm - Featured Lecture: The German 

Aortic Valve Therapy Registry (GARY): 

Comparison of Surgery vs. TAVR 

and Introduction to the New 

AKL TAVR Risk Score 


2:26 pm - Discussion 

2:36 pm - The New Transcatheter Valve 

Therapy US Registry: Concept, Status 

Update, and Future Possibilities 

John D. Carroll 


Session VI. Evidence-Based Medicine 

Corner II: Focus on TAVR Complications 

Moderators: Josep Rodes-Cabau, 


Discussants: Raimund A. Erbel, 

Philippe Généreux, Rebecca Tung Hahn, 

Samir R. Kapadia, Susheel Kodali, 

Karl-Heinz Kuck, Raj Makkar, D. Craig Miller, 

Georg Nickenig, Nicolo Piazza, 


2:46 pm - An Overview of TAVR Complications 

from a Meta-analysis Using VARC Definitions 





66 


is pArAvAlvUlAr regUrgitAtion After 

tAvr the ‘next Big thing’? 

2:56 pm - Paravalvular Regurgitation as a 

Strong Predictor of Post-TAVR Mortality 


3:03 pm - 3-D Annulus Sizing (Using MSCT or 

3-D Echo) Is Now the Gold Standard and 

Helps to Reduce Paravalvular Regurgitation 

After TAVR 

Hasan Jilaihawi 

post-DilAtion After tAvr . . . 

3:10 pm - Reduces Paravalvular Regurgitation 

Benoit Daneault 

3:15 pm - But Also May Increase Stroke 


3:20 pm - And Also Should Be Based 

on Hemodynamic Assessments: 

The Dimensionless AR Index 

Georg Nickenig 


tAvr stroke Controversy revisiteD 

3:31 pm - Stroke Risk After TAVR: 

Results from a Large Meta-analysis 

Raimund A. Erbel 

3:38 pm - New-Onset Atrial Fibrillation After 

TAVR: More Frequent Than Reported and a 

Possible Predictor of Stroke 


3:45 pm - Bottom Line: What Is the Relative 

Importance of Stroke Risk After TAVR 

Compared to Surgery? 

Samir R. Kapadia 


reeMphAsizing the CliniCAl iMpACt 

of vAsCUlAr CoMpliCAtions? 

3:58 pm - Frequency, Predictors, and 

Consequences of Major Vascular 

Complications After TAVR 


4:05 pm - Improved Patient Screening, 

Meticulous Access and Closure Techniques, 

and Lower Profile Catheter Systems Can 

Reduce Major Vascular Complications 

to

Session III. ASD Transcatheter Closure: 

Safety Dominates 

Moderators: Stephen J.D. Brecker, 

John F. Rhodes 

Discussants: John D. Carroll, Ted E. Feldman, 

Ziyad M. Hijazi, Horst Sievert 

4:00 pm - ASD Closure: Current Techniques, 

Avoiding Erosion, and the Role of Surgery 

Ziyad M. Hijazi 

4:15 pm - ASD Closure: European Perspectives 

Horst Sievert 

DeBAte: shoUlD AsD ClosUre 

only Be Done in shD/ChD Centers 

of exCellenCe? 

4:27 pm - No! 


4:37 pm - Yes! 



Session IV. Case Presentations in ASD and 

PFO Closure Showcasing Special 

Techniques, Challenges, Patient Selection, 

and Complications 

Moderators: John M. Lasala, 

Jonathan M. Tobis 

Discussants: Frank F. Ing, Paul H. Kramer, 

Eustaquio Maria Onorato, Igor F. Palacios, 

Ramon Quesada, Maarten J. Suttorp 

5:00 pm - Case 1 

Clifford J. Kavinsky 

5:15 pm - Case 2 


5:30 pm - Case 3 

Horst Sievert 

5:45 pm - Case 4 



sPEcial twilight 

sEssions 

These sessions are only CME accredited. 

Featured Clinical Research I 

6:00 pm-8:00 pm 

Room C221-222 

Moderators: Peter H. Stone, S. Chiu Wong 

Discussants: Thomas Aversano, 

Nicolas A.F. Chronos, Germano Di Sciascio, 

Jens R. Jensen, Aaron V. Kaplan, 

Gervasio A. Lamas 

6:00 pm - Prospective, Multicenter Evaluation 

of the 18 Fr Direct Flow Transcatheter Aortic 

Valve: CE Mark Study 

Joachim Schofer 



6:15 pm - Prospective, Multicenter Evaluation 

of the Portico Transcatheter Aortic Valve: 

Acute Results and One-Year Outcomes 

Ganesh Manoharan 


6:30 pm - REOPEN-AMI: A Prospective, 

Randomized Trial of Intracoronary Adenosine 

and Nitroprusside in Patients with ST- 

Segment Elevation Myocardial Infarction 

Niccoli Giampaolo 


6:45 pm - A Prospective, Randomized Trial 

of Rosuvastatin Loading Prior to PCI 

Josef Veselka 


7:00 pm - A Prospective, Randomized Trial of 

N-Acetyl Cysteine and Sodium Bicarbonate 

in Patients with ST-Segment Elevation 


Per Thayssen 


7:15 pm - SUPPORT-1: A Prospective, 

Randomized Trial of a Lipoic Acid-Based 

Cytoprotectant in Patients Undergoing 

Elective PCI 



7:30 pm - DEBATE-SFA: A Prospective, 

Randomized Trial of Paclitaxel Coated 

Balloon Angioplasty Prior to Nitinol Stenting 

in Patients with SFA and Popliteal Lesions 

Francesco Liistro 


7:45 pm - STOP-IC: A Prospective, 

Randomized Trial of Cilostazol After 

Endovascular Treatment of 

Femoropopliteal Lesions 

Hiroyoshi Yokoi 



Featured Clinical Research II 

6:00 pm-8:00 pm 


Moderators: Erick Schampaert, 

Adam J. de Belder 

Discussants: John A. Ambrose, Roberto Corti, 

Robert J. Gil, Maurizio Menichelli, 

Robert W. Yeh, Ralf Zahn 

6:00 pm - PARADOX: A Prospective, 

Randomized Trial of Clopidogrel and 

Prasugrel in Smokers and Nonsmokers 

Paul A. Gurbel 



TranscaTheTer 


TherapeuTics 

6:15 pm - A Prospective, Randomized Trial 

of Tailored Clopidogrel Therapy vs. Prasugrel 

in Patients with High On-Treatment 

Platelet Reactivity 

Laurent Bonello 


6:30 pm - J-DESSERT: A Prospective, 

Randomized Trial of Paclitaxel-Eluting vs. 

Sirolimus-Eluting Stents in Patients With 

and Without Diabetes 

Masato Nakamura 


6:45 pm - PARIS One Year: Impact of DAPT 

Cessation and Nonadherence on Adverse 

Events Following PCI 

Roxana Mehran 


7:00 pm - VERDICT/FIRST: Prospective, 

Multicenter Study Examining the Correlation 

Between IVUS and FFR Parameters in 

Intermediate Lesions 



7:15 pm - RESOLVE: A Multicenter Study 

Evaluating the Diagnostic Accuracy of 

iFR Compared to FFR 

Allen Jeremias 


7:30 pm - PADN-1: Pulmonary Artery 

Denervation for the Treatment of Refractory 

Pulmonary Hypertension 

Shao Liang Chen 


7:45 pm - Plasmonic Photothermal 

Therapy of Atherosclerotic Lesions with 

Silica-Gold Nanoparticles 

Alexander N. Kharlamov 



Focus on India: Interactive Case 

Review and Panel Discussion 

6:00 pm-8:00 pm 

Room D237-239 

Moderators: Ajay J. Kirtane, Susheel Kodali, 

Manish Parikh 

6:00 pm - Welcome and Introductions 

6:05 pm - Submitted Case Presentations and 

Discussion (Coronary) 

Case Presenters: TBA 

Case Discussants: Ziad A. Ali, Usman Baber, 

Hitinder S. Gurm, Duane S. Pinto, 

Sunil V. Rao, Nirat Beohar, Varinder P. Singh 



68 


6:50 pm - Dinner Break 

7:10 pm - Submitted Case Presentations and 

Discussion (Coronary/Peripheral/Structural) 

Case Presenters: TBA 

Case Discussants: Somjot S. Brar, 

Samir R. Kapadia, Kishore J. Harjai, 

Prakash Krishnan, Sahil A. Parikh, Adhir Shroff 

7:50 pm - Closing Remarks 


Partnership Session: Approach 

to Complex PCI and STEMI: 

From Revascularization to 

Complication Management 

Sponsored by TCT Mediterranean 

6:00 pm-8:00 pm 

Room D231-232 

Moderators: Thierry Corcos, 

George D. Dangas, Omer Goktekin 

6:00 pm - Welcome and Introduction 


Session I. PCI vs. CABG Case Selection 

Moderators: Didier Carrié, George D. Dangas 

Discussants: Davide Capodanno, 

Gennaro Sardella 

6:04 pm - Utility of Scoring Systems in 

High-Risk PCI Stratification 

Davide Capodanno 

6:16 pm - How to Choose Between CABG and 

PCI in Complex CAD: A Practical Approach 



Session II. STEMI: State of the Art 

Moderator: Georges Ghanem 

Discussants: Mohammed El Deeb, 

Roxana Mehran 

6:38 pm - STEMI Programs in the 

Middle East: Organization, Unique 

Challenges, and Results 

Mohammed El Deeb 

6:50 pm - Choice of Antiplatelet Therapies 

in ACS/STEMI 

Roxana Mehran 


Session III. Complex PCI Case Reviews 

Moderators: Thierry Corcos, Luigi Salemme 

Panel Discussants: Panayiotis Avraamides, 

Habib Gamra, Nicholas N. Kipshidze, 

Mohamed Sobhy 

7:12 pm - Case 1: Complex CAD: 

CABG or PCI? 

Murat Cayli 

7:22 pm - Case 2: A Complex Bifurcation: 

Dedicated or Provisional? 

Issam D. Moussa 

7:32 pm - Case 3: An Unusual Complication 

Luigi Salemme 

7:42 pm - Case 4: A Complicated STEMI 

Alp Burak Catakoglu 

7:43 pm - Wrap-up: Take-home from Cases 


Partnership Session: How 

to Treat Complex Coronary 

Lesions 

Sponsored by CIT in Partnership with TCT 

6:00 pm-8:00 pm 


Moderators: Run-Lin Gao, Martin B. Leon, 


Discussants: Yaling Han, Paul Hsien-Li Kao, 

Michael Kang-Yin Lee, Shuzheng Lu, 

Shubin Qiao, Weimin Wang 

Case I. A Complex Left Main Bifurcation 

6:00 pm - Case Presentation: A Complex 

Left Main Bifurcation 

Jian Liu 

6:05 pm - How Would I Treat This 

Patient? Part 1 

Yuejin Yang 





6:22 pm - Case Resolution 

Jian Liu 

6:27 pm - Moderator Wrap-up 

Case II. A Complex Chronic Total Occlusion 

6:30 pm - Case Presentation: A Complex 

Chronic Total Occlusion 

Lei Ge 






Jiyan Chen 


6:52 pm - Case Resolution 

Lei Ge 


Case III. STEMI with Multivessel Disease 

7:00 pm - Case Presentation: STEMI 

with Multivessel Disease 

Qi Zhang 



Lefeng Wang 



Hongbing Yan 


7:22 pm - Case Resolution 

Qi Zhang 


Case IV. Long Lesion and Small 

Vessel Disease 

7:30 pm - Case Presentation: Long Lesion 

and Small Vessel Disease 

Jie Qian 



YunDai Chen 



Haichang Wang 


7:52 pm - Case Resolution 

Jie Qian 



Partnership Session: Left Main 

and Bifurcation Stenting: 

Integrated Use of FFR and IVUS 

Sponsored by Angioplasty Summit-TCTAP 


6:00 pm-8:00 pm 

Room D233-234 

Moderators: Gary S. Mintz, Seung-Jung Park, 


Discussants: Antonio Colombo, Jean Fajadet, 

David E. Kandzari, Soo-Jin Kang, 

Young-Hak Kim, Akiko Maehara, 


6:00 pm - Welcome and Introductory Remarks 


6:03 pm - Morphology and Distribution of 

Left Main and Non-Left Main Bifurcation 

Atherosclerosis: What’s Different, and 

Does It Matter? 

Akiko Maehara 


6:16 pm - Non-Left Main Bifurcation PCI: 

Integrated Use of FFR and IVUS 

Soo-Jin Kang 

6:31 pm - Left Main PCI: Integrated Use 

of FFR and IVUS 

Gary S. Mintz 


7:00 pm - Two Complex Non-Left Main 

Bifurcation Cases: My Solutions 

Jean Fajadet, David E. Kandzari

7:30 pm - Two Distal Left Main Bifurcation 

Cases: My Solutions 


7:45 pm - Two Distal Left Main 

Trifurcation Cases: My Solutions 



Partnership Session: Snapshot 

of Latin America Practice 

and Research 

Sponsored by SOLACI in 


6:00 pm-8:00 pm 

Room D235-236 

Moderator: Oscar A. Mendiz 

Discussants: Jorge A. Belardi, Jorge Gaspar, 

Juan F. Granada, Jamil Abdalla Saad 

Problem I. Thrombus Containing Lesions: 

Practical Procedural Management 

6:00 pm - Case Presentation with Discussion 

Martinez Sepulveda 

6:13 pm - Evidence-Practice Intersection: 

How I Approach Thrombus in My Daily 

Practice (and Why) 



Problem II. End-Stage Coronary 

Artery Disease 


Ariel Duran 


Why We Still Believe Angiogenesis Can 

Be an Alternative for No-Option Patients 

Alberto J. Crottogini 


Problem III. Left Main PCI: 

How It Is Approached in Latin America, 

and How It Should Be 


Rogerio Sarmento-Leite 


Latin American Perspective: Our Routine 

Daily Approach and Outcomes 

Jose Armando Mangione 


Problem IV. Paravalvular Leak After TAVR 


Marco A. Perin 


What We Know, What We Don’t, and 

How to Treat 





Partnership Session: 


Sponsored by TCT Russia in 


6:00 pm-8:10 pm 

Room D229-230 

Moderators: Bagrat Alekyan, Juan F. Granada, 

Gary S. Mintz 

Discussants: Sergey A. Abugov, 

Vladimir Ganyukov, William A. Gray, 

Barry T. Katzen, Zaza Kavteladze, 

Alexander Grigorievich Osiev, 

Alexey Protopopov 

6:00 pm - Interventional Therapy 

of STEMI: Perspectives from the 

Russian Federation Database 

Bagrat Alekyan 

6:05 pm - Case 1: PCI in STEMI 

Alexey Protopopov 

6:13 pm - Thrombectomy Devices: 

Alternatives, Tips and Tricks 

Petr Kala 

6:23 pm - Stent Selection in STEMI: 

Critical Review of the Data 


6:33 pm - Case 2: PCI in STEMI 

Vladimir Ganyukov 

6:41 pm - Pharmacological Decisions in 

STEMI Intervention 



7:01 pm - Structural Heart Disease 

Intervention: Perspectives from the 

Russian Federation Database 

Bagrat Alekyan 

7:06 pm - Case 3: LAA Occlusion Case 

Alexander Grigorievich Osiev 

7:14 pm - Tips and Tricks in LAA Deployment 


7:24 pm - Case 4: Percutaneous Repair 

of Thoracic Aortic Aneurysms 

Sergey A. Abugov 

7:32 pm - Tips and Tricks During TAA Repair 


7:40 pm - Case 5: Complex Peripheral 

Vascular Intervention 

Zaza Kavteladze 

7:50 pm - Below the Knee Intervention: 

Technique, Biological Considerations, 

and Beyond 

Hans Krankenberg 




TranscaTheTer 


TherapeuTics 

Partnership Session: The Elderly 

Patient: Better Treatment in the 

United States or Europe? 

Sponsored by p-c-i live in 


6:00 pm-8:00 pm 

Room C225-256 

Moderators: Hans R. Figulla, Sigmund Silber 

6:00 pm - Introduction 


Case I. An Elderly Patient with 

Aortic Valve Stenosis 

6:05 pm - Case Presentation 

Wolfgang Bocksch 

6:15 pm - European Perspectives 


6:20 pm - US Perspectives 



Case II. An Elderly Patient with Acute 



Bernhard Witzenbichler 


Christian Hengstenberg 


Roxana Mehran 


Case III. An Elderly Patient with 

Mitral Regurgitation 




Gerhard C. Schuler 




Case IV. An Elderly Patient with 

Stable Coronary Heart Disease 








7:45 pm - Take-home Messages 

Harald G.W. Mudra 




Which subscription 

is right for you? 

www.tctmd.com 

The Source for Interventional 

Cardiovascular News and Education

Breakfast Meetings ............................................................................. 164 


SCAI ELM Session .....................................................................................72 


Cardiology with Concepts of Endovascular Therapy (Part 2) ..............72 

TCT for Nurses and Technologists .......................................................73 

TCT: An Integrated Course for Surgeons 

and Interventionalists ................................................................... 74, 111 



Coronary Intervention .................................................................................74 

Peer-Reviewed Research 

Poster Abstract Sessions ...........................................................................74 

Challenging Case Video Presentations .......................................................98 

Oral Abstract Sessions .............................................................................100 

Presentation Theater .......................................................................... 165 


Endovascular Intervention 2012 (Part 2) ...................................................105 

First-in-Human Studies: Global Regulatory and 

Translational Considerations ....................................................................106 

Hot Topics in Cardiology: ACC.12 with TCT Highlights 

for the Interventional, Invasive, and General Cardiologist ........................107 

Identifying the High-Risk Patient and Lesion: 

From Vulnerable Plaque to Ischemia ........................................................108 

Interventional Heart Failure ......................................................................109 

Launching and Sustaining Your Career ....................................................109 

Left Atrial Appendage Closure: Indications, Devices, and Techniques .....109 

Next-Generation DES and Bioabsorbable Scaffolds ................................110 

The Valvular Heart Disease Summit (Part 2): Mitral Valve Therapies .........111 

Transradial Angiography and Intervention: From Basic to Advanced .......112 

Evening Programs ............................................................................... 166 

Tuesday 

October 23, 2012 MIaMI BEaCh COnvEnTIOn CEnTEr · MIaMI, FL 



TranscaTheTer 


TherapeuTics

72 

Tuesday, ocTober 23 

brEakfast MEEtings 

7:00 am-8:00 am 

Please see page 164 for the Breakfast 

Meeting schedule. 

sPEcial sEssions 

SCAI ELM Session 

In Partnership with the ACC and CRF 

Please note this session is by invitation only. 

7:00 am-1:30 pm 

Room B118 


Moderators: Frank Hildner, Srihari S. Naidu, 

William W. O’Neill 

Discussants: J. Dawn Abbott, 

Mauricio G. Cohen, George D. Dangas, 

Douglas E. Drachman, Cindy L. Grines, 

James B. Hermiller Jr, Allen Jeremias, 

Navin K. Kapur, Morton J. Kern, 

Alexandra J. Lansky, Lynn F. Peng, 

Duane S. Pinto, Ramon Quesada, 

Paul Sorajja, Gregg W. Stone, 

Jennifer A. Tremmel, Thomas M. Tu 

7:00 am - Breakfast 

7:30 am - Welcome and Introductions 

Srihari S. Naidu 

7:45 am - ELM Presentation 

J. Dawn Abbott 



Mauricio G. Cohen 



Douglas E. Drachman 










Lynn F. Peng 






Paul Sorajja 



Jennifer A. Tremmel 



Thomas M. Tu 


11:30 am - Interventional Cardiology and the 

Andreas Gruentzig Society 


12:00 pm - History of SCAI and CCI 

Frank Hildner 

12:30 pm - Lunch 


board rEviEw coursE 

with sElf-assEssMEnt 

for intErvEntional 

cardiology with 

concEPts of 

Endovascular 

thEraPy (Part 2) 

8:00 am-6:00 pm 



8:00 am - Introduction 


Cardiac Cath Lab Basics 

Moderators: Steven R. Bailey, 


Discussants: Aaron D. Kugelmass, 

Michael J. Lim, Roxana Mehran 

8:02 am - Coronary Angiography and 

Ventriculography: Anatomy and Anomalies 

Michael J. Lim 


8:30 am - Chronic Kidney Disease, Contrast 

Agents, and Radiocontrast Nephropathy 

Roxana Mehran 


8:50 am - Selection of Angioplasty Guiding 

Catheters, Wires, and Balloons 

Aaron D. Kugelmass 


9:10 am - Angioplasty, Atherotomy, and 

Atherectomy: Mechanisms of Action, 

Results, and Current Indications 

Steven R. Bailey 



Stents 

Moderators: George D. Dangas, 


10:00 am - Bare Metal vs. Drug-Eluting Stents: 

Mechanisms of Action and Comparative 

Effectiveness and Safety 



10:30 am - Drug-Eluting Stent Systems: 

Design Differences and Comparative 

Effectiveness and Safety 



11:00 am - In-Stent Restenosis: 

Mechanisms, Predictors, and Treatment 

Roxana Mehran 


11:30 am - Stent Thrombosis: 

Mechanisms, Predictors, and Treatment 



12:00 pm - Lunch Break 


Devices and Outcomes 



1:00 pm - Complex Lesions: 

Bifurcations and CTOs 



1:30 pm - Thrombectomy and Distal Protection 

in Native Coronary Artery and Saphenous 

Vein Graft Lesions 



2:00 pm - Multivessel Disease and Left Main 

Intervention: Indications and Outcomes 

David R. Holmes Jr 



Special Interventional Imaging 

and Physiology Session 

Moderators: Massoud A. Leesar, 

Gary S. Mintz 

3:00 pm - Physiologic Lesion Assessment: 

Key Clinical Results, Guidelines, and Case 

Presentations (with Integrated Q&A) 


3:30 pm - Discussion with Q&A

3:45 pm - Intravascular Ultrasound, Near 

Infrared Spectroscopy and OCT: Key Clinical 

Results, Guidelines, and Case Examples 

(with Integrated Q&A) 

Gary S. Mintz 


Essentials of Vascular Disease 

Moderators: Michael R. Jaff, Jeffrey W. Olin 

4:30 pm - Endovascular Rescue During 

Cardiac Interventions 

Prakash Krishnan 


5:00 pm - Essentials of Aortic and Peripheral 

Arterial (Upper/Lower Extremity) Diseases: 

Guidelines, Assessment, and Outcomes 

Jeffrey W. Olin 


5:30 pm - Essentials of Carotid Artery 

Diseases: Guidelines, Assessment, and 

Outcomes 

Jose M. Wiley 


5:45 pm - Essentials of Renal Artery Disease: 

Guidelines, Assessment, and Outcomes 




tct for nursEs and 

tEchnologists 

These sessions are only CNE accredited. 

Breakout Symposium I. 

The Great Debates 

8:00 am-12:00 pm 

Room A208-209 

Moderator: Russell A. Brandwein 

Use of Appropriateness Criteria 

Discussants: Manesh R. Patel, 

Janet F. Wyman 

8:00 am - Didactic Overview 

Janet F. Wyman 

8:12 am - Protagonist 

Manesh R. Patel 

8:24 am - Antagonist 


8:36 am - Rebuttal and Discussion 

Selection of Antiplatelet Therapy in ACS: 

Prasugrel vs. Ticagrelor 

Discussants: Giuseppe Biondi Zoccai, 

Pilar Dolcimascolo, David F. Kong 


Pilar Dolcimascolo 

9:00 am - Pro: Prasugrel! 

Giuseppe Biondi Zoccai 

9:12 am - Pro: Ticagrelor! 

David F. Kong 



The Future of Aortic Stenosis Treatment 

Discussants: Julie Logan, Nicolo Piazza, 



Julie Logan 

9:48 am - TAVR Will Be for All! 

Nicolo Piazza 

10:00 am - SAVR Still the Way for Most! 



Femoral vs. Radial Access 

Discussants: Robert J. Applegate, 

Kenneth A. Gorski, Paul S. Teirstein 


Kenneth A. Gorski 

10:36 am - Pro: Femoral! 


10:48 am - Pro: Radial! 



Certification Standards for 

Cath Lab Staff 

Discussants: Jeff Davis, Regina Deible, 

Christopher M. Nelson 


Regina Deible 

11:24 am - Perspective 1 

Jeff Davis 

11:36 am - Perspective 2 

Christopher M. Nelson 



Breakout Symposium II. 

Leadership Session: 

Integration and Innovation 

8:00 am-12:00 pm 

Room B210-211 

Moderators: Michael Guiry, Hilary Nierenberg 

Compensation Models 2012: 

Where Are the Incentives? 

Discussants: Anthony Long, 

James M. Palazzo 

8:00 am - Health Care Reform, Payment 

Reform, and the Implications of Accountable 

Care Organizations 

James M. Palazzo 


TranscaTheTer 


TherapeuTics 

8:30 am - How Do You Value and 

Evaluate a Cardiology Practice? 

Anthony Long 


Physician and Hospital Integration 

Discussants: Charles L. Brown III, 

Glenna Friedman, Monica Losquadro 

9:00 am - Creating an Incentive Structure 

Using Score Cards, RVUs, and Benchmarks 

Charles L. Brown III 

9:12 am - Appropriateness Criteria: 

Implications for Clinical Practice 

Monica Losquadro 

9:24 am - How to Code and Get Reimbursed: 

Putting the New Models into Practice 

Glenna Friedman 


Operations 

Discussants: Anthony Dawson, Michael Guiry, 

Anthony Long, Andrew W. Proctor, 

Brian Sweeney 

9:42 am - Reimbursement and Practice 

Implications for Same-Day PCI 

Anthony Long 

10:00 am - Operational Efficiency: 

Finding the Hidden Opportunity 

Anthony Dawson 

10:12 am - Supply Chain Management: 

Lowering Costs and Utilization 

Michael Guiry 

10:24 am - Managing Patient Flow to Optimize 

Care and Outcomes 

Brian Sweeney 

10:36 am - Leveraging IT Systems to Improve 

Operational Performance 

Andrew W. Proctor 


Innovation Hour 

Discussants: David R. Holmes Jr, 

Paul Keckley, Mahesh M. Uberoi, 

Santosh Venkatesha 

11:00 am - Lessons Learned from International 

Health Care Systems 

Paul Keckley 

11:12 am - Leveraging the Cloud for 

Telemedicine 

Mahesh M. Uberoi 

11:24 am - Utilizing Technology to 

Geographically Expand Your Practice 

Santosh Venkatesha 

11:36 am - What Does Cardiovascular Health 

Care Look Like in 2022? 





TuEsday - OCTOBEr 23, 2012

74 



Surgical, Interventional, and 

Hybrid Procedures (Part 1): 

Coronary Intervention 

Co-sponsored by American Association for 

Thoracic Surgery 

8:00 am-12:15 pm 



Session I. Multivessel Disease 

Moderators: A. Pieter Kappetein, 


Discussants: William E. Boden, 

William F. Fearon, Ajay J. Kirtane, 

Michael J. Mack, David X. Zhao 

8:00 am - PCI and CABG from Bari to Syntax: 

Incorporating the Data Into Practice 


8:12 am - When Do I Prefer CABG for MVD? 

The Interventionalist’s Perspective 


8:22 am - When Do I Prefer PCI for MVD? 

The Surgeon’s Perspective 


8:32 am - CABG Plus PCI for MVD: 

The Hybrid Option 

David X. Zhao 

8:44 am - When Should MVD Be 

Managed Medically? 

William E. Boden 

DeBAte: CUrrent UtilizAtion of 

CABg in the Us 

8:54 am - CABG Today Is Under-Utilized! 


9:06 am - CABG Today Is Over-Utilized! 



Session II. Left Main Disease 

Moderators: Raj Makkar, David Taggart 

Discussants: Friedrich W. Mohr, 

Seung-Jung Park, Gregg W. Stone 

DeBAte: is pCi the preferreD option for 

pAtients with left MAin DiseAse? 

9:30 am - Yes: Today and Definitely Tomorrow! 


9:40 am - CABG Will Always Be the 

Preferred Approach! 


9:50 am - What Will We Learn from the EXCEL 

Trial that We Do Not Already Know? 



Session III. Hybrid Treatment of 

Coronary Artery Disease 

Moderators: Mark Vesely, David X. Zhao 

Discussants: Michael Argenziano, 

Isaac George, Jean-Michel Paradis, 

John D. Puskas 

strAtegies for hyBriD revAsCUlArizAtion 

froM experienCeD Centers 

10:10 am - Hybrid Revascularization: 

The Emory Approach 

John D. Puskas 



The Columbia Approach 

Michael Argenziano 



The Vanderbilt Approach 

David X. Zhao 



The University of Maryland Approach 

Mark Vesely 


10:54 am - Concurrent Coronary Artery and 

Valvular Heart Disease 1: Hybrid PCI with 

Surgical Valves 

Isaac George 

11:04 am - Concurrent Coronary Artery 

and Valvular Heart Disease 2: Hybrid PCI 

with Transcatheter Valves 

Jean-Michel Paradis 


Session IV. CAD Case Presentations: 

CABG, PCI, Hybrid, or Medical Therapy? 

Multidisciplinary Perspectives 

Moderators: Susheel Kodali, Mathew Williams 

Discussants: William E. Boden, 

William F. Fearon, Isaac George, 

A. Pieter Kappetein, Friedrich W. Mohr, 

John D. Puskas, Mark Vesely, 

Robaayah Zambahari 

11:25 am - Three Cases of Increasing Clinical 

and Anatomic Complexity 

Kendra J. Grubb 


PostEr abstract 

sEssions 

8:00 am-10:00 am 

Hall D 


Antithrombin and 

Antiplatelet Agents 

TCT-720. Triple vs. Dual Antiplatelet Therapy 

in Patients with Acute Myocardial Infarction 

and Renal Insufficiency: Results from Korea 

Acute Myocardial Infarction Registry 

Sang Yup Lim et al 

TCT-721. P2Y12 Reactivity Units (PRU) to 

Predict Hyporesponsiveness to Clopidogrel 

in Patients with Chest Pain with Prior 

History of Coronary Artery Stenting in 

Emergency Department 

Rakesh K. Sharma et al 

TCT-722. Platelet Function Testing Predicts 

Bleeding In Patients Exposed To Clopidogrel 

Undergoing Coronary Artery Bypass Grafting 

Grant W. Reed et al 

TCT-723. Transferring from Clopidogrel 

Loading Dose to Prasugrel Loading Dose in 

Acute Coronary Syndrome Patients: High 

On-Treatment Platelet Reactivity Analysis of 

the TRIPLET Trial 

Jean G. Diodati et al 

TCT-724. Clopidogrel Loading Doses Result in 

Favourable Changes in Nitric Oxide (NO) 

Metabolism in Patients with Stable Angina 

Undergoing Percutaneous Coronary 

Intervention (PCI) 

Richard A. Anderson et al 

TCT-725. Point-of-Care Genetic Testing of 

Eleven CYP2C19 Single Nucleotide 

Polymorphisms Identifies Extensive and 

Reduced Metabolizers of Clopidogrel with 

High Accuracy in Patients With Coronary 


David Erlinge et al 

TCT-726. Residual Platelet Reactivity 

Threshold After Clopidogrel Loading Dose to 

Predict Long-term Clinical Outcome in 

Patients with Acute Coronary Syndrome: 

Insights from the RECLOSE2-ACS Study 

Renato Valenti et al 

TCT-727. Meta-analysis Comparing Bleeding 

Rates After Low vs. High Dose Clopidogrel 

in Patients Undergoing Percutaneous 

Coronary Intervention and Receiving a 

Glycoprotein IIb/IIIa Inhibitor 

Christopher M. Huff et al

TCT-728. Clinical Presentations, Antiplatelet 

Strategies, and Prognosis of Patients with 

Stent Thrombosis: An Observational Study 

of 140 Patients 

Ya-Ling Han et al 

TCT-729. Discontinuation of Long-term 

Clopidogrel Therapy Is Associated with 

Death and Myocardial Infarction After 

Saphenous Vein Graft Percutaneous 


Somjot Brar et al 

TCT-730. Hospitalization Costs of Acute 

Coronary Syndrome Patients Undergoing 

Percutaneous Coronary Intervention: 

Comparison Between Clopidogrel 

and Prasugrel Patients in a US 

Hospital Database 

Jay Bae et al 

TCT-731. Switching from Clopidogrel to 

Prasugrel in Patients Undergoing Coronary 

Stent Implantation 

Guido Parodi et al 

TCT-732. Paraoxonase 1 Gene Polymorphism 

Does Not Affect Clopidogrel Response 

Variability but Is Associated with Clinical 

Outcome After Percutaneous Coronary 

Intervention 

Jin Joo Park et al 

TCT-733. Relation of Proton Pump Inhibitor 

and Cytochrome P450 2C19 Polymorphisms 

on Pletelet Reactivity in Patients with 

Coronary Syndromes 

Zenko Nagashima et al 

TCT-734. Influence of Platelet Reactivity 

and Inflammation on Periprocedural 

Myonecrosis in East Asian Patients 

Undergoing Elective Percutaneous 


Young-Hoon Jeong et al 

TCT-735. Pharmacodynamic Effect of 

Adjunctive Cilostazol vs. High-Dose 

Clopidogrel in Acute Coronary Syndrome 

Patients According to the CYP2C19 

Genotype (ACCEL-GENOTYPE) study 

Young-Hoon Jeong et al 

TCT-736. Markedly Reduced Platelet Inhibition 

with Clopidogrel Given to Patients 

Undergoing Therapeutic Hypothermia 

Post-Cardiac Arrest 

Rohit Moudgil et al 

TCT-737. Relationship Between Post- 

Treatment Platelet Reactivity and Ischemic 

and Bleeding Events at One-Year Follow-up 

in Acute Coronary Syndrome Patients 

Receiving Prasugrel 

Laurent Bonello et al 


TCT-738. Thrombocytes and 

IndividuaLization of Oral Antiplatelet 

Treatment After Percutaneous Coronary 

Intervention (TAILOR) 

Nadia Paarup Dridi et al 

TCT-739. Effect of Ticagrelor on the Outcomes 

of Patients with Prior Coronary Artery 

Bypass Graft Surgery: Insights from the 

Platelet Inhibition and Patient Outcomes 

(PLATO) trial 

Emmanouil Brilakis et al 

TCT-740. Clinical Impact of Extended 

Dual Antiplatelet Therapy After 

Percutaneous Coronary Interventions in the 

Drug-Eluting Stent Era: A Meta-analysis of 

Randomized Trials 

Salvatore Cassese et al 

TCT-741. Impact of Clinical Presentation on 

Platelet Inhibition by Ticagrelor Compared to 

Clopidogrel: Insights from a Single-Center 

Cohort of the PLATO Trial 

Daniel Aradi et al 

TCT-742. Individual and Regional Variations in 

Dual Antiplatelet Therapy Dose and Duration 

in a Large, Randomized International Trial 

Comparing Two Drug-Eluting Stents: Results 

from PROTECT 

Laura Mauri et al 

TCT-743. Platelet Function Monitoring in 

Patients with Acute Myocardial Infarction: 

Does Time Matter? 

Rebecca Torguson et al 

TCT-744. Double (360 mg) Loading Dose of 

Ticagrelor in Patients with ST-Elevation 

Myocardial Infarction Undergoing Primary 

Percutaneous Coronary Intervention 

Dimitrios Alexopoulos et al 

TCT-745. Can Aspirin/Clopidogrel Resistance 

Affect the Occurrence of Intra-Stent 

Thrombi? 

Junbeom Park et al 

TCT-746. Physicians’ Response to Platelet 

Function Testing After Percutaneous 

Coronary Therapy: Does High On-Treatment 

Platelet Reactivity Testing Impact 

Antiplatelet Strategy? 

Gabriel Sardi et al 

TCT-747. Efficacy and Safety of Intensified 

Antiplatelet Therapy on the Basis of Platelet 

Reactivity Testing in Patients After 


Systematic Review and Meta-analysis 

Daniel Aradi et al 

TCT-748. Double the Dose of Clopidogrel or 

Switch to Prasugrel to Antagonize Proton 

Pump Inhibitor Interaction 

Jean-Philippe Collet et al 


TranscaTheTer 


TherapeuTics 

TCT-749. Heparin vs. Bivalirudin: In-Hospital 

and 30-Day MACE in Patients Having 

DES Implantation 

Evan Shlofmitz et al 

TCT-750. Can the Rate of Acute Stent 

Thrombosis with Bivalirudin Anticoagulation 

During Primary PCI in STEMI Be Reduced 

with Modified Pharmacologic Regimens? 

Andreas Baumbach et al 

TCT-751. Novel Oral Anticoagulants in 

Patients with Acute Coronary Syndromes: 

Meta-analysis of Randomized 

Controlled Trials 

András Komócsi et al 

TCT-752. Ecarin Clotting Time (ECT) More 

Accurately Reflects Bivalirudin 

Concentration Than Activated Clotting Time 

(ACT) in Patients Undergoing Percutaneous 

Coronary Intervention Using Bivalirudin 

Anticoagulation 

Ronan J. Margey et al 

TCT-753. Impact of Bivalirudin on 

Periprocedural Events in Patients 

Undergoing Rotational Atherectomy: 

A Subanalysis of the Randomized 

ROTAXUS Trial 

Mohamed Abdel-Wahab et al 

Aortic Valve Disease and TAVR 

TCT-800. Transcatheter Aortic Valve 

Replacement (TAVR) with a New Self- 

Expanding Percutaneous Heart Valve and 

Motorized Delivery System 

Ronald Binder et al 

TCT-801. Outcome After a TAVI Procedure 

with Self-Expanding Bioprothesis Using 

CoreValve or Accutrack Delivery Device: 

France 2 Registry Results 

Gauthier Mouillet et al 

TCT-802. Impact of Experience on TAVI 

Outcome a Propensity Matched Analysis 

from the PRAGMATIC Plus Initiative 

Nicolas M. Van Mieghem et al 

TCT-803. Emergency and Prophylactic Use of 

Miniaturized Veno-Arterial Extracorporeal 

Membrane Oxygenation (vaECMO) in 

Transcatheter Aortic Valve Implantation 

Oliver Husser et al 

TCT-804. Safety and Efficacy of 14 Fr 

Balloon-Expandable Sheath for 


Hirotsugu Mitsuhashi et al 

TCT-805. Impact of Pulmonary Hypertension 

on Outcome After Transcatheter Aortic 

Valve Implantation 

Alexander Lauten et al 



76 


TCT-806. Long-term Outcomes from the 

CoreValve Transcatheter Aortic Valve 

Australia-New Zealand Study 

Ian T. Meredith et al 

TCT-807. Self-Expandable Transcatheter 

Aortic Valve Implantation for Aortic Stenosis 

After Mitral Valve Surgery 

Giuseppe Bruschi et al 

TCT-808. Expansion Geometry of the Edwards 

Sapien XT Aortic Valve Following a 

MSCT-Guided Oversizing Approach 

Alexander W. Leber et al 

TCT-809. Impact of New Conduction Defect 

After TAVI on Left Ventricular Function at 

One-Year Follow-up 

Rainer Hoffmann et al 

TCT-810. Assessment of Doubtful Aortic 

Stenosis by Measuring Simultaneous 

Transaortic Pressure: A Pilot Study with 

Fractional Flow Reserve Guidewire 

Romain Chopard et al 

TCT-811. Hospitalisation Cost of TAVI in 

Belgium: An Analysis in One University 

Hospital 

Johan Bosmans et al 

TCT-812. Thirty-day Outcome of the 18-Fr 

Direct Flow Medical Valve in Patients with 

Severe Aortic Stenosis: Results from the 

DISCOVER Trial 

Joachim Schofer et al 

TCT-813. Long-term Performance of a 

Transfemorally Implantable Nonmetallic, 

Retrievable, and Repositionable Aortic Valve 

in Patients with Severe Aortic Stenosis 

Four-Year Follow-up of the 22-Fr Direct Flow 

Medical Valve 

Klaudija Bijuklic et al 

TCT-814. Health Related Quality of Life 

Following Transcatheter Aortic Valve 

Implantation: Results from the CoreValve 

ADVANCE Study 

Johan Bosmans et al 

TCT-815. Prognostic Role of Serum Cardiac 

Biomarker Elevation After Transcatheter 


Israel Barbash et al 

TCT-816. Anticipated Utilization of 

Transcatheter Aortic Valve Replacement 

Reflects Cautious Optimism of the US 

Interventional Cardiology Community 

Akshar Y. Patel et al 


Replacement with a New Balloon 

Expandable Percutaneous Heart Valve 

Ronald Binder et al 

TCT-818. Balloon Aortic Valvuloplasty In 

Severe Aortic Stenosis And Prevention of 

Restenosis in Elderly 

Matjaz Bunc et al 

TCT-819. Effect of Transfemoral Aortic Valve 

Implantation on Plasma Brain Natriuretic 

Peptide Levels and Its Predictive Value for 

30-Day and One-Year Survival 

Karim El Chilali et al 


Implantation (TAVI) In Patients Unsuitable 

for a Transfemoral Approach: 

A Comparison Between Transapical 

and Transaxillary Approaches 

Jason Leung Kwai Chan et al 

TCT-821. Initial Experience with Transfemoral 

Implantation of the Prosthesis Edwards 

Sapien XT Without Previous Valvuloplasty in 

Patients with Severe Aortic Stenosis 

Eulogio J. Garcia et al 

TCT-822. Computed Tomography Evaluation 

Prior to CoreValve Implantation Predicts 

Postprocedural Aortic Regurgitation 

Sabine Bleiziffer et al 

TCT-823. In-Vitro Assessment of the Influence 

of Oval Annuli on the Hydrodynamic 

Function of Percutaneous Heart 

Valve Prostheses 

Maximilian Kuetting et al 

TCT-824. The Impact of Creation of a 

Transcatheter Aortic Valve Program on 

Surgical Aortic Valve Replacement (SAVR) 

Volume and Outcomes: A Single-Center 

Experience 

Firas E. Zahr et al 

TCT-825. Antegrade-Transseptal, Retrograde, 

or Trasapical Access to the Ascending Aorta 

Hemodynamic: A Comparision Study in a 

Porcine Model 

Sabine Wipper et al 

TCT-826. Does Diabetic Status Impact the 

Outcome of TAVR Procedures? Insights from 

the France2 Registry 

Eric Van Belle et al 

TCT-827. Interaction Between Perivalvular 

Aortic Regurgitation and Delivery Approach: 

Impact on Clinical Outcome After TAVI: 

Insights from the France 2 Registry 

Eric Van Belle et al 

TCT-828. Standardized Segmentation of Aortic 

Annulus Across Multimodalities Imaging 

Techniques: Location of Annulus 

Calcification Predicts Periprosthetical 

Leaks Post TAVI 

Vlad Ciobotaru et al 

TCT-829. Invasive Systemic Arterial 

Hemodynamics in Low Gradient Severe 

Aortic Stenosis with Preserved Ejection 

Fraction 

Mackram Eleid et al 

TCT-830. Immediate and Delayed Effects of 

Stent Crimping on Pericardial Leaflets of 

Transcatheter Valves 

Arash Kheradvar et al 


Implantation in Patients of Small Body Size 

Thierry Lefèvre et al 

TCT-832. Epidemiology of Severe Aortic 

Stenosis in the Elderly: A Systematic 

Review and Meta-analysis of Published 

Prevalence Estimates 

Ruben L. J. Osnabrugge et al 

TCT-833. Is Transcatheter Aortic Valve 

Implantation a Cost-effective Treatment in 

Patients Who Are Ineligible for Surgical 

Aortic Valve Replacement? 

James Eaton et al 

TCT-834. Qualitative Assessment on TAVI 

Utilization: A European Perspective 

Rachele Busca et al 

TCT-835. Permanent Pacemaker Implantation 

After Transcatheter Aortic Valve 

Implantation: Is There Any Impact 

on Survival? 


TCT-836. Prediction of Paravalvular Leaks 

After Transcatheter Aortic Valve Implantation 

by Valvular or Annular Calcification 

Gudrun Feuchtner et al 

TCT-837. Effectiveness and Possible 

Complications of Post-Dilatation in Patients 

with Residual Significant Aortic 

Regurgitation Following Valve Implantation 

Using Both Edwards and CoreValve 

Systems: A Single-Center Study 

Ahmed Rezq et al 

TCT-838. Using Inferior Epigastric Artery for 

Vascular Access Optimization During 


Manolis Vavuranakis et al 

TCT-839. Early Changes of Left Ventricle 

Deformation Indices After Transcatheter 

Aortic Valve Implantation: A Speckle 

Tracking Echocardiographic Study 


TCT-840. Mortality Risk for Transcatheter 

Aortic Valve Implementation Patients 

Eventually Approaches General 

Population: Innovative Time Series Analysis 

of Outcomes 

Hala Sharaf et al 

TCT-841. One-Year Outcomes Following 

Transcatheter Aortic Valve Implantation vs. 

Surgical Aortic Valve Replacement 

in Patients Over 75 Years: The Elderly 

Pilot Study 

Alaide Chieffo et al

TCT-842. Embolic Particles Show Surprising 

Size Dependent Predilection for Cerebral vs. 

Peripheral Arteries: Results from 

Computational Fluid Dynamic Modeling 

Shawn C. Shadden et al 


Implantation with Edwards SAPIEN XT vs. 

Medtronic CorEvalve REvalving System with 

AccuTrak: The SAPERE Pilot Study 

Gill L. Buchanan et al 

TCT-844. Clinical Outcome of Patients with 

Low-Flow, Low-Gradient Aortic Stenosis 

After Transcatheter Aortic Valve Implantation 

Jury Schewel et al 

TCT-845. Clinical Outcome of Patients with 

Paradoxical Low-Flow, Low-Gradient Aortic 

Stenosis After Transcatheter Aortic Valve 

Implantation 

Jury Schewel et al 

TCT-846. Acute Assessment of Transcatheter 

Aortic Valve Performance After Implantation 

into Degenerated Aortic Surgical 

Bioprostheses 

Ulrich Schäfer et al 

TCT-847. Adequate Choice of the Post 

Dilatation Balloon Size in Patients 

Undergoing TAVI Based on the CT 

Scan Analysis 

Ahmed Rezq et al 

TCT-848. Clinical Impact of Paravalvular Leaks 

on Biomarkers and Survival After 


Dimitry Schewel et al 

TCT-849. Predictive Reliability of Logistic 

EuroScore II in Patients Undergoing 

Transcatheter Aortic Valve Implantation: 

Assessment and Comparison to Classic 

Systems of Preoperative Risk Stratification 

Lenard Conradi et al 

TCT-850. Early Clinical Outcome of 

Transcatheter Valve-in-Valve Implantation in 

the Nordic Countries 

Leo Ihlberg et al 

TCT-851. Patients Referred for 


Reasons for Rejection and Survival in a 

Real-world Population 

Kirsten Boerlage-van Dijk et al 

TCT-852. Successful Transfemoral 

Implantation of a Medtronic CoreValve in 

Patients with Severe Aortic Regurgitation: 

A Single-Centre Experience 

Marco Luciano Rossi et al 

TCT-853. Procedural Results of Direct 

Implantation of the Self-Expanding 

CoreValve Aortic Bioprosthesis Without 

Prior Valvuloplasty 

Emmanuel Chorianopoulos et al 


TCT-854. Prognostic Value of Preinterventional 

Troponin T Levels in Patients with Severe 

Aortic Stenosis Undergoing TAVR 

Emmanuel Chorianopoulos et al 

TCT-855. Chronic Obstructive Pulmonary 

Disease in Patients Undergoing 


Insights on Clinical Outcomes, Prognostic 

Markers, and Functional Status Changes 

Michael Mok et al 

TCT-856. Impact of Transcatheter Aortic Valve 

Implantation on Aortic-Mitral Valve Coupling 

Wendy Tsang et al 

TCT-857. 3-D Multidetector Computed 

Tomography Predictors of Prosthesis-Patient 

Mismatch in Transcatheter Aortic Valve 

Replacement 

Melanie Freeman et al 

TCT-858. Transapical Aortic Valve 

Replacement with The JenaValve: Less 

Pravalvular Leackage and Higher 

Transvalvular Gradient 



Implantation with Edwards SAPIEN vs. 

Medtronic CoreValve Revalving System 

Devices: A Multicenter Collaborative Study 

The PRAGMATIC Initiative: Pooled 

Rotterdam-Milano-Toulouse in Collaboration 

Alaide Chieffo et al 

TCT-860. Does the Logistic EuroScore II 

Better Predict Outcomes Following 

Transcatheter Aortic Valve Implantation? 

Results from the Milan Registry 


TCT-861. The Effect of Inflammation on Left 

Ventricular Function After Trancatheter Aortic 



TCT-862. Flow Characteristics of the 

CoreValve and Potential Underestimation of 

Aortic Valve Cross-Sectional Area Following 

Transcatheter Valve Implantation 

Alison Duncan et al 

TCT-863. Severe Decline in Platelet Count in 

Patients Treated by Transcatheter Aortic 

Valve Replacement Is an Independent 

Correlate for Worse Clinical Outcome 

Danny Dvir et al 

TCT-864. A Comparison of the Femoral and 

Radial Crossover Techniques for Vascular 

Access Management in Transcatheter Aortic 

Valve Implantation: The Milan Experience 

Helen Curran et al 

TCT-865. Rotational Aortography with CT 

Reconstruction Can Guide Transcatheter 

Aortic Valve Replacement and Predict 

Prosthetic Regurgitation 

Carlos Alfonso et al 


TranscaTheTer 


TherapeuTics 


Implantation in Patients with Bicuspid 

Aortic Valve Disease: Results from the 

Milan Registry 


TCT-867. Clinical Impact of Persistent Left 

Bundle Branch Block After CoreValve 

Revalving System Implantation: Insight from 

a Multicenter Italian Registry 

Luca Testa et al 

TCT-868. Incidence, Predictors, and Impact of 

Bleeding After Transcatheter Aortic Valve 

Implantation 

Bogdan Borz et al 

TCT-869. Percutaneous Clousure of 

Paravalvular Aortic Leak with AVP III Device, 

Clinical Follow-up Late 


TCT-870. Frailty Assessment Tools: Impact on 

Short-term Outcome After TAVI 

Felix Woitek et al 

TCT-871. Leveraging Preparatory Balloon 

Aortic Valvuloplasty (BAV) During TAVI for 

Improved Valve Sizing: A Simple Way to 

Reduce Paravalvular Aortic Regurgitation?! 

Polykarpos Christos Patsalis et al 

TCT-872. Results of Transfemoral TAVI in 

Partner-Like Patients: A Comparison with 

Real-world Patients 

Fadi Al-Rashid et al 

TCT-873. Results of Transfemoral Aortic Valve 

Implantation (TF-TAVI) Performed by External 

Cardiologists in Collaboration with an 

Experienced Multidisciplinary Heart Team at 

a Specialized Center 

Philipp Kahlert et al 

TCT-874. Hemodynamic Assessment of 

Residual Paravalvular Aortic Regurgitation 

(PAR) After TAVI: Impact of Myocardial 

Supply-Demand Ratio (DPTI:SPTI) 

on Survival 

Polykarpos Christos Patsalis et al 

TCT-875. Frailty Is a Major Determinant of 

Length of Stay After Transcatheter Aortic 

Valve Replacement 

Abhijit Ghatak et al 

TCT-876. Decreasing B-Type Natriuretic 

Peptide Predicts Survival After Transcatheter 


Peeyush Grover et al 

TCT-877. Historical Trends in Outcomes 

Following Aortic and Mitral Heart Valve 

Replacement Procedures: A Population- 

Based Study of 29,582 Medicare Patients 

from 1997 to 2009 

Jasmine Patel et al 



78 


TCT-878. Transaortic Valve Implantation (TAVI) 

Normalises Subendocardial Function in 


Alison Duncan et al 

TCT-879. SIMPLIPHieDE (Single-Center 

IMPella LVAD Supported PCI in High-Risk 

Group of Patients: Detroit Medical Center 

Experience) Balloon Aortic Valvuloplasty: 

Technique and Clinical Outcomes 

Haroon Faraz et al 

TCT-880. CT-Angiography vs. Angiography in 

Iliacofemoral Tract Diameter Assessment: 

The Imaging Modality Can Be Determinative 

in Choice of Approach for Transcatheter 

Aortic Valve Implantation 

Esther M.A. Wiegerinck et al 

TCT-881. Embolic Cerebral Insults and 

Microbleeds After Percutaneous Aortic Valve 

Replacement and Surgical Aortic Valve 

Replacement Detected by Magnetic 

Resonance Imaging 

Stephan Ensminger et al 

TCT-882. Has Balloon Aortic Valvuloplasty for 

Severe Aortic Stenosis Improved Outcomes 

in the Transcatheter Aortic Valve 

Replacement Era? 

Itsik Ben-Dor et al 

TCT-883. Calcification Displacement and 

Tissue Deformation Due to Transcatheter 

Aortic Valve Replacement: An Image-Based 

Analysis Method 

Bart Bosmans et al 

TCT-884. Frequency and Causes of Stroke 

During or After Transcatheter Aortic Valve 

Implantation 

Rutger-Jan Nuis et al 


Implantation with Medtronic CoreValve vs. 

Medtronic CoreValve with Accutrak 

Delivery System 


TCT-886. Predictors of Vascular Complications 

in Patients Undergoing Balloon Aortic 

Valvuloplasty 

Roxana Mehran et al 

TCT-887. TAVR: Three-Year Results of 

Transapical vs. Transfemoral Approach in a 

Real-world Population of 1,000 Patients with 

Severe Aortic Stenosis 

G. Schymik et al 

TCT-888. Patients with Aortic Stenosis 

Referred for Transcatheter Aortic Valve 

Implantation: Treatment Decision, 

In-Hospital Outcome and Determinants 

of Survival 


TCT-889. Sex-Related Clinical Characteristics 

and Outcome Before and After Transcatheter 



TCT-890. Gender Differences in Patients with 

Severe Aortic Stenosis Undergoing 


Stefan Stortecky et al 

TCT-891. Outcomes of Transcatheter Aortic 

Valve Replacement vs. Standard Therapy 

Among Women Deemed Too High Risk for 

Surgery in the PARTNER Trial 

Susheel Kodali et al 

TCT-892. Predictors of “Futility” with 

Transcutaneous Aortic Valve Replacement 

Therapy (TAVR): An Analysis from the 

PARTNER Randomized Trial 

Nirat Beohar et al 

TCT-893. Does Left Ventricular Hypertrophy 

Affect Outcomes in Patients Undergoing 

Transcatheter Aortic Valve Replacement? 

Nimesh Desai et al 

TCT-894. Impact of Transcatheter Aortic Valve 

Implantation on Mitral Regurgitation: 

Insights from a Multicenter Study 

Konstantinos Toutouzas et al 

TCT-895. Prediction of Implanted TAVI 

Prosthetic Size by 3-D–TEE Assessment 

Ulrich Hink et al 

TCT-897. Variation in Use, Costs, and Hospital 

Profitability for Aortic Valve Replacement 

Procedures: A Descriptive Analysis 

Mary Ann Clark et al 

TCT-898. Incidence and Impact of Acquired 

Thrombocytopenia on Bleeding Events and 

Mortality After Transcatheter Aortic Valve 

Replacement (TAVR) 

Philippe Généreux et al 

TCT-899. Risk of Respiratory Failure After 

Minimally Invasive Transapical Aortic Valve 

Implantation 

Martin Haensig et al 

TCT-900. High-Degree Atrioventricular Block 

and Need for Permanent Pacemaker 

Implantation After Transcatheter and 

Surgical Aortic Valve Replacement 

Irene Franzoni et al 

TCT-901. Improved Mitral Valve Performance 

After Transapical Aortic Valve Implantation 

Martin Haensig et al 

TCT-902. Report from the Swedish TAVI 

Register: Comparison of Two Valve Types 

Jan Harnek et al 

TCT-903. Incidence and Predictors of Left 

Bundle Branch Block After Transcatheter 


Irene Franzoni et al 

TCT-904. Catheter Laboratory Predictors of 

Postprocedure Paraprosthetic Aortic 

Regurgitation Following Self-Expanding 

Medtronic CoreValve Implantation: 

A Multicentre Registry Analysis 

Omar Ali et al 

TCT-905. Direct Aortic Implantation of a 

Self-Expandable Aortic Bioprosthesis: 

The European Experience 


TCT-906. Towards Simulation-Based 

Preoperative Planning of Transcatheter 


Carl J. Schultz et al 


Replacement for Pure Severe Native Valve 

Aortic Regurgitation 

David A. Roy et al 

TCT-908. Gender-Related Differences in 

Baseline Characteristics and Clinical 

Outcome of Transcatheter Aortic Valve 

Implantation 

Mohamed Abdel-Wahab et al 

TCT-909. Minimizing Radiation Exposure 

during Transcatheter Aortic Valve 

Replacement (TAVR) Procedures 

Adesh Ramsewak et al 

TCT-910. Patient-Specific Computational 

Modeling of Transcatheter Aortic 


Elaine Tseng et al 


TCT-675. Prolonged Ischemia, Detected by 

Intracoronary Electrocardiography, After 

Coronary Bifurcation Stenting Predicts 

Adverse Events During Mid-term Follow-up 

Alexander Alexandrov et al 

TCT-676. The Glider Balloon: A Useful Device 

for the Treatment of Bifurcation Lesions 

Carlo Briguori et al 

TCT-677. Use of Troponin to Diagnose 

Periprocedural Myocardial Infarction: Effect 

on Composite Endpoints in the British 

Bifurcation Coronary Study (BBC ONE) 

James A. Cockburn et al 

TCT-678. Tryton-Xience for the Treatment of 

Complex Coronary Bifurcation Lesions: 

A Single-Center Consecutive Series 

Daniela Trabattoni et al 

TCT-679. Coronary bifurcation Angle from 3-D 

Predicts Clinical Outcomes After Stenting 

Bifurcation Lesions 

Shao Liang Chen et al

TCT-680. Long-term Outcome of Patients with 

Bifurcated Lesions Randomized to Sirolimus 

of Everolimus Eluting Stent: The Sea-Corp 

BC Study 

Francesco Burzotta et al 

TCT-681. Long-term Outcomes of Simple and 

Complex Coronary Bifurcation Lesions (CBL) 

Treated with Drug-Eluting Stents 

Leonard Ngunga et al 

TCT-682. Long-term Outcomes of Two Stent 

Technique for the Treatment of Complex 

Coronary Bifurcations in the Drug-Eluting 

Stent Era: A Comparison of Three 

Contemporary Strategies 

Leonard Ngunga et al 

TCT-683. The Impact of Side Branch 

Predilatation on Procedural and Long-term 

Clinical Outcomes in Coronary Bifurcation 

Lesions Treated by Provisional Approach: 

Results from the COBIS (Coronary 

BIfurcation Stent) Registry 

Pil Sang Song et al 

TCT-684. Regular Drug Eluting Stent vs. 

Dedicated Bifurcation Paclitaxel-Eluting 

Stent (BiOSS) in Coronary Bifurcation 

Treatment: POLBOS (POLish Bifurcation 

Optimal treatment Strategy) Randomized 

Study 

Robert J. Gil et al 

TCT-685. Push-and-Bend Technique for 

Coronary Bifurcations 

Achim Gutersohn et al 

TCT-686. T-Stenting with Two Drug-Eluting 

Stents vs. One Drug-Eluting Stent with Side 

Branch PTCA: Long-Term Pathological 

Findings in Bifurcation Lesions 

Seung-Jin Oh et al 

TCT-687. First-in-Man (FIM) Study of 

Dedicated Bifurcation Sirolimus-Eluting 

Stent BiOSS (Bifurcation Optimization Stent 

System) LIM: Nine-Months Results 

Robert J. Gil et al 

TCT-688. Treatment of Bifurcation Lesions 

with a Drug-Eluting Stent with 

Biodegradable Polymer 

Fazilatum Nesa Malik et al 

TCT-689. Impact of Final Kissing Ballooning 

on Stent Expansion, Apposition, and 

Neointimal Hyperplasia in Coronary 

Bifurcation Lesions Treated with One-Stent 

Technique 

Joo-Yong Hahn et al 

TCT-690. Safety and Clinical Efficacy of 

Sideguard Stent for Treatment of Bifurcation 

Lesions: Interim Results from the European 

Sideguard Bifurcation Registry Study 

Farzin Fath-Ordoubadi et al 


TCT-691. The Feasibility and Safety of Balloon 

Dilation Over the Jailed Wire to Reopen the 

(Sub-)Occluded Side Branch During 

Provisional Stenting 

Li Chengxiang et al 

TCT-692. Impact of Treatment Strategy on 

Clinical Outcomes Differs Between Patients 

with Left Main and Those with Non-Left Main 

Bifurcation Lesions 

Young Bin Song et al 

Bleeding, Thrombosis, 

Embolization, and Other 

Complications 

TCT-546. Timing of Access Site Bleeding After 

Transfemoral Coronary Intervention 

Pranjal K. Boruah et al 

TCT-547. Ischemic Stroke Associated with 

Left Cardiac Catheterization: The Importance 

of Modifiable and Non-Modifiable Risks 

Factors 

Batric Popovic et al 

TCT-548. Long-term Follow-up After 

Percutaneous Coronary Intervention with 

Polytetrafluoroethylene-Covered SYMBIOT 

Stents Compared to Bare Metal Stents, With 

and Without FilterWire Embolic Protection, in 

Diseased Saphenous Vein Grafts: The 

STROMBOLI Trial 

Johan Bennett et al 

TCT-549. Impact of Clinical Presentation on 

In-Hospital Bleeding Outcomes in 


Joshua P. Loh et al 

TCT-550. The Impact of Upstream 

Anticoagulation on In-Hospital Bleeding in 

Patients with Acute Coronary Syndrome 


Intervention 


TCT-551. Prophylactic Use of Intracoronary 

Nicardipine in Conjunction with Distal 

Protection Devices During Vein Graft 

Intervention: Synergistic Effect of Combining 

Drugs and Devices 

Michael P. Savage et al 

TCT-552. The Impact of Vascular Access for 

In-Hospital Major Bleeding in Acute 

Coronary Syndrome Patients with Moderateto 

Very High-Bleeding Risk 

Keun-Ho Park et al 

TCT-553. One-Year Cardiovascular and Renal 

Outcome of Sodium Bicarbonate in 

Comparison with Saline for Prevention of 

Contrast-Induced Nephropathy After Cardiac 

Catheterization: A Randomized Control Trial 

Junichi Tazaki et al 


TranscaTheTer 


TherapeuTics 

TCT-554. Postprocedure Major Bleeding 

Events in Patients Undergoing Percutaneous 

Coronary Intervention: Validation of 

BLEEDRS-A Simplified HAS-BLED Score 

Imdad Ahmed et al 

TCT-555. Release of Bioactive Lipids During 

Percutaneous Coronary, and Peripheral 

Arterial Interventions in Humans: 

Lipidomic Analysis of Distal Embolic 

Protection Devices 

Amir Ravandi et al 

TCT-556. The Incidence and Outcome of 

Devices “Stuck” in the Coronary Artery 

During Percutaneous Coronary Intervention: 

A Toyohashi Experience 

Masashi Kimura et al 

TCT-557. The Risk of In-Hospital Bleeding and 

Long-term Mortality in Patients with 

ST-Elevation Myocardial Infarction Treated 

with Primary Percutaneous Coronary 

Intervention 

H. Boden et al 

TCT-558. Red Cell Distribution Width as a 

Correlate of Post-Percutaneous Intervention 

Bleeds 

Omid Fatemi et al 

TCT-559. On-Treatment Platelet Reactivity 

Testing Before Coronary Artery Bypass 

Surgery: Does It Predict In-Hospital Major 

Bleeding? 


TCT-560. Impact of Intraprocedural Coronary 

No Reflow on Two-Year Clinical Outcomes 

Following Percutaneous Coronary 

Intervention with Drug-Eluting Stents 

Amro Elnagar et al 

TCT-561. Risk Stratification and Outcomes of 

Patients with Prior Coronary Artery Stenting 

Undergoing Noncardiac Surgery 

Andrew L. Goodman et al 

TCT-562. Temporal Trends in Cost and 

Resource Utilization Following PCI- 

Associated Gastrointestinal Bleeding 

Vabhave Pal et al 

Bare Metal and 

Drug-Eluting Stents 

TCT-601. Real-world Experience of the 

Polymer-Free Rapamycin-Eluting YUKON- 

Choice Stent: Five-Year Results from a 

Prospective Registry 

Marc-Alexander Ohlow et al 

TCT-603. Proximal Coronary Artery Stenting: 

DES vs. BMS and LAD vs. the Rest 

Fredrik Calais et al 

TCT-604. Per-Lesion Interobserver Variability 

and Impact on Syntax Score 

Gerardo Nau et al 



80 


TCT-605. Impact of Stent Overlap on 

Long-term Clinical Outcomes in 

Patients Treated with Newer-Generation 


Crochan J. O’Sullivan et al 

TCT-606. Cost-effectiveness of Everolimus- 

Eluting Stents Compared to Propensity 

Score-Matched Bare Metal Stents in 

Contemporary Clinical Practice 

Robert J. Applegate et al 

TCT-607. Clinical Outcome in Chinese 

Patients with Long Lesion or Small Vessel/ 

Multivessel Disease Receiving XIENCE V 

Everolimus-Eluting Stent: Early Results from 

the SEEDS Study 

Yuejin Yang et al 

TCT-608. Two-Year Outcomes After 

Implantation of XIENCE PRIME and XIENCE 

PRIME Long Lesion Stents in Patients with 

Coronary Artery Disease: Results of the 

SPIRIT PRIME Multicenter Pivotal 

Clinical Trial 

Marco Costa et al 

TCT-610. Long-term Outcomes of Complete 

vs. Incomplete Revascularization After 

Drug-Eluting Stent Implantation in Patients 

with Multivessel Coronary Disease 

Zhan Gao et al 

TCT-611. Effect of Stent Inflation Pressure and 

Postdilatation on the Outcome of Coronary 

Artery Intervention: A Report of More Than 

90,000 Stent Implantations 

Ole Fröbert et al 

TCT-612. Two-Year Outcomes Following 

Implantation of 32 mm and 38 mm Platinum 

Chromium Everolimus-Eluting Element 

Stents in Long Coronary Lesions 

Paul Teirstein et al 

TCT-613. A Prospective Randomized 

Multicenter Trial to Assess the Everolimus- 

Eluting Stent System (Promus Element) for 

Coronary Revascularization in a Population 

of Unrestricted Patients 

Jean Fajadet et al 

TCT-614. Remote Ischemic Preconditioning 

Improves Outcome out to Six-Years 

Following Elective Percutaneous Coronary 

Intervention: The CRISP-Stent Trial 

Stephen P. Hoole et al 

TCT-615. Coating Damage of Drug-Eluting 

Stent Occurs in Front Edge Strut: A 

Scanning Electron Microscopy Study 

Takashi Kubo et al 

TCT-616. Comparison of Long-term Outcomes 

with Everolimus-Eluting and Sirolimus- 

Eluting Stents in Small Coronary Artery 

Disease 

Hironori Kitabata et al 

TCT-617. How Do Results from RCTs 

and Registries Differ? 

Philip Urban et al 

TCT-618. Percutaneous Coronary Intervention 

in a Complex Patient Population: 

A Comparison of First- vs. Second- 

Generation Drug-Eluting Stent Use on 

In-Hospital and One-Year Outcomes 


TCT-619. Prognostic Implications of 

Percutaneous Coronary Interventions 

Performed According to the Appropriate Use 

Criteria for Coronary Revascularization 

Israel Barbash et al 

TCT-620. What Is the Optimal 

Revascularization Strategy for Percutaneous 

Coronary Intervention of Distal Anastomotic 

Lesions After Coronary Bypass Surgery? 

Salem Badr et al 

TCT-621. Drug-Eluting Stent Event Registry of 

Thrombosis (DESERT): The International 

Drug-Eluting Stent Thrombosis Registry, 

Angiographic Assessment 

Ron Waksman et al 

TCT-622. Angiographic Outcomes in 

“One-Stop” Hybrid Coronary 

Revascularization vs. Percutaneous 

Coronary Intervention for the Treatment of 

Multivessel Coronary Artery Disease: 

A Propensity Score Matching Analysis 

Yi Shi et al 

TCT-623. Efficacy of Additional Ballooning 

with a Dual Wire Balloon After Rotational 

Atherectomy to Expand the Drug-Eluting 

Stent for Heavily Calcified Coronary Lesions 

Ryuichi Kato et al 

TCT-624. Clinical Outcomes with Everolimus- 

Eluting Stent for the Treatment of Cardiac 

Allograft Vasculopathy 

Babak Azarbal et al 

TCT-625. Three-Year Follow-up of a 

Randomized Comparison of Nobori, 

Biolimus A9-Eluting Stent with Cypher, 

Sirolimus-Eluting Stent for Coronary 

Revascularization in Japanese Population 

Takeshi Kimura et al 

TCT-626. Impact of Periprocedural Myocardial 

Infarction on In-Hospital and Two-Year 

Clinical Outcomes in Patients Undergoing 

Percutaneous Coronary Intervention with 


Seung-Woon Rha et al 

TCT-627. Does Direct DES Stenting Reduce 

Restenosis? A Randomized Comparison of 

Direct Stent Implantation to Stenting with 

Predilation or Provisional Stenting in Elective 

PCI Patients 

Samer Somi et al 

TCT-628. Drug-Eluting Stent Implantation for 

the Treatment of Bare Metal or Drug-Eluting 

Stent Restenosis 

Shintaro Nezuo et al 

TCT-629. Real-world Comparison of Clinical 

Outcomes of Patients Who Received New 

Generation Platinum Chromium Everolimus- 

Eluting Stent vs. Cobalt Chromium 

Everolimus-Eluting Stent 

Ruogu Li et al 

TCT-630. ENERGY 1,000-Subject Registry 

with a Thin Strut Bare Metal Stent with 

Passive Coating Presenting One-Year MACE 

Data on Prespecified Subgroups 

Raimund Erbel et al 

TCT-632. Contemporary PCI Practices Across 

Three Continents: A Glimpse into the 

Preliminary Results of e-Nobori Study 

Jawed Polad et al 

TCT-633. Impact of Ad Hoc Percutaneous 

Coronary Intervention with Drug-Eluting 

Stent in Angina Patients 

Young-Hak Kim et al 

TCT-634. Randomized Comparison of Direct 

Stenting with Conventional and Provisional 

Stent Implantation in Elective PCI Patients 

Using Bare Metal and Drug-Eluting Stents 

Samer Somi et al 

TCT-635. Cost-effectiveness of Everolimus- 

Eluting Stents Compared to First-Generation 

Drug-Eluting Stents in Contemporary 

Clinical Practice 


TCT-636. Final Three-Year Results Following 

Resolute Zotarolimus-Eluting Stent 

Implantation in the RESOLUTE 

International Trial 

Franz-Josef Neumann et al 

TCT-637. A Novel Bioactive and Coating-Free 

Stent Surface Exhibits a Reduction in 

Neointimal Hyperplasia by Decreasing 

Platelet Aggregation and Promoting 

Endothelialization 

Adam Groothuis et al 

TCT-638. Late Catch-up Restenosis of 

Drug-Eluting Stents: Evidence from 

Comparison with Bare Metal Stents in 

Japanese CAD Patients 

Yuki Horita et al 


Implantation of the Resolute Zotarolimus- 

Eluting Stent in Vessels < 2.5 mm Diameter 

Ronald Caputo et al 

TCT-640. Very Late Stent Thrombosis Is 

Associated with Lower Mortality Than Early 

Stent Thrombosis: A Report from the VHA 

CART Program 

Ehrin J. Armstrong et al

TCT-641. The Effect of Balloon Angioplasty 

Compared with Drug-Eluting Stent (DES) 

Implantation for the Treatment of DES 

In-Stent Restenosis 

Taku Ichihashi et al 

TCT-642. Two Zotarolimus-Eluting Stent 

Generations: A Meta-analysis of 12 

Randomized Trials vs. Other Limus-Eluting 

Stents and an Adjusted Indirect Comparison 


TCT-643. Abluminal-Only Coating Everolimus- 

Eluting Coronary Stent Provides an 

Antiinflammatory Vascular Effect Compared 

to Bare Metal Stents in the Familial 

Hypercholesterolemic Swine 

Armando Tellez et al 

TCT-644. Drug-Eluting Stents in the Elderly: 

Very Long-term Clinical Outcomes (up to 

10 Years) of Octogenarians in the DESIRE 

Registry 

Bruno Palmieri et al 

TCT-645. Comparison of Angiographic and 

Clinical Outcomes Among Patients with 

Sirolimus-, Paclitaxel-, Zotarolimus-, and 

Everolimus-Eluting Stent Implantation in 

Small Coronary Target Vessels and 

Long Lesions 

Soon Jun Hong et al 

TCT-646. Primary Results Following 

Percutaneous Coronary Intervention with the 

38-mm Resolute Zotarolimus-Eluting Stent 

Shirish Hiremath et al 

TCT-647. Value of High-Density Lipoprotein 

Cholesterol in Predicting Future 

Cardiovascular Events of Patients with 

Low-Density Lipoprotein Cholesterol at the 

Time of Percutaneous Coronary Intervention 


TCT-648. Impact of Stent Structural Design 

and Deployment Pressure on Strut 

Apposition and Recoil 

Nicolas Foin et al 

TCT-649. Safety and Efficacy of Overlapping 

Second Generation Drug-Eluting Stents 

Based Upon Two-Year Clinical Outcomes: 

Results from the Pooled Analysis of Five 

Trials from the International Global 

RESOLUTE Program 

Vasim Farooq et al 

TCT-650. Impact of the New BioMime 

Sirolimus-Eluting Stent in Complex Patients 

of Daily Practice: Preliminary Results of the 

meriT-2 Study 

Erlon O. de Abreu-Silva et al 

TCT-651. Feasibility and Clinical Outcomes of 

< 38 mm Long Drug-Eluting Stent Treatment 

for Diffuse Coronary Artery Disease in 

Egyptian Population 

Mohamed Loutfi et al 


TCT-652. A Comparison of Drug-Eluting 

Stents in a Bench Artery Dissection Model 

Joseph Berglund et al 

TCT-653. Assessment of Endothelial Function 

in Patients Randomly Treated with a 

Polymer-Free Sirolimus-Eluting Stent and Its 

Bare Metal Equivalent: Results of the 

VESTASYNC II Trial 

Breno Almeida et al 

TCT-654. Comparison in the Five-Year 

Outcome of Pericardium and 

Polytetrafluoroethylene-Covered Stents for 

Saphenous Vein Graft Lesions 

Sandeep Basavarajaiah et al 

TCT-655. Outcomes of High-Risk Patients 


Interventions in the Ambulatory vs. 

In-Hospital Setting 

Mark Kahn et al 

TCT-656. Low Incidence of Stent Thrombosis 

in Asian Races: Multicenter Registry in Asia 

Seven-Year Follow-up Result 

Sunao Nakamura et al 

TCT-657. Multicenter, Prospective, 

Randomized, Single-Blind, Consecutive 

Enrollment Evaluation of Elixir DESyne 

Novolimus-Eluting Coronary Stent System 

with Durable Polymer to Endeavor 

Zotarolimus-Eluting Coronary Stent System: 

Three-Year Clinical and Nine-Month 

Angiographic and IVUS Results: 

EXCELLA II Study 

Stefan Verheye et al 

TCT-658. Do Drug Eluting Stents Improve 

Survival in All Comers? 

Tudor Vagaonescu et al 

TCT-659. Trends in Revascularization and 

Mortality for BMS and DES Coronary 

Stenting Procedures: A Medicare Study 

of 156,300 Patients 

Jasmine Patel et al 

TCT-660. Incidence and Predictors of Stroke 


Intervention in United States 

Vladimir Lakhter et al 

TCT-661. Clinical Relevance of Endothelial 

Dysfunction after Everolimus-Eluting Stent 

Implantation Compared to First Generation 

Drug-Eluting Stent 

Yoshifumi Nakajima et al 

TCT-662. One-Year Outcomes Following PCI 

in Patients with Asymptomatic CAD: 

A Report from the NHLBI Dynamic Registry 

Mohun Ramratnam et al 

TCT-663. A United Kingdom Perspective on 

the Appropriateness of Percutaneous 

Coronary Intervention in Stable Angina 

Benjamin J. Wrigley et al 


TranscaTheTer 


TherapeuTics 

TCT-664. Seven-Year Clinical Outcomes of 

Sirolimus-Eluting Stent vs. Bare-Metal Stent: 

A Matched Analysis from a Real-world 

Single-Center Registry 

Jin-Sung Lee et al 

TCT-665. Profile and Outcome of Very Late 

Bare Metal Stent Thrombosis Treated with 


Ivan Gomez Blazquez et al 

TCT-666. Long-term Prognosis of In-Stent 

Restenosis After Drug-Eluting Stent 

Implantation and Predictors of Recurrent 

Restenosis: Data from the ASAN DES-ISR 

Registry 

Won-Jang Kim et al 

TCT-667. Restenosis After Coronary Stenting 

in 10,004 Patients with Follow-up 

Angiography 


TCT-668. Everolimus-Eluting Stents vs. 

First-Generation Drug-Eluting Stents 

(Sirolimus or Paclitaxel) for Treatment of 

Drug-Eluting Stent In-Stent Restenosis 

Sachin S. Goel et al 

TCT-669. Incidence and Correlates of Stent 

Thrombosis up to 10 Years After 

Drug-Eluting Stent Implantation in 

Daily Clinical Practice 

Ricardo A. Costa et al 

TCT-670. Impact of Moderate and Severe 

Coronary Calcification on One-Year 

Outcomes After PCI with DES: 

A Pooled Analysis of 11,651 Patients 

from 14 Randomized Trials 

Philippe Généreux et al 

TCT-671. Drug-Eluting Stent Fracture: Guiding 

the Study of Today and Tomorrow’s Stent 

Designs with Yesterday’s Clinical 

Experiences 

Chad Abunassar et al 

TCT-672. Impact of Angiographical Lesion 

Complexity Score and In-Hospital Outcome 

After Percutaneous Coronary Intervention: 

Analysis from Japanese Multicenter Registry 

Ayaka Endo et al 

TCT-673. Drug-Eluting Stents vs. Bare Metal 

Stents for Saphenous Vein Graft Lesions: 

Meta-analysis of Randomized Trials 

Alban Dibra et al 

TCT-674. Implication of Periprocedural 

Biomarker Elevation After Stent Implantation: 

Analysis from the Pooled XIENCE V Trials 

Gregg W. Stone et al 



82 


Bioresorbable Vascular 

Scaffolds and 

Bioabsorbable Polymers 

TCT-563. Multicenter, First-in-Man Evaluation 

of the Myolimus-Eluting Bioresorbable 

Coronary Scaffold: Six-Month Clinical and 

Imaging Results 

Stefan Verheye et al 

TCT-564. Biodegradable-Polymer Biolimus 

Eluting Stents Show Better Antiproliferative 

Efficacy and Vascular Healing Pattern Than 

Permanent-Polymer Paclitaxel Eluting Stents 

in a Preclinical Coronary Model 

Armando Pérez De Prado et al 

TCT-565. NOYA I: A Prospective Randomized 

Trial of the Biodegradable Polymer NOYA 

Sirolimus-Eluting Stent Compared with the 

Durable Polymer FIREBIRD 2 Sirolimus- 

Eluting Stent in Patients with Coronary 

Artery Disease: Nine-Month Angiographic 

and 24-Month Clinical Results 

Kefei Dou et al 

TCT-566. SYNERGY Biodegradable Polymer 

Everolimus Eluting Coronary Stent: Porcine 

Vascular Compatibility and Polymer 

Safety Study 

Gregory J. Wilson et al 

TCT-567. Long-term Safety and Efficacy of 

Biodegradable Polymer-Coated Sirolimus- 

Eluting Stents in “Real-World” Practice: 

Five-Year Follow-up of the CREATE 

(Multicenter Registry of EXCEL 

Biodegradable Polymer Drug-Eluting 

Stents) Study 

Ya-Ling Han et al 

TCT-568. Real Polymer-Free Sirolimus- and 

Probucol-Eluting vs. Biodegradable Polymer 

Sirolimus-Eluting Stents for Obstructive 

Coronary Artery Disease: DKPLUS-Wave 1: 

A Multicenter, Randomized, Prospective Trial 

Shao Liang Chen et al 

TCT-569. Five-Year Clinical Outcomes of 

Biodegradable Polymer Biolimus-Eluting 

Stents vs. Durable Polymer Sirolimus-Eluting 

Stents in Patients With and Without Diabetes 

Mellitus: A LEADERS Substudy 

Axel Linke et al 

TCT-570. Stents with Absorbable Tissue- 

Deployable Coatings Can Distribute Drug 

More Uniformly Between Struts 

Abraham R. Tzafriri et al 

TCT-571. A Preliminary Study of 

Biodegradable Iron Stent in Mini-Swine 

Coronary Artery 

Chao Wu et al 

TCT-572. One-Year Preclinical Data on a Novel 

Drug-Eluting Stent with Amino Acid-Based 

Bioabsorbable Drug Carrier Mounted on an 

Integrated Delivery System (IDS) 

Jose Costa Jr et al 

TCT-573. Randomized Comparison of 

Biolimus-Eluting (Nobori) and Everolimus- 

Eluting (Xience/Promus) Stents in Patients 

with Multivessel Coronary Artery Disease: 

Twelve-Month Follow-up Data from 

COMPARE II Study 

Peter Smits et al 

TCT-574. Drug-Eluting Stent with 

Biodegradable Polymer in Patients with 

STEMI: Short- and Long-term Outcomes: 

Data from e-NOBORI and NOBORI 2 Trials 

Andres Iñiguez et al 

TCT-575. Different Vessel Healing Patterns 

Following Delivery of Everolimus and 

Paclitaxel Eluted from Biodegradable 

Polymer Coated Stents Implanted in Porcine 

Coronary Arteries 

Piotr P. Buszman et al 

TCT-576. COMPARE II: One-Year Clinical 

Data for the Treatment of Small 

Vessels (< 2.75mm) 


TCT-577. COMPARE II: One-Year Outcomes of 

a Large Randomized All-Comers Study 


TCT-578. First-in-Human Evaluation of a Novel 

Sirolimus-Eluting Stent with a Bioabsorbable 

Polymer for the Treatment of Single De Novo 

Noncomplex Coronary Lesions 

Erlon O. de Abreu-Silva et al 

TCT-579. One-Year Clinical Outcome of 

Biodegradable and Permanent Polymer 

Drug-Eluting Stents for Multivessel Disease 

or Long Lesion (< 28mm) in Patients with 

Stable and Unstable Angina 

Jun-Won Lee et al 

TCT-580. COMPARE II: One-Year Clinical Data 

of the Treatment of Long Lesions (> 20mm) 


TCT-581. Multislice Computed Tomography 

Angiography as a Noninvasive Angiographic 

and Functional Assessment of the 18-Month 

Performance of a Novel Radiolucent 

Bioresorbable Coronary Scaffolding Device 

(ABSORB Cohort B Trial) 

Patrick Serruys et al 

TCT-582. Eighteen-Month Clinical and 

Imaging Results from the DESSOLVE I 

First-in-Human Trial of the MiStent SES with 

Absorbable Polymer 

John A. Ormiston et al 

TCT-583. Multicenter, Prospective, 

Randomized, Single-Blind, Consecutive 

Enrollment Evaluation of Novolimus-Eluting 

Coronary Stent System with Bioabsorbable 

Polymer Compared to a Zotarolimus-Eluting 

Coronary Stent System: Twleve-Month 

Clinical and Six-Month Angiographic and 

IVUS Results: The EXCELLA BD Study 

Alexandre Abizaid et al 

TCT-584. Nine-Month Imaging and 12-Month 

Clinical Results from the DESSOLVE II 

Randomized Trial of the MiStent SES with 

Absorbable Polymer 

William Wijns et al 

Carotid and Neurovascular 

Disease and Intervention 

TCT-190. Use of Optical Coherence 

Tomography (OCT) for Characterization of 

Carotid Plaque in Patients with Severe 

Asymptomatic Carotid Stenosis 

Mehmet Cilingiroglu et al 

TCT-191. Percutaneous Transluminal 

Angioplasty and Stenting of Extracranial 

Vertebral Artery Stenoses 

Isabelle Henry et al 

TCT-192. Vertebral Angioplasty Stenting: 

Are Protection Devices Useful? 


TCT-193. Use of Drug-Eluting Balloon for the 

Treatment of In-Stent Restenosis After 

Carotid Artery Stenting 

Piero Montorsi et al 

TCT-194. Impact of Asymptomatic New 

Cerebral Lesions in DW-MRI After Carotid 

Artery Stenting on Long-term Prognosis 

Klaudija Bijuklic et al 

TCT-195. Novel Quantitative Virtual Histology 

Parameters in the Asymptomatic and 

Symptomatic Carotid Atherosclerotic Plaque 

Imaging: Data from the First 222 Patients in 

CRACK-VH Study 

Piotr Musialek et al 

TCT-196. Chronic Cerebrospinal Venous 

Insufficiency: The Association Between the 

Extent of Extracranial Venous Anomalies 

and Clinical Severity and Duration of 

Multiple Sclerosis 

Juraj Madaric et al 

TCT-197. Carotid Artery Stenting With or 

Without Predilatation, Protected, or 

Unprotected: Acute Results and 

Complications 

Alexander Kypta et al 

TCT-198. EuroScore Risk Model as Predictor 

of Early and One-Year Results After Carotid 

Artery Stenting and Carotid Endarterectomy 

Pavel Bolotov et al

TCT-199. The Transradial Approach Is Safe 

and Effective for Carotid Artery Stenting 

Sasko Kedev et al 

TCT-200. Endovascular Revascularization for 

Cerebral Ischemia in Takayasu Arteritis: 

Five-Year Experience 

Amar N. Patnaik et al 

TCT-201. Intravascular Ultrasound (IVUS) 

Validation of Noninvasive and Invasive 

Measures of Carotid Stenosis Severity in 

CARUS (Carotid Artery intravasculaR 

Ultrasound academic regiStry) 


TCT-202. Effect of Contralateral Occlusion on 

Index Internal Carotid Artery (ICA) Duplex 

Doppler Velocities: Quantitative Analysis 

Using Intravascular Ultrasound (IVUS) to 

Match Index ICA Stenosis Severity. 


TCT-203. Reproducibility of In Vivo Virtual 

Histology Intravascular Ultrasound 

Evaluation of the Carotid Atherosclerotic 

Plaque Using Novel Quantitative Parameters 


Cath Lab Advances 

TCT-314. A Bridging Solution for Hybrid 

Operating Suites: Periprocedural New 

Generation C-Arm Imaging During Cardiac 

Interventional Procedures 

Guy Friedrich et al 

TCT-315. A Hybrid Simulator for Femoral 

Artery Access Training 

Erhard Kaiser et al 

TCT-316. Radiation Dose Surveillance Using 

Automated, Remote-Site Dose Monitoring in 

Cardiac Catheterization Laboratories 

Across Asia-Pacific 

Punitha Arasaratnam et al 

TCT-317. Implementation of a Real-time Skin 

Dose Tracking System in a Cardiac 

Catheterization Laboratory 

Neil Dashkoff et al 

TCT-318. Contrast Agent and Radiation 

Exposure in Revascularisation of Chronic 

Coronary Total Occlusions: Magnetic 

Navigation vs. Conventional PCI 

Sabine Scherzer et al 

TCT-319. Improvement of Coronary Lesions 

Quantification with Rotational Angiography 

“XperSwing” 

Leire Unzue et al 

TCT-320. Rotational Angiography with 

“Xperswing” Technique: Comparative 

Analysis of Radiation Dose Compared to 

Conventional Angiography 



TCT-321. Rotational Angiography with 

Xperswing: Safety and Accuracy Compared 

to Conventional Angiography 


TCT-322. Radiation Exposure in 

Standard Views During Diagnostic 

Coronary Angiography 

Pranjal K. Boruah et al 

TCT-323. Preprocedural Fasting for Diagnostic 

and Interventional Coronary Procedures: 

Is It Neccessary? 

Tahir Hamid et al 

TCT-324. New Simulation System for 

Percutaneous Coronary Intervention Training 

Improves Resident Performance 

Makoto Hyodo et al 

TCT-325. Patients Skin Radiation Doses in a 

Contemporary Cohort of Patients 

Undergoing Percutaneous Interventional 

Cardiology Procedures 

Juan M. Nogales-Asensio et al 

TCT-326. The Occupational Effects of 

Interventional Cardiology Results from the 

WIN for Safety Survey 


TCT-327. Rotational Angiography with 3-D 

Reconstruction Following Motion Field 

Estimation for Evaluation of Geometry of the 

Implanted Medtronic CoreValve Frame: 

Comparison with MSCT 

Carl J. Schultz et al 

TCT-328. C-Arm Angiography (DYNA-CT) for 

3-D Coronary Reconstruction and 

Myocardial Perfusion Assessment 

Harald Rittger et al 

TCT-329. Effectiveness of Fluoroscopy-Save 

vs. Cinematography at Reducing Radiation 

Exposure During Diagnostic Coronary 

Angiography: A Randomized Controlled Trial 

Binita Shah et al 

TCT-330. The Effect of Automated Contrast 

Injection Systems on Contrast Volume Use 

During Diagnostic Coronary Angiography 

and Percutaneous Coronary Interventions 

Shahar Lavi et al 

TCT-331. Experience Is Associated with 

Shorter Procedure Time and Reduced 

Radiation with Robotic-Enhanced Coronary 

Intervention: Results from the PRECISE 

Multicenter Study 

Giora Weisz et al 

TCT-332. Validation of Transapical Access 

Accuracy of Computed Tomographic 

Angiography-Fluoroscopy Fusion-Guided 

Structural Heart Disease Interventions 

Bryce N. Einhorn et al 


TranscaTheTer 


TherapeuTics 

TCT-333. New Simulation System for 


Training: Rhythmically Beating 

Vascular Model 


TCT-334. Fusion of a Full-Scale Patient 

Simulator with an Endovascular Simulator to 

Improve Quality of Human Factors Training 

with Cath Lab Teams 

Erhard Kaiser et al 

TCT-335. MITOS Multimodality Imaging 

Operating System 

Andreas Melzer et al 

TCT-336. Patient-Specific Rehearsal 

Prior to Endovascular Aneurysm 

Repair: A Pilot Study 

Liesbeth M. Desender et al 

Chronic Kidney Disease and 

Acute Renal Insufficiency 

TCT-133. Role of Arterial Stiffness and 

Impaired Renal Function in the Progression 

of Nonculprit Coronary Lesions After 


Hidehiro Kaneko et al 

TCT-135. Contrast Use and Acute Kidney 

Injury in Contemporary Clinical Practice 


TCT-136. Impact of Preoperative Chronic 

Kidney Disease on Transcatheter Aortic 

Valve Implantation Outcome 

Nicolas Dumonteil et al 

TCT-137. Is Urinary Neutrophil Gelatinase- 

Associated Lipocalin the “Renal Troponin” in 

Invasive Cardiology? 

Tilman Perrin et al 

TCT-138. Veropaque: A Novel Contrast 

Formulation Mitigates Contrast-Induced 

Acute Kidney Injury 

Gerold Mosher et al 

TCT-139. Prognosis and Incidence of Acute 

Kidney Injury According to the Valve 

Academic Research Consortium After 


Marc Bedossa et al 

TCT-140. Trend of Clinical Outcomes in 

Patients with Chronic Kidney Disease and 

End-Stage Renal Disease Following 


James E. Lai et al 

TCT-141. Age, Glomerular Filtration Rate, 

Ejection Fraction, and the AGEF Score Are 

Predictors of Contrast-Induced Nephropathy 

(CIN) in Patients with ST-Elevation 

Myocardial Infarction (STEMI) 

Undergoing Primary PCI 

Giuseppe Ando et al 



84 


TCT-142. Association of Acute Kidney Injury 

with Mortality Post TAVR 

Elizabeth M. Holper et al 

TCT-144. Impact of Chronic Kidney Disease 

on Platelet Reactivity and Clinical Outcomes 

of Patients Undergoing Percutaneous 


Fabio Mangiacapra et al 

TCT-145. The Significance of VARC-Defined 

Acute Kidney Injury After Transcatheter 

Aortic Valve Implantation Using the 

Balloon-Expandable Edwards Bioprosthesis 

Muhammed Z. Khawaja et al 

TCT-146. The Effect of Drug-Eluting Stents on 

Clinical and Angiographic Outcomes in 

Renal Failure Patients with Dialysis: 

Multicenter Registry in Asia 


TCT-147. High-Dose Atorvastatin Pretreatment 

for Preventing Contrast-Induced 

Nephropathy in Patients Receiving Primary 


Prespecified Substudy of a Prospective 

Randomized Clinical Trial 

Hyun-Sook Kim et al 

TCT-148. Blood Transfusion and the Risk of 

Acute Kidney Injury Following Transcatheter 



TCT-149. Impact of Chronic Kidney Disease 

on Myocardial Infarct Size and Adverse 

Events in ST-Elevation Myocardial Infarction: 

Results from the INFUSE-AMI Trial 

Usman Baber et al 

TCT-150. Prognostic Value of Different 

Definitions of Contrast Induced Acute 

Kidney Injury in STEMI: Analysis from the 

HORIZONS-AMI Trial 

Rudolf Jarai et al 

Chronic Total Occlusions 

TCT-439. Incidence of Procedural 

Complications in Patients Undergoing 

Percutaneous Coronary Chronic Total 

Occlusion Interventions: A Systematic 

Review and Meta-analysis 

Vishal G. Patel et al 

TCT-440. Two-Year Clinical Outcomes of 

Primary Stenting of Totally Occluded Native 

Coronary Arteries III (PRISON III): A 

Randomized Comparison of Sirolimus- 

Eluting Stent Implantation with Zotarolimus- 

Eluting Stent Implantation for the Treatment 

of Total Coronary Occlusions 

Koen Teeuwen et al 

TCT-441. Enhanced Endothelial Tubule 

Formation in Response to Proly-Hydroxylase 

Inhibitor FG-2216: A Step Towards 

Therapeutic Angiogenesis in Chronic 

Total Occlusions 

Benjamin J. Wrigley et al 

TCT-442. The Impact of High Residual Platelet 

Reactivity After Clopidogrel Loading on 

Cardiac Mortality in Patients Treated by 

Percutaneous Coronary Intervention for 



TCT-443. Predictors of Reocclusion After 

Successful Drug-Eluting Stent Supported 

Percutaneus Coronary Intervention for 



TCT-444. Chronic Total Occlusion Lesion 

Revascularization Alone vs. Complete 

Revascularization in Chronic Total Occlusion 

Patients with Multivessel Disease 


TCT-445. Radial vs. Femoral Access for 

Percutaneous Coronary Interventions in 

Patients with Chronic Total Occlusion 


TCT-446. Long-Term Clinical Outcomes After 


Chronic Total Occlusions in Elderly Patients 

(< 75 years): Five-Year Outcomes from a 

1,791 Patient Multinational Registry 

Loes Hoebers et al 

TCT-447. Effects of Vibration on Frictional 

Resistance During Angioplasty Device 

Insertion: Possible Application of a Newly 

Designed Support System to Complex 


Satoru Sakamoto et al 

TCT-449. Short- and Long-term Clinical 

Outcomes of Chronic Total Occlusion 

Treatment with a Latest Generation 

Drug-Eluting Stent 

Alejandro Alcocer Chauvet et al 

TCT-450. Improvement in LV Systolic Function 

with Ischemia-Guided (Fractional Flow 

Reserve) Chronic Total Occlusion 

(CTO) Intervention 

Mayank Agrawal et al 

TCT-451. Application of the “Hybrid 

Approach” to Chronic Total Occlusion 

Interventions 

Tesfaldet T. Michael et al 

TCT-452. Drug-Eluting Stents for the 

Treatment of Chronic Total Occlusion: 

A Comparison with Sirolimus, Paclitaxel, 

Zotarolimus (Endeavor Resolute), 

BiolimusA9, EPC Capture and Everolimus- 

Eluting Stent: Multicenter Registry in Asia 


TCT-453. Serial Angiographic Follow-up After 

Successful Implantation of Sirolimus-, 

Paclitaxel-, Everolimus-, and Zotarolimus- 

Eluting Stents for Chronic Total Occlusions: 



TCT-454. Periprocedural Myocardial Infarction 

in Chronic Total Occlusion Percutaneous 

Coronary Interventions: A Systematic 

Cardiac Biomarker Evaluation Study 

Nathan Lo et al 

TCT-455. Coronary Chronic Total Occlusion 

Revascularization: Immediate Procedural 

Outcomes from a Multicenter US Registry 

Tesfaldet T. Michael et al 

TCT-456. Radial Approach to CTO 

Recanalisation Is as Successful and 

Safer Than Femoral: Single Centre 

Observational Study 

Solomon D. Asgedom et al 

Diabetic Patients 

TCT-337. Clinical Outcome of Diabetic and 

Nondiabetic Patients Treated with Second- 

Generation Zotarolimus-Eluting and 

Everolimus-Eluting DES 

Kenneth Tandjung et al 

TCT-338. Meta-analysis of Percutaneous 

Coronary Intervention vs. Coronary Artery 

Bypass Graft Surgery in Patients with 

Diabetes and Left Main and/or Multivessel 


Yu Jie Zhou et al 

TCT-339. Comparison of 12-month Clinical 

Outcomes in Patients with Chronic Total 

Occlusion (CTO) Lesion Between Diabetic 

and Nondiabetic: A Multicenter Study of 

e-CTO Investigators 

Cheol Ung Choi et al 

TCT-340. Efficacy and Safety of 

Biodegradable Polymer Biolimus-Eluting 

Stents vs. Durable Polymer Everolimus- 

Eluting Stents in Diabetic Patients: 

A Prospective Nonrandomized Single-Center 

Long-term Comparison 

Pierre Sprimont et al 

TCT-341. Impact of Chronic Statin Therapy on 

Development of Glucose Intolerance and 

New Onset Diabetes Mellitus in Asian 

Population 

Sang-Ho Park et al 

TCT-342. Impact of Diabetes Mellitus on 

Clinical Outcomes After Percutaneous 

Coronary Intervention with Drug-Eluting 

Stents for Unprotected Left Main 


Thierry Lefèvre et al

TCT-343. Paclitaxel Drug-Eluting Balloon vs. 

Standard Angioplasty to Reduce Restenosis 

in Diabetic Patients with In-Stent Restenosis 

of the Superficial Femoral and Proximal 

Popliteal Artery 

Francesco Liistro et al 

TCT-344. Importance of Optimal Reperfusion 

in Diabetic Patients Treated with Primary 


ST-Elevation Myocardial Infarction 

M.A. Velders et al 

TCT-345. Effect of Body Mass Index and 

Diabetes Mellitus on Angiographic 

Outcomes in Patients Undergoing Primary 

Percutaneous Coronary Intervention Using 

Different Drug-Eluting Stents 

Seiji Habara et al 

TCT-346. Clinical Impact of Five-Month 

Follow-up Glycosylated Hemoglobin on 

Cardiovascular Outcomes in Diabetic 

Patients with ST-Segment Elevation 

Myocardial Infarction Undergoing Primary 


Hye Won Lee et al 

TCT-347. Clinical Outcome of Biolimus-Eluting 

vs. Sirolimus-Eluting Coronary Stent 

Implantation In Patients With and Without 

Diabetes Mellitus: A SORT OUT V Substudy 

Michael Maeng et al 

TCT-348. The Effect of Drug-Eluting Stents on 

Clinical and Angiographic Outcomes in 

Diabetic Patients, Three-Years Results: 




Treatment of Small Coronary Artery with 

Diabetes Mellitus: A Comparison with 

Sirolimus, Paclitaxel, Zotarolimus (Endeavor 

Resolute), Biolimus A9, EPC Capture, and 

Everolimus-Eluting Stent: Multicenter 

Registry in Asia 



Treatment of Very Long Coronary Artery 

Stenosis with Diabetes Mellitus: 


Zotarolimus (Endeavor Resolute), Biolimus 

A9, EPC Capture, and Everolimus-Eluting 

Stent: Multicenter Registry in Asia 


TCT-351. The Obesity Paradox in Patients 

with Diabetes Mellitus After Percutaneous 

Coronary Intervention with Sirolimus-Eluting 

Stent: Comparison of De Novo and In-Stent 

Restenosis Lesions 

Yoshikazu Shigemoto et al 


TCT-352. Angiographic Features of 

Atherosclerotic Superficial Femoral Artery 

Disease in Diabetics and Nondiabetics 

Presenting with Claudication 

Atif Mohammad et al 

TCT-353. Long-term Outcomes of 

Biodegradable Polymer Drug-Eluting 

Stents vs. Durable Polymer Sirolimus-Eluting 

Stents in Patients with Diabetes: A Pooled 

Analysis of Individual Patient Data from 

the ISAR-TEST 4 and LEADERS 


Lamin King et al 

TCT-354. Plaque Excision Is an Effective 

Treatment Option for Diabetic Patients: 

Results from the DEFINITIVE LE Study 

Lawrence Garcia et al 

TCT-355. Coronary Stents in Patients with 

Diabetes Mellitus: The Diabetes and 

Drug-Eluting Stent (DiabeDES IV) 

Randomized Angiography Trial 


Drug-Coated Balloons 

TCT-585. Six-Month Results of the BIOLUX PI 

First-in-Man Study Comparing a Paclitaxel- 

Releasing Balloon Catheter vs. an Uncoated 

Balloon Catheter in Femoropopliteal Lesions 

Dierk Scheinert et al 

TCT-586. Impact of Restenosis Pattern on 

Angiographical Outcomes After Paclitaxel- 

Eluting Balloon Angioplasty for Drug-Eluting 

Stent Restenosis 

Shunsuke Kubo et al 

TCT-587. Drug-Coated Balloon for De Novo 

Coronary Lesions: Results from the 

Valentines II Trial 


TCT-588. Cost-effectiveness of Paclitaxel- 

Coated Balloon Angioplasty for Treatment of 

Coronary Restenosis in Bare-Metal Stents 

Klaus Bonaventura et al 

TCT-589. Reaching Further in the Treatment of 

Calcified Small Vessel Disease: Is Rota-DEB 

an Option? 

Paula Mota et al 

TCT-590. Efficacy of Paclitaxel-Eluting Balloon 

Catheter in Patients with Recurrences After 

Drug-Eluting Stent Implantation for In-Stent 

Restenosis 

Seiji Habara et al 


TranscaTheTer 


TherapeuTics 

TCT-591. Biological Efficacy and Vessel 

Healing of Second Generation Paclitaxel 

Coated Balloons: A Comparative Study with 

the Original PACCOCATH Technology in the 

Iliofemoral In-Stent Restenosis Model in the 

Familial Hypercholesterolemic Swine 


TCT-592. Familial Hypercholesterolemic Swine 

In-Stent Restenosis Model but Not 

Contemporaneous Injury Plus Treatment 

Model, Predicts Efficacy of Drug-Coated 

Balloon in Peripheral Arteries 

Maxwell E. Afari et al 

TCT-594. Efficacy and Safety of Drug-Eluting 

Balloon Compared to Drug-Eluting Stent for 

the Treatment of In-Stent Restenosis (ISR) 

Myung-Hyun Kim et al 

TCT-595. Pantera Lux Drug Coated Balloon: 

12-Month Results on 1,064 Patients of the 

International DELUX Registry 

Gert Richardt et al 

TCT-596. Pantera Lux Drug-Coated Balloon: 

12-Month Results on the Diabetics 

Subgroup of the International 

DELUX Registry 

Christoph Naber et al 

TCT-597. Acute Delivery and Long-term 

Retention of Sirolimus Nanoparticles Using a 

Novel Porous Angioplasty Balloon in the 

Porcine Coronary Model 


TCT-598. Luminal Fibrin as a Key Component 

in Mechanism of Action in Drug-Coated 

Balloon Technologies 


TCT-599. Angiographic and Clinical Outcome 

in the Treatment of Restenosis of Drug- 

Eluting Stents with Drug Coated Balloons 

in Diabetics: Insights from the PEPCAD- 

DES Study 


TCT-600. Angiographic and Clinical Outcomes 

of Paclitaxel Coated Balloon Angioplasty vs. 

Uncoated Balloon Angioplasty in Drug- 

Eluting Stent Restenosis: Insights from the 

PEPCAD-DES Study 


Endovascular Aortic Repair 

and Thoracic Endovascular 

Aortic Repair 

TCT-115. Hybrid Endovascular Repair for 

Aortic Arch Pathology: Intermediate 

Outcomes and Complications 

Woong Chol Kang et al 



86 


TCT-116. A New Concept oStent: The 

Multilayer Flow Modulator; First-in-Human 

Study in Thoracoabdominal and Abdominal 

Aortic Aneurysms 

Michel C. Henry et al 

TCT-117. Periprocedural and Follow-up 

Outcomes After Endovascular Abdominal 

Aortic Aneurysm Repair by Interventional 

Cardiologists 

Abhijeet Basoor et al 

TCT-118. Successful EVAR for Short-Necked 

Abdominal Aortic Aneurysms Using Balloon 

Expandable Stents by Interventional 

Cardiologists 

Abhijeet Basoor et al 

TCT-119. The Clinical Significance of Coronary 

Angiography in Elderly Patients Undergoing 

Endovascular Repair for Type B Aortic 

Dissection 

Pengcheng He et al 

TCT-120. The Policy of Total Percutaneous 

Abdominal Aortic Aneurysm Repair: 


Juraj Madaric et al 

TCT-121. Thoracic Aortic Pseudoaneurysm 

Following Endovascular Stent Graft 

Placement for Treatment of Type B 

Dissection: What Causes It? 

Rolf Alexander Janosi et al 

TCT-122. Endovascular Stent-Graft 

Implantation in Patients with Unstable Acute 

Intramural Hematoma: Is Endovascular 

Repair for Intramural Hematoma Over- 

Treatment or Suitable Treatment? 

Hyunmin Choi et al 

TCT-123. Initial Experience of Chimney 

Technique in Case of Aortic Arch Pathologies 

Involving the Supra-Aortic Branches 

Renat S. Akchurin et al 

TCT-124. Endovascular Repair of Abdominal 

and Iliac Aneurysm Repair with Preservation 

of Pelvic Flow 

Patick Kelly et al 

TCT-125. A Novel Antimicrobial-Bonded Aortic 

Graft for Aortic Graft Infection 

Ibrahim Aboshady et al 

TCT-126. Endurant US Pivotal Trial: 

Two-Year Outcomes 

Brij Maini et al 

TCT-127. The Impact of Later Generation 

Thoracic Aortic Stent Grafts as 

Demonstrated in the VALOR II Trial 

Zvonimir Krajcer et al 

TCT-128. Disruptive Endovascular Technology 

with Multilayer Flow Modulator Stents (MFM) 

as a Therapeutic Option in the Management 

of Thoracoaortic Aneurysms: Early Results 

from MFM Registry 

Sherif Sultan et al 

TCT-129. Contemporary Comparison of the 

Paradigm Shift in Rupture AAA Management; 

12-Year Experience in a Tertiary Referral 

Centre of Endovascular Repair of RAAA 

(REVAR) vs. Open Repair (OR) 

Sherif Sultan et al 

TCT-130. Clinical Efficacy and Cost per 

Quality-Adjusted Life Years with Pararenal 

Endovascular Aortic Repair (PEVAR) for 

Pararenal AAA Compared with Open 

Surgical Repair 

Niamh Hynes et al 

TCT-131. Cerebral Ischemia After Thoracic 

Endovascular Aortic Repair: A Diffusion- 

Weighted Magnetic Resonance 

Imaging Study 

Philipp Kahlert et al 

Gender, Age, and Other 

Demographic Considerations 

TCT-356. Circumferential Therapeutic 

Ultrasound for the Treatment of Resistant 

Hypertension: Preliminary Results of Human 

Feasibility Study (SOUND-ITV) 

Peter Neuzil et al 

TCT-357. Trends and Outcomes of Primary 

Percutaneous Coronary Intervention (PPCI) 

in Octogenarians Including a Comparison 

Between Radial and Femoral PPCI 

Strategies: A Single-Centre Experience 

Parisha Khan et al 

TCT-358. Food and Drug Administration 

Approved Cardiovascular Medical Devices: 

A 10-Year Review of the Participation of 

Women and Ethnic Subgroups 

Beverly Gallauresi et al 

TCT-359. Percutaneous Coronary Intervention 

In Octogenarians: Single, High-Volume, 

United Kingdom Center Experience 

Refai Showkathali et al 

TCT-360. Is There a Difference of Management 

for ST-Elevation Myocardial Infarction 

Regarding Gender? Myth or Reality? 

Data from a Prospective Registry 

of 5,000 Patients 


TCT-361. Gender-Based Analysis of 

Everolimus-Eluting Stent Safety in the 

Bern-Rotterdam Cohort 

Giulio G. Stefanini et al 

TCT-362. Incidence, Background, Treatment 

Strategies and the Prognosis in Very Elderly 

Patients with Acute Myocardial Infarction: 

From Japanese Multicenter Database 

Takafumi Yamane et al 

TCT-363. Safety and Long-term Outcomes 

After Percutaneous Coronary Interventions in 

Patients with Liver Disease: Report from the 

National Heart, Lung, and Blood Institute 

Dynamic Registry 

Oscar Marroquin et al 

TCT-364. Gender Related Disparity in 

Cardiovascular Risk Factors and 

Treatment Options 

Keyur Parikh et al 

TCT-365. Cardiovascular Screening in OB/ 

GYN Clinics for Early Identification and 

Referral of Women at Risk: Results from the 

Women’s Heart Health Initiative, an OB/GYN 

Screening Pilot Program 

Roxana Mehran et al 

TCT-366. Impact of Gender on Adverse 

Cardiac Events in Patients with Large 

Anterior Myocardial Infarction: Results from 

the INFUSE-AMI Trial 

Nilusha Gukathasan et al 

TCT-367. Gender Impact on Patients 

Treated with Drug-Eluting Stents: Three-Year 

Follow-up Data 

Fazilatum Nesa Malik et al 

TCT-368. Lower Socioeconomic Status 

Predicts Major Adverse Cardiac Events 

(MACE) and Increased Mortality Post- 

Percutaneous Intervention (PCI): 

Independent Hazard vs. Intersection of 

Modifiable Risk Factors? 

Sandeep Nathan et al 

TCT-369. Comparison of Target Lesion and 

Vessel Revascularization in Women of 

Different Age Groups After Percutaneous 

Coronary Intervention for Acute 

Coronary Syndrome 

Soha Ahmad et al 

TCT-370. Outcomes According to Sex 

Following Unprotected Left Main 

Stenting with Drug-Eluting Stents: 

The Milan Experience 


Heart Failure, LV Dysfunction, 

and Shock 

TCT-372. Coronary Artery Disease in Patients 

with Reduced Left Ventricular Systolic 

Function Treated with Medicine, Surgery, 

or Percutaneous Coronary Intervention: 

A Retrospective Review of Outcomes Within 

a Multicenter Health Care System 

Matthew LaBarbera et al 

TCT-373. Impact of Epicardial Fat Volume on 

Coronary Artery Disease in Symptomatic 

Patients with a Zero Calcium Score 

Tsuyoshi Ito et al

TCT-374. Long-term Survival and Neurological 

Outcome of In-Hospital Cardiac Arrest 

Patients Rescued by Extracorporeal 

Cardiopulmonary Resuscitation 

Jin-Ho Choi et al 

TCT-375. Optimizing Rotational Atherectomy 

in High-Risk Percutaneous Coronary 

Interventions: Insights from the 

PROTECT Study 

Mauricio G. Cohen et al 

TCT-376. SIMPLIPHieDE Study: Single-Center 

IMPella LVAD Supported PCI in High-Risk 

Group of Patients: Detroit Medical Center 

Experience: Clinical Outcomes 

Haroon Faraz et al 

TCT-377. Impact of New Onset Acute Heart 

Failure in Patients with Acute Myocardial 

infarction Underwent Successful 

Revascularization 

Keun-Ho Park et al 

TCT-378. Interim Analysis of the Reitan 

Catheter Pump (RCP) Heart Failure Efficacy 

Study: RCP Improves Cardiovascular and 

Renal Function in Acute Decompensated 

Heart Failure (ADHF) 

Thomas R. Keeble et al 

TCT-379. Percutaneous Transcatheter Aortic 

Valve Closure Successfully Treats Left 

Ventricular Assist Device-Associated Aortic 

Insufficiency and Improves Cardiac 

Hemodynamics 

Kishan S. Parikh et al 

TCT-380. Hemodynamic Effects of a 

Catheter-Deployed Intra-Aortic 

Micro-Axial Entrainment Pump in a 

Porcine Acute HF Model 

Joggy George et al 

TCT-381. First Report of Acute and Short-term 

Outcomes from a Confirmatory (Cohort B) 

Study of Percutaneous Ventricular 

Restoration (PVR) Therapy Using the 

Parachute Device in Patients with 

Ischemic Dilated Heart Failure 

Martyn Thomas et al 

TCT-382. Percutaneous and Surgical 

Circulatory Support for Medically Refractory 

Right Ventricular Failure with a Centrifugal- 

Flow Pump 

Navin K. Kapur et al 

TCT-383. Transcutaneous-Powered 

Electrohydraulic Counterpulsation System 

for Ambulatory Nonobligatory Chronic 

Heart Failure Treatment 

William E. Cohn et al 


TCT-384. The Coronary Sinus Reducer: A 

Device-Based Therapy for Refractory 

Angina: Interim Safety Results of the 

Ongoing COSIRA Clinical Trial and Efficacy 

Results of the CS Reducer Registry 

Shmuel Banai et al 

TCT-385. Comparative Economic Outcomes in 

Cardiogenic Shock Patients Managed with 

the Minimally Invasive Impella or 

Extracorporeal Life Support 

Anson Cheung et al 

TCT-386. Predictors of In-Hospital Mortality in 

Patients Undergoing Pericardiocentesis in 

United States 

Paul L. Hermany et al 

TCT-387. Short- and Long-term Outcomes of 

Coronary Revascularization in Patients with 

Severe Left Ventricular Dilatation 

Nie Shaoping et al 

TCT-388. Multislice Computer Tomography 

Analysis of Percutaneous Ventricular 

Restoration (PVR) Using the Parachute 

Device in Patients with Heart Failure Post 

Anterior Wall Myocardial Infarction: 

First-in-Man Experience 

Hiram Bezerra et al 

TCT-389. Acute and Six-Month Clinical and 

Echocardiographic Outcomes of the 

First-in-Human Experiences with the 

Implantation of a Novel Catheter-Based 

Ventricular Partitioning Device in Patients 

with Ischemic Heart Failure and Dilated 

Left Ventricle 

Marco Costa et al 

TCT-390. Outcome of the Impella Device for 

Acute Mechanical Circulatory Support 

Anthony Lemaire et al 

TCT-391. Selected CD133+ Endothelial 

Progenitor Cells to Create Angiogenesis in 

No-Option Patients: Preliminary Results of 

Safety and Feasibility 

Pilar Jimenez-Quevedo et al 

Imaging 

TCT-241. Value of Optical Coherence 

Tomography Beyond the Napkin Ring Sign in 

CT Angiography for Detecting Coronary 

Lipid-Core Plaques as Determined by 

Histology: A Multimodality Imaging Study in 

Human Donor Hearts 

Christopher L. Schlett et al 

TCT-242. Accuracy of Optical 

Coherence Tomography Measurement 

Compared to Intravascular Ultrasound: 

OPUS-CLASS Study 

Takashi Akasaka et al 


TranscaTheTer 


TherapeuTics 

TCT-243. Comparison of Neointimal Coverage 

of Everolimus-Eluting Stents and Sirolimus- 

Eluting Stents: Optical Coherence 

Tomography Subanalysis from the 

RESET Trial 


TCT-244. Impact of Intensive Statin Therapy 

on Plaque Characteristics as Assessed by 

Serial Optical Coherence Tomography 


TCT-245. Impact of Statin Therapy on Plaque 

Microstructures on Optical Coherence 

Tomography 

Yu Kataoka et al 

TCT-246. Comparison of Intravascular 

Ultrasound vs. Angiography-Guided 

Drug-Eluting Stent Implantation: 

A Meta-analysis of Randomized 

Trials and Observational Studies 

Involving 17,570 Patients 

Yaojun Zhang et al 

TCT-247. Incidence and Characterization of 

Stent Dissections in Women vs. Men: 

A Report from the Massachusetts 

General Hospital Optical Coherence 

Tomography Registry 

Magdalena A. Zeglin-Sawczuk et al 

TCT-248. Early and Late Stent Thrombosis: 

Different Clinical Entities? IVUS Findings 


TCT-249. Different Optical Coherence 

Tomography Neointimal Tissue Appearance 

of Drug-Eluting Stent Restenosis After 


Satoko Tahara et al 

TCT-250. Predictors of In-Stent Restenosis by 

Optical Coherence Tomography Derived 

Tissue Characterization in the Novel In-Stent 

Neointimal Hyperplasia Model of Familial 

Hypercholesterolemic Swine 


TCT-251. Impact of Plaque Composition 

Assessed by iMap-intravascular Ultrasound 

on Elevation of High Sensitive Cardiac 

Troponin T After Percutaneous Coronary 

Intervention 

Seiji Koga et al 

TCT-252. Impact of Prediabetic Status on 

Coronary Atherosclerosis: A Multivessel 

Angioscopic Study 

Osamu Kurihara et al 

TCT-253. Patient and Lesion Characteristics 

of Peripheral Artery Disease Concomitant 

with Coronary Artery Disease: Insights 

from Virtual Histology Intravascular 

Ultrasound Analysis 

Daisuke Ogasawara et al 



88 


TCT-254. Epicardial Fat Volume and Coronary 

Plaque Characteristics 

Kennosuke Yamashita et al 

TCT-255. Peri-Strut Low Intensity Areas 

Identified by Optical Coherence Correlated 

with the Degree of Neointimal Formation 

After Three-Years Following Stent 

Implantation in Humans 


TCT-256. Evaluation of Coronary Arterial 

Calcification Using Ex Vivo Imaging by 

Optical Frequency Domain Imaging 

Takeshi Ijichi et al 

TCT-257. Angioscopy Study from a Large 

Patient Population Comparing Sirolimus- 

Eluting Stent with Biodegradable vs. 

Durable Polymer 

Shao Liang Chen et al 

TCT-258. Impact of the Type of the Underlying 

Plaque on the Neointima Tissue Developed 

After a Bioresorbable Scaffold Implantation: 

A Serial Optical Coherence Tomography 

Study 

Christos V. Bourantas et al 

TCT-259. Impact of Stent Edge Plaque Burden 

on Lumen Preservation After DES 

Implantation: A 3-D IVUS Analysis from the 

J-DESsERT Trial 

Hideki Kitahara et al 

TCT-260. Coronary Artery Plaque Regression 

and Change in Plaque Composition 

Associated with Statin Therapy Extend for a 

Long-term: Results from the Extended 

TRUTH Study 

Tsuyoshi Nozue et al 

TCT-261. Five-Year Clinical Outcomes of the 

OLIVUS-Ex (Impact of OLmesartan on 

progression of coronary atherosclerosis: 

Evaluation by IntraVascular UltraSound 

Extension) Trial 

Atsushi Hirohata et al 

TCT-262. Effect of Statin Pretreatment on the 

Morphology of Coronary Culprit Plaques in 

Patients with Stable Angina Pectoris: 

An Intravascular ultrasound and Optical 

Coherence Tomography Study 

Kenichiro Saka et al 

TCT-263. Coronary Evaginations Are Caused 

By Positive Vessel Remodeling and Are 

Nearly Absent Following Implantation of 

Newer-Generation Drug-Eluting Stents: 

An Optical Coherence Tomography and 

Intravascular Ultrasound Study 

Maria D. Radu et al 

TCT-264. Relation Between Peak High 

Sensitivity CRP Levels Before Coronary 

Angiography and Culprit Lesion Morphology 

in Non-ST-Segment Elevation Acute 

Coronary Syndrome: An Optical Coherence 

Tomography Study 

Kenichiro Saka et al 

TCT-265. Combination of Large Plaque 

Burden and Low Wall Shear Stress Results 

in Greater Progression of Coronary 

Atherosclerosis than Low Wall Shear 

Stress Alone in Patients with Coronary 


Michel T. Corban et al 

TCT-266. Frequency of Spotty Calcification 

Among Lipid-Core Plaques Using Combined 

Intracoronary Near-Infrared Spectroscopy 

and Intravascular Ultrasound 

Ryan D. Madder et al 

TCT-267. Comparison of Coronary Plaque 

Components Between Nonculprit Lesion 

in Patients with Acute Coronary Syndrome 

and Target Lesion in Patients with Stable 

Angina: Virtual Histology-Intravascular 

Ultrasound Analysis 

Young Joon Hong et al 

TCT-268. Incidence and Predictors of Tissue 

Prolapse After Percutaneous Coronary 

Intervention for Saphenous Vein Graft 

Disease: Intravascular Ultrasound Study 

Young Joon Hong et al 

TCT-271. Stent Thrombosis After Intravascular 

Ultrasound-Guided Stent Implantation 

Yoshihide Fujimoto et al 

TCT-272. The Role of Macrophage 

Accumulations on Bare Metal Stent Failure 

Presenting with Acute Coronary Syndrome: 

Observation by Optical Coherence 

Tomography 

Yuetsu Kikuta et al 

TCT-273. Serial Evaluation of Peri-Strut Low 

Intensity Area on Optical Coherence 

Tomography After Drug-Eluting 

Stents Implantation 

Eui Im et al 

TCT-274. Relationship Between Arterial 

Remodeling, Fibrous Cap Thinning and Lipid 

Accumulation: A Serial Integrated 

Backscatter Intravascular Ultrasound and 

Optical Coherence Tomography Study 

Teruyoshi Kume et al 

TCT-275. The Evolution of Thin-Capped 

Fibroatheroma in Left Main Coronary Artery 

As Assessed by Serial Virtual Histology 

Intravascular Ultrasound Analysis 

Sang-Wook Kim et al 

TCT-276. Culprit Lesion Phenotype May 

Depend on Lesion Location in Patients with 

ST-Elevation Acute Myocardial Infarction: 

TAMI-R Study 

Sang-Wook Kim et al 

TCT-277. High Level of Copeptin in ST- 

Elevation Acute Myocardial Infarction 

Patients Is Associated with In-Hospital 

Mortality and Plaque Rupture: 

TAMI-COP Study 

JeeEun Kwon et al 

TCT-278. Two-Year Clinical Impact of 

Postprocedural Incomplete Stent Apposition 

and Late Acquired Incomplete Stent 

Apposition After Deployment of Zotarolimus 

Eluting Stent or Everolimus Eluting Stent 

Sang-Rok Lee et al 

TCT-279. Characterization of Plaque Removed 

by Rotational Atherectomy 

Paula Mota et al 

TCT-280. Acute and Long-term Prognostic 

Impact of Attenuated Plaque in Patients with 

Acute Coronary Syndrome 

Hiroyuki Okura et al 

TCT-281. The Association Between 

Cholesterol Crystal and Features of Plaque 

Vulnerability on Optical Coherence 

Tomography 

Yu Kataoka et al 

TCT-282. The REMEDEE OCT Study: A 

Prospective Randomized Study of the Early 

Vascular Healing of a Novel Dual Therapy 

Stent in Comparison with an Everolimus- 

Eluting Stent 

Ulf Landmesser et al 

TCT-283. Intimal Hyperplasia and Vascular 

Remodeling After Everolimus-Eluting and 

Sirolimus-Eluting Stent Implantation in 

Diabetic Patients: The Randomized Diabetes 

and Drug-Eluting Stent (DiabeDES) IV 

Intravascular Ultrasound Trial 

Lisbeth Antonsen et al 

TCT-284. Significant Correlation Between 

Coronary and Carotid Atherosclerotic Plaque 

Components by Intravascular Ultrasound 

Virtual Histology in Patients with 

Generalized Atherosclerosis 

Dace Sondore et al 

TCT-285. Frequency and Type of 

Neoatherosclerosis Five Years After 


An Optical Coherence Tomography Study 

Masanori Taniwaki et al 

TCT-286. Characteristics of OCT Findings for 

Lesions Avoiding Onset of AMI 

Hiroshi Ishimori et al

TCT-288. Impact of the Prevalence of 

Diabetes Mellitus on Coronary Plaque 

Vulnerability Assessed by Integrated 

Backscatter Intravascular Ultrasound 

Iwata Atsushi et al 

TCT-289. Clinical Feasibility of Higher- 

Frequency IVUS for Quantitative 

Measurements of Native Coronary Lesions: 

First-in-Human Experience with 60 MHz vs. 

40 MHz IVUS Imaging 

Ching-Chang Huang et al 

TCT-290. Vascular Tissue Reaction to Acute 

Malapposition in Human Coronary Arteries: 

Sequential Assessment with Optical 

Coherence Tomography 

Juan Luis Gutiérrez-Chico et al 

TCT-291. Detection of Thin and Thick Fibrous 

Caps Overlying Lipid Core Coronary Plaques 

with a Catheter-Based Near-Infrared 

Spectroscopy System 

Sean Madden et al 

TCT-292. Evaluation of Neointimal Healing and 

Late Luminal Loss of Endothelial Progenitor 

Cell Capturing Sirolimus-Eluting (COMBO) 

Stent by Optical Coherence Tomography: 

The EGO-COMBO Study 

Stephen Wai Luen Lee et al 

TCT-293. Neointimal Tissue Characteristics 

Based on Optical Coherence Tomography 

Analysis Following Paclitaxel Coated 

Balloon Treatment in a Porcine Iliofemoral 

Vascular Territory 


TCT-294. Temporal Course of Vessel Healing 

After Everolimus-Eluting Stent Implantation 

Hiromasa Otake et al 

TCT-295. Neointimal Growth Pafter Between 

Biodegradable Polymer Biolimus-Eluting or 

Permanent Polymer Everolimus-Eluting Stent 

Implantation Assessed with Newly 

Developed “Spread Out Neointimal 

Topography:” Results from 

ISAR-TEST 6 OCT Trial 

Tomohisa Tada et al 

TCT-296. Comparison of Zotarolimus-Eluting 

Stents vs. Everolimus-Eluting Stents vs. 

Sirolimus-Eluting and in Patients with Long 

Coronary Artery Lesions Assessed by 

Volumetric Intravascular Ultrasound Analysis 

Young-Rak Cho et al 

TCT-297. Stent Edge Dissections Detected by 

Optical Coherence Tomography, Incidence, 

Predictors, and 12-Month Outcomes 

Rasmus D. Christensen et al 

TCT-300. Differential Prognostic Impact of 

Intravascular Ultrasound Utilization 

According to Implanted Stent Length 

Jeong Yoon Jang et al 


TCT-301. Feasibility and Results of Novel Side 

Branch Evaluation by Reconstructed 3-D 

Optical Coherence Tomography: Matched 

Analysis of Baseline and 12-Month 

Follow-up in Native, Jailed, and 

Opened Side Branches 

Niels R. Holm et al 

TCT-302. Evaluation of the Novel DESolve 

Myolimus-Eluting Bioresorbable Coronary 

Scaffold System for Treatment of De Novo 

Coronary Arteries: Six-Month Optical 

Coherence Tomography Results from the 

DESolve FIM Trial 

Daniel Chamié et al 

TCT-303. Predictors of Acute and Late 

Persistent Stent Malapposition After 


A Follow-up Optical Coherence 


Eui Im et al 

TCT-304. Neoatherosclerosis and Impaired 

Vascular Healing Are Associated with 

Clinical Presentation Late After Coronary 

Stent Implantation: An Optical Coherence 


Antonios Karanasos et al 

TCT-305. Correlation Between Predicted to 

Observed Coronary Drug-Eluting Stent (DES) 

Expansion as Determined by Intravascular 

Ultrasound (IVUS): Variance Between 

Stent Platforms and Impact of Lesion 

Characteristics 

Sandeep Nathan et al 

TCT-306. Intravascular Ultrasound Findings in 

Complex Coronary Bifurcation Lesions 

Treated with Single Stenting vs. Double 

Stenting Strategies 


TCT-307. Comparison of Optical Coherence 

Tomography and Intravascular Ultrasound 

Imaging for Left Main Stenting 

Thibault Lhermusier et al 

TCT-308. Intravascular Ultrasound-Guided 

Everolimus-Eluting Stent Implantation 

Resolves the Disadvantage of Thin-Strut 

Cobalt Chromium Platform in Diabetes: 

Comparison of Three Different Type 

Platform Stents 

Hachidai Takahashi et al 

TCT-309. Correlation Between Fractional Flow 

Reserve and Intravascular Ultrasound in 

Patients with Isolated Ambiguous Left 

Main Stenosis 

Jacek Legutko et al 

TCT-310. Plaque Neovascularization 

Correlates with Thermal Heterogeneity as 

Measured by Microwave Radiometry 

Konstantinos Toutouzas et al 


TranscaTheTer 


TherapeuTics 

TCT-311. Rate of Plaque Negative to Plaque 

Positive Conversion in Patients by Serial 

64-Slice Computed Tomography Coronary 

Angiography (CTCA) 

Laurn Contreras et al 

TCT-312. Coronary Plaque Regression by 

64-Slice Computed Tomography Coronary 

Angiography (CTCA): Pipe Dream or 

Real Possibility 

Laurn Contreras et al 

TCT-313. Incidence and Morphologic 

Characteristics of Plaques That Evolve into 

Culprit Lesions: A Coronary CT Angiography 

Natural History Study 

James L. Smith et al 

Left Main Stenting 

TCT-693. Impact of the Syntax Score on the 

Outcome of the Left Main After Drug-Eluting 


Klaus Tiroch et al 

TCT-694. Clinical and Angiographical 

Outcomes of Percutaneous Coronary 

Intervention with Triple Kissing 

Balloon Technique After Drug-Eluting 

Stent Implantation for Left Main 

Trifurcation Disease 

Shunsuke Kubo et al 

TCT-695. Single vs. Double Stenting 

for the Left Main Coronary Bifurcation: 

A Systematic Review and Meta-Analysis 

Wassef Karrowni et al 

TCT-696. Impact of Bifurcation Angle on Major 

Cardiac Events After Cross Over Single 

Stent Strategy In Unprotected Left Main 

Bifurcation Lesion: 3-D Quantitative 

Coronary Angiographic Analysis 

Kisaki Amemiya et al 

TCT-697. Provisional Side Branch Stenting 

for 1.1.1 Distal Left Main Percutaneous 



TCT-699. Comparison of Transradial Coronary 

Intervention vs. Coronary Artery Bypass 

Grafting for Unprotected Left Main Disease 

in Patients with Acute Coronary Syndrome 

Yu Jie Zhou et al 

TCT-700. A Systematic Review and Metaanalysis 

of Ostial and Trunk vs. Distal 

Lesions in Unprotected Left Main 

Coronary Artery Stenting 

Wassef Karrowni et al 


Unprotected Left Main Stenting with 

First- vs. New-Generation Drug-Eluting 

Stents: The FINE Registry 




90 


TCT-702. The Impact of Pre- and Post- 

Dilatation on Stent Deformity After Single 

Stenting and Kissing Balloon Technique in a 

Large Left Main Bifurcation Model: Insights 

from In Vitro Bench Testing 

Takenori Domei et al 

TCT-703. Comparison of Five-Years Clinical 

Outcome of Drug-Eluting Stent Implantation 

in High-Angled Bifurcation and Narrow- 

Angled Bifurcation Lesion of Unprotected 

Left Main Coronary Arteries 


TCT-704. Short- and Long-term Clinical 

Outcomes of Left Main Treatment with a 

Latest Generation Drug-Eluting Stent 

Bernard Chevalier et al 

TCT-705. A Comparison of Clinical Outcomes 

in Patients with Left Main Disease Treated 

with CABG vs Drug-Eluting Stents: 

A Single-Center Experience 

Daniel A. Zanuttini et al 

TCT-706. Dedicated Bifurcation Optimization 

Stent System BiOSS in Distal Left Main 

Bifurcation Stenosis: First-in-Human 

Results: Data from BIOSS Registry 

(Poland and Bulgaria) 

Alexander Alexandrov et al 


Treatment of Left Main Coronary Artery 

Disease with Bifurcated Lesions: 


Zotarolimus (Endeavor Resolute), Biolimus 

A9, EPC Capture, and Everolimus-Eluting 

Stent: Multicenter Registry in Asia 


TCT-708. Long-term Effectiveness and Safety 

of Triple vs. Dual Antiplatelet Therapy After 


Unprotected Left Main Coronary 


Hyun Jong Lee et al 

TCT-709. Predictors of Main Branch 

Restenosis Following Drug-Eluting Stent 

Implantation in Patients with De Novo 

Unprotected Distal Left Main Bifurcation 

Coronary Lesions: The MIlan and New- 

TOkyo (MITO) Registry 

Kensuke Takagi et al 

TCT-710. Prognostic Impact of Left Main 

Coronary Artery Revascularization in 

Multivessel Coronary Artery Disease 

Jung-Min Ahn et al 

Mitral Valve Disease 

and Intervention 

TCT-779. Acute Severe Mitral Regurgitation 

Following Balloon Mitral Valvotomy: 

Echocardiographic Features, Operative 

Findings, and Outcome in 50 Surgical Cases 

Manjunath C. Nanjappa et al 

TCT-780. Baseline Systolic Left Ventricular 

Function Determines Hemodynamic 

Adaptation Following Percutaneous 

Mitral Valve Repair: Assessment by 

Conductance Catheter 

Volker Rudolph et al 

TCT-781. Concept of the Central Clip: 

When to Use One or Two MitraClips 

Eduardo Alegria et al 

TCT-782. Immediate Reduction of RT3D Color 

Doppler Vena Contracta Area After 

Transcatheter Mitral Leaflet Repair: 

Influence of the EVEREST Criteria 

Bjoern Plicht et al 

TCT-783. Successful MitraClip Therapy in 

Elderly Patients Not Amenable to Surgery: 

Serial Assessment of Echocardiographic 

and Clinical Variables Out to Two Years 

Michael Schlueter et al 

TCT-784. Prognostic Implications of Moderate 

and Severe Mitral Regurgitation in 

Contemporary Clinical Care 

Ajay Sinhal et al 

TCT-785. Single-Center Experience in 

Transcatheter Paravalvular Leak Closure: 

Procedural Success and Long-term 

Follow-up 

Reda Ibrahim et al 

TCT-786. Cost-effectiveness of the MitraClip 

Compared with Mitral Valve Surgery: 

12-Month Results from the EVEREST II 

Randomized Controlled Trial 

Matthew R. Reynolds et al 

TCT-787. Effectiveness of Transcatheter Mitral 

Valve Repair in Degenerative Mitral 

Regurgitation in High Surgical Risk Patients 

D. Scott Lim et al 

TCT-788. The EVEREST II Randomized 

Controlled Trial (RCT): Three-Year Outcomes 

Ted Feldman et al 

TCT-789. Optimizing Plugs Size for 

Transcatheter Paravalvular Leak Closure with 

Amplatzer Vascular Plug III Devices 

Piotr Pysz et al 

TCT-790. Prediction of Long-term Clinical 

Outcome According to the Etiology of Mitral 

Regurgitation in Patients Undergoing 

MitraClip Therapy 

Volker Rudolph et al 

TCT-791. Percutaneous or Surgical Repair for 

Functional Mitral Regurgitation: 

Comparison of Patient Characteristics 

and Clinical Outcomes 

Lenard Conradi et al 

TCT-792. Mitral Inflow Patterns at Rest and 

During Exercise Following MitraClip 

Implantation 

Kirsten Boerlage-van Dijk et al 

TCT-793. Effects of Preoperative Tricuspid 

Regurgitation on Mitral Regurgitation 

Treatment with the MitraClip Device in 

High-Risk Patients 

Maurizio Taramasso et al 

TCT-794. Percutaneous Closure of 

Paravalvular Mitral Prosthetic Regurgitation 

with AVPIII Device 


TCT-795. Procedural Success Is Improved 

with a Second MitraClip Placement Without 

Additional Complications 

Takashi Matsumoto et al 

TCT-796. The MitraClip Procedure for 

Functional Mitral Regurgitation Results in a 

Significant Change in Procedural 

Hemodynamics 

Wen Loong Yeow et al 

TCT-797. Transcatheter Mitral Valve-in-Valve/ 

Valve-in-Ring Implantations for Degenerative 

Post-Surgical Valves: Results from the 

Global Valve-in-Valve Registry 


TCT-798. The 3C-HF as a New Predictor of 

Outcomes After MitraClip 

Francesco Maisano et al 

TCT-799. MitraClip Feasibility and Efficacy in 

the Contest of Unfavorable Valve Anatomy 

Nicola Buzzatti et al 

Peripheral Vascular Disease 


TCT-151. Endovascular Intervention in 

Patients with Critical Limb Ischemia in 

Taiwan: Patient Outcomes in 333 

Consecutive Limb Procedures with 

a Six-Year Follow-up 

Hsuan Li Huang et al 

TCT-152. Impact of Body Surface Area on 

Outcomes in Patients with Lower Extremity 

Peripheral Arterial Disease 

Alix J. Tercius et al 

TCT-153. Renal Artery Aneurysms: First 

Human Treatment with the Multilayer 

Flow Modulator 


TCT-154. The Multilayer Flow Modulator Stent 

for the Treatment of Popliteal Aneurysm 

Michel C. Henry et al

TCT-155. A New Concept of Stent: The 

Multilayer Flow Modulator: First Human 

Study In Peripheral and Visceral Aneurysms 


TCT-156. Renal Angioplasty and Stenting: 

Limitations and Role of Embolic 

Protection Devices 


TCT-157. Increased Local Cytokine Production 

at Culprit Superficial Femoral Artery Plaques 

Cameron Donaldson et al 

TCT-158. Impact of Subclinical Peripheral 

Arterial Disease Severity on Middle and 

Long-term Outcomes in Patients with 

ST-Elevation-Myocardial Infarction 

Daniel E. Monopoli et al 

TCT-159. Effects of PRT-201, a Recombinant 

Human Type I Pancreatic Elastase, 

Treatment on the Elastin Content and 

Compliance of Atherosclerotic Tibial Arteries 

Following Ex Vivo Angioplasty 

Steven K. Burke et al 

TCT-160. Effects of PRT-201, a Recombinant 

Human Type I Pancreatic Elastase, 

Treatment on the Elastin Content and 

Compliance of Atherosclerotic Tibial Arteries 

Using a Perfusion Myograph 

Steven K. Burke et al 

TCT-161. Long-term Effect of Transcatheter 

Intraarterial Administration of Bone Marrow 

Mononuclear Cells in Patients with Critical 

Limb Ischemia 

Jean-Claude M. Lubanda et al 

TCT-162. Distal Embolization and Protective 

Devices: Mortality, Operating Room Time, 

Length of Stay, and Costs 

Eric J. Dippel et al 

TCT-163. Drug-Eluting Balloon for Below-the- 

Knee Angioplasty: One-Year Results from a 

Single-Center DEB-BTK Registry 

Grigore Popusoi et al 

TCT-164. Below-the-Knee Drug-Eluting 

Stents Have Improved Patency, and 

Symptoms Compared to Bare Metal 

Stents: A Meta-analysis 

Alexandre M. Benjo et al 

TCT-165. Evaluation of Long-term Vascular 

Responses to Fluorocopolymer coated 

Self-Expanding Low-Dose Paclitaxel-Eluting 

Stent in Porcine Iliofemoral Model 

Dongming Hou et al 

TCT-166. Association Between Leg Wound 

Site and Prognosis of Hemodialysis Patients 

with Critical Limb Ischemia After Isolated 

Infrapopliteal Balloon Angioplasty 

Masatsugu Nakano et al 


TCT-167. Clinical and Angiographic Outcome 

About External Iliac Artery: Internal Iliac 

Artery Bifurcation Lesion Which Jailed IIA 

Comparison Between Crossover Stenting 

Strategy and Noncrossover Stenting 

Takuro Takama et al 

TCT-168. Patency Rates of Intraluminal vs. 

Device Assisted Subintimal Endovascular 

Revascularization of the Chronic Total 

Occlusion in the Superficial Femoral Artery 

Anvar Babaev et al 

TCT-169. E-MISAGO: The Largest Ongoing 

Real Life Registry of Misago SX Nitinol Stent 

in Daily Use: Clinical Outcome at One Year 

Johannes Ruef et al 

TCT-170. Vascular Injury Influences Drug 

Transfer and Vessel Healing Following 

Paclitaxel-Coated Balloon Delivery in the 

Peripheral Arteries of Swine 


TCT-171. Paclitaxel Balloon Delivery Results 

in Homogeneous In-Stent Neointimal 

Distribution and Reduction of Stent Edge 

Stenosis Progression in the Peripheral 

Swine Model 


TCT-172. Drug-Coated Balloon for Peripheral 

Arteries: Results from Preclinical 

Experiments Using the Freeway DCB 

Rembert Pogge Von Strandmann et al 

TCT-173. Bare-Nitinol Stent vs. Paclitaxel- 

Coated Balloon for Femoropopliteal 

Revascularization: An Adjusted Indirect 

Comparison Meta-analysis of 



TCT-174. EPIC Nitinol Stent Treatment of Iliac 

Artery Lesions: 12-Month Outcomes in the 

ORION Study 

Daniel Clair et al 

TCT-175. Optimal Antiplatelet Regimen for 

Critical Limb Ischemia Due to Pure Isolated 

Infrapopliteal Lesions 

Junichi Tazaki et al 

TCT-176. Recanalization of Infrapopliteal 

Chronic Total Occlusions in Critical 

Limb Ischemia 

Gagan D. Singh et al 

TCT-177. Controlled Paclitaxel Delivery to the 

Peripheral Vasculature with the TAPAS Drug 


Mehdi Shishehbor et al 

TCT-178. Impact of Varying Injury Severity and 

Multiple Treatments on Arterial 

Histopathology Early After Paclitaxel-Coated 

Balloon Treatment of the Iliofemoral Arteries 

of Domestic Swine 



TranscaTheTer 


TherapeuTics 

TCT-179. Procedural and Clinical Outcomes 

After Endovascular Intervention for 

Femoral-Tibial Graft Stenosis 

Christopher Balwanz et al 

TCT-180. Mid-term Outcomes Following 

Endovascular Intervention for Iliac Artery 


Usman Javed et al 

TCT-181. Totally Occluded In-Stent 

Restenosis After Superficial Femoral Artery 

Stenting Does Not Worsen the Long-term 

Outcomes but Tend to Recur Occlusively 

Sanghoon Shin et al 

TCT-182. Angioplasty of the Hand Arteries in 

Critical Hand Ischaemia 

Zoltán Ruzsa et al 

TCT-183. Acute Outcomes for a Below-the- 

Knee Use of a Novel Balloon Catheter: 

First-in-Man Clinical Study 

Dierk Scheinert et al 

TCT-184. Subintimal Angioplasty or Bypass 

Surgery in CLI Patients with TASC II 

Type C/D Lesions: Mid- to Long-term 

Clinical Outcomes 

Niamh Hynes et al 

TCT-185. Association Between the Ankle- 

Brachial Index and the Severity of Coronary 


Yong Kyu Park et al 

TCT-186. Relationship Between Improvement 

of Skin Perfusion Pressure, Clinical 

Outcomes, and Wound Blush After 

Successful Endovascular Treatment 

Makoto Utsunomiya et al 

TCT-187. Factors of Restenosis After 

Endovascular Treatment for Iliac Artery 

Hideyuki Takimura et al 

TCT-188. Efficacy of the Novel 

Ultrasonography “Vascular Elastography” 

Guided Endovascular Therapy 

Hideyuki Takimura et al 

TCT-189. Plaque Excision as a Treatment 

Option for Popliteal Atherosclerotic 

Disease: One-Year Results from 

the DEFINITIVE LE Study 

James McKinsey et al 

PFO, ASD, and Congenital 

Heart Disease 

TCT-770. Transcatheter Device Closure 

of Atrial Septal Defect In Infants and 

Young Children 

Edwin Francis et al 



92 


TCT-771. Long-term Results of a Comparison 

of Three Patent Foramen Ovale 

Closure Devices in a Randomized 

Trial (Amplatzer vs. CardioSEAL, 

STARflex vs. Helex Occluder) 

Marius Hornung et al 

TCT-772. Role Of Non-ECG Gated Contrast 

CT in Preventing Percutaneous Pulmonary 

Valve Implantation-Related Coronary 

Compromise 

Oliver J. Monfredi et al 

TCT-773. Transcatheter Closure of 

Perimembranous Ventricular Septal Defect 

with the Amplatzer Membranous VSD 

Occluder 2 

Apostolos Tzikas et al 

TCT-774. Ten-Year Experience with 

Transcatheter Closure of Perimembranous 

Ventricular Septal Defects Using the 

Amplatzer Asymmetric Perimembranous 

Ventricular Septal Defect Occluder 

in Children 

Vasileios Thanopoulos et al 

TCT-775. Novel System for Detection of 

Cardiac Right to Left Shunts 

Robert Sommer et al 

TCT-776. UNES (Utah Nickel Elution Studies) 

Anwar Tandar et al 

TCT-777. Non-Cerebrovascular Systemic 

Arterial Embolic Events from Paradoxical 

Embolization via Patent Foramen Ovale 

Ronan J. Margey et al 

TCT-778. Long-term Outcomes After 

Transcatheter Closure of Patent 

Foramen Ovale 

Sammy Elmariah et al 

Physiologic Assessment 

TCT-218. Evaluating Ischemia in the 

Myocardium of a Chronic Total Occlusion 

to Determine the Value of Percutaneous 

Recanalization 

Rajesh Sachdeva et al 

TCT-219. Evaluating Ischemia of an 

Intermediate Stenosis in a Donor Artery 

During Recanalization of a Chronic 

Total Occlusion 

Rajesh Sachdeva et al 

TCT-220. The Impact of the Supply Area on 

the Fractional Flow Reserve Value in Stable 


Yasutsugu Shiono et al 

TCT-221. Diagnostic Performance of 

Intracoronary Gradient-Based Methods by 

Coronary Computed Tomographic 

Angiography for the Evaluation of 

Physiologically Significant Coronary Artery 

Stenoses: A Validation Study with FFR 


TCT-222. Combining Parameters of Coronary 

Angiography and Intracoronary Pressure 

Measurement Predicts More Preciously the 

Severity of the Ischemia on the Myocardial 

Perfusion Scintigraphy Than the Fractional 

Flow Reserve Alone 

Zsolt Köszegi et al 

TCT-223. Instantaneous Fractional Flow 

Reserve: Conceptual Implications for 

Myocardial Perfusion Imaging 

David Barmby et al 

TCT-224. Long-term Clinical Outcomes of 

Medical Therapy vs. Coronary 

Revascularisation in Patients with 

Intermediate Stenoses Guided 

by Pressure Wire 

Hongyu Shi et al 

TCT-225. The Role of Collateral Pressure 

Index Assessing Collateral Function 

and Coronary Hemodynamics in Patients 

with Total or Nearly Total Occluded 

Coronary Lesions 

Jang Hoon Lee et al 

TCT-226. Comparison of Endothelial Function 

in the Left Main Coronary Artery and 

Epicardial Arterial Segments 

Rishi Puri et al 

TCT-227. Outcomes of Deferred FFR-Negative 

Stenoses: Real-world Experience in a 

Community-Based Cardiac Referral Center 

Michael Ho et al 

TCT-228. Coronary Endothelial Dysfunction 

Predicts Long-term Prognosis in Patients 

With Successful First-Generation Drug- 

Eluting Stents Implantation Without Residual 

Stenosis at Chronic Stage 

Shigenori Ito et al 

TCT-229. The Safety and Feasibility of 

Nicorandil Compared to Adenosine 

Triphosphate as Hyperemic Agents for 

Fractional Flow Reserve Measurements 

Daiki Kato et al 

TCT-230. Instantaneous Wave-Free Ratio (iFR) 

and Gradient (iFG): New Promising 

Adenosine-Independent Alternative to 

Fractional Flow Reserve: Preliminary Results 

from the FORECAST Study 

Salvatore De Rosa et al 

TCT-231. Investigation of Fractional Flow 

Reserve Correlation with Direct Anatomical 

Parameters Using a Percutaneous Model of 

Coronary Artery Stenosis 

Ricardo Petraco et al 

TCT-232. Left Ventricular Filling Pressures 

Affect Measurements of Fractional 

Flow Reserve 

Robert A. Leonardi et al 

TCT-234. Prediction of Fractional Flow 

Reserve Using Contrast Media Flow Data 

Under Vasodilatation and the Parameters of 

3-D Coronary Angiography 


TCT-235. Accuracy of 320 Computed 

Tomography Coronary Angiography in 

Detection of Functionally Significant 

Stenoses: Comparison with FFR 

Brian Ko et al 

TCT-236. The Diastolic Wave-Free Period Is 

the Most Suitable Period in the Cardiac 

Cycle for the Assessment of a Coronary 

Stenosis: Implications for the Accurate 

Calculation of the Instantaneous 

Wave-Free Ratio (iFR) 

Sayan Sen et al 

TCT-237. Fractional Flow Reserve vs. 

Angiographic Guidance of Percutaneous 

Coronary Intervention: A Systematic Review 

and Meta-analysis 

Jung-Min Ahn et al 

TCT-238. The Instantaneous Wave-Free Ratio 

(iFR) and Fractional Flow Reserve (FFR) 

Have Equivalent Diagnostic Categorisation 

When Compared to Flow Based Indices 


TCT-239. Does Adenosine Administration 

Improve Diagnostic Classification of the 

Instantaneous Wave-Free Ratio (iFR)? 


TCT-240. Benefits and Costs of Routine 

Fractional Flow Reserve Assessment in All 

Major Epicardial Vessels During Elective 

Invasive Angiography 

Brian Ko et al 

Pulmonary Thromboembolism 

and Hypertension and 

Tricuspid Disease 

TCT-754. Efficacy and Safety of Balloon 

Pulmonary Angioplasty for Peripheral Type 

Chronic Thromboembolic Pulmonary 

Hypertension. 

Yu Taniguchi et al 

TCT-755. Beneficial Vascular Remodeling and 

Hemodynamic Improvement following 

Balloon Pulmonary Angioplasty for Chronic 

Thromboembolic Pulmonary Hypertension 

Hiroto Kinutani et al 

TCT-756. Role of Trellis Catheter in the 

Treatment of IVC Filter Thrombosis 

Mohsen Sharifi et al 

TCT-757. Rapid Resolution of Right Ventricular 

Dysfunction Using Ultrasonic Thrombolysis 

in Massive and Submassive Pulmonary 

Embolism Patients 

Tod C. Engelhardt et al

TCT-758. Percutaneous Thrombectomy with 

Right Coronary Judkins 8-Fr Guide Catheter 

for the Treatment of High-Risk Acute 

Pulmonary Embolism 

Jose Luis Ojeda Delgado et al 

TCT-759. Ultrasound-Accelerated 

Thrombolysis for the Treatment of 

Acute Pulmonary Embolism 

Matthew E. Wiisanen et al 

Renal Denervation 

TCT-204. Impact of Temperature, Energy 

Output and Impedance Drop During Renal 

Denervation on the Long-term Outcome 


TCT-205. Histologic Analysis of Renal Nerve 

Injury Following Catheter-Based Renal 

Denervation in Obese Hypertensive Canines 

Jeffrey R. Henegar et al 

TCT-206. A Pilot Study on Renal Sympathetic 

Denervation for Resistant Hypertension in 

the West of Ireland 

Imtiaz A. Kalyar et al 

TCT-207. Beta Radiation for Renal Nerve 

Denervation: Initial Feasibility and Safety 


TCT-208. Catheter-Based Renal 

Sympathetic Denervation: Results of 

the Heidelberg Registry 

Michael Kirchberger et al 

TCT-209. Durable Reduction in Blood Pressure 

in the First Cohort of Patients Treated with 

Renal Sympathetic Denervation Therapy for 

Resistant Hypertension 

Sonny Palmer et al 

TCT-210. Decrease of the Norepinephrine 

Release from Sympathetic Nerves During 



TCT-211. Ambulatory Blood Pressure and 

Dipping-Pattern After Catheter-Based Renal 

Sympathetic Denervation in Patients with 


Felix Mahfoud et al 

TCT-212. First Report of the Six-Month 

First-in-Human Results of the OneShot 

Renal Denervation System: The RHAS Study 

John A. Ormiston et al 

TCT-213. Safety and Efficacy of a Novel 

Multielectrode Renal Denervation Catheter in 

Resistant Hypertension: Three-Month Data 

from the EnligHTN I Trial 

Stephen G. Worthley et al 

TCT-215. Effect of Renal Denervation Therapy 

on Blood Pressure and Pulse Pressure in 

Young Compared to Old Patients 

Tobias Graf et al 


TCT-216. A Preclinical Comparative 

Histological Evaluation of the Renal Artery 

and Nerves in the Human Cadaver and 

Swine Model 

Radhika R. Tunstall et al 

TCT-217. Pathologic Insight into Nerve Injury 

in Swine Treated with Ultrasound Renal 

Artery Denervation System 

Addisalem Taye Makuria et al 

Statins, Beta-blockers, and 

Other Pharmacologic Agents 

TCT-711. Nicorandil Prevents Microvascular 

Dysfunction Resulting from Percutaneous 

Coronary Intervention in Patients with 

Stable Angina Pectoris 

Atsushi Hirohata et al 

TCT-712. Can Amelioration of HDL-C Level by 

Pitavastatin Improve Clinical Outcomes in 

Acute Myocardial Infarction Patients 


Intervention? 


TCT-713. The Benefit of Beta-blocker Therapy 

in Hospital Survivors Receiving Primary 

Percutaneous Coronary Intervention After 

ST-Elevation Myocardial Infarction from the 

Korea Acute Myocardial Infarction Registry 


TCT-714. A Meta-Analysis of Randomized 

Controlled Trials Appraising The Efficacy and 

Safety of New Oral Antithrombotics in 


Kyu-Nam Choi et al 

TCT-715. First Demonstration of Dose 

Dependent Effect of Statin Therapy on 

Urinary 11-Dehydrothromboxane B2 Levels 

in Patients Undergoing Coronary 

Angiography 

Paul A. Gurbel et al 

TCT-717. Impact of Antianginal Therapy and 

Rate Pressure Product Control on the Need 

for Repeat Revascularization Post-PCI 

Subhash Banerjee et al 

TCT-718. Statin Is More Effective in Acute 

Myocardial Infarction Patients in Atrial 

Fibrillation with High Level of High 

Sensitivity C-Reactive Protein Than Those 

with Low Level 

Hae Chang Jeong et al 

TCT-719. Effects of Ranolazine in Patients 

with Acute Coronary Syndrome and Stable 

Angina According to Whether They Undergo 


Observations from the MERLIN-TIMI 36 Trial 

Benjamin M. Scirica et al 


TranscaTheTer 


TherapeuTics 

STEMI and NSTEMI 

TCT-457. The Use of a Dedicated Coronary 

Bifurcation Stent in Patients Presenting with 


Maik J. Grundeken et al 

TCT-458. Late Outcomes of Patients with 

Myocardial Infarction Undergoing Drug- 

Eluting Stent Implantation in Daily 



TCT-459. Long-term Outcome in Patients with 

ST-Elevation Myocardial Infarction and 

Infarct-Related Coronary Artery Ectasia 

treated with Primary Percutaneous 


Gian Battista Danzi et al 

TCT-460. Comparison of Safety and Efficacy 

Between Transradial Intervention (TRI) and 

Transfemoral Intervention (TFI) in Acute 

Myocardial Infarction: Result from KORMI 

Registry Data 

Byung-Hyun Joe et al 

TCT-462. Invasive Strategies and Outcomes 

for Non-ST-Segment Elevation Acute 

Coronary Syndromes: A 12-Year Experience 

from SWEDEHEART 

Peter Damman et al 

TCT-463. In-Hospital Mortality Following 

Primary Angioplasty in the Setting of Cardiac 

Arrest Is High and Varies Depending on 

Patient Location at the Time of Arrest: 

A UK Registry Database Study 

Vijay Kunadian et al 

TCT-464. The Killip Classification Is Still 

Useful in Current Practice? An Analysis 

of 4,342 Patients in the Regional 

Acute Myocardial Infarction Registry 

of Brittany (ORBI) 


TCT-465. Prevalence, Correlation, and Clinical 

Outcome of Intraprocedural Stent 

Thrombosis in Patients Undergoing Primary 


Acute Coronary Syndrome 

Yingjia Xu et al 

TCT-466. Clinical impact of the Use of 

Thrombus Aspiration Devices in Primary 

Angioplasty: Insights from the Multicentric 

Study ESTROFA-MI 

Jose M. De La Torre Hernandez et al 

TCT-467. Clinical Outcomes After Anterior 


According to LAD Lesion Location: 

The INFUSE-AMI Trial 

Sorin Brener et al 



94 


TCT-468. Impact of Successful Thrombus 

Retrieval During Primary Percutaneous 

Coronary Intervention with Thrombus 

Aspiration on Infarct Size and Microvascular 

Obstruction: Insight from Contrast-Enhanced 

Magnetic Resonance Imaging 

Romain Chopard et al 

TCT-469. Frequency, Timing, and Implications 

of Reinfarction After Primary Stenting in 

ST-Segment Elevation Myocardial Infarction: 

The HORIZONS-AMI Trial 

Samantha Stone et al 

TCT-470. Manual Thrombectomy During 

Primary Percutaneous Coronary Intervention 

Can Preserve the Index of Microcirculatory 

Resistance in Patients with Anterior 

ST-Segment Elevation Myocardial Infarction 

Seong Ill Woo et al 

TCT-471. The Impact of First- vs. Second- 

Generation Drug-Eluting Stents on 

Immediate- and Intermediate-term 

Outcomes in a Complex ST-Segment 

Elevation Myocardial Infarction Population 


TCT-472. Prognosis of Patients Presenting 

with Non ST-Segment Elevation Myocardial 

Infarction and Nonobstructive Coronary 

Artery Disease: Propensity Score Matched 

Cohort from the ACUITY Trial 

David Planer et al 

TCT-473. Admission at Nights or Weekends 

Has No Adverse Effect on Mortality for 

ST-Elevation Myocardial Infarction Patients 

Treated by Primary Percutaneous 

Coronary Intervention: Single-Center 

Study from a Large Tertiary Cardiac 

Unit In United Kingdom 


TCT-474. Paclitaxel-Eluting Balloon in Primary 

Percutaneous Coronary Intervention in 

Amsterdam (PAPPA): Sustained Safety and 

Efficacy at 12-Months Follow-up 

Nicola S. Vos et al 

TCT-475. Association of the P53 Codon 72 

Polymorphism with Infarct Size and Left 

Ventricular Ejection Fraction in Patients 

with ST-Segment Elevation Acute 


Juan Carlos Rama Merchan et al 

TCT-476. Relationship Between Reference 

Vessel Diameter and the Incidence and 

Impact of Incomplete Coronary 

Revascularization Following PCI in ACS: 

The ACUITY Trial 

Gregg Rosner et al 

TCT-477. The Reperfused Myocardial Infarct 

Core Shows Extensive Hemorrhage with 

Loss of Vascular Integrity: A Comparison 

of Findings from Cardiovascular Magnetic 

Resonance Imaging with Histology 

Lourens Robbers et al 

TCT-478. Comparison of Leaman Weighing 

Factor and Individualized Coronary 

Angiographic Area at Risk Assessment with 

Autopsy Findings 


TCT-479. Impact of Left Ventricular 

Dysfunction and Multi-Vessel Disease 

After Primary Percutaneous Coronary 

Intervention: Three-Year Outcomes from 

the HORIZONS-AMI Trial 

Benoit Daneault et al 

TCT-480. Outcomes in Patients with 

Nonobstructive Coronary Artery Disease 

With and Without Cardiac Biomarker 

Elevations: The ACUITY Trial 

Jonathan D. Newman et al 

TCT-481. Comparison of Newer Generation 

Drug-Eluting Stents with Bare Metal Stents 

in Patients with Acute ST-Segment 

Elevation Myocardial Infarction: 

A Pooled Analysis of EXAMINATION 

and COMFORTABLE AMI Trials 

Manel Sabate et al 

TCT-482. Four-Year Follow-up After One- 

Stage Percutaneous Coronary Intervention 

of Left Main Stenosis and Infarct-Related 

Left Anterior Descending or Circumflex 

Arteries in Patients with Acute Coronary 

Syndrom with ST-Elevation MI 

Evgeniy Merkulov et al 

TCT-483. Impact of Smoking on Outcomes 

of Acute Myocardial Infarction After 


The Smoker’s Paradox 

Yun-Kyeong Cho et al 

TCT-484. Prognostic Value of Simple Standard 

12-Lead Electrocardiographic Parameters 

for Predicting Clinical Outcomes in Hospital 

Survivors After Acute Myocardial Infarction 


TCT-485. A Simple Strategy to Significantly 

Reduce the “Door-to-Balloon” Time in 

Patients with Acute ST-Elevation 


Alexander Joost et al 

TCT-486. Relationship Between White Blood 

Cell Count and Final Infarct Size in Patients 

with ST-Segment Elevation Acute Myocardial 

Infarction Undergoing Primary Percutaneous 

Coronary Intervention: Analysis from the 

INFUSE-AMI Trial 

Tullio Palmerini et al 

TCT-487. Door-to-Balloon Time as a Function 

of Mode of Referral: Results from the Ontario 

Provincial Cardiac Care Network Database 

Michel Le May et al 

TCT-488. Impact of Multivessel Coronary 

Artery Disease With or Without a Concurrent 

Chronic Total Occlusion on Survival in 

Patients Treated with Rescue Angioplasty 

Francesco De Felice et al 

TCT-489. Stent Thrombosis After Primary PCI 

for STEMI in Relation to Nonusage of 

Dual Antiplatelet Therapy Over Time: 

Results of the HORIZONS-AMI Trial 

Bimmer Claessen et al 

TCT-490. Coronary Artery Disease and 

Tako-tsubo Cardiomyopathy: 

A Possible Association 

Guido Parodi et al 

TCT-491. Incidence and Predictors of 30-Day 

Mortality in Elderly Patients with ST-Segment 

Elevation Acute Myocardial Infarction 

Undergoing Primary Angioplasty 

Antonio Alejandro De Miguel Castro et al 

TCT-492. Impact of Vessel Size on 

Angiographic and Clinical Outcomes of 

Revascularization with Drug-Eluting Stent in 

Patients with Acute Myocardial Infarction 

Shin Eun Lee et al 

TCT-493. The Clinical Utility of High-Sensitive 

Troponin T to Predict Infarct Size, Left 

Ventricular Function, and Adverse Outcome 

in Patients with First ST-Elevation Myocardial 

Infarction Treated with Primary Percutaneous 

Coronary Intervention. 

H. Boden et al 

TCT-494. Impact of Level of Physician Training 

on Transfer of ST-Segment Elevation 


Edward O’Leary et al 

TCT-495. Percutaneous, Transendocardial 

Injection of Bone Marrow Derived 

Mononuclear Cells Significantly Improves 

Left Ventricular Ejection Fraction in 

Patients Following Acute Myocardial 

Infarction: ALSTER Stem Cell Trial 

Christian Heeger et al 

TCT-496. Physician’s Procedure Volume and 

Not Years of Experience, Determine 

Needle-to-Balloon Time in Primary 



TCT-497. ST-Segment Elevation Acute 

Myocardial Infarctions Diagnosed by the 

Emergency Department: Impact on False 

Positive Calls and Door-To-Balloon Time 

Tudor Vagaonescu et al

TCT-498. Chronic Myocardial Tissue Effects 

of Intracoronary Supersaturated Oxygen 

in a Porcine Model of Anterior 


Greg L. Kaluza et al 

TCT-499. Prediction of Lesion Type-Related 

MACE by sFLT-1 and GDF-15: Results from 

The PROSPECT Study 

Martin Mockel et al 

TCT-500. Silent Occlusion but Not Restenosis 

Without Occlusion After Primary 

Percutaneous Intervention Strongly Predicts 

Both Deterioration of Cardiac Function and 

Future Clinical Events 

Shinichiro Yamada et al 

TCT-501. Impact of Adjunctive Thrombectomy 

on Myocardial Perfusion in Patients 

Undergoing Primary Percutaneous Coronary 

Intervention for Acute Myocardial Infarction: 

An Updated Meta-analysis 

Jae-Sik Jang et al 

TCT-502. Small vs. Large Culprit Vessel Size 

in Primary Percutaneous Coronary 

Intervention for ST-Elevation Myocardial 

Infarction: Incidence, Clinical Characteristics 

and Outcome Differences 


TCT-503. Predictors of Longtime Survival 

in Acute Myocardial Infarction in 

Elderly Patients 


TCT-504. Long-term Outcomes Among 

Patients with False-Positive STEMI 

Activations: A Report from the 

ACTIVATE-SF Registry 

Tyson Turner et al 

TCT-505. Prognostic Impact of Anaemia In 

Patients with ST-Elevation Myocardial 

Infarction Treated by Primary PCI 

Vrijraj Rathod et al 

TCT-506. Out-of-Hours Outcomes in STEMI 

Patients Treated with Primary Percutaneous 


Krishnaraj S. Rathod et al 

TCT-507. Left Bundle Branch Block 

Activations for Primary Percutaneous 

Coronary Intervention: Nonspecific Finding 

or a Marker for Increased Mortality? 

Adam J. Brown et al 

TCT-508. Optimal Medical Treatment in 

Patients with Hypertension Undergoing 


for Acute Myocardial Infarction 

Doo Sun Sim et al 


TCT-509. Low Overall Rates of 

Angiographically Visible Distal Embolization 

in INFUSE-AMI: Possible Explanation for 

Lack of Efficacy of Manual Aspiration 

Thrombectomy 

Magdi El-Omar et al 

TCT-510. Impact of Insurance Status on the 

Mortality Outcome of Patients with 



TCT-511. High Level of Preprocedural 

High-Sensitivity C-Reactive Protein Predicts 

Stent Thrombosis After Percutaneous 

Coronary Intervention in Patients with 

Acute Myocardial Infarction 

Hae Chang Jeong et al 

TCT-512. Echocardiographic Correlates of 

Persistent ST-Elevation on ECG in STEMI 

Patients Undergoing Percutaneous 


Manu Kaushik et al 

TCT-513. Simple Measures of ST-Segment 

Resolution Predict Infarct Size: 


Joe Dizon et al 

TCT-514. Intracoronary Infusion of 

Mononuclear Cells Compared with Standard 

Therapy After Acute Myocardial Infarction: 

Two-Year Magnetic Resonance Imaging 

Results of the Randomized Controlled 

Hebe Trial 

Ronak Delewi et al 

TCT-516. Microvascular Obstruction Detected 

by MRI Is a Predictor of Recovery from 

Myocardial Stunning: The INFUSE-AMI Trial 

Akiko Maehara et al 

TCT-517. Effects of Intravenous Human Atrial 

Natriuretic Peptide on Left Ventricular 

Function In Patients with Reperfused Acute 

Myocardial Infarction: An Assessment by 

Cardiac Magnetic Resonance Imaging 

Takayuki Onishi et al 

TCT-518. Clinical Outcomes of Multiple Stent 

Implantation in patients with ST-Segment 

Elevation Myocardial Infarction Undergoing 


Jun-Hyok Oh et al 

TCT-519. Randomized Study to Assess the 

Effect of ThRombus Aspiration on Flow Area 

in STEMI Patients: An Optical Frequency 

Domain Imaging Study (TROFI): 2-D and 3-D 

Analysis of Six-Month OFDI Follow-up 

Yoshinobu Onuma et al 

TCT-520. Descriptive Study of Patients with 


Presenting with Out-of-Hospital 

Cardiac Arrest 

Fizzah Choudry et al 


TranscaTheTer 


TherapeuTics 

TCT-521. Predictors of Outcome in Patients 

with ST-elevation Myocardial Infarction 

Presenting with Out-of-Hospital 


Fizzah Choudry et al 

TCT-522. National Trends in Case Fatality 

based on Anatomical Location of 

ST-Elevation Myocardial Infarction in 

Hospitalized Patients, 1993 to 2009 

Abhishek J. Deshmukh et al 

TCT-523. Complete Coronary Occlusion of the 

Infarct-Related Artery in Patients Presenting 

with Acute Non-ST-Elevation Myocardial 

Infarction: Role of the GRACE Risk Score 

Alexander Joost et al 

TCT-524. Does the Zwolle Percutaneous 

Coronary Intervention Risk Index Identify 

Low Risk ST-Elevation Myocardial Infarction 

Patients for Early Discharge? 

Craig E. Strauss et al 

TCT-525. Reduction of Apolipoprotein B/A-I 

Ratio During Follow-up Predicts Lower 

Adverse Event Rate at One Year After 


Jae Yeong Cho et al 

TCT-526. Is There Sufficient Evidence to 

Discourage the Use of Multivessel 

Angioplasty During STEMI? An Analysis of 

35,008 Patients 


TCT-527. Contemporary Outcomes of 

ST-Elevation Myocardial in Patients with 

Prior Bypass Graft 

Louis Kohl et al 

TCT-528. Clinical Syntax Score and Long-term 

Outcome After Successful Primary PCI 

Andreas Synetos et al 

TCT-529. Five Types of Drug-Eluting Stents 

Including Zotarolimus-Eluting Stent with 

Biolinx Polymer Show Similar Clinical 

Outcomes for the Treatment of ST-Segment 


Kyounghoon Lee et al 

TCT-530. Predictors and Clinical Outcomes 

Related to Door-in Door-out Times 

Ross Garberich et al 

TCT-531. Positive Predictive Value Of 

Clinically Suspected ST-Segment Elevation 

Myocardial Infarction Using Angiographic 

Verification 


TCT-532. The Effect of Northeast Japan 

Earthquake on Acute Myocardial Infarction 

Nobuyuki Kuroiwa et al 

TCT-533. Impact of High-Density Lipoprotein- 

Cholesterol on One-Year Outcome of 


Undergoing PCI 

Yun-Kyeong Cho et al 



96 


Stent Fracture and 

Longitudinal Deformation 

TCT-534. Longitudinal Stent Deformation: 

Insights on Mechanisms, Treatments, and 

Outcomes from the Food and Drug 

Administration Manufacturer and User 

Facility Device Experience Database 

Mamas Mamas et al 

TCT-536. Biomechanical Assessment of the 

Longitudinal Compression Behavior of 

Drug-Eluting Coronary Stents: An In Vitro 

Comparative Study 

Régis Rieu et al 

TCT-538. Predictors of Stent Fracture and 

Impact on Neointimal Proliferation: 

Experimental Insights into the Mechanisms 

of Drug-Eluting Stent Failure 

Seung-Jin Oh et al 

TCT-539. The Longitudinal Elongation of the 

Contemporary Drug-Eluting Stent in a 

Tapered Benchtop Model 

Masaki Takenaka et al 

TCT-540. Longitudinal Drug-Eluting Stent 

Elongation Phenomenon Due to High 

Pressure Additional Dilatation: Insights from 

Bench Testing 

Takenori Domei et al 

TCT-541. Coronary Computerized Tomography 

for Systematic Screening of Coronary Stent 

Fractures in Patients at High Risk 

Lisa Krenn et al 

TCT-542. Axial Integrity of Coronary Stents: 

Evaluation Using Intravascular Ultrasound 


TCT-543. Partial Strut Fracture in Everolimus- 

Eluting Stents: An Intravascular 

Ultrasound study 

Shinji Inaba et al 

TCT-544. Case Series of 100 Cases of 

Longitudinal Stent Deformation 

Doug Fraser et al 

TCT-545. The Impact of Sirolimus-Eluting 

Stent and Evelolimus-Eluting Stent on 

the In-Stent Restenosis and Stent 

Fracture: Evaluating Peri-Stent Contrast 

Staining Lesions After Drug-Eluting 


Tahei Ichinohe et al 

Structural, Nonvalvular 

Intervention 

TCT-760. Mid-term Outcomes of Alcohol 

Septal Ablation for Obstructive Hypertrophic 

Cardiomyopathy in Patients with Sigmoid vs. 

Neutral Ventricular Septum 

Josef Veselka et al 

TCT-761. Complications of Alcohol Septal 

Ablation for Hypertrophic Obstructive 

Cardiomyopathy with Focus on Complete 

Heart Block: A European Multicenter Study 

Josef Veselka et al 

TCT-763. Impact of Left Atrial Appendage 

Occlusion with Percutaneous Device on 

Left Atrial Function 

Pedro M. Almeida et al 

TCT-764. Safety and Biocompatibility of the 

Coherex WaveCrest Left Atrial Appendage 

Occluder in a 30-Day Canine Study 

Yanping Cheng et al 

TCT-765. First In Vivo Evaluation of the 

Ultrasept Left Atrial Appendage 

Closure Device 

Yanping Cheng et al 

TCT-766. Early Safety of the Amplatzer 

Cardiac Plug for Left Atrial Appendage 

Occlusion 

David Meerkin et al 

TCT-767. Long-term Outcomes Following 

Percutaneous Left Atrial Appendage Closure 

with the Amplatzer Cardiac Plug Device in 

Patients with Nonvalvular Atrial Fibrillation 

and Contraindications for 

Anticoagulation Therapy 

Reda Ibrahim et al 

TCT-768. Noninvasive Cardiac Arrhythmia 

Therapy Using High-Intensity Focused 

Ultrasound (HIFU) Ablation 

Jing Huang et al 

TCT-769. Functional Performance and 

Structural Maturation of Decellularised 

Pericardial Valves in Central Venous 

Position: An Experimental Study 


Unusual Coronary Pathology: 

Spasm, Spotaneous Dissection, 

and Others 

TCT-429. Synergistic Effects of Hemoglobin, 

Platelet, and C-Reactive Protein in the 

Development of Coronary Spasm 

Ming-Yow Hung et al 

TCT-430. Myocardial Bridging Increases 

Diffuse and Focal Chronic Stent Recoil 

Following Drug-Eluting Stent Implantation 

Ryotaro Yamada et al 

TCT-431. High Prevalence of a Coronary 

Spasm to Ergonovine Testing in Patients 

with Stable Angina Pectoris and 

Unobstructed Coronary Arteries. 

Shigeru Saito et al 

TCT-432. Angiographic Characteristics 

according to Acetylcholine Dose 

Responsible for Significant Coronary 

Artery Spasm 

Woong Gil Choi et al 

TCT-433. Impact of Beta-blocker on 

Angiographic and Clinical Parameters During 

Intracoronary Acetylcholine Provocation Test 

Sung Il Im et al 

TCT-434. Implantation of Sirolimus-Eluting 

Stent in Patients with Vasospastic Angina 

Deteriorates Late Catch-up Phenomenon. 

Naoki Oka et al 

TCT-435. Spontaneous Coronary Dissection: 

10 Years of Follow-up in Our Cath Lab 

Simone Muraglia et al 

TCT-436. Association of Myocardial Bridge 

and Acetylcholine Dose Response in 

Patients with Vasospastic Angina 

Sung Il Im et al 

TCT-437. The Impact of Gender Difference on 

Angiographic Characteristics During 

intracoronary Acetylcholine Provocation Test 

in Korean Patients 


TCT-438. Spontaneous Coronary Artery 

Dissection as a Cause of Acute Coronary 

Syndrome: A Case Series and 

Management Options 

Ankit Garg et al 

Vascular Access 

TCT-392. Silent Cerebral Infarcts 

Following Cardiac Catheterization: 

A Randomized Comparison of Radial 

and Femoral Approaches 

Michele Hamon et al 

TCT-393. A Randomized Trial Comparing Two 

Vascular Closure Devices: PROGLIDE and 

the Novel EXOSEAL After Percutaneous 

Femoral Procedures 

Madjid Hattab et al 

TCT-394. True Arterial Puncture Site (TAPS) 

Is Different from Perceived Arterial 

Puncture Site (PAPS) on Femoral 

Sheath Angiography (FSA) 

Zeshan Rana et al 

TCT-395. Ultrasound-Guided Radial Artery 

Access by a Nonultrasound-Trained 

Interventional Cardiologist Improved 

First-Attempt Success Rates and 

Shortened Time for Successful Radial 

Artery Cannulation 

Jonathan Roberts et al 

TCT-396. Assessment of Early Radial Injury 

After Transradial Coronary Intervention by 

High-Resolution Ultrasound Biomicroscopy: 

Innovative Technology Application 

Yujie Zhou et al

TCT-397. Coronary Procedures by 

Left vs. Right Transradial Approach 

in Diabetic Population 

Saidur R. Khan et al 

TCT-398. Anatomy of Femoral and Inferior 

Epigastric Arteries Relative to the Femoral 

Head by Angiography: Insights from the 

Femoral Arterial Access with Ultrasound 

Trial (FAUST) 

Arnold Seto et al 

TCT-399. Increased Radiation Exposure In 

Transradial Approach: A Real Drawback 

or a Problem? 

Jan Skvaril et al 

TCT-400. Risk of Brain Injury During 

Diagnostic Coronary Angiography: 

Comparison Between Single and 

Double Catheter Strategy During Right 

Transradial Approach 

Andrea Pacchioni et al 

TCT-401. A Comprehensive Easily Applicable 

Approach to Graduation of Radial Artery 

Spasm Related to Transradial Interventions 

Andrea Pacchioni et al 

TCT-402. Comparison of Procedural and 

Long-term Outcomes Between Transradial 

and Transfemoral Approach for Triple Vessel 

Coronary Artery Disease Intervention 

Kefei Dou et al 

TCT-403. Percutaneous Ultrasound-Guided 

Thrombin Injection as a Safe and Efficacious 

Primary Treatment of Iatrogenic Femoral 

Pseudoaneurysms for the Interventional 

Cardiologist 

Daniel Chen et al 

TCT-404. Efficacy and Safety of Total 

Percutaneous Femoral Closure Following 

Stent Graft Implantation Using Preclose 

Technique 

Donghoon Choi et al 

TCT-405. Transradial Approach Decreases 

in-Hospital Mortality in Patients with 

Cardiogenic Shock: A Single- 

Center Experience 

Oriol Rodriguez-Leor et al 

TCT-406. Transradial Balloon Aortic 

Valvuloplasty 

Steven L. Goldberg et al 

TCT-407. Vascular Hemostasis Devices: 

Food and Drug Administration Perspective 

on Reported Risks 

Deborah L. Yoder et al 

TCT-408. Sheathless Guide Catheters 

in Complex Transradial PCI: 


Raul M. Valdesuso et al 


TCT-409. Radial Access: Is There and 

Increased Risk of Operator Radiation 

Exposure During a Right vs. Left 

Radial Approach? 


TCT-410. Arteriotomy Location Guided by 

Fluoroscopy Plus Real-time Ultrasound: 

In Defense of the Femoral Approach 


TCT-411. Use of Sheathless Guide Catheter 

with Transradial Percutaneous Coronary 

Intervention: Single-Center Experience 

with 7,853 Procedures 

Mitsuru Kahata et al 

TCT-412. Diltiazem, Verapamil, or 

Dinitrate Isosorbid for Prevention of 

Radial Artery Spasm in Percutaneous 


Olivier Varenne et al 

TCT-413. Left and Right Heart 

Catheterizations Utilizing the Radial 

Artery and Forearm Vein: 


Simone Muraglia et al 

TCT-414. Angiographic Predictive Factors of 

Vascular Complications After Transcatheter 

Aortic Valve In Patients Treated with Prostar 

Closure Device 


TCT-415. Transradial Catheterization Is Not 

Associated with Increased Patient Radiation 

Exposure Compared to Transfemoral 

Access: A Meta-analysis 


TCT-416. Did the RIVAL Trial Increase 

Transradial Coronary Intervention in Patients 

with Acute Myocardial Infarction? Results 

from Korea Working Group on Myocardial 

Infarction Registry 

Hye Won Lee et al 

TCT-418. Doppler Control of Radial Artery 

After Use of TR Band Following 

Coronarography and/or Angioplasty: 

DRABAND Study Results 

Jacques Monsegu et al 

TCT-419. Complete Percutaneous Approach 

for Arterial Access and Closure for Device 

Deployment in the Transfemoral 

Transcatheter Aortic Valve Replacement: 

A Comparison with Surgical Cut-down 

Tarun Chakravarty et al 

TCT-420. Major Vascular Complication and Its 

Management After Complete Percutaneous 

Arterial Access and Closure in Transfemoral 


Mamoo Nakamura et al 


TranscaTheTer 


TherapeuTics 

TCT-421. Lower Periprocedural Quality of Life 

in STEMI Patients Undergoing PCI with 

Femoral Access 

Lukasz Koltowski et al 

TCT-422. Large 22 Fr to 24 Fr Femoral Vein 

Hemostasis with a Subcutaneous Stitch 

or a Double Perclose Closure Is 

Effective and Safe 

Asma Hussaini et al 

TCT-423. Profile, Safety, and One-Year 

Outcome of Patients with Same-Day 

Discharge After Percutaneous Coronary 

Intervention Using Different Vascular Access: 

A High-Volume Single-Center Experience 

Asma Hussaini et al 

TCT-424. Trends in Access Site Choice for PCI 

and Influence on Mortality: Observational 

Data from the British Cardiovascular 

Intervention Society PCI Database 

Karim Ratib et al 

TCT-425. Repeated Transradial 

Catheterization: Feasibility, 

Efficacy, and Safety 

Marinos Charalambous et al 

TCT-426. Balloon Angioplasty Tamponade 

Facilitated Seal of Large Diameter 

Arteriotomy Vascular Access During 

Endovascular interventions from the 

SIMPLIPHIEDE Study (Single-Center Impella 

LVAD Supported PCI in High-Risk Group of 

Patients: Detroit Medical Center Experience) 

Obrad Kokanovic et al 

TCT-427. Transradial Access for Primary 

Percutaneous Coronary Interventions in 

Octogenarian Patients with Acute Myocardial 

Infarction: The ORA-STEMI (Octogenarians 

Radial Access in ST-Elevation Myocardial 

Infarction) Registry 

Antonio A. De Miguel et al 

TCT-428. Radial Access Does Not Affect 

Door-to-Balloon Time in Patients 

Undergoing Primary PCI 

Rosario Parisi et al 



98 


challEnging casE 

vidEo PrEsEntations 


Session I. Highest Scored 

Submitted Cases 

8:00 am-10:00 am 

Hall D 

Moderators: Robbert J. de Winter, 

Giuseppe M. Sangiorgi 

Discussants: Amr Abbas, Joseph D. Babb, 

YunDai Chen, Stéphane Cook, Nicola Corvaja, 

Henning Kelbaek, Guy LeClerc, Gabor Sutsch 

TCT-1000. Balloon-Expandable Aortic 

Prosthesis Dysfunction Due to 

Leaflet Thrombosis 

Linda Cota 

TCT-1001. A Novel Method of Stent Delivery 

by Mother-Child-Grandchild Technique 

Takashi Ashikaga 

TCT-1002. An Unusual Finding Following New 

Generation Drug-Eluting Stent Implantation 

Angelo Anzuini 

TCT-1003. Radial Artery Perforation During 

Transradial Catheterization Successfully 

Managed with Coil Embolization 

Hutton Brantley 

TCT-1004. Coronary Stent Retrieved from 

Lower Limb 

Rasheed Saadi 

TCT-1005. A Case of Acute Occlusive 

Dissection of the Right Coronary Artery 

Happened While Stenting to the Left 

Anterior Descending Artery 

Yoshiki Nagata 

TCT-1006. Retrograde Guidewire 

Trapping Technique Used for Chronic Total 

Occlusion with Anomalous Origin of Right 

Coronary Artery 

Long Hong 

TCT-1007. Successful Percutaneous 

Endovascular Retrieval of a Coil in Left 

Ventricle Migrated During Embolization for 

Pulmonary Arteriovenous Malformation 

Pyung Chun Oh 

TCT-1008. Giant Coronary Artery Aneurysm: 

Management of STEMI and Transcatheter 

Approach to Exclude Aneurysm 

Frances Wood 

TCT-1009. Successful Percutaneous Treatment 

of Left Main Coronary Artery Compromised 

by Extrinsic Compression from an Acquired 

Aneurysm of Left Sinus of Valsalva 

Peter Hausinger 

TCT-1010. Stenting of Right Coronary Artery 

Ostium for Acute Inferior Myocardial 

Infarction Due to Type A Aortic Dissection 

Veeran Subramaniam 

TCT-1011. Because Crossing Is Just the 

Beginning. . . . Complications of a 

Retrograde Chronic Total Occlusion 


Vishal Patel 

TCT-1012. Aortic Arch Aneurysm: Antegrade 

Transapical Stentgraft Placement with 

Transsupraaortic Chimney Grafts 

Michael Gawenda 

TCT-1013. Corsair Prolapse Causing 

Circulatory Collapse 

Ulf Jensen 

TCT-1014. An Unusual Myocardial Infarction 

Jacopo Oreglia 

TCT-1015. A New Effective Method Using a 

Child Catheter for Catching the Retrograde 

Wire Within the CTO 

Kensuke Yokoi 

TCT-1016. Pulmonary Venous Atrial Thrombus 

Leading to Killip IV Inferior and Anterolateral 

STEMI Complicated by Refractory 

Ventricular Fibrillation in a Patient with 

D-Transposition of Great Arteries and 

Anomalous Circumflex Artery and Prior 

Senning Atrial Switch 

Donald Lynch 

TCT-1017. Extensive Dissection of 

Unprotected Left Main Coronary Artery into 

Left Anterior Descending and Left Circumflex 

Arteries and Left Coronary Sinus During 

Percutaneous Coronary Intervention for Left 

Anterior Descending Artery: Step-by-Step 

Out-of-the-Box Solution 

Uday Khanolkar 

TCT-1018. Acute Coronary Syndrome and 

Bowel Ischaemia in a Patient with Extensive 

Fibromuscular Dysplasia Affecting the 

Coronary Ostia: High-Risk Left Main 

Coronary Artery PCI as a Last Resort 

Benjamin Wrigley 

TCT-1019. Guiding Catheter Dissection During 

Rotational Atherectomy: A Bail-Out Strategy 

Utilizing a 6-Fr Diagnostic Catheter 

Nanda Panigrahi 

TCT-1020. A Complicated Rescue PCI 

Involving a Left Main Trifurcation and 

Circumflex Rupture on a 38-Year-Old Male 

Prodromos Anthopoulos 

TCT-1021. Usuful Bifurcation Guidewire 

Technique: Reverse Wire Technique 

Taku Iwaki 

TCT-1022. Interventional Treatment of Acute 

Myocardial Infarction Due to Acute Aortic 

Dissection with Left Main Coronary Artery 

Compression Syndrome 

Kostadin Kichukov 

TCT-1023. The Long and Winding Road: 

Transcatheter Coiling and Use of a Vascular 

Plug for Treatment of Progressive Dyspnea 

and Right Heart Failure Secondary to 

Coronary Artery Fistulas 

Maya Kommineni 

TCT-1024. Anteretrograde Approach 

Technique Performed for CTO Case 

Tadashi Yamamoto 

TCT-1025. Balloon Aortic Valvuloplasty and 

Complex Left Main/Multivessel 

Percutaneous Coronary Intervention in a 

Patient with Severe Impaired Left Heart 

Function and High Syntax Score 

Ka Chun Alan Chan 

TCT-1026. An Enigmatic Vessel: Where and 

How to Go? 

Max Woo 

TCT-1027. Cutting the Edge with Cutting Edge 

Technology 

Auroa Badin 

TCT-1028. Retrograde CTO Techniques to 

Perform Left Main Stenting in an 18 Year Old 

with Previous Kawasaki Disease 

Elizabeth Holper 

TCT-1029. Successful Double Radial Approach 

RCA CTO PCI by Reverse CART Technique 

Through Epicardial Collateral After Two 

Failed Attempts 

Pengcheng He 

TCT-1030. Acute Left Main Coronary Infarction 

with Cardiogenic Shock Treated with Primary 

Stenting Assisted by Both PCPS and IABP 

Followed by Stem Cell Therapy 

Jae-hwan Lee 

TCT-1031. The “Occlusive Crush” Technique: 

A Novel Safe Method to Occlude Fistulas or 

to Stop Bleedings 

Alessandro Lualdi 

TCT-1032. LAD to LAD Retrograde Chronic 

Total Occlusion Recanalisation via an 

Intraseptal Loop 


TCT-1033. Percutaneous Coronary 

Intervention for Abnormal Ostium of Right 

Coronary Artery by 4-Fr Guiding Catheter via 

Transulnar Artery Approach 

Xianghua Fu 

TCT-1034. Left Main Coronary Artery 

Compression from Enlarged Pulmonary 

Artery Due to Pulmonary Hypertension 

Kazuho Kamishima 

TCT-1035. Peripartum Acute ST-Elevation 

Myocardial Infarction from Spontaneous 

Coronary Artery Dissection 

Ankur Kalra

TCT-1036. Successful Removal of an 

Intracoronary Foreign Body 

Mladen Vidovich 

TCT-1037. A Tail of Two Rings: Sequential 

Emergency PCI for Haemodynamic and 

Arrhythmic Complications of Mitral and 

Tricuspid Valve Repair 

Niket Patel 

TCT-1038. Unprotected Single Coronary Artery 

Main Stem Angioplasty 

Niket Patel 

TCT-1039. Combining CrossBoss, Laser, and 

Rotational Atherectomy Adjunctive Therapy 

for the Success in a Resistant Chronic Total 

Occlusion 

Nimit Shah 

TCT-1040. Double Crush Technique Using 

Simultaneous Dual Vascular Access Site to 

Treat Two Contiguous Bifurcation Lesions of 

the Left Anterior Descending Artery 

Karl Isaaz 

TCT-1041. Prior Recanalization of Saphenous 

Vein Graft Occlusive Lesion for Intravascular 

Ultrasound Guide Wiring to Select Native 

Right Coronary Artery Chronic Total 

Occlusion in Retrograde Approach 

Shuichi Ishizuka 

TCT-1042. A Case of Quadrification Stenting 

Prabhu Halkati 

TCT-1043. Primary Angioplasty in a Woman 

with Left Main Coronary Artery Occlusion 

and Cardiogenic Shock 

Ronen Jaffe 

TCT-1044. Successful PCI RCA CTO Requiring 

Staged Procedures as Well as Both 

Antegrade and Retrograde Approaches 

William Wilson 

TCT-1045. A Novel Technique of Controlled 

Antegrade Subintimal Tracking (CAT) to 

Cross Chronic Total Occlusion 

Sandeep Basavarajaiah 

TCT-1046. A Case of Massive Dissection of 

Left Main 

Anwar Khan 

TCT-1047. Unprotected Left Main PCI through 

a Fenestrated Type A Aortic Dissection Flap 

Alfred Burris Ii 

TCT-1048. Lund University Cardiac Arrest 

System (LUCAS) Assisted PCI in an 

Octogenarian Presenting with Cardiogenic 

Shock 

Periklis Davlouros 

TCT-1049. A case of FFR-guided coronary 

intervention to previous myocardial infarct 

area 

Issei Ishida 


TCT-1050. Complex Left Main PCI Done 

Without the Guiding Catheter Support 

J. Shivkumar Rao 

TCT-1051. Cutdown Carotid Revascularization 

Scott Schultz 

TCT-1052. A Challanging Case of PCI with 

Rotablation of the Last Major Patent Vessel 

Tariq Azeem 

TCT-1053. Severe Aortic Regurgitation 


Intervention 

Nimit Shah 

TCT-1054. Anteater Technique: Novel Use of 

the Guideliner Catheter 

Michael Luna 

TCT-1055. Primary PCI in Anomalous 

Coronary: Wire-First Approach 

Abhijit Kulkarni 

TCT-1056. Big Surprise After Successful 

Deployment of Two Tryton Stents: The Value 

of Patience 

Ricardo Sanz-Ruiz 

TCT-1057. Unusual Case of Left Main 

Coronary Artery Embolisation 

Narendra Khanna 

TCT-1058. Retrograde CTO with Single 

Guiding Catheter 

Pravin Goel 

TCT-1059. Evolving Applications for Rotational 

Atherectomy in the Subintimal Space to 

Facilitate Chronic Total Occlusion (CTO) 

Percutaneous Coronary Intervention (PCI) 

Vivek Kodoth 

TCT-1060. Use of the Guideliner Catheter to 

Implant Covered Stents in a Multistented 

Saphenous Vein Graft Presenting an 

Important False-Aneurysm 

Stephane Noble 

TCT-1061. Interventional Closure of Coronary 

Fistula in Heart Transplant Patient 

Markus Ferrari 

TCT-1062. Primary PCI with Mechanical 

Circulatory Support 

Andrew Asherson 

TCT-1063. Bridge to Recovery in a Patient 

with Churg-Strauss Myocarditis by 

Long-term Percutaneous Support with an 

Impella 2.5 

Markus Ferrari 

TCT-1064. Aorto-Esophageal Fistula 

Presenting as a Life-threatening Problem 

Paramdeep Sandhu 

TCT-1065. Radial Percutaneous Transluminal 

Angioplasty with Stenting to Abdominal 

Aorta, Celiac Trunk, and Renal Artery in 

Takayasu Arteritis 

Keyur Parikh 


TranscaTheTer 


TherapeuTics 

TCT-1066. Endovascular Repair of a Left 

Common Iliac Artery Aneurysm with 

Anomalous Renal Artery Supply to Crossed 

Renal Ectopia and its Periprocedural 

Complications 

Thomas George 

TCT-1067. Endovascular Repair of Descending 

Thoracic Aortic Pseudoaneurysm in a Patient 

with Loeys-Dietz II Syndrome 

Ankur Kalra 

TCT-1068. Retrograde Percutaneous Digital 

Artery Access for Challenging Case of 

Critical Limb Ischemia in Diabetic Patient 

Luis Palena 

TCT-1069. Acute Limb Ischemia Due to 

Abdominal Compartment Syndrome 

Atsuo Maeda 

TCT-1070. Endovascular Repair of Ascending 

Aortic Aneurysm by Transapical Approach 

and Chimney Technique 


TCT-1071. Ultrasound Accelerated 

Thrombolysis: A Novel Approach for the 

Treatment of Right Atrial Clot in Transit 

Avichai Eres 

TCT-1072. Bilateral Renal Artery Stenosis of 

Which Left Renal Artery Is CTO 

Chandrashekhar Makhale 

TCT-1073. Percutaneous Revascularization of 

a Chronic Total Occlusion of the Left Lower 

Pulmonary Vein 

Dale Murdoch 

TCT-1074. Exclusion of Giant Pseudo 

Aneurysm with Stent Graft by Double Access 

Alejandro Goldsmit 

TCT-1075. Recanalization of an Occluded 

Superficial Artery Stent with Stent Puncture 

in Patient with Critical Limb Ischemia 

Roberto Gandini 

TCT-1076. Successful Recanalization of 

Inferior Vena Cava Obstruction Presenting as 

Hepatic Venous Outflow Obstruction in a 

Young Patient 

Dattatreya Rao 

TCT-1077. Acute Critical Hand Ischaemia Due 

to Brachial Artery Occlusion After 

Recanalisation from Left Radial Access 

Zoltán Ruzsa 

TCT-1078. Solitary Kidney Revascularization 

with Aortic Near-Occlusion for Renal 

Preservation 

Brian Kolski 

TCT-1079. Coeliac Artery Ostial CTO 

Angioplasty Through Retrograde Technique: 

So Near, Yet So Far Away 

Harinder Bali 



100 


TCT-1080. Use of a Double Snare Technique 

to Remove a Trapped Balloon Catheter from 

the Superior Vena Cava 

Salman Arain 

TCT-1081. Left Main Compression by a Huge 

Pulmonary Artery Aneurysm: Intravascular 

Ultrasound Analysis and Revascularization 

with a Drug-Eluting Stent 

Felipe Hernandez 

TCT-1082. A Case of Pressure Wire Fracture 

and Migration While Crossing a Bjork-Shiley 

Aortic Valve 

Monica Jiddou 

TCT-1083. Acute Left Main Occlusion 

During TAVI 

Pawel Kleczynski 

TCT-1084. Coronary Fistula to the 

Left Atrial Appendage 

Eduardo Infante De Oliveira 


Implantation for Pure Aortic Regurgitation 

as Bridge to Emergent Liver Transplantation 

Giuseppe Bruschi 

TCT-1086. Transfemoral Pulmonary Valve 

Implantation for Severe Pulmonary 

Insufficiency Following Ross Procedure 

Karl Stangl 

TCT-1087. Percutaneous Closure of a Giant 

Right Coronary Artery-Left Ventricular 

Coronary Cameral Fistula with Large Ostium 

Secundum Atrial Septal Defect 

Ravindranath Shankarappa 

TCT-1088. Transcatheter Tricuspid 

Valve-in-Valve Replacement Resulting 

in Four Different Prosthetic Heart Valves 

in a Single Patient 


TCT-1089. Transcatheter Implantation of 

Degenerated Tricuspid Bioprosthesis with 

the 29-mm Edwards XT SAPIEN Valve 

Patrizia Presbitero 

TCT-1090. Challenging Case of Valve-in-Valve 

TAVI: The Importance of Attention to 

Fine Detail 

Narasimharajapura Rajendra 

TCT-1091. Percutaneous Transapical Closure 

of a Paravalvular Leak in a St. Jude 

Mechanical Mitral Valve Prosthesis: 

An Challenging Complication 

Karl Poon 

TCT-1092. Left Ventricular Embolization of an 

Aortic Balloon-Expandable Bioprosthesis: 

Balloon Capture and Reimpaction as an 

Alternative to Emergent Conversion to 

Open-Heart Surgery 

Nicolas Dumonteil 

TCT-1093. Interrupted Aortic Arch: 

Successful Endovascular Technique 

Using a Transseptal Needle 

Imad Alhaddad 

TCT-1094. The Challenge of Early Surgical 

and Transcatheter Closure of Post-Infarct 

Ventricular Septal Defect 

Frances Wood 

TCT-1095. Emergency Covered Stent 

Implantation for the Pulmonary Vein Rupture 

Following Balloon Angioplasty 

Takashi Matsumoto 

TCT-1096. Successful Antegrade Transfemoral 

Implantation of an Edwards Sapien Valve 

Within a Degenerated Mitral Valve 

Bioprosthesis in a Patient with Prior Surgical 

ASD Closure 

Simone Schleger 

TCT-1097. Percutaneous Mitral Valve Repair 

with the MitraClip Device in Acute Massive 

Mitral Regurgitation Complicated by 

Cardiogenic Shock Due to Papillary Muscle 

Rupture in a Patient with ST-Elevation Acute 

Myocardial Infarction (STEMI) 

Marco Barbierato 

TCT-1098. Personalized Medicine for Valvular 

Heart Disease: First-in-Man Percutaneous 

Pulmonary Valve-in-Valve Implantation Using 

29-mm Edwards Sapien Valve 

Harsimran Singh 

TCT-1099. Percutaneous Closure of 

Paravalvular Leak After Transcatheter 


Matthew Price 

TCT-1100. Left Main Coronary Artery Stenosis 

After Arterial Switch Operation in a 

21-Year-Old Woman Treated With 

Drug-Eluting Stent Implantation 

Ricardo Sanz-Ruiz 

oral abstract sEssions 


Access Sites and Their 

Management 

10:30 am-12:30 pm 

Room C219 

Moderators: Ian C. Gilchrist, S. Chiu Wong 

Discussants: Luis A. Guzman, 

Christoph K. Naber, Sudhir Rathore, 


10:30 am - TCT-25. Cardiac Catheterization 

via Ulnar: Deductive Approach After 10 

Years of Experience 

Raul Valdesuso 


10:45 am - TCT-26. Radial vs. Femoral 

Access for Primary PCI: Observational Data 

from the British Cardiovascular Intervention 

Society Database 

Karim Ratib 


11:00 am - TCT-27. Transformation from a 

Predominant Transfemoral to Transradial 

Access Site for Percutaneous Coronary 

Intervention (PCI): Insights into an 

Achievable Revolution within Five Years 

Richard Anderson 


11:15 am - TCT-28. Is the Rate of Femoral 

Access Site Complications Increased in the 

Hands of “Radialists?” 

Stefano Rigattieri 


11:30 am - TCT-29. Radial vs. Femoral Access 

for Coronary Angiography and Intervention 

in Patients with Acute Coronary Syndromes: 

Results of the Zwolle Myocardial Infarction 

Study Group 

Rik Hermanides 


11:45 am - TCT-30. Clinical Outcomes 

Following Radial vs. Femoral Artery Access 

in Primary or Rescue Percutaneous Coronary 

Intervention in Scotland: Retrospective 

Cohort Study of 4,534 Patients 

Colin Berry 


12:00 pm - TCT-31. Clinical Benefit of Radial 

vs. Femoral Approach in Percutaneous 

Coronary Intervention with Intra-aortic 

Balloon Pump Support 

Enrico Romagnoli 


12:15 pm - TCT-32. Neurological 

Complications Following PCI: Incidence and 

Trends During a Period of Transition from 

Femoral to Radial Access. Observational 

Data from the British Cardiovascular 


PCI Database 

Karim Ratib 



Adjunct Imaging and Physiology 

10:30 am-12:30 pm 

Room D239 

Moderators: James A. Goldstein, 

Habib Samady 

Discussants: Allen Jeremias, Pedro A. Lemos, 

Jonathan S. Roberts, Pim A.L. Tonino

10:30 am - TCT-17. Serial Changes of 

Everolimus-Eluting Stent Malapposition: An 

Optical Coherence Tomography Subanalysis 

from the RESET Trial 

Kunihiro Shimamura 


10:45 am - TCT-18. Long-term Outcome of 

Discordance Between Fractional Flow 

Reserve and Coronary Flow Velocity 

Reserve After Deferral of Percutaneous 


Tim P. van de Hoef 


11:00 am - TCT-19. Fractional Flow Reserved 

Derived from Computed Tomographic 

Angiography (FFRCT) for Intermediate 

Severity Coronary Lesions: Results from the 

DeFACTO Trial (Determination of Fractional 

Flow Reserve by Anatomic Computed 

TOmographic Angiography) 

James K. Min 


11:15 am - TCT-20. IVUS Predictors of Stent 

Thrombosis: Results from the Prospective, 

Multicenter ADAPT-DES Study 

Akiko Maehara 


11:30 am - TCT-21. Use of IVUS Reduces 

Stent Thrombosis: Results from the 

Prospective, Multicenter ADAPT-DES Study 



11:45 am - TCT-22. Combination of High Wall 

Shear Stress, Plaque Burden, and Plaque 

Phenotype Has Incremental Value for 

Prediction of Increased Plaque Vulnerability 

in Patients with Coronary Artery Disease 

Michel Corban 


12:00 pm - TCT-23. Detection by Near-Infrared 

Spectroscopy of Large Lipid Core Plaques at 

Culprit Sites in Patients with Acute 

ST-Segment Elevation Myocardial Infarction 

Ryan D. Madder 


12:15 pm - TCT-24. Combined Near-Infrared 

Spectroscopic and Intravascular Ultrasound 

Assessment of Coronary Plaque Burden and 

Lipid Pools: Validation with Histology 

Rishi Puri 




Bioresorbable 

Vascular Scaffolds 

10:30 am-12:30 pm 


Moderators: John A. Ormiston, 

Evelyn S. Regar 


Antoine Lafont, Detlef G. Mathey, 

Miodrag C. Ostojic 

10:30 am - TCT-33. Intracoronary Optical 

Coherence Tomography and Histology of 

Overlapping Everolimus-Eluting 

Bioresorbable Vascular Scaffolds in a 

Porcine Coronary Artery Model: The 

Potential Implications for Clinical Practice 

Vasim Farooq 


10:45 am - TCT-34. ABSORB EXTEND: 

An Interim Report on the 12-Month 

Clinical Outcomes from the First 250 

Patients Enrolled 

Antonio L. Bartorelli 


11:00 am - TCT-35. Evaluation of the Absorb 

Everolimus Eluting Bioresorbable Vascular 

Scaffold (Absorb BVS) in the Treatment of 

Patients with de Novo Native Coronary 

Artery Lesions: Three-Year Clinical Results 

of the ABSORB Cohort B1 Trial 



11:15 am - TCT-36. Circumferential 

Distribution of the Neointima Tissue at 

Six-Month and Two-Year Follow-up After a 

Bioresorbable Scaffold Implantation: A Serial 

Optical Coherence Tomography Study 

Christos Bourantas 


11:30 am - TCT-37. Five-year Clinical 

Outcomes and Noninvasive Angiographic 

Imaging Results with Functional Assessment 

After Bioresorbable Everolimus-Eluting 

Scaffold Implantation in Patients with De 

Novo Coronary Artery Disease 

Yoshinobu Onuma 


11:45 am - TCT-38. Two-Year Clinical Data of 

Cohort 1 and Multimodality Imaging Results 

Up to One-Year Follow-up of the 

BIOSOLVE-I Study with the Paclitaxel- 

Eluting Bioabsorbable Magnesium 

Scaffold (DREAMS) 

Michael Haude 



TranscaTheTer 


TherapeuTics 

12:00 pm - TCT-39. Six-Month Angiographic 

Follow-up of the Novel DESolve Myolimus- 

Eluting Bioresorbable Coronary Scaffold for 

the Treatment of Noncomplex Coronary 

LesionsL Results from the 

DESolve I First-in-Man Trial 

Ricardo A. Costa 


12:15 pm - TCT-40. Incidence and Acute 

Clinical Outcomes of Small Side Branch 

Occlusion After Implantation of Everolimus- 

Eluting Bioresorbable Vascular Scaffold in 

the ABSORB-EXTEND Single-Arm Trial 

Takashi Muramatsu 



Carotid, Neurovascular, and 


10:30 am-12:30 pm 


Moderators: Roger M. Greenhalgh, 

James D. Joye 

Discussants: Vivek Gupta, 

Daniel J. McCormick, Thomas M. Shimshak, 

Michael H. Wholey 

10:30 am - TCT-1. Risk Factors for Cerebral 

Embolization After Carotid Artery Stenting 

with Embolic Protection: A DW-MRI Study in 

827 Patients 

Klaudija Bijuklic 


10:45 am - TCT-2. Periprocedural Outcomes 

After Carotid Artery Stenting with the First 

15,000 Patients Enrolled in the SAPPHIRE 

Worldwide Study 



11:00 am - TCT-3. Early Results of Multicenter, 

Prospective Trial of TEVAR for Blunt 

Thoracic Aortic Injury (RESCUE Trial) 

Ali Khoynezhad 


11:15 am - TCT-4. Impact of Catheter 

Fragmentation Followed by Local 

Intrapulmonary Thrombolysis in Acute High 

Risk Pulmonary Embolism as Primary 

Therapy: Acute and Long-term Outcomes 

Bishav Garg 


11:30 am - TCT-5. Efficacy of Cardiatis 

Multilayer Flow Modulator in Peripheral and 

Visceral Aneurysms Repair: Italian 

Multicenter Registry Results at 


Maria Antonella Ruffino 




102 


11:45 am - TCT-6. Biodegradable Polymerbased 

Biolimus A9-Eluting Stent for the 

Treatment of Infrapopliteal Arteries in Critical 

Limb Ischemia: Long-term Clinical and 

Angiographic Follow-up 

Eugenio Stabile 


12:00 pm - TCT-7. Plaque Excision as a 

Treatment Option for Critical Limb 

Ischemia: One-Year Results of the 

DEFINITIVE LE Study 




Coronary Intervention I. 

Complex Lesions and 

Patient Subsets 

10:30 am-12:30 pm 


Moderators: Lisette Okkels Jensen, 

Richard A. Schatz 

Discussants: Adriano Caixeta, Luis Gruberg, 

Azeem Latib, Graham Nichol 

10:30 am - TCT-65. Clinical Impact of 

IVUS-guided Left Main PCI: Insights from 

the Multicenter Study ESTROFA-LM 



10:45 am - TCT-66. Impact of Residual Chronic 

Total Occlusion of Right Coronary Artery on 

the Long-term Outcome in Patients Treated 

for Unprotected Left Main Disease: The 

Milan and New Tokyo (MITO) Registry 

Kensuke Takagi 


11:00 am - TCT-67. Impact of Hemodynamic 

Support with Impella vs. Intraaortic Balloon 

Counterpulsation on Prognostically 

Important Ischemic Endpoints: Results 

from the PROTECT-II Trial 



11:15 am - TCT-68. The Use of Percutaneous 

Left Ventricular Assist Device vs. Intra-aortic 

Balloon Pump for Hemodynamic Support 

During High-Risk PCI 



11:30 am - TCT-69. PEPCAD-DES: A 

Randomized, Multicenter, Single-Blinded 

Trial Comparing Paclitaxel Coated Balloon 

Angioplasty with Plain Balloon Angioplasty 

in Drug-Eluting-stent Restenosis: 

12-Month Results 

Harald Rittger 


11:45 am - TCT-70. Comparison of 

Efficacy and Safety Between Sirolimus, 

Paclitaxel, Everolimus-Eluting Stent and 

SeQuent Please, a Drug-Eluting Balloon 

on the Outcome of Patients with Diffuse 

In-Stent Restenosis after Bare Metal 


Sunao Nakamura 


12:00 pm - TCT-71. Intravascular Ultrasound- 

Guided Systematic Two-Stent Techniques 

for Coronary Bifurcation Lesions Reduced 

Late Stent Thrombosis and ST-Elevation 




12:15 pm - TCT-72. Impact of Gender on 

Adverse Cardiovascular Events Following 

Percutaneous Coronary Intervention: Pooled 

Analysis from the SPIRIT II, III, and IV Trials 

Usman Baber 



Coronary Intervention II. 


and Their Treatment 

10:30 am-12:30 pm 

Room C220 

Moderators: Mauro Carlino, Jonathan M. Hill 

Discussants: Kevin J. Beatt, Charles Chan, 

Masato Nakamura, Simon Walsh 

Chronic Total Occlusions and 

Their Treatment 

10:30 am - TCT-73. Noninvasive Evaluation 

of Coronary Artery Collateral Flow Using 

Computed Tomographic Angiography 

Jin-Ho Choi 


10:45 am - TCT-74. Impact of Preprocedural 

Coronary CT Angiography on the Procedural 

Success of Percutaneous Coronary 

Intervention for Chronic Total Occlusion: 

A Multicenter Study of e-CTO Investigators 

Jin-Ho Choi 


11:00 am - TCT-75. Lumen Enlargement of 

the Coronary Segments Located Distal to 

Chronic Total Occlusions Successfully 

Treated with Drug-Eluting Stents at 

Follow-up 

Josep Gomez-Lara 


11:15 am - TCT-76. Predictive Value of the 

J-CTO Score in Percutaneous Coronary 

Interventions for Chronic Total Occlusions 



11:30 am - TCT-77. Initial and Midterm 

Angiographic Outcomes of Septal 

Channel Perforation Related to Retrograde 

Recanalization for Chronic Total Occlusions 

Hiroyuki Tanaka 


11:45 am - TCT-78. Long-term (Four-Year) 

Clinical Outcomes of Total Occlusions and 

Completeness of Revascularisation in the 

Synergy between Percutaneous Coronary 

Intervention with Taxus and Cardiac 

Surgery Trial 

Vasim Farooq 


12:00 pm - TCT-79. Chronic Total Occlusions 

in Sweden: Report from the Swedish 

Coronary Angiography and Angioplasty 

Registry (SCAAR) 

Truls R. Munddal 


12:15 pm - TCT-80. Incidence of Periprocedual 

Myocardial Infarction in Chronic Total 

Occlusion PCI and Impact on 

Clinical Outcome 

Tasuku Hasegawa 



Drug-Eluting Stents: 

Long-term Results 

10:30 am-12:30 pm 


Moderators: Kenneth Chin, Paul Vermeersch 

Discussants: Larry S. Dean, 

Daljeet S. Gambhir, Elvin Kedhi, 

Gervasio A. Lamas 

10:30 am - TCT-41. The Impact of Left 

Main Disease on Long-term Clinical 

Outcomes Among Patients Treated With 

the Unrestricted Use of Everolimus-Eluting, 

Sirolimus-Eluting, and Paclitaxel-Eluting 

Stents: A Substudy of the Bern- 

Rotterdam Cohort 

Giulio Stefanini 


10:45 am - TCT-42. Long-term Safety and 

Efficacy of Percutaneous Coronary 

Intervention with Stenting and Coronary 

Artery Bypass Surgery for Left Main 

Disease: Final Five-Year Follow-up of 

the SYNTAX Trial 



11:00 am - TCT-43. Final Five-year Follow-up 

of the SYNTAX Trial: Optimal 

Revascularization Strategy in Patients 

with Three-vessel Disease 


11:10 am - Discussion

11:15 am - TCT-44. LEADERS: Five-Year 

Follow-up from a Prospective, Randomized 

Trial of Biolimus A9-Eluting Stents with a 

Biodegradable Polymer vs. Sirolimus-Eluting 

Stents with a Durable Polymer: Final Report 

of the LEADERS study 



11:30 am - TCT-45. Long-term Safety and 

Effectiveness of XIENCE V Everolimus 

Eluting Coronary Stent System in Real-world 

Population: Three-Year Clinical Outcomes 

from the XIENCE V USA Study 



11:45 am - TCT-46. Comparison of Polymer- 

Free BioFreedom? Stents with Durable 

Polymer Taxus Liberté Stents: 

Three-Year Results from the BioFreedom 

First-in-Man Trial 



12:00 pm - TCT-47. Two-Year Clinical Outcome 

of the TWENTE Trial, A Randomized 

Controlled Trial Comparing Second- 

Generation Zotarolimus-Eluting Resolute 

Stents vs. Everolimus-Eluting Xience V 

Stents in Real-world Patients 

Clemens von Birgelen 


12:15 pm - TCT-48. Two-Year Follow-up and 

Subgroup Analysis of a Polymer-Free 

Sirolimus- and Probucol-Eluting Stent vs. 

A New Generation Zotarolimus-Eluting Stent 

in Coronary Artery Disease 

Lamin King 



Interventional Pharmacology 

10:30 am-12:30 pm 


Moderators: James H. Chesebro, Marc Cohen 

Discussants: Jorge Gaspar, 

Christoph A. Kaiser, Norman E. Lepor, 

Keyur H. Parikh 

10:30 am - TCT-49. A Comparison of 5 mg 

Prasugrel with 75 mg Clopidogrel in Very 

Elderly Coronary Artery Disease Patients: 

Pharmacodynamics and Rates of High 

On-Treatment Reactivity 

Joseph Jakubowski 


10:45 am - TCT-50. Influence of Age on 

Clinical Outcomes in Patients with NSTEMI 

Undergoing Treatment with Abciximab Plus 

Unfractionated Heparin vs. Bivalirudin: 

Analysis of the ISAR React 4 Study 

Lamin King 



11:00 am - TCT-51. Comparison of Clopidogrel 

and Prasugrel in Patients with Unprotected 

Left Main Disease Treated with Everolimus- 

Eluting Stents: Insight from the Florence Left 

Main-PCI Registry 

Renato Valenti 


11:15 am - TCT-52. Bivalirudin Reduces 

Cardiac Mortality in Patients with 

and Without Major Bleeding: 

The HORIZONS-AMI Trial 



11:30 am - TCT-53. Assessment of 

30-Day Rehospitalization for Acute 

Myocardial Infarction in Patients with 

Acute Coronary Syndrome Who Received 


A Comparative Effectiveness Study of 

Clopidogrel And Prasugrel 

Jay Bae 


11:45 am - TCT-54. The Influence of Smoking 

Status on the Pharmacodynamics of 

Prasugrel and Clopidogrel: 

The PARADOX Study 

Paul A. Gurbel 


12:00 pm - TCT-55. Major Adverse Cardiac 

Events Associated with Discontinuation of 

Clopidogrel Treatment Within the First 

Year After Coronary Stent Implantation in 

Western Denmark 

Michael Maeng 


12:15 pm - TCT-56. Incremental Value of 

Platelet Reactivity Over a Risk Score of 

Clinical and Procedural Variables in 

Predicting Bleeding Events After 


Fabio Mangiacapra 



Renal Denervation and 

Hypertension 

10:30 am-12:30 pm 

Room D231-232 

Moderators: Stefan Verheye, Thomas Zeller 

Discussants: Maurizio Menichelli, 

Allan Schwartz, Christodoulos I. Stefanadis, 

Marco V. Wainstein 

10:30 am - TCT-9. Morphological Assessment 

of Renal Arteries After Radiofrequency 

Catheter-based Sympathetic Denervation 

in a Porcine Model 

Michael Joner 



TranscaTheTer 


TherapeuTics 

10:45 am - TCT-10. Efficacy of Renal 

Denervation is Positively Impacted by 

Longitudinal Treatments 

Meital Mazor 


11:00 am - TCT-11. Renal Sympathetic 

Denervation: Inducing an Instantaneous 

and Persisting 24h Ambulatory Blood 

Pressure Drop in Patients with 

Resistant Hypertension: Results from 

the Halle-RDN-Registry 

Alexander Plehn 


11:15 am - TCT-12. Long-term Follow-up of 

Catheter-Based Renal Denervation for 

Resistant Hypertension Confirms Durable 

Blood Pressure Reduction 

Markus R. Schlaich 


11:30 am - TCT-13. Renal Resistive Indices, 

Urinary Albumin Excretion and Renal 

Function in Patients with Resistant 

Hypertension After Catheter-Based Renal 

Sympathetic Denervation 

Felix Mahfoud 


11:45 am - TCT-14. Effects of Renal 

Sympathetic Denervation on Heart Rate and 

Atrioventricular Conduction in Patients with 


Christian Ukena 


12:00 pm - TCT-15. Histomorphometric 

Evaluation of 2-D Characteristics and 3-D 

Sympathetic Renal Nerve Distribution in 

Hypertensive vs. Normotensive Patients 



12:15 pm - TCT-16. Renal Artery Nerve 

Distribution and Density in the Porcine 

Model: Biological Implications for the 

Development of Radiofrequency 

Ablation Therapies 

Armando Tellez 



STEMI/NSTEMI and Primary PCI 

10:30 am-12:30 pm 

Room D233-234 

Moderators: Thomas Aversano, 

Rajesh M. Dave 

Discussants: Karel T. Koch, Suhas S. Lele, 

Massimo Napodano, On Topaz 



104 


10:30 am - TCT-57. Angiographic Reperfusion 

Indices Predict Infarct Size and Mortality: 




10:45 am - TCT-58. Effects of Mechanical 

Thrombectomy and Intracoronary 

Abciximab on Coronary Flow and Infarct 

Size During Primary PCI: Analysis from the 

INFUSE-AMI Trial 

Jan-Henk Dambrink 


11:00 am - TCT-59. Effect of Intracoronary 

Abciximab and Aspiration Thrombectomy on 

Microvascular Obstruction in Large Anterior 

Myocardial Infarction: The INFUSE-AMI 

MRI Substudy 

Akiko Maehara 


11:15 am - TCT-60. CompariSon of Manual 

Aspiration with Rheolytic Thrombectomy in 

Acute Myocardial Infarction: The Final 

Six-Month Results of the SMART Primary 

PCI Trial 

Guido Parodi 


11:30 am - TCT-61. Infarct Size-Determined 

Uptake of CD34+ Cells in the Peri-Infarct 

Zone and Left Ventricular Remodeling: 

Insights from Integration of Labeled 

Cells Uptake SPECT Visualization with 

Sequential Cardiac MRI 

Piotr Musialek 


11:45 am - TCT-62. Impact of Atrial Fibrillation 

in Patients with STEMI Before and 

After Primary PCI: Insights from the 

HORIZONS-AMI Trial 

A. Rene 


12:00 pm - TCT-63. Remote Ischemic 

Perconditioning Improves Long-term Clinical 

Outcome in Patients Undergoing Primary 



Astrid D. Sloth 


12:15 pm - TCT-64. Bypassing the 

Emergency Department is Associated 

with Faster Reperfusion in Patients with 

Pre-hospital ST-segment Elevation: 

Findings from the Reperfusion of Acute 

Myocardial Infarction in Carolina Emergency 

Departments (RACE) Project 

Akshay Bagai 



Structural and Nonvalvular 

Intervention 

10:30 am-12:30 pm 

Room D235-236 

Moderators: Steven L. Almany, 


Discussants: Zahid Amin, Mark Goldberger, 

Randall J. Lee, Matthew J. Price 

10:30 am - TCT-371. First Clinical Evaluation 

of a Novel Percutaneous Right Ventricular 

Assist Device: The Impella RP 

Anson Cheung 


10:45 am - TCT-82. Cost-effectiveness Of 

Transcatheter Left Atrial Appendage 

Occlusion Compared with Five Alternative 

Anticoagulation Strategies for Stroke 

Prevention in Atrial Fibrillation: 

A Markov Decision Analysis 

Bryan Yan 


11:00 am - TCT-83. Watchman Left Atrial 

Appendage Closure in Atrial Fibrillation 

Patients with Contraindication to Oral 

Anticoagulation: the “Aspirin Plavix 

Registry” (ASAP) 

Horst Sievert 


11:15 am - TCT-84. Watchman Left Atrial 

Appendage Closure in Atrial Fibrillation 

Patients 75 Years or Greater; 

A Sub-Analysis of the PROTECT AF Study 

Saibal Kar 


11:30 am - TCT-85. Efficacy and Safety of 

Percutaneous Patent Foramen Ovale Closure 

in Patients with a Hypercoagulable Disorder 

Ignacio Cruz-Gonz lez 


11:45 am - TCT-86. Results of the Amplatzer 

Cardiac Plug European Multicenter 

Prospective Observational Study 

Jai-Wun Park 


12:00 pm - TCT-87. Safety and Efficacy of 

the MitraClip for the Treatment of Patients 

with a Dilated Left Ventricle and Functional 


Anita Asgar 


12:15 pm - TCT-81. Long-term Safety and 

Efficacy of Percutaneous Left Ventricular 

Transapical Access and Closure for 

Structural Heart Disease Interventions 

Chad Kliger 



Transcatheter Aortic 

Valve Replacement I 

10:30 am-12:30 pm 

Room D237-238 

Moderators: Wesley R. Pedersen, 

Leif Thuesen 

Discussants: Todd M. Dewey, Brij Maini, 

Oscar A. Mendiz, Vinod H. Thourani 

10:30 am - TCT-89. Timing, Predictive 

Factors and Prognostic Value of 

Cerebrovascular Events in a Large Cohort 

of Patients Undergoing Transcatheter 


Luis Nombela-Franco 


10:45 am - TCT-90. Predictive Factors and 

Long-Term Clinical Consequences of 

Persistent Left Bundle Branch Block 

Following Transcatheter Aortic 

Valve Implantation with a Balloon- 

Expandable Valve 

Maria Urena 


11:00 am - TCT-91. Perivalvular Aortic 

Regurgitation in Balloon-Expendable and 

Self-expendable TAVI Procedures: Predictors 

and Impact on Clinical Outcome: Insights 

from the FRANCE2 Registry 

Eric van Belle 


11:15 am - TCT-92. Does Mitral Regurgitation 

Impact the Outcome of TAVI Procedures? 

Insights from the FRANCE2 Registry 

Eric van Belle 


11:30 am - TCT-93. Relationship of 

Transcatheter and Surgical Aortic Valve 

Replacement with Left Ventricular Function 

in High-Risk Patients with Aortic Stenosis 

Sammy Elmariah 


11:45 am - TCT-94. Outcomes of Patients with 

Severe Aortic Stenosis and Chronic 

Obstructive Pulmonary Disease Treated with 

Transcatheter vs. Surgical Aortic Valve 

Replacement vs. Medical Therapy 

Danny Dvir 


12:00 pm - TCT-95. Outcomes of Transcatheter 

vs. Surgical Aortic Valve Replacement in 

Women: Insights from the Randomized 

PARTNER Trial 


12:10 pm - Discussion

12:15 pm - TCT-96. Influence of Gender on 

Clinical Outcomes Following Transcatheter 

Aortic Valve Implantation: Results from the 

UK TAVI Registry on Behalf of the UK TAVI 

Steering Group and the National Institute for 

Cardiovascular Outcomes Research 

Rasha Al-Lamee 



Transcatheter Aortic 

Valve Replacement II 

10:30 am-12:30 pm 

Room D240-241 

Moderators: Ganesh Manoharan, Brad I. Munt 

Discussants: Pamela S. Douglas, 

Chaim S. Lotan, Bernhard Reimers, 

Alfredo Trento 

10:30 am - TCT-97. Three-dimensional 

Echocardiographic Measurements of the 

Aortic Annulus Predict Paravavular 

Regurgitation Following Transcatheter 




10:45 am - TCT-98. The Impact of Effective 

Aortic Annulus Sizing by 3-D Computed 

Tomography on Paravalvular Leak 

Development After Transcatheter 


Fabian Plank 


11:00 am - TCT-99. The Vancouver Computed 

Tomography Sizing Guidelines for 


with Balloon-Expandable Valves 

Alex Wilson 


11:15 am - TCT-100. Transcatheter Aortic 

Valve Replacement for Degenerative 

Bioprosthetic Surgical Valves: Results 

from the Global Valve-in-Valve Registry 

Danny Dvir 


11:30 am - TCT-101. Twelve-Month Results of 

a Second-Generation Transapical Aortic 

Bioprosthesis for the Treatment of 


Joerg Kempfert 


11:45 am - TCT-102. Transapical Aortic Valve 

Implantation: Six- and 12-Month Results 

from a Multicenter Study Using the 

JenaValve Second-Generation Transcatheter 

Aortic Valve Implantation System 

Hendrik Treede 



12:00 pm - TCT-103. The Transaortic 

Approach for Transcatheter Aortic Valve 

Replacement: Initial Clinical Experience 

in the United States 

Joel Lardizabal 


12:15 pm - TCT-104. Feasibility Study of the 

Repositionable Lotus Aortic Valve 

Replacement System: Three-Month 

Outcomes in 11 Patients at High 

Surgical Risk (REPRISE I) 




PrEsEntation thEatEr 

12:15 pm-1:15 pm 

Please see page 165 for the Presentation 

Theater schedule. 



2012 (Part 2) 

1:00 pm-6:00 pm 

Room A208-209 


Session VI. LINC at TCT: Special Section 

on Lower Extremity Intervention 

Moderators: Dierk Scheinert, Andrej Schmidt 

Discussants: Max Amor, John R. Laird Jr, 

Craig M. Walker, Thomas Zeller 

interventionAl teChniqUes for CoMplex 

AortoiliAC oCClUsions 

1:00 pm - Recanalization of Aortoiliac CTOs: 

Access Strategies and the Value of 

Occlusion Devices 


1:07 pm - Balloon-Expandable vs. Self- 

Expanding vs. Covered Stents In Iliac 

Arteries: Insights from Clinical Trials 

and Clinical Practice 

Tony Das 

1:14 pm - Brachial and Radial Approaches 

for Iliofemoral Interventions 

Max Amor 



TranscaTheTer 


TherapeuTics 

reCorDeD CAse 

1:26 pm - Percutaneous Reconstruction 

of a Complete Aortoiliac Occlusion 

(Leriche Syndrome) 


ADvAnCeD ApproAChes for 

feMoropoliteAl oCClUsions 

1:46 pm - Tips and Tricks for Successful 

Crossing of Femoropopliteal CTOs 

Andrej Schmidt 

1:53 pm - After CTO Recanalization, 

What Is the Role of Drug-Eluting 

Devices, Covered Stents, Etc? 

Thomas Zeller 

2:00 pm - The Last Frontier: Interventional 

Techniques for Recanalization of the 

Popliteal Artery 

Dierk Scheinert 


reCorDeD CAse 

2:12 pm - Retrograde SFA Recanalization for 

In-Stent-Occlusion with Puncture of the 

Occluded Stents 


pioneering teChniqUes for 

revAsCUlArizAtion in CritiCAl 

liMB isCheMiA 

2:32 pm - The Angiosome Concept in Clinical 

Practice: Implications for Patient-Specific 

Revascularization Approaches 

Lindsay S. Machan 

2:39 pm - Access and Techniques for 

Retrograde Tibial Recanalization 

Craig M. Walker 

2:46 pm - Recanalization of Pedal Arteries: 

Anatomy, Imaging, and Wiring Techniques 

Marco Manzi 


reCorDeD CAses 

2:58 pm - Retrograde Tibial Recanalization 


Session VII. Infrapopliteal Intervention 

Moderators: Alex Powell, 


Discussants: William H. Julien, 

Hugo F. Londero, Robert A. Lookstein, 

Erich Minar 


3:18 pm - Intervention for Claudication 

Due to Infrapopliteal Disease: Targets 

and Techniques 




106 


3:25 pm - Planning Infrapopliteal Intervention 

for CLI: Approach and Toolbox Options 

Mahmood K. Razavi 

3:32 pm - A Multidisciplinary Approach to 

CLI Is Essential: Wound Care, Risk Factor 

Modification, and Endovascular Therapy 

James P. Zidar 

3:39 pm - Blue-Toe Syndrome: 

Does Thrombolysis Have a Place? 


3:46 pm - Importance of Sustained 

Patency and the Role of DES for 

Infrapopliteal Intervention 



Mini-DeBAtes 

4:00 pm - Debate 1: Is Endovascular 

Intervention the First-line Therapy 

for CLI? Pro! 

Tony Das 

4:05 pm - Debate 1: Is Endovascular 

Intervention the First-line Therapy 

for CLI? Con! 



4:15 pm - Debate 2: Is Straight-Line Flow to 

the Foot Sufficient (And Is the Angiosome 

Concept Nonsense)? Pro! 

Mehdi H. Shishehbor 

4:20 pm - Debate 2: Is Straight-Line Flow to 

the Foot Sufficient (And Is the Angiosome 

Concept Nonsense)? Con! 

Andrej Schmidt 


4:30 pm - Debate 3: Is Long-term Patency 

Following Tibial Intervention for Critical 

Limb Ischemia Necessary? Pro! 

Thomas Zeller 

4:35 pm - Debate 3: Is Long-term Patency 

Following Tibial Intervention for Critical 

Limb Ischemia Necessary? Con! 

Alex Powell 


Session VIII. Vascular Complications 

Moderators: Robert D. Safian, 

Robert M. Schainfeld 

Discussants: John A. Bittl, 

Anthony J. Comerota, Constantino S. Pena, 

Luigi Salemme 

ACCess site CoMpliCAtions 

4:45 pm - Femoral Access Site Complications: 

Diagnostic and Therapeutic Tips and Tricks 

Stephen R. Ramee 

4:52 pm - Failures and Complications of 

Closure Devices: Device-Specific 

Characterization and Management 

Robert M. Schainfeld 

4:59 pm - Radial, Brachial, and Axillary 

Access: Tips for Success and Traps 

for Disaster 

Lindsay S. Machan 


tArget vessel CoMpliCAtions 

5:11 pm - Vessel Rupture and Perforation: 

Frequency, Locations, and Management 

Zvonimir Krajcer 

5:18 pm - Selection and Use of Coils 

for Embolization of Perforations 

John H. Rundback 

5:25 pm - Selection and Use of Stent 

Grafts for Vessel Rupture 

James F. Benenati 


life-threAtening or fAtAl vAsCUlAr 

CoMpliCAtions: CAse presentAtions 

5:37 pm - Case 1: During a TAVR 


5:42 pm - Case 2: During an EVAR or TEVAR 


5:47 pm - Case 3: During an Iliofemoral 

Intervention 


5:52 pm - Case 4: During Carotid Artery 

Stenting: Extracerebral or Access Vessel 

Related 

Fayaz Shawl 


First-in-Human Studies: Global 

Regulatory and Translational 

Considerations 

1:00 pm-6:00 pm 

Room B217-218 


Session I. Bioabsorbable Vascular Scaffolds 

Moderators: Jacques J. Koolen, 


Discussants: Syed Hossainy, Greg L. Kaluza, 

Paul J. Miller, Richard J. Rapoza, 

Pamela P. Simons, Mitchell Sugarman, 

Ron Waksman 

1:00 pm - State-of-the-Field Keynote: Impact 

of Emerging Biomaterials on Next- 

Generation Bioabsorbable Vascular 

Scaffold Development 

Syed Hossainy 

1:15 pm - Preclinical Review: Update on 

Emerging Programs and Validation Methods 


1:25 pm - Early Human Clinical Studies: 

Patient Selection, Technical Considerations, 

and Endpoints 


1:35 pm - Highlighted Abstract: TCT-563. 

Multicenter, First-in-Man Evaluation of 

the Myolimus-Eluting Bioresorbable 

Coronary Scaffold: Six-Month Clinical 

and Imaging Results 



Session II. Drug-Coated Balloons 

Moderators: Elazer R. Edelman, 


Discussants: Juan F. Granada, Greg L. Kaluza, 

Paul J. Miller, Dierk Scheinert, Bruno Scheller, 

Pamela P. Simons, Mitchell Sugarman, 

Gunnar Tepe 

2:00 pm - State-of-the-Field Keynote: 

Technical and Biological Challenges for 

Future DCB Development 


2:15 pm - Preclinical Review: 

Experimental Pathways for Evaluation of 

Drug Transfer, Tissue Pharmacokinetics, 

and Vascular Effects 




and Endpoints 



Six-Month Results of the BIOLUX PI 

First-in-Man Study Comparing a Paclitaxel- 

Releasing Balloon Catheter vs. an Uncoated 

Balloon Catheter in Femoropopliteal Lesions 



Session III. Transcatheter Aortic 

Valve Replacement (TAVR) 

Moderators: Juan F. Granada, Renu Virmani 

Discussants: Todd M. Dewey, Susheel Kodali, 

Jean-Claude Laborde, Ian T. Meredith, 

Paul J. Miller, Stanton J. Rowe, 

Pamela P. Simons, Mitchell Sugarman 


Emerging Opportunities for Future TAVR 

Development: Stroke, Paravalvular 

Leaks, and Beyond 


3:15 pm - Preclinical Review: 

Experimental Considerations and 

Challenges for TAVR Validation 

Stanton J. Rowe 


Patient Selection, Technical 

Considerations, and Endpoints 

Ian T. Meredith



(TAVR) with a New Self-Expanding 

Percutaneous Heart Valve and Motorized 


Ronald Binder 


Session IV. Interventional Heart Failure 

Moderators: Marvin J. Slepian, Renu Virmani 

Discussants: Daniel Burkhoff, 

JoAnn Lindenfeld, Paul J. Miller, 

Pamela P. Simons, Mitchell Sugarman 


Future Perspectives in the Device-Based 

Treatment for Heart Failure 


4:15 pm - Preclinical Review: Experimental 

Models and Biological Considerations for 

the Validation of Heart Failure Devices 




and Endpoints 

William T. Abraham 


Three-Year Clinical Outcomes of the 

First-in-Human Experience with 

Percutaneous Ventricular Restoration 

Using the Parachute Device in Patients 

with Ischemic Heart Failure and Dilated 

Left Ventricle 

Marco A. Costa 


Session V. Renal Artery Denervation 

Moderators: Juan F. Granada, Renu Virmani 

Discussants: Deepak L. Bhatt, Tim A. Fischell, 

James R. Margolis, Paul J. Miller, 

Pamela P. Simons, Paul A. Sobotka, 

Mitchell Sugarman 


The Next Challenge: Improving Technical 

Efficiency and Biological Response 

(Nonresponders) 

Deepak L. Bhatt 

5:15 pm - Preclinical Review: Perirenal Nerve 

Distribution, Density, and Quantification: 

Implications for the Evaluation of Device 

Safety and Efficacy 

Renu Virmani 



and Endpoints 

Paul A. Sobotka 


Circumferential Therapeutic Ultrasound for 

the Treatment of Resistant Hypertension: 

Preliminary Results of Human Feasibility 

Study (SOUND-ITV) 

Peter Neuzil 




Hot Topics in Cardiology: 

ACC.12 with TCT Highlights 

for the Interventional, Invasive, 

and General Cardiologist 

1:00 pm-6:05 pm 

Ballroom A 

Welcome and Introduction to the 

ACC.12 with TCT HIghlight Session 

Patrick T. O’Gara, E. Murat Tuzcu 

Session I. Acute Coronary 

Syndrome Updates 

Moderators: Ajay J. Kirtane, Sunil V. Rao 

Discussants: Steven R. Bailey, 

Jessica L. Mega 


Ajay J. Kirtane, Sunil V. Rao 

1:10 pm - Legends Video: Braunwald: 

Reducing MI Size 

1:13 pm - Late Breaking Trials: BRIDGE-ACS 

(Multimodality Approach to Adherence), 

INFUSE-AMI (STEMI), and IMMEDIATE (GIK) 


1:23 pm - Legends Video: Fuster: Vulnerable 

Plaque and Thrombosis 

1:26 pm - Point-of-Care Platelet and 

Genetic Testing 


1:36 pm - Year in Review: ACS and STEMI 


1:52 pm - Legends Video: Colombo: PCI 

1:55 pm - State of the Art 

Sunil V. Rao 


Session II. Stable Ischemic Heart 

Disease Updates 

Moderators: Rudiger Lange, David A. Morrow 

Discussant: Robert D. Simari 


Rudiger Lange, David A. Morrow 

2:20 pm - Late Breaking Trials: CORONARY 

(On-Pump vs. Off-Pump CABG), CPORT 

(Nonprimary PCI Without Surgical 

Backup), ASCERT (CABG vs. PCI), 

and TRAP2-TIMI 50 (Vorapaxar 

for SIHD Patients) 

David A. Morrow 

2:36 pm - Stem Cell Therapies: State of the Art 

(Including the FOCUS Trial) 

Robert D. Simari 

2:52 pm - Innovators Video: Mack 



TranscaTheTer 


TherapeuTics 

Session III. Prevention Updates 

Moderators: Elizabeth A. Jackson, 

Jeffrey T. Kuvin 

Discussants: Deepak L. Bhatt, Donna Polk 


Elizabeth A. Jackson, 


3:08 pm - Legends Video: Fuster (Polypill) 

3:11 pm - Late Breaking Trials: 

STAMPEDE (Bariatric Surgery) and 

PCSK9 (LDL Reduction) 

Elizabeth A. Jackson 

3:19 pm - Hypertension: Renal Denervation 


3:25 pm - Legends Video: Yacoub (Africa) 

3:28 pm - Late Breaking Trials: Venous 

Thromboembolic Disease EINSTEIN-PE 

(Rivaroxaban) 


3:34 pm - Year in Review: 

Preventative Cardiology 

Donna Polk 


Session IV. Imaging Updates 

Moderators: Karthik Ananthasubramaniam, 

Issam Mikati 

Discussant: Robert O. Bonow 


Karthik Ananthasubramaniam 

3:55 pm - Late Breaking Trials: ACRIN-PA (CTA 

in Low-Intermediate Risk Chest Pain) and 

ROMICAT II (CTA in Low-Intermediate Risk 

Chest Pain) 

Issam Mikati 

4:04 pm - Viability Testing, Clinical 

Decision Making 

TBA 


Cardiovascular Imaging 

Karthik Ananthasubramaniam 

4:22 pm - Innovators Video: 

Narula (Molecular Imaging) 


Session V. Heart Failure Updates 

Moderators: Biykem Bozkurt, 

Dennis M. McNamara 

Discussants: William T. Abraham, 

Sharon Hunt, E. Magnus Ohman 


Biykem Bozkurt, 


4:40 pm - Circulatory Support for 

Cardiogenic Shock 

E. Magnus Ohman 



108 


4:46 pm - Contemporary LVAD Therapy: 

Destination, Recovery, Bridge? 

Sharon Hunt 

4:51 pm - Treatment of Acute 

Decompensated HF 


4:57 pm - Updated CRT Guidelines 



Heart Failure Therapies 

Biykem Bozkurt 


Session VI. Arrhythmia Updates 

Moderators: Peter A. Brady, Ralph J. Verdino 

Discussants: Gust Bardy, John Camm 


Peter A. Brady, Ralph J. Verdino 

5:23 pm - Subcutaneous Defibrillators 

Gust Bardy 

5:31 pm - Management of the Device Patient 

for the Non-EP MD 

Ralph J. Verdino 

5:39 pm - Atrial Fibrillation: (1) CHADS2 

vs. CHA2DS2-VASc Risk Assessment, and 

(2) AHA/ACC vs. ACCP/ESC Approach to 

Stroke Prevention. 

Peter A. Brady 

5:47 pm - Year in Review: Arrhythmias 

John Camm 



Identifying the High-Risk Patient 

and Lesion: From Vulnerable 

Plaque to Ischemia 

1:00 pm-6:10 pm 

Room B212-213 

Session I. Ischemia, Vulnerable Plaque, 

and the Vulnerable Patient 

Moderators: Daniel S. Berman, Daniel I. Simon 

Discussants: Adam J. de Belder, 

Henricus J. Duckers, Dariusz Dudek, 

Pedro R. Moreno, Nico H.J. Pijls, 

Robert L. Wilensky 

1:00 pm - Introductory Lecture. A New 

Paradigm Revisited: From Ischemia 

to Vulnerable Plaque 


1:10 pm - Pathogenesis of Vulnerable 

Plaque 2012: What’s New? 

Renu Virmani 

1:20 pm - Blood, Tissue, and Genetic 

Markers for Vulnerable Plaque: 

From Theory to Practice 

Jozef Bartunek 

1:30 pm - Is Ischemia a Marker of Plaque 

Vulnerability and Future Thrombosis? 


the greAt vUlnerABle plAqUe DeBAte: 

is vUlnerABle plAqUe A systeMiC or 

foCAl DiseAse? 

1:40 pm - Vulnerable Plaque Is a Systemic 

Inflammatory and Vascular Disease 

Valentin Fuster 

1:50 pm - Most Diseases Are Systemic: 

It’s the Focal Manifestations that Count! 

James E. Muller 

2:00 pm - The Vulnerable Mind: Connections 

Between the Cortex and Coronaries 

Amir Lerman 


Session II. Noninvasive Imaging to Identify 

the High-Risk Patient and Plaque 

Moderators: Jonathon A. Leipsic, 

Robert S. Schwartz 

Discussants: Stephen E. Epstein, 

Roger J. Laham, Konstantinos Toutouzas, 


2:25 pm - CTA Imaging and Prognosis: 

From Calcium Scoring to Coronary Anatomy 

Szilard Voros 

2:35 pm - Potential Role for Pan-Vascular 

Imaging: Insights from the HRP Project 

Valentin Fuster 

2:45 pm - The Case for CT-FFR as the Optimal 

Screening Tool: Latest DEScover and 

DeFACTO Results 


2:55 pm - Reevaluating the Radiation 

Risk of CT Angiography 

Andrew J. Einstein 

3:05 pm - Statement: Molecular Imaging Will 

Transform the Evaluation of Atherosclerosis! 

Farouc Jaffer 

3:15 pm - Advanced Imaging for 

Vulnerable Plaque Detection: 

The Future Is (Almost) Now! 

Jagat Narula 


Session III. Invasive Imaging to Identify 

the High-Risk Patient and Plaque 

Moderators: James A. Goldstein, 


Discussants: Takashi Akasaka, Takashi Kubo, 

Francesco Prati, Evelyn S. Regar, 

Habib Samady 

3:40 pm - Should VH-IVUS Be Used as a 

Clinical Tool to Detect and Treat Vulnerable 

Plaque TODAY: From PROSPECT to VIVA 

Patrick A. Calvert 

3:50 pm - OCT as a Clinical Tool for 


New Insights and Future Studies 

Shiro Uemura 

4:00 pm - NIRS as a Clinical Tool for 


Findings in Patients with Acute STEMI 


4:10 pm - Implications of Low- and High-Shear 

Stress to Atherosclerosis Progression and 

Rupture: Predictions Beyond PREDICTION 

Peter H. Stone 

4:20 pm - Vignettes on Plaque Stability 1: 

Insights from the VH Registry and 

HORIZONS-AMI 

Akiko Maehara 

4:25 pm - Vignettes on Plaque Stability 2: 

Insights from Serial Imaging in IBIS II 



Session IV. Therapeutic Implications of the 

High-Risk Patient and Plaque 

Moderators: John A. Ambrose, 

Robert D. Simari 


Sheldon Goldberg, Daniel I. Simon, 

Christodoulos I. Stefanadis 

4:45 pm - Do Statins and Other Therapies 

Alter Vulnerable Plaque Characteristics? 

Insights from Imaging 

Pedro R. Moreno 

4:55 pm - Darapladib and STABILITY Update 


5:05 pm - PCSK9 Inhibitors: The Holy Grail? 

Evan A. Stein 

5:15 pm - The HDL Hypothesis: A Critical 

Reappraisal 


5:25 pm - Therapies Based on ApoA1 and 

ApoA1 Milano: Overview of the Field 

Bryan Brewster 

5:35 pm - What Will It Take for Focal Therapy 

of Vulnerable Plaque to Become a Reality? 

Preclinical and Clinical Insights 


5:45 pm - Nanoparticle-Based Therapies for 

Atherosclerosis: The NANOM FIM Study 

Alexander N. Kharlamov 


6:00 pm - Adjourn

Interventional Heart Failure 

1:00 pm-6:10 pm 

Room B210-211 


Session I. Keynote Address 

Moderators: William T. Abraham, Stefan Anker 

1:00 pm - New Devices in the Old World: 

A European View of Device Development 

for Heart Failure 

Stefan Anker 

Session II. Electrical Therapies for CHF 

Moderators: William T. Abraham, Stefan Anker 

Discussants: Robin E. Germany, 

Spencer H. Kubo, Kimberly Selzman 

1:15 pm - CRT Applicability in Key Subgroups: 

Earlier (NYHA I/II), Later (NYHA IV), and 

Female Patients 

Kimberly Selzman 

1:25 pm - BioControl 

Spencer H. Kubo 

1:35 pm - Respicardia 

Robin E. Germany 


Session III. Progress with Ventricular 

Assist Devices 

Moderators: Eric A. Rose, Richard Smalling 

Discussants: Keith D. Aaronson, 

William T. Abraham, Henning Rud Andersen, 

Robert D. Dowling, Robert E. Michler, 

Leslie W. Miller, John O’Connell 

1:55 pm - Background Medical and Device 

Therapies for Patients with VADs 

Emma Birks 

2:05 pm - REVIVE-IT 

Keith D. Aaronson 

2:15 pm - ROADMAP 

John O’Connell 

2:25 pm - Counterpulsation for Chronic Heart 

Failure: Sunshine 


2:35 pm - CircuLite for Patients with 

INTERMACS 4, 5, and 6 

Leslie W. Miller 

2:45 pm - Autologous Cardiac Stem Cells in 

VAD Patients 

Robert E. Michler 

2:55 pm - SynCardia 

Marvin J. Slepian 

3:05 pm - Counterpulsation with SYMPHONY 

for Chronic Heart Failure 

Robert D. Dowling 

3:15 pm - pVADs in Cardiogenic Shock 

Mark B. Anderson 

3:25 pm - Thoratec Percutaneous Heart Pump 




Session IV. Anatomic Abnormalities of the 

Valve and the LV Chamber 

Moderators: JoAnn Lindenfeld, 

Robert J. Siegel 

Discussants: Stephan Baldus, 

Robert E. Michler, Martyn R. Thomas 

3:50 pm - Overview: Addressing Structure in 

Structural Heart Disease 


4:00 pm - First Report of a Confirmatory 

(Cohort B) Study of the Parachute Device in 

Ischemic Dilated Cardiomyopathy 


4:10 pm - BioVentrix Minimally Invasive 

Reshaping of the Anterior Infarcted Heart 

Lon S. Annest 

4:20 pm - MitraClip in Patients with CHF 

Stephan Baldus 


Session V. Heart Failure with Preserved 

Ejection Fraction (HFPEF) 

Moderators: Ileana L. Pina, Jay S. Yadav 

Discussants: Ted E. Feldman, 

Mitchell W. Krucoff, William C. Little 

4:40 pm - HFPEF: Overview of 

Pathophysiology and Therapies 

William C. Little 

4:50 pm - DC Devices: Interatrial 

Shunt for HFPEF 


5:00 pm - CVRx: Results in Heart Failure 

William C. Little 

5:10 pm - CorAssist 



Session VI. Cellular and Noncellular 

Implants for Heart Failure 

Moderators: Daniel Burkhoff, Bernard J. Gersh 

Discussants: Jozef Bartunek, 


5:30 pm - Overview 1: Biological Therapies 

for Heart Failure: Clinical Perspectives 

and Progress 


5:40 pm - Overview 2: Biological Therapies 

for Heart Failure: Regulatory Perspectives 

Steve Winitsky 

5:50 pm - Post-MI Alginate to Prevent 

Remodeling 





TranscaTheTer 


TherapeuTics 

Launching and Sustaining 

Your Career 

1:00 pm-6:00 pm 

Room A104-105 


Session I. Early Success Begets Success 

Moderator: Pamela S. Douglas 

Discussants: J. Dawn Abbott, Nirat Beohar, 

David J. Cohen, Lynn F. Peng, Thomas M. Tu, 

Howard T. Walpole 

1:00 pm - Contracts 101 

Thomas M. Tu 

1:35 pm - Payment Reform: 

Prepare for the Changes 

Pamela S. Douglas 

2:00 pm - Lifelong Learning and Staying 

Abreast of the Literature 

J. Dawn Abbott 

2:15 pm - The CV Service Line: Patients, 

Products, and Referrals 



Session II. High Career Achievement 

Moderator: Paul Sorajja 

Discussants: Navin K. Kapur, 

Norman E. Lepor, Srihari S. Naidu, 

Jennifer A. Tremmel, Howard T. Walpole 

3:10 pm - Post-Fellowship Skill Training: 

Proctoring and Beyond 

Paul Sorajja 

3:35 pm - The Physician Executive: 

Do I Need an MBA or Not? 


4:00 pm - Emotional Intelligence and 

Crucial Conversations 


4:25 pm - Leadership Pathways in 

National Societies 




Left Atrial Appendage 

Closure: Indications, Devices, 

and Techniques 

1:00 pm-6:13 pm 

Room B214-215 

Session I. LAA Closure: Emerging Data 

Moderators: Peter Sick, Horst Sievert 

Discussants: Peter C. Block, A. Marc Gillinov, 

Saibal Kar, Jai-Wun Park, Vivek Y. Reddy, 

Mark Reisman 



110 


1:00 pm - Various Techniques for Surgical LAA 

Closure (With and Without Thoracoscopy): 

Acute and Long-term Outcomes 

A. Marc Gillinov 

1:08 pm - Long-term Results from 

PROTECT AF: Is the Risk-Benefit Ratio 

Really Uncertain? 


1:16 pm - Prevail Study: Design and 

Current Status 

Saibal Kar 

1:21 pm - Outcomes and Insights from 

the European ACP Registry 

Jai-Wun Park 

1:29 pm - The Spectrum of Early 

Complications of LAA Closure: 

Have They Been Eliminated? 


1:37 pm - Epicardial LAA Closure with 

the LARIAT (SentreHEART): Simple, Safe, 

and Effective? 

Mark Reisman 

1:45 pm - LAA Closure in Anticoagulation 

Contraindicated Patients: The ASAP Trial 

and Beyond 

Horst Sievert 

1:53 pm - The Spectrum of Late Complications 

of LAA Closure: Device-Specific 

Mechanisms, Incidence, and Prevention 

Peter C. Block 

2:01 pm - Quality-of-Life and Cost- 

Effectiveness After LAA Closure 

Vivek Y. Reddy 


Session II. Weighing the Risks and 

Benefits of Therapeutic Alternatives 

Moderators: Peter C. Block, 

Brian K. Whisenant 

Discussants: Shephal Doshi, Roxana Mehran, 

Peter Sick, Gregg W. Stone 

2:23 pm - Modeling the Risk of Stroke and 

Bleeding in Atrial Fibrillation: What Are the 

Optimal Risk Scores? 

Roxana Mehran 

2:33 pm - Synthesis of the New ESC LAA 

Closure Guidelines 

Peter Sick 

2:43 pm - The New Anticoagulants: 

A Meaningful Step Forward? 


2:53 pm - Acute Success Rates, Complication, 

and Long-term Stroke Risks After AF 

Ablation: A Critical Appraisal of a 

Mixed Literature 

Shephal Doshi 


Session III. Imaging for LAA Closure 

Moderators: Saibal Kar, Vivek Y. Reddy 

Discussants: Rebecca Tung Hahn, 

Ilona Hoffmann, Carlos E. Ruiz 

3:13 pm - A Primer of LAA Closure Imaging: 

Essential Views and Pattern Recognition 


3:23 pm - 2-D TEE, 3-D TEE, and Fluoro-Echo 

Overlay: What Is Essential and What Is 

Nice to Have? 

Ilona Hoffmann 

3:33 pm - CT and MRI for Patient Selection 

and Procedural Guidance 

Carlos E. Ruiz 

3:43 pm - ICE Guidance for LAA Closure: 

Advantages and Limitations 



Session IV. Evolution of LAA 

Closure Devices 

Moderators: David R. Holmes Jr, 


Discussants: Alexander J. Javois, Yat-Yin Lam, 

Vivek Y. Reddy, Peter Sick, Horst Sievert 

4:03 pm - Attributes of the Perfect LAA 

Closure Device: What All the Companies 

Should Strive For 

Horst Sievert 

4:13 pm - The New Fourth-Generation 

WATCHMAN (BSC-Atritech): Device Design 

and Results of the EVOLVE Trial 


4:23 pm - WaveCrest (Coherex Medical): 

Device Iteration, Human Outcomes, and 

Clinical Trial Directions 

Saibal Kar 

4:33 pm - PFM Medical: Device Description 

and Preclinical Results 

Alexander J. Javois 

4:38 pm - Lifetech LAA Closure Device: 

Description and Preclinical Results 

Yat-Yin Lam 

4:43 pm - Cardia LAA Closure Device: 

Description and Preclinical Results 



Session V. LAA Closure Tips and Tricks 



Discussants: Steven L. Almany, 

Maurice Buchbinder, Brij Maini, 

David W.M. Muller, Matthew J. Price, 

Ramon Quesada, Gerhard C. Schuler, 


4:58 pm - WATCHMAN Tips and Tricks 

Peter Sick 

5:08 pm - Case Presentation: 

A Complicated WATCHMAN Case 

Horst Sievert 

5:18 pm - ACP Tips and Tricks 

David W.M. Muller 


A Complicated ACP Case 

Jai-Wun Park 

5:38 pm - LARIAT Tips and Tricks 

Steven J. Yakubov 


A Complicated LARIAT Case 

Randall J. Lee 

5:58 pm - How to Become Trained and 

Start a LAA Closure Program 



Next-Generation DES and 

Bioabsorbable Scaffolds 

1:00 pm-6:07 pm 



Session I. The Potential for Novel 

Technologies 

Moderators: Juan F. Granada, 

Robert S. Schwartz 

Discussants: Nicolas A.F. Chronos, 

Joost Daemen, Keith D. Dawkins, 

Michael Joner, Charles A. Simonton, 

Josiah N. Wilcox 

1:00 pm - Current Perspectives on DES 

Outcomes: Is There a Clinical Need for 

Development of Next Generation DES 

Systems? 


1:08 pm - Balancing Device Polymeric Load 

and Long-term Absorption Will Result in the 

Ideal DES Platform: Bioresorbable Vascular 

Scaffolds Are the Future! 

Jean-François Tanguay 

1:16 pm - Strut Architecture and Polymer 

Configuration Modulates Device Outcomes: 

Current Nonabsorbable DES Systems Will 

Be Difficult to Improve Upon! 


1:24 pm - Early Cellular Interaction and 

Biomaterials: Bioabsorbable Polymers and 

Advanced Metallic Surfaces Are the Next 

Logical Step! 


1:32 pm - Vascular Healing and the Evolution 

of DES Technologies: Pathology Insights 

from Human Specimens 

Renu Virmani 


Session II. Metallic Drug-Eluting Stents 

with Bioabsorbable Polymers 

Moderators: Dean J. Kereiakes, Alan C. Yeung 

Discussants: Marco A. Costa, Yaling Han, 

Chaim S. Lotan, Simon Walsh, Bo Xu 

1:52 pm - Synergy (Boston Scientific) Program 

Update 


2:02 pm - TARGET I: A Prospective, 

Randomized Trial of a Biodegradable 

Polymer-based Sirolimus-Eluting Stent vs an 

Everolimus-Eluting Stent (MicroPort) 

Run-Lin Gao 

2:09 pm - DESSOLVE II: A Prospective, 

Randomized Trial of a Biodegradable 

Polymer-based Sirolimus-Eluting Stent vs a 

Zotarolimus-Eluting Stent (Micell) 


2:16 pm - Orsiro (BIOTRONIK) 

Program Update 


2:23 pm - BioMime (Meril Life Sciences) 


Ashok Seth 

2:30 pm - Abluminus (Envision Scientific) 


Sameer I. Dani 

2:37 pm - REMEDEE Combo 

(OrbusNeich) Program Update 

Michael Haude 

2:44 pm - DESyneBD (Elixir Medical) 



2:51 pm - Inspiron (Scitech) Program Update 

Pedro A. Lemos 

2:58 pm - Sirolimus-Eluting Stent 

(Svelte Medical) Program Update 

Mark W.I. Webster 


Session III. Polymer-Free Metallic 


Moderators: Raimund A. Erbel, 

Philip M. Urban 

Discussants: Vinay K. Bahl, Graham A. Cassel, 

Ricardo A. Costa, Giulio Guagliumi, 

John M. Lasala, Daniel I. Simon 

3:20 pm - Yukon (Translumina) 


Julinda Mehilli 

3:30 pm - Cre8 (CID) Program Update 

Didier Carrié 

3:37 pm - BioFreedom (Biosensors 

International) Program Update 


3:44 pm - Amazonia Pax (MINVASYS) 


Jean Fajadet 


3:51 pm - VESTAsync (MIV Therapeutics) 



3:56 pm - Nanoparticle-Based Stents 1: 

Mitsui (Meril Life Sciences) Program Update 


4:01 pm - Nanoparticle-Based Stents 2: 

FOCUS np (Envision Scientific) 


Ashok Seth 

4:06 pm - Progress with a Hollow-Core 

Zotarolimus-Filled Stent (Medtronic) 

Josiah N. Wilcox 


Session IV. Bioresorbable Vascular 

Scaffolds: Latest Designs and Clinical 

Study Evidence 

Moderators: Dean J. Kereiakes, Ron Waksman 

Discussants: Adrian P. Banning, 

Stephen G. Ellis, Jacques J. Koolen, 

Detlef G. Mathey, Yoshinobu Onuma, 

Jean-François Tanguay 

4:26 pm - ABSORB (Abbott Vascular) Program 

to Date: Integrated Insights from 

Multimodality Imaging 


4:38 pm - Vasomotion After Metallic and 

Bioabsorbable Implants: Evaluation and 

Clinical Relevance 


4:45 pm - ABSORB (Abbott Vascular) Clinical 

Program to Date (Including the Six-Month 

EXTEND Results): Strengths, Limitations, 

and Unknowns of 

the ABSORB Stent 


4:57 pm - Can BVS Be Used in 

Complex Coronary Anatomy? 

A Series of Case Presentations 


5:07 pm - ABSORB III and IV (Abbott Vascular) 

Pivotal Clinical Trial Program 


5:12 pm - ReZolve (REVA Medical) Clinical 



5:22 pm - First-in-Man Results with a 

Myolimus-Eluting Bioabsorbable PLLA- 

Based Vascular Scaffold (Elixir DESolve) 


5:32 pm - Progress with Drug-Eluting 

Magnesium Resorbing Stents (BIOTRONIK): 

DREAMS 2-Year Results 

Michael Haude 

5:42 pm - The ART Stent: Design and 

Early First-in-Man Experiences 

Jean Fajadet 


TranscaTheTer 


TherapeuTics 

5:47 pm - The Amaranth Stent: Design 

and Future Directions 


5:52 pm - Design of a Fully Drug-Eluting 

Bioabsorbable Scaffold with EPC-Capture 

Technology 

Robert J. Cottone 



The Valvular Heart Disease 

Summit (Part 2): Mitral 

Valve Therapies 

1:00 pm-6:21 pm 


Session I. Standards and Global Practices 

Moderators: Blase A. Carabello, 

Francesco Maisano 

Discussants: James S. Gammie, 

Robert A. Guyton, Gregg W. Stone 

1:00 pm - The 2012 ESC Mitral Valve 

Guidelines: What’s New, and How Should 

They Affect Practice? 


1:10 pm - Practice Trends in the United States: 

Nonadherence to the Mitral Valve Guidelines 

James S. Gammie 

1:20 pm - The Mitral VARC Initiative 



Session II. Mitral Valve Anatomy 

and Imaging 

Moderators: Rebecca Tung Hahn, 


Discussants: David H. Adams, Jeroen J. Bax, 

Paul A. Grayburn, Maurice E. Sarano, 

Robert J. Siegel, Nina C. Wunderlich 

1:35 pm - New Insights into Normal 

and Diseased Mitral Valve Anatomy 

David H. Adams 

1:45 pm - Essentials of 2-D and 3-D 

Mitral Valve Imaging 

Nina C. Wunderlich 

1:55 pm - Rationale for Quantitative 

Echocardiography to Grade MR Severity 

and a Critical Appraisal of Its Accuracy 

and Utility 

Paul A. Grayburn 

2:05 pm - Imaging the Mitral Valve: 

Beyond Echo 

Jeroen J. Bax 




112 


instrUCtive DeBAte 1. shoUlD the 

Definition of “severe” Mr Be Different 

for fUnCtionAl AnD DegenerAtive Mr? 

2:25 pm - Yes: The Quantitative Threshold 

Should Be Lowered! 


2:33 pm - No: Changing Standards Would 

Be Premature! 


2:41 pm - Case Example: How Severe 

Is the MR in this Patient? 



Session III. Functional Mitral Regurgitation: 

Diagnosis and Treatment 

Moderators: Michael J. Mack, Mark Reisman 

Discussants: Stefan Anker, Michael 

Argenziano, Steven F. Bolling, Ted E. Feldman, 

Karl-Heinz Kuck, D. Craig Miller, 

Patrick T. O’Gara, Sonna M. Patel-Raman, 

Jason H. Rogers, Allan Schwartz, 


2:57 pm - Functional MR Due to Idiopathic 

vs. Ischemic Cardiomyopathy (and Due to 

Anterior vs. Posterior Infarction): 

Similarities and Differences 


3:05 pm - Do Beta Blockade, Afterload 

Reduction, and Other Medical Therapies 

Improve Prognosis in Functional MR? 

Review of the Literature and Practical 

Recommendations 

Jason H. Rogers 

3:13 pm - CRT in the Management of the 

Patient with Heart Failure and Severe MR 


3:23 pm - MR with Normal Left Ventricular 

Ejection Fraction: What Is It and How 

Should It Be Treated? 

Patrick T. O’Gara 

3:31 pm - Varying Annuloplasty Rings and 

Nonannuloplasty Surgical Approaches for 

Ischemic MR: Do They Make a Difference? 

D. Craig Miller 


instrUCtive DeBAte 2: whAt is stAnDArD 

of CAre for the treAtMent of severe 

fUnCtionAl Mr? 

3:51 pm - Follow the (Lack of) Evidence: 

Medical Therapy and CRT! 

Allan Schwartz 

3:56 pm - Few Patients with Functional MR 

Are Treated Surgically: Duke Database 

Results 


4:01 pm - Surgery Is the Obvious Choice! 

Steven F. Bolling 

4:06 pm - The MitraClip Has an Important 

Role to Play! 


4:11 pm - FDA View on Standard of Care 

for Functional MR 

Sonna M. Patel-Raman 


new triAls in fUnCtionAl Mr 

4:25 pm - CTSN Trials: Rationale and Status 


4:33 pm - COAPT 


4:38 pm - RESHAPE 

Karl-Heinz Kuck 


Session IV. When Mitral Surgery Fails 

Moderators: Scott Lim, Jason H. Rogers 

Discussant: Francesco Maisano 

4:51 pm - Valve-in-Valve and 

Valve-in-Ring Experiences 



Session V. Additional MitraClip 

Considerations 

Moderators: Stephan Baldus, Ted E. Feldman, 

Saibal Kar 

Discussants: Paul A. Grayburn, 

Francesco Maisano, Michael J. Rinaldi, 


5:12 pm - MitraClip Registries: ACCESS-EU, 

GERMAN Registry, ESC Registry, High-Risk 

Registry, and REALISM: What Have We 

Learned Recently? 


5:27 pm - When Should the MitraClip Be 

Considered for Front-Line Therapy of 

Degenerative MR? 

Michael J. Rinaldi 

5:37 pm - Imaging Guidance for MitraClip 

Eligibility and Implantation: Top 10 

Tips and Tricks 

Paul A. Grayburn 

5:47 pm - Two MitraClip Case Surprises: 

One in Whom It Worked and One in 

Whom It Didn’t 


5:59 pm - Surgical Perspectives of the 

MitraClip and Its Role in the Treatment of 

Severe Degenerative and Functional MR 




Transradial Angiography and 

Intervention: From Basic to 

Advanced 

1:00 pm-6:00 pm 

Room A201-205 

Session I. Transradial Basics 

Moderators: Martial Hamon, Varinder P. Singh 

Discussants: Douglas G. Fraser, 

Samir B. Pancholy, Tejas Patel, 

Kimberly A. Skelding, Jennifer A. Tremmel 

1:00 pm - From Access to the Coronaries: 

Strategies for Success and Troubleshooting 

Douglas G. Fraser 

1:15 pm - Diagnostic and Guide Catheter 

Selection and Manipulation 


1:25 pm - Radial Artery Hemostasis 

and Occlusion 

Samir B. Pancholy 

1:35 pm - Complications of the Radial 

Approach: Frequency, Prevention, 

and Management 

Tejas Patel 

1:50 pm - Radial Artery Patency After 

Transradial Angiography and Intervention: 

The Next “Open Artery” Hypothesis? 



Session II. Acute Coronary Syndromes, 

Antithrombotic Therapy, and Radial Access 

Moderators: Olivier F. Bertrand, 

Shamir R. Mehta 

Discussants: Robert J. Applegate, Ivo Bernat, 

Philippe Garot, Luis A. Guzman, 


2:15 pm - Radial Approach and Reduced 

Mortality: Causal or Confounding? 

Olivier F. Bertrand 

trAnsrADiAl priMAry pCi DeBAte 

2:25 pm - Believe the Data! Radial Approach 

for Primary PCI Is Preferred! 


2:35 pm - Radial Approach Offers No 

Benefit Over Femoral Plus Bivalirudin! 


2:45 pm - Radial Approach for NSTEMI: 

Case Closed or Worth Changing Practice? 



Session III. Transradial Science 

Moderators: Yves R. Louvard, Tejas Patel 

Discussants: Olivier F. Bertrand, 

Ian C. Gilchrist, Martial Hamon, Yuji Ikari, 

Shamir R. Mehta, James Nolan, 

Christopher Pyne, Ramon Quesada

3:15 pm - Highlights of the Radial Literature 

from the Past Year 


3:30 pm - Antithrombotic Strategies in 

Patients on Chronic Oral Anticoagulation 

Ramon Quesada 

3:45 pm - Radial Circulation: Do We Need 

to Check for Dual Circulation of the Hand 

Before Accessing the Radial Artery? 

Ian C. Gilchrist 

4:00 pm - Is There a Higher Risk of Stroke 

With the Radial Approach? Reasons 

and Results 

Martial Hamon 

4:15 pm - Miniaturization: The Future of 

Transradial? 

Yuji Ikari 


Session IV. Transradial Intervention: 

Operational and Policy Issues 

Moderators: Olivier F. Bertrand, Sunil V. Rao 

Discussants: Sanjit S. Jolly, 

Jose L. Leiva-Pons, Yves R. Louvard, 

Duane S. Pinto, Adhir Shroff 

4:45 pm - Transradial Learning Curve: 

What Does It Take to Become Proficient? 


5:00 pm - Economics of the Radial Approach: 

Do the Older Data Still Apply Today? 


5:15 pm - Vascular Access Choice and 

Radiation Exposure 

Sanjit S. Jolly 

5:30 pm - Same-Day Discharge After Radial 

PCI: Protocols and Practice 

Sunil V. Rao 



EvEning PrograMs 

7:00 pm-8:30 pm 

Please see page 166 for the Evening 

Programs schedule. 



TranscaTheTer 


TherapeuTics 



Contact us: 

Tel: 845-580-3100 

E-mail: skirballinfo@crf.org 

www.skirballresearchcenter.org 

Visit us at booth 596 located in the Exhibit Hall. 


RESEARCH 

FOUNDATION 

Skirball Research Center 

Redefi ning Preclinical Cardiovascular 

Translational Research 

The CRF Skirball Research Center is a state-of-the-art facility dedicated to 

the investigation of novel concepts, treatments, and devices. Our team of 

interventionalists, surgeons, and pathologists guide early ideas and inventions 

through comprehensive research programs in order to introduce practical clinical 

therapies to patients. 

The CRF Skirball Research Center is the starting point for technological advances 

that will ultimately improve the lives of those suffering from cardiovascular disease 

and is defined by innovative thinking. 

Research Cores 

• Interventional vascular biology 

• Applied cardiovascular imaging 

• Regenerative interventional therapies 

• Structural heart disease 

• Interventional pharmalogy 





Main Arena .......................................................................................... 116 

How to Treat Theater: Coronary Artery Disease ................................ 117 

How to Treat Theater: Structural Heart and Endovascular Disease .. 118 


Challenging Case Theater 1 .....................................................................118 


Maintenance of Certification (MOC) Course ...................................... 120 


Japan-US Synergies in Global Medical Device Innovation: 

Harmonization by Doing (HBD) at TCT .....................................................120 

Edited Taped Case Presentations ....................................................... 121 

Challenging Case Video Presentations .............................................. 121 



and Interventionalists ................................................................. 123, 132 


Deep Dive: Stroke Prevention Therapies ..................................................123 

From Clinical Trial Evidence to Clinical Practice: 

Unraveling the Issues ...............................................................................123 

Innovative Surgical Techniques and Technologies ....................................124 

Next-Generation Transcatheter Mitral Valve Therapies .............................124 

The Use and Abuse of Appropriate Use Criteria (AUC): 

A Case-Based Tutorial ..............................................................................125 

Lunchtime Activities 

Hot Topics ................................................................................................125 

Learn the Technique .................................................................................127 



Deep Dive: Hypertension and Renal Artery Denervation ..........................130 

Next-Generation Transcatheter Aortic Valve Therapies ............................131 

Optimizing Use of Today’s Antithrombotic and Antiplatelet 

Drugs in ACS and PCI ..............................................................................132 


Valvular and Structural Heart Disease ......................................................132 

The Skeptic’s Corner: Controversies in Interventional Cardiology ............133 


Wednesday 




TranscaTheTer 


TherapeuTics

116 

Wednesday, ocTober 24 


7:00 am-8:00 am 



Main arEna 

8:00 am-6:00 pm 

Hall D 

Plenary Session I. Live Cases I 

Live Case Moderator: Gregg W. Stone 

Live Case Co-Moderators: Martin B. Leon, 


Live Case Discussants: Rafael Beyar, 

Bernard R. Chevalier, Alaide Chieffo, 

Carlo Di Mario, Anthony H. Gershlick, 

Carey D. Kimmelstiel, Michael J. Mack, 

Nicolo Piazza, Simon Redwood, 

Charanjit S. Rihal, Ron Waksman, 


8:00 am - NewYork-Presbyterian Hospital/ 


New York, NY 

8:45 am - Shaare Zedek Medical Center 


Plenary Session II. Welcome 

and Introduction to TCT 2012 

Moderators: Martin B. Leon, Gregg W. Stone 

9:30 am - Welcome to TCT 2012! 

Plenary Session III. A Memorial 

to Geoffrey O. Hartzler, MD 


Discussants: Bonnie Brown, 

Howard A. Cohen, Antonio Colombo, 

Gary Curtis, Lee Giorgi, David R. Holmes Jr, 

Bob Jackson, Warren L. Johnson, Joel Kahn, 

Martin B. Leon, Barry D. Rutherford, 

Shigeru Saito, Patrick W. Serruys, 

William N. Starling, Dave Strelow 

9:35 am - Introduction to an Extraordinary Life 


9:40 am - Geoff Hartzler . . . in His Own 

Words: A Video Tribute 

9:58 am - Discussion: Personal 

Remembrances 

Moderator: Gregg W. Stone 

Plenary Session IV. TCT 2012 

Geoffrey O. Hartzler Master 

Operator Award 


10:20 am - Presentation of the Geoffrey O. 

Hartzler Master Operator Award 

Award Presenter: Gregg W. Stone 

Award Recipient: Barry D. Rutherford 

Plenary Session V. TCT 2012 

Game-Changing Therapies I. 

The “Hottest” New 

Interventional Therapy: Renal 

Denervation for Refractory 

Hypertension 

Moderators: William W. O’Neill, 


Discussants: Andreas Baumbach, 

Deepak L. Bhatt, Michael Böhm, 

Justin E. Davies, Felix Mahfoud, 

James R. Margolis, Klaus D. Mathias, 

C. Venkata S. Ram, Horst Sievert, 


10:30 am - Renal Sympathetic Denervation as 

the “Ideal Target” for Refractory 

Hypertension: Anatomy and Pathophysiology 

Michael Böhm 

10:40 am - What’s Known and Not Known 

About Renal Denervation for Hypertension: 

Critical Appraisal of the Clinical Data 


10:50 am - Catheter-Based Technology 

Alternatives for Renal Denervation 

Horst Sievert 

11:00 am - Beyond Hypertension: Future 

Prospects for Renal Denervation Therapy 



Plenary Session VI. 

Late Breaking Trials I 


Co-Moderator: Antonio Colombo 

Discussants: David J. Cohen, Cindy L. Grines, 

Jose P.S. Henriques, Spencer B. King III, 

Jacques J. Koolen, Simon Redwood, 

Habib Samady, Philippe Gabriel Steg, 

Holger Thiele, Harvey D. White, 


11:20 am - FAME 2 

Cost-effectiveness: 

A Prospective, Randomized 

Trial Evaluating the 

Cost-effectiveness of 

FFR-Guided PCI in Patients 

with Stable Coronary Artery Disease 



11:40 am - MASTER: A 

Prospective, Randomized 

Trial of a PET Micronet 

Mesh-Covered Stent vs. 

Standard Stents 

in Patients with ST- 

Segment Elevation Myocardial Infarction 



12:00 pm - ISAR-LEFT 

MAIN 2: A Prospective, 

Randomized Trial of 

Everolimus-Eluting vs. 

Zotarolimus-Eluting Stents 

in Patients with 

Unprotected Left Main Disease 

Julinda Mehilli 


Plenary Session VII. 

First Report Investigations I 

Moderator: Stephan Windecker 

Discussants: Sheldon Goldberg, 

Karel T. Koch, Karl-Heinz Kuck, 

Roger J. Laham, Jan J. Piek, Manel Sabate, 

Peter C. Smits, Gerald S. Werner 

12:20 pm - PARTNER Cohort 

B Three Year: Clinical and 

Echocardiographic 

Outcomes from a 


Trial of Transcatheter Aortic 

Valve Replacement in “Inoperable” Patients 



12:35 pm - TRILOGY ACS 

Angiographic Cohort: A 


Trial of Prasugrel vs. 

Clopidogrel in Patients with 

Non-ST-Segment Elevation 

ACS Who Are Medically Managed After 

Coronary Angiography 

Stephen D. Wiviott 


12:50 pm - A Prospective, 

Randomized Trial of Nitinol 

Stents vs. Balloon 

Angioplasty in Obstructive 

Popliteal Lesions 

Thomas Zeller 


Plenary Session VIII. 

Live Cases II 

Live Case Moderator: Martin B. Leon 

Live Case Co-Moderator: Eberhard Grube 

Live Case Discussants: Deepak L. Bhatt, 

Giancarlo Biamino, Edoardo Camenzind, 

Roger M. Greenhalgh, Kishore J. Harjai, 

Zvonimir Krajcer, John R. Laird Jr, 

Azeem Latib, Bernhard Reimers, 

Bruno Scheller, Craig M. Walker 

1:00 pm - Baptist Cardiac and 


Miami, FL 

1:45 pm - Instituto Dante Pazzanese 


São Paulo, Brazil

Plenary Session IX. Coronary 

Revascularization Highlights 

Moderators: David R. Holmes Jr, 


Discussants: Rory Hachamovitch, 

David J. Maron, Laura Mauri, 

Manesh R. Patel, Patrick W. Serruys, 

Gregg W. Stone, David Taggart, 

William S. Weintraub, Robert L. Wilensky 

2:30 pm - The Forgotten “Art” of Advanced 

Medical Therapy: The Case for a 

Conservative Approach in Managing 

Coronary Disease 

William S. Weintraub 

2:45 pm - Advanced Directive: 

Treat Only Ischemia-Producing Lesions! 

The Mandate for Functional Guidance 

Before or During PCI 

Rory Hachamovitch 

3:00 pm - Evolutionary Revascularization 

Strategies for Coronary Artery Disease: From 

Anatomy to Ischemia to Vulnerable Plaque 



Plenary Session X. 

Live Cases III 


Live Case Co-Moderator: 


Live Case Discussants: Charles J. Davidson, 

Adam J. de Belder, Petr Kala, Ran Kornowski, 

Gary S. Mintz, Michael Mooney, 

Massimo Napodano, Barry D. Rutherford, 

Joachim Schofer, Vinod H. Thourani, 


3:30 pm - St. Paul’s Hospital/University 

of British Columbia 


4:15 pm - Scripps Green Hospital 

La Jolla, CA 

Plenary Session XI. 

Endovascular Horizons 

Moderators: Jeffrey W. Olin, 


Discussants: Gary M. Ansel, 

L. Nelson Hopkins, John R. Laird Jr, 

Reginald I. Low, Philip M. Meyers, 

Jacques Moret, Stephen R. Ramee, 

Jason H. Rogers, James P. Zidar 

5:00 pm - Interventional Stroke Therapy: 

Unraveling the Gordian Knot 

Jacques Moret 

5:15 pm - Endovascular Management 

of Erectile Dysfunction: Overview 

and Future Potential 



5:30 pm - A Visionary Roadmap for 

Endovascular Intervention: Growth 

Opportunities and Probing the Known 

and the Unknown 




how to trEat thEatEr: 

coronary artEry disEasE 

7:50 am-6:00 pm 




Intervention I 

Moderator: Yves R. Louvard 

Co-Moderator: David G. Rizik 

8:00 am - Left Main PCI vs. CABG Today: 

A Guide to Clinical Decision Making 


8:15 am - Technical Considerations for Left 

Main Intervention: From Stent Strategies 

to Imaging Guidance to Staging and 

Hemodynamic Support 


Live Cases: Left Main and 

Bifurcation Intervention I 

Live Case Moderator: Yves R. Louvard 

Live Case Co-Moderator: David G. Rizik 

Live Case Discussants: Amr Abbas, 

Takashi Akasaka, David Antoniucci, 

James C. Blankenship, Francesco Burzotta, 

Charles Chan, Marco A. Costa, Andrejs Erglis, 

Dietmar H. Glogar, Masato Nakamura 

8:30 am - Ferrarotto Hospital 


9:30 am - Mount Sinai Medical Center 

Miami, FL 


Intervention II 

Moderator: George D. Dangas 

Co-Moderator: Seung-Jung Park 

10:30 am - Bifurcation Lesion Stenting: 

Impact of Stent Geometry and Technique 

on Outcomes (and Potential of Dedicated 

Bifurcation Stents) 


10:45 am - An Algorithmic Approach for 

(Non-Left Main) Bifurcation Stenting 

Based on Lesion Anatomy 



TranscaTheTer 


TherapeuTics 

Live Cases: Left Main and 

Bifurcation Intervention II 

Live Case Moderator: Roxana Mehran 

Live Case Co-Moderator: Seung-Jung Park 

Live Case Discussants: Adrian P. Banning, 

Antonio L. Bartorelli, Davide Capodanno, 

Shao Liang Chen, Fernando Cura, 

Nicolas Foin, Liliana R. Grinfeld, 

Michael S. Lee, Julinda Mehilli 

11:00 am - Shaare Zedek Medical Center 


12:00 pm - Instituto Dante Pazzanese 



CTO Intervention I 

Moderator: J. Aaron Grantham 

Co-Moderator: Etsuo Tsuchikane 

1:00 pm - CTO Antegrade Intraluminal and 

Reentry Techniques: Didactic Review 

William L. Lombardi 

1:15 pm - CTO Antegrade Intraluminal 

and Reentry Techniques: A Series of 

Illustrative Cases 


Live Cases: CTO Intervention I 

Live Case Moderator: J. Aaron Grantham 

Live Case Co-Moderator: Etsuo Tsuchikane 

Live Case Discussants: Yasushi Asakura, 

Ronald Caputo, Richard R. Heuser, 

Jonathan M. Hill, Angela Hoye, 

Kazuaki Mitsudo, Sudhir Rathore, 

Jonathan S. Roberts, Shigeru Saito, 



La Jolla, CA 


La Jolla, CA 

CTO Intervention II 

Moderator: William L. Lombardi 

Co-Moderator: Osamu Katoh 

3:30 pm - CTO Retrograde Techniques: 

Didactic Review 


3:45 pm - CTO Retrograde Techniques: 

A Series of Illustrative Cases 

Osamu Katoh 


WEdnEsday - OCTOBEr 24, 2012

118 


Live Cases: CTO Intervention II 

Live Case Moderator: William L. Lombardi 

Live Case Co-Moderator: Osamu Katoh 

Live Case Discussants: Carlo Briguori, 

Mauro Carlino, Kenneth Chin, 

Yasuhiro Honda, Keiichi Igarashi, 

Manish A. Parikh, Satoru Sumitsuji, 

R. Michael Wyman, Masahisa Yamane 

4:00 pm - Piedmont Heart Institute 

Atlanta, GA 

5:00 pm - Piedmont Heart Institute 

Atlanta, GA 



structural hEart and 

Endovascular disEasE 

8:00 am-6:00 pm 



Transcatheter Valve Therapies I 

Moderator: Josep Rodes-Cabau 

Co-Moderator: Victor Guetta 

8:00 am - Patient Selection for TAVR: 

Risk Stratification, Important Patient 

Subgroups, and the Heart Team 

Scott Lim 

8:15 am - Patient Selection for the MitraClip: 

Clinical vs. Anatomic Considerations, 

and Diagnosis of “Severe” MR 


Live Cases: Transcatheter 

Valve Therapies I 

Live Case Moderator: Josep Rodes-Cabau 

Live Case Co-Moderator: Victor Guetta 

Live Case Discussants: Bruce Bowers, 

Raimund A. Erbel, Philippe Généreux, 

Brad I. Munt, Amit Segev, 

Kimberly A. Skelding, Terje K. Steigen, 

Konstantinos Toutouzas, George W. Vetrovec 

8:30 am - Instituto Dante Pazzanese 





New York, NY 

Transcatheter Valve Therapies II 

Moderator: Martyn R. Thomas 

Co-Moderator: Raoul Bonan 

10:30 am - Clinical Outcomes After TAVR: 

Risks vs. Benefits 


10:45 am - Clinical Outcomes After MitraClip: 

Risks vs. Benefits (in FMR vs. DMR) 



Valve Therapies II 

Live Case Moderator: Martyn R. Thomas 

Live Case Co-Moderator: Raoul Bonan 

Live Case Discussants: Lutz Buellesfeld, 

Haim Danenberg, Jan Harnek, Neil E. Moat, 

Augusto D. Pichard, Michael J. Reardon, 

Konstantinos Spargias, Pieter R. Stella, 

Peter Wenaweser 

11:00 am - St. Paul’s Hospital/University 

of British Columbia 


12:00 pm - Ferrarotto Hospital 


Iliac and SFA Intervention 

Moderator: Lawrence A. Garcia 

Co-Moderator: Erich Minar 

1:00 pm - SFA Intervention: State of the 

Art Today and in 2020 

Gary M. Ansel 

1:15 pm - Femoropopliteal Atherectomy: 

A Critical Appraisal 


Live Cases: Iliac and SFA 

Intervention 

Live Case Moderator: Lawrence A. Garcia 

Live Case Co-Moderator: Erich Minar 

Live Case Discussants: Mark C. Bates, 

Mark W. Burket, Frank J. Criado, 

Eric J. Dippel, James D. Joye, R. Stefan Kiesz, 

Hans Krankenberg, Robert D. Safian, 

Luigi Salemme 

1:30 pm - Park-Krankenhaus Leipzig 


Renal, Aortic, and Mesenteric 

Intervention 

Moderator: Frank J. Criado 

Co-Moderator: J. Michael Bacharach 

3:30 pm - Evolution in Endograft Technology 

and Applications 


3:45 pm - Renal Artery Stenting: What Are 

the Indications for Intervention in 2012? 


Live Cases: Renal, Aortic, 

and Mesenteric Intervention 

Live Case Moderator: Frank J. Criado 

Live Case Co-Moderator: 

J. Michael Bacharach 

Live Case Discussants: Max Amor, 

Jacques Busquet, Tyrone J. Collins, 

Adrian Ebner, Michel Camille Henry, 

Thosaphol Limpijankit, Robert A. Lookstein, 

Mahmood K. Razavi, Mehdi H. Shishehbor 



Miami, FL 



Miami, FL 


intErnational 

MultiPlEx thEatEr 

These sessions are not CME/CNE accredited. 

Challenging Case Theater 1 

8:00 am-5:00 pm 

Hall A-IMT 1 

TAVR 2012: Unanswered Questions 

Sponsored by the German Society of 

Cardiology Working Group on 


Moderators: Michael Haude, 

Christoph K. Naber 


Stephan M. Ensminger, Rudiger Lange, 

Axel Linke 

8:00 am - Case 1: Why I Chose CoreValve for 

This TAVR Procedure 

Huseyin Ince 

8:15 am - Case 2: Why I Chose Sapien for This 

TAVR Procedure 

Axel Linke 

8:30 am - Case 3: TAVR for a Degenerated 

Aortic Bioprosthesis 

Peter Boekstegers 

8:45 am - Case 4: Complication Management 

During TAVR 

Ulrich J. Gerckens 

Complex Approach to Multivessel 

Disease and Left Main STEMI 

Sponsored by the Czech Society of 



Moderators: Petr Kala, Josef Stasek 

Discussants: Pavel Cervinka, Martin Mates, 

Roman Stipal, Josef Veselka, Michael Zelizko 

9:00 am - Case 1 

Ivo Bernat 

9:15 am - Case 2 

Marian Branny 

9:30 am - Case 3 

Ladislav Groch 

9:45 am - Case 4 

David Horak

Challenging Case Reviews in Modern 


Sponsored by the Korean Society 

of Cardiology 

Moderators: Yang-Soo Jang, Joo-Young Yang 

Discussants: Taehoon Ahn, Inho Chae, 

Wook Sung Chung, Kyoo-Rok Han 

10:00 am - Case 1: TAVR by Transaortic 

Approach in a Patient with Severe Aortic 

Stenosis and Peripheral Arterial Disease 

Young-Guk Ko 

10:15 am - Case 2: FFR-Guided Decision 

Making for Anomalous Origin of RCA 

Bon-Kwon Koo 

10:30 am - Case 3: Resuscitated Cardiac 

Arrest in a Patient with PCI-Related Acute 

Left Main Thrombosis: A PCPS Case 

Hyeon-Cheol Gwon 

10:45 am - Case 4: Complex PCI Through 

the Transradial Approach 

Kook-Jin Chun 

Unexpected PCI Complications 

Sponsored by the Finnish Cardiac Society 

Moderators: Matti Jaakko Niemela, 

Hannu Romppanen 

Discussants: Pasi Karjalainen, Mikko Pietila, 

Antti Ylitalo 

11:00 am - Case 1: Subacute Intramyocardial 

Hemorrhage and Tamponade After 

Elective PCI of a CTO 

Matti Jaakko Niemela 

11:15 am - Case 2: Severe Clinical Instability 

After Elective Stenting of the LCX and LAD: 

What Went Wrong? 

Mikko Pietila 

11:30 am - Case 3: Elective PCI of Triple 

Vessel Disease with Coronary Perforation 

and Emergency CABG 

Olli A. Kajander 

11:45 am - Case 4: Late Bare Metal Stent 

Thrombosis in the Light of OCT: 

Management Options? 

Pasi Karjalainen 


STEMI Intervention: Canadian Perspectives 

Sponsored by the Canadian Association of 


Moderators: Eric A. Cohen, Michael P. Love 

Discussants: Erick Schampaert, 

Jean-François Tanguay, Robert C. Welsh 

2:00 pm - Case 1: Go Radial or Go Home? 


2:15 pm - Case 2: STEMI Cocktails 


2:30 pm - Case 3: Drip Ship and Fix, or Drip 

Ship and Wait? 

Christopher Buller 


2:45 pm - Case 4: To Stage or Not to Stage? 


Complex PCI: Problem Solving 

Sponsored by the Chinese Society 

of Cardiology 

Moderators: Run-Lin Gao, Yuejin Yang 

Discussants: Xianghua Fu, Yaling Han, 

Jian’an Wang, Yujie Zhou 

3:00 pm - Case 1: A Left Main Bifurcation 

Treated with a Two-Stent Technique 

Wenyi Guo 

3:15 pm - Case 2: Retrograde Approach 

to a Complex Chronic Total Occlusion 

Bin Zhang 

3:30 pm - Case 3: Left Main PCI in a 

Patient with Cardiogenic Shock 

Xuebo Liu 

3:45 pm - Case 4: A Severely Calcified Lesion 

Treated with Rotational Atherectomy 

Yongjian Wu 

Unusual Solutions for Unusual Problems 

Sponsored by the Belgian Working Group 

on Interventional Cardiology 

Moderators: Walter Desmet, Claude Hanet 

Discussants: Kristoff Cornelis, 

Suzanne Marie Pourbaix, Paul Vermeersch 

4:00 pm - Case 1: Late Complication After 

Rotational Atherectomy 

Edouard R. Benit 

4:15 pm - Case 2: An Unexpected Outcome 

After PCI 

Tom Adriaenssens 

4:30 pm - Case 3: When Kissing Goes Wrong 

Philippe Selleslagh 

4:45 pm - Case 4: A Severely Stenosed 

Tricuspid Bioprostheses 

Antoine Guédès 



8:00 am-5:00 pm 

Hall A-IMT 2 

PCI Complications Usually Begin 

with a “Simple Case” 

Sponsored by the Croatian Cardiac Society 

Working Group of Interventional Cardiology 

Moderators: George D. Dangas, 

Aleksander Ernst, Maja Strozzi 

Discussants: Zdravko Babic, Robert Bernat, 

Edvard Galic, Hrvoje Pintaric 

8:00 am - Case 1: Percutaneous Treatment of 

Catheter-Induced Dissection of the 

LMCA and Aortic Root 

Tomislav Sipic 


TranscaTheTer 


TherapeuTics 

8:15 am - Case 2: Broken Tip of a Diagnostic 

Right Coronary Artery Catheter 

Tomislav Krcmar 

8:30 am - Case 3: From Simple to Nightmare 

Jozica Sikic 

8:45 am - Case 4: Treatment of Multiple Huge 

SVG Aneurysms: Stent or Surgery? 

Kristina Maric 

Swiss Complication Pearls 

Sponsored by the Swiss Society of 

Cardiology Working Group on Interventional 

Cardiology and Acute Coronary Syndrome 

Moderators: Christoph A. Kaiser, 

Peter Wenaweser 

Discussants: Gabor Sutsch, 

Daniel Weilenmann, Stephan Windecker 

9:00 am - Case 1: A Fatal Retrograde 

Left Main Dissection 

Daniel Suerder 

9:15 am - Case 2: Left Ventricular Perforation 

by a Pigtail Catheter 

Stéphane Cook 

9:30 am - Case 3: A Spectacularly Errant 

TAVR Post Dilatation 

Stephane Noble 

9:45 am - Case 4: Disastrous Complication 

of a Transapical Paravalvular Mitral 

Leak Closure 

Roberto Corti 

Difficult Decisions During Primary PCI 

for STEMI 

Sponsored by the Polish Cardiac Society 

Moderators: Dariusz Dudek, Robert J. Gil 

Discussants: Maciej Lesiak, Andrzej J. Ochala, 

Adam Witkowski 

10:00 am - Case 1: Patient with STEMI and 

Cardiogenic Shock with Acute Left Main 

Coronary Artery Occlusion 

Stanislaw Bartus 

10:15 am - Case 2: Patient with STEMI and 

Acute Saphenous Vein Graft Occlusion 

Krzysztof W. Reczuch 

10:30 am - Case 3: Patient with STEMI, 

Skull Base Fracture, and Aspirin Allergy: 

How to Treat? 


10:45 am - Case 4: Patient with STEMI, 

Proximal LAD Occlusion, and Complex Left 

Main/Multivessel Disease: How to Treat? 

Jacek Legutko 



120 


Taiwanese Complex 

Cardiovascular Interventions 

Sponsored by the Taiwan Society of 


Moderators: Jun-Jack Cheng, 

Roxana Mehran 

Discussants: Paul Hsien-Li Kao, 

Wen-Lieng Lee, Chuen-Den Tseng 

11:00 am - Case 1: Multiple CTOs and a 

Calcified Critical Lesion After Failed CABG 

Wen-Lieng Lee 

11:15 am - Case 2: Recanalization of Bilateral 

Carotid Artery Occlusion 


11:30 am - Case 3: The Balloon-Cushion 

Stenting Technique in Left Main Primary PCI 

Po-Ming Ku 

11:45 am - Case 4: Multiple Access 

Approaches for a Long Iliofemoral Occlusion 

Hsuan-Li Huang 


Revascularization Strategies for Complex 

Left Main Disease and Left Coronary 

Ostial Disease 

Sponsored by the Colegio Argentino de 

Cardioangiólogos Intervencionistas 

Moderators: Liliana R. Grinfeld, 

Alfredo Rodriguez, Ernesto M. Torresani 

Discussants: Jose A. Alvarez, 

Jorge Bluguermann, Mauricio G. Cohen, 

Anibal A. Damonte, Victor P. Moles, 

Jose Gomez Moreno 

2:00 pm - Introduction and Objectives 

Ernesto M. Torresani 

ostiAl lCx: CUlotte AlwAys 

2:05 pm - Clinical Case Presentation 

Ruben A. Piraino 

2:15 pm - Expert Case Review and Discussion 

ostiAl lCx: reverse t or Mini-CrUsh 

Are the strAtegies of ChoiCe 


Jorge A. Baccaro 


ostiAl lAD: single-stent ApproACh 

is the Best 


Antonio Pocovi 


DeBUlking strAtegies DUring left MAin 

AnD BifUrCAtions teChniqUes 


Jorge H. Leguizamon 



3:40 pm - Take-home Message 

Alfredo Rodriguez 



PCI: The Good, the Bad, and the Ugly 

Sponsored by the Cardiological 

Society of India 

Moderators: Vinay K. Bahl, Ashok Seth 

Discussants: Amal Kumar Banerjee, 

Upendra Kaul, Saumitra Ray 

4:00 pm - Case 1: Thankfully, the Nightmare Is 

Over! (My Worst Complication) 

Samuel K. Mathew 

4:15 pm - Case 2: How Clever of Me! 

(My Most Innovative Solution) 

Sundeep Mishra 

4:30 pm - Case 3: This I Will Never Forget! 

(My Most Educational Case) 

Vishal Rastogi 

4:45 pm - Case 4: Case Exotica 

Ajit Mullasari 


MaintEnancE of 

cErtification (Moc) 

coursE 

8:00 am-2:00 pm 





8:02 am - Interventional Cardiology 2012 

Update Module Review 

Moderators: Tayo A. Addo, 


Discussants: Nicola Corvaja, Kishore J. Harjai 


10:15 am - Interventional Cardiology 2011 


Moderators: Duane S. Pinto, Kishore J. Harjai 

Discussants: Tayo A. Addo, 


12:00 pm - Interventional Cardiology 2010 


Moderators: Charles E. Chambers, 

Nicola Corvaja 





Japan-US Synergies in 

Global Medical Device 

Innovation: Harmonization 

by Doing (HBD) at TCT 

8:00 am-12:30 pm 

Room C219 

Session I. Keynote: The Japan-US Medical 

Device Landscape 2012 

Moderators: Mitchell W. Krucoff, Shigeru Saito 

8:00 am - “Japan First:” Speeding Device 

Introduction in Japan 

Akihiro Koide 

8:20 am - Pragmatic Pre- and Post-Market 

Global Harmonization: Lessons from Japan 

and the United States 

Andrew Farb 

8:40 am - Japan-US Synergies in the Global 

Marketplace: An Industry View 

Neal Fearnot 

Session II. Critical Limb Ischemia (CLI) in 

Japan and the United States 

Moderator: Kazuo Kawahara 

Discussants: Kenneth J. Cavanaugh Jr, 

William A. Gray, Akihiro Koide, 

Mitchell W. Krucoff, Robert Thatcher, 

Christopher J. White, Hiroyoshi Yokoi 

Neal Fearnot 

9:00 am - CLI and Device Intervention 

in Japan 

Hiroyoshi Yokoi 

9:10 am - CLI Definitions: Can We Speak the 

Same Language? Update on the Peripheral 

Academic Research Consortium (PARC) 


9:20 am - CLI and Device Intervention Across 

the Pacific: An FDA View 

Kenneth J. Cavanaugh Jr 



Session III. Percutaneous Valves in Japan 

and the United States 

Moderators: John Laschinger, Taka Uchida 

Discussants: Jodi Akin, Koji Ikeda, 

Fumiaki Ikeno, Michael J. Mack, 

Manuela Negoita, David Reuter, 

Stanton J. Rowe, Huay Cheem Tan, 

Kim Trautman 

10:30 am - TAVR in Japan and the 

United States 

Jodi Akin 

10:40 am - Percutaneous Mitral Valve: Where It 

Fits in Japan-US Today 

David Reuter

10:50 am - Pre- and Post-Market Application 

of International Registries: The TVT 

Registry Example 



Session IV. Japan-US Synergies in 


Moderators: Kazuhiro Sase, Gary Thompson 

Discussants: Masayuki Kawahara, 

Akihiro Koide, Mitchell W. Krucoff, 

Stephen Rowland, Shigeru Saito, 

Kazuaki Sekiguchi, Huay Cheem Tan, 

Robert Thatcher, Takahiro Uchida 

11:30 am - Bioabsorbable Stent Components 

and Stents 

Shigeru Saito 

11:40 am - Intervention in Calcific Coronary 

Arteries: A PMDA View 

Masayuki Kawahara 

11:50 am - Biological Enhancement for 

Endothelial Capture 




EditEd taPEd casE 

PrEsEntations 

9:30 am-5:30 pm 


Unusual Interventions 

Presentation Theater 1 

Moderators: Massoud A. Leesar, Brij Maini, 


9:30 am - The “Body Floss” Technique for 

Treatment of a Challenging Total Femoral 

Artery Occlusion 

Thomas M Todoran 

10:00 am - Superior Vena Cava Total Occlusion 

Sunil Pisharody 

10:30 am - Radial Percutaneous Transluminal 

Angioplasty with Stenting of Celiac Artery 

and Suprarenal Abdominal Aorta in 

Ventilated Patient with Takayasu Arteritis and 

Severe Heart Failure 



3-D Theater 

Exhibit Hall 

3-D Edited Taped Case Presentation 

1:30 pm - 3-D Interventional Cardiovascular 

Procedure 

Silvio Bezerra 


Imaging and Physiology 


Moderators: Marco A. Costa, Javier Escaned, 

Petr Kala 

2:00 pm - STEMI in Thrombotic, 

Vasoconstricted RCA with OCT Analysis 

Robert-Jan van Geuns 

2:30 pm - Effect of Side Branch Stenosis on 

FFR of Proximal Main Vessel Stenosis 

Madhavpeddi Sai Aditya 


TAVR 


Moderators: Peter C. Block, Rainer Hoffmann, 

Augusto D. Pichard 

4:00 pm - Transcatheter Aortic Valve and 

Valve-in-Valve Implantation in a Beating 

Porcine Heart: Intracardiac Endoscopic View 

Guido Gelpi 

4:30 pm - Control of Acute Kidney Injury in 

TAVR by Extremely Low Contrast 

Multimodality Imaging Including Intracardiac 

Echocardiography 

Thomas Bartel 

5:00 pm - Cutting Balloon Valvuloplasty 

Ramesh K. Adiraju 


challEnging casE vidEo 

PrEsEntations 

Session II. Coronary 

10:00 am-11:00 am 

Hall D 


TCT-1101. A “Simple” Angioplasty 

of a “Straightforward” Lesion 

Vivek Mehan 

TCT-1102. Retrograde Dissection of the Aortic 

Sinus of Valsalva During Percutaneous 


Ming-yow Hung 

TCT-1103. Acute Myocardial Infarction 

in a Postpartum Patient: Is This a 

Coronary Dissection? 

Kamal Kotak 

TCT-1104. Campylobacter Jejuni Colitis 


Ashish Shah 

TCT-1105. Combined Retrograde and 

Antegrade Approach with Rotablation for 

Treating Saphenous Vein Graft to the Obtuse 

Marginal and Right Coronary Artery Chronic 


Miha Cercek 


TranscaTheTer 


TherapeuTics 

TCT-1106. Stentboost Subtract Assistance 

in Coronary Bifurcation Angioplasty Using 

a Capella Stent 

Gerardo Nau 

TCT-1107. Ventricular Fibrillation Coinciding 

with Phentermine Initiation 

Patrick Tobbia 

TCT-1108. Extrinsic Compression of an 

Anomalous Left Circumflex Coronary Artery, 

Causing Ischemia Early After Aortic Valve 

Replacement: Percutaneous Treatment with 

Intravascular Ultrasound Guidance 

Guglielmo Bernardi 

TCT-1109. Successful Percutaneous 

Recanalization of a Chronic Total Coronary 

Occlusion Using a Retrograde Approach 

Through an Occluded Bypass Graft 

Karl Isaaz 

TCT-1110. Use of LASER in Treatment 

of Under-Expanded Stent 

Ashish Shah 

TCT-1111. Corsair Microcatheter-Induced 

Spiral Dissection in a Patient While 

Attempting PCI of a Chronic Total Occlusion 

Tahir Hamid 

TCT-1112. Rotablation in a Patient with 

Cardiogenic Shock and Acute ST-Elevation 


Refai Showkathali 

TCT-1113. A Case of Successful Removal 

of IVUS Catheter Tip Cutoff and Trapped 

in Right Coronary Artery 

Pyung Chun Oh 

TCT-1114. Thrombus-Laden Right Coronary 

Lesion: A Novel Therapeutic Option 

Yean Lim 

TCT-1115. Retrograde Approach to a Chronic 

Total Occlusion in Patient on ECMO Support 

After Recent Myocardial Infarction 

Omar Hassan 

TCT-1116. A Complication Highlighting the 

Importance of IVUS Use in Left Main PCI 


TCT-1117. Complicated PTCA of Left Main 

Total Occlusion in NSTEMI 

Dram Thirugnanam 

TCT-1118. Percutaneous Coronary 

Intervention (PCI) in a Lady with Immune 

Thrombocytopenic Purpura (ITP): 

Complicated by Stent Thrombosis 

Ashish Shah 

TCT-1119. A Rare Complication of Mycotic 

Aneurysm of Coronary After DES 

Implantation of LM Lesion: A Case Report 

Wei-chun Chang 



122 


TCT-1120. Retrograde Brachiocephalic 

Artery Recanalization with Carotid Artery 

Distal Protection from Dual Access 

(Radial and Femoral) 

Zoltán Ruzsa 

TCT-1121. Large Thrombus Burden 

After Primary Angioplasty 

Felipe Maia 

TCT-1122. A Sting in the Tail: Compassionate 

Coronary Stenting in an Elderly Patient with 

a Mechanical Aortic Valve and Eminent 

Noncardiac Surgery 

Tom Hyde 

TCT-1123. Limitations of Dissection 

and Reentry Techniques in the Treatment 

of In-Stent Restenosis Chronic 


Shantu Bundhoo 

TCT-1124. Contrast Limitation by the Use of 

the TwinPass Microcatheter in the Treatment 

of Chronic Total Occlusions via the 

Retrograde Approach 

Shantu Bundhoo 

TCT-1125. Tale of Two Ruptured Plaques: 

A Case of Multivessel Acute Coronary 

Thrombosis 

Behnam Tehrani 

TCT-1126. Chronic Total Occlusoin 

Treated with Retrograde CrossBoss 

Sarah Johnson 

TCT-1127. Risks and Consequences: 

A Case of Very Late Stent Thrombosis 

Behnam Tehrani 

TCT-1128. Retrograde Left Main CTO PCI 

via OM Venous Graft 

Levente Molnár 

TCT-1129. Successful Treat LAD CTO by 

Transconus Branch Retrograde 300-cm Wire 

Externalization Technique in the Occluded 

Three-Vessel Patient 

Tien-yu Wu 

TCT-1130. CT-Guided Retrograde Dissection 

Reentry Recanalization of a Chronic Total 

Occlusion with a Large Proximal Cap 

Aneurysm in Adult Kawasaki Disease 

Sean Gallagher 

TCT-1131. Management of Left Main Stem 

Disease in a Patient with Previous 

Emergency Cardiac Surgery for 

Aortic Dissection 

Ganesh Nallur Shivu 

TCT-1132. A Case of Longitudinal Stent 

Elongation with Unique 3-D OCT Images 

Takehiro Yamashita 

TCT-1133. The Pilgrim Stent 

Jose Diaz Fernandez 

TCT-1134. Post-Stenotic Aneurysm 

Revealed by STEMI 

Nicolas Boudou 

TCT-1135. Functional LIMA Graft Recover 

After CTO PCI in LAD with Rotablator 


TCT-1136. Percutaneous Recanalization of a 

Chronically Occluded Saphenous Vein Graft 

Inge Wijnbergen 

TCT-1137. Heavily Thrombotic Lesion During 

Primary PTCA: New Insight with New Device 

Nagendra Chouhan 

TCT-1138. Lost and Found: A Novel Approach 

to Recrossing a Coronary Dissection 

Eric Fuh 

TCT-1139. Cardiogenic Shock in Left Main 

and Three Vessels Coronary Artery Disease 

Amr Hassan 

TCT-1140. A Case of Myocardial Ischemia Due 

to Compression of the Left Main Trunk by a 

Large Unruptured Thoracic Aortic Aneurysm 

Takayuki Mitsuda 

TCT-1141. Successful Retrieval of a Wire 

“Missing” in the Brachial Artery by Means 

of a Snare Device and Guiding Catheter 

Li Shen 

TCT-1142. Retrieval of Jailed and Broken 

Guidewire in a Primary Angioplasty 

Louie Fischer 

TCT-1143. A Successful Stent Delivery with 

the 4-Fr Guide Catheter Instead of 5-Fr 

Guide Catheter at Mother-Child Technique 

Taku Iwaki 

TCT-1144. Need for Guideliner in Left Main 

Stem Percutaneous Coronary Intervention: 

Game Changer 

Nikesh Malik 

TCT-1145. Application of New Tips, 

Techniques, and Guidelines Lead to a 

Successful Distal Left Main Angioplasty 

with Two Stents 

Grigorios Tsigkas 

TCT-1146. Treatment of LM with Dedicated 

Bifurcation Stent in AMI Patient 

Indulis Kumsars 

TCT-1147. Trifurcation Stenting in 

Cardiogenic Shock: All at Once 

Gianluca Caiazzo 

TCT-1148. Ostial LMCA and Ostial RCA 

Stenting in a Patient with Aortoarteritis 

and Unusual Anatomy 

Sai Nvbk 

TCT-1149. Closing Subclavian Aneurysm 

in Right Aortic Arch by Covered Stent 

Rishi Gupta 

TCT-1150. Iatrogenic Stent Deformation in 

the Left Main Coronary Artery Elucidated 

by IVUS and (3-D) OCT Images 

Maarten Van Leeuwen 

TCT-1151. No-Reflow Following 

Carotid Artery Stenting 

Angelo Anzuini 

TCT-1152. The Successful Left Main 

Recanalization in a Patient with Anterior 

Myocardial Infarction and Cardiac Arrest 

Lukasz Lewicki 

TCT-1153. 3-D Optical Coherence Tomography 

for Guidance of Complex Percutaneous 

Coronary Interventions 

Roberto Diletti 

TCT-1154. A Case of Stent Deformity Using 

Taxus Element Stent at Primary PCI for AMI 

Wataru Nagamatsu 

TCT-1155. Successful Treatment of Peristent 

Aneurysm Using Microcoils Secondary to 

Prior Percutaneous Coronary Intervention 

Due to Old Myocardial Infarction 

Sho Torii 

TCT-1156. Intracoronary Rendezvous 

Technique to Avoid Redundant Stenting 

Within Pseudolumen 

Hidetsugu Sakai 

TCT-1157. Transient Crush to Rescue 

Side-Branch Occlusion in Bifurcation Treated 

with the Provisional Stenting Strategy 

Jérôme Van Rothem 

TCT-1158. Management of a Heavy Calcified 

Lesion of the Left Main 


TCT-1159. PCI to Anomalous LAD in 

the Presence of True LAD 

Prabhu Halkati 

TCT-1160. Thrombectomy with Novel “Mother 

in Child” Technique via Radial Approach 

Gabriel Maluenda


10:00 am-1:15 pm 

Please see page 170 for the Presentation 

Theater schedule. 

Morning sPotlight 

sEssions 

Deep Dive: Stroke 

Prevention Therapies 

8:00 am-12:00 pm 

Room A101-102 

Session I. The Noninterventional 

Management of Cardioembolic Stroke 

Moderators: Michael D. Ezekowitz, 

Freek W.A. Verheugt 

Discussant: Paul H. Kramer 

8:00 am - The Heart as a Source of Stroke: 

Etiologies and Risk Amplifiers 

Paul H. Kramer 

8:10 am - Anticoagulation Choices for Atrial 

Fibrillation: Which Drug for Which Patient? 

Michael D. Ezekowitz 

8:25 am - Rationale for Medical Therapy 

to Prevent Systemic Embolization in 

Patients with PFO 

David E. Thaler 

8:35 am - Indications for and Duration of 

Pharmacologic Therapy in Patients with 

Left Ventricular Aneurysm and Thrombus 



Session II. Interventional Approaches 

to Cardioembolic Stroke 

Moderators: William A. Gray, Vivek Y. Reddy 

Discussants: David W.M. Muller, Horst Sievert, 

Robert J. Sommer, Steven J. Yakubov 

9:00 am - Surgical LAA Exclusion: 

Is It Effective? 


9:10 am - Does Atrial Fibrillation Ablation 

Reduce Cardioembolic Stroke? 


9:20 am - Transcatheter LAA Occlusion: 

The Watchman Experience as Proof 

of Principle 

David W.M. Muller 

9:35 am - Next-Generation LAA Occlusion 

Devices: AMPLATZER (St. Jude Medical) 

and WAVECREST (Coherex Medical) 

Horst Sievert 

9:47 am - The SentreHeart Transpericardial 

Approach to LAA Occlusion 



9:59 am - PFO Closure to Prevent Venous-to- 

Systemic Embolism: Intuitive, Yes —but 

Where Are the Data? 



Session III. Interventional Approaches to 

Arterial-to-Arterial Stroke 

Moderators: Lee R. Guterman, Jeffrey W. Olin 

Discussants: Tyrone J. Collins, William A. Gray 

10:27 am - Atherosclerotic Carotid 

Bifurcation Stenosis: Primary and 

Secondary Prevention Strategies 


10:39 am - Indications and Timing for 

Intervention in Carotid Artery Dissection 

Lee R. Guterman 

10:51 am - Management of Fibromuscular 

Dysplasia of the Carotid Artery 


11:03 am - When Does Brachiocephalic and 

Vertebral Disease Warrant Intervention for 

Stroke Prevention, and What Are the 

Expected Outcomes? 

Tyrone J. Collins 


Session IV. Flash Debates in 

Cardioembolic Therapies 

Moderators: Robert S. Schwartz, 

Robert J. Sommer, Gregg W. Stone 

Discussants: Eric R. Bates, 

Michael D. Ezekowitz, James D. Joye, 


iMproveMents in AntiCoAgUlAtion 

therApy oBviAte the neeD for lAA 

oCClUsion therApies 

11:30 am - Pro! 


11:35 am - Con! 


11:40 am - Discussion and Vote 

is renAl Artery DenervAtion A 

stroke prevention therApy? 

11:45 am - Pro! 

James D. Joye 

11:50 am - Con! 

Eric R. Bates 

11:55 am - Discussion and Vote 



TranscaTheTer 


TherapeuTics 

From Clinical Trial Evidence 

to Clinical Practice: 

Unraveling the Issues 

8:00 am-11:30 am 

Room A104-105 


Roxana Mehran 

8:03 am - Keynote Address: Translating 

Clinical Evidence into Clinical Practice: 

A Critical Appraisal (with Case Examples) 

Sanjay Kaul 

Session I. Acute MI Therapies 

Moderators: Roxana Mehran, Stuart J. Pocock 

Discussants: Christopher B. Granger, 

Henning Kelbaek, Helen Parise, 

Matthew T. Roe, Philippe Gabriel Steg 

8:23 am - Lessons from the HORIZONS-AMI 

and INFUSE-AMI Trials 

Helen Parise 

8:38 am - A View to Future Trials: 

HORIZONS-AMI II and Others 

Roxana Mehran 


Session II. Value of Functional 

Ischemia in Clinical Practice 

Moderators: Roxana Mehran, Stuart J. Pocock 

Discussants: Christopher B. Granger, 

David J. Maron, Bonnie H. Weiner, 

Stephen G. Worthley 

9:03 am - Lessons from FAME II 

Stuart J. Pocock 

9:15 am - Design and Rationale of ISCHEMIA 

David J. Maron 


Session III. Valvular Heart Disease: Focus 

on Patient Selection/Composite Endpoints 

Moderators: David J. Cohen, Stuart J. Pocock 

Discussants: Somjot S. Brar, Ted E. Feldman, 

Karl-Heinz Kuck, Michael J. Mack, 


9:42 am - Lessons from EVEREST II 


9:57 am - Design and Rationale of COAPT 


10:07 am - Lessons from the PARTNER Trials 

Stuart J. Pocock 

10:22 am - Design and Rationale of 

the CoreValve Trials 





124 


Session IV. Debate: Observational 

Registries vs. RCTs 

Moderators: Kevin J. Beatt, Stuart J. Pocock 

Discussants: Somjot S. Brar, 

Charles J. Davidson, Sheldon Goldberg, 

Robert A. Harrington, William S. Weintraub 

10:52 am - Registries Get at Reality: 

ASCERT and Others! 

William S. Weintraub 

11:04 am - If You Want the Truth, Randomize! 

Robert A. Harrington 


11:30 am - Adjourn 

Innovative Surgical Techniques 

and Technologies 

Co-sponsored by the American Association 

for Thoracic Surgery 

8:00 am-12:05 pm 



Session I. Coronary Artery Disease 

Moderators: A. Marc Gillinov, Neil E. Moat 

Discussants: Stephanie Lynn Mick, 

Craig R. Smith, David X. Zhao 

8:00 am - Is Off-Pump Ever the Right Choice? 

Craig R. Smith 

8:10 am - Intraoperative Graft Assessment: 

Flow Analysis vs. Angiogram? 

David X. Zhao 

8:20 am - All Arterial Revascularization: 

Is It Really Worth the Effort? 

Stephanie Lynn Mick 


Session II. Valvular Heart Disease 

Moderators: Neil E. Moat, Vinod H. Thourani 

Discussants: Isaac George, A. Marc Gillinov, 

Wilson Y. Szeto 

8:40 am - Transcatheter Mitral Technology 

on the Horizon 


8:50 am - Surgery After Failed MitraClip 

Procedures: How Often Is Repair Feasible? 

Michael J. Davidson 

9:00 am - Sutureless Surgical Aortic Valve 

Replacement: Is There a Role in the 

TAVR Era? 


9:10 am - Transapical Closure of 

Paravalvular Leaks 

Isaac George 

9:20 am - LV Apical Closure Devices 


9:30 am - Robotic Mitral Repair: 

Gimmick or Major Advance? 



Session III. Atrial Fibrillation 

Moderator: Husam H. Balkhy 

Discussants: William E. Cohn, A. Marc Gillinov, 


9:55 am - Lone Surgical Treatment of Atrial 

Fibrillation: Meaningful Progress in the 

Past 15 Years? 

William E. Cohn 

10:05 am - Hybrid Surgical and 

Percutaneous AF Ablation 

Husam H. Balkhy 

10:15 am - Concomitant Surgical Ablation: 

What Is the Right Procedure? 


10:25 am - Closure of the Left Atrial 

Appendage: Surgical Approaches 

and Results 


10:33 am - Closure of the Left Atrial 

Appendage: Transcatheter Approaches 

and Results 



Session IV. Heart Failure 

Moderators: William E. Cohn, 

Stephanie Lynn Mick 

Discussants: Robert E. Michler, Amit Patel 

10:51 am - The Future of Surgical VADs 

William E. Cohn 

11:05 am - Is SVR for CHF DOA? 


11:15 am - Stem Cell Therapy: 

The Hype and the Hope 

Amit Patel 


Session V. Surgical Innovations 

Moderators: Emile Bacha, William E. Cohn 

Discussants: Husam H. Balkhy, 

Michael J. Davidson, Isaac George, 

A. Marc Gillinov, A. Pieter Kappetein, 

Wilson Y. Szeto, Vinod H. Thourani 

11:35 pm - Past Successes and Future Needs: 

A Roundtable Discussion 


Next-Generation Transcatheter 

Mitral Valve Therapies 

8:00 am-12:06 pm 

Room A201-202 


Session I. Past Revisited and Future 

Predicted 

Moderators: Maurice Buchbinder, 

Horst Sievert 

Discussants: David H. Adams, Jan Harnek, 

Howard C. Herrmann, Samir R. Kapadia, 

D. Craig Miller, Nicolas M. van Mieghem 

8:00 am - A Retrospective Analysis of a 

Decade of (Mostly) Failed Device 

Approaches for Mitral Regurgitation (MR): 

Why Has Progress Been So 

Agonizingly Slow? 


instrUCtive DeBAte: will trAnsCAtheter 

therApies ever MAtCh the sUrgiCAl 

stAnDArD for Mr? 

8:10 am - No: In This Case Even the Most 

Ingenious Percutaneous Approaches Are 

Doomed to Fall Short! 

Patrick M. McCarthy 

8:18 am - Yes: Like PCI and CABG, 

It’s Only a Matter of Time (and Money)! 

Jan Harnek 


Session II. Coronary Sinus 

Mitral Annuloplasty 

Moderators: Ted E. Feldman, 


Discussants: Steven L. Goldberg, Jan Harnek, 

Robert J. Lederman, Robert J. Lederman, 

Ahmed Magdy, Wesley R. Pedersen, 


8:36 am - The Carillon: Device Iteration, 

New Data, New Trials 

Steven L. Goldberg 

8:46 am - Two Instructive Carillon Cases: 

One That Worked and One That Didn’t 


8:58 am - Mitral Valve Cerclage: Concept 

and Practicality 

Robert J. Lederman 


Session III. Direct Mitral Annuloplasty 

Moderators: Eberhard Grube, Karl-Heinz Kuck 

Discussants: Lutz Buellesfeld, 

Robert A. Guyton, Richard R. Heuser, 

Franz X. Kleber, Francesco Maisano, 

Konstantinos Spargias, Zoltan G. Turi 

9:16 am - Challenges for Percutaneous 

Suture and Band Annuloplasty: 

Surgical Perspectives 

Robert A. Guyton 

9:26 am - Mitralign “Bident” Program Update 

Lutz Buellesfeld 

9:36 am - Accucinch (Guided Delivery 

Systems) Program Update 

Franz X. Kleber 

9:46 am - Cardioband (Valtech Cardio) 



9:56 am - Perspectives on Direct Annuloplasty: 

Who Are the Right and Wrong Patients 

(with Case Examples)? 


10:04 am - Discussion with Q&A

Session IV. Transcatheter Mitral 


Moderators: Francesco Maisano, 


Discussants: Shmuel Banai, Jose A. Condado, 

Michael J. Davidson, Adrian Ebner, 

George Lutter, Nicolo Piazza, 

Lars Sondergaard 

10:16 am - Position Statement from a Surgeon: 

Transcatheter MV Replacement Is a Step 

Backward and Unlikely to Work! 

Michael J. Davidson 

10:26 am - Featured Lecture: CardiAQ 

Program Update: Featuring the World’s 

First Successful Transcatheter Mitral 

Valve Implant 

Lars Sondergaard 

10:38 am - Tiara (Neovasc) Program Update 

Shmuel Banai 

10:46 am - Lutter Valve Update 

George Lutter 


Session V. Other Transcatheter 

Mitral Approaches 

Moderators: Scott Lim, Michael J. Mack 

Discussants: Richard C. Daly, D. Craig Miller, 

Alfredo Trento, Nicolas M. van Mieghem, 

Francis C. Wells, Jian Ye 

11:08 am - First Report: St. Jude Medical 

Percutaneous Mitral Repair Device: 

Device Description, Preclinical, and 

First-in-Human Results 

Francis C. Wells 

11:20 am - CardioSolutions MitraSpacer: 

Temporary Use and Permanent Implant 

Jian Ye 

11:30 am - Do Adjustable Mitral Annuloplasty 

Rings Address an Unmet Clinical Need? 

Patrick M. McCarthy 

11:38 am - Micardia Update: Surgical and 

Percutaneous Device Progress 

Maurice Buchbinder 

11:46 am - Neocord Update: From Surgical 

TACT Trial Update to Percutaneous Chords 

Richard C. Daly 



The Use and Abuse of 

Appropriate Use Criteria (AUC): 

A Case-Based Tutorial 

8:00 am-12:00 pm 

Room A204-205 

Session I. Current Options for Ensuring 

PCI Quality Performance 

Moderators: Ajay J. Kirtane, Manesh R. Patel 

Discussants: Joseph D. Babb, Kurt Huber, 

Spencer B. King III, J. Jeffrey Marshall, 

Steven P. Marso 


8:00 am - AUC: We Must Be Knights, Not 

Knaves, for the Profession 

Spencer B. King III 

8:15 am - Good Intentions Gone Bad: 

Problems with AUC 


8:30 am - The Hippocratic Oath as a 

Guide Rather Than the AUC 

J. Jeffrey Marshall 

8:40 am - ESC Guidelines: No Need for AUC 

for PCI: A European Perspective 

Kurt Huber 


Session II. Case-Based Debates on the 

AUC (for Diagnostic Catheterization 

and Revascularization) 

Moderators: J. Jeffrey Marshall, 


Discussants: Joseph D. Babb, Sorin J. Brener, 

Larry S. Dean, Kurt Huber, Ajay J. Kirtane, 

Manesh R. Patel, Samin K. Sharma 

9:10 am - Case Presentation 1: How to Use 

the AUC as Part of Routine Morbidity and 

Mortality Conference Review 



9:30 am - Case Presentation 2: Example 

of Abuse of AUC 



9:50 am - Case Presentation 3: Uncovered 

AUC Scenarios: How Should These Types 

of Cases Be Handled? 



10:10 am - Case Presentation 4: AUC and the 

Elephant in the Room: Unnecessary Stents 

Larry S. Dean 


Session III. AUC Moving Forward: 

Obstacles and Goals 

Moderator: Manesh R. Patel 


Hitinder S. Gurm, Christopher J. White 

10:30 am - Tools for Everyday Use of AUC 


10:45 am - Peer Review and Incorporation 

of AUC 


11:00 am - AUC and State PCI Registries: 

The Michigan State PCI Registry Example 

Hitinder S. Gurm 

11:15 am - Face the Facts, AUC Are Here to 

Stay: 2012 Update on the Current Use 

and Future Directions of AUC 





TranscaTheTer 


TherapeuTics 

lunchtiME activitiEs 

Hot Topics 

ACC Special Fellows Session I. Valvular 

Heart Disease: Year in Review 2012 

12:15 pm-1:48 pm 




E. Murat Tuzcu 

12:15 pm - Percutaneous Mitral Valve Repair: 

Insights on Patient Selection and Results in 

Degenerative and Functional Mitral 

Regurgitation 



12:30 pm - Evaluation and Treatment of 

Right-Sided Valve Disease (Pulmonary 

and Tricuspid) 

Michael J. Landzberg 


12:45 pm - Low Gradient Aortic Stenosis 

in Patients with Low and Preserved Left 

Ventricular Ejection Fraction: From 

Evaluation to Treatment 

Philippe Pibarot 


1:00 pm - Role of Multimodality Imaging in 

the Evaluation of Aortic Valve Disease 



1:15 pm - Patient Selection for TAVR: Which 

Patients Should and Should Not Undergo a 

TAVR Procedure? 



1:30 pm - TAVR in 2012: Clinical Evidence 

and Unresolved Issues 

Raj Makkar 



Difficult Patients in 


12:15 pm-1:50 pm 


Moderators: Alexandra J. Lansky, 

John A. McPherson, Manish A. Parikh 


Michael J. Rinaldi, Fayaz Shawl 

12:15 pm - Approach to the Patient with 

Renal Failure and Multivessel CAD 

Harry R. Phillips 






12:35 pm - Management of Diffuse 

Restenosis After DES 



12:50 pm - Strategies for the ACS Patient 

with Chronic Atrial Fibrillation 

C. Michael Gibson 


1:05 pm - Revascularization in the Patient 

with Severe Aortic Stenosis 



1:20 pm - Approach to Threatened, Imminent, 

and Actual Cardiac Arrest in the Cath Lab 



1:35 pm - Options for Patients with ACS 

and No Palpable Pulses 

Alexander Grigorievich Osiev 



Dual Antiplatelet Therapy Controversies 

12:15 pm-1:45 pm 


Controversy i. DeBAte: whiCh ADp 

AntAgonist in ACs? 

Moderators: A. Michael Lincoff, 



Joost Daemen, Walter Desmet, David Erlinge, 

Lisa K. Jennings, Shamir R. Mehta, 

Michelle O’Donoghue, Matthew J. Price 

12:15 pm - Prasugrel Is the Gold Standard! 


12:25 pm - Ticagrelor Is the Right Choice: 

More Potent, Better Data! 

Dimitrios Alexopoulos 

12:35 pm - Clopidogrel Is Still the Choice 

for Most! 


12:45 pm - A Representative Case with 

a Complication: Stent Thrombosis or 

Major Bleed? 

David Erlinge 


Controversy ii. DeBAte: DUrAtion of 

DApt post Des 

Moderators: Dean J. Kereiakes, 


Discussants: Joost Daemen, 

Germano Di Sciascio, Myeong-Ki Hong, 

Laura Mauri, Wojciech Wojakowski 

1:05 pm - Longer Is Better Is Old 

School Thinking! 


1:15 pm - The Longer the Better Is Still 

the Way to Go, at Least for Now! 

Laura Mauri 

1:25 pm - A Representative Case with a 

Complication: Stent Thrombosis or 

Major Bleed? 




Guideline Directions and Controversies 

(Part 1): STEMI and NSTEMI 

12:15 pm-1:45 pm 


Moderators: Neal S. Kleiman, 

Frederick Kushner 

12:15 pm - Should All Patients with STEMI 

Be Transferred to a PCI-Capable Hospital? 

Jacqueline E. Tamis-Holland 


12:30 pm - Medical Therapy During 

Interhospital Transport: Fibrinolytic and/or 

Anticoagulant? 

Frans Van de Werf 


12:45 pm - Should Aspiration Thrombectomy 

Be First-line Therapy? 

Sameer Mehta 


1:00 pm - PCI of the Non-Infarct Vessel: 

Go or No-Go? 

John A. Bittl 


1:15 pm - Should P2Y12 Antagonists Be 

Continued Through CABG in Patients 

with ACS? 



1:30 pm - Systemic Hypothermia: For Hospital 

Arrest and Myocardial Infarction? 

Goran K. Olivecrona 



Novel Findings from Randomized 

and Nonrandomized Studies 

12:15 pm-1:45 pm 

Room D235-236 


Moderators: James H. Chesebro, 

Michael J. Cowley 

Discussants: Donald Cutlip, Hitinder S. Gurm, 

Luis A. Guzman, Michalis Hamilos, 

Eric Horlick, Norman E. Lepor 

12:15 pm - PARTNER: Early and Late 

Outcomes of Transcatheter Valve-in-Valves 

for Failed Balloon Expandable Transcatheter 

Aortic Valves 

Raj Makkar 


12:30 pm - PARTNER: Prognostic Value of Low 

Flow in Patients with Severe Aortic Stenosis 



12:45 pm - ADAPT-DES IVUS Substudy: Utility 

of IVUS in Delineating the Mechanism of and 

Preventing Stent Thrombosis 

Akiko Maehara 


1:00 pm - Stent Thrombosis Results from a 

Registry in 18,334 Patients 

Tomohisa Tada 


1:15 pm - DESERT: Final Analysis of the 

Clinical and Angiographic Predictors of Stent 

Thrombosis from a Large, Multicenter 

Registry 

Ron Waksman 


1:30 pm - ATLAS ACS-2 TIMI 51: Stent 

Thrombosis in Patients with Acute Coronary 

Syndromes Treated with Rivaroxaban 




So You Think You Have a Great Idea? 

An Inventor’s Workshop 

Sponsored by Stanford Biodesign 

12:15 pm-1:45 pm 



Moderator: Paul G. Yock 

Discussants: Maurice Buchbinder, 

Thomas J. Fogarty, Julio C. Palmaz, 

Richard S. Stack 

12:15 pm - Introduction and Goals 

Paul G. Yock 

12:18 pm - Secret Sauce: The Right 

Clinical Need 

Todd J. Brinton 

12:26 pm - Assessing the Market 

(Without Hiring an MBA) 

Jay Watkins 

12:34 pm - IP 101: Is Your Device Patentable? 

James R. Shay 

12:42 pm - Mapping out FDA and CE Strategy 

Aaron V. Kaplan 

12:50 pm - Getting Real: Practical Next Steps 

Peter J. Fitzgerald

12:58 pm - Q&A with the Master Inventors 


Special Circulation Journal Session: The 

Most Important Papers from the Last Year 

12:15 pm-1:45 pm 

Room D233-234 



David P. Faxon 

rethinking the DUrAtion of DUAl 

AntiplAtelet therApy 

Moderator: Theodore A. Bass 

Discussants: J. Dawn Abbott, 

Dominick J. Angiolillo, Hyeon-Cheol Gwon, 

Mitchell W. Krucoff, Marco Valgimigli 

12:16 pm - Six-Month vs. 12-Month Dual 

Antiplatelet Therapy After Implantation of 

Drug-Eluting Stents: The Efficacy of Xience/ 

Promus vs. Cypher to Reduce Late Loss 

After Stenting (EXCELLENT) Randomized, 

Multicenter Study. Circulation. 

2012;125:505-513. 


12:23 pm - Short- vs. Long-term Duration of 

Dual Antiplatelet Therapy After Coronary 

Stenting: A Randomized Multicentre Trial. 

Circulation. 2012;125:2015-2026. 



expAnDing inDiCAtions for tAvr 

Moderator: David O. Williams 

Discussants: Peter Boekstegers, 

Antonio Colombo, Michael J. Davidson, 

Sachin S. Goel 

12:46 pm - Percutaneous Coronary 

Intervention in Patients with Severe Aortic 

Stenosis: Implications for Transcatheter 

Aortic Valve Replacement. Circulation. 

2012;125:1005-1013. 

Sachin S. Goel 

12:55 pm - Transcatheter Aortic Valve 

Implantation in Patients With Severe Left 

Ventricular Dysfunction: Immediate and 

Mid-term Results: A Multicenter Study. 

Circ Cardiovasc Interv. 2012;5:253-260. 



who neeDs CoMplete revAsCUlArizAtion? 

Moderator: David P. Faxon 

Discussants: Sripal Bangalore, Donald Cutlip, 

Jane A. Leopold, Gregg Rosner, 

Gary L. Schaer, Stephan Windecker 

1:15 pm - Impact of Completeness of 

Revascularization on Long-term 

Cardiovascular Outcomes in Patients with 

Type 2 Diabetes Mellitus: Results from the 

Bypass Angioplasty Revascularization 

Investigation 2 Diabetes (BARI 2D). 

Circ Cardiovasc Interv. 2012;5:166-173. 



1:22 pm - Impact of the Presence and Extent 

of Incomplete Angiographic 

Revascularization After Percutaneous 

Coronary Intervention in Acute Coronary 

Syndromes: The ACUITY Trial. Circulation. 

2012;125:2613-2620. 

Gregg Rosner 


1:44 pm - Concluding Remarks 

David O. Williams 


Tough Calls in the Cath Lab: What Is This, 

and What Do We Do Now? 

12:15 pm-1:45 pm 

Room D231-232 


CAse presentAtions 

Moderators: Carlo Di Mario, Zoltan G. Turi 

12:15 pm - Tough Call During a TAVR 

Raj Makkar 

12:35 pm - Tough Call Using MitraClip 


12:55 pm - Tough Call During Cardiac Support 


1:05 pm - Tough Call During a LAA Occlusion 


1:25 pm - Tough Call During a HOCM Ablation 

Carey D. Kimmelstiel 




Acute Stroke Intervention 

12:15 pm-1:45 pm 

Room A209 

Moderators: L. Nelson Hopkins, 

Philip M. Meyers 

Discussants: Mohammad Ali Aziz-Sultan, 

Italo Linfante, Stephen R. Ramee 

CAse i 

12:15 pm - Anatomy for Stroke Intervention 


12:21 pm - Concentric Merci Case 


CAse ii 

12:30 pm - Patient Selection: Clinical Imaging 

Italo Linfante 

12:36 pm - Penumbra Case 

Italo Linfante 

CAse iii 

12:45 pm - Successful Stent-Retriever Case: 

Current Technical Options for Successful 

Revascularization 

Mohammad Ali Aziz-Sultan 


TranscaTheTer 


TherapeuTics 

12:51 pm - Stent-Retriever Case 

Mohammad Ali Aziz-Sultan 

CAse iv 

1:00 pm - Complication Avoidance and 

Management 


1:06 pm - Hemorrhage Post Revascularization 


CAse v 

1:15 pm - How to Train Non- 

Neurointerventionalists to Treat 

Acute Ischemic Stroke 


1:21 pm - Perforation and Management 




Complex Congenital Intervention 

12:15 pm-1:45 pm 

Room B211 

Moderators: Ziyad M. Hijazi, John F. Rhodes 

Discussants: Elchanan Bruckheimer, 

Huseyin Ince, Doff B. McElhinney, 

Horst Sievert, Robert J. Sommer 

12:15 pm - Coarctation of the Aorta: 

Techniques for Stent Implantation 


12:25 pm - Two Illustrative Cases of 

Coarctation Stent Placement: 

One Uncomplicated, One Complex 

Horst Sievert 


12:45 pm - Coronary AV Fistulas: 

Treatment Techniques 


12:55 pm - Two Illustrative Cases of Fistula 

Occlusion: One Uncomplicated, 

One Complex 



1:15 pm - Percutaneous Pulmonary Valve 

Replacement: Indications and Technique 

Doff B. McElhinney 

1:25 pm - Two Illustrative Cases: One Melody, 

One Edwards 




CTO Antegrade Reentry Techniques 

12:15 pm-1:45 pm 

Room B210 

Moderators: Stéphane Rinfret, 


Discussants: Tony J. DeMartini, 

Ashish Pershad, James Spratt 



128 


12:15 pm - History and Evolution of Antegrade 

Dissection Reentry Techniques for Coronary 

Chronic Total Occlusion PCI 


12:28 pm - Utilization of Intravascular 

Ultrasound for Intralesional Rewiring in CTO: 

A Step-by-Step Approach 


12:41 pm - The Stingray Reentry Technology 


12:54 pm - How to Manage the Dissection 

Space: Knuckle Wires, CrossBoss, 

Catheter Exchanges, and More 


1:07 pm - Troubleshooting Loss of 

Visualization During Dissection Reentry 

James Spratt 

1:20 pm - Putting It All Together: 

Tips and Tricks to Optimize Technical 

Success Using Dissection Reentry in 

the Antegrade Direction 




Interventional “Rich Emotional Experiences” 

12:15 pm-1:45 pm 

Room B214 

Moderators: Sorin J. Brener, 

David R. Holmes Jr, Jeffrey J. Popma 

CoronAry perforAtions 

12:15 pm - Case Presentation: Massive 

Coronary Perforation 


12:22 pm - Why It Happens and How 

to Prevent It 


slow AnD no reflow After pCi 

12:35 pm - Case Presentation: No Reflow 


12:42 pm - Predictors and Therapies for 

Abrupt Vessel Closure and No Reflow 


left MAin BifUrCAtion stenting 

with CoMpliCAtions 

12:55 pm - Case Presentation: Distal Left Main 

Stenting with Complications 

Kenneth Chin 

1:02 pm - One or Two Stents —and How 

to Avoid Complications 

Kenneth Chin 

vAsCUlAr ACCess CoMpliCAtions 

1:15 pm - Case Presentation: A Terrible 

Vascular Complication 


1:22 pm - How to Screen for Femoral TAVR 

Compatibility Plus Avoid and Treat Access 

Site Complications 




Nuts and Bolts of IVUS 

12:15 pm-1:45 pm 

Room B212 

Moderators: John McB. Hodgson, 


Discussants: Stéphane Cook, 

Danny Dvir, Rainer Hoffmann, 

Erick Schampaert, 


12:15 pm - Fundamentals of IVUS 

Acquisition and Analysis 

John McB. Hodgson 

12:23 pm - Case 1: Standard IVUS Guided 

Pre- and Post-Stent Implantation 

John McB. Hodgson 

12:33 pm - Case 2: IVUS Guided Diagnosis 

and Therapy of In-Stent Restenosis 


12:43 pm - Case 3: IVUS Guided Stenting 

in Calcified Disease 

Rainer Hoffmann 

12:53 pm - Case 4: IVUS for Intermediate 

Left Main Lesions 


1:03 pm - Using IVUS for Assessment 

and Treatment Guidance of 

PCI Complications 


1:11 pm - Case 5: Malapposition or Strut 

Deformation Resulting in Thrombosis 

Danny Dvir 

1:21 pm - Case 6: Geographic Miss 

(or The Ultimate Miss: Lost Stent) 

Akiko Maehara 

1:31 pm - VH-IVUS: Cath Lab Basics 


1:39 pm - Case 7: Potential Clinical Use 

of VH-IVUS in the Cath Lab 

Akiko Maehara 


Transseptal Puncture 

12:15 pm-1:45 pm 

Room A208 

Moderators: William A. Gray, Morton J. Kern 

Discussants: Saibal Kar, Igor F. Palacios, 

Ramon Quesada, Brian K. Whisenant 

session i. DiDACtiC overview 

12:15 pm - Anatomy of the Interatrial Septum 

for the Interventionalist 



12:30 pm - Transseptal Puncture: Step-by- 

Step With and Without Echo Guidance 



session ii. trAnsseptAl CAses 

12:45 pm - Case 1: Complication of 

Transseptal Puncture 

Igor F. Palacios 

12:57 pm - Case 2: Optimal Transseptal 

Puncture for the MitraClip 

Saibal Kar 

1:09 pm - Case 3: Optimal Transseptal 

Puncture for LAA Occlusion 


1:21 pm - Case 4: Transseptal Puncture 

for Hemodynamic Assessment 

Morton J. Kern 

1:33 pm - Case 5: Transseptal Puncture 

for Paravalvular Leak Closure 

Ramon Quesada 


Venous Disease Intervention 

12:15 pm-1:45 pm 

Room B213 

session i. Deep venoUs DiseAse 

Moderators: Raghu Kolluri, 


12:15 pm - The Deep Vein Thrombosis 

Problem: How Strong Is the CAVENT 

Study Evidence? 


12:22 pm - Is There Any Benefit in 

Recanalizing Chronic Central 

Venous Occlusions? 


12:29 pm - Catheter Intervention in 

Pulmonary Embolism: When and How 

Nilesh Goswami 

12:36 pm - Case 1: A Patient with Bilateral 

Deep Vein Thrombosis 


12:43 pm - Case 2: Management of Clotted 

Inferior Vena Cava Filter 


12:50 pm - Case 3: Single Session Treatment 

of Iliofemoral Deep Vein Thrombosis 

Greg Mishkel 

session ii. sUperfiCiAl venoUs systeM 

Moderators: Raghu Kolluri, 


12:57 pm - Update in the Management of 

Superficial Venous Disease 

Lowell Kabnick

DeBAte: in pAtients with ChroniC 

venoUs insUffiCienCy, MUst the 

oBstrUCtive lesions in the Deep 

venoUs systeM Be stenteD Before 

treAting the sUperfiCiAl systeM? 

1:07 pm - Pro! 


1:14 pm - Con! 

Raghu Kolluri 

1:21 pm - Case 4: Ambulatory Phlebectomy 

(Office-Based) 

Raghu Kolluri 

1:28 pm - Case 5: Perforator Ablation 

Step by Step 

Lowell Kabnick 

1:35 pm - Update on Interventions 

for Dialysis Fistulas 

John A. Bittl 




Session III. Coronary 

2:00 pm-3:00 pm 

Hall D 


TCT-1161. Acute Myocardial Infarction and 

Thrombus in Ascendant Aorta: Approach, 

Diagnosis, and Outcome: The Treatment 

of a Nonstenotic Cause of Acute 


Felix Damas De Los Santos 

TCT-1162. Rotational Ablation for a Protruding 

Stent from the Ramus Branch Which 

Compromised the Ostium of LCX 

Max Woo 

TCT-1163. Left Main Stem Thrombotic 

Closure as a Presentation of Acute 

Myocardial Infarction Complicated by 

Cardiogenic Shock 

Marco Wainstein 

TCT-1164. “Pot and Tap” in Left Main 

Stenting Where Two Stents Were Used 

Sivakumar Rathinavel 

TCT-1165. Successful Treatment of Prolonged 

Out-of-Hospital Cardiac Arrest with 

Automatic Mechanical Chest Compression 

Enabling Performance of Primary PCI 

Petr Hajek 

TCT-1166. PCI in Left Circumflex Artery 

with Important Angulation 


TCT-1167. Complex Coronary Intervention 

Using Percutaneous Left Ventricular 

Assist Device 

Harit Desai 


TCT-1168. Hidden Micro-Channel 

Tracking by Reverse Wire Technique 

in Percutaneous Coronary Intervention 

for Semioccluded Lesion 

Keita Okayama 

TCT-1169. A Retrieval of 

Polytetrafluoroethylene-Covered 

Stent After Unsuccessful Delivery 

to Coronary Perforation 

Kentaro Meguro 

TCT-1170. Successful Two Steps Antegrade 

Recanalization of a Complex Chronic Total 

Coronary Occlusion With 5-Fr Guiding 

Catheter For Guidewire Crossing at Second 

Attempt and Switch to a 7-Fr Guiding 

Catheter Using an Antegrade Guidewire 

Anchoring Technique 

Karl Isaaz 

TCT-1171. PCI of Giant Aneurysm Lesions 

on STEMI by Radial Approach 

Mauricio Vanegas 

TCT-1172. Intravascular Ultrasound Guided 

Antegrade Wiring of Stumpless Chronic 

Total Coronary Occlusion 

Patrick Siegrist 

TCT-1173. Collapse of the Stent in RCA: 

Challenges Faced 

Ganesh Kumar 

TCT-1174. From STEMI to Pulmonary 

Embolism: Intrapulmonary Fibrinolysis 

Application During Cardiopulmonary 

Resuscitation 

Dejan Jovic 

TCT-1175. “TAVI Is Not the End of the Story:” 

A Case Report of Percutaneous Coronary 

Intervention After Transcatheter Aortic 


Slim Mehdi 

TCT-1176. An Unusual Case of Coronary 

Artery Dissection: Semicompliant Balloon 

Rupture at Low Pressure Resulting in 

Barotrauma and Distant Proximal Extensive 

Dissection of an Uninvolved Bifurcation 

Rupert Williams 

TCT-1177. Coronary Artery Rupture During 

Left Main Intervention in a Patient with 

Severe Aortic Stenosis 

Niket Patel 

TCT-1178. Treatment of Late Incomplete Stent 

Apposition after Subintimal Sirolimus and 

Everolimus Eluting Stent Implantation 

Shimpei Nakatani 

TCT-1179. A Successful Team Treatment for 

Left Main Shock Syndrome 

Cheng Yutong 

TCT-1180. Retrograde CTO via RV Marginal 

John Forrest 


TranscaTheTer 


TherapeuTics 

TCT-1181. Bypass Graft Angiogram Guided 

Left Main and Right Coronary Artery Total 

Occlusion Percutaneous Coronary 

Intervention in Single Sitting 

Vijayakumar Subban 

TCT-1182. Anchor Technique for 

Stent Deployment 

Yusuf Kumble 

TCT-1183. Visualization of Kissing Balloon 

Dilation Induced Stent Deformation by 

Optical Coherence Tomography 

Antonios Karanasos 

TCT-1184. Stent Slippage or Breakage 

Balijepalli Sudhakar 

TCT-1185. Iatrogenic Migration of 

Carotid Stent 


TCT-1186. Left Main Stenting in a Nine-Year- 

Old Child with Hypercholesteroleamia 

Nireen Okasha 

TCT-1187. The LIMA Is Not Enough: PCI to 

Left Main Stem CTO to Improve Flow in the 

Circumflex 

Benjamin Wrigley 

TCT-1188. Retrograde CTO PCI Complicated 

by Wire Knot Formation Involving Antegrade 

and Retrograde Wires 


TCT-1189. Antegrade Approach for 

Three Vessel CTO Lesions 

Euihong Ko 

TCT-1190. How Do I Treat RCA 

Perforation When Only Transradial 

5-Fr Sheath Available? 

Hsiu-yu Fang 

TCT-1191. Rotational Atherectomy for Stent 

Ablation of Severe Recent Underexpanded 


Roberto Garbo 

TCT-1192. Primary Angioplasty: How Extreme 

Can It Be? 


TCT-1193. Coronary Vasospasm Associated 

with Thyrotoxicosis 

Wook Bum Pyun 

TCT-1194. Successful Removal of Entrapped 

Intravascular Ultrasound Catheter Due to 

Longitudinal Deformation of Recent 

Generation Drug-Eluting Stent 

Yoshiyuki Suzuki 

TCT-1195. Anchoring Balloon to Assist Access 

to a Jailed LAD During Primary PCI 

Enrique Gutierrez Ibañes 

TCT-1196. When One Stent Is Not 

Enough: Using a Dedicated Stent 

for Bifurcation Disease 

Peter O’kane 



130 


TCT-1197. Longitudinal Deformation of 

Promus Element Stent by Passive Deep 

Engagement of Guiding Catheter During 

Retrograde Recanalization of Chronic 

Total Occlusion 

Jung-kyu Han 

TCT-1198. More Than Just Muscle Bridging 

Sunita Avinash 

TCT-1199. Longitudinal Stent Deformation in 

Complex Left Main Bifurcation Stenting with 

TRYTON and PROMUS ELEMENT Stents 

Jose Diaz Fernandez 

TCT-1200. Rotational Atherectomy and Stent 

Implantation on Right Coronary Artery in a 

Patient with a History of Previous Ineffective 

Attempts of PCI on the Same Artery 

Cinzia Moncalvo 

TCT-1201. Management of Life Threatening 

Left Anterior Descending Artery Perforation 

with Double Guide Intubation 

Nimit Shah 

TCT-1202. Mechanical Thrombectomy Using 

Fogarty’s Technique in Occlusion of the Left 

Main Coronary Artery in Acute Myocardial 

Infarction and Cardiogenic Shock 

Maria Antonieta De Medeiros 

TCT-1203. Use of Rotational Atherectomy in a 

Distal Undilatable Lesion After Proximal 

Stent Deployment in Chronic Total 

Occclusion 

Divyesh Sharma 

TCT-1204. Usefulness of Noncontrast 

Coronary Computed Tomography for 

Percutaneous Coronary Intervention of 


Teppei Sugaya 

TCT-1205. Successful PCI for LAD Total 

Occlusion to Control Electrical Storm 

Mikio Kishi 

TCT-1206. Non-ST-Elevation Myocardial 

Infarction with Totally Occluded LAD 

with Lt. Main Bifurcated Lesion 

Hyunsu Kim 

TCT-1207. PCI to Distal Left Main 

Critical Stenosis 

Amr Hassan 

TCT-1208. A Hole New Experience 

Peter Haworth 

TCT-1209. Left Main Chronic Total 

Occlusion Treated with Single Stent: 

Simplifying the Complex 

Sarita Rao 

TCT-1210. Modified T-Stenting of a 

Bifurcation Lesion in LCX in a Patient 

with Severe Two Vessel CAD 

Balijepalli Sudhakar 

TCT-1211. A “Forced” Rotablator 

During Primary PCI 

Massimo Mancone 

TCT-1212. PCI with Multiple Complications: 

Impact of New Technologies in 

Successful Management 

Paramdeep Sandhu 

TCT-1213. IVUS-Guided Antegrade and 

Retrograde Complex Right Coronary 

Artery CTO-PCI 

Roberto Garbo 

TCT-1214. IVUS-Guided Retrograde 

Ostial LAD CTO-PCI Through Tortuous 

Epicardial Collateral 

Roberto Garbo 

TCT-1215. Common Complication 

with Uncommon Solution 

Wirash Kehasukcharoen 

TCT-1216. LMCA Stenting: Reverse 

Minicrush Technique 

Ashwin Tumkur 

TCT-1217. Antegrade Approach to 14-Year- 

Old Long and Calcified CTO Complicated by 

Stent/Balloon Perforation 

Ashwin Mehta 

TCT-1218. Successful Antegrade PCI for 

LAD-CTO Using Reverse Wire Technique 

Hiroki Watanabe 

TCT-1219. First-in-Human Experience in the 

Dilatation, Capture, and Removal of 

Atheromatous Plaque, from the Lesion Site, 

Post-Directional Atherectomy with the New 

0.14” Below-the-Knee Proteus Balloon in the 

Treatment of High-Risk Critical Limb 

Ischemia Patient 

Prakash Makam 

TCT-1220. Huge Thrombus Burden 

in a STEMI: When Aspiration Catheters 

Do Not Help! 

Narasimharajapura Rajendra 

aftErnoon sPotlight 

sEssions 

Deep Dive: Hypertension 

and Renal Artery Denervation 

2:00 pm-6:26 pm 

Room A201-202 

Session I. Renal Denervation: 

Rationale and Preclinical Science 

Moderators: Justin E. Davies, 


Discussants: Juan F. Granada, 

Markus P. Schlaich, Robert S. Schwartz 

2:00 pm - Resistant Hypertension: Prevalence 

and Global Impact 

Stefan C. Bertog 

2:10 pm - Physiologic Rationale for 

Interventional Therapies in Hypertension 

C. Venkata S. Ram 

2:20 pm - Translational Medicine and Renal 

Denervation: Preclinical Animal Models 

and Histoanatomy 

Renu Virmani 


Session II. Clinical Endpoints and Trial 

Design in Renal Denervation 

Moderators: Deepak L. Bhatt, Justin E. Davies 


Paul A. Sobotka, Thomas Zeller 

2:40 pm - Measuring the Clinical Effects 

of Renal Denervation: Are Office Blood 

Pressure and 24-Hour Ambulatory Blood 

Pressure Monitoring the Best Surrogates? 


2:50 pm - Three-Year Results from 

SYMPLICITY HTN-1 and SYMPLICITY 

HTN-2: What the Data Do (and Don’t) Tell Us 

Michael Böhm 

DeBAte: is A shAM triAl reAlly neCessAry? 

3:05 pm - SYMPLICITY Results Are Too Good 

to Be True: That’s Why We Need a Sham 

Trial Design! 

Darrel P. Francis 

3:13 pm - Sham Trials Are Burdensome and 

Introduce Their Own Errors! 



Session III. Real-world Experiences with 


Moderators: Felix Mahfoud, Horst Sievert 

Discussants: Klaus D. Mathias, 

Dierk Scheinert, Terje K. Steigen 

3:31 pm - Lessons Learned Using the 

Symplicity Catheter 1: Procedural 

Do’s and Don’ts 

Andreas Baumbach 

3:41 pm - Lessons Learned Using the 

Symplicity Catheter 2: Complex Anatomy 

and Case Selection 

Erwin Blessing 

3:51 pm - The Clinical Use of Renal 

Denervation Is Already Expanding Beyond 

Trial Indications: Insights from the German 

GREAT Registry 

Felix Mahfoud 


Session IV. Emerging Technologies 

for Renal Denervation 

Moderators: Erwin Blessing, Horst Sievert 

Discussants: Todd J. Brinton, John M. Flack, 

Krishna J. Rocha-Singh

4:09 pm - Properties of My Dream Device 

Horst Sievert 

4:14 pm - Sympathetic Renal Denervation: 

Results of the EnligHTN I Study 

(St. Jude Medical) 

Vasilios Papademetriou 

4:21 pm - Paradise (ReCor) 


4:28 pm - V2 (Vessix Vascular) 

James R. Margolis 

4:35 pm - Sound Intervention 


4:42 pm - TIVUS (CardioSonic) 


4:47 pm - OneShot (Maya Medical) 


4:52 pm - External Focused Ultrasound (Kona) 

Todd J. Brinton 

4:59 pm - Extravascular Renal Denervation 

(Ablative Solutions) 

Tim A. Fischell 

5:04 pm - Vincristine Local Delivery for Renal 

Artery Denervation 

Christodoulos I. Stefanadis 


Session V. Future Targets and Trials 

for Renal Sympathetic Denervation 

Moderators: Felix Mahfoud, Paul A. Sobotka 

Discussant: Darrel P. Francis 

5:19 pm - Systolic and Diastolic Heart Failure 

Justin E. Davies 

5:29 pm - Moderate Hypertension and ESRD 

Markus P. Schlaich 

5:39 pm - Diabetes/Metabolic Syndrome 

Felix Mahfoud 

5:49 pm - Obstructive Sleep Apnea 

Adam Witkowski 

5:59 pm - Beyond Renal Denervation 


6:09 pm - Hypertension Therapies: A Word 

of Caution 



6:26 pm - Adjourn 


Next-Generation Transcatheter 

Aortic Valve Therapies 

2:00 pm-6:15 pm 

Room A204-205 


New TAVR Systems I. New and Iterative 

Creations from the TAVR Industry Leaders 



Discussants: Vasilis Babaliaros, 

Todd M. Dewey, Gregory P. Fontana, 

Eberhard Grube, Jean-Claude Laborde, 

Augusto D. Pichard, E. Murat Tuzcu, 

Nicolas M. van Mieghem 

2:00 pm - Do We Need New and Evolutionary 

TAVR Systems? Rationale and Critical 

Design Features 

Nicolo Piazza 


eDwArDs lifesCienCes 

2:10 pm - Next-Generation Balloon- 

Expandable Technology: SAPIEN 3 


2:20 pm - A Novel Self-Expanding TAVR 

System: CENTERA 


2:30 pm - A Novel Balloon-Expandable 

TAVR System for Aortic Regurgitation 

Jian Ye 

2:35 pm - New Expandable Sheaths 

and TA Systems 

Isaac George 


MeDtroniC 

2:45 pm - Next-Generation Self-Expanding 

Technology: CoreValve Evolut and Beyond 


2:55 pm - The Next-Generation Engager 

TAVR System 


3:05 pm - New TAVR Accessory Devices 

Lutz Buellesfeld 


New TAVR Systems II. Newcomers With 

Significant Clinical Experiences 

Moderators: Raj Makkar, Ganesh Manoharan 

Discussants: Stephan M. Ensminger, 

Isaac George, Reginald I. Low, Ian T. Meredith, 

Helge Moellmann, Martyn R. Thomas, 


3:15 pm - Direct Flow Medical TAVR System 




TranscaTheTer 


TherapeuTics 

syMetis ACUrAte tAvr systeM 

3:30 pm - Updates from the 

Transapical Program 


3:38 pm - Updates from the 

Transfemoral Program 

Helge Moellmann 


JenAvAlve AnD st. JUDe MeDiCAl 

3:51 pm - JenaValve TAVR System 

Stephan M. Ensminger 


4:06 pm - St. Jude Medical Portico 

TAVR System 

Raj Makkar 


4:21 pm - Boston Scientific Sadra Lotus 

TAVR System 



New TAVR Systems III. Newcomers Without 

Significant Clinical Experiences 

Moderators: Raj Makkar, Ganesh Manoharan 

Discussants: Maurice Buchbinder, 

Lutz Buellesfeld, Michael J. Davidson, 

Hans R. Figulla, Nicolo Piazza, 

Gerhard C. Schuler, Nicolas M. van Mieghem 

4:36 pm - Heart Leaflet Technologies 

TAVR System 


4:41 pm - Colibri Heart Valve System 

Ziyad M. Hijazi 

4:46 pm - Valve Medical TAVR System 


4:51 pm - Endoluminal Sciences: 

A New Concept for Eliminating 

Paravalvular Regurgitation 

Raj Makkar 


Cerebral Protection Devices and 

Vascular Access and Closure 

Moderators: Eberhard Grube, 


Discussants: Philippe Généreux, 

Joerg Kempfert, Christoph K. Naber, 

Josep Rodes-Cabau, Eric E. Roselli, 

Pieter R. Stella 

CereBrAl proteCtion 

5:02 pm - Will Cerebral Embolic Protection 

Devices Reduce Strokes After TAVR? 


5:10 pm - Embrella Embolic Deflector: 

Clinical Experiences and PROTAVI Update 




132 


5:18 pm - Claret Medical Montage Cerebral 

Filter: Clinical Experiences 


5:26 pm - Keystone Heart Embolic Deflector: 

Clinical Experiences 

Pieter R. Stella 


vAsCUlAr ACCess AnD ClosUre 

5:39 pm - The Landscape of Transarterial 

“Large Hole” Vascular Closure Devices 


5:49 pm - Novel Transapical Left Ventricular 

Access and Closure Devices 


5:55 pm - Early First-in-Human Use 

Experiences with the Apica Transapical 

Access and Closure System 

Joerg Kempfert 

6:01 pm - Early First-in-Human Use 

Experiences with the Entourage Transapical 

Access and Closure System 

Gregory P. Fontana 



Optimizing Use of Today’s 

Antithrombotic and Antiplatelet 

Drugs in ACS and PCI 

2:00 pm-6:10 pm 

Room A104-105 

Session I. Trial and Drug Update 

Moderators: David J. Moliterno, 


Discussants: C. Michael Gibson, 

Robert A. Harrington, Roxana Mehran, 


2:00 pm - Bivalirudin: New Analyses, 

New Studies 


2:10 pm - The Potential of Otamixaban 

as a Procedural Anticoagulant 

Philippe Gabriel Steg 

2:20 pm - Prasugrel Update: TRILOGY 


2:30 pm - Ticagrelor Update: PLATO: 

Recent Analyses 


2:40 pm - Cangrelor Update: CHAMPION 

PHOENIX 


2:50 pm - Rivaroxaban Update: ATLAS-ACS-2 

TIMI-51: Recent Analyses and FDA Redux 


3:00 pm - Factor IXa Inhibition 

(Aptamer) Update 

Roxana Mehran 

3:10 pm - GP IIb/IIIa Inhibition: 

New Studies, New Insights 

David J. Moliterno 


Session II. Pharmacology Debates 

Moderators: Sorin J. Brener, 


Discussants: Michael Kim, Steven P. Marso, 

Jessica L. Mega, Franz-Josef Neumann, 

Michelle O’Donoghue, Duk-Woo Park, 

Dirk Sibbing 

DeBAte i. At leAst 12 Months of DUAl 

AntiplAtelet therApy for All Des pAtients 

3:40 pm - Pro! 


3:50 pm - Con! 


4:00 pm - Rebuttal and Discussion with Q&A 

DeBAte ii. Utility of genetiC testing in 

piCking AntiplAtelet therApy 

4:10 pm - Pro! 


4:20 pm - Con! 

Franz-Josef Neumann 


DeBAte iii. Utility of point-of-CAre 

plAtelet fUnCtion testing 

4:40 pm - Pro! 


4:50 pm - Con! 

Duk-Woo Park 


Session III. Great Cases 

Moderators: Neal S. Kleiman, 

A. Michael Lincoff 

Discussants: Dominick J. Angiolillo, 

Lisa K. Jennings, David F. Kong, 

Issam D. Moussa, Harvey D. White 

5:10 pm - Case 1: Peri-PCI Management 

of the Recently Placed Stent 


5:25 pm - Case 2: Peri- and Post-Procedural 

Management of the Patient with 

Stent Thrombosis 


5:40 pm - Case 3: The Patient with a 

Recently Placed DES in Need of 

Emergent Major Surgery 

Harold L. Dauerman 

5:55 pm - Case 4: The Patient with Atrial 

Fibrillation Presenting with an Acute 




Surgical, Interventional, and 

Hybrid Procedures (Part 2): 

Valvular and Structural 

Heart Disease 

Co-sponsored by the American Association 

for Thoracic Surgery 

2:00 pm-6:15 pm 



Session I. Transfemoral and Alternate 

Access for TAVR 

Moderators: Wilson Y. Szeto, 


Discussant: Michael J. Reardon 

2:00 pm - As Transfemoral Devices Become 

Smaller, Will There Be a Role for 

Alternative Access? 


2:10 pm - Statement: Transaortic Access 

Is Preferable to Transapical Access! 

Michael J. Reardon 

2:20 pm - Percutaneous Femoral Artery 

Closure During TAVR 


2:30 pm - Non-TAVR Procedures Performed 

via a Transapical Approach 



Session II. TAVR Potpourri 

Moderators: Ian T. Meredith, Wilson Y. Szeto 

Discussants: Vinayak Bapat, Eberhard Grube, 

Charanjit S. Rihal, Rhonda Robb 

2:50 pm - Valve-in-Valve for Failed 

Bioprosthetic Valves 

Vinayak Bapat 

3:00 pm - Percutaneous Closure of TAVR 


Charanjit S. Rihal 

3:10 pm - Off-Label Use of the Edwards 

Sapien RF3 System in the United States 


3:20 pm - TAVR Trends in Europe and What 

to Expect in the Future 

Rhonda Robb 

3:30 pm - TAVR: Next-Generation Devices 



Session III. Transcatheter Mitral 

Valve Procedures 

Moderators: A. Marc Gillinov, Saibal Kar 

Discussants: Stephan Baldus, 

A. Pieter Kappetein, Francesco Maisano, 

Neil E. Moat, Jason H. Rogers 

3:50 pm - Multidisciplinary Approach to 


Neil E. Moat 

4:00 pm - A Surgeon’s Candid Experience with 

the MitraClip 


4:10 pm - MitraClip for Functional MR: COAPT: 

Update and Expectations 


4:15 pm - MitraClip for Functional MR: 

RESHAPE Update and Expectations 


4:20 pm - Atypical Pathology Treated 

with the MitraClip 


4:30 pm - Transcatheter Mitral Valve 

Devices on the Horizon 



Session IV. Valve Surgery Updates 

Moderators: A. Marc Gillinov, 


Discussants: David H. Adams, Emile Bacha, 

Steven F. Bolling, James S. Gammie, 

Allan Stewart 

4:50 pm - Is Aortic Valve Repair 

Superior to Replacement? 

Allan Stewart 

5:00 pm - The Role of Hybrid Procedures 

in Congenital Heart Surgery 

Emile Bacha 

5:10 pm - Minimally Invasive Mitral Repair: 

Is It for Everyone (Surgeon and Patient)? 


5:20 pm - Artificial Chords: When and How? 

James S. Gammie 

5:30 pm - Who Should Have a Mitral 

Valve Replacement? 

Steven F. Bolling 

5:40 pm - Tricuspid Valve Repair: 

When and How? 


5:50 pm - The Impact of a TAVR Program 

on Surgical Volume 





The Skeptic’s Corner: 

Controversies in 


2:00 pm-5:40 pm 

Room A101-102 


Panel I. Interventional Cardiology and 

Surgery at the Crossroads 

Moderators: Eric R. Bates, Craig R. Smith 

Discussants: David Brown, 

Maurice Buchbinder, James S. Gammie, 

Philippe Garot, Robert A. Guyton, Sanjay Kaul, 

Ajay J. Kirtane, Vincent On-Hing Kwok, 

Harold L. Lazar, Daniel I. Simon 

CoMMonly helD view 1: AsCert is right! 

CABg proviDes optiMAl revAsCUlArizAtion 

for stABle MUltivessel CAD 

2:00 pm - Contrarian Position: ASCERT Is 

Hopelessly Confounded. PCI Outcomes 

Are No Worse, and PCI Is More Widely 

Acceptable and Applicable! 



CoMMonly helD view 2: pCi for left MAin 

DiseAse is skAting on thin iCe! 

2:22 pm - Contrarian Position: Left Main PCI 

Will Make CABG Obsolete! 

Sheldon Goldberg 


CoMMonly helD view 3: MitrAl 

regUrgitAtion is A sUrgiCAl DiseAse 

2:44 pm - Contrarian Position: Interventional 

Devices Will Soon Be Able to Manage the 

Spectrum of Mitral Pathology! 



CoMMonly helD view 4: tAvr will 

ChAnge the treAtMent lAnDsCApe 

for AortiC stenosis 

3:06 pm - Contrarian Position: More Strokes, 

Vascular Complications, Unknown Durability: 

Not So Fast! 

Lawrence H. Cohn 


CoMMonly helD view 5: CArotiD Artery 

stenting shoUlD not Be the stAnDArD 

of CAre for AsyMptoMAtiC CArotiD 

Artery DiseAse 

3:28 pm - Contrarian Position: Evidence- 

Based Nonsense! 

Max Amor 



TranscaTheTer 


TherapeuTics 

Panel II. Interventional Cardiology and 

Pharmacotherapy Controversies 

Moderators: Sanjay Kaul, Daniel I. Simon 

Discussants: Eric R. Bates, Donald Cutlip, 

James A. Goldstein, Ajay J. Kirtane, 

Guy LeClerc, Chaim S. Lotan, 

Roxana Mehran, Tabassome Simon, 

Mohamed Sobhy 

CoMMonly helD view 6: there is 

insUffiCient eviDenCe to reCoMMenD 

genetiC AnD plAtelet fUnCtion testing 

post CoronAry stenting 

3:50 pm - Contrarian Position: Get Your Heads 

Out of the Sand! Genomics and Platelet 

Function Testing Will Revolutionize Tailored 

Antiplatelet Therapy! 



CoMMonly helD view 7: left AtriAl 

AppenDAge oCClUsion DeviCes CAn never 

MAtCh Up to orAl AntiCoAgUlAnts 

4:12 pm - Contrarian Position: Oral 

Anticoagulants Introduce More Problems 

Than They Solve! 

Greg Mishkel 

4:22 pm - Discussion with Q&A 

CoMMonly helD view 8: ffr shoUlD 

replACe CliniCAl JUDgMent AnD 

noninvAsive stress testing pre-pCi in 

stABle CAD 

4:34 pm - Contrarian Position: People Who 

Make These Statements Don’t Take Care of 

Patients (or Read the Literature Carefully)! 



CoMMonly helD view 9: rivAroxABAn plUs 

DUAl AntiplAtelet therApy will optiMize 

phArMACotherApy for ACs 

4:56 pm - Contrarian Position: A Case of 

Enthusiasm Exceeding the Evidence! 

Matthew T. Roe 


CoMMonly helD view 10: DUAl AntiplAtelet 

therApy post stenting shoUlD Be given 

for At leAst one yeAr if not longer 

5:18 pm - Contrarian Position: Evidence Is 

Leaning Towards Shorter Treatment Duration 





7:00 pm-8:30 pm 





Medical research is a continuum 

that begins with a promising 

concept and concludes with proving 

the safety and efficacy of a new 

therapy in a controlled clinical 

trial. CRF’s Clinical Trials Center 

provides comprehensive 

and complete trial design, 

evaluation, and analysis services. 

Contact us: 

Business Development 

CRF Clinical Trials Center 

Tel: 646-434-4136 

E-mail: BusinessDev@crf.org 

www.crf.org/CTC 

Visit us at booth 595 located in Exhibit Hall. 

CardiovasC ular 

r esearC h 

Foundation 

Clinical Trials Center 

Experts in Design, Core Laboratories, 

and Regulatory Support 

The Clinical Trials Center (CTC) sets the standard for conducting clinical research, 

offering a full spectrum of interventional and pharmacological evaluations with 

unmatched expertise. The CTC combines the comprehensive knowledge of leading 

physicians and technologists to streamline the research process from Phase I 

through Phase IV trials. 

The CTC provides the full spectrum of services needed for successful clinical 

research, including clinical and regulatory strategy, protocol and database 

development, statistical analysis, safety surveillance, and core laboratory 

capabilities. This full portfolio of abilities means our clients can have a tailored 

research plan that meets their needs. 





Main Arena .......................................................................................... 136 


How to Treat Theater: Structural Heart and Endovascular Disease .. 138 




Maintenance of Certification (MOC) Course ...................................... 140 


FDA Town Hall Meeting ............................................................................140 


and Interventionalists ......................................................................... 143 


Alcohol Septal Ablation Symposium ........................................................142 

Aortic Aneurysm Repair and Stent-Graft Devices.....................................143 

Integrating IVUS and FFR into Clinical Practice .......................................143 

Primary PCI for STEMI: Drugs, Devices, and Technique Controversies ....144 

Edited Taped Case Presentations ....................................................... 144 




Hot Topics ................................................................................................146 




Drug-Coated Balloons (DCB): Clinical Data and Applications ..................151 

International Debating Chamber: Interventional Cardiology on Trial .........151 

Next-Generation Intravascular Imaging and Physiology: 

RF-IVUS, OCT, NIR Spectroscopy, iFR, and CT-FFR ................................152 


Thursday 




TranscaTheTer 


TherapeuTics

136 

Thursday, ocTober 25 


7:00 am-8:00 am 



Main arEna 

8:00 am-6:00 pm 

Hall D 

Plenary Session XII. 

Live Cases IV 


Live Case Co-Moderator: Antonio Colombo 

Live Case Discussants: Steven L. Almany, 

Simon R. Dixon, Dariusz Dudek, 

David P. Faxon, Run-Lin Gao, 

Christian W. Hamm, Marie-Claude Morice, 

John A. Ormiston, Ashok Seth, 

Gerald S. Werner, Stephan Windecker 

8:00 am - Cardiovascular Centre, ZNA 

Middelheim Hospital 


8:45 am - Cardiovascular Center Aalst 


Plenary Session XIII. Clinical 

Trial Design and Interpretation 

Moderators: Stuart J. Pocock, 


Discussants: John D. Carroll, Donald Cutlip, 

Pamela S. Douglas, David R. Holmes Jr, 

Stefan K. James, Neal S. Kleiman, 

Sunil V. Rao, Patrick W. Serruys, 

William S. Weintraub, Stephan Windecker 

9:30 am - The Misinterpretation of Clinical 

Trials: Common Errors and Case Examples 

Sanjay Kaul 

Increased Importance of Large Registries 

9:45 am - Part 1: Evolving Lessons from 

the Swedish National SCARR Registry 

Stefan K. James 

9:55 am - Part 2: Will the Transcatheter Valve 

Therapy Registry Transform US Regulatory 

Strategies? 



Plenary Session XIV. TCT 2012 

Game-Changing Therapies II. 

Is Interventional Heart Failure 

the Next Big Breakthrough? 

Moderators: William T. Abraham, 

Robert D. Dowling 

Discussants: Daniel Burkhoff, Neal L. Eigler, 

Francisco Fernandez-Aviles, Timothy D. Henry, 

Navin K. Kapur, Joseph G. Rogers, 

Warren Sherman, Marvin J. Slepian, 

Jochen W¨öhrle, Andreas M. Zeiher 

10:15 am - Novel Device-Based Therapies 

for Advanced Heart Failure 


10:25 am - Does Chronic Indwelling Pressure 

Monitoring in Heart Failure Represent a 

True Paradigm Shift? 


10:35 am - Stem Cell Strategies for Myocardial 

Repair: Predicting the Future 

Francisco Fernandez-Aviles 


Plenary Session XV. TCT 2012 

Career Achievement Award 


11:00 am - TCT 2012 Career 

Achievement Award 

Award Presenter: Martin B. Leon 

Award Recipient: Renu Virmani 

Plenary Session XVI. 

Late Breaking Trials II 


Co-Moderator: David R. Holmes Jr 

Discussants: David P. Faxon, 

Christian W. Hamm, Robert A. Harrington, 

William W. O’Neill, John F. Rhodes, 

David E. Thaler, Pascal Vranckx, 


11:15 am - RESPECT: A 


Trial of PFO Closure vs. 

Medical Therapy in 

Patients with Cryptogenic 

Stroke 


11:27 am - The PC Trial: A 


Trial of PFO Closure vs. 

Medical Therapy in 

Patients with Cryptogenic 

Embolism 



11:55 am - A Prospective, 

Randomized Trial of 

Sliding-Scale Hydration for 

Prevention of Contrast 

Nephropathy 



Plenary Session XVII. First 

Report Investigations II 

Moderator: Antonio Colombo 

Co-Moderator: Daniel I. Simon 

Discussants: Upendra Kaul, Neal S. Kleiman, 

Mitchell W. Krucoff, Frederick Kushner, 

Steven V. Manoukian, Julinda Mehilli, 

Philip M. Urban, Alan C. Yeung 

12:15 pm - ADAPT-DES One 

Year: A Large-Scale, 

Multicenter, Prospective, 

Observational Study of 

the Impact of Clopidogrel 

and Aspirin 

Hyporesponsiveness on Patient Outcomes 



12:30 pm - AIDA STEMI MRI: 

Cardiac MRI Substudy from 

a Prospective, Randomized 

Trial of Intracoronary 

Abciximab in Patients with 

ST-Segment Elevation 


Holger Thiele 


12:45 pm - A Prospective, 

Randomized Trial 

of Post-Conditioning in 

Patients with ST-Segment 

Elevation Myocardial 

Infarction 

Joo-Yong Hahn 


Plenary Session XVIII. 

Live Cases V 


Live Case Co-Moderator: Ted E. Feldman 

Live Case Discussants: Jorge A. Belardi, 

Donald Cutlip, Mark A. de Belder, 

John S. Douglas Jr, Stephen G. Ellis, 

Jacques J. Koolen, Paul H. Kramer, 

John M. Lasala, Francesco Maisano, 

Doff B. McElhinney, Sigmund Silber 

1:00 pm - Nationwide Children’s Hospital 

Columbus, OH 

1:45 pm - Swedish Health Services 

Seattle, WA

Plenary Session XIX. Adjunctive 

Pharmacology Spotlight 

Moderators: E. Magnus Ohman, 


Discussants: Dominick J. Angiolillo, 

Laurent Bonello, C. Michael Gibson, 

Christopher B. Granger, Robert A. Harrington, 

Dean J. Kereiakes, Ajay J. Kirtane, 

David J. Moliterno, Matthew J. Price, 

Daniel I. Simon, Stephen D. Wiviott 

A Plethora of New Drugs: Meaningful 

Differences and Clinical Use 

Recommendations 

2:30 pm - Part 1: Oral Anticoagulants 

Christopher B. Granger 

2:40 pm - Part 2: Antiplatelet Agents 



Platelet Resistance and Genetic Testing: 

Shifting Tides 

3:00 pm - Part 1: Justifying “My Guidelines:” 

Selective but Important Value 


3:10 pm - Part 2: Only a Research Tool 



Plenary Session XX. 

Live Cases VI 


Live Case Co-Moderator: Patrick W. Serruys 

Live Case Discussants: Steven R. Bailey, 

John D. Carroll, Howard C. Herrmann, 

Saibal Kar, Dean J. Kereiakes, 

Christoph A. Nienaber, Manish A. Parikh, 

Jason H. Rogers, Carlos E. Ruiz, 

Leif Thuesen, Jonathan M. Tobis 

3:30 pm - Rush University Medical Center 

Chicago, IL 

4:15 pm - NewYork-Presbyterian Hospital/ 


New York, NY 

Plenary Session XXI. Structural 

Heart Disease Controversies 

Moderators: Howard C. Herrmann, 


Discussants: David H. Adams, 

Stephen J.D. Brecker, Ted E. Feldman, 

James B. Hermiller Jr, Eric Horlick, 

Saibal Kar, Carlos Pedra, Vivek Y. Reddy, 

Charanjit S. Rihal, Peter Sick, Horst Sievert, 


5:00 pm - The Complex Landscape of 

Interventional Mitral Valve Therapies: 

Present Status and Future Directions 



5:15 pm - Has PFO Closure for Stroke 

Prevention Finally Gotten Enough 

RESPECT? 


5:30 pm - Will Transcatheter Left Atrial 

Appendage Closure Transform 

Management of Atrial Fibrillation? 





coronary artEry 

disEasE 

7:50 am-6:00 pm 



Multivessel and Diffuse 

Disease Intervention I 

Moderator: David J. Cohen 

Co-Moderator: David O. Williams 

8:00 am - When Is PCI Justified in Complex 

(Non-Left Main) Multivessel Disease with 

Current Drug-Eluting Stents? 

Dean J. Kereiakes 

8:15 am - Ischemic vs. Anatomical 

Revascularization: How to Improve 

PCI Outcomes 

Pim A.L. Tonino 

Live Cases: Multivessel and 

Diffuse Disease Intervention I 

Live Case Moderator: David J. Cohen 

Live Case Co-Moderator: David O. Williams 

Live Case Discussants: Fernando Alfonso, 

Didier Carrié, Michael J. Cowley, 

David A. Cox, Debabrata Dash, Karel T. Koch, 

Jacek Legutko, Sunao Nakamura, 

Duk-Woo Park 

8:30 am - CARE Hospitals 


9:30 am - Cardiovascular Centre, 

ZNA Middelheim Hospital 


Multivessel and Diffuse 

Disease Intervention II 

Moderator: Patrick W. Serruys 

Co-Moderator: Nico H.J. Pijls 

10:30 am - Ten Practical Tips and Tricks 

to Enhance PCI Outcomes in Complex 

Coronary Disease 



TranscaTheTer 


TherapeuTics 

10:45 am - Optimizing Adjunct 

Pharmacotherapy Before, During, and 

After PCI: An Evidence-Based Tutorial 


Live Cases: Multivessel and 

Diffuse Disease Intervention II 

Live Case Moderator: Patrick W. Serruys 

Live Case Co-Moderator: Nico H.J. Pijls 

Live Case Discussants: Vinay K. Bahl, 

Sripal Bangalore, Erwin Blessing, 

Mauricio G. Cohen, Pedro A. Lemos, 

Ahmed Magdy, Expedito E. Ribeiro, 

Alfredo Rodriguez, Simon Walsh 

11:00 am - Cardiovascular Center Aalst 


12:00 pm - Royal Sussex County Hospital 


Complex and Unusual 

Coronary Intervention I 

Moderator: Ian T. Meredith 

Co-Moderator: David R. Holmes Jr 

1:00 pm - Frequency, Prevention, 

and Management of DES Thrombosis 


1:15 pm - Evaluation and Treatment of 


Christoph A. Kaiser 

Live Cases: Complex and 

Unusual Coronary Intervention I 

Live Case Moderator: Ian T. Meredith 

Live Case Co-Moderator: David R. Holmes Jr 

Live Case Discussants: Sorin J. Brener, 

Louis A. Cannon, Pavel Cervinka, 

Eric A. Cohen, Ozgen Dogan, Vladimír Džavík, 

Thomas A. Ischinger, Samuel K. Mathew, 


1:30 pm - Royal Sussex County Hospital 


2:30 pm - Fundación Favaloro 



Coronary Intervention II 

Moderator: George D. Dangas 

Co-Moderator: Ulrich Sigwart 

3:30 pm - Primary PCI: Current Procedural 

Controversies and Decision-Making 

Michel R. Le May 

3:45 pm - The Spectrum of Hemodynamic 

Support (from IABP to ECMO): How to 

Choose and Use 

Holger Thiele 


Thursday - OCTOBEr 25, 2012

138 



Unusual Coronary Intervention II 

Live Case Moderator: George D. Dangas 

Live Case Co-Moderator: Ulrich Sigwart 

Live Case Discussants: Ziad A. Ali, 

Olivier F. Bertrand, John A. Bittl, 

Joseph P. Carrozza Jr, Graham A. Cassel, 

Harold L. Dauerman, Gennaro Sardella, 

Bradley H. Strauss, 


4:00 pm - Mount Sinai Medical Center 

Miami, FL 

5:00 pm - Fundación Favaloro 




structural hEart and 

Endovascular disEasE 

8:00 am-6:00 pm 



Carotid and Neurointervention 

Moderator: Jay S. Yadav 

Co-Moderator: Klaus D. Mathias 

8:00 am - Carotid Artery Stenting 2012: 

An Analytical Look at the Therapy and 

Its Place in the Management of Severe 

Carotid Stenosis 


8:15 am - Interventional Therapy of 

Acute Stroke: Current Indications, 

Tools, and Outcomes 

Alex Abou-Chebl 

Live Cases: Carotid and 

Neurointervention 

Live Case Moderator: Jay S. Yadav 

Live Case Co-Moderator: Klaus D. Mathias 

Live Case Discussants: Alex Abou-Chebl, 

Herbert D. Aronow, Tony Das, 

Carmelo Grasso, Zaza Kavteladze, 

D. Christopher Metzger, Juan C. Parodi, 

Fayaz Shawl, Eugenio Stabile 

8:30 am - Baptist Cardiac 

and Vascular Institute 

Miami, FL 



New York, NY 

Adult Congenital Intervention I 

Moderator: Eric Horlick 

Co-Moderator: Peter C. Block 

10:30 am - Role of ICE and 3-D Echo 

for Interventional Procedures 

Frank E. Silvestry 

10:45 am - Patient Selection for PFO Closure: 

Who Should Be Treated Always, 

Sometimes, and Never? 


Live Cases: Adult 

Congenital Intervention I 

LIve Case Moderator: Eric Horlick 

LIve Case Co-Moderator: Peter C. Block 

Live Case Discussants: Stephen J.D. Brecker, 

Patrick A. Calvert, Marc D. Feldman, 

Frank F. Ing, Saibal Kar, 

Eustaquio Maria Onorato, Marlon Rosenbaum, 

On Topaz, Nicolas M. van Mieghem 

11:00 am - CARE Hospitals 


12:00 pm - NewYork-Presbyterian Hospital/ 


New York, NY 

Adult Congenital Intervention II 

Moderator: John F. Rhodes 

Co-Moderator: Horst Sievert 

1:00 pm - Outcomes of ASD Closure 

with a Deficient Rim 

Frank F. Ing 

1:10 pm - Has Progress Been Made 

with Post-MI VSD Closure? 

Eustaquio Maria Onorato 

1:20 pm - Acute and Late Outcomes 

of Stenting for Coarctation (Covered 

and Uncovered) 

Lee N. Benson 


Congenital Intervention II 

Live Case Moderator: John F. Rhodes 

Live Case Co-Moderator: Horst Sievert 

Live Case Discussants: Zahid Amin, 

Emile Bacha, Lee N. Benson, 

Steven L. Goldberg, David W.M. Muller, 

Igor F. Palacios, Peter Sick, 

Maarten J. Suttorp, Steven J. Yakubov 


Chicago, IL 

2:30 pm - Children’s Hospital 

Columbus, OH 

Adult Congenital 

Intervention III 

Moderator: Doff B. McElhinney 

Co-Moderator: Bagrat Alekyan 

3:30 pm - Coronary AV Fistula Closure: 

Indications, Techniques, and Outcomes 


3:45 pm - Transcatheter Pulmonary Valve 

Replacement: Clinical Trials and 

Real-world Experiences 

William E. Hellenbrand 


Congenital Intervention III 

Live Case Moderator: Doff B. McElhinney 

Live Case Co-Moderator: Bagrat Alekyan 

Live Case Discussants: Vasilis Babaliaros, 

William E. Hellenbrand, Michael Kim, 

Daniel J. McCormick, Srihari S. Naidu, 

Christopher D. Nielsen, Lynn F. Peng, 

Matthew J. Price, Negar Salehi, 

Daniel Soffer 

4:00 pm - Swedish Health Services 

Seattle, WA 


Chicago, IL 


intErnational 

MultiPlEx thEatEr 

These sessions are not CME/CNE accredited. 


8:00 am-5:00 pm 

Hall A-IMT 1 

Treating Difficult Cases in 

the Cath Lab 

Co-sponsored by the Hellenic Cardiological 

Society and Cyprus Society of Cardiology 

8:00 am-9:00 am 

Moderators: Panayiotis Avraamides, 

George Parcharidis 

Discussants: Georgios Georgiou, 

Themis Komodromos, Georgios Sianos, 

Konstantinos Toutouzas 

8:00 am - Case 1: A 42-Year-Old Female with 

True Severe Resistant Hypertension 

Konstantinos P. Tsioufis 

8:15 am - Case 2: Functional Assessment of 

Coronary Artery Stenosis After Coronary 

Artery Bypass Graft 

Ioannis (John) Kanakakis 

8:30 am - Case 3: Complex Thrombus 

Management 

Panayiotis Avraamides 

8:45 am - Case 4: Concominant Carotid 

and Coronary Disease 

Christos Christou

Hypothermia for Treatment of ST-Segment 


Sponsored by the Swedish Society of 



Moderators: Rikard B.A. Linder, 

Goran K. Olivecrona 

Discussants: Ole Frobert, Jens R. Jensen, 

Anders Jonsson, Elmir Omerovic 

9:00 am - Case 1: Being Coldhearted Is Good 

When Taking Care of a Heart Attack! 

David Erlinge 

9:15 am - Case 2: A Chilled Triple Dissection, 

It’s Not a Drink! 

Ulf Jens Jensen 

9:30 am - Case 3: Hypothermia Treatment in a 

Patient with Stress-Induced Cardiomyopathy 


Petur Petursson 

9:45 am - Case 4: Cardiac Arrest at an Outside 

Hospital, Management in Stockholm 

Risto Jussila 

Challenging Case Presentations in 


Sponsored by the Iranian Society of 


Moderators: Virendrasinh C. Chauhan, 

Mahmoud Hashemian 

Discussants: Seyed Mohammad Hassan Adel, 

Javad Kojuri, Majid Naghibzadeh Mashayekh 

10:00 am - Case 1: PDA Closure in a Patient 

with Severe Pulmonary Hypertension 

Negar Salehi 

10:15 am - Case 2: Complex CTO Intervention 

with the Crusade Device 

Seyed Ebrahim Kassaian 

10:30 am - Case 3: ASD Closure with an IAS 

Aneurysm and Lack of Aortic Rim 

TBA 

10:45 am - Case 4: Complicated LCA Bi-Ostial 

Lesion Intervention 

Iraj Firouzy 

Challenges in the Cath Lab 

Sponsored by the Sociedad de Cardiología 

Intervencionista de México 

Moderators: Joel Estrada Gallegos, 

Jos Alfredo Merino Rajme 

Discussants: Marco Alcantara, 

Felipe De Jesus Gonzalez Camid, Adrian 

Davila Bortoni, Fernando Huerta Liceaga 

11:00 am - Case 1: Complex Coronary 

Intervention 

Arturo Abundes Velasco 

11:15 am - Case 2: Carotid Intervention in a 

Complex Aortic Arch 

Felix Damas de los Santos 


11:30 am - Case 3: Transhepatic Approach for 

Atrial Septal Defect Closure 

Homero A. Ramirez 

11:45 am - Case 4: Endovascular Treatment 

of a Thoracoabdominal Aneurysm 

Luis R. Virgen Carrillo 


Interventional Challenges in Structural 

Heart Disease 

Sponsored by the Italian Society of Invasive 

Cardiology 

Moderators: Alberto Cremonesi, 

Angelo Ramondo 

Discussants: Mario Carminati, 

Arturo Giordano, Giovanni Sorropago, 

Gian Paolo Ussia 

2:00 pm - Case 1: TAVI for Aortic Insufficiency: 

A Beneficial Spread 

Francesco Bedogni 

2:15 pm - Case 2: Mitral Valve Bioprosthesis 

Degeneration with Perivalvular Leak: 

When One Door Closes, Another Opens 

Sergio Berti 

2:30 pm - Case 3: How Can You Mend a 

Broken Heart? 

Francesco Meucci 

2:45 pm - Case 4: Percutaneous Mitral Valve 

Repair: Clipping the Wings to Make Them Fly 

Carmelo Grasso 

PCI in Acute Coronary Syndromes: 

Interesting Cases from Malaysia Live 

Sponsored by the Interventional 

Cardiovascular Society 

of Malaysia 

Moderators: Kenneth Chin, Mohd Ali Rosli 

Discussants: G.H. Choo, Muda Nasir, 

Kui-Hian Sim, Robaayah Zambahari 

3:00 pm - Case 1: PCI in a Thrombotic Lesion 

Kui-Hian Sim 

3:15 pm - Case 2: Double Balloon Nightmare: 

Percutaneous Transseptal Mitral 

Commissurotomy and PCI 

Robaayah Zambahari 

3:30 pm - Case 3: STEMI with Cardiogenic 

Shock in a Young Man 

Mohd Ali Rosli 

3:45 pm - Case 4: Primary PCI for Left Main 

STEMI With Cardiogenic Shock 

G.H. Choo 

TAVR Nightmares 

Sponsored by the Cardiac Society of 

Australia and New Zealand 

Moderators: David W.M. Muller, 

Darren L. Walters 

Discussants: Ian T. Meredith, 



TranscaTheTer 


TherapeuTics 

4:00 pm - Case 1: Late 

Prosthesis Embolization 

David Smyth 

4:15 pm - Case 2: Valve-in-Valve 

Implantation for Annular Rupture 

Martin Ng 

4:30 pm - Case 3: Device Embolization During 

Direct Aortic Valve Implantation 

Darren L. Walters 

4:45 pm - Case 4: Thoracic Aortic Dissection 

During Aortic Valve Implantation 

Ajay Radheshyam Sinhal 



8:00 am-5:00 pm 

Hall A-IMT 2 

High-Risk Patients and High-Risk Lesions: 

How to Treat 

Sponsored by the Egyptian Society of 

Cardiology 

Moderators: Khairy Abdel Dayem, 

Mohamed Sobhy 

Discussants: Ihab Attia, Adel El Etriby, 

Ayman Magd, Ashraf Reda 

8:00 am - Case 1: Primary PCI for AMI: 

Which Is the Infarct Artery? 

Sherif El Beltagy 

8:15 am - Case 2: A Complex Rescue PCI 

Amr Mahmoud Zaki 

8:30 am - Case 3: CTO: Should I Stay or 

Should I Go? 

El Sayed Farag 

8:45 am - Case 4: Same Patient, Same Artery, 

Same Doctor, What’s New? 

Hany Ragy 

Complex Coronary Intervention: 

Case Presentations 

Sponsored by the Japanese Association of 

Cardiovascular Intervention and 

Therapeutics 

Moderators: Takeshi Kimura, 

Masato Nakamura 

Discussants: Yutaka Hikichi, 

Shunichi Miyazaki, Koichi Nakao, 

Takafumi Ueno 

9:00 am - Case 1: FFR Decision-Making in a 

Patient with Left Main Disease and 

Atrial Septal Defect 

Naoto Inoue 

9:15 am - Case 2: IVUS-Guided Reverse CART 


9:30 am - Case 3: Transradial Retrograde 

Approach for a Chronic Total Occlusion 

Yuji Ikari 



140 


9:45 am - Case 4: Culotte Stenting of a Left 

Main Distal Bifurcation Lesion 

Kazushige Kadota 

Complex Management 

Options in TAVR 

Sponsored by the Israel Heart Society 

Working Group on Interventional Cardiology 

Moderators: Yaron Almagor, Ran Kornowski 

Discussants: Ronen Jaffe, Eli I. Lev, 

Eugenia Nikolsky, Amit Segev, Michael Yonash 

10:00 am - Case 1: TAVR in a Very Large Aortic 

Valve Annulus 

Victor Guetta 

10:15 am - Case 2: TAVI for a Failed 

Bioprosthetic Valve 

Ariel Finkelstein 

10:30 am - Case 3: TAVR in a Patient with 

Severe CAD 

Haim Danenberg 

10:45 am - Case 4: TAVR in a Patient with 

Severely Depressed Left Ventricular 

Ejection Fraction 

Ariel Roguin 

The Spectrum of Cardiovascular 

Intervention 

Sponsored by the Dutch Working Group of 


Moderators: Jacques J. Koolen, Jan J. Piek 

Discussants: Gillian A. Jessurun, 

T. Oude Ophuis, Martin G. Stoel, 

Maarten J. Suttorp 

11:00 am - Case 1: Thrombectomy in Primary 

PCI Using a Trevo-Device 

Robbert J. de Winter 

11:15 am - Case 2: A Complication from the 

Retrograde Approach for CTO 

Ren J. van der Schaaf 

11:30 am - Case 3: An Unusual Cause of 

LIMA Dysfunction 

Jeroen Vos 

11:45 am - Case 4: Managing a Peripheral 

Coronary Perforation 

Koen Teeuwen 


Gi2 and SBHCI in 


session i. new generAtion Des 

AnD DApt Controversies 

Moderators: Alexandre Abizaid, 

Pedro A. Lemos 

Discussants: Jamil Abdalla Saad, 

Rogerio Sarmento-Leite 

2:00 pm - Relevant New DES Features 

to Enhance Safety 


2:10 pm - Will Polymer-Free DES Be Safer 

Than Bare Metal Stents? 


2:20 pm - What Evidence Is Necessary to 

Shorten DAPT After DES? 

Fausto Feres 

2:30 pm - Are Bioabsorbable Vascular 

Scaffolds Really a Breakthrough? 

Ron Waksman 


session ii. whAt new teChnologies 

will Be inCorporAteD into My CAth lAB 

in the next five yeArs? 

Moderators: Carlos Pedra, Augusto D. Pichard 

Discussants: Dimytri Siqueira, 

Marco V. Wainstein 

3:00 pm - Futuristic TAVR Devices 

and Cerebral Protection 


3:10 pm - Initiating a Renal 

Denervation Program 


3:20 pm - Promising LAA Closure Devices 

and the Structural Heart Team Approach 

Carlos Pedra 

3:30 pm - The Future of Interventional 

Cardiology Is Telemedicine 



PCI in 2012 and Beyond 

Sponsored by Advanced Cardiovascular 

Solutions 

Moderators: B.K. Goyal, Susheel Kodali 

Discussants: Praveer Agarwal, 

Balram Bhargava, Ali Faizal, P.K. Goel, 

Girish Kawthekar, Sundeep Mishra, 

Lekha R.A. Pathak, Gokul M. Reddy 

4:00 pm - How I Use Adjunctive Imaging/ 

Physiology (IVUS, FFR, OCT) to Help 

Me Do PCI 


4:15 pm - Complex Bifurcation PCI Case 

P.K. Goel 


4:30 pm - PCI with an Endovascular Twist! 

Balram Bhargava 


4:45 pm - My Worst (but Salvaged) 

Complication in the Last Year 

Ali Faizal 


MaintEnancE of 

cErtification (Moc) 

coursE 

8:00 am-2:00 pm 





8:05 am - Interventional Cardiology 2012 


Moderators: Tayo A. Addo, 


Discussants: Nicola Corvaja, Kishore J. Harjai 


10:15 am - Interventional Cardiology 2011 


Moderators: Duane S. Pinto, Daniel Soffer 



12:00 pm - Interventional Cardiology 2010 


Moderators: Charles E. Chambers, 

Nicola Corvaja 





FDA Town Hall Meeting 

8:00 am-5:00 pm 

Ballroom A 


Part I. Cardiovascular Medical Device 

Innovation: Barriers and Solutions: 

Session I. The FDA’s Safety and Innovation 

Act: Medical Device User Fees: Implications 

for New Device Applications 

Moderators: Tony Blank, 

Matthew G. Hillebrenner 

Discussants: Ashley B. Boam, Andrew Farb, 

Thomas J. Fogarty, Michal Geva, 

Robert A. Hopkins, Aaron V. Kaplan, 

Bray Patrick-Lake, Glenn Reicin, 

Stephen Rowland, Michael Weinstein, 

Giora Weisz 

8:00 am - Opening Remarks 

Matthew G. Hillebrenner 

8:05 am - Impact of FDASIA on Clinical Trials 

Ashley B. Boam 

8:15 am - Large Medical Device Company 

Perspectives 

Tony Blank

8:23 am - A View from a Small Medical 

Device Company 

Stephen Rowland 

8:31 am - Perspectives from the 

VC Community 

Michal Geva 

8:39 am - Moderated Discussion with 

Audience Participation: A View to the Future: 

New Guidance and Leadership from the FDA 

Part I. Session II. Cardiovascular Device 

Innovation: A Blueprint for Solutions 

Moderators: Ashley B. Boam, 


Discussants: Kevin Ballinger, Michael Buck, 

Daniel Canos, Elazer R. Edelman, 

Andrew Farb, Peter J. Fitzgerald, 

Louis B. Jacques, Aaron V. Kaplan, 

John Laschinger, Sonna M. Patel-Raman, 

Bray Patrick-Lake, Glenn Reicin, 

Martin T. Rothman, Stanton J. Rowe, 

Richard S. Stack, Tamara Syrek Jensen 

9:10 am - Barriers for Device Development: 

What’s Broke and How to Fix It 

Aaron V. Kaplan 

9:18 am - From Barriers to Solutions: Creating 

a Sound “Ecosystem” for Innovation in the 

United States 


9:28 am - FDA’s Stimulus Plan: Benefit-Risk 

Principles, Innovation Initiatives, and Early 

Feasibility Studies Guidance 

Andrew Farb 

9:38 am - Continuity Equation: Streamlining 

Processes from Pre-Market Approval to 

Post-Market Surveillance 

Roxana Mehran 

9:46 am - Global Registry Models to Stimulate 

International Collaboration and Innovation 

Daniel Canos 

9:54 am - The Reimbursement Factor: 

Alignment Between Federal Agencies 

and Societies 

Tamara Syrek Jensen 


Audience Participation: Facilitating 

Innovation in the United Staets 

Part I. Session III. New DES 

and DES New Issues 

Moderators: Donald Cutlip, Roxana Mehran 

Discussants: David A. Cox, Keith D. Dawkins, 

Dennis J. Donohoe, Andrew Farb, 

Tim A. Fischell, Anthony H. Gershlick, 

David E. Kandzari, Laura Mauri, 

Semih Oktay, Stephen Rowland, Sean Salmon, 

Ashwani Sastry, Charles A. Simonton, 

Sara Toyloy, Ron Waksman 


topiC 1: An opC MoDel for 

“stAnDArD” Des ApprovAl 

10:45 am - Justifying an OPC Model for DES 

Approval: General Principals 

Laura Mauri 

10:53 am - A Clinician’s Perspective 


11:01 am - FDA Perspectives 

Ashwani Sastry 


Audience Participation: OPCs for 

Standard DES 

topiC 2: new Des AnD expAnDeD 

CliniCAl inDiCAtions 

11:30 am - What’s Needed for . . . 

Bioabsorbable Polymer Delivery and 

Bioabsorbable Scaffolds? 

Ron Waksman 

11:37 am - What’s Needed for . . . 

Label Expansion (Bifurcations, Left Main, 

AMI, CTO, etc)? 

Donald Cutlip 

11:44 am - FDA Perspectives 

Ashwani Sastry 


Audience Participation: New DES and 

Expanded Indications 

topiC 3: long-terM AnD short-terM 

DApt Use After Des 

12:15 pm - Completed and Ongoing 

Clinical Trials 

Laura Mauri 

12:23 pm - Proposals for New Short-term 

DAPT Use Trials After DES 

Roxana Mehran 

12:31 pm - FDA Perspectives 

Andrew Farb 

12:36 pm - Moderated Discussion with 

Audience Participation: DAPT Use After DES 

1:00 pm - Lunch Break 


TranscaTheTer 


TherapeuTics 

Part II. Interventional Hot Topics: 

Session IV. Should Novel Therapies Be 

Reserved Only for Refractory Patients? 

Moderators: Sonna M. Patel-Raman, 


CAse exAMple 1: DeviCe therApies 

for MitrAl regUrgitAtion 

Moderators: Sonna M. Patel-Raman, 


Discussants: Deepak L. Bhatt, 

Steven F. Bolling, Keith D. Dawkins, 

Jamey Jacobs, Saibal Kar, John Laschinger, 

Martin T. Rothman, Joachim Schofer, 

Charles A. Simonton, Paul A. Sobotka, 

Niel F. Starksen, Mark A. Turco 

1:45 pm - Why Clinical Research in Mitral 

Valve Disease Has Been Challenging: 

Rationale for MVARC 


1:53 pm - COAPT Trial: Lessons and 

Perspectives from the Design Phase 



Audience Participation: Devices for 


CAse exAMple 2: renAl DenervAtion 

for refrACtory hypertension 

Moderator: Deepak L. Bhatt 

Discussants: Steven F. Bolling, 

Steven S. Brooks, Kenneth J. Cavanaugh Jr, 

Todd D. Courtney, Saibal Kar, 

Francesco Maisano, Martin T. Rothman, 

Joachim Schofer, Charles A. Simonton, 

Paul A. Sobotka, Niel F. Starksen, 

Mark A. Turco 

2:25 pm - Is This the Next Breakthrough 

Therapy? Technology and Data Overview 


2:33 pm - SIMPLICITY 3 Update: Issues with 

Enrolling Refractory Patients 



Audience Participation: Renal Denervation 

for Hypertension 



142 


Part II. Session V. Managing a 

Breakthrough New Technology: 

TAVR Regulatory Conundrums 

Moderators: Matthew G. Hillebrenner, 


topiC 1: ApprovAl pAthwAys for ‘iterAtive’ 

AnD new tAvr DeviCes 



Discussants: Jodi Akin, Charles J. Davidson, 

Keith D. Dawkins, Jacques Essinger, 

Peter J. Fitzgerald, Gregory P. Fontana, 

John Laschinger, Randall T. Lashinski, 

Frank Litvack, Bernard Lyons, Raj Makkar, 

Sonna M. Patel-Raman, Nicolo Piazza, 

Rhonda Robb, Joachim Schofer, 

E. Murat Tuzcu, Larry L. Wood 

3:05 pm - Registry Data Should Be Sufficient 

to Approve My “Next Version” TAVR System! 

Jodi Akin 

3:13 pm - Can We be More Creative 

Than “Device vs. Device” Trials for 

New TAVR Systems? 

Raj Makkar 


Audience Participation: Iterative and 

New TAVR Devices 

topiC 2: how to expAnD tAvr 

CliniCAl inDiCAtions 










E. Murat Tuzcu, Larry L. Wood 

3:45 pm - The European TAVR “Test Track:” 

After Five Years, Have TAVR Use Patterns 

Drifted out of Control? 

Nicolo Piazza 

3:53 pm - Defending the TVT Registry as a 

Mechanism to Facilitate Expansion of TAVR 

Clinical Indications 



Audience Participation: TAVR Clinical 

Indications 

topiC 3: ‘ACCessory’ tAvr DeviCes: 

CliniCAl triAl reqUireMents 










Martyn R. Thomas, Sadaf Toor, 

Hendrik Treede, E. Murat Tuzcu, 

Larry L. Wood 

4:22 pm - Cerebral Embolic Protection 

During TAVR: Metrics for Evaluating Safety 

and Efficacy 


4:30 pm - What’s the Fuss! Large Hole 

Vascular Closure Devices (Transfemoral and 

Transapical) Should Only Require a Simple 

Safety Registry 



Audience Participation: “Accessory” 

TAVR Devices 



sEssions 

Alcohol Septal 

Ablation Symposium 

8:00 am-12:00 pm 

Room A104-105 

Session I. Hypertrophic Cardiomyopathy 

(HCM): Diagnosis and Management 

Moderators: Bernard J. Gersh, 

Sherif F. Nagueh 

Discussants: John S. Douglas Jr, 


8:00 am - Epidemiology and Natural 

History of HCM 

John S. Douglas Jr 

8:15 am - HCM and Sudden Cardiac Death: 

When to Consider an ICD 

Bernard J. Gersh 

8:30 am - Dynamic Obstruction: 

Mechanisms and Implications for Treatment 


8:45 am - HCM Management: 

What Do the Guidelines Say? 



Session II. Alcohol Septal Ablation: 

Today and Tomorrow 

Moderators: Michael A. Fifer, Ulrich Sigwart 

Discussants: Richard G. Bach, 

Sherif F. Nagueh, Srihari S. Naidu, 

Christopher D. Nielsen, Rod H. Stables 

9:20 am - Historical Perspective on 

Alcohol Septal Ablation 

Ulrich Sigwart 

9:30 am - Case Selection for 


Sherif F. Nagueh 

9:45 am - Alcohol Septal Ablation: 

The Procedure Step by Step 

Christopher D. Nielsen 

10:00 am - Complications: 

How to Avoid, How to Treat 


10:15 am - Inpatient and Outpatient 

Management After Alcohol Septal Ablation 

Michael A. Fifer 

10:30 am - Long-term Outcomes of 


Richard G. Bach 

10:45 am - The Future? Radiofrequency 

Catheter Septal Ablation for HCM 

Rod H. Stables 


Session III. Alcohol Septal Ablation: 

The Great Cases 

Moderators: Srihari S. Naidu, Ulrich Sigwart 

Discussants: Valerian Fernandes, 

Carey D. Kimmelstiel, Rod H. Stables 

11:10 am - Great Case 1 

Valerian Fernandes 





11:40 am - Roundtable Discussion: 

Training and Demonstration of Competence, 

Building a Center of Excellence, and 

Future Directions 

12:00 pm - Adjourn

Aortic Aneurysm Repair 

and Stent-Graft Devices 

Sponsored by the International Society 

of Endovascular Specialists 

8:00 am-12:00 pm 

Room A101-102 


Session I. Abdominal (EVAR) Part I 

Moderators: Jacques Busquet, 


Discussants: Frank J. Criado, 

Barry T. Katzen, Zvonimir Krajcer 

8:00 am - The Changing Nature of 

AAA Disease in the 21st Century 

Frank J. Criado 

8:10 am - The Changing Pattern of AAA Repair 

in the United States: Is There Still a Role for 

Elective Open Repair? 


8:20 am - Review of Current AAA 

Endografts and Future Devices to 

Address Unmet Needs 


8:30 am - Post-EVAR Follow-up and Imaging 

Surveillance: Current and Future Trends 


8:40 am - Type II Endoleaks: Implications, 

Treatment, and Prevention 


8:50 am - Treatment of Type I Endoleaks: 

Techniques and Results 


9:00 am - Low-Profile Stent-Graft Delivery 

Systems Are Coming: What Do They 

Mean for the Field? 



Session II. Abdominal (EVAR) Part II 

Moderators: Zvonimir Krajcer, 


Discussants: Jacques Busquet, 

Barry T. Katzen, W. Anthony Lee, 


9:25 am - Anatomic Assessment and On-Label 

vs. Off-Label Device Use: Are There 

Implications for Long-term Outcomes? 


9:35 am - Aortoiliac Aneurysmal Disease: 

Optimal Repair Techniques Using 

Available Devices 


9:45 am - Treatment of Juxtarenal AAA: 

What Are the Endovascular Options in 2012? 

W. Anthony Lee 

9:55 am - EVAR for Ruptured AAA: 

Still Controversial? 

W. Anthony Lee 



Session III. Thoracic (TEVAR) 

Moderators: Frank J. Criado, Wilson Y. Szeto 

Discussants: Ali Azizzadeh, 

Edward B. Diethrich, Christoph A. Nienaber, 

Joseph J. Ricotta II 

10:20 am - Thoracic Aortic Repair in 

the Endovascular Era: Current and 

Future Perspectives 

Edward B. Diethrich 

10:30 am - Long-Term Outcomes with TEVAR: 

Impact of Indication and Case Selection 

Ali Azizzadeh 

10:40 am - Forget Treating Chronic 

Dissections: The Opportunity to Maximize 

Impact Is in the Acute Phase 


10:50 am - No Man’s Land: Managing 

Zone 0 and the Aortic Arch 


11:00 am - Endovascular, Hybrid, and 

Open Approaches: Decision-making in 

Paravisceral and Thoracoabdominal 

Aneurysms 

Joseph J. Ricotta II 

11:10 am - TEVAR-Related Type A Dissection: 

Causes and Prevention Strategies 


11:20 am - Traumatic Aortic Injury: Will TEVAR 

Ever Replace Open Surgery as the Standard 

of Care? 

Ali Azizzadeh 

11:30 am - Neurological Complications of 

TEVAR: Prevention and Management 




Integrating IVUS and FFR into 


8:00 am-12:05 pm 

Room A204-205 

Session I. FFR: The Basics 

Moderators: John McB. Hodgson, 


Discussants: William F. Fearon, 

Morton J. Kern, Nico H.J. Pijls 

8:00 am - What Is FFR, and How Is It 

Different from Other Indices? 


8:10 am - Practical Aspects of FFR: 

Tips to Avoid Making Mistakes 



TranscaTheTer 


TherapeuTics 

8:22 am - FAME II: Results and Implications 

Nico H.J. Pijls 


Session II. FFR Case Presentations 

Moderators: Nils Johnson, Morton J. Kern 

Discussants: Valerian Fernandes, 

Robert J. Gil, Allen Jeremias, Habib Samady 

8:45 am - Case 1: FFR in Bifurcations 

Bon-Kwon Koo 

8:55 am - Case 2: FFR and Multivessel Disease 


9:05 am - Case 3: FFR and Left Main Disease 

Michalis Hamilos 

9:15 am - Case 4: FFR in ACS 

Petr Kala 

9:25 am - Case 5: FFR in Tandem Lesions 


Session III. IVUS: The Basics 

Moderators: Hector M. Garcia-Garcia, 


Discussants: Yasuhiro Honda, Soo-Jin Kang, 

Akiko Maehara, Gary S. Mintz, 


9:35 am - Practical Aspects of IVUS: How to 

Recognize Artifacts and Avoid Mistakes 

Akiko Maehara 

9:45 am - Preintervention IVUS: From 

Intermediate Lesion Assessment to 

High-Risk Plaques 


9:57 am - Can IVUS Be Used to Assess 

Intermediate Lesions? Final FIRST Results 

Ron Waksman 

10:07 am - IVUS-Guided PCI: From Stent 

Sizing to Predicting Thrombosis and 

Restenosis 

Gary S. Mintz 

10:19 am - IVUS Assessment of Stent 

Thrombosis and Restenosis 

Soo-Jin Kang 


Session IV. IVUS: Case Presentations 

Moderators: Soo-Jin Kang, Akiko Maehara 

Discussants: Hector M. Garcia-Garcia, 

John McB. Hodgson, Gary S. Mintz 

10:45 am - IVUS in Acute Coronary Syndromes 

Jerzy Pregowski 

10:55 am - IVUS During CTO Intervention 


11:05 am - IVUS and Acute Stent 

Complications 

Fernando Alfonso 

11:15 am - IVUS and Late Stent Complications 

Jose de Ribamar Costa Jr 



144 


Session V. Clinical Strategies 

Moderators: Massoud A. Leesar, 

Gary S. Mintz 

Discussant: Kenneth Chin 

11:25 am - How I Integrate FFR and IVUS in 

the Cath Lab and Why 


11:35 am - Integrated IVUS and FFR Case 1: 

A Left Main Intervention 

Case Presenter: 


11:45 am - Integrated IVUS and FFR Case 2: 

A Non-Left Main Intervention 


11:55 am - The Final Word: Neither IVUS nor 

FFR Explain It All—Use Common Sense! 



Primary PCI for STEMI: Drugs, 

Devices, and Technique 

Controversies 

8:00 am-12:10 pm 

Room A201-202 

Session I. Primary PCI in the Era of New 

Antiplatelet and Anticoagulant Agents 

Moderators: Cindy L. Grines, Harvey D. White 

8:00 am - Debate: Prasugrel or Ticagrelor 

Should be Used in Nearly All Cases! 

Dominick J. Angiolillo 

8:10 am - Debate: Clopidogrel is Enough 

and Still Plays a Role for Most! 

Michael P. Love 

8:18 am - Glycoprotein IIb/IIIa Inhibitors in the 

Era of Bivalirudin and New Oral Antiplatelet 

Agents: Is Intracoronary Application the 

Standard of Choice? 

Rajesh M. Dave 


8:41 am - Debate: Bivalirudin Is the Preferred 

Anticoagulant Strategy During STEMI! 

Roxana Mehran 

8:49 am - Debate: Enoxaparin or 

Unfractionated Heparin Plus/Minus 

Glycoprotein IIb/IIIa Inhibitors Is the 

Preferred Anticoagulant Strategy 

During STEMI! 

Gilles Montalescot 

8:57 am - Should Rivaroxaban Be Used in 

STEMI Patients, and Does Choice of ADP 

Antagonist (with Rivaroxaban) Matter? 



9:22 am - Debate: Pharmacoinvasive Therapy 

Is the Method of Choice for Long and 

Intermediate Transfer Times! 


9:30 am - Debate: Primary PCI Is the Default 

Reperfusion Method Irrespective of 

Time to Transfer! 

Cindy L. Grines 


Session II. Procedural Management 

Choices During Primary PCI for STEMI 

Moderators: Sorin J. Brener, Manel Sabate 

Discussants: Michael Haude, 

Harald G.W. Mudra, Graham Nichol, 

Jennifer A. Tremmel, Marco Valgimigli 

9:48 am - Statement: Second Generation DES 

Are Safer Than BMS and Should Be Used in 

All Patients 


9:58 am - Might a Self-Expanding Stent 

Have a Role in STEMI? Interim Results 

from APPOSITION III 

Harald G.W. Mudra 

10:06 am - Should Emergent Catheterization 

Be Performed in All Patients Resuscitated 

from Out-of-Hospital Cardiac Arrest? 

Graham Nichol 

10:14 am - Debate: Transradial Access Should 

Be the Default Access Site in STEMI 

Patients! 


10:22 am - Debate: Transfemoral Access 

Should Be the Default Access Site in 

STEMI Patients! 

Michael Haude 


Procedural Management Choices 

for Infarct Size Reduction 

Moderators: Anne K. Kaltoft, Holger Thiele 

10:45 am - Debate: Yes to Routine 

Thrombectomy in STEMI: New Trials 

Are Not Needed! 

Giuseppe De Luca 

10:53 am - Debate: No to Routine 

Thrombectomy in STEMI: Still Yet 

to Be Demonstrated! 



Discussants: Giuseppe De Luca, Sanjit S. Jolly 

11:13 am - Should Left Ventricular Mechanical 

Support Be Used Routinely in Patients with 

LV Dysfunction and Cardiogenic Shock? 


11:23 am - Is Intraaortic Balloon 

Counterpulsation Really Useful in 

Cardiogenic Shock? Results of the 

IABP-SHOCK II Trial 

Holger Thiele 

11:33 am - Hypothermia in STEMI: When, 

to Whom, and How? (Cardiac Arrest, 

Cardiogenic Shock, Stable STEMI) 

Michael Mooney 



EditEd taPEd casE 

PrEsEntations 

9:30 am-5:00 pm 



Endovascular Interventions 

Moderators: Richard R. Heuser, David Planer, 

Mark A. Turco 

9:30 am - Peripheral Intervention with 

Enhanced Efficiency Using Novel, 

Multifunctional GPSCath Balloon Catheter 

Gregory Sampognaro 

10:00 am - New Technique to Reach 

Superficial Femoral Artery in 

Descending Puncture 

Alejandro Goldsmit 

10:30 am - RF Balloon Catheter Renal 

Denervation Treatment of a Patient with 

Uncontrolled Hypertension 

Meital Mazor 


Nonvalvular Structural Heart 

Interventions 

Moderators: Ulf Jens Jensen, Scott Lim, 


2:00 pm - Alcohol Septal Ablation in HOCM 

with CT and ICE Guidance 


2:30 pm - PSOV Closure with MVSD Occluder 

Giuseppe Gioia 

3:00 pm - IVUS-Guided Percutaneous 

Paravalvular Leakage Closure 

Peter den Heijer 


Coronary Interventions 

Moderators: Maurice Buchbinder, 

J. Aaron Grantham, Satoru Sumitsuji 

4:00 pm - Subintimal Transcatheter Withdrawal 

(STRAW) of Hematoma Compressing the 

Distal True Lumen: A Novel Technique 

to Facilitate Distal Reentry During 

Recanalization of Chronic Total Occlusions 

Elliot Smith 

4:30 pm - Orbital Atherectomy 


5:00 pm - Adjourn



Session IV. Coronary 

and Endovascular 

10:00 am-11:00 am 

Hall D 


TCT-1221. Unexpected Occlusion, 

Unexpected Recanalization 

Evgeniy Merkulov et al 

TCT-1222. Floating Coronary Stent 

M.reza Habibzadeh et al 

TCT-1223. Retrograde Recanlize LM 

Ostium CTO Without Stump in a Twice 

CABG Patient 

Hsiu-yu Fang et al 

TCT-1224. A Successful Case with Severe 

Calcified Chronic Total Occlusion Without 

Stamp Using Retrograde Approach 

Yuji Sakanoue et al 

TCT-1225. Catheter-Directed Thrombolysis for 

Subacute Stent Thrombosis After Failure of 

Conventional Treatment Strategies 

Jon George et al 

TCT-1226. A Novel Percutaneous Implant for 

the Treatment of Resistant Hypertension 

Benjamin Scott et al 

TCT-1227. Excimer Laser Ablation for 

Intracoronary Organic Huge Thrombus in 

a Case of Recent Myocardial Infarction: 

Angioscopic Evidence of Effectiveness 

Masak Awata et al 

TCT-1228. Percutaneus Coronary Intervention 

in Chronic Total Occlusion: Finding Micro 

Channel and Crushing the Rock 

Sodiqur Rifqi et al 

TCT-1229. Acute Coronary Syndrome in 

Patient with Severe Pulmonary Hypertension 

and Left Main Coronary Artery Compression: 

Role of Intravascular Ultrasound in Diagnosis 

and Optimization of PCI 

Arkadiusz Pietrasik et al 

TCT-1230. A Case of Sheathless Transradial 

Coronary Intervention for Complex Coronary 

Lesions Using a Standard Guiding Catheter 

Jaehuk Choi et al 

TCT-1231. Bridging a Long Coronary 

Aneurysm with Overlapping Stentgrafts 

Inside a Long Length Drug-Eluting Stent 

as Scaffold in Acute MI Case 

Srikant Shetty et al 

TCT-1232. Severe Longitudinal 

Stent Deformation 

David Roy et al 


TCT-1233. Transradial PCI-Successful 

Stent Retrieval 

Surya Prakasa Rao Vithala et al 

TCT-1234. Left Atrial Inflow and Outflow 

Obstruction from Epicardial Hematoma 

Complicating a Retrograde Approach 

Joji Varghese et al 

TCT-1235. Left Main Bifurcation Stenting 

with Mini Crush 

Viveka Kumar et al 

TCT-1236. Entrappment of Side Branch 

Guide Wire 

Vikrant Vijan et al 

TCT-1237. Myocardial Infarction with 

Persistent Shock Due to Right Heart 

Failure Despite Percutaneous Left 

Ventricular Support 

Patrick Hunziker et al 

TCT-1238. Three-Year Follow-up After 

PCI of a 54-Year-Old Patient with 

Three-Vessel Disease Including Two 

Chronic Total Occlusions by Optical 


Martin Bergmann et al 

TCT-1239. Optical Coherence 

Tomography (OCT) Helping with 

Culprit Lesion Identification 

Ashish Shah et al 

TCT-1240. A Case of Successful Bailing Out 

from Coronary Perforation Complicated with 

PCI for RCA-CTO 

Hiroyuki Kunii et al 

TCT-1241. Use of Chimney Stent in the 

Left Subclavian Artery for Blunt Thoracic 

Aortic Injury 

Won Ho Kim et al 

TCT-1242. Optimal Treatment of Massive 

Bilateral Deep Venous Thrombosis of Lower 

Extremities, Iliac Veins, and IVC Filter 

Mohsen Sharifi et al 

TCT-1243. Multilevel Endovascular Access 

Successful Treat Long Total Occlusion: From 

Iliac Ostium to Distal Femopopliteal Artery 

Tien-yu Wu et al 

TCT-1244. Unusual Case of Spontaneous 

Thrombosis of Lower Abdominal Aorta in a 

Patient with Idiopathic Thrombocytopenic 

Purpura: Successful Endovascular Treatment 

Abdul Basit et al 

TCT-1245. Less Than Common: 

Retrograde Popliteal to Common 

Femoral Revascularization 

Eric Fuh et al 

TCT-1246. Brachio-Femoral Parallel Wiring 

After Abdominal Aortic Dissection in an 

Aortoiliac Bifurcating Osteal Stenosis 

Treated with Final Kissing Stenting 

Nanda Panigrahi et al 


TranscaTheTer 


TherapeuTics 

TCT-1247. Ipsilateral 300 cm Wire 

Externalization Technique in the 

Infrapopliteal CTO Lesion 

(Transplantar Loop) 

Tien-yu Wu et al 

TCT-1248. Left Subclavian Intervention 

Complicated by Acute Anterior Wall 


Kintur Sanghvi et al 

TCT-1249. Middle Aortic Syndrome with Renal 

Involvement an uncommon Presentation of 

Takayasu Arteritis Treated with Stenting 

Madahavpeddi Aditya et al 

TCT-1250. Endovascular Management 

of Chronic Iliac Vein Occlusion in 

May-Thurner Syndrome 

Jon George et al 

TCT-1251. A Technically Challenging Case 

of Renal Artery Bifurcation Stenting 

Requiring Dual Access (Brachial and 

Femoral) Approach 

Rajiv Ananthakrishna et al 

TCT-1252. Successful True Lumen Restenting 

Through Folse Lumen Stent Strut for 

In-Stent Occlusion in the Superficial 

Femoral Artery 

Yoshimitsu Soga et al 

TCT-1253. Celiac Artery and Superior 

Mesenteric Artery Angioplasty in a 

Young Female 

Deepak Davidson et al 

TCT-1254. Endovascular Treatment in 

Challenging Case of Charcot Ischemic 

and Infected Foot 

Luis Palena et al 

TCT-1255. Four Cases to Revascularize 

Difficult and Long 20 cm BTK CTO 

Lesions by the “SSD” (Super Speed 

Drilling) Technique 

Shinichiro Sakota et al 

TCT-1256. Concurrent Endovascular Repair 

of Extensive Thoracic Aortic and Infrarenal 

Aorto-Iliac Aneurysms 

Ezhilan Janakiraman et al 

TCT-1257. Successful Angioplasty with 

Retrograde Direct Superficial Femoral Artery 

Puncture After Failed Bidirectional Approach 

in Chronic Femoral Artery Occlusion 

Taku Iwaki et al 

TCT-1258. IVUS-Assisted Recanalization of 

Long SFA Total Occlusion from Its Ostium 

Jae-hwan Lee et al 

TCT-1259. Static Contrast Technique for 

Creating Transpedal Arterial Access in 

Patients with Tibioperoneal Occlusions 

John Chien-hwa Chang et al 



146 


TCT-1260. Endovascular Management of 

Total Aortic Occlusion in Hypoplastic 

Aortic Syndrome 

Hossam Mansour et al 

TCT-1261. Subintimal Angioplasty for Severe 

Calcified Total Occlusion of Iliac Artery with 

Confluent Two-Balloon Technique After 

PTA Failure with Outback Reentry Device 

Woong Chol Kang et al 

TCT-1262. Intramural Hematoma 

William Mcmillan et al 

TCT-1263. A Case of Successful Penetration 

of Superficial Femoral Artery Chronic Total 

Occlusion Lesion with Bidirectional 

Approach via Bridging Collateral Branch 

Saving the Collateral Branch from Deep 

Femoral Artery 

Nobuhiro Hara et al 

TCT-1264. Intrahepatic Budd Chiari Syndrome: 

Transhepatic Percutaneous Stenting of 

Right Hepatic Vein 

Raja Mantri et al 

TCT-1265. Subintimal Antegrade Stenting 

(Reverse Stent CART Technique) to Facilitate 

Retrograde Wire Reentry in Successful 

Treatment of BT? Occlusion with CLI 

Valeri Gelev et al 

TCT-1266. Percutaneous Stenting for 

IVC Obstructioon 

Raja Mantri et al 

TCT-1267. A “Neocarena Reconstruction” 

Technique: A New Practice Tool to Manage 

Side Branch Occlusion After Covered Stent 

Implantation in Vascular Injuries 

Chiara Bernelli et al 

TCT-1268. Using Amplatzer Plug for Neck 

Remodeling in Challenging Endovascular 

Aortic Repair for Contained Rupture 

Abdominal Aortic Aneurysm 

Roberto Gandini et al 

TCT-1269. Successful Stenting of Anastomotic 

Stenosis of the Left Pulmonary Artery After 

Bilateral Lung Transplantation 

Thomas Konorza et al 

TCT-1270. Unique Application of 

Percutaneous Mitral Valvotomy Balloon 

for Post Liver Transplant Inferior Vena 

Cava Occlusion 

Vipil Roy et al 

TCT-1271. Coeliac and Mesenteric Artery 

Occlusion: Newer Endovascular Approach 

to Vascular Emergency 

Ashraf Manzil et al 

TCT-1272. Endovascular Repair of 

Giant Ruptured Aneurysm of Coeliac/ 

Hepatic Artery 

Harinder Bali et al 

TCT-1273. Endovascular treatment of 

an Abdominal Aortic Stenosis After 

AAA Surgery 

Felix Damas De Los Santos et al 

TCT-1274. Percutaneous Repair of a Large 

Sacular Infra-Renal Abdominal Aortic 

Aneurysm by Making Aorto Uni-Iliac Device 

on the Table Using Atrium Stents and 

Vascular Plug 

Narendra Khanna et al 


12:15 pm-1:15 pm 



lunchtiME sEssions 

Hot Topics 

ACC Special Fellows Session II. Oral 

Anticoagulation 2012 for VTE, Atrial 

Fibrillation, and Valvular Heart Disease 

12:15 pm-1:45 pm 



Moderators: C. Michael Gibson, 

Jonathan L. Halperin 

12:15 pm - Novel Anticoagulants for Stroke 

Prevention in Patients with Atrial Fibrillation 

Jonathan L. Halperin 

12:50 pm - Novel Anticoagulants in Patients 

with Acute Coronary Syndromes 




Cath Lab Directors Lunch: Managing the 

Present, Preparing for the Future 

12:15 pm-1:45 pm 



12:15 pm - Introductory Remarks 

Kishore J. Harjai 

session i. AppropriAteness AnD ADvoCACy 

Moderator: Jeffrey W. Moses 



12:18 pm - Are Appropriate Use Criteria Ready 

for Clinical Practice? Cath Lab 

Director’s View 


12:26 pm - The Misrepresentation of 

Interventional Cardiology in the Lay Media 


12:33 pm - Advocacy for Interventional 

Cardiology: Time for a Wake-up Call 



session ii. foCUs on the yoUng 

interventionAlist 

Moderator: David J. Cohen 

Discussants: Tony Das, Brij Maini 

12:45 pm - Navigating Local Politics: A Career 

Guide for Young Interventionalists 

Brij Maini 

12:54 pm - Managing Your Reputation as 

an Interventional Cardiologist 

Brij Maini 

1:02 pm - A Stepwise Approach to Building a 

Career in Interventional Cardiology Research 



session iii. innovAtion, invention, 

AnD reseArCh 

Moderator: Neal L. Eigler 

Discussants: Adnan Kastrati, Giora Weisz 

1:15 pm - The Dos and Don’ts of Initiating 

Prospective Randomized Clinical Trials 


1:23 pm - The Future Cath Lab: Focus on 

Innovation, Interspecialty Collaboration, 

and Lifelong Learning 

Giora Weisz 

1:31 pm - The Interventionalist as Inventor/ 

Entrepreneur: A Personal Journey 

Neal L. Eigler 





CT Planning for Transcatheter Aortic 


12:15 pm-1:45 pm 

Room D235-236 


Moderator: James K. Min 

Discussants: Gudrun Feuchtner, 

Jonathon A. Leipsic, Robert J. Siegel, 

David A. Wood 

12:15 pm - CT for Aortoiliofemoral and 

Aortic Valve Assessment 

Gudrun Feuchtner 


12:33 pm - CT for Aortic Annulus Sizing and 

Angle Prediction of TAVR Deployment 



12:51 pm - CT for Preventing and Predicting 

TAVR-Associated Complications 

James K. Min 


1:09 pm - Reconciling Discordance Between 

Echo and CT in TAVR 



1:27 pm - Imaging for TAVR: An 

Interventionalist’s Perspective 

David A. Wood 



Disparities in Interventional Cardiology: 

Taking a Broader View 

12:15 pm-1:45 pm 

Room D231-232 

Moderators: Yele Aluko, A.J. Conrad Smith 

Discussants: Alexandre Abizaid, 

Christian W. Hamm, Manesh R. Patel, 


12:15 pm - Geographic Disparities in the 

Management of ACS in the United States: 

Making the Case for Standardization of Care 

Yele Aluko 

12:25 pm - Variations in the Management of 

ACS in South America: A Viewpoint from 

South of the Border 


12:35 pm - Variations in Management of ACS 

in Europe: Implications for Health Care 

Reform in the United States 

Christian W. Hamm 


1:00 pm - Racial Disparities in Interventional 

Cardiology in the United States: Behavior, 

Biology, or Bias? 

A.J. Conrad Smith 


point CoUnterpoint: AppropriAte Use 

CriteriA: in seArCh of institUtionAl 

AnD inDiviDUAl ACCoUntABility 

1:15 pm - Pro: Tracking and Aiming for 

Appropriate Use Criteria Goals Will 

Optimize Physician Performance and 

Patient Outcomes! 


1:25 pm - Con: A Strict Reliance on 

Appropriate Use Criteria Is Misguided Policy! 


1:35 pm - Discussion and Closing Comments 



Extended Results from Important 

Drug-Eluting Stent Trials 

12:15 pm-2:00 pm 

Room D237-238 

Moderators: Joost Daemen, 

Stephen G. Worthley 

Discussants: James C. Blankenship, 

Robbert J. de Winter, Daljeet S. Gambhir, 

Antoine Lafont, Erick Schampaert, 

Bonnie H. Weiner 

12:15 pm - EXAMINATION Two-Year: 

A Prospective, Randomized Trial of 

Everolimus-Eluting vs. Bare Metal Stents in 

Patients with ST-Segment Elevation 


Manel Sabate 


12:30 pm - RESET Two-Year: A Prospective, 

Randomized Trial of Everolimus-Eluting vs. 

Sirolimus-Eluting Stents 

Ken Kozuma 


12:45 pm - TWENTE Two-Year: A Prospective, 

Randomized Trial of Everolimus-Eluting vs. 

Zotarolimus-Eluting Stents 



1:00 pm - SORT OUT IV Three-Year: 

A Prospective, Randomized Trial of 

Everolimus-Eluting vs. Sirolimus-Eluting 

Stents 

Lisette Okkels Jensen 


1:15 pm - LEADERS Five-Year: A Prospective, 

Randomized Trial of Bioabsorbable 

Polymer-based Biolimus-Eluting vs. 

Sirolimus-Eluting Stents 



1:30 pm - SYNTAX SCORE II: An Improved 

Risk Score Based on Clinical and 

Angiographic Variables 

Vasim Farooq 


1:45 pm - Long-Term Results of 

Bifurcation Stenting with Everolimus- 

Eluting vs. Sirolimus-Eluting Stents: 

The SEA-CORP BC Trials 





TranscaTheTer 


TherapeuTics 

Interventional Cardiology, Cardiovascular 

Genetics, and the Era of Personalized 

Medicine 

12:15 pm-1:45 pm 

Room D233-234 

Moderators: Christopher B. Granger, 

W. Craig Hooper, H. Robert Superko 

Discussant: Paddy Barrett 

12:15 pm - 2C19 and Warfarin: Clinical Utility 

or Do New Medications Make It Obsolete? 

Christopher B. Granger 

12:35 pm - Case Study 

Christopher B. Granger, 


12:45 pm - Genetic Testing for 9p21: 

The Case for Health Care Insurance 

Reimbursement 

H. Robert Superko 




1:15 pm - 4q25 and Prediction of Atrial 

Fibrillation: How Can This Information Help 

the Clinician? 

Paddy Barrett 





Minimizing and Managing 

Cath Lab Complications 

12:15 pm-1:45 pm 



Moderators: Cindy L. Grines, 


Discussants: Fernando Alfonso, 

Stephen Balter, Ronald Caputo, 

Charles E. Chambers, Anne K. Kaltoft, 

Roger J. Laham, Greg Mishkel, 

Massimo Napodano, Theodore L. Schreiber, 

Molly Szerlip, Mark W. I. Webster 

MAnAgeMent of lArge throMBUs 

BUrDen (AnD eMBolizAtion) 

12:15 pm - Topic Essentials 

Anne K. Kaltoft 



Use of iMpellA for high-risk pCi 


Theodore L. Schreiber 


Molly Szerlip 

spontAneoUs CoronAry DisseCtion 


Greg Mishkel 



148 




rADiAtion MAnAgeMent in CoMplex 

CoronAry interventions 




Mark W.I. Webster 

ChAllenges in gUiDing CAtheter 

sUpport AnD stent Delivery 




Ronald Caputo 

longitUDinAl stent DeforMAtion 






Optimizing Care for Women with 

Cardiovascular Disease 

12:15 pm-1:45 pm 



Moderators: Alexandra J. Lansky, 

Anna Sonia Petronio, Jennifer A. Tremmel 

Discussant: Eugenia Nikolsky 

12:15 pm - Introduction and Session Goals 


12:20 pm - Gender Variation in Plaque 

Characteristics and Vulnerability: Lessons 

from PROSPECT 

Akiko Maehara 


12:35 pm - Diagnostic Considerations in 

Women with Intermediate Coronary Lesions: 

Insights from FAME 



12:50 pm - Gene Expression in the Diagnosis 

of Coronary Artery Disease: Is There a Role 

in Women? 

John A. McPherson 


1:05 pm - TAVR Outcomes in Women: 

The European Experience 

Anna Sonia Petronio 


1:20 pm - Bleeding Complications in Women 

Undergoing Revascularization: Implications 

for Adjunctive Pharmacology and Prevention 

Eugenia Nikolsky 


1:35 pm - Case Presentation: Spontaneous 

Coronary Disection, an Under-Recognized 

Cause of ACS in Women 

Greg Mishkel 


Special JACC Session: How to Write and 

Evaluate Medical Journal Articles 

12:15 pm-1:45 pm 



Moderators: Anthony N. DeMaria, 

Spencer B. King III, Jagat Narula 

12:15 pm - How to Write Publishable Papers 

(with Examples of Dos and Don’ts 

Anthony N. DeMaria 


12:45 pm - How to Revise Your Manuscript 

Jagat Narula 


1:15 pm - Evaluating a Research Paper: 

What Constitutes a Good Review 

Spencer B. King III 





Complex Bifurcation Lesions 

12:15 pm-1:45 pm 

Room B211 

Moderators: Thierry Lefevre, 

Issam D. Moussa, David G. Rizik 

Discussants: Francesco Burzotta, 

Alaide Chieffo, Evald H. Christiansen 



12:18 pm - When Is a Two-Stent 

Technique Needed? 


12:28 pm - Case 1: A Complex Bifurcation 

with One Stent 

Thierry Lefevre 


12:43 pm - Case 2: A Complex Bifurcation 

with Two Stents (T-Stenting) 



12:58 pm - Case 3: A Complex Bifurcation with 

Two or More Stents (Culotte Stenting) 



1:13 pm - How to Solve Difficult Side 

Branch Access Issues 


1:23 pm - Case 4: Difficult Side Branch Access 

Evald H. Christiansen 


1:38 pm - Conclusions 



Nuts and Bolts of FFR 

12:15 pm-1:45 pm 

Room B212 


session i. the BAsiCs 

Moderators: William F. Fearon, Bon-Kwon Koo 

12:15 pm - Coronary Physiology and FFR 


12:25 pm - Can Any IVUS/OCT Parameters 

Replace FFR? 

Bon-Kwon Koo 

session ii. the CAses 

Moderators: William F. Fearon, Bon-Kwon Koo 

12:30 pm - Cases 1 and 2: FFR in Acute 

Coronary Syndromes 

Habib Samady 

12:45 pm - Cases 3 and 4: FFR in Multiple 

and Serial Stenoses 


1:00 pm - Cases 5 and 6: FFR in Left Main 

Disease: From Simple Ostial to Complex 

Soo-Jin Kang 

1:15 pm - Cases 7 and 8: FFR in Non-Left 

Main Bifurcation Lesions 

Nick Curzen 

1:30 pm - Cases 9 and 10: FFR Cases with 

Possible Pitfalls 



Paravalvular Leak Closure 

12:15 pm-1:45 pm 

Room A208 

Moderators: Eulogio J. Garcia, 


Discussants: Miguel A. Garcia-Fernandez, 

Vuyisile T. Nkomo, Carlos E. Ruiz 

12:15 pm - Echocardiographic Diagnosis 

and Guidance of Aortic Paravalvular 

Leak Closure 

Vuyisile T. Nkomo 

12:25 pm - Tips and Tricks for Percutaneous 

Closure of Aortic Paravalvular Leaks 

Charanjit S. Rihal

12:35 pm - Percutaneous Closure of an Aortic 

Paravalvular Leak: Step by Step Case 

Eulogio J. Garcia 

12:45 pm - Echocardiographic Diagnosis and 

Guidance of Mitral Paravalvular Leak Closure 

Miguel A. Garcia-Fernandez 

12:55 pm - Other Imaging Techniques for 



1:05 pm - Step-by-Step Case: Percutaneous 

Closure of Mitral Paravalvular Leak: 

Anterograde Approach 


1:15 pm - Step-by-Step Case: Percutaneous 



Eulogio J. Garcia 

1:25 pm - Step-by-Step Case: 


Transapical Approach 




Percutaneous Edge-to-Edge Mitral Valve 

Repair: Tips and Tricks 

12:15 pm-1:45 pm 

Room A209 

Moderators: Karl-Heinz Kuck, Scott Lim 

12:15 pm - Patient Selection for 

MitraClip Procedures 

Gorav Ailawadi 

12:30 pm - Imaging: 2-D and 3-D TEE by 

and for the Interventionalist 

Scott Lim 

12:45 pm - Case Review 1: How to Do 

the Transseptal for MitraClip 

Richard Smalling 

1:00 pm - Case Review 2: How to Do Multiple 

Clip Implants for Functional MR 

Huseyin Ince 

1:15 pm - Case Review 3: How to Decide 

About a Second Clip for DMR 


1:30 pm - Case Review 4: How to Deal with 

Valve Complications 



The Retrograde Approach to CTOs 

Presented in Association with Complex 

Cardiovascular Therapeutics 

12:15 pm-1:45 pm 

Room B213 

Moderators: Osamu Katoh, Etsuo Tsuchikane 

12:15 pm - Collateral Channel Navigation: 

What’s the Key of Success? 

Osamu Katoh 


12:25 pm - Crossing CTO Lesions: 

How to Ensure and Facilitate 

Masahisa Yamane 

12:35 pm - Case 1: My Own Complex 





Craig A. Thompson 









Transradial Intervention 

12:15 pm-1:45 pm 

Room B210 

Moderators: Philippe Généreux, Sanjit S. Jolly, 

Margaret B. McEntegart 

Discussants: Olivier F. Bertrand, James Nolan, 


12:15 pm - The Basics of Transradial Access 



12:30 pm - Complications of 

Transradial Access 



12:45 pm - Radial Sheath Removal and 

Prevention of Radial Occlusion 



1:00 pm - Radial Angiography and PCI in 

Patients with Prior CABG 

Margaret B. McEntegart 


1:15 pm - Radial Access and 

Primary PCI in STEMI 



1:30 pm - The Radial Learning Curve 

James Nolan 

1:40 pm - Wrap-up and Final Comments 



TranscaTheTer 


TherapeuTics 



Session V. Imaging and 

Physiologic Lesion 

Assessment and Structural 

2:00 pm-3:00 pm 

Hall D 


TCT-1275. Follow-up of Spontaneous 

Coronary Artery Dissection: Detection 

of Intramural Hematoma and Serial Findings 

of Non-Contrast T1-Weighted Magnetic 

Resonance Imaging 

Takahiro Nakashima et al 

TCT-1276. A Case of Stent Ablation in Left 

Anterior Descending Coronary Artery 

Observed by Optical Coherence Tomography 

Yuzo Kagawa et al 

TCT-1277. Longitudinal Stent Elongation 

Kensuke Matsushita et al 

TCT-1278. Can 64-Slice Computed 

Tomography Coronary Angiography Help 

You Assess Caliber and Length of the Stent 

in a Long Small Distal Subtotal Occlusion in 

36-Year-Old Male with CABG? 

Hesham Naiem et al 

TCT-1279. Instantaneous wave-free ratio 

(iFR) to guide coronary revascularisation 

following acute severe reaction to 

intravenous adenosine 

Sukhjinder Nijjer et al 

TCT-1280. The First Clinical Application of 

the Instantaneous Wave-Free Ratio (iFR) 

to Guide Coronary Intervention 

Sukhjinder Nijjer et al 

TCT-1281. A Filling Defect in the Coronary 

Artery Accompanied by ST-Segment 

Elevation Is Not Always a Thrombus 

Ioannis Iakovou et al 

TCT-1282. Multiple Stent Fractures After 

Retrograde Chronic Total Occlusion 

Percutaneous Intervention 

Felipe Hernandez et al 

TCT-1283. Optical Coherence Tomographic 

Findings of In-Stent Neoatherosclerosis 

After Xience V Stent Implantation 

Setsuo Kumazaki et al 

TCT-1284. Rescue Management of 

Spontaneous Coronary Artery 

Dissection Guided by Optical 

Coherence Tomography (OCT) 

Nicolas Combaret et al 



150 


TCT-1285. Multiple Recanalized Images 

of Thrombotic Occlusion after Coronary 

Artery Dissection Insights from Optical 


Hiroaki Takashima et al 

TCT-1286. A Case of Very Late Stent 

Thrombosis: Five Years After Sirolimus- 

Eluting Stent Implantation Observed 

by OCT and Angioscope 

Takayuki Ishihara et al 

TCT-1287. Is It a Really Easy Case? 

Only IVUS Tells the Truth 

Seiko Ide et al 

TCT-1288. Fractional Flow Reserve Can 

Predict an Unusual Complication During 


Which Was Difficult to Recognize with 

Other Modalities 

Hideto Yano et al 

TCT-1289. Hemodynamic Significance of 

Coronary Cameral Fistula Assessed by 

Fractional Flow Reserve 

Jun-hyok Oh et al 

TCT-1290. Stent Thrombosis: The Value 

of OCT to Elaborate the Mechanism 

Richard Anderson et al 

TCT-1291. Slow Flow and Neoatherosclerosis 

in a Patient with Very Late Instent 

Restenosis After Sirolimus-Eluting Stent 

Implantation: Insight from Optical 

Coherence Tomography Analysis 

Kenji Sakata et al 

TCT-1292. Yellow Means Trouble 

David Erlinge et al 

TCT-1293. Mulimodality Imaging Reveals 

Necessity of Embolization Protection 

Devices During Intervention of Vulnerable 

Plaque in Native Coronary Arteries 

Heike Hildebrandt et al 

TCT-1294. Double Device Failure During TAVI 

Pawel Kleczynski et al 

TCT-1295. Direct Aortic Transcatheter 

Aortic Valve Implantation in a Patient with 

Porcelain Aorta 


TCT-1296. Percutaneous Closure of Acquired 

Gerbode-Type Membranous Septum Defect 

Grzegorz Smolka et al 

TCT-1297. Late Embolization of a Vascular 

Plug III Device After Mitral Paravalvular 

Leak Closure 

Dabit Arzamendi et al 

TCT-1298. Late Complication After 

Percutaneous ASD Closure 

Pawel Kleczynski et al 

TCT-1299. Successful Treatment by 

Transcatheter Aortic Valve Implantation of 

Severe Aortic Regurgitation in Patient with 

Ascending Aorta Prosthesis 

Marco Luciano Rossi et al 

TCT-1300. Retrograde Percutaneous Closure 

of a Ventricular Septal Defect After 

Myectomy for Hypertrophic Obstructive 

Cardiomyopathy 

Apurva Badheka et al 

TCT-1301. Simultaneous Antegrade and 

Retrograde Approach During PTMC in a 

Case of Severe Rheumatic Mitral Stenosis 

with Significant Submitral Fusion 

Dattatreya Rao et al 

TCT-1302. Percutaneous Closure of a Left 

Ventricular Pseudoaneurysm After Sapien 

XT Transapical Transcatheter Aortic Valve 

Replacement 

Anna Bortnick et al 

TCT-1303. Simultaneous Stenting of Systemic 

and Pulmonary Venous Baffle Obstruction 

After a Mustard Procedure 

Dhaval Parekh et al 

TCT-1304. Plugging the Hole: Successful 

Percutaneous VSD Closure and Initiation of 

Veno-Arterial Extracorporeal Membrane 

Oxygenation as a Bridge to Recovery 

Maya Kommineni et al 

TCT-1305. A Challenging Left Atrial 

Appendage Closure 

Pedro Carrilho-ferreira et al 

TCT-1306. Strut Fractures of 

CoreValve Frames 

Chen Mao et al 

TCT-1307. Use of 3-D MRA Overlay to Guide 

Transcatheter Pulmonary Valve Replacement 

in an Adult with Tetralogy of Fallot 

Jamil Aboulhosn et al 

TCT-1308. Trancatheter Treatment of 

Lutembacher Syndrome: A Case Report 

Suresh Patted et al 

TCT-1309. Catastrophic Simultaneous Severe 

Aortic and Mitral Regurgitation Due to a Low 

CoreValve Implantation Resolved with a 

Valve-in-Valve Maneuver 

Yigal Piña-reyna et al 

TCT-1310. Complex Percutaneous Repair of 

Ascending to Descending Aorta Graft and 

Descending Aortic Pseudoaneurysm in a 

Patient with Congenital Interrupted Aorta 

and Recurrent Obstruction 

Dominik Wiktor et al 

TCT-1311. Partial Closure of Largest (Ever 

Made) Secundum Atrial Septal Defect Using 

a Fenestrated Occlutech Figulla Flex II ASD 

48-mm Device in a Patient with Near 

Systemic Pulmonary Artery Pressure: 

Case Report 

Eustaquio Maria Onorato et al 

TCT-1312. Ventricular Septum Defect and 

Complete AV Block After TAVI 

Marco Agrusta et al 

TCT-1313. Successful Percutaneous Double 

Valve Treatment for Severe Mitral 

Regurgitation and Severe Aortic Stenosis 

with MitraClip Followed by Transcutaneous 

Aortic Valve Replacement (TAVR) with a 

Edwards Sapien Valve in an Extreme 

Risk Surgical Patient 

Gian-carlo Giove et al 

TCT-1314. Percutaneous Brock Procedure 

Balram Bhargava et al 

TCT-1315. Combined Percutaneous Balloon 

Mitral Valvuloplasty and Left Atrial 

Appendage Occlusion Device Implantation 

for Rheumatic Mitral Stenosis and Atrial 

Fibrillation 

Dale Murdoch et al 

TCT-1316. Hybrid Transapical 

Device Closure of Left Ventricular 

Pseudoaneurysm Under Transoesophageal 

Echocardiographic Guidance 

Vijayakumar Subban et al 

TCT-1317. Rise of the Machines: Cutting-Edge 

Interventional Heart Failure Therapies for 

Patients on the Brink 

Christian Nagy et al 

TCT-1318. Closure of an ASD in a Patient 

with Pulmonary Hypertension 

Geoffrey Crimmins et al 

TCT-1319. Snaring a Embolized Coil at 

Intracerebral Artery During Coronary Artery 

Fistula Embolization 

Hsiu-yu Fang et al 

TCT-1320. Transcatheter Mitral Valve Repair 

Early After Primary Percutaneous Coronary 

Angioplasty of Left Main 

Claudia Fiorina et al 

TCT-1321. Transcatheter Closure of a Large 

Postinfarction Ventricular Septum Defect 

with an Amplatzer Septal Occluder 

Grzegorz Smolka et al 

TCT-1322. Transfemoral TAVI Complicated 

by Left Main Occlusion 

Fadi Al-rashid et al 


Implantation in a 26-Year-Old Nonoperable 

Patient with Aortic Stenosis 

Ricardo Sanz-ruiz et al

TCT-1324. Balloon Jailed in to the 

CoreValve Frame 

Maciej Dabrowski et al 

TCT-1325. Apical Hypertrophic 

Cardiomyopathy: A Preliminary 

Attempt at Palliation Using Subselective 

Alcohol Ablation 

Jorge Escobar et al 

TCT-1326. Closure of Psuedoaneurysm of the 

Ascending Aorta via a Percutaneous Left 

Ventricular Apical Approach 

James Slater et al 

TCT-1327. Is It Safe to Stretch a SAPIEN 

Valve? A Case of Successful Valve-in-Valve 

TAVR to Correct Severe Paravalvular Leak in 

a Patient with Undersized Aortic Valve 

Mihir Kanitkar et al 

aftErnoon sPotlight 

sEssions 

Drug-Coated Balloons (DCB): 

Clinical Data and Applications 

2:00 pm-5:56 pm 

Room A201-202 


Session I. Paclitaxel-Coated 

Balloon Technology 

Moderators: Juan F. Granada, Bruno Scheller 

2:00 pm - Impact of Paclitaxel Formulation on 

Drug Transfer, Tissue Pharmacokinetics, 

and Biological Activity 


2:10 pm - Paclitaxel Delivery and Tissue 

Effects: Similarities and Critical 

Differences with DES 

Renu Virmani 

Session II. Coronary DCB Program Update 

Moderators: Detlef G. Mathey, Pieter R. Stella 

2:20 pm - The Big Picture: Potential Role of 

DCB in a Mature Coronary DES Market 

(SeQuent Please Worldwide Registry) 


2:30 pm - Coronary ISR: An Accepted 

Clinical Indication in the DES World? 


2:40 pm - The PEPCAD Coronary Program: 

Iopromide-Based PCB Coating 

(B. Braun Medical) 

Bruno Scheller 


2:50 pm - SEDUCE: A Prospective, 

Randomized Trial of Drug Coated Balloon 

vs. Everolimus-Eluting Stent in for BMS 

Restenosis: Optical Coherence 

Tomography Assessment 

Tom Adriaenssens 

2:58 pm - DES-Type Results with a DCB Plus 

BMS in Native Coronary Arteries? INDICOR 

Results (B. Braun Medical) 

Upendra Kaul 

3:06 pm - From IMPACT-ISR to BELLO: 

Urea-Based PCB Coating (Invatec) 


3:16 pm - The VALENTINE Trials: 

Shellac-Based PCB Coating (Eurocor) 


3:26 pm - From PEPPER to DELUX Registry: 

BTHC-Based PCB Coating (BIOTRONIK) 


3:36 pm - First-in-Man Results with a Novel 

Nanoparticle-Based Sirolimus-Coated 

Balloon in Coronary In-Stent Restenosis 

Lesions (Concept Medical) 

Suhas S. Lele 

3:44 pm - Development of a Drug-Coated 

Scoring Balloon: Preliminary Results from 

the PATENT-C First-in-Human Study 

Gary Gershony 


Session III. Peripheral Programs Update 

Moderators: Christoph K. Naber, 


4:07 pm - Role of DCB in SFA Intervention: 

Predictions Five Years into the Future 

Thomas Zeller 

4:15 pm - DEBATE-BTK: A Prospective, 

Randomized Trial of Paclitaxel Coated 

Balloon Angioplasty in Diabetic Patients with 

Critical Limb Ischemia Undergoing 

Angioplasty of Below-the-Knee Vessels 

Francesco Liistro 

4:23 pm - The DEFINITIVE-AR Trial: 

Clinical Update 

Gunnar Tepe 

4:31 pm - The Invatec-Medtronic 

Peripheral PCB Program 


4:39 pm - The BIOLUX-P-I Trial: 

Clinical and Angiographic Results 


4:49 pm - The LEVANT II US-Pivotal 

Study Update 



Session IV. Research and 

Development Perspectives 

Moderators: Juan F. Granada, William A. Gray 


TranscaTheTer 


TherapeuTics 

5:11 pm - Regulatory Requirements for 

DCB Development and Approval in 

the United States 

Kenneth J. Cavanaugh Jr 

5:21 pm - DCB Cost-Effectiveness Analysis: 

What Results Must Be Seen for Success 

in the United Statee? 


5:31 pm - Future DCB Technologies: 

Challenges and Opportunities 




International Debating 

Chamber: Interventional 

Cardiology on Trial 

Sponsored by the British Cardiovascular 



2:00 pm-6:00 pm 

Room A104-105 

2:00 pm - Introduction, Session Outline, 

and Goals 

Anthony H. Gershlick 

Conflagration I. Revascularization in 

Patients with Diabetes Mellitus and 

Multivessel Disease 

Moderators: Nick Curzen, 



Robert A. Henderson, A. Pieter Kappetein, 

D. Craig Miller, William S. Weintraub 

2:03 pm - Session and Participant Introduction 


2:06 pm - Case Presentation Introduction: 

A Young Diabetic Patient with Multivessel 

Disease Referred for PCI 

Daniel J. Blackman 

Motion: pCi is the optiMUM 

revAsCUlArizAtion strAtegy for Most 

DiABetiCs with MUltivessel DiseAse 

2:09 pm - Pro: All Diabetic Patients with 

Multivessel Disease Should Be Offered PCI! 


2:19 pm - Con: CABG Is a Superior 

Revascularization Strategy for Most 

Patients with Multivessel Disease! 

D. Craig Miller 

2:29 pm - Discussion: Jury Deliberations 

(Issue in General and Patient Specific) 

2:49 pm - Panel and Audience Vote 

2:52 pm - Case Presentation Conclusion: 

Procedural and Late Patient Outcomes 




152 


2:55 pm - Final Judicial Sentence and 

Take-home Messages 


Conflagration II. TAVR with Diseased 

Femoral Arteries 

Moderators: Martin B. Leon, 


Discussants: Daniel J. Blackman, 

Joseph P. Carrozza Jr, Robert A. Henderson, 

Philip A. MacCarthy, Zoltan G. Turi 




Patient with Severe AS and Diseased 

Femoral Arteries Offered Transapical TAVR 

Mark A. de Belder 

Motion: the trAnsAortiC ApproACh 

shoUlD Move the trAnsApiCAl ApproACh 

to the history Books 

3:06 pm - Pro: The Transaortic Approach Has 

Clear Benefits Over the Transapical 

Approach! 

Vinayak Bapat 

3:16 pm - Con: There Are No Good Data for 

the Transaortic Approach, and Transapical 

Results Are Improving! 

Todd M. Dewey 

3:26 pm - Discussion: Jury Deliberations 




Procedural and Patient Outcomes 


3:52 pm - Final Judicial Sentence 



Conflagration III. Timing of 

Revascularization in Non-ST-Segment 

Elevation Acute Coronary Syndrome 

Moderators: Mark A. de Belder, 



Miles C. Dalby, William S. Weintraub 




A Patient with Acute Coronary Syndrome 

Undergoing Immediate PCI 

Miles C. Dalby 

Motion: high-risk non-st-segMent 

elevAtion ACs shoUlD Be treAteD 

like priMAry AngioplAsty 

4:03 pm - Pro: Delaying Is of No Benefit and 

Only Increases Health Costs: Why Wait?! 

Gilles Montalescot 

4:13 pm - Con: Patients Benefit from Cooling 

Off with Pharmacological Stabilization! 


4:25 pm - Discussion: Jury Deliberations 




Procedural and Late Patient Outcomes 

Miles C. Dalby 

4:51 pm - Final Judicial Sentence 



Conflagration IV. Timing of Complete 

Revascularization in Acute Myocardial 

Infarction 

Moderators: Adnan Kastrati, 

Philip A. MacCarthy 


David J. Cohen, Nick Curzen, 

Anthony H. Gershlick, Ronen Jaffe 


Philip A. MacCarthy 


Patient Undergoes Primary Angioplasty and 

Is Found to Have Lesions in Two Non- 

Infarct-Related Arteries 


Motion: the goAl of priMAry AngioplAsty 

is to reCAnAlize the infArCt relAteD 

Artery only 

5:02 pm - Pro: Treating Bystander Disease 

in the Primary PCI Setting Increases Risk! 

Ran Kornowski 

5:12 pm - Con: Patients Should Undergo 

Complete Revascularization in One Sitting: 

Longer Term Outcomes Will Be Superior! 


5:22 pm - Discussion: Jury Deliberations 




Procedural and Patient Outcomes 


5:48 pm - Final Judicial Sentence and 




Next-Generation Intravascular 

Imaging and Physiology: 

RF-IVUS, OCT, NIR Spectroscopy, 

iFR, and CT-FFR 

2:00 pm-6:08 pm 

Room A101-102 


Session I. Determining Lesion Significance 

Moderators: Allen Jeremias, Morton J. Kern 

Discussants: Joseph D. Babb, Jozef Bartunek, 

Michalis Hamilos, Michael J. Lim 

2:00 pm - Foundation Talk: New Modalities to 

Assess Lesion Significance: How Should 

They Be Evaluated? 

Bon-Kwon Koo 

2:10 pm - CT-FFR: Background and 

Clinical Data 

James K. Min 

2:22 pm - iFR: Background and Clinical Data 


2:34 pm - Correlation Between FFR and iFR: 

An Independent Validation Study 

Nils Johnson 

2:44 pm - Basal Stenosis Resistance Index: 

Background and Clinical Data 

Tim P. van de Hoef 

2:54 pm - A Challenge to All Basal Modalities: 

Why They Can Never Be as Good as 

Hyperemic Indices 


3:04 pm - OCT/FFR Correlation: Do the 

Combined Technologies Have a Role in 

Assessing Lesion Severity? 

Javier Escaned 


Session II. Guiding Percutaneous 

Coronary Interventions: IVUS, RF-IVUS, 

OCT, and NIR Spectroscopy 

Moderators: Giulio Guagliumi, 

Guillermo Tearney 

Discussants: Marco A. Costa, 

Hector M. Garcia-Garcia, Massoud A. Leesar, 


3:29 pm - OCT to Risk Stratify and Guide PCI 

Procedures 1: Preintervention Assessment 

Takashi Kubo 

3:39 pm - OCT to Risk Stratify and Guide PCI 

Procedures 2: Postintervention Assessment 

Francesco Prati 

3:49 pm - Beyond OFDI: Next-Generation 

OCT Systems 

Brett E. Bouma 

3:59 pm - Identifying and Managing 

Embolic-Prone Lesions: IVUS, 

RF-IVUS, OCT, and NIRS 

Emmanouil S. Brilakis

4:09 pm - New VH-IVUS Insights from 

PROSPECT and HORIZONS-AMI 

Akiko Maehara 


Session III. Case Presentations 

Moderators: Akiko Maehara, Evelyn S. Regar 

Discussants: Carlo Di Mario, 

Marc D. Feldman, James A. Goldstein, 


4:31 pm - Case 1: OCT Case 

Jingbo Hou 

4:41 pm - Case 2: VH-IVUS Case 

Dariusz Dudek 

4:51 pm - Case 3: NIRS Case 


5:01 pm - Case 4: IFR Case 

Sayan Sen 

Session IV. Early and Late Stent Outcomes: 

Insights from New Imaging Modalities 


Gary S. Mintz 

Discussants: Fernando Alfonso, 

Giulio Guagliumi, Yasuhiro Honda 

5:11 pm - Mechanisms and Predictors of Stent 

Thrombosis and Restenosis: Insights from 

Grayscale and VH-IVUS 

Akiko Maehara 

5:21 pm - Mechanisms and Predictors 

of Stent Thrombosis and Restenosis: 

Insights from OCT 


5:31 pm - Mechanisms and Predictors 

of Stent Thrombosis and Restenosis: 

Insights from NIRS 

James A. Goldstein 

5:41 pm - BVS Follow-up Using Multiple 

Imaging Modalities: Research 

Implications vs. Clinical Utility 

Yoshinobu Onuma 




7:00 pm-8:30 pm 





TranscaTheTer 


TherapeuTics 



Pioneering New Therapies for 

the Treatment of Heart Disease 

More than 81 million people live with heart disease 

worldwide. Many of them will benefi t from 

interventional procedures developed or refi ned by 

the Cardiovascular Research Foundation (CRF) . . . . 

WE INVESTIGATE 

Early Stage Technologies During Preclinical Research 

WE EVALUATE 

Promising New Therapies by Designing and Implementing 

Multiple Phases of Human Clinical Trials 

WE EDUCATE 

Medical Professionals and the Public to 

Enhance Patient Outcomes 



RESEARCH 

FOUNDATION 

A Passion for Innovation


Main Arena .......................................................................................... 156 



RESPECT and PC Trial Deep Dive: Implications for 

PFO Closure to Prevent Cryptogenic Stroke ............................................157 

TAVR Site Readiness: Starting a Program and 

Achieving Optimal Outcomes ...................................................................157 

The STEMI Center of Excellence: Strategies to 

Optimize Outcomes in AMI.......................................................................158 


Hot Topics ................................................................................................159 


FRiday 

October 26, 2012 MIaMI BEaCh COnvEnTIOn CEnTEr · MIaMI, FL 



TranscaTheTer 


TherapeuTics

156 

friday, ocTober 26 


7:00 am-8:00 am 



Main arEna 

8:00 am-3:15 pm 

Hall D 

Plenary Session XXII. 

Live Cases VII 


Live Case Co-Moderator: Ganesh Manoharan 

Live Case Discussants: Jeroen J. Bax, 

Daniel J. Blackman, Roberto Corti, 

Larry S. Dean, Ulrich J. Gerckens, 

Victor Guetta, Rainer Hoffmann, 

Paul Hsien-Li Kao, Karl-Heinz Kuck, 

Reginald I. Low, Raj Makkar 

8:00 am - University Hospital Bonn 

Bonn, Germany 

8:45 am - Hôpital Charles Nicolle 

Rouen, France 

Plenary Session XXIII. 

Transcatheter Aortic Valve 

Replacement 2012 

Moderators: Ian T. Meredith, 


Discussants: David H. Adams, Martin B. Leon, 

Reginald I. Low, D. Craig Miller, Neil E. Moat, 

Patrick T. O’Gara, Nicolo Piazza, 

Jeffrey J. Popma, Allan Schwartz, 


9:30 am - State of TAVR in 2012: 

Appropriate Clinical Indications 

and Ongoing Controversies 


9:45 am - A Surgeon’s Perspective on 

TAVR Clinical Use Patterns in Europe 

Neil E. Moat 

9:55 am - Update on the Commercial Launch 

of TAVR in the United States: Site Selection, 

Training, Clinical Indications, Case Volumes, 

and Clinical Outcomes 



Plenary Session XXIV. Vascular 

Drug Delivery Breakthroughs 

Moderators: Andrea Abizaid, Juan F. Granada 

Discussants: David J. Cohen, 

Antonio Colombo, Stephen G. Ellis, 

Run-Lin Gao, Adnan Kastrati, 

Pedro A. Lemos, John A. Ormiston, 

Sahil A. Parikh, Gregg W. Stone, 

Renu Virmani, Ron Waksman, Alan C. Yeung 

10:20 am - Bioabsorbable Drug-Eluting 

Scaffolds Are the Future! The Science 

Behind the Dream 


10:35 am - Current and Future Clinical 

Applications of Drug-Coated Balloons: 

From Bench to Bedside 



Plenary Session XXV. TCT 2012 

Thomas J. Linnemeier Spirit of 


Young Investigator Award 


11:00 am - TCT 2012 Thomas J. Linnemeier 

Spirit of Interventional Cardiology Young 

Investigator Award 

Award Presenter: Gregg W. Stone, 


Award Finalists: Ehrin J. Armstrong, 

Philippe Généreux, Giulio Stefanini 

Plenary Session XXVI. 

Late Breaking Trials III 


Co-Moderator: Patrick W. Serruys 

Discussants: Olivier F. Bertrand, 

Michael J. Cowley, Donald Cutlip, 

Frederick Feit, Martial Hamon, Adnan Kastrati, 

Ian T. Meredith, Graham Nichol, 

Matthew J. Price, St phane Rinfret, 

Sigmund Silber, Zoltan G. Turi, 


11:15 am - XIMA: A 


Trial of Everolimus-Eluting 

Stents vs. Bare-Metal 

Stents in Octogenarians 

Adam J. de Belder 


11:35 am - ISAR-DESIRE 3: A 


Trial of Paclitaxel-Eluting 

Balloons vs. Paclitaxel- 

Eluting Stents vs. Balloon 

Angioplasty for Restenosis 

of “Limus”-Eluting Coronary Stents 

Robert A. Byrne 


11:55 am - STEMI-RADIAL: A 


Trial of Radial vs. Femoral 

Access in Patients with 

ST-Segment Elevation 


Ivo Bernat 


Plenary Session XXVII. 

TCT 2012 Late Breaking Trials 

Critique and Interpretation 


Discussants: Andrea Abizaid, David J. Cohen, 

Antonio Colombo, Donald Cutlip, 

Carlo Di Mario, William F. Fearon, 

William A. Gray, Spencer B. King III, 

Ajay J. Kirtane, Franz-Josef Neumann, 

Seung-Jung Park, Patrick W. Serruys, 

William S. Weintraub, Giora Weisz 

12:07 pm - TCT 2012 Late Breaking Trials 

Critique and Interpretation 

Plenary Session XXVIII. 

TCT 2012 Masters Series 

Moderators: Martin B. Leon, Gary S. Mintz, 


Discussants: Andrea Abizaid, 

John A. Ambrose, George D. Dangas, 

Juan F. Granada, William A. Gray, 

Cindy L. Grines, Ajay J. Kirtane, 

Marie-Claude Morice, Wesley R. Pedersen, 

Patrick W. Serruys, Giora Weisz 

1:00 pm - Seminal Pathobiologic Insights 

Which Have Shaped and Guided 

Interventional Cardiovascular Medicine 

Renu Virmani 


1:20 pm - The Odyssey of Transcatheter Aortic 

Valve Replacement (TAVR): From Concept 

to Clinical Reality: A 10-Year 

Anniversary Celebration 



1:40 pm - Reflections on Coronary Stents: 

From Bare Metal to Drug-Eluting to 

Bioabsorbable: My Personal Delights 

and Dilemmas 



2:00 pm - The Revolutionary Impact of 

Interventional Imaging and Physiologic 

Assessment: Milestones Met and a 

Future Vision 

Gary S. Mintz


2:20 pm - The Interventional Pharmacotherapy 

Legacy: Facilitating and Transforming 

Clinical Outcomes 



2:40 pm - The Future of Clinical Research: 

Migrating to an Era of Informatics and 

Personalized Medicine 

Robert M. Califf 

2:55 pm - A Subspecialty at the Crossroads: 

Financial Constraints, the Affordable Care 

Act, Resource Allocations, Physician 

Training, and Medical Education: Bold 

Predictions for the Next 10 Years! 

John C. Lewin 




coronary artEry 

disEasE 

7:50 am-1:00 pm 




Coronary Intervention III 

Moderator: Ajay J. Kirtane 

Co-Moderator: Maurice Buchbinder 

8:00 am - Coronary Complication Spectacle: 

From Air Emboli to Dislodged Stents to No 

Reflow, Perforations, and More 

John S. Douglas Jr 

8:15 am - Coronary Aneurysms and AV 

Fistulae: When and How to Treat 



Unusual Coronary 

Intervention III 

Live Case Moderator: Ajay J. Kirtane 

Live Case Co-Moderator: Maurice Buchbinder 

Live Case Discussants: Kevin J. Beatt, 

Charles E. Chambers, Giulio Guagliumi, 

Allen Jeremias, Vincent On-Hing Kwok, 

Roger J. Laham, Henry H. Ting, 

Robert L. Wilensky, Bernhard Witzenbichler 

8:30 am - Mount Sinai Medical Center 

Miami, FL 

9:30 am - University Hospital Bonn 

Bonn, Germany 


Transcatheter Valve 

Therapies III 

Moderator: Jeffrey J. Popma 

Co-Moderator: Gerhard C. Schuler 

10:30 am - TAVR Technology and Techniques: 

Transcatheter Valve Systems, Accessory 

Devices, and Alternative Access Sites 

Nicolo Piazza 

10:45 am - The Expert MitraClip Procedure: 

From Transseptal Puncture to 

Echocardiographic Guidance and 

Procedural Tips and Tricks 

Saibal Kar 


Valve Therapies III 

Live Case Moderator: Jeffrey J. Popma 

Live Case Co-Moderator: Gerhard C. Schuler 

Live Case Discussants: Shmuel Banai, 

Andreas Baumbach, David L. Brown, 

Jose A. Condado, Eulogio J. Garcia, 

Isaac George, Vivek Gupta, 

Jean-Claude Laborde, David Planer 

11:00 am - Hôpital Charles Nicolle 

Rouen, France 

12:00 pm - University Hospital Bonn 

Bonn, Germany 



sEssions 

RESPECT and PC Trial 

Deep Dive: Implications for 

PFO Closure to Prevent 

Cryptogenic Stroke 

8:00 am-12:00 pm 

Room A201-202 


Part I 

Moderators: Horst Sievert, Robert J. Sommer, 


Discussants: John D. Carroll, Sanjay Kaul, 

Jeffrey L. Saver, Richard Smalling, 


8:00 am - PC Trial Recap 


8:15 am - PC Trial: Additional Findings 


8:30 am - RESPECT: Primary Results 

and More New Data 



TranscaTheTer 


TherapeuTics 

8:45 am - RESPECT: Insights into Ischemic 

Stroke and Its Treatment 

Jeffrey L. Saver 

9:00 am - The PFO Closure Procedure: Safety 

and Effectiveness Lessons from RESPECT 


9:15 am - Study Design Issues with 

RESPECT and the PC Trial 

Sanjay Kaul 


Part II 

Moderators: John D. Carroll, 

Shunichi Homma, Bray Patrick-Lake 

Discussants: David E. Thaler, 


10:15 am - Best Echo Practices and 

Identifying the Pathogenic PFO 

Shunichi Homma 

10:30 am - Paradoxical Embolism and Stroke: 

Insights from RESPECT 


10:45 am - With These Randomized Data: 

What’s Next for Clinical Practice, Device 

Development, and Future Research? 


11:00 am - With These Randomized Data: 

The Patient’s Perspective 

Bray Patrick-Lake 



TAVR Site Readiness: 

Starting a Program and 

Achieving Optimal Outcomes 

8:00 am-12:00 pm 

Room A104-105 

The Multidisciplinary TAVR Heart Team: 

Core Concepts and Cultural Transformation 

Moderators: Nicolo Piazza, Mathew Williams 

Discussants: Henning Rud Andersen, 

Russell A. Brandwein, Benoit Daneault, 

Philippe Généreux, Marian C. Hawkey, 

Hasan Jilaihawi, Scott Lim, Tamim Nazif, 

Jean-Michel Paradis, Wilson Y. Szeto, 

Brian K. Whisenant, David A. Wood, 


8:00 am - Keynote Lecture 1: What Is a 

“Heart Team,” and Why Is it Essential for 

a Successful TAVR Program? 

Nicolo Piazza 


8:15 am - The Surgeon as “Gatekeeper” 

and Engaged Partner in TAVR 



FrIday - OCTOBEr 26, 2012

158 



8:25 am - The TAVR Interventionalist: 

Specialized Skill Requirements 

Scott Lim 


8:35 am - Tips and Tricks for a Facilitated 

Early Discharge Plan After TAVR Procedures 

David A. Wood 


8:45 am - The Crucial and Complementary 

Roles of Advanced Imaging (Echo and CT) 

in TAVR 

Hasan Jilaihawi 


8:55 am - Non-Physician Experts Are the 

Soul of the TAVR Heart Team 

Marian C. Hawkey 


9:05 am - A “Live” Multidisciplinary 

TAVR Heart Team Case Presentation 

Tamim Nazif , Jean-Michel Paradis 


Discussants: Russell A. Brandwein, 

Marian C. Hawkey, Scott Lim, 


Patient Screening Is the Key 

to TAVR Success 

Moderators: Susheel Kodali, 



Bruce Bowers, David L. Brown, 

Mauricio G. Cohen, Haim Danenberg, 

Isaac George, Philip Green, Ran Kornowski, 

Susan J. Schnell, Nicolas M. van Mieghem 

9:25 am - Keynote Lecture 2: Essentials of 

Risk Stratification for TAVR: Moderate, High, 

and Extreme Risk, Futility, and More . . . 



9:40 am - The Importance of Frailty 

Assessments in TAVR Patient Screening 

Philip Green 


9:50 am - Developing an Efficient and Effective 

TAVR Patient Screening Process: Outreach 

Programs, Valve Clinics, Screening Workups, 

and Case Scheduling 

Bruce Bowers 


10:00 am - Managing Expectations in the 

“Real World:” Communication with Referring 

Physicians, Families, and Patients 



TAVR Site Evaluations, Training, 

and Logistics 



Michael J. Davidson, Ulrich J. Gerckens, 

James B. Hermiller Jr, Jean-Claude Laborde, 

Alan B. Lumsden, Michael J. Reardon, 

Rhonda Robb, Kristen Skelton 

10:10 am - Guidelines for Selecting a 

TAVR Site in the United States 

Kristen Skelton 


10:20 am - Criteria for TAVR Site Selection 

Outside the United States 

Jean-Claude Laborde 


10:30 am - Creating the Optimal TAVR 

Procedural Venue: Hybrid Cath Lab/ORs, 

Staffing, Stocking, and Other Logistics 

Alan B. Lumsden 


10:40 am - TAVR Training Programs and 

Case Proctoring 

Vasilis Babaliaros 


10:55 am - Keynote Lecture 3: The US 

Commercial TAVR Site Activation Program: 

Update, Analysis, Report Card, and 

Future Expectations 



Managing a Successful TAVR Program 

Moderators: Nicolo Piazza, Martyn R. Thomas 

Discussants: Perry Bridger, 

Maurice Buchbinder, Patricia E. Knipper, 

Jean-Michel Paradis, Anna Sonia Petronio 

11:10 am - The In-Patient Heart Valve Clinical 

Service: Optimizing Care for TAVR and 

Non-TAVR Patients 



11:20 am - Introducing the TVT Registry: 

Concept, Current Status, and 

Future Directions 



reiMBUrseMent for tAvr proCeDUres 

in the UniteD stAtes 

11:30 am - Understanding and Complying with 

the CMS National Coverage Determination 

Perry Bridger 

11:35 am - Realities and Recommendations 

from a Commercial TAVR Site Perspective 

Patricia E. Knipper 


11:45 am - Open Roundtable Discussion: 

Among New TAVR Commercial Sites in the 

United States, the Secrets of a 

Successful Program 


Discussants: Frank Bowen, 

George D. Dangas, Augustin Delago, 

John Goncalves, David M. Mego, 

Michael Nolen, Joshua Rovin, 

Richard Keith Schwartz, Douglas Spriggs 


The STEMI Center of 

Excellence: Strategies to 

Optimize Outcomes in AMI 

8:00 am-12:00 pm 

Room A101-102 

Controversies in STEMI Systems of Care 

Moderators: Christian W. Hamm, 

Ivan C. Rokos 

Discussants: Eric R. Bates, Holger Thiele 

8:00 am - The New European STEMI 

Guidelines: What Are the Differences 

from US Guidelines and Why? 

Christian W. Hamm 

8:15 am - New Guideline Door-to-Balloon 

Time of 120 Minutes for Transferred 

STEMI Patients: Taking a Knee or Evidence- 

Based Decision? 

Eric R. Bates 

8:30 am - Pharmacoinvasive Approach vs. 

Primary PCI for Transferred STEMI Patients 

Holger Thiele 


Mission Lifeline 

Moderators: Alice K. Jacobs, Gary L. Schaer 

Discussants: Sameer Mehta, Ivan C. Rokos 

9:00 am - Mission Accomplished and 

Saving Lives? 

Alice K. Jacobs 

9:12 am - Why Are Some Hospital 

Networks More Successful? 

Sameer Mehta 

9:24 am - False Activations of the Cath Lab: 

New Insights and Recommendations 

Gary L. Schaer 

9:36 am - Do We Need Payment Incentives 

to Optimize STEMI Networks? 

Ivan C. Rokos 


Strategies to Shorten Reperfusion Times 

Moderators: William J. French, Sameer Mehta 

Discussants: Eric A. Cohen, Michel R. Le May 

10:00 am - Potential and Pitfalls of Ambulance 

Triage and STEMI Transfer Networks 

Eric A. Cohen

10:15 am - Old and New Strategies to 

Reduce D2B Times 

Sameer Mehta 

10:30 am - Prehospital ECG Transmission and 

the Call 911 Protocol for STEMI 

Referral Centers 

William J. French 

10:40 am - Is it Time for Regional Cardiac 

Arrest Programs? Code ROSC in Ottawa 

Michel R. Le May 


Performance Measures for STEMI and PCI 

Moderators: Brahmajee K. Nallamothu, 

Henry H. Ting 

Discussant: Jeptha P. Curtis 

11:00 am - Performance Measures in PCI 

and STEMI: Do They Improve Care or 

Restrict Decision-Making? 

Brahmajee K. Nallamothu 

11:15 am - Volume-Outcome Relationships 

for STEMI: Is More Better? 

Jeptha P. Curtis 

11:30 am - Risk-Standardized 30-Day 

Mortality Rates: What Are They and 

How Do We Improve Them? 

Henry H. Ting 



lunchtiME sEssions 

Hot Topics 

ACC Special Practitioners Session at TCT: 

How to Manage, Maintain, and Expand Your 


12:15 pm-1:45 pm 



Moderators: Tony Das, 

D. Christopher Metzger, Lowell F. Satler 

Discussants: Eric J. Dippel, Roger Gammon 

12:15 pm - Using Data (“Cloud”) Integration 

to Improve Your Practice’s Responsiveness 

and Regional Outreach 

Lowell F. Satler 


12:30 pm - Should Clinical Research 

Be an Important (or Profitable) Part of 

Your Practice? How to Succeed 



12:45 pm - Reinventing Yourself: How to 

Add New Procedures (eg, Peripheral, 

Carotid, TAVR, Structural) 

Tony Das 



1:00 pm - How to Maximize Practice 

Performance in Large Practices: 

Independent or Hospital Integrated? 

Generalist or Subspecialization? Equal Split 

or Productivity Based? And More 

Eric J. Dippel 


1:15 pm - How to Maximize Referrals to 

Your Practice: Is the “Spoke and Hub” 

Model Dead? 

Roger Gammon 


1:30 pm - Roundtable Discussion 


Career Development for the 

“New” Interventionalist 

12:15 pm-1:45 pm 



Moderators: Sahil A. Parikh, Manish A. Parikh 



12:20 pm - Getting Started in an 

Academic Group Practice: 

What to Do and What Not to Do 

Michael J. Rinaldi 

12:30 pm - Getting Started in a University 

Practice: What to Do and What Not to Do 

Robert W. Yeh 

12:40 pm - Building a Niche: How to 

Transition from the “New” Interventionalist 

to the “Expert” 

James P. Zidar 

12:50 pm - Balancing Multiple Skills: 

Coronary and Peripheral 

Sahil A. Parikh 


Coronary and Structural 



Avoiding Getting Spread Too Thin 


1:20 pm - Juggling Clinical Practice and 

Clinical Research 


1:30 pm - Things to Do in Your First Five 

Years to Grow Your Career 


1:40 pm - Discussion: Tips, Tricks, and 

Rookie Mistakes When Starting as an 

Interventionalist 



TranscaTheTer 


TherapeuTics 

Diabetes and Cardiovascular Disease: 

Treating the Whole Patient 

12:15 pm-1:45 pm 


Moderators: Michael E. Farkouh, 

Frederick Feit, Steven P. Marso 



12:17 pm - Diabetes Mellitus, Multivessel, 

and Left Main Disease: CABG for All! 

Joseph F. Sabik 

12:27 pm - Diabetes Mellitus, Multivessel, 

and Left Main Disease: Not So Fast, 

PCI for Many! 

Kevin J. Beatt 

12:37 pm - Discussion: Diabetes Multivessel 

and Left Main Disease: CABG vs. PCI 

Discussants: Kevin J. Beatt, 

Francesco Burzotta, Upendra Kaul, 

Joseph F. Sabik 

12:47 pm - Introducing Disruptive DES 

Technology into BARI 2D: Lessons Learned, 

Insights Gained 


12:57 pm - Optimizing the Diabetic Formulary: 

Managing the Triad of Glycemic Control, 

Blood Pressure, and Hyperlipidemia 

Michael E. Farkouh 

1:07 pm - Evaluating the Safety of 

Emerging Diabetic Therapies 


1:17 pm - Discussion: Optimizing Medical 

Therapy for Diabetic Patients in 2012 

Discussants: Michael E. Farkouh, 

Frederick Feit, Steven P. Marso, 

Verghese Mathew 

1:27 pm - Case: A 62-Year-Old Diabetic 

Patient with ACS and Moderate 

Renal Failure 

Verghese Mathew 

1:42 pm - Concluding Remarks 



Guideline Directions and Controversies 

(Part 2): Decision Making with the 

Heart Team Approach 

12:15 pm-1:45 pm 



Moderators: Brahmajee K. Nallamothu, 

Henry H. Ting 

Discussants: Joseph D. Babb, Eric R. Bates, 

Megan Coylewright, Isaac George, 




160 


CAse presentAtions: introDUCtion 

12:15 pm - Case 1: Patient with Stable Class 1 

Angina Treated with Aspirin and Statin and a 

Mid LAD 70% Stenosis 

Megan Coylewright 

12:20 pm - Case 2: Patient with Stable Class 3 

Angina, Triple-Vessel CAD, and Intermediate 

Syntax and STS Scores 


12:25 pm - What Do the Guidelines and 

Appropriate Use Criteria Recommend? 

Eric R. Bates 

the heArt teAM pAnel: how Do we 

DeCiDe on AlternAtive treAtMents? 

12:35 pm - Referring Cardiologist Perspective 

Joseph D. Babb 

12:40 pm - Interventional Cardiologist 

Perspective 


12:45 pm - Cardiac Surgeon Perspective 

Isaac George 

12:50 pm - What Is the Role for Shared 

Decision Making? 

Henry H. Ting 

1:00 pm - Controversies and Bringing 

It All Together 

Brahmajee K. Nallamothu 


CAse presentAtions: DisCUssion 

AnD resolUtion 

1:25 pm - Case 1: Patient with Stable 

Class I Angina Treated with Aspirin and 

Statin and a Mid LAD 70% Stenosis 


1:35 pm - Case 2: Patient with Stable Class III 

Angina, Triple-Vessel CAD, and Intermediate 

Syntax and STS Scores 



Prevention of Contrast-Induced Acute 

Kidney Injury: Focus on Hydration and 

New Frontiers 

12:15 pm-1:45 pm 


Moderators: Antonio L. Bartorelli, 

Roxana Mehran, Richard Solomon 

Discussants: Somjot S. Brar, Carlo Briguori, 

Fikret Er, Eugenia Nikolsky 

12:15 pm - Welcome, Introduction, 

and Session Goals 


12:20 pm - Contrast-Induced Acute 

Kidney Injury: Have We Reached a 

Ceiling in Prevention? 

Roxana Mehran 

12:30 pm - Balancing Diuresis and 

Hydration to Prevent CI-AKI 

Richard Solomon 

12:40 pm - Alternative Approaches for 

Hydration: MYTHOS, REMEDIAL II, 

and Others 


12:50 pm - A Well Calculated Hydration 

Scheme: The Role of Heart Pressure 

to Gauge Hydration 


1:00 pm - A Guide to Hydration Modalities: 

Normal Saline vs. Bicarbonate, Timing, 

and Duration 

Carlo Briguori 

1:10 pm - Ischemic Preconditioning to 

Prevent CIN: Hype or Hope? 

Fikret Er 

1:20 pm - A Case-Based Discussion: 

Take-home Messages and Clinical 

Practice Implications 

Eugenia Nikolsky 





Acute Infarct Angioplasty 


12:15 pm-1:45 pm 

Room B211 

Moderators: Simon R. Dixon, 


Discussants: David A. Cox, 

James A. Goldstein, Jose P.S. Henriques, 

John C. Messenger 

12:15 pm - Cases 1 and 2: When and How to 

Use Aspiration and Mechanical 

Thrombectomy 

David A. Cox 

12:30 pm - Cases 3 and 4: What to Consider 

When Treating Acute Stent Thrombosis 


12:45 pm - Cases 5 and 6: How to Intervene in 

Acute Saphenous Vein Graft Occlusion 

Simon R. Dixon 

1:00 pm - Cases 7 and 8: When and How to 

Use LV Support Devices in Acute MI 

Jose P.S. Henriques 

1:15 pm - Cases 9 and 10: How to Manage 

Acute MI with Right Ventricular Shock 


1:30 pm - Cases 11 and 12: Complications 

of Acute Infarct Angioplasty 

John C. Messenger 


Left Main Intervention 

12:15 pm-1:45 pm 

Room A208 

Moderators: Andrejs Erglis, Raj Makkar 

Discussants: James B. Hermiller Jr, 

William W. O’Neill, Stéphane Rinfret 

12:15 pm - Important Facts from the Literature 

Relevant for Day-to-Day Left Main PCI 

Raj Makkar 

12:25 pm - Step-by-Step Approach to 

Two-Stent Techniques for Left Main 

Bifurcation PCI: Coulette, Mini-Crush, 

Double Barrel, and More 

Andrejs Erglis 


12:45 pm - How to Perform Left Main PCI 

via the Radial Approach 


12:55 pm - How to Use FFR and IVUS 

During Left Main PCI 


1:05 pm - When and What to Use for 

LV Support in Left Main PCI 


1:15 pm - Debulking and Plaque Modification 

in Left Main PCI: When and How 


1:25 pm - My Most Important Lessons from 

Two Decades of Left Main PCI 




Management of DES Thrombosis 

and Restenosis 

12:15 pm-1:45 pm 

Room B210 

12:15 pm - Welcome and Introduction 


stent throMBosis 

Moderators: Fernando Alfonso, 

Christoph A. Kaiser 

12:17 pm - Update: Everything You Need 

to Know About Stent Thrombosis 

Management in 2012 


12:29 pm - Case 1: Subacute DES Thrombosis 

After Elective PCI (with Imaging) 

Francesco Prati 

12:39 pm - Case 2: DES Thrombosis 

After STEMI 

Tamim Nazif 

12:49 pm - Case 3: Very Late Stent 

Thrombosis: The Role of Adjunctive Imaging 

During Treatment 

Giulio Guagliumi

estenosis 

Moderators: Fernando Alfonso, 


12:59 pm - Update: Everything You Need to 

Know about Treatment of Restenosis in 2012 

Alan C. Yeung 

1:11 pm - Case 1: Management of 

Focal DES ISR 

Ioannis Iakovou 

1:21 pm - Case 2: Management of DES ISR 

with Drug-Coated Balloon 

Andrzej J. Ochala 

1:31 pm - Case 3: Management of Late 

Restenosis Due to Neoatherosclerosis 

with Plaque Rupture 

Robert A. Byrne 

1:41 pm - Take-home Lessons 




Transcatheter Aortic Valve Replacement: 

Tips and Tricks 

12:15 pm-1:45 pm 

Room A209 

Moderators: Corrado Tamburino, 


Discussants: Raoul Bonan, Lutz Buellesfeld, 

Haim Danenberg, Michael J. Reardon, 

Stefan Sack, Gerhard C. Schuler, 


12:15 pm - Introduction to the TAVR Procedure 


12:20 pm - Case 1: Paravalvular Leak 


12:28 pm - How to Minimize Paravalvular Leak 

Corrado Tamburino 


12:40 pm - Case 2: Alternative (Nonfemoral) 



12:48 pm - What Are the Preferred Access 

Options in Nontransfemoral Cases? 



1:00 pm - Case 3: Incorrect Valve Placement 



TranscaTheTer 


TherapeuTics 

1:08 pm - Strategies for Accurate 

Valve Placement 



1:20 pm - Case 4: TAVR-Related Stroke 


1:28 pm - Minimizing Stroke During TAVR 



1:40 pm - Conclusions and 






traNScatheter 

cardiOvaScular 

therapeuticS 

twenty-fifth 

AnniversAry 

Save the date 

Oct 28-NOv 1, 2013 

SaN FraNciScO 

the MOScONe ceNter 

www.tctconference.com

Tuesday 

Breakfast Meetings ....................................................................................164 

Presentation Theater Programs ..................................................................165 

Evening Programs .....................................................................................166 

Wednesday 




Thursday 




Friday 


SatelliteS 

October 23-26, 2012 MIaMI BEaCh COnvEnTIOn CEnTEr · MIaMI, FL 



TranscaTheTer 


TherapeuTics

164 

saTelliTe symposia 

tuEsday, octobEr 23 

Breakfast Meetings 

Contemporary CTO PCI: BridgePoint 

Medical and the Hybrid Approach 

Miami Beach Convention Center, C227-228 

Sponsored by BridgePoint Medical 

ChAirs 


University of Missouri Kansas City and 

Mid America Heart Institute 



Yale New Haven Hospital 

New Haven, CT 

fACUlty 



Atlanta, GA 

James Spratt, BSc, MD 

Forth Valley Royal Hospital 

Larbert, United Kingdom 

Simon Walsh, MD, MRCP 

Belfast Trust 


AgenDA 


7:00 am - Hybrid Algorithm: US and EU 

Training/Proctoring Experience 


7:15 am - Angiographic Evaluation 

and Procedural Approach 

Dimitri Karmpaliotis 

7:30 am - BridgePoint Case Presentation 1 

Simon Walsh 

7:40 am - BridgePoint Case Presentation 2 

James Spratt 

7:50 am - Wrap-up Discussion with Q&A 


Innovative Hybrid Therapy for Complex 

Cardiovascular Problems: Collaborative 

Care Case Reviews 

Miami Beach Convention Center, D233-234 

Sponsored by Cardiovascular Research 

Foundation 

Supported through an educational grant 

from Medtronic CardioVascular 

ChAirs 




New York, NY 




New York, NY 

fACUlty 

Harit Desai, MD 



Jeffrey Lee, MD 

University of Maryland 

Baltimore, MD 

Gustavo Olivotti, MD 



Carlos Sada, MD 



Mukta Srivastava, MD 


Baltimore, MD 

Ulrich Uluft, MD 



AgenDA 




7:03 am - Rare Evidence of Extrinsic Dynamic 

Compression in the Middle Third-Distal Left 

Anterior Descending Artery by Cartilaginous 

Part of the Penultimate Left Rib Arc 

Gustavo Olivotti, Carlos Sada 


7:22 am - Hybrid Coronary Intervention 

Mukta Srivastava 


7:41 am - Mitral Perivalvular Leak Repair via 

Transapical Approach 

Harit Desai, Ulrich Uluft 



Incorporating the Treatment of Chronic 

Venous Insufficiency into Your Practice 


Sponsored by Covidien 

ChAir 




New York, NY 

fACUlty 

Jose I. Almeida, MD 

Miami Vein Center 

Miami, FL 

Michelle Sloan, APN 

Eastlake Cardiovascular 

St. Clair Shores, MI 

AgenDA 


7:00 am - Welcome 


7:05 am - Disease State and Prevalence of 

Chronic Venous Insufficiency 


7:20 am - CVI Treatment with Radiofrequency: 

Getting Started in Treating Veins 

Jose I. Almeida 

7:35 am - Practice Development Techniques 

Michelle Sloan 



Rethinking EVAR: Disruptive Technologies 

for Aortic Interventions 


Sponsored by Endologix, Inc. 

ChAir 


MidOhio Cardiology and Vascular 

Columbus, OH 

fACUlty 

Edward B. Diethrich, MD 

Arizona Heart Foundation 

Phoenix, AZ 



Miami, FL 


Texas Heart Institute 

Houston, TX

AgenDA 



7:05 am - Unresolved Challenges 

in AAA Repair 

Gary M. Ansel 

7:15 am - Ventana Fenestrated System: 

Expanding the Number of Patients Eligible 

for EVAR 

Edward B. Diethrich 

7:25 am - The Next Frontier in EVAR: 

Percutaneous Access and Closure 


7:35 am - From EVAR to EVAS: Revolutionary 

Polymer Sealing Technology 




Tryton Growing Clinical Data Displacing 

Provisional Stenting? 


Sponsored by Tryton Medical, Inc. 

ChAirs 




New York, NY 


Thoraxcenter 


fACUlty 



Kingsport, TN 




Giuseppe Tarantini, MD, PhD 

University of Padova 

Padova, Italy 

Mladen Vidovich, MD 

University of Illinois at Chicago 


Chicago, IL 

Joanna Wykrzykowska, MD, PhD 

Amsterdam Medical Center 


AgenDA 


7:00 am - The Tryton Pivotal IDE Study: 

Overview, Update, and Next Steps 



7:10 am - Tryton Pooled Analysis Shows 

Excellent TVF Rates Compared with 

Historical Data 

Joanna Wykrzykowska 

7:20 am - Case Presentations 

Moderators: D. Christopher Metzger, 

David G. Rizik, Giuseppe Tarantini, 

Mladen Vidovich 

7:50 am - Discussion and Key Messages 



Expanding Your Interventional Practice 

with Peripheral Procedures 


Sponsored by Volcano Corporation 

fACUlty 

Julian Javier, MD 

Physicians Regional 

Naples, FL 

Prakash Krishnan, MD 


New York, NY 


St. John’s Hospital 


AgenDA 


7:00 am - What Does It Take to Overcome the 

Obstacles and Establish a Successful and 

Growing EVAR and TEVAR Practice 

Greg Mishkel 

7:15 am - Cardiologists and Veins: Why? 

Julian Javier 

7:30 am - How to Build a Peripheral Vascular 

Disease Practice 

Prakash Krishnan 


Presentation Theater Programs 

LEVANT I: 24-Month Data and Lutonix ® 

Drug-Coated Balloon 

Miami Beach Convention Center, 


Sponsored by Bard Peripheral 

Vascular/Lutonix 

ChAir 




AgenDA 

12:15 pm - The LEVANT I 24-Month Data 




TranscaTheTer 


TherapeuTics 

SYMPLICITY HTN-3 Trial: Evaluating Renal 

Denervation for Treatment-Resistant 

Hypertension 



Sponsored by Medtronic, Inc. 

ChAirs 

George L. Bakris, MD, DMSc 

University of Chicago Pritzker 


Chicago, IL 



Atlanta, GA 

fACUlty 

Murray D. Esler, MB, BS, PhD 

Baker IDI Heart and Diabetes Institute 


Krishna Rocha-Singh, MD 



AgenDA 


George L. Bakris 

12:20 pm - Resistant Hypertension: 

The Prevalence and Burden 

George L. Bakris 

12:30 pm - Introduction to Renal Denervation 

and Sympathetic Nervous System 

Murray D. Esler 

12:45 pm - SYMPLICITY Clinical Trial Program 

Krishna Rocha-Singh 

1:00 pm - SYMPLICITY HTN-3 Trial Design and 

Current Status 






SaTELLITE SyMPOSIa - OCTOBEr 23-26, 2012

166 


Evolving Antiplatelet Strategies for ACS: 

An Evidence-Based Expert Panel Debate 



Sponsored by North American Center 

for Continuing Medical Education 

Supported through an educational 

grant from AstraZeneca 

This activity has been approved 

for 1 AMA PRA Category 1 Credit 

ChAir 


VA Boston Healthcare System and 


Boston, MA 

fACUlty 

David J. Cohen, MD, MSc 





Durham, NC 



Paris, France 

AgenDA 

12:15 pm - What Is Your Periprocedural 

Antiplatelet Strategy for ACS Patients 

Undergoing PCI? 

David J. Cohen, E. Magnus Ohman, 



12:30 pm - What Is Your Interpretation of 

Recent Guidelines and Clinical Data on 

Available Antiplatelets? 




12:45 pm - What Considerations Are 

Factored into Your Postprocedural 

Antiplatelet Strategy for Patients Who 

Have Undergone PCI? 




1:00 pm - What Is Your Position on the 

Value of Platelet Reactivity Testing in 

the Interventional Setting? 





Evening Programs 

C A R D I O VA S C U L A R · R E S E A R C H · F O U N D AT I O N · 

Issues with DAPT: A Case-Based 

Roundtable with Experts 

The Perry South Beach Hotel, Ballroom 

Sponsored by Cardiovascular 

Research Foundation 

Supported through educational 

grants from Abbott Vascular and 



for 1.5 AMA PRA Category 1 Credits 

ChAirs 



New York, NY 




fACUlty 

Fausto Feres, MD 






New York, NY 




New York, NY 

Laura Mauri, MD, MSc 


Boston, MA 


Dipartimento Cardiovascolare, 

Policlinico S. Orsola 

Bologna, Italy 


University Hospitals, Case Medical Center 

Cleveland, OH 

AgenDA 

6:30 pm - Dinner Reception 

7:00 pm - Welcome, Introductions, 

and Session Goals 


7:05 pm - A Mini-Review of the Latest ACC, 

AHA, and ESC Guidelines on DAPT and PCI 


reAl-worlD CAses 

7:15 pm - Case 1: Patient with STEMI and DES 



Discussants: Fausto Feres, Laura Mauri, 

Daniel I. Simon 

7:20 pm - Panel and Synthesis 

7:27 pm - Case 2: Patient Post-DES 

Requiring Noncardiac Surgery 



Discussants: Fausto Feres, Laura Mauri, 



7:39 pm - Case 3: A Bleeding Patient 

Post-DES 

TBA 


7:51 pm - Case IV: Patient with Atrial 

Fibrillation and DES 



review of CUrrent DAtA on DApt 

DUrAtion with next generAtion Des 

8:01 pm - EES: SPIRIT and More 



8:06 pm - RESOLUTE: The Latest Data 

Laura Mauri 


8:11 pm - Endeavor: PROTECT, OPTIMIZE 

Fausto Feres 


8:16 pm - BES: Leaders Program 



8:21 pm - Synthesis: Final Words and Take 

Home Messages 



The Challenge of Coronary Calcification: 

From Yesterday to Tomorrow 

Ritz Carlton South Beach Hotel, Salon 1-2 


Foundation 


from Cardiovascular Systems, Inc. 



ChAirs 



Washington, DC




New York, NY 

fACUlty 

David C. Auth, PhD, NAE 


Seattle, WA 



San Diego, CA 

Jeffrey Chambers, MD 

Metropolitan Heart and Vascular Institute 





New York, NY 


Swedish Heart and Vascular Institute 

Seattle, WA 

Gert Richardt, MD, PhD 

Segeberger Kliniken 

Bad Segeberg, Germany 

Richard A. Shlofmitz, MD 

St. Francis Hospital 

Roslyn, NY 

AgenDA 


7:00 pm - Prevalence and Impact of 

Coronary Calcification: Insights from 

Intravascular Imaging 

Gary S. Mintz 

7:10 pm - Impact of Coronary Calcification 

in the DES Era: Problem Solved? 


7:22 pm - Featured Lecture: PTCA 

and Rotational Atherectomy for 

Calcified Lesions: A “No-Holds-Barred” 

Historical Perspective 

David C. Auth 

7:37 pm - Lessons Learned from Rotational 

Atherectomy in Heavily Calcified Lesions 

Mark Reisman 

7:49 pm - Case 1: Complex Rotational 

Atherectomy: What I Learned the 

“Hard” Way 


7:59 pm - ROTAXUS Revisited: Results, 

Implications, and Future Directions 

for Plaque Decalcification 

Gert Richardt 

8:09 pm - Orbital Atherectomy: 

Technology Description, Technique, 

and the ORBIT Studies 



8:21 pm - Case 2: Orbital 

Atherectomy Vignettes 

Richard A. Shlofmitz 

8:31 pm - Discussion and Closing Comments 


Vascular Restoration: The Bioabsorbable 

DESolve Scaffold Platform 

Loews Miami Beach Hotel, 

Americana Ballroom-Salon 4 

Sponsored by Elixir Medical Corporation 

ChAir 


New York-Presbyterian Hospital/ 


New York, NY 

fACUlty 








Antwerp Cardiovascular Institute, 

ZNA Middleheim Hospital 


Bernard Witzenbichler, MD 



AgenDA 


7:00 pm - Elixir Medical Program Overview 


7:12 pm - DESyne Clinical Data 

Bernard Witzenbichler 

7:24 pm - DESyne BD Clinical Data 


7:36 pm - DESolve Scaffold Preclinical Testing 


7:48 pm - DESolve Scaffold Clinical Data 







TranscaTheTer 


TherapeuTics 

High-Risk ACS: Overcoming the Limitations 

of Current Anticoagulant Therapy— 

Dialogue with the Experts 


Americana Ballroom-Salon 1-2 

Jointly sponsored by Beth Israel Medical 

Center and St. Luke’s and Roosevelt 

Hospitals and Health Education Alliance, Inc. 

This CME activity is supported by an 

educational grant from sanofi-aventis U.S. 

Inc., A SANOFI COMPANY 



ChAir 




Boston, MA 

fACUlty 



New York, NY 



Paris, France 

AgenDA 


7:00 pm - The Evolving Landscape of 

Anticoagulation in High-Risk ACS: 

Where Are We and Where Are We Going? 


Discussants: Roxana Mehran, 


7:30 pm - The Balance Between Ischemic 

Events and Bleeding: Can It Be Optimized? 

Roxana Mehran 

Discussants: Deepak L. Bhatt, 


8:00 pm - Novel Anticoagulants: Exploring 

the Data to Reveal the Promise 


Discussants: Deepak L. Bhatt, Roxana Mehran 


Twenty Years of FFR: From Experimental 

Index to Standard of Care 

Loews Miami Beach Hotel, Poinciana 

Ballroom 

Sponsored by St. Jude Medical 

ChAir 


University of California, Irvine 

Irvine, CA 



168 


fACUlty 






Stanford, CA 

Nico H.J. Pijls, MD, PhD 



Peter N. Ver Lee, MD 

Eastern Maine Medical Center 

Bangor, ME 

AgenDA 


7:00 pm - Course Welcome, Overview, 

Objectives 


7:05 pm - Discovery, Evolution, and Validation 

of FFR 


7:30 pm - From Intermediate Lesions to 

Complex Coronary Disease 


7:45 pm - FFR and Clinical Outcomes: DEFER, 

FAME, FAME II, and More 


8:00 pm - FFR in Everyday Use 

Peter N. Ver Lee 

8:10 pm - What Makes FFR Unique? Did We 

Make Gruentzig’s Dream Come Alive? 


8:20 pm - Closing Comments 



wEdnEsday, octobEr 24 


Evolution of the AngioSculpt Technology: 

Preliminary Clinical Results with a 

Drug-Coated Scoring Balloon and a 

Valvuloplasty Device 


Sponsored by AngioScore 

ChAir 




New York, NY 

fACUlty 

Ronald K. Binder, MD 

St. Paul’s Hospital/University of 

British Columbia 



John Muir Cardiovascular Institute 

Piedmont, CA 


Universität des Saarlandes 


Patrick L. Whitlow, MD 


Cleveland, OH 

AgenDA 


7:00 am - Welcome and Opening Remarks 


7:03 am - Evolution of the AngioSculpt 

Technology Platform for Coronary and 

Peripheral Vascular Disease: Next 

Generation Devices 


7:15 am - Role of the AngioSculpt Device in 

Complex Coronary Lesions and Bifurcations 


7:25 am - Early Results from PATENT-C: 

A Randomized FIM Trial Evaluating a 

Drug-Coated AngioSculpt Scoring Balloon 

in Coronary ISR 


7:35 am - Early Clinical Experience with a 

Valvuloplasty Scoring Balloon in the 

Treatment of Critical Aortic Valve Stenosis 

Ronald K. Binder 

7:45 am - Panel Discussion 

Ronald K. Binder, Martin B. Leon, 

Bruno Scheller, Patrick L. Whitlow 

7:55 am - Closing Remarks 

Gary Gershony 



Hemodynamics: “There’s an App for That!” 

Session I. Basic Concepts and 

Understanding Medical Management 

of Critical Patients 



Foundation 


from ABIOMED, Inc. 



ChAir 


Washington University School of Medicine 

St. Louis, MO 

fACUlty 





Columbia University 

New York, NY 

AgenDA 


7:00 am - Welcome and Overview 


7:05 am - Lecture 


7:35 am - Case Presentation 


7:40 am - Case Discussion 

Mark B. Anderson, Daniel Burkhoff, 

John A. Lasala 


Expand Your Access Options: Retrograde 

Tibiopedal Access for Treatment of Total 

Occlusions 


Sponsored by Cook Medical 

fACUlty 

Yazan Khatib, MD 

First Coast Cardiovascular Institute 


Jihad A. Mustapha, MD 

Metro Health Heart and Vascular 

Grand Rapids, MI 

Aravinda Nanjundappa, MD 

West Virginia University 

Charleston, WV

AgenDA 


7:00 am - Retrograde Tibiopedal Access: How 

to Cross Lesions You Thought You Couldn’t 

Yazan Khatib 

7:15 am - The Angiosome Approach to 

Tibiopedal Access 

Jihad A. Mustapha 

7:30 am - Choosing the Right Imaging 

Modality for Tibiopedal Access 

Aravinda Nanjundappa 

7:45 am - Questions and Answers 


The Next Generation of Intervention: 

Renal Denervation, Lower Limb 

Revascularization, and Stroke Treatment 


Sponsored by Covidien 

ChAir 




New York, NY 

fACUlty 

L. Nelson Hopkins, MD 

Buffalo General Medical Center 

Buffalo, NY 

John R. Laird Jr, MD 






AgenDA 


7:00 am - Welcome and Opening Remarks 


7:05 am - Renal Denervation: Evidence for 

Resistant Hypertension and Perspectives 

on Current Technologies 


7:19 am - The Data Delivered for Lower Limb 

Revascularization: Directional Atherectomy 

and CTO Options 


7:33 am - Stroke Treatment: 

The Next Generation 





Provisional Treatment Approach of a 

Medina 1.1.1 Bifurcation Lesion: When and 

How to Treat the Side Branch? 

Miami Beach Convention Center, D229-230 

Sponsored by Minvasys 

ChAir 



New York, NY 

fACUlty 

Jacques Berland, MD 

Clinique Saint Hilaire 

Rouen, France 

Bruno Gracia del Blanco, MD 

Val d’Hebron Hospital 

Barcelona, Spain 

Antoine Lafont, MD 

Hospital European Georges Pompidou 

Paris, France 

Marco A. Perin, MD, PhD 

Hospital Albert Einstein 


AgenDA 



Roxana Mehran 

7:05 am - Provisional Approach with the Nile 

PAX and My Strategy for the Side Branch 

Bruno Gracia del Blanco 

7:30 am - Provisional Approach with the Nile 

PAX and My Strategy for the Side Branch 

Jacques Berland 

7:55 am - Conclusion and 


Roxana Mehran 


The Science of Left Atrial Appendage 

Closure: Clinical Experience of the 

LARIAT Suture Delivery Device 


Sponsored by SentreHEART, Inc. 

ChAir 



Miami, FL 

fACUlty 


Scripps Green Hospital 

La Jolla, CA 


Baptist Cardiac and Vascular 

Institute of Miami 

Miami, FL 


TranscaTheTer 


TherapeuTics 

Miguel Valderrábano, MD, FACC 

The Methodist Hospital 

Houston, TX 

AgenDA 


7:00 am - Evolution of LAA Closure: 

The Innovation of Tradition 


7:10 am - Overview of LARIAT Clinical Data 


7:20 am - The Electrophysiologist’s 

Perspective 

Miguel Valderrábano 

7:30 am - Lessons Learned from the 

Baptist Experience 

Ramon Quesada 

7:40 am - Moderated Q&A 

Moderator: William W. O’Neill 

Discussants: Matthew J. Price, Ramon 

Quesada, Miguel Valderrábano 


OCT to Guide Daily PCI Decision Making 



ChAir 


Saint Luke’s Health System 


fACUlty 



New York, NY 

Francisco Prati, MD 

San Giovanni Hospital 

Rome, Italy 

AgenDA 


7:00 am - Welcome and Course Objectives 


7:05 am - Angiography Alone vs. Angiography 

and OCT to Guide Decision Making During 

PCI: The CLI-OPCI Study 

Francisco Prati 

7:20 am - PCI Optimization Using Optical 

Coherence Tomography: A Representative 

Case Example 


7:35 am - OCT Assessment of Plaque 

Erosion and Use to Guide Treatment 

Strategy in the AMI Patient 

Jagat Narula 

7:50 am - Question and Answer 

Steven P. Marso, Jagat Narula, Francisco Prati 




170 


Radial Access PCI: A Positive 

Economic Impact! 


Sponsored by Terumo Interventional 

Systems 

ChAir 

Adhir Shroff, MD, MPH 

University of Illinois Hospital and 

Health Sciences System 

Chicago, IL 

fACUlty 

Daniel H. Steinberg, MD 



David Wohns, MD, FACC, FSCAI 

West Michigan Heart 


AgenDA 


7:00 am - Radial Access PCI: Clinical Impact 

and Cath Lab Economics 

Adhir Shroff 

7:15 am - Radial Access PCI Economics 

in a Teaching Institute 

Daniel H. Steinberg 

7:30 am - Radial vs. Femoral: Economic 

and Clinical Data from a Large Tertiary 

Care Facility 

David Wohns 



The Crucial Role of FFR in the Post- 

SYNTAX Era 



ChAir 


University of California, Irvine 

Irvine, CA 

fACUlty 


Imperial College London Trust 


AgenDA 


7:00 am - How FFR Makes Complex PCI Less 

Complex: The Importance of a Functional 

SYNTAX Score 

7:25 am - Simplifying Decisions in Serial 

Lesions 

7:40 am - A Glimpse into the Future of 

MVD with New Wire Technology and 

iFR Functionality 



How Should I Treat Hemodynamically 

Unstable Patients Undergoing PCI? 



Sponsored by MAQUET Cardiovascular 

ChAir 




fACUlty 

Henry Cusnir, MD 

Florida Medical Center 

Fort Lauderdale, FL 

Navin K. Kapur, MD 


Boston, MA 

Atman P. Shah, MD 

The University of Chicago Hospital 

Chicago, IL 




AgenDA 


Simon Redwood 

10:05 am - Complex Case Presentation 1 

Henry Cusnir 

10:10 am - Case Review 


10:20 am - How Did I Treat? 

Henry Cusnir 


10:30 am - Complex Case Presentation 2 

Atman P. Shah 

10:35 am - Case Review 

Holger Thiele 

10:45 am - How Did I Treat? 

Atman P. Shah 


Henry Cusnir, Navin K. Kapur, Simon 

Redwood, Atman P. Shah, Holger Thiele 

10:55 am - Take-home Messages 

Simon Redwood 


Interventional Cardiovascular Medicine in 

Asia: Current Approaches and Challenges 



Sponsored by Medtronic CardioVascular 

ChAirs 

Fang Chen, MD 

Beijing Anzhen Hospital 



Monash Medical Centre Clayton 


fACUlty 

Chi-Hung Huang, MD 

Cathay General Hospital 


Yang-Soo Jang, PhD 

Yonsei University Health System 


Michael K. Lee, MD, MBBS 

Queen Elizabeth Hospital 

Kowloon, China 

J. Shiv Kumar Rao, MBBS, MD 

Apollo Hospital 

Secunderabad, India 




Ajay R. Sinhal, MBBS, MD, DM 

Flinders Medical Centre 


Huay Cheem Tan, MD 

National University Heart Centre 

Singapore, Malaysia 


Sayama Hospital 

Sayama City, Japan 

AgenDA 

12:15 pm - Objectives and Introduction 


12:19 pm - Complex PCI in a Diabetic Patient 

J. Shiv Kumar Rao 

12:22 pm - How Would I Treat 

Masahisa Yamane 

12:25 pm - How Would I Treat 

Chi-Hung Huang

12:28 pm - How Did I Treat 

J. Shiv Kumar Rao 



12:35 pm - Consensus 


12:36 pm - Structural Heart Case Presentation 

Mohad Ali Rosli 


Ajay R. Sinhal 




Mohad Ali Rosli 





12:53 pm - Complex Case Presentation: 

Resistent Hypertension 

Michael K. Lee 




Yang-Soo Jang 


Michael K. Lee 






Moderator: Fang Chen 


New Frontiers in Interventional Cardiology: 

A Luncheon Symposium with Experts 



Sponsored by Meril Life Sciences Pvt. Ltd. 

ChAir 

Upendra Kaul, MD, PhD 

Fortis Escorts Hospital 


fACUlty 

Pawel E. Buszman, MD, PhD 

American Heart of Poland 


Karl-Heinz Kuck, MD, PhD 

Asklepios Hospital St. Georg 


Roberto Botelho, MD, PhD 

Triangulo Heart Institute 

Uberlandia, Brazil 


Ali Faizal, MD, DM 

Malabar Institute of Medical Science 

Calicut, India 

M.S. Hiremath, MD, DM, MNAMS 

Ruby Hall Clinic 

Pune, India 


The Centre of Endosurgery and Lithotripsy 





New York, NY 

C.N. Manjunath, MD, DM 

Sri Jayadeva Institute of Cardiovascular 

Sciences and Research 

Bangalore, India 




Teguh Santoso, MD, FACC, FESC 

Medistra Hospital, Indonesia 

Jakarta, Indonesia 


Escorts Heart Institute and Research Centre 


Adam Witkowski, MD, PhD 



AgenDA 

12:15 pm - Next Generation of Stent Designs: 

NexGen and the Polish ACS Experience 

Pawel E. Buszman 

12:23 pm - BioMimicry in DES: BioMime and 

meriT Clinical Update 

Ashok Seth 

12:31 pm - The Evolving Interventional 

Landscape: Futuristic DES, Valves, 

and Beyond 


12:41 pm - Leapfrogging to Bioresorbable 

Scaffolds: MeRes 


12:49 pm - BioMime Indian Experience 

M. S. Hiremath 

12:57 pm - BioMime Brazil Experience 





TranscaTheTer 


TherapeuTics 

STENTYS IDE Trial in STEMI: The Self- 

Apposing Stent Revolution Is Coming to 

the United States 



Sponsored by STENTYS 

ChAir 


Foundation of Cardiovascular Medicine 

San Diego, CA 

fACUlty 



Boston, MA 



New York, NY 

Harald G. W. Mudra, MD, PhD 

Klinikum Neuperlach 

Munich, Austria 

Robert-Jan van Geuns, MD, PhD 



AgenDA 

12:15 pm - Better Stent Sizing Leads to 

Better Outcomes: The Self-Apposing 

Stent Technology 


12:25 pm - Real-world Use in 1000 

STEMI Patients: APPOSITION III 

One-Year Interim Results 

Harald G. W. Mudra 

12:45 pm - Routine Clinical Practice and 

Experience with a Self-Apposing Stent 

Robert-Jan van Geuns 

1:00 pm - STENTYS Randomized IDE Trial in 

STEMI: The APPOSITION V Study in the 

United States and Worldwide 

Roxana Mehran 



Emerging Technology and Trial Designs: 

Challenging Conventional Strategies 


Poinciana Ballroom 

Sponsored by Biosensors International 

ChAirs 

Teguh Santoso, MD, PhD 

Medistra Hospital 

Jakarta, Indonesia 


Thoraxcenter 




172 


fACUlty 




Gennaro Sardella, MD 

Policlinico Umberto I University 

Rome, Italy 

Philip M. Urban, MD 

Hôpital de la Tour 





AgenDA 


7:00 pm - Introduction and Objectives 

Teguh Santoso 

7:05 pm - Five Years Ahead: Final Report on 

LEADERS, the First All-Comers DES Trial 


7:20 pm - Biolimus-Eluting Stents in STEMI 

Patients: Update from the COMFORTABLE 

AMI Trial 


7:35 pm - Can Stent Design Impact the 

Treatment of Bifurcation Lesions? 


7:50 pm - Are Current DES the Final Answer? 


8:05 pm - DES, Bleeding Risk, and the 

“Non-Comers” Population 


DisCUssion 




The Future of Stents, TAVR, Left Atrial 

Appendage Closure, and Renal 

Denervation: A Case-Based Review 


Sponsored by Boston Scientific Corporation 

ChAirs 

Ted M. Feldman, MD 

Evanston Hospital 

Evanston, IL 

Jeffrey M. Moses, MD 

New York-Presbyterian Hospital/ 


New York, NY 

fACUlty 



San Diego, CA 


The Christ Hospital 

Cincinnati, OH 


Monash Medical Centre 

Clayton, Australia 




AgenDA 


7:00 pm - Welcome 

Ted M. Feldman, Jeffrey M. Moses 

7:15 pm - Drug-Eluting Stent Advancements 

Dean Kereiakes 

7:30 pm - Transcatheter Aortic Valve 

Replacement 


7:45 pm - Left Atrial Appendage Closure 


8:00 pm - Renal Denervation for Resistant 

Hypertension 


8:15 pm - Wrap Up 

Jeffrey M. Moses 



TAVR 2012: A Year to Remember! 

Loews Miami Beach Hotel, Americana 

Ballroom-Salon 4 


Foundation 


from Edwards Lifesciences 



ChAirs 




New York, NY 




fACUlty 


University of Colorado 

Denver, CO 




Josep Rodés-Cabau, MD 

Québec Heart and Lung Institute/ 

Laval University 

Québec, Canada 


University of Pennsylvania Medical Center 




Atlanta, GA 



Cleveland, OH 

AgenDA 


seCtion i 

7:00 pm - New Clinical Research: 

The Year in Review 


7:15 pm - Panel Discussion 

seCtion ii 

7:18 pm - New Techniques: Annulus 

Measurements and Alternative Access Sites 

Raj Makkar 


seCtion iii 

7:36 pm - New Technology: Next- 

Generation Devices 

Josep Rodés-Cabau 


seCtion iv 

7:54 pm - New National Registry 

and Reimbursement 



seCtion v 

8:12 pm - New TAVR Sites: A Roundtable 

Discussion with New TAVR Commercial Sites 

Vinod H. Thourani, E. Murat Tuzcu 

8:30 pm - Adjourn


Myth Busters: Is Complete Coronary 

Revascularization Really Essential? 




Foundation 


from Gilead Sciences 



ChAirs 




New York, NY 




New York, NY 

fACUlty 




New York, NY 


Mayo Clinic 

Rochester, MN 

AgenDA 



Giora Weisz 

7:05 pm - The Positive and Negative Impact of 

Incomplete Revascularization After PCI 



7:25 pm - Incomplete Revascularization After 

Surgery: Knowns and Unknowns 



7:45 pm - Pathways to Reduced Ischemia 1: 

Hybrid PCI-CABG 



8:05 pm - Pathways to Reduced Ischemia 2: 

Adjuvant Pharmacotherapies 

Giora Weisz 




MGuard Embolic Protection Stent: A New 

Era in STEMI Treatment 


Sponsored by InspireMD 

ChAirs 


Heart Center at the Isar 





New York, NY 

fACUlty 



Milan, Italy 




Dariusz Dudek, MD, PhD 


Krakow, Poland 



Bonn, Germany 




New York, NY 




AgenDA 


7:00 pm - The Unmet Need in STEMI 


7:10 pm - The MGuard Embolic Protection 

Stent Technology 


7:20 pm - MGuard World Experience: What Did 

We Learn? 

Dariusz Dudek 

7:35 pm - Challenging Cases 

7:55 pm - Master Trial Design and Results 


8:15 pm - Conclusions and 

Takeaway Messages 




TranscaTheTer 


TherapeuTics 

thursday, octobEr 25 



Hemodynamics: “There’s an App for That!” 

Session II. Understanding the Effects of 

Mechanical Support Devices 



Foundation 

Supported through an educational 

grant from ABIOMED, Inc. 



ChAir 



St. Louis, MO 

fACUlty 





Columbia University 

New York, NY 


University of California Irvine 

Irvine, CA 

AgenDA 


7:00 am - Welcome and Overview 


7:05 am - Lecture 


7:35 am - Case Presentaiton 

Mark B. Anderson 

7:45 am - Case Discussion 

Mark B. Anderson, Daniel Burkhoff, 

Morton J. Kern, John M. Lasala 




174 



Renal Denervation for Treatment-Resistant 

Hypertension: A Focused Update 



Foundation 


from Medtronic CardioVascular 



ChAirs 



Atlanta, GA 




New York, NY 

fACUlty 




Boston, MA 


Imperial College London NHS Trust 



CardioVascular Center Frankfurt, 

Sankt Katharinen 



Hennepin County Medical Center 


AgenDA 


7:00 am - A Primer on the Science Behind 



7:15 am - The Symplicity Clinical Trial Program 


7:30 am - Selected Case Studies 

Horst Sievert 

7:45 am - Renal Denervation: Present/Future 

Applications 


7:55 am - Discussion and Q&A 


Introducing Robotic-Assisted PCI into 

Your Daily Cath Lab Practice 

Miami Beach Convention Center, D229-230 

Sponsored by Corindus Vascular Robotics 

and Philips Healthcare 

ChAirs 



Stanford, CA 




New York, NY 

fACUlty 

Joseph P. Carrozza Jr, MD 

Steward St. Elizabeth’s Medical Center 

Boston, MA 

J. Jeffrey Marshall, MD 

Northeast Georgia Heart Center 

Gainesville, GA 


VCU Medical Center 

Richmond, VA 

AgenDA 


7:00 am - Opening Remarks 


7:05 am - CorPath 200 System Overview: 

Robotic-Assisted PCI 


7:15 am - The PRECISE Trial Results 

Giora Weisz 

7:25 am - A Day in a CorPath Lab: Treating 

Different Patients with a Robotic System 

J. Jeffrey Marshall 

7:40 am - Robotics in the Cath Lab: 

Hospital’s Perspective 

Joseph P. Carrozza Jr 

7:50 am - Roundtable Discussion 

Moderator: Peter J. Fitzgerald 

Discussants: Joseph P. Carrozza Jr, 

J. Jeffrey Marshall, George W. Vetrovec, 

Giora Weisz 


Direct Flow Medical Transcatheter 

Aortic Valve System 


Sponsored by Direct Flow Medical, Inc. 

ChAirs 


UC Davis Heart Center 




Cleveland, OH 

fACUlty 



Milan, Italy 

Charles J. Davidson, MD 


Chicago, IL 



Massy, France 


Henry Ford Hospital 

Detroit, MI 




AgenDA 



Reginald I. Low 

7:05 am - Direct Flow Medical Transcatheter 

Aortic Valve: Technical Overview 

Charles J. Davidson 

7:15 am - DISCOVER Trial Clinical Results 

Thierry Lefevre, Joachim Schofer 

7:30 am - Improving Outcomes: Clinical Case 

Review of DFM Technology 


7:45 am - Future Clinical Trials: Assessment 

and Implications of Aortic Regurgitation 


7:55 am - Questions and Answers 



Titanium Nitride Oxide Bioactive Stent: The 

Evidence-Based Choice in Acute Coronary 

Syndrome 


Sponsored by Hexacath SAS 

ChAir 

Pasi Karjalainen, MD, PhD 


Pori, Finland 

fACUlty 

Michaël Angioi, MD 

University Hospital Nancy 

Nancy, France 

Joan A. Gomez-Hospital, MD 

Bellvitge Hospital Universitari 

Barcelona, Spain

AgenDA 


7:00 am - CATS-AMI Study New Insights 

Michaël Angioi 


7:20 am - TiTAN AMI Spanish Registry 

Joan A. Gomez-Hospital 


7:40 am - The BASE-ACS Study Follow-up 

Pasi Karjalainen 



Imaging STEMI Culprit Plaques with Near 

IR Spectroscopy: Clinical Implications 


Sponsored by InfraReDx, Inc. 

ChAir 



Royal Oak, MI 

fACUlty 

David Erlinge, MD, PhD 

Lund University Hospital 

Lund, Sweden 

Ryan D. Madder, MD 

Frederik Meijer Heart and Vascular Institute, 

Spectrum Health System 


AgenDA 


7:00 am - Introductions and Symposium 

Objectives 


7:05 am - The NIRS Signature of 

STEMI Culprit Plaques 


7:20 am - Yellow Means Trouble: The Early 

Swedish Experience with TVC-Guided PCI 

David Erlinge 

7:35 am - TVC-Guided PCI and Its Role 

in Your Interventional Practice 





OrbusNeich’s COMBO Dual Therapy 

Stent: Addressing the Limitations of 



Sponsored by OrbusNeich 

ChAirs 

Stephen W.L. Lee, MD 

Queen Mary Hospital 




New York, NY 

fACUlty 


Lukaskrankenhaus Neuss 

Neuss, Germany 

Jonathan M. Hill, MD, MRCP 



Ulf Landmesser, MD, PhD 

University Hospital of Zurich 


AgenDA 


7:00 am - Addressing the Unmet Needs of 

Balancing Bleeding and Ischemic Events: 

A “Real-world” Daily Dilemma for 

the Practicing Cardiologist 

Roxana Mehran 

7:10 am - COMBO Dual Therapy Stent 

Technology: The Results from the 

REMEDEE Study 

Michael Haude 

7:25 am - Assessing EPC Capture Effects on 

Vascular Healing 

Jonathan M. Hill 

7:35 am - Early Healing and Endothelial 

Response with COMBO Stent: REMEDEE 

OCT Study Design and Preliminary Results 

Ulf Landmesser 

7:50 am - Focus on the Future: 

Discussion with Q&A 

Stephen W.L. Lee 


Strategies to Address Guidelines, Necessity 

and Improve PCI Outcomes 



fACUlty 





TranscaTheTer 


TherapeuTics 

Jasvindar Singh, MD, FACC 


St. Louis, MO 

Bernard Witzenbichler, MD 



AgenDA 


7:00 am - FFR-Guided PCI in Practice Today: 

Meeting Necessity and Quality Demands 


7:20 am - Intravascular Imaging in Complex 

PCIs: Improving Outcomes to Reduce 

Readmissions 

Jasvindar Singh 

7:40 am - Translating the Newest ADAPT 

Data into Today’s Routine Clinical Practice 

Bernard Witzenbichler 



Why Drug-Eluting SFA Stents Will 

Replace Bare Metal Stents 



Sponsored by Cook Medical 

ChAir 



Columbus, OH 

fACUlty 

Mark W. Burket, MD 


Toledo, OH 




AgenDA 

12:15 pm - Your Life on Drugs: Will We Ever 

Go Back to Bare Metal Stents in the SFA? 

Gary M. Ansel 

12:30 pm - What Are the True Costs of 

Treating In-Stent Restenosis? 


12:45 pm - How Drug-Eluting Stents Have 

Affected My Practice 



Discussants: Gary M. Ansel, Mark W. Burket, 





176 


Emerging Regions Interventional 

Cardiology Symposium: India 



Sponsored by India Medtronic Pvt. Ltd. 

ChAirs 

A.B. Mehta, MD 

Jaslok Hospital and Research Centre 

Mumbai, India 

Vinay K. Bahl, MD, DM 






New York, NY 

fACUlty 

Thomas Alexander, MD 

KMCH Hospital 

Coimbatore, India 

Shirish Hiremath , MD 

Ruby Hall Clinic 

Pune, India 

Fazila T. Malik, MD 

NHFH and RI 

Dhaka, India 

Sundeep Mishra, MD, DM 



Keyur H. Parikh, MD 

Care Institute Medical Sciences 



Escorts Heart Institute and Research Centre 


Nakul Sinha, MD 

Sahara Hospital 

Lucknow, India 

AgenDA 

12:15 pm - Introductions 

Fazila T. Malik, Nakul Sinha 

12:18 pm - Opening Remarks 

A.B. Mehta, Vinay K. Bahl, Manish A. Parikh 

12:20 pm - Emergence of Interventional 

Cardiology in India 

Sundeep Mishra 

12:30 pm - Initiating Innovative Therapies 

Ashok Seth 

12:40 pm - Resistant Hypertension: Patient 

Pathways to Treatment 


12:50 pm - Making Complex Coronary 

Lesions Simple 

Shirish Hiremath 

1:00 pm - Establishing a System of Care 

for STEMI 

Thomas Alexander 

1:10 pm - Discussions 

A.B. Mehta, Manish A. Parikh 


From Short Stay to Same Day: Optimizing 

Outpatient PCI Pathways 



Sponsored by The Medicines Company 

ChAirs 

Harold L. Dauerman, MD 





Durham, NC 

fACUlty 

Ehtisham Mahmud, MD 

University of California 

San Diego, CA 



Boston, MA 

AgenDA 

12:15 pm - What Is the Rationale and the 

Expected Benefits of Early Discharge? 

Ehtisham Mahmud 

Moderator: Harold L. Dauerman 

12:27 pm - What Are the Economic 

Implications? 


Moderator: Harold L. Dauerman 

12:39 pm - Is Same Day Discharge Safe? 


12:51 pm - How to Organize the 

Clinical Pathway? 



Discussants: Harold L. Dauerman, 

Ehtisham Mahmud, Duane S. Pinto, 

Sunil V. Rao 




Drug-Coated Balloon Technologies: 

Today and Tomorrow 




Foundation 


from AngioScore, BIOTRONIK, Boston 

Scientific Corporation, Cook Medical, 

EuroCOR GmbH, Lutonix/Bard, Medtronic 

CardioVascular 



ChAirs 





Universitätsklinikum des Saarlandes 


fACUlty 



Milan, Italy 



New York, NY 





Herzzentrum Freiburg-Bad Krozingen 

Bad Krozingen, Germany 

AgenDA 


7:00 pm - SFA and Below-the-Knee DCB 

Applications: Update on the Data and 

Competitive Technologies 

Thomas Zeller 

7:10 pm - Coronary DCB Applications: 

Current Uses and Future Applications 



7:30 pm - Experimental Evaluation of Device 

Success: Local Tissue Effects, Distal 

Embolization, and Beyond 

Renu Virmani

7:40 pm - Sirolimus Analogues and 

DCB Development: Emerging 

Concepts, Biological Considerations, 

and Technical Challenges 


7:50 pm - Technological Challenges for 

DCB Development: Where Is Future 

Innovation Needed? 



8:15 pm - Economic Issues in PAD: 

Implications for DCB Technology 





Knights of the Roundtable 2012: Defending 

and Challenging AMI Therapies 





from AstraZeneca and through an 

independent grant from The Medicines 

Company 



ChAirs 



Detroit, MI 




New York, NY 




New York, NY 

fACUlty 

Dimitrios Alexopoulos, MD 

Patras University Hospital 

Patras, Greece 


University of Florida-Shands 



Hôpital Universitaire Nord 

Marseille, France 


Lehigh Valley Hospital 

Bethlehem, PA 


Nick Curzen, BM, PhD 

Southampton University Hospitals 

Southampton, United Kingdom 


Eastern Piedmont University 

Novara, Italy 


New York University Medical Center 

New York, NY 


Guthrie Clinic 

Sayre, PA 

Jose P.S. Henriques, MD, PhD, MBA 



Stefan K. James, MD 

Uppsala Clinical Research Center 

Uppsala, Sweden 


McMaster University 


Michael R. Le May, MD 

University of Ottawa Heart Institute 

Ottawa, Canada 





Padova University Hospital 

Padova, Italy 




Harvey D. White, DSc 

Green Lane Cardiovascular Service, 






Stephen D. Wiviott, MD 


Boston, MA 


University Hospital Ulm 

Ulm, Germany 

AgenDA 


UnsettleD issUes in steMi i. 

prAsUgrel vs. tiCAgrelor? 

7:00 pm - The Case for Prasugrel 




Laurent Bonello, Frederick Feit, 



TranscaTheTer 


TherapeuTics 

7:08 pm - The Case for Ticagrelor 




Laurent Bonello, Frederick Feit 

7:16 pm - The Case for Cangrelor 

Dominick J. Angiolillo 




7:24 pm - The Case for Selective 

Use of Clopidogrel 

Nick Curzen 





UnsettleD issUes in steMi ii. Des AnD 

prAsUgrel DUrAtion 

7:44 pm - How Beneficial are Best-in-Class 

DES and Potent ADP Antagonists? 

Anticipating HORIZONS–AMI II 


Moderator: Cindy L. Grines 

Discussants: Giuseppe De Luca, 

Kishore J. Harjai, Michael R. Le May 


UnsettleD issUes in steMi iii. DeAling 

with throMBUs, i prefer . . . 

8:04 pm - Aspiration Thrombectomy 




Jose P.S. Henriques, Massimo Napodano, 


8:12 pm - Intracoronary Abciximab 






8:20 pm - A Mesh-Covered Stent 






8:28 pm - Do Whatever You Want: In Most 

Cases, it Doesn’t Matter 

Holger Thiele 









178 



Emerging Technologies for Peripheral 

Interventions: Device Selection, Technical 

Approach, and Clinical Outcomes 




Foundation and Baptist Health South Florida 


from Cardiovascular Systems, Inc. 



ChAirs 


The CRF Skirball Research Center 




Miami, FL 

fACUlty 


Saint Luke’s Mid-America Heart Institute 


Tony Das, MD 

Presbyterian Heart Institute-Dallas 

Dallas, TX 



Kingsport, TN 

Jihad A. Mustapha, MD 

Metro Heart and Vascular Institute 

Wyoming, MI 



Miami, FL 





CVPath Institute, Inc 


AgenDA 


7:00 pm - Opening Remarks 


7:05 pm - Pathological Features of Peripheral 

Atherosclerotic Disease: Implications for 

Device Selection 

Renu Virmani 

7:15 pm - Impact of SFA Lesion Complexity 

on Device Selection and Clinical Outcomes 

(Case-Based Presentation) 


7:25 pm - Technical Approaches to BTK 

Intervention: Device Selection and 

Anatomical Considerations 

(Case-Based Presentation) 

Jihad A. Mustapha 


7:45 pm - Reentry Devices: A Necessary 

Interventional Tool! (Case-based 

Presentation) 

Alex Powell 

7:55 pm - Calcium Ablation in the Periphery: 

A Critical Review of Available Technologies 

and Clinical Data (Case-based Presentation) 

Tony Das 

8:05 pm - DCB, Atherectomy, and Stents: 

Technical and Biological Considerations 

for Device Selection 


8:15 pm - Cost-Benefit Analysis and Multiple 

Device Use for Peripheral Interventions 


8:25 pm - Wrap-up Discussion 


The Novel FIREHAWK DES Platform: 

Targeting the Future 


Sponsored by MicroPort Medical 

ChAirs 




Jiyan Chen, MD 

Guangdong Provincial People’s Hospital 





New York, NY 

Bo Xu, MD 

Fu Wai Hospital, National Center for 



fACUlty 

Shaoliang Chen, MD 

Affiliated Nanjing First Hospital of 

Nanjing Medical University 

Nanjing, China 


Fu Wai Hospital, National Center for 




Shenyang Northern Hospital 

Shenyang, China 


Yale School of Medicine 

New Haven, CT 

Weifeng Shen, MD 

Affiliated Ruijin Hospital of Shanghai 

Jiao Tong University School of Medicine 


Haichang Wang, MD 

Xijing Hospital, the Fourth Military 

Medical University 

Xi’an, China 

Yuejin Yang, MD 

Fu Wai Hospital, National Center 

for Cardiovascular Diseases 


AgenDA 


7:00 pm - Opening: Ideal DES Platform 

for the Future 


7:10 pm - FIREHAWK Abluminal Groove Filled 

Biodegradable Polymer Sirolimus-Eluting 

Stent: Angiographic and Clinical Results 

Run-Lin Gao 


7:40 pm - IVUS Findings of FIREHAWK from 

TARGET I Trial 

Weifeng Shen 

7:50 pm - Angioscopic Findings of FIREHAWK 

vs. XIENCE V from TARGET I Trial 

Shaoliang Chen 

8:00 pm - Case Presentation with FIREHAWK: 

IVUS and FFR Guided PCI for Complex Left 

Main with Multivessel Disease 

Yuejin Yang 



RESPECT PFO Closure Trial: The 

Investigator Perspective 

Loews Miami Beach Hotel, Poinciana 

Ballroom 


ChAirs 

Jeffrey L. Saver, MD 

University of California 




Denver, CO 

fACUlty 

Lee A. MacDonald, MD 

South Denver Cardiology 

Littleton, CO

Richard Smalling, MD, PhD 

Memorial Hermann Heart and 


Houston, TX 

David E. Thaler, MD, PhD 


Boston, MA 

AgenDA 


CAUtion: AMplAtzer pfo oCClUDer is An 

investigAtionAl DeviCe. liMiteD By feDerAl 

(or U.s.) lAw to investigAtionAl Use. not 

AvAilABle for sAle in the U.s. 


7:05 pm - RESPECT Trial: Design Review and 

Primary Outcomes 


7:20 pm - How RESPECT Differs from Closure I 


7:30 pm - RESPECT and Recent 

Pharmacological Trials 


7:40 pm - RESPECT from the 

Neuro Perspective 

Jeffrey L. Saver 

7:50 pm - RESPECT: A Single-Center 

Experience in IC and Neuro Partnership 

Lee A. MacDonald 

8:00 pm - RESPECT Results: Impact 

on International Practice 

8:10 pm - Panel Discussion: Collaborating 

for Optimal Patient Care 

Moderator: John D. Carroll 

8:35 pm - Q&A 


friday, octobEr 26 




Guidewire Design and Selection: 

A User’s Guide 





from Abbott Vascular 



ChAirs 




New York, NY 




New York, NY 

fACUlty 

Christopher E. Buller, MD 

St. Michael’s Hospital 




Atlanta, GA 

AgenDA 




7:05 am - Anatomy and Design of Coronary 

Guidewires 101: Engineering for the 

Interventionalist 

Christopher E. Buller 

7:15 am - Applied Use of Coronary 

Guidewires: Basic Principles 


CAse presentAtions 

7:30 am - CTO Wires: Antegrade and 

Retrograde Approaches 


7:40 am - Hydrophilic and Support Wires 





TranscaTheTer 


TherapeuTics 

Management of Complex PCI Patients: 

Award-Winning Case Presentations 





from ABIOMED, Inc. 

ChAirs 

Mauricio Cohen, MD 

Miller School of Medicine, 


Miami, FL 

Sean Pinney, MD 


New York, NY 

fACUlty 

Maya Kommineni, MD 

University of Chicago 

Chicago, IL 

Aung Myat, MD 

King’s College London 


Sibin Zacharius, MD 

Beaumont Hospital 

Royal Oak, MI 

AgenDA 


7:00 am - Impella-Supported LMCA/ 

Multivessel Coronary Intervention: Case 

Selection, Technical Considerations, 

and Interventional Strategy 

Maya Kommineni 


7:20 am - Impella-Assisted Unprotected 

Left Main Stenting Requiring Preemptive 

Iliac Revascularization 

Sibin Zacharius 


7:40 am - The Impella 2.5 Percutaneous LVAD: 

Essential Hemodynamic Support During 

Emergency High-Risk Multivessel 


Aung Myat 





180 


Intraaortic Balloon Counterpulsation for 

Percutaneous Aortic Valve or Complex PCI 

Procedures: Award Winning Case 

Presentations 





from MAQUET Cardiovascular 

ChAirs 

Tayo A. Addo, MD 

UT Southwestern Medical Center 

Dallas, TX 

Vijayalakshmi Kunadian, MBBS, MD 



fACUlty 

Teeranan Angkananard, MD 

Srinakharinwiroth University 

Nakorn-nayok, Thailand 

Chiara Bernelli, MD 

San Raffaele Hospital, Milan 

Milan, Italy 

Ankur Kalra, MD 

Minneapolis Heart Institute at Abbott 

Northwestern Hospital 


AgenDA 


7:00 am - Peripartum Acute ST-Elevation 

Myocardial Infarction from Spontaneous 

Coronary Artery Dissection 

Ankur Kalra 


7:20 am - Salvage Percutaneous Mitral Valve 

Repair with MitraClip in a Patient with 

Cardiogenic Shock: The Essential Role 

of the IABP 

Chiara Bernelli 


7:40 am - Thai Athlete with Sudden VF 


Teeranan Angkananard 


8:00 am - Adjourn



Save the Date 

Celebrating Partnerships in 

Improving Patient Care 

HONORING THE 

AMERICAN COLLEGE OF CARDIOLOGY 

AND SPECIAL GUESTS 

Friday, December 14, 2012 · 6:30 PM 

Mandarin Oriental · Time Warner Center 

80 Columbus Circle · New York, NY 

Cocktails, Dinner, and Dancing 

For more information, 

please visit www.pulsegala.org or contact 

Irma Damhuis at 646-434-4690 or idamhuis@crf.org. 

TranscaTheTer 


TherapeuTics 



182 

Poster AbstrAct MAP 

1034 

1033 

1032 

1031 

1030 

1029 

1028 

1027 


1025 

1024 

1023 


1021 

1020 

1019 

1018 

1017 

1016 

1015 

1014 

1013 

1012 

1011 

1010 

1009 

35” w x 48”t 

1035 

1036 

1008 

1007 

1043 1062 

1044 1061 

1045 1060 

1046 1059 

1047 1058 

1048 1057 

1049 1056 

1050 1055 

1051 1054 

1052 1053 

35” w x 48”t 

1037 

1038 

145 

146 

1006 

1005 

140 

143 

35” w x 48”t 

1039 

1040 

1063 1082 

1064 1081 

1065 1080 

1066 1079 

1067 1078 

1068 1077 

1069 1076 

1070 1075 

1071 1074 

1072 1073 

144 

147 

150 

115 

139 

142 

Chronic Kidney 

Disease and Acute 

Renal Insu�ciency 

(133-150) 18 faces 

1004 

1003 

149 

116 

138 

141 

35” w x 48”t 

1041 

1042 

1083 1102 

1084 1101 

1085 1100 

1086 1099 

1087 1098 

1088 1097 

1089 1096 

1090 1095 

1091 1094 

1092 1093 

137 

136 

148 

117 

118 

121 

119 

120 

1003 

1002 

127 

124 

135 

130 


123 

1001 

1000 

134 

131 

170 

167 

169 

168 

125 


133 

132 

171 

166 

129 

128 

161 

160 

172 

165 

EVAR and TEVAR 

(115-132) 18 faces 

162 

159 

179 

178 

173 

164 

163 

158 

314 317 320 323 325 327 330 333 336 

344 345 346 347 

180 

177 

184 

157 

174 

183 

Peripheral Vascular 

185 

156 

175 

182 

Disease and Intervention 

(151-189) 

15439 

faces153 

152 151 

190 

191 

192 

193 

194 

195 

196 

197 

198 

199 

186 

155 


321 

319 

318 

316 

315 

353 

354 

342 

343 

176 

181 

335 

334 

332 

331 

329 

328 


324 

Cath Lab Advances 

23 faces 

314 - 336 

188 

189 

187 

Carotid and Neurovascular Disease and 

Intervention (190 - 203) 14 faces 

200 201 

202 203 

207 206 

205 204 


(204 - 217) 14 faces 

355 

348 

348 

337 

350 

349 

339 

338 

352 

351 

Diabetic Patients 

(19 faces) 

337 - 355 

341 

340 

359 

360 

217 

216 

215 

214 

213 

212 

211 

210 

209 

208 

361 

358 

303 

304 

267 


363 

364 

362 

365 

357 

369 

356 

370 

299 


272 

Unusual Coronary Pathology: Spasm, Spotaneous Dissection, and Others 

(10 faces) 429 - 438 

298 

300 

302 

305 

308 

309 





366 

368 

307 

310 

271 

273 

367 

Gender, Age, and Other 

Demographic Considerations 

(15 faces) 356 - 370 

301 

306 


270 

238 

239 

438 

429 

294 

295 

293 

296 

292 

297 

279 

311 

278 

312 

277 

313 

258 

259 

257 


256 


243 

274 

242 

275 

241 

276 

437 

430 

404 

403 

402 

401 

288 

283 

IMAGING 

(73 faces) 

241 - 313 

235 

236 

252 

247 

234 

237 

398 

397 

240 

218 219 

ENTRANCE 

Entrance 

410 

409 

421 

400 

282 

280 

246 

244 

233 

232 



436 

431 

290 

291 

289 

287 

284 

254 

255 

253 

251 

248 

413 

408 

405 

420 

399 

396 



424 

395 

281 

245 

231 


Physiologic Assessment 

(218 - 240) 23 faces 

435 

432 

411 

412 

414 

407 

406 

419 

394 

393 


423 

286 

285 

250 

249 

427 

392 

417 

418 

434 

433 

415 

416 


(37 faces) 392-428 



381 

382 

230 


425 


380 

379 

383 

384 

428 

378 

385 

Stent Fracture and 

Longitudinal Deformation 

483 

482 

484 

481 

(12 faces)534-545 

386 

377 

388 

389 

534 

535 

544 

537 

542 

539 

376 

387 


and Shock (21 faces) 

371-391 



569 

568 

372 

390 

391 

371 

536 

545 

538 

543 

540 

541 

567 

566 

719 718 717 716 

711 712 713 714 715 

Statins, Beta-blockers, and Other 

Pharmacologic Agents (9 faces) 

711-719 

479 

478 

480 

477 

570 

571 

572 

565 

440 

441 

455 

442 

474 

473 

475 

472 

476 

471 

439 

456 

462 

463 

454 

443 


(18 faces) 439-456 

375 

373 

374 

381 

382 

446 

447 

470 

485 

380 

379 

383 

384 

448 

449 

458 

459 

461 

533 

464 

530 

465 

529 

499 

500 

498 

501 

509 

508 

451 

450 

532 

531 

469 

486 

493 

502 

378 

385 

445 

452 

457 

460 

496 

495 

497 

494 

507 

506 

511 

512 

BVS and Bioabsorbable Polymers 

(22 Faces) 563 - 584 

444 

453 

468 

487 

492 

503 

466 

528 

467 

527 

488 

524 

489 

523 

490 


491 

521 

504 

518 

505 

517 

STEMI/NSTEMI 

77 faces (457-533) 

386 

377 

388 

389 

702 

701 

700 

699 

376 

387 


and Shock (21 faces) 

371-391 

576 

575 

574 

573 

564 

563 

577 

584 

583 

582 

372 

390 

391 

371 

578 

579 

580 

581 

703 

704 

510 

513 

705 

698 


525 

520 

519 

514 

516 

375 

373 

LM Stenting 

(18 faces) 

693-710 

374 

679 

688 

515 

563 

584 

689 

678 

779 

797 

581 

580 

709 

708 

697 

706 

682 

681 

677 

676 

780 

799 

798 

796 

781 

782 

783 

795 

556 

555 

594 

553 

550 562 

549 546 

548 

547 



(21 faces) 779-799 

784 

794 

559 

552 

557 

558 

551 

561 

560 

787 

786 

785 

793 

Bleeding, Thrombosis, Embolization, 

and Other Complications (17 faces) 

564 

583 

707 

696 

680 

687 

720 

693 

582 

579 

685 

686 

692 

675 

683 

684 


(18 faces) 675-692 Structural Non-Valvular, 

HOCM & Congenital Heart Disease 

(10 faces) 760-769 

690 

691 

632 

631 

628 

627 


621 

618 

617 

565 

578 

546-562 

575 

574 

566 

577 

BVS and Bioabsorbable Polymers 

(22 faces) 563-584 

600 

585 

694 

695 

637 

634 

641 

630 

645 


649 

624 

653 

620 

599 

586 

635 

636 

633 

640 

629 

644 

625 

648 

623 

652 

619 

616 

576 

573 

760 

658 

615 

571 

572 

598 

587 

736 

735 

763 

762 

638 

639 

642 

643 

646 

647 

650 

651 

654 

657 

567 

570 

761 

769 

739 

740 

788 

790 

791 

792 

655 

656 

659 

660 

611 

610 

607 

606 

603 

602 

568 

569 

767 

768 

597 

588 

Drug-Coated Balloon (16 faces) 585-600 

738 

737 

731 

734 

741 

733 

742 

732 

730 

764 

766 

789 

765 

770 

BMS and DES Studies 

(74 faces) 601-674 

728 

729 

594 

589 

743 

727 

754 

759 

773 

772 

662 

613 

666 

608 

670 

605 

674 

601 

596 

595 

746 

745 

614 

661 

612 

665 

608 

669 

604 

673 

Pulmonary Thromboembolism 

and Hypertension 

and Tricuspid Disease 

(6 faces) 754 - 759 

755 

758 

771 

778 

744 


Antithrombin and Antiplatelet Agents (34 faces) 

720-753 

776 

777 

663 

664 

667 

668 

671 

672 

593 

590 

774 

775 

756 

757 

PFO,ASD,and Congenital 

Heart Disease(9 faces) 770-778 

749 

725 

592 

591 

747 

748 

880 

823 

750 

724 


813 

723 


800 

911 

753 

721 

883 

812 

881 

882 

910 

909 

751 

752 

844 

843 

840 

831 

828 

827 

820 

819 

884 

811 

907 

908 

720 

842 

873 

830 

877 


825 

818 

817 

810 

809 

801 

906 

804 

803 

863 

872 

875 

876 

879 

824 

815 

816 

895 

808 

845 

862 

841 

874 

Aortic Valve Disease and TAVR 

(111 faces) 800-911 

829 

878 

821 

814 

885 

894 

802 

905 

852 

851 

836 

835 

864 

871 

888 

887 

903 

904 

850 

849 

834 

833 

870 

869 

886 

893 

805 

902 

896 

807 

855 

848 

839 

832 

867 

868 

891 

892 

853 

854 

837 

838 

865 

866 

889 

890 

806 

901 

856 

847 

899 

900 

846 

861 

897 

898 

859 

860 

857 

858 

Poste 

Struc 

Aorti 

Mitra 

PFO, 

Struc 

Pulm 

Coron 

Antith 

Statin 

LM St 

Bifurc 

BMS 

Drug- 

BVS a 

Bleed 

Stent 

STEM 

Chron 

Unus 

Vascu 

Heart 

Gend 

Diabe 

Cath 

Imag 

Imag 

Physi 

Endo 

Caroti 

Perip 

Rena 

Chron 

EVAR



cAtAgories # AbstrActs 

Coronary 

antithrombin and antiplatelet agents 720-753 

Statins, beta-blockers, and other Pharmacologic agents 711-719 

lm Stenting 693-710 

bifurcation Stenting 675-692 

bmS and DES Studies 601-674 

Drug-Coated balloon 585-600 

bVS and bioabsorbable Polymers 563-584 

bleeding, Thrombosis, Embolization, and other Complications 546-562 

Stent fracture and longitudinal Deformation 534-545 

STEmI/nSTEmI 457-533 

Chronic Total occlusions 439-456 

Unusual Coronary Pathology: Spasm, Spotaneous Dissection, and others 439-456 

Vascular access 392-428 

Heart failure, lV Dysfunction, and Shock 371-391 

Gender, age, and other Demographic Considerations 356-370 

Diabetic Patients 337-355 

Cath lab advances 314-336 

oTHEr 

Pulmonary Thromboembolism and Hypertension and Tricuspid Disease 754-759 

EnDoVaSCUlar 

Carotid and neurovascular Disease and Intervention 190-203 

Peripheral Vascular Disease and Intervention 151-189 

renal Denervation 204-217 

Chronic Kidney Disease and acute renal Insufficiency 133-150 

EVar and TEVar 115-132 

ImaGInG 

Imaging 241-313 

Physiologic assessment 218-240 

STrUCTUral 

aortic Valve Disease and TaVr 800-911 

mitral Valve Disease and Intervention 779-799 

Pfo, aSD, and Congenital Heart Disease 770-778 

Structural non-Valvular, HoCm, and Congenital Heart Disease 760-769 

trAnscAtheter 

cArdiovAsculAr 

therAPeutics 


SaTEllITE SymPoSIa - oCTobEr 23-26, 2012

184 

MiAMi beAch 

convention center 

Washington avenue 

coronary theater 

Convention Center Drive 

structural heart / 

endovascular theater 

Main Arena 

international 

Multiplex 

theater 1-2 

challenging case videos 

crF Partnership 

Pavilion booth 

hands on heart

crF skirball booth 

crF / ctc booth 

tct global educational 

Partnerships booth 


Washington avenue 

Presentation 

theater 1 

Convention Center Drive 


Presentation 

theater 2 

Presentation 

theater 3 

Physician training 

center 

3-d theater 

trAnscAtheter 

cArdiovAsculAr 

therAPeutics 


SaTEllITE SymPoSIa - oCTobEr 23-26, 2012

“ The people that constantly bitch about old age. 

Well, if you bitch about old age, what choice have you got? 

If you’re not old, you’re dead.” 

93-year-old Eugenie Kaye is quite a character. As a young woman, she was a member of the Czech national swim 

team and qualified for the 1936 Berlin Olympics with the fastest time–only to be barred from competing by the Nazis 

because her swim club was a Jewish organization. She escaped Czechoslovakia just before Hitler occupied her country. 

Sadly, her family was not so fortunate. They all perished in Auschwitz. 

Years later, Eugenie developed serious health problems due to her failing heart valve. She knew she wouldn’t 

survive open heart surgery. Fortunately, she was accepted into the PARTNER trial pioneered at NewYork-Presbyterian / 

Columbia University Medical Center, where over 500 TAVR procedures have been performed since the trial’s inception– 

the most in America. 

Eugenie is living a full and active life once again. She says, “I thank God for NewYork-Presbyterian Hospital and 

the surgeon’s golden hands. Here I am in full bloom!” 

We are proud to be part of the TCT conference and look forward to our continued collaboration to advance the field 

of cardiovascular medicine and improve care for patients everywhere. 

Visit NewYork-Presbyterian’s booth outside the main arena.

Embolic Protection Coronary Stent 

THE ONLY EMBOLIC 

PROTECTION STENT 

for AMI PATIENTS 

MicroNet Mesh-Based Stent Designed to: 

� Trap Thrombus 

� Seal Ruptured Plague 

� Prevent Distal Embolization 

� Optimize Reflow 

Join the InspireMD Evening Symposium: 

October 24th, 6:30PM, Ritz Carlton Hotel, Salon 1&2 

MGuard Embolic Protection Stent: 

A New Era in STEMI Treatment 

Chairman: Gregg W. Stone 

> Visit us at Booth #867 

Not available for sale in the USA 

MAL-046-12-01 | berlinerdesign

Evolutionary Change. 

Revolutionary Device. 

Visit Gore at 

Booth 362 

Introducing the newest evolution of the GORE ® VIABAHN ® Endoprosthesis 

with Heparin Bioactive Surface 

Now with an even lower delivery profile, GORE ® VIABAHN ® Device offers more options for endoluminal bypass. 

�� 6 Fr delivery profile for 5 and 6 mm, 7 Fr delivery profile for 7 and 8 mm devices 

�� 0.018" / 0.014" guidewire compatibility 

�� Intended to provide thromboresistant surface 

�� 120 cm catheter length 

INTENDED USE / INDICATIONS The GORE ® VIABAHN ® Endoprosthesis is indicated for improving blood flow in patients with symptomatic 

peripheral arterial disease in superficial femoral artery lesions with reference vessel diameters ranging from 4.0 – 7.5 mm. The GORE ® 

VIABAHN ® Endoprosthesis is indicated for improving blood flow in patients with symptomatic peripheral arterial disease in iliac artery 

lesions with reference vessel diameters ranging from 4.0 – 12 mm. CONTRAINDICATIONS The GORE ® VIABAHN ® Endoprosthesis is 

contraindicated for non-compliant lesions where full expansion of an angioplasty balloon catheter was not achieved during predilatation, 

or where lesions cannot be dilated sufficiently to allow passage of the delivery system. Do not use the GORE ® VIABAHN ® 

Endoprosthesis with Heparin Bioactive Surface in patients with known hypersensitivity to heparin, including those patients who have 

had a previous incidence of Heparin-Induced Thrombocytopenia (HIT) type II. Refer to Instructions for Use at goremedical.com for a 

complete description of all warnings, precautions and adverse events. 

�� 

Products listed may not be available in all markets. 

GORE ® , PERFORMANCE BY DESIGN, VIABAHN ® , and designs are trademarks of W. L. Gore & Associates. 

© 2012 W. L. Gore & Associates, Inc. AR0374-EN1 JULY 2012 

Available in 

6 Fr 

PERFORMANCE 

by design

La Innovación Importa 

Technologies that transform. 

Products that perform. 

© 2012 Boston Scientific Corporation or its affiliates. All rights reserved. IC-106103-AA AUG2012 

TAVR 

LAA Closure 

Coronary Stents 


Imaging & Specialty

The XIENCE V ® , XIENCE 

nano, XIENCE PRIME and 

XIENCE PRIME LL (XIENCE 

Family) of Everolimus Eluting 

Coronary Stents on the MULTI- 

LINK VISION ® or MULTI-LINK 

MINI VISION ® Delivery Systems 

INDICATIONS 

The XIENCE Family of Everolimus Eluting Coronary 

Stent Systems are indicated for improving coronary 

luminal diameter in patients with symptomatic 

heart disease due to de novo native coronary 

artery lesions (XIENCE V and XIENCE nano 

length ≤ 28 mm and XIENCE PRIME and XIENCE 

PRIME LL length ≤ 32 mm) with reference 

vessel diameters of 2.25 mm to 4.25 mm. 

CONTRAINDICATIONS 

The XIENCE Family of stents is contraindicated for 

use in patients: 

�� 

coagulant therapy 

�� 

balloon inflation or proper placement of the 

stent or stent delivery system 

�� 

everolimus or structurally-related compounds, 

cobalt, chromium, nickel, tungsten, acrylic and/ 

or fluoropolymers. 

WARNINGS 

�� 

not been opened or damaged prior to use. 

�� 

because device use has been associated with 

stent thrombosis, vascular complications and/ 

or bleeding events. 

�� 

who are not likely to comply with the 

recommended antiplatelet therapy. 

PRECAUTIONS 

�� 

by physicians who have received appropriate 

training. 

�� 

hospitals where emergency coronary artery 

bypass graft surgery is accessible. 

�� 

dilatation of the arterial segment containing the 

stent. Long-term outcomes following repeat 

dilatation of the stent are presently unknown. 

�� 

patients with severe contrast agent allergies. 

�� 

catheter tip during stent delivery, deployment 

and balloon withdrawal. Before withdrawing the 

�� 

balloon deflation by fluoroscopy to avoid 

guiding catheter movement into the vessel and 

�� 

�� 

�� 

infarction (MI) or death. 

�� 

Indications for Use, patient outcomes may differ 

from the results observed in the SPIRIT family of 

trials. 

�� 

�� 

and lesions outside of the labeled indications 

XIENCE V, XIENCE nano, XIENCE PRIME, XIENCE PRIME LL, MULTI-LINK VISION 

and MULTI-LINK MINI VISION are trademarks of the Abbott Group of Companies. 

©2012 Abbott. All rights reserved. AP2934466-US Rev. B 08/12 

may have an increased risk of adverse events, 

including stent thrombosis, stent embolization, 

MI or death. 

�� 

cyclosporine is associated with increased 

serum cholesterol and triglycerides levels. 

�� 

proportional to the number and total length of 

implanted stents. See Instructions for Use for 

current data on multiple stent implantation. 

�� 

of stents have not been established for subject 

populations with the following clinical settings: 

Patients with prior target lesion or in-stent 

restenosis related brachytherapy, patients in 

whom mechanical atherectomy devices or laser 

angioplasty devices are used simultaneously, 

women who are pregnant or lactating, men 

intending to father children, pediatric patients, 

unresolved vessel thrombus at the lesion site, 

coronary artery reference vessel diameters < 

2.25 mm or > 4.25 mm or lesion length > 32 

mm, lesions located in saphenous vein grafts, 

unprotected left main coronary artery, ostial 

lesions, chronic total occlusions, lesions located 

at a bifurcation or previously stented lesions, 

diffuse disease or poor flow (TIMI < 1) distal 

�� 

�� 

myocardial infarction (AMI) or evidence of 

thrombus in target vessel, moderate or severe 

�� 

stent restenosis. 

�� 

clearance of some prescription medications 

when it was administered orally along with 

cyclosporine (CsA). Formal drug interaction 

studies have not been performed with the 

XIENCE Family of stents because of limited 

�� 

the stent. 

�� 

Consideration should be given to patients 

taking other immunosuppressive agents or who 

are at risk for immune suppression. 

�� 

patients and advanced renal cell carcinoma 

patients was associated with increased serum 

cholesterol and triglycerides, which in some 

�� 

�� 

the XIENCE Family of stents, in single and in 

�� 

length for XIENCE V and XIENCE nano and 

up to 71 mm in length for XIENCE PRIME and 

XIENCE PRIME LL, are MR Conditional. They 

can be scanned safely under the conditions in 

the Instructions for Use. 

�� 

handled, placed, implanted and removed 

according to the Instructions for Use. 

POTENTIAL ADVERSE EVENTS 

Adverse events (in alphabetical order) which may 

be associated with coronary stent use in native 

coronary arteries include but are not limited to: 

�� 

or hemorrhage, Acute myocardial infarction, 

Allergic reaction or hypersensitivity to 

contrast agent or cobalt, chromium, nickel, 

tungsten, acrylic and fluoropolymers; and 

drug reactions to antiplatelet drugs or contrast 

agent, Aneurysm, Arterial perforation and 

injury to the coronary artery, Arterial rupture, 

�� 

ventricular, Bleeding complications, which 

�� 

Coronary artery spasm, Coronary or stent 

embolism, Coronary or stent thrombosis, 

�� 

emboli (air, tissue or thrombotic), Emergent 

or non-emergent coronary artery bypass 

graft surgery, Fever, Hypotension and/or 

hypertension, Infection and pain at insertion 

site, Injury to the coronary artery, Ischemia 

(myocardial), Myocardial infarction (MI), Nausea 

and vomiting, Palpitations, Peripheral ischemia 

(due to vascular injury), Pseudoaneurysm, Renal 

Failure, Restenosis of the stented segment of 

the artery, Shock/pulmonary edema, Stroke/ 

cerebrovascular accident (CVA), Total occlusion 

of coronary artery, Unstable or stable angina 

pectoris, Vascular complications including at 

�� 

Vessel dissection. 

Adverse events associated with daily oral 

administration of everolimus to organ transplant 

patients include but are not limited to: 

�� 

�� 

�� 

�� 

�� 

�� 

�� 

�� 

Hematuria; Hyperglycemia (may include 

new onset of diabetes); Hyperlipidemia; 

Hyperkalemia; Hypertension; Hypokalemia; 

Hypomagnesemia; Hypophosphatemia; 

Increased serum creatinine; Infections and 

serious infections: bacterial, viral, fungal, 

and protozoal infections (may include herpes 

virus infection, polyoma virus infection which 

may be associated with BK virus associated 

nephropathy, and/or other opportunistic 

infections); Insomnia; Interaction with strong 

inhibitors and inducers of CY3PA4; Leukopenia; 

Lymphoma and other malignancies (including 

skin cancer); Male infertility (azospermia 

and/or oligospermia); Mucosal inflammation 

(including oral ulceration and oral mucositis); 

Nausea; Neutropenia; Non-infectious 

�� 

procedural, and back; Proteinuria; Pruritus; 

�� 

Thrombotic microangiopathy (TMA)/Thrombotic 

thrombocytopenic purpura (TTP)/Hemolytic 

uremic syndrome (HUS); Tremor; Urinary tract 

infection; Upper respiratory tract infection; 

Vomiting. 

�� 

contact with those that have had live vaccines 

should be avoided. Fetal harm can occur when 

administered to a pregnant woman. There 

may be other potential adverse events that are 

unforeseen at this time. 

Prior to use, please reference the Instructions for 

Use at www.AbbottVascular.com/ifu for more 

information on indications, contraindications, 

warnings, precautions and adverse events.

192 


program

October 22-26, 2012 - TCT Conference

Create successful ePaper yourself

Delete template?

Save as template?